{"meta":{"query_hash":"eac09bd1f6b0","filters":{"venue":"Multiple Sclerosis and Related Disorders"},"cohort_total":487,"direct_labels_cover":4,"predictions_cover":487,"exported":487,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/eac09bd1f6b0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+and+Related+Disorders"},"results":[{"id":"W1535513754","doi":"10.1016/j.msard.2015.05.008","title":"Clinical decision-making in multiple sclerosis: Challenges reported internationally with emerging treatment complexity","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axdev Group (Canada)","funders":"","keywords":"Medicine; Psychological intervention; Health care; Alternative medicine; Family medicine; Adverse effect; Nursing","score_opus":0.22303808730265753,"score_gpt":0.3674495509594118,"score_spread":0.14441146365675425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535513754","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11715143,0.059528105,0.008889015,0.77951604,0.004793184,0.00046931987,0.00035913085,0.000053023432,0.029240755],"genre_scores_gemma":[0.8709132,0.037081253,0.024379805,0.058782615,0.0062102573,0.00051461475,0.0004285096,0.000127565,0.0015622297],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.75378007,0.19040938,0.023350146,0.006942762,0.020026501,0.005491182],"domain_scores_gemma":[0.35396707,0.48370403,0.04060334,0.014795096,0.085464336,0.021466158],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2880557,0.00050685764,0.0019022278,0.00636897,0.0062377527,0.02240045,0.0063367416,0.0048533003,0.007817593],"category_scores_gemma":[0.50302553,0.00076103746,0.0013726426,0.008478502,0.01159986,0.013622399,0.017102398,0.012537556,0.00066105707],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010247078,0.0008585695,0.07880177,0.006781042,0.0013942065,0.001165844,0.10110149,0.003659387,0.00049473764,0.067656204,0.08408515,0.65297693],"study_design_scores_gemma":[0.0009285852,0.0010600328,0.08268649,0.054147027,0.00094001647,0.00227789,0.30104148,0.008269569,0.0011658297,0.25097603,0.29549974,0.0010073341],"about_ca_topic_score_codex":0.023580117,"about_ca_topic_score_gemma":0.042670343,"teacher_disagreement_score":0.2880557,"about_ca_system_score_codex":0.013521472,"about_ca_system_score_gemma":0.057753228,"threshold_uncertainty_score":0.87795407},"labels":[],"label_agreement":null},{"id":"W1551155942","doi":"10.1016/j.msard.2015.05.009","title":"Neurologists׳ accuracy in predicting cognitive impairment in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Cognitive impairment; Cognition; Physical medicine and rehabilitation; Psychiatry","score_opus":0.08852712692423444,"score_gpt":0.2958466182721283,"score_spread":0.2073194913478939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1551155942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850965,0.006413263,0.00017226569,0.0011029432,0.00023550936,0.00001959381,0.0009831438,0.000028394104,0.0059484453],"genre_scores_gemma":[0.99777955,0.0008152547,0.00014580513,0.00014385626,0.00011375464,0.0000052459845,0.00050330337,0.0000026092887,0.0004906001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996994,0.0012344156,0.0005197175,0.00038337466,0.000607875,0.00026056415],"domain_scores_gemma":[0.9839453,0.009078348,0.0029485885,0.00072275224,0.0025448014,0.00076013996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057902136,0.00044994015,0.00067440356,0.002140844,0.00062913884,0.0015943358,0.00067033264,0.0014144941,0.0015620266],"category_scores_gemma":[0.027179582,0.00043947305,0.0010684865,0.0011347828,0.0004070472,0.0015714737,0.0007046712,0.00084879907,0.000659835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035658077,0.00005482505,0.9936354,0.000051882318,0.00036875714,0.000050648818,0.000119523116,0.0001690345,0.00004596453,0.000020157355,0.00063407345,0.004493052],"study_design_scores_gemma":[0.000063973275,0.00016262189,0.99640286,0.000083354884,0.000548348,0.00033893296,0.00033991752,0.001156739,0.00012337689,0.00010566207,0.000657575,0.000016560245],"about_ca_topic_score_codex":0.01755534,"about_ca_topic_score_gemma":0.02363287,"teacher_disagreement_score":0.01755534,"about_ca_system_score_codex":0.00054245215,"about_ca_system_score_gemma":0.0007069437,"threshold_uncertainty_score":0.034906268},"labels":[],"label_agreement":null},{"id":"W1676731399","doi":"10.1016/j.msard.2015.09.002","title":"Relapses in multiple sclerosis: Relationship to disability","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Biogen; GlaxoSmithKline; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Clinical trial; Intensive care medicine; Pediatrics; Physical disability; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Psychiatry","score_opus":0.18619970594508337,"score_gpt":0.35030000335067557,"score_spread":0.1641002974055922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1676731399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089945344,0.9997223,0.000011800388,0.000061716746,0.00003819958,0.0000029988244,0.000015445674,0.0000010125777,0.000056679313],"genre_scores_gemma":[0.0012470274,0.9984421,0.00007095201,0.00011823966,0.000060217688,0.0000049838136,0.000016716378,4.2782375e-7,0.00003936917],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987,0.00034480076,0.00043802796,0.00017690487,0.00028812728,0.0000521796],"domain_scores_gemma":[0.9950299,0.0033574377,0.0011741531,0.000045348195,0.00029617955,0.000096845826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023531334,0.001131751,0.0044906544,0.0062088636,0.0002752025,0.0019141427,0.0011188185,0.0017159807,0.004012534],"category_scores_gemma":[0.006658575,0.00058370834,0.0021549114,0.00666523,0.00078804285,0.001729835,0.0012093794,0.0017127498,0.00033176568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039569568,0.000111789836,0.0020334644,0.42944786,0.0051663374,0.00023852603,0.00029440032,0.0003515891,0.00035875375,0.0012197901,0.010584862,0.54979706],"study_design_scores_gemma":[0.00069874397,0.00068770035,0.027059747,0.5499015,0.0473016,0.003638698,0.0013943827,0.00043287923,0.0004482345,0.0033710208,0.36484382,0.0002217925],"about_ca_topic_score_codex":0.0035960758,"about_ca_topic_score_gemma":0.010437927,"teacher_disagreement_score":0.0062088636,"about_ca_system_score_codex":0.0010291811,"about_ca_system_score_gemma":0.002392975,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"grok","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W1740897416","doi":"10.1016/j.msard.2015.07.013","title":"Neuro-oncology dilemma: Tumour or tumefactive demyelinating lesion","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Demyelinating disease; Differential diagnosis; Dilemma; Multiple sclerosis; Reading (process); Demyelinating Disorder; Intervention (counseling); Intensive care medicine; Disease; Pathology; Psychiatry","score_opus":0.15526152833495424,"score_gpt":0.37498763200266777,"score_spread":0.21972610366771353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740897416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053896325,0.9980927,0.00004789302,0.00092955696,0.00040987326,0.0000028957793,0.000010202634,0.0000027395517,0.00045018434],"genre_scores_gemma":[0.0013596563,0.99457425,0.00023408016,0.002530712,0.0008914416,0.0000054646616,0.000024401459,0.0000014333548,0.00037857913],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9993043,0.00017935998,0.00020642417,0.000097085955,0.00017129003,0.00004149605],"domain_scores_gemma":[0.9983292,0.0011376175,0.00026674077,0.00002609214,0.00017862757,0.00006174528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011425775,0.00076213846,0.0025058505,0.0037906219,0.00049432396,0.001963238,0.0009879171,0.003146151,0.0036043325],"category_scores_gemma":[0.0037650415,0.00032166246,0.0007879963,0.0030150886,0.0014894769,0.003032681,0.0010818333,0.0026111123,0.00095842965],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016841915,0.000060517323,0.0007269267,0.10089411,0.0005432387,0.003532719,0.000267387,0.0002707154,0.0010056023,0.008697557,0.10277907,0.7810536],"study_design_scores_gemma":[0.00008793517,0.000070925715,0.0013530311,0.06346291,0.0010095093,0.01721064,0.0006726187,0.00012587209,0.0002505229,0.0058369646,0.90985537,0.00006368815],"about_ca_topic_score_codex":0.0016948469,"about_ca_topic_score_gemma":0.0045521515,"teacher_disagreement_score":0.0037906219,"about_ca_system_score_codex":0.00096875837,"about_ca_system_score_gemma":0.0025478702,"threshold_uncertainty_score":0.012057662},"labels":[],"label_agreement":null},{"id":"W1963477604","doi":"10.1016/j.msard.2015.07.014","title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; McGill University; University of British Columbia; Dalhousie University; St. Francis Xavier University; University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Health Research Foundation","keywords":"Medicine; Multiple sclerosis; Comorbidity; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.15926200120024797,"score_gpt":0.2815926175422206,"score_spread":0.12233061634197262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963477604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992121,0.006424267,0.00007814496,0.00015467628,0.000025747486,0.000008051325,0.00023286785,0.000002151848,0.000953062],"genre_scores_gemma":[0.99862206,0.0009989843,0.00007596781,0.000029702589,0.000025782443,0.0000048975326,0.00015451034,8.676706e-7,0.000087145876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975751,0.0010314409,0.0005700978,0.00024374842,0.00033284098,0.00024680633],"domain_scores_gemma":[0.99135405,0.0020294706,0.004945803,0.00038902066,0.0005494094,0.0007322236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013847663,0.00031644263,0.0007114354,0.0015128965,0.00088981877,0.0013992712,0.00038696118,0.0007195614,0.0024696449],"category_scores_gemma":[0.012091338,0.00030490354,0.0013496727,0.003156694,0.00034402046,0.0005894253,0.0011360159,0.0007890554,0.00012601797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013144872,0.000033800316,0.9973131,0.00006417036,0.00045149337,0.00006441028,0.00007543226,0.000018392655,0.00010450772,0.000020417478,0.00004439803,0.0016785528],"study_design_scores_gemma":[0.0000035966639,0.0000333863,0.99941707,0.000029609835,0.00012180448,0.00013418005,0.000120913304,0.000038894865,0.000012496136,0.000020009487,0.00006532351,0.000002755857],"about_ca_topic_score_codex":0.01073253,"about_ca_topic_score_gemma":0.016452087,"teacher_disagreement_score":0.01073253,"about_ca_system_score_codex":0.00042115594,"about_ca_system_score_gemma":0.00067075976,"threshold_uncertainty_score":0.021340132},"labels":[],"label_agreement":null},{"id":"W1964237140","doi":"10.1016/j.msard.2012.08.004","title":"Substantial burden of dizziness in multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Interquartile range; Confidence interval; Odds ratio; Quality of life (healthcare); Physical therapy; Multiple sclerosis; Internal medicine; Psychiatry","score_opus":0.04611344163085638,"score_gpt":0.22958104881448974,"score_spread":0.18346760718363336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964237140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794462,0.014486121,0.00029463085,0.0010101111,0.0000542235,0.00000902292,0.0009376891,0.000021100188,0.0037409987],"genre_scores_gemma":[0.9941679,0.004443828,0.00015593955,0.000080038415,0.00013828899,0.000002995674,0.0005420075,0.0000031728982,0.00046581822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977225,0.000065337445,0.000028430095,0.000040602386,0.00006295906,0.000030428926],"domain_scores_gemma":[0.99924743,0.00016197171,0.00029791926,0.000052719333,0.00011678662,0.00012320606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025536187,0.00021657627,0.0004061092,0.0007881461,0.00037822194,0.0005929407,0.00020662452,0.00030824903,0.003146127],"category_scores_gemma":[0.0016157835,0.00013582416,0.00021411282,0.0013523322,0.00023359332,0.00039500959,0.00048495375,0.00031695713,0.0003875147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014647386,0.0000744477,0.9018738,0.00032407593,0.00033701406,0.0035041983,0.00028063197,0.00019539545,0.00977235,0.00026519323,0.002162114,0.07974615],"study_design_scores_gemma":[0.0000059826925,0.000041434443,0.9977235,0.00001482371,0.00003274797,0.0013359502,0.00009730583,0.000045584624,0.00005848344,0.00008590502,0.0005552711,0.000003035512],"about_ca_topic_score_codex":0.0050936504,"about_ca_topic_score_gemma":0.008102977,"teacher_disagreement_score":0.0050936504,"about_ca_system_score_codex":0.0002932646,"about_ca_system_score_gemma":0.00045145646,"threshold_uncertainty_score":0.010524869},"labels":[],"label_agreement":null},{"id":"W1966050297","doi":"10.1016/j.msard.2015.02.002","title":"Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Dysautonomia; Medicine; Multiple sclerosis; Meta-analysis; Internal medicine; Cardiology; Physical therapy; Disease; Immunology","score_opus":0.18933934262164684,"score_gpt":0.31559233959242977,"score_spread":0.12625299697078293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966050297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005566474,0.9935226,0.00034975307,0.0000737459,0.000113700604,0.000042518954,0.00018401441,0.000011839979,0.0001353739],"genre_scores_gemma":[0.14939396,0.847213,0.0015458614,0.00059210084,0.0002884797,0.0001526709,0.00047407587,0.000017798913,0.00032201406],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99743974,0.0008882022,0.00081837905,0.0004348644,0.00028951935,0.00012924802],"domain_scores_gemma":[0.99537057,0.00331505,0.0006825027,0.00020590103,0.00033222578,0.00009376223],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0050014467,0.002517623,0.010923548,0.002614205,0.0004875403,0.0019772141,0.0015545595,0.0016697804,0.0035475502],"category_scores_gemma":[0.008607455,0.001321644,0.020184778,0.003938689,0.00041788645,0.0014333308,0.0014909302,0.001710366,0.0002845258],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031772158,0.000057788493,0.010318412,0.18168497,0.7783728,0.00026832137,0.000102280625,0.0004759068,0.0005698485,0.00013157562,0.0008127066,0.024028031],"study_design_scores_gemma":[0.00058808585,0.00016053411,0.008414303,0.006841233,0.9818844,0.0001297012,0.000056193065,0.00011075696,0.00009351868,0.0001956354,0.0014945563,0.00003108859],"about_ca_topic_score_codex":0.0034612748,"about_ca_topic_score_gemma":0.010588543,"teacher_disagreement_score":0.98907644,"about_ca_system_score_codex":0.00084230676,"about_ca_system_score_gemma":0.0012554007,"threshold_uncertainty_score":0.026450455},"labels":[],"label_agreement":null},{"id":"W1971770137","doi":"10.1016/j.msard.2015.02.005","title":"Achieving patient engagement in multiple sclerosis: A perspective from the multiple sclerosis in the 21st Century Steering Group","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Centre Hospitalier de l’Université de Montréal","funders":"EMD Serono; Multiple Sclerosis Society; Teva Pharmaceutical Industries; Sanofi","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology; Artificial intelligence","score_opus":0.2841576429537343,"score_gpt":0.3570499051392593,"score_spread":0.07289226218552503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971770137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020431833,0.98918915,0.00007448668,0.009389667,0.00036767605,0.000014208983,0.000011461902,0.000002880026,0.0007463],"genre_scores_gemma":[0.0048418143,0.9899143,0.00038099606,0.0042019747,0.00029086816,0.000049606304,0.000022178987,0.000002564113,0.0002956547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99556077,0.0025364046,0.00049404224,0.00021127614,0.0007581331,0.000439313],"domain_scores_gemma":[0.98454267,0.011478541,0.000858542,0.00012940259,0.0018242468,0.001166542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014340932,0.0007479809,0.00202209,0.0022581944,0.0009988762,0.0037600494,0.0015910426,0.004333415,0.0027808482],"category_scores_gemma":[0.015195833,0.00029203529,0.0014622672,0.0032235093,0.0012139914,0.0030643956,0.003561436,0.006311666,0.00049295963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013764414,0.00018486942,0.0007213537,0.054367535,0.0003571433,0.00014650759,0.0014629356,0.0002809703,0.00019998534,0.013113733,0.04098642,0.88804096],"study_design_scores_gemma":[0.00012317383,0.00024933918,0.0024432433,0.14095333,0.0004975171,0.0005062916,0.002300329,0.00012552994,0.0002164774,0.006391412,0.8461346,0.000058721074],"about_ca_topic_score_codex":0.005209566,"about_ca_topic_score_gemma":0.015359304,"teacher_disagreement_score":0.014340932,"about_ca_system_score_codex":0.0033832109,"about_ca_system_score_gemma":0.016010603,"threshold_uncertainty_score":0.075843036},"labels":[],"label_agreement":null},{"id":"W1976230349","doi":"10.1016/j.msard.2013.12.007","title":"Thrombotic microangiopathy in Interferon Beta treated multiple sclerosis patients: Review of literature and report of two new cases","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Medicine; Thrombotic microangiopathy; Multiple sclerosis; Interferon beta; Microangiopathy; Adverse effect; Disease; Interferon beta-1a; Intensive care medicine; BETA (programming language); Internal medicine; Dermatology; Immunology; Diabetes mellitus","score_opus":0.03895654620137163,"score_gpt":0.27182653165383974,"score_spread":0.23286998545246812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976230349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004263236,0.99391913,0.00021629457,0.00027636468,0.00011799703,0.000010328514,0.000032792166,0.000010344593,0.0011535342],"genre_scores_gemma":[0.022678649,0.9751702,0.00056574174,0.00048743136,0.0004697718,0.000010991744,0.00008968056,0.0000033811698,0.00052407035],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997199,0.000041272117,0.000093933784,0.00005117095,0.000061582956,0.000032067986],"domain_scores_gemma":[0.9994586,0.00026862283,0.00015302736,0.000017982473,0.000059594506,0.000042184583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031547478,0.0007967342,0.0014328293,0.003235828,0.00040685863,0.0013160143,0.0010073594,0.0016515754,0.0011298411],"category_scores_gemma":[0.0009812382,0.0002861226,0.0005385228,0.002570346,0.00062206003,0.0013373545,0.00057443045,0.00092944206,0.0004660208],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024098887,0.00019060317,0.01178505,0.027347976,0.00043606784,0.21793438,0.00097176514,0.00047270054,0.0063135144,0.0014756137,0.021292979,0.7115383],"study_design_scores_gemma":[0.00004990525,0.00016851007,0.0138142025,0.006348036,0.00074424373,0.78745127,0.0008459182,0.00021404527,0.0015387527,0.001328286,0.18741065,0.000086226486],"about_ca_topic_score_codex":0.0008121236,"about_ca_topic_score_gemma":0.0013312477,"teacher_disagreement_score":0.003235828,"about_ca_system_score_codex":0.0003364437,"about_ca_system_score_gemma":0.0006972333,"threshold_uncertainty_score":0.0037796497},"labels":[],"label_agreement":null},{"id":"W2001146581","doi":"10.1016/j.msard.2013.11.005","title":"Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Tolerability; Adverse effect; Clinical trial; Disease; Interferon; Intensive care medicine; Depression (economics); Internal medicine; Immunology","score_opus":0.09804602375119577,"score_gpt":0.31789769229828535,"score_spread":0.2198516685470896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001146581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035329643,0.9994804,0.000020842966,0.00002910518,0.000016224285,0.000003579293,0.000012794505,8.789816e-7,0.00008284544],"genre_scores_gemma":[0.0034419,0.9962604,0.00008425794,0.00007282597,0.000030339657,0.000006166386,0.00002527813,4.9826804e-7,0.000078374076],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99955803,0.00011650317,0.00012899698,0.00005202112,0.00012370231,0.00002067758],"domain_scores_gemma":[0.99904686,0.00063434115,0.00020344024,0.000012814679,0.0000812884,0.000021201546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015130802,0.0006127856,0.002689855,0.0012980384,0.00013437631,0.00065623614,0.00088619365,0.0007266094,0.0018607979],"category_scores_gemma":[0.0018309897,0.00023686844,0.0013762481,0.0016596493,0.00031015894,0.0005789828,0.00035400141,0.00078576704,0.00024603057],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011610958,0.00010216829,0.000700408,0.14459434,0.0025152268,0.00019708258,0.00009402746,0.0002792211,0.001744359,0.00042247825,0.0044689714,0.8437206],"study_design_scores_gemma":[0.0034172256,0.004356967,0.036692146,0.19174764,0.053361528,0.00781454,0.0008614101,0.00076497643,0.0061007096,0.0033211396,0.69132245,0.00023927771],"about_ca_topic_score_codex":0.0013105707,"about_ca_topic_score_gemma":0.0026688462,"teacher_disagreement_score":0.002689855,"about_ca_system_score_codex":0.00046873247,"about_ca_system_score_gemma":0.0008053938,"threshold_uncertainty_score":0.008002043},"labels":[],"label_agreement":null},{"id":"W2002339381","doi":"10.1016/j.msard.2012.07.004","title":"Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Medicine; Multiple sclerosis; Primary biliary cirrhosis; Autoimmune hepatitis; Interferon; Cirrhosis; Interferon beta; Autoimmune disease; Immunology; Liver disease; Hepatitis; Disease; Gastroenterology; Internal medicine","score_opus":0.018338449541394183,"score_gpt":0.2002302896517374,"score_spread":0.1818918401103432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002339381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97490036,0.0026076215,0.00060691574,0.0065742508,0.00038692867,0.00011908648,0.00029188005,0.00012021958,0.014392854],"genre_scores_gemma":[0.99575293,0.00066702184,0.00036444992,0.0011594446,0.0011173267,0.00001433998,0.000117013675,0.000023610814,0.00078378356],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99907076,0.00013041028,0.00019436097,0.00018424116,0.00012087083,0.00029925318],"domain_scores_gemma":[0.9969844,0.0010958478,0.0003701304,0.00017926251,0.00018721785,0.0011831382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056043,0.0025226322,0.0017315296,0.004534801,0.00429397,0.0016536673,0.0018907532,0.0076561016,0.006281729],"category_scores_gemma":[0.005552692,0.0014704767,0.0019957817,0.002319356,0.00215951,0.002542153,0.001562121,0.0041450565,0.0014920599],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024812095,0.00007409237,0.02209144,0.000024856656,0.000015996327,0.9761111,0.00012703477,0.00003700266,0.0004152883,0.000059691454,0.00025399576,0.0005413137],"study_design_scores_gemma":[0.000050965304,0.00020821772,0.029236624,0.000025795489,0.000060223167,0.9688429,0.0002927382,0.00032540783,0.0003926512,0.00017752625,0.00035977206,0.00002713164],"about_ca_topic_score_codex":0.0039553563,"about_ca_topic_score_gemma":0.003679236,"teacher_disagreement_score":0.0076561016,"about_ca_system_score_codex":0.0017446614,"about_ca_system_score_gemma":0.0014030922,"threshold_uncertainty_score":0.021014512},"labels":[],"label_agreement":null},{"id":"W2005104380","doi":"10.1016/j.msard.2014.05.005","title":"First-dose effects of fingolimod: Pooled safety data from three phase 3 studies","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; National Research Foundation; Novartis","keywords":"Fingolimod; Medicine; Bradycardia; Cardiology; Heart rate; Internal medicine; Electrocardiography; Atrioventricular block; Anesthesia; Disopyramide; Multiple sclerosis; Blood pressure","score_opus":0.02777977866621691,"score_gpt":0.257610424226585,"score_spread":0.22983064556036806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005104380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7986938,0.16964701,0.00905196,0.00081005396,0.00050417526,0.0026239117,0.010467283,0.0007434345,0.0074584545],"genre_scores_gemma":[0.9716115,0.016594253,0.0020205313,0.0009453366,0.00035807793,0.00083560747,0.0063774,0.00012508545,0.0011321894],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99663085,0.0015591249,0.00043634282,0.00052573544,0.00055400614,0.00029392925],"domain_scores_gemma":[0.9934783,0.0026555369,0.0020618099,0.0009091146,0.00052139536,0.00037391132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009010822,0.0019647279,0.005833055,0.0011928406,0.00047605598,0.0022373155,0.0009502786,0.0015272778,0.0026304878],"category_scores_gemma":[0.008257388,0.00067876786,0.00997171,0.0012802186,0.0006136672,0.0014113823,0.0006692899,0.0022356098,0.0005064341],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59733164,0.0019203508,0.025630293,0.008944248,0.17747974,0.00036046986,0.00025121463,0.0057107084,0.017933343,0.00029099802,0.005379474,0.15876748],"study_design_scores_gemma":[0.28703997,0.111821055,0.24294963,0.0012716545,0.31911123,0.0018906458,0.00026046994,0.0031701005,0.013896226,0.0023728197,0.015907302,0.0003089216],"about_ca_topic_score_codex":0.0007140161,"about_ca_topic_score_gemma":0.0013812792,"teacher_disagreement_score":0.009010822,"about_ca_system_score_codex":0.0011618441,"about_ca_system_score_gemma":0.001181413,"threshold_uncertainty_score":0.04765433},"labels":[],"label_agreement":null},{"id":"W2006831887","doi":"10.1016/j.msard.2014.09.211","title":"Health-related quality of life in patients with longstanding ‘benign multiple sclerosis’","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Multiple sclerosis; Quality of life (healthcare); Dermatology; Intensive care medicine; Immunology","score_opus":0.057166858253274076,"score_gpt":0.2762775956961433,"score_spread":0.2191107374428692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006831887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983347,0.00083986216,0.00001263637,0.00013296682,0.000011721234,0.0000029356647,0.00013334015,7.3220684e-7,0.0005311662],"genre_scores_gemma":[0.9995865,0.00013440901,0.000012270446,0.00004351467,0.000012195386,0.0000023561795,0.00013956228,3.032499e-7,0.00006901912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999537,0.00018967314,0.00006879241,0.00005983758,0.00005304856,0.00009170997],"domain_scores_gemma":[0.9987589,0.00029060506,0.00050709397,0.00005316056,0.00013971695,0.00025058124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054808444,0.0001967497,0.0003817402,0.00067580485,0.00056037126,0.0006348354,0.00019960424,0.00051616353,0.001558758],"category_scores_gemma":[0.0032277575,0.0001440611,0.00047022605,0.0010288963,0.0004543027,0.00068213843,0.00056304684,0.000609999,0.00015574248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007597234,0.0001724767,0.9939062,0.000067894696,0.00022957966,0.00021852371,0.000624064,0.000031454467,0.0003033103,0.0000516294,0.0001884547,0.0034466127],"study_design_scores_gemma":[0.000020090503,0.0003071236,0.99854726,0.000010287907,0.000050768638,0.0002682666,0.000495089,0.000030267529,0.000033052424,0.00003401496,0.00019791095,0.0000058561286],"about_ca_topic_score_codex":0.005851103,"about_ca_topic_score_gemma":0.005501789,"teacher_disagreement_score":0.005851103,"about_ca_system_score_codex":0.00038544726,"about_ca_system_score_gemma":0.00029363195,"threshold_uncertainty_score":0.011634052},"labels":[],"label_agreement":null},{"id":"W2007702618","doi":"10.1016/j.msard.2014.08.002","title":"Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: A randomized, placebo-controlled, multiple-dose study","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; London Health Sciences Centre","funders":"Celgene","keywords":"Multiple sclerosis; Medicine; Randomized controlled trial; Placebo; Placenta; Human placenta; Internal medicine; Pregnancy; Immunology; Pathology; Alternative medicine; Fetus","score_opus":0.028786300396516366,"score_gpt":0.2540695841590502,"score_spread":0.22528328376253381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007702618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871868,0.006494594,0.0005027932,0.00046305914,0.00031190357,0.0034462556,0.00051546516,0.00009587139,0.000983222],"genre_scores_gemma":[0.9855882,0.004108703,0.0017602484,0.0010729288,0.00056423293,0.0045607914,0.000550255,0.00001604108,0.0017786612],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937755,0.00033806192,0.000049649916,0.000100523495,0.000066075474,0.00006804855],"domain_scores_gemma":[0.99912745,0.00026613526,0.00020434297,0.000068789544,0.00006437355,0.00026889797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016494822,0.0011813033,0.0027489224,0.00057182834,0.00043432627,0.0007795321,0.00077641953,0.0020531348,0.004122974],"category_scores_gemma":[0.0013733061,0.00060252176,0.001051071,0.00047429287,0.0010295293,0.0006817043,0.00035082686,0.0021924097,0.0005612797],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9715234,0.011387053,0.00046765743,0.00044065804,0.00036762256,0.000032672928,0.000031851145,0.00011404985,0.0033726757,0.000041374282,0.00027844417,0.01194266],"study_design_scores_gemma":[0.8837317,0.11390447,0.0011930092,0.00001870368,0.00020829051,0.00002338529,0.00000938492,0.00011181806,0.00043089953,0.000033719323,0.00032862442,0.0000059711556],"about_ca_topic_score_codex":0.00046079495,"about_ca_topic_score_gemma":0.0007554628,"teacher_disagreement_score":0.004122974,"about_ca_system_score_codex":0.0004881344,"about_ca_system_score_gemma":0.0009360692,"threshold_uncertainty_score":0.013792694},"labels":[],"label_agreement":null},{"id":"W2013199340","doi":"10.1016/j.msard.2012.11.003","title":"The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Pharmacogenomics; Multiple sclerosis; Drug; Drug reaction; Adverse effect; Intensive care medicine; Pharmacology; Immunology","score_opus":0.0915563427425296,"score_gpt":0.3518274075304867,"score_spread":0.2602710647879571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013199340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014683799,0.9990914,0.00017656757,0.00018133575,0.00006362527,0.0000028314046,0.000013914099,0.0000042129427,0.00031929722],"genre_scores_gemma":[0.0011528999,0.9979917,0.0003120013,0.00017005557,0.00014117153,0.0000038853746,0.000022028169,9.1442337e-7,0.00020538594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997366,0.00006675284,0.000041078194,0.000040844632,0.00009617086,0.00001843452],"domain_scores_gemma":[0.99934226,0.0004003602,0.00010521688,0.000015803776,0.0001056577,0.000030706244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009433114,0.00073293486,0.0019199911,0.0018572437,0.00016324554,0.00081576,0.00080062007,0.0010172112,0.0024529602],"category_scores_gemma":[0.0010501617,0.00019641717,0.0007810743,0.0017763883,0.0003679428,0.0007329265,0.000605057,0.0014102578,0.00073804054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010805617,0.00010109126,0.00042009354,0.0107015725,0.00024372975,0.0002508192,0.000025554658,0.00028468276,0.00127323,0.001468042,0.006702195,0.9784209],"study_design_scores_gemma":[0.00019685319,0.00052947365,0.006867429,0.009142414,0.0013867593,0.0035728926,0.00011477199,0.00051904656,0.0020495688,0.00628821,0.9692574,0.000075243464],"about_ca_topic_score_codex":0.0011647235,"about_ca_topic_score_gemma":0.0023285232,"teacher_disagreement_score":0.0024529602,"about_ca_system_score_codex":0.00035612326,"about_ca_system_score_gemma":0.0009771246,"threshold_uncertainty_score":0.00820601},"labels":[],"label_agreement":null},{"id":"W2013347874","doi":"10.1016/j.msard.2013.08.002","title":"Bilateral trochlear nerve palsy in a patient with neuromyelitis optica","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Ophthalmology and Eye Disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Neuromyelitis optica; Medicine; Multiple sclerosis; Cranial nerve palsy; Palsy; Trochlear nerve; Surgery; Pathology; Immunology","score_opus":0.012470846217821607,"score_gpt":0.20406477836707482,"score_spread":0.19159393214925322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013347874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95701796,0.0049885837,0.001198925,0.0065833014,0.00065907324,0.00014829423,0.0004684971,0.00028917493,0.028646162],"genre_scores_gemma":[0.99487513,0.0009345865,0.00042517012,0.0012520285,0.0008491688,0.000017547929,0.00008493676,0.000032482036,0.001528985],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99918145,0.00006995875,0.00014572481,0.00017347418,0.0001412074,0.00028815455],"domain_scores_gemma":[0.9975103,0.00092558464,0.0004947246,0.00016433008,0.00021562024,0.00068948226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042474997,0.0026645164,0.0013199716,0.0046033277,0.0038442162,0.0015936125,0.0020164137,0.0070756483,0.005253092],"category_scores_gemma":[0.0055386093,0.001354221,0.0012767907,0.0021555738,0.0028864283,0.002411495,0.0020746891,0.003212982,0.0013948512],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043005803,0.00001745424,0.0042047733,0.000012492637,0.0000052556625,0.9949155,0.000049168626,0.000021091935,0.00023004171,0.000029948334,0.000112478025,0.00035870002],"study_design_scores_gemma":[0.000021389358,0.000060404138,0.008312361,0.00001613039,0.000023075394,0.9908127,0.00014874354,0.00012803175,0.00018583618,0.00009709185,0.00018142244,0.00001281492],"about_ca_topic_score_codex":0.007960211,"about_ca_topic_score_gemma":0.007831371,"teacher_disagreement_score":0.007960211,"about_ca_system_score_codex":0.0021049117,"about_ca_system_score_gemma":0.0016672703,"threshold_uncertainty_score":0.017573416},"labels":[],"label_agreement":null},{"id":"W2031617600","doi":"10.1016/j.msard.2013.07.001","title":"Moving toward earlier treatment of multiple sclerosis: Findings from a decade of clinical trials and implications for clinical practice","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Glatiramer acetate; Clinically isolated syndrome; Placebo; Clinical trial; McDonald criteria; Natalizumab; Pediatrics; Fingolimod; Disease; Physical therapy; Internal medicine; Alternative medicine; Pathology; Psychiatry","score_opus":0.45045643630905796,"score_gpt":0.49496657379006515,"score_spread":0.044510137481007184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031617600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044845747,0.9995097,0.000021357944,0.00026357005,0.000047496284,0.0000033914566,0.0000047807184,0.0000013813212,0.000103498525],"genre_scores_gemma":[0.0006275392,0.99877685,0.000105013045,0.0003808311,0.00005988966,0.000007872689,0.000007521965,0.0000010142052,0.00003343148],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752086,0.00093868905,0.00060745655,0.00031353274,0.0005523676,0.00006716045],"domain_scores_gemma":[0.9819999,0.01347405,0.0018599428,0.00027972218,0.0020338318,0.0003526634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008164696,0.0009959086,0.004001901,0.0032084296,0.00026840708,0.0022369875,0.001462117,0.0024693238,0.0037486993],"category_scores_gemma":[0.014957199,0.0003928169,0.0014978859,0.0047253678,0.0013008943,0.002561419,0.0009464389,0.002863276,0.0007817843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044383426,0.00007634621,0.00027255111,0.17495126,0.0006509191,0.00011962932,0.00018984392,0.00023225165,0.0005352627,0.0030588168,0.011804902,0.80766445],"study_design_scores_gemma":[0.00060823484,0.0008127873,0.0049884343,0.3082735,0.0050528874,0.0018358469,0.000592657,0.0001909402,0.0006657975,0.0058273496,0.67106724,0.00008436821],"about_ca_topic_score_codex":0.001638303,"about_ca_topic_score_gemma":0.003188134,"teacher_disagreement_score":0.008164696,"about_ca_system_score_codex":0.0018408606,"about_ca_system_score_gemma":0.0039760713,"threshold_uncertainty_score":0.043179512},"labels":[],"label_agreement":null},{"id":"W2033461650","doi":"10.1016/j.msard.2014.08.003","title":"Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Biogen Idec; Biogen","keywords":"Medicine; Placebo; Multiple sclerosis; Interferon beta-1a; Clinically isolated syndrome; Internal medicine; Magnetic resonance imaging; Gastroenterology; Randomized controlled trial; Radiology; Pathology; Interferon beta; Immunology","score_opus":0.028910441075158843,"score_gpt":0.27207735077641765,"score_spread":0.24316690970125882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033461650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984896,0.0006387795,0.000044032586,0.00007669963,0.000009409842,0.000007721377,0.00003495757,0.0000023677637,0.0006963527],"genre_scores_gemma":[0.9996464,0.00012256709,0.000054813037,0.000030721356,0.000017547056,0.0000041655617,0.00005198163,0.0000012251402,0.00007053635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942446,0.00033955494,0.00006508986,0.000044314515,0.000061708655,0.00006488039],"domain_scores_gemma":[0.9944807,0.0028987261,0.001679241,0.00016478793,0.00021883445,0.00055763894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011677442,0.00040125242,0.00051772525,0.0008193646,0.0002723376,0.00048660522,0.0003094799,0.0007097336,0.001501913],"category_scores_gemma":[0.0064325472,0.00018958667,0.00036708981,0.0004963902,0.0003936037,0.0004385877,0.00022288469,0.000587323,0.00019789604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041300394,0.00034755672,0.9816743,0.00006659096,0.0001427072,0.0006283472,0.00011492475,0.0001216797,0.0046894616,0.000037144346,0.00011581993,0.00793137],"study_design_scores_gemma":[0.00006813559,0.0008880961,0.99694675,0.000019550907,0.0000786443,0.0010652478,0.00011478812,0.00019559365,0.00044749168,0.000041315092,0.00012947533,0.0000050123763],"about_ca_topic_score_codex":0.001090727,"about_ca_topic_score_gemma":0.0011471343,"teacher_disagreement_score":0.001501913,"about_ca_system_score_codex":0.000259543,"about_ca_system_score_gemma":0.0002677349,"threshold_uncertainty_score":0.006175697},"labels":[],"label_agreement":null},{"id":"W2042115859","doi":"10.1016/j.msard.2012.11.002","title":"CNS vasculitis in children","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Vasculitis; Multiple sclerosis; Differential diagnosis; Disease; Pathogenesis; Epidemiology; Pathology; Immunology","score_opus":0.027282652981673497,"score_gpt":0.25330668239568593,"score_spread":0.22602402941401245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042115859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013339594,0.99922884,0.000029062352,0.00007426996,0.00008348111,0.0000030698288,0.000015048649,0.0000024226795,0.00043042426],"genre_scores_gemma":[0.000902698,0.9986304,0.00007501468,0.000105759405,0.000113255286,0.0000033768179,0.000019915124,5.6129306e-7,0.00014907087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970716,0.000047621153,0.0000876406,0.00004561031,0.0000793034,0.0000327538],"domain_scores_gemma":[0.9994987,0.0002161628,0.00017115482,0.000009483908,0.00006285742,0.000041616968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885654,0.0010868168,0.0019901262,0.0039220243,0.00030473413,0.0010944757,0.00056483404,0.0008733302,0.0031020641],"category_scores_gemma":[0.0010216852,0.00039456657,0.00068390014,0.0034644492,0.00051971263,0.0012127825,0.00096422096,0.0012978542,0.0006571687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011650231,0.00006224725,0.002108238,0.054618996,0.00038070095,0.0015643631,0.00015253421,0.00032520125,0.0006971249,0.0010304032,0.027423078,0.91152054],"study_design_scores_gemma":[0.00016414482,0.0001685423,0.012245227,0.05556497,0.0021916262,0.026790068,0.0004267947,0.00014409164,0.00050850544,0.0012274098,0.9004987,0.00006992507],"about_ca_topic_score_codex":0.003963825,"about_ca_topic_score_gemma":0.009586562,"teacher_disagreement_score":0.003963825,"about_ca_system_score_codex":0.0006864347,"about_ca_system_score_gemma":0.0019751114,"threshold_uncertainty_score":0.010377467},"labels":[],"label_agreement":null},{"id":"W2042737626","doi":"10.1016/j.msard.2013.10.006","title":"Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; London Health Sciences Centre; Western University","funders":"Novartis Pharma; EMD Serono; Genentech; Daiichi Sankyo Europe; Sanofi; European Commission; Glenmark Pharmaceuticals; Eli Lilly and Company; CSL Behring; Novartis Pharmaceuticals Corporation; Biogen; Novo Nordisk; Teva Pharmaceutical Industries; National Research Foundation; Universitätsspital Basel","keywords":"Fingolimod; Medicine; Glatiramer acetate; Discontinuation; Placebo; Adverse effect; Multiple sclerosis; Internal medicine; Disease; Immunology; Pathology; Alternative medicine","score_opus":0.0934681497190447,"score_gpt":0.349094815101173,"score_spread":0.2556266653821283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042737626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162734,0.0051021744,0.0007387988,0.00016141382,0.00012062987,0.00021847892,0.0013398806,0.000021241287,0.00067012437],"genre_scores_gemma":[0.9976641,0.00030270583,0.00028332035,0.000091544935,0.000076822675,0.00017529396,0.0011446386,0.000016656424,0.00024489049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98673475,0.007989095,0.0014895538,0.001482015,0.0015706387,0.00073397043],"domain_scores_gemma":[0.9864377,0.009043172,0.0019765915,0.00155615,0.00047720427,0.0005091868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01574005,0.0008245261,0.0036593943,0.0008732579,0.0003250089,0.0012718496,0.0007782503,0.0008349546,0.0017068865],"category_scores_gemma":[0.01396106,0.0003137929,0.012788141,0.0008953209,0.00035096836,0.0006224829,0.00067610765,0.0012267138,0.000115106996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37196293,0.00070154713,0.42606443,0.0011266038,0.1540438,0.0006462413,0.0005654422,0.0022085037,0.0055208043,0.00024323794,0.0018602815,0.0350561],"study_design_scores_gemma":[0.014236733,0.020623285,0.89332545,0.0001370712,0.061225418,0.00052489573,0.0004714313,0.0038133971,0.0022402066,0.0007292989,0.0025583606,0.000114440154],"about_ca_topic_score_codex":0.0011389767,"about_ca_topic_score_gemma":0.001943383,"teacher_disagreement_score":0.01574005,"about_ca_system_score_codex":0.0005171492,"about_ca_system_score_gemma":0.00084133015,"threshold_uncertainty_score":0.08324236},"labels":[],"label_agreement":null},{"id":"W2043370356","doi":"10.1016/j.msard.2013.03.001","title":"Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health; Health Sciences Centre","funders":"","keywords":"Medicine; Incidence (geometry); Population; Medical record; Disease; Multiple sclerosis; Internal medicine; Medical prescription; Epidemiology; Demography; Environmental health; Immunology","score_opus":0.03971804447623006,"score_gpt":0.27330132800020895,"score_spread":0.2335832835239789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043370356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980252,0.00005459507,0.00040517366,0.000026511036,0.000005865483,0.00011083452,0.0009464158,0.000007952985,0.0004175476],"genre_scores_gemma":[0.9958515,0.00008160009,0.0008067554,0.00005964686,0.000020042478,0.00019849492,0.0028061138,0.000007110308,0.00016865866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978496,0.00085184496,0.00023583768,0.00041446576,0.000529196,0.000118985154],"domain_scores_gemma":[0.9938724,0.0012210086,0.001541962,0.0013110677,0.0015742921,0.0004792342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046148286,0.0005666547,0.00043176053,0.0014485243,0.00069159793,0.000775945,0.0010678661,0.0008726614,0.00075069594],"category_scores_gemma":[0.010486157,0.00046726904,0.0007264609,0.0011103151,0.00058977236,0.00055384135,0.0010821898,0.0009215412,0.00050219765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008523208,0.00011503835,0.9981048,0.000014170153,0.00009008459,0.00005838567,0.00019528971,0.000045821405,0.00025707908,0.000012519245,0.00011629575,0.0009053327],"study_design_scores_gemma":[0.000017340823,0.00010668715,0.99919933,0.0000048737566,0.000027432312,0.00023866304,0.00006320058,0.00012289773,0.00006894951,0.000011475594,0.00013637493,0.0000027562735],"about_ca_topic_score_codex":0.0053180163,"about_ca_topic_score_gemma":0.0044570947,"teacher_disagreement_score":0.0053180163,"about_ca_system_score_codex":0.00049957697,"about_ca_system_score_gemma":0.00078564003,"threshold_uncertainty_score":0.024405837},"labels":[],"label_agreement":null},{"id":"W2046066091","doi":"10.1016/j.msard.2012.03.006","title":"B cells in MS: Why, where and how?","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Inflammation; Disease; Mechanism (biology); Myelin; Immunology; Central nervous system; Neuroscience; Pathology; Biology; Internal medicine","score_opus":0.02934495998023967,"score_gpt":0.2244944407992191,"score_spread":0.19514948081897943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046066091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038183105,0.9986442,0.000085402906,0.00056949095,0.00041587398,0.000001536953,0.0000061062733,0.0000042010693,0.00023508331],"genre_scores_gemma":[0.00040677137,0.99791974,0.00015850386,0.00040916982,0.0007377872,0.000004018142,0.000013742432,9.889296e-7,0.00034919137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975234,0.00005429502,0.00003527499,0.000043637134,0.00008097351,0.000033570126],"domain_scores_gemma":[0.99959224,0.00015261958,0.00005695569,0.000012130058,0.000116696094,0.00006934412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091588823,0.001205704,0.0020358486,0.0016562555,0.000430443,0.001474529,0.001266924,0.0025376747,0.002114368],"category_scores_gemma":[0.0008517117,0.00034778516,0.0003850029,0.0019905772,0.0011292584,0.002410832,0.0010442253,0.0029926696,0.0020669617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001238405,0.000053304084,0.00022951476,0.009143315,0.00007447445,0.0002324023,0.0000613871,0.0002453342,0.001450268,0.0030896678,0.07931084,0.90598553],"study_design_scores_gemma":[0.000033603497,0.00006242843,0.00071445754,0.003273147,0.00011301351,0.0013516688,0.00009588845,0.00008174661,0.00031576556,0.0030080604,0.99092823,0.000022012004],"about_ca_topic_score_codex":0.0013640611,"about_ca_topic_score_gemma":0.0020166375,"teacher_disagreement_score":0.0025376747,"about_ca_system_score_codex":0.00089108467,"about_ca_system_score_gemma":0.0014364285,"threshold_uncertainty_score":0.0070732236},"labels":[],"label_agreement":null},{"id":"W2056201587","doi":"10.1016/j.msard.2013.06.017","title":"Increased deep gray matter iron is present in clinically isolated syndromes","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Society; Canada Research Chairs; Multiple Sclerosis Society of Canada; Health Research Board","keywords":"Medicine; Gray (unit); Multiple sclerosis; Dermatology; Psychiatry; Nuclear medicine","score_opus":0.028814022370232915,"score_gpt":0.2759955838907996,"score_spread":0.24718156152056667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056201587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738497,0.0010826726,0.000051984618,0.000045945922,0.0000067251503,0.000005397254,0.000068398986,0.0000027095002,0.0013511304],"genre_scores_gemma":[0.9994295,0.00022949495,0.00011177525,0.00003316227,0.000023325161,0.0000029744174,0.00006061001,0.0000012117697,0.000107848486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957734,0.00013477218,0.00008901188,0.00007740887,0.000077139885,0.000044388973],"domain_scores_gemma":[0.99702495,0.0010303418,0.0012155426,0.00012733608,0.0003082943,0.00029357558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007791069,0.00040446894,0.00047809712,0.002385241,0.000460445,0.0005582476,0.00030444056,0.00051652873,0.0025911618],"category_scores_gemma":[0.0047415057,0.00018350143,0.00015434276,0.0010681017,0.0006343107,0.00054092833,0.00054711907,0.00029403422,0.00015694553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010974683,0.00010493263,0.9756447,0.00021488646,0.00022620535,0.0037401277,0.0005572096,0.000025274661,0.011060511,0.0001354334,0.00020929794,0.006983954],"study_design_scores_gemma":[0.00002584065,0.00020546268,0.9933681,0.000025286046,0.00010369661,0.004873446,0.00042012634,0.000030014924,0.00058019557,0.00013664359,0.00022708489,0.000004158277],"about_ca_topic_score_codex":0.0015339828,"about_ca_topic_score_gemma":0.0023810305,"teacher_disagreement_score":0.0025911618,"about_ca_system_score_codex":0.00018905614,"about_ca_system_score_gemma":0.00027075395,"threshold_uncertainty_score":0.0086683035},"labels":[],"label_agreement":null},{"id":"W2066064324","doi":"10.1016/j.msard.2012.12.003","title":"Validation of MRI predictors of multiple sclerosis diagnosis in children with acute CNS demyelination","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Public Health Ontario; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Prospective cohort study; Cohort; Multiple sclerosis; Predictive value; Clinically isolated syndrome; Predictive value of tests; Internal medicine; Pediatrics; Immunology","score_opus":0.022676100496885544,"score_gpt":0.243213334480317,"score_spread":0.22053723398343147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066064324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991529,0.00014003077,0.00009341717,0.0000451428,0.000008793185,0.000008482792,0.00017292664,0.0000034552172,0.00037477518],"genre_scores_gemma":[0.99933785,0.00008406123,0.00020815872,0.000013874607,0.0000069917037,0.000014243106,0.00026087076,0.0000033537892,0.00007048795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810284,0.0008682527,0.00026529856,0.00021867822,0.00028865333,0.00025624267],"domain_scores_gemma":[0.9894298,0.004224113,0.0031866569,0.0006947264,0.0018631566,0.0006016563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032157686,0.00059733255,0.0004606186,0.001369703,0.00050036353,0.00091821764,0.0005907783,0.0007134047,0.0009690491],"category_scores_gemma":[0.018715413,0.00034008487,0.0005454279,0.0009411551,0.0006506909,0.0009366214,0.0008345124,0.00083219365,0.00029949838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007927082,0.00002855631,0.9986848,0.000009383219,0.000022661603,0.00004347156,0.000117656076,0.000040928084,0.00022720973,0.000013286846,0.00004202352,0.0006906773],"study_design_scores_gemma":[0.000009339413,0.0001593778,0.9980956,0.000022337947,0.000043072465,0.0003682025,0.00035085093,0.00023484844,0.00047893822,0.000014896978,0.00021927849,0.0000032600592],"about_ca_topic_score_codex":0.004947561,"about_ca_topic_score_gemma":0.005713116,"teacher_disagreement_score":0.004947561,"about_ca_system_score_codex":0.00050564716,"about_ca_system_score_gemma":0.0011525182,"threshold_uncertainty_score":0.017006874},"labels":[],"label_agreement":null},{"id":"W2077138786","doi":"10.1016/j.msard.2012.08.001","title":"Cognitive and neuropsychiatric disease manifestations in MS","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Cognition; Psychiatry; Disease; Cognitive impairment; Mental health; Pathology","score_opus":0.0799669021878602,"score_gpt":0.3268902966310698,"score_spread":0.24692339444320957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077138786","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005115977,0.9997645,0.000015026391,0.0000356131,0.000030842006,0.00000204706,0.000009659134,0.0000010679759,0.00009010747],"genre_scores_gemma":[0.00044865167,0.99929225,0.00006701192,0.00006804008,0.000052832333,0.0000027914418,0.000012565784,2.7806107e-7,0.000055716555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995396,0.00008854432,0.00016633804,0.00006784527,0.000111410154,0.0000262331],"domain_scores_gemma":[0.99891984,0.0006593002,0.00024617105,0.000015314283,0.00011946305,0.000040000952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011152034,0.0011505033,0.0033552658,0.006153301,0.00027551228,0.0015317205,0.00095319154,0.0011097166,0.0029968198],"category_scores_gemma":[0.0018788555,0.0004901955,0.0011551881,0.0063602943,0.00057180406,0.0016450321,0.000992947,0.001131377,0.00046689613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017034909,0.00008940814,0.0007663264,0.14312522,0.0009385029,0.00030978041,0.0001263734,0.0002500998,0.0005899722,0.0007963493,0.012421108,0.84041667],"study_design_scores_gemma":[0.00034697837,0.00041859373,0.016156917,0.16209461,0.01082149,0.006747828,0.00069977815,0.00030737766,0.00059887883,0.0029747423,0.79865646,0.00017637854],"about_ca_topic_score_codex":0.0038944895,"about_ca_topic_score_gemma":0.009314025,"teacher_disagreement_score":0.006153301,"about_ca_system_score_codex":0.0007336823,"about_ca_system_score_gemma":0.0017659233,"threshold_uncertainty_score":0.010025382},"labels":[],"label_agreement":null},{"id":"W2080669720","doi":"10.1016/j.msard.2013.06.015","title":"MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Hotchkiss Brain Institute; University of Manitoba; McGill University; McGill University Health Centre; Hospital for Sick Children; University of Saskatchewan; University of Calgary; Western University; University of Toronto; SickKids Foundation; University of British Columbia","funders":"","keywords":"Incidence (geometry); Medicine; Demography; Epidemiology; Ethnic group; Geography; Pathology","score_opus":0.11074921417805134,"score_gpt":0.3339412673334964,"score_spread":0.22319205315544505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080669720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038107843,0.99512994,0.000068237896,0.00012389514,0.000058166817,0.00014001815,0.00051629735,0.000006608992,0.00014605964],"genre_scores_gemma":[0.031869292,0.96698236,0.00042548127,0.00028516538,0.00003159554,0.00016466735,0.00015078307,0.0000033753438,0.000087326414],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962442,0.00074988423,0.001861456,0.00035265405,0.0005969204,0.00019497437],"domain_scores_gemma":[0.99209607,0.0043090736,0.0024973003,0.00014627143,0.0007674541,0.00018381592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042678816,0.001543858,0.008427131,0.01151638,0.00055967306,0.0022669232,0.0014097751,0.0016380465,0.003649446],"category_scores_gemma":[0.016608428,0.0016142896,0.008935556,0.0147198215,0.00088503846,0.0020513916,0.0020380623,0.0011189725,0.00018990002],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002596644,0.000020379804,0.004757875,0.94180655,0.029883157,0.00018805497,0.00033372568,0.000097444194,0.00020185804,0.00009893814,0.0010409125,0.021311361],"study_design_scores_gemma":[0.000777902,0.000281895,0.033881787,0.5108791,0.43708783,0.0010772647,0.0012189457,0.000100724224,0.00022026205,0.00022668054,0.014158104,0.00008949735],"about_ca_topic_score_codex":0.027107248,"about_ca_topic_score_gemma":0.10004822,"teacher_disagreement_score":0.027107248,"about_ca_system_score_codex":0.0032232243,"about_ca_system_score_gemma":0.007646572,"threshold_uncertainty_score":0.05389893},"labels":[],"label_agreement":null},{"id":"W2082026472","doi":"10.1016/j.msard.2014.06.004","title":"Corrigendum to “The case for vitamin D supplementation in multiple sclerosis” [Mult. Scler. Relat. Disord. 2 (2013) 281–306]","year":2014,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Vitamin D and neurology; Regret; Harm; Vitamin; Number needed to treat; Disease; Internal medicine; Relative risk; Immunology; Psychology; Confidence interval","score_opus":0.03540118076370324,"score_gpt":0.23442800424744814,"score_spread":0.1990268234837449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082026472","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053958793,0.0024490368,0.00012093292,0.07119493,0.9226787,0.000021913445,0.0001645673,0.00008730856,0.0032286013],"genre_scores_gemma":[0.0032979755,0.011550648,0.0009462786,0.20983635,0.6234767,0.00011114099,0.0005100153,0.00024397504,0.1500269],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99721366,0.00046214316,0.0005632062,0.00039755163,0.0010265695,0.00033680984],"domain_scores_gemma":[0.9896052,0.0032523633,0.00064014306,0.00046990928,0.005230658,0.0008017769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022768886,0.0022786853,0.002498259,0.0033176013,0.0025154217,0.0031550783,0.0032589796,0.0119266035,0.04052644],"category_scores_gemma":[0.025561655,0.0010261817,0.0025134962,0.0015391426,0.0021750003,0.0025933785,0.0019395973,0.011437652,0.027875507],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017081009,0.0000081961825,0.000043740558,0.00007011246,0.0000076971555,0.00040224873,0.000008303472,0.000015634538,0.000020339909,0.00019985183,0.9955777,0.0036290325],"study_design_scores_gemma":[0.00003514628,0.000029841038,0.0009747753,0.000355513,0.000040160256,0.000983544,0.000047389527,0.00011614229,0.00013819715,0.0008077657,0.9964371,0.000034489018],"about_ca_topic_score_codex":0.021354768,"about_ca_topic_score_gemma":0.03276689,"teacher_disagreement_score":0.04052644,"about_ca_system_score_codex":0.0036058861,"about_ca_system_score_gemma":0.0034040376,"threshold_uncertainty_score":0.13557446},"labels":[],"label_agreement":null},{"id":"W2082278718","doi":"10.1016/j.msard.2012.03.003","title":"Autoantibodies against aquaporin-4 and myelin oligodendrocyte glycoprotein in paediatric CNS demyelination: Recent developments and future directions","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"","keywords":"Neuromyelitis optica; Medicine; Acute disseminated encephalomyelitis; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunology; Autoantibody; Aquaporin 4; Antibody; Myelin; Demyelinating disease; Demyelinating Disorder; Oligodendrocyte; Pathogenesis; Disease; Central nervous system; Pathology; Experimental autoimmune encephalomyelitis; Internal medicine","score_opus":0.05407009413105779,"score_gpt":0.3009606424040809,"score_spread":0.2468905482730231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082278718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007715805,0.9996344,0.000031737767,0.00009151209,0.000048865502,0.0000011074854,0.0000070799247,0.0000017734061,0.00010635328],"genre_scores_gemma":[0.000557653,0.9990445,0.00009432548,0.00010010079,0.000095225885,0.000001877366,0.000012367042,4.541424e-7,0.00009356582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972767,0.00004383451,0.00007150769,0.000050330662,0.00007865982,0.000027949214],"domain_scores_gemma":[0.99934536,0.00031777483,0.0001391,0.000009354897,0.00014129697,0.000047065336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008855893,0.00095588894,0.0022902426,0.003323347,0.00019741264,0.0012251653,0.0007793847,0.0012602697,0.0021616358],"category_scores_gemma":[0.0011161865,0.0003456855,0.0006818014,0.0035224042,0.0004519762,0.0016296392,0.00072724605,0.0012087413,0.0007685825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024613668,0.00008489908,0.0009405237,0.036541957,0.00032966357,0.0005973377,0.00007935214,0.0003050626,0.0014224859,0.0009263286,0.01708168,0.9414446],"study_design_scores_gemma":[0.00020109252,0.00030141103,0.009394174,0.020841353,0.0024453641,0.008089602,0.00040094866,0.00035513137,0.0011179061,0.0025300337,0.95422316,0.00009968768],"about_ca_topic_score_codex":0.001641851,"about_ca_topic_score_gemma":0.0032269703,"teacher_disagreement_score":0.003323347,"about_ca_system_score_codex":0.00051872013,"about_ca_system_score_gemma":0.0012948391,"threshold_uncertainty_score":0.0072313547},"labels":[],"label_agreement":null},{"id":"W2082490967","doi":"10.1016/j.msard.2012.05.001","title":"Computerized cognitive testing for patients with multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Canada Research Chairs","funders":"","keywords":"Neuropsychology; Cognition; Medicine; Neuropsychological testing; Multiple sclerosis; Neuropsychological assessment; Cognitive test; Neuropsychological test; Physical medicine and rehabilitation; Psychiatry","score_opus":0.11894524235970247,"score_gpt":0.30594174571457217,"score_spread":0.1869965033548697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082490967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002593315,0.9994623,0.000023333223,0.000055746234,0.00003678208,0.000005861305,0.000023140718,0.0000021270673,0.00013139898],"genre_scores_gemma":[0.004717997,0.9945328,0.0002094471,0.0002966635,0.00008006726,0.00001895107,0.00005292789,9.3925024e-7,0.00009017137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993839,0.00016596814,0.00019556834,0.00008753968,0.00013881686,0.000028179613],"domain_scores_gemma":[0.99749845,0.0017567133,0.00042936104,0.000032105916,0.00023272757,0.00005066881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011972721,0.0012405484,0.004049025,0.0038762784,0.00024390935,0.00088261854,0.0011118047,0.0010501812,0.0023411745],"category_scores_gemma":[0.005112531,0.00031581544,0.0017237362,0.0033131014,0.00041605937,0.00083467184,0.00068645435,0.0011232434,0.0002585679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067137316,0.00019073856,0.0021664898,0.14568816,0.0036803165,0.00019904425,0.000084063104,0.000174279,0.0003859838,0.00027654492,0.009518696,0.8369643],"study_design_scores_gemma":[0.004219357,0.0026954573,0.070729576,0.42169443,0.0997342,0.006705213,0.0010230787,0.00070429064,0.0023611004,0.0029825282,0.38676828,0.00038243373],"about_ca_topic_score_codex":0.0061961953,"about_ca_topic_score_gemma":0.014558048,"teacher_disagreement_score":0.0061961953,"about_ca_system_score_codex":0.00072738534,"about_ca_system_score_gemma":0.0017091052,"threshold_uncertainty_score":0.01232028},"labels":[],"label_agreement":null},{"id":"W2094244969","doi":"10.1016/j.msard.2012.07.003","title":"A proposed methodology to estimate the cumulative life-time UVB exposure using geographic information systems: An application to multiple sclerosis","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health; Simon Fraser University","funders":"","keywords":"Multiple sclerosis; Medicine; Proxy (statistics); Sun exposure; Sunlight; Demography; Statistics; Immunology","score_opus":0.08826487081443886,"score_gpt":0.3370960559294761,"score_spread":0.24883118511503727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094244969","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021874981,0.00018400988,0.97574586,0.00040385372,0.00007795973,0.0002066897,0.00056683575,0.00026049776,0.0006794389],"genre_scores_gemma":[0.2515207,0.00028216396,0.7453792,0.00009372885,0.0000940992,0.00052263256,0.0009425562,0.00002126655,0.0011436669],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99745864,0.0013210909,0.00018623925,0.00047556456,0.0004476207,0.000110908804],"domain_scores_gemma":[0.9936841,0.003925777,0.00044796703,0.00033252942,0.0015077213,0.000101792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049032113,0.00077587477,0.00092284946,0.0032020754,0.0007483656,0.002224592,0.0017163458,0.0015237428,0.0019201702],"category_scores_gemma":[0.014522929,0.00044892266,0.00128811,0.004070016,0.00042142766,0.0015448934,0.001390879,0.0009820664,0.00044725873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002332952,0.00048594948,0.0764999,0.0005321429,0.0011529153,0.00038651083,0.0004978806,0.39356965,0.0039546727,0.041048765,0.0042177164,0.47742063],"study_design_scores_gemma":[0.000040397314,0.00009754744,0.00752461,0.000041145002,0.000090046364,0.00016657244,0.00015610158,0.97925055,0.000787233,0.00997995,0.0018210147,0.00004487039],"about_ca_topic_score_codex":0.018653072,"about_ca_topic_score_gemma":0.011900727,"teacher_disagreement_score":0.018653072,"about_ca_system_score_codex":0.0010863675,"about_ca_system_score_gemma":0.0029931988,"threshold_uncertainty_score":0.03708899},"labels":[],"label_agreement":null},{"id":"W2096243634","doi":"10.1016/j.msard.2014.06.001","title":"CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Health and Care Research; University of Alberta","keywords":"CD20; Medicine; Flow cytometry; Immunology; Multiple sclerosis; Inflammation; Fas ligand; Apoptosis; Antigen; Programmed cell death; Biology","score_opus":0.02386338981250617,"score_gpt":0.23574816432708853,"score_spread":0.21188477451458237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096243634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993715,0.0029714485,0.0006383561,0.00005572805,0.000020395566,0.00002786,0.00010447863,0.000039341314,0.0024274215],"genre_scores_gemma":[0.9960795,0.001232509,0.00070423685,0.00009887067,0.00005347006,0.000033634944,0.00020970401,0.000010615881,0.0015775383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989665,0.00001836321,0.000008640052,0.00002092809,0.000020546608,0.000034920573],"domain_scores_gemma":[0.9998518,0.000025745107,0.00004243412,0.000010004434,0.000036042027,0.000034033164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015959523,0.0003464907,0.00034278867,0.0008489208,0.00025408177,0.0003224239,0.00012386365,0.00035417895,0.004775462],"category_scores_gemma":[0.00043494365,0.000119196906,0.000114759685,0.00040807892,0.00017720024,0.00033146437,0.00020873616,0.00020165242,0.00060456706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002982908,0.0002635958,0.059616495,0.00039328187,0.00007593028,0.0029498967,0.00045057083,0.000083035426,0.87256074,0.0002924241,0.00060992554,0.05972124],"study_design_scores_gemma":[0.00041909298,0.00520273,0.63724405,0.00018444752,0.00045756873,0.037488427,0.0016544961,0.0010227339,0.29399976,0.002213632,0.020065393,0.000047600908],"about_ca_topic_score_codex":0.00036822807,"about_ca_topic_score_gemma":0.00048357612,"teacher_disagreement_score":0.004775462,"about_ca_system_score_codex":0.00010289842,"about_ca_system_score_gemma":0.00010321928,"threshold_uncertainty_score":0.015975535},"labels":[],"label_agreement":null},{"id":"W2103526247","doi":"10.1016/j.msard.2015.05.010","title":"Health care utilization before and after intensive care unit admission in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Manitoba Health; University of Winnipeg; University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Medicine; Intensive care unit; Population; Incidence (geometry); Comorbidity; Emergency medicine; Quartile; Cohort; Pediatrics; Intensive care medicine; Internal medicine; Environmental health; Confidence interval","score_opus":0.09086773463233234,"score_gpt":0.313579904261413,"score_spread":0.2227121696290807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103526247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988906,0.00038209194,0.000024958426,0.000052848733,0.0000040596433,0.000004834242,0.00041831733,0.0000019816107,0.00022027992],"genre_scores_gemma":[0.9991352,0.00016157617,0.00003184781,0.000021547557,0.0000073872766,0.0000040757373,0.0005517448,9.535912e-7,0.000085578555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991825,0.00021233739,0.00009558189,0.00011620712,0.00018568923,0.00020766916],"domain_scores_gemma":[0.99773264,0.00030807854,0.0012324564,0.00007294667,0.00026216847,0.00039175732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006359445,0.00019082408,0.0003080046,0.0010350656,0.0003890896,0.0007185469,0.00039899815,0.00052702933,0.0011741918],"category_scores_gemma":[0.0029802395,0.00018259994,0.00053102657,0.0015459417,0.00027290345,0.00034815105,0.00051308033,0.0005522557,0.00014406741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003507311,0.000021668482,0.99897146,0.00000840229,0.000048896803,0.000049705814,0.000053828255,0.00007288062,0.000035003868,0.000008109037,0.000053825537,0.00064117735],"study_design_scores_gemma":[0.0000017319395,0.000023064971,0.9996159,0.000008180975,0.000008863703,0.00005317594,0.00006948346,0.000159065,0.000014374183,0.000005954551,0.000038172613,0.0000020405485],"about_ca_topic_score_codex":0.07951013,"about_ca_topic_score_gemma":0.07628756,"teacher_disagreement_score":0.07951013,"about_ca_system_score_codex":0.0012201088,"about_ca_system_score_gemma":0.0010683857,"threshold_uncertainty_score":0.15809464},"labels":[],"label_agreement":null},{"id":"W2115266762","doi":"10.1016/j.msard.2012.06.001","title":"The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of British Columbia; McGill University; McGill University Health Centre; University of Alberta; University of Manitoba","funders":"","keywords":"Fibromyalgia; Medicine; Incidence (geometry); Population; Epidemiology; Cohort; Medical record; Cohort study; Physical therapy; Rochester Epidemiology Project; Internal medicine; Demography; Population based study; Environmental health","score_opus":0.03990284989607915,"score_gpt":0.27237564528386604,"score_spread":0.2324727953877869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115266762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924976,0.0001887456,0.00005430774,0.000041408242,0.0000068948475,0.000005957356,0.0001311979,0.0000033339077,0.00031837446],"genre_scores_gemma":[0.99944955,0.00012173352,0.000044996883,0.000048336435,0.000021560276,0.000008005234,0.00014926004,0.0000016820787,0.00015493465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994147,0.00019319652,0.000068358546,0.00013299417,0.00010258887,0.00008815026],"domain_scores_gemma":[0.9990269,0.00018502842,0.0003453899,0.00010869969,0.00013004887,0.00020399316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006235434,0.00043586254,0.0007105106,0.0010425325,0.000758253,0.0009480981,0.00032989628,0.0011903334,0.0020528377],"category_scores_gemma":[0.0018228341,0.0007739899,0.0008985872,0.0014830614,0.00047755492,0.000959959,0.00041890168,0.0010030445,0.00036863532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000219149,0.000097283795,0.9983027,0.000008933858,0.0001232156,0.00010264756,0.00014533251,0.00000903125,0.00036003467,0.000007861436,0.00006032066,0.0005634949],"study_design_scores_gemma":[0.000010523901,0.0001060756,0.9993538,0.0000012657215,0.00003663823,0.00023753385,0.00015548209,0.000025643161,0.000016774138,0.0000080255795,0.000045196466,0.0000030045337],"about_ca_topic_score_codex":0.004856279,"about_ca_topic_score_gemma":0.004696165,"teacher_disagreement_score":0.004856279,"about_ca_system_score_codex":0.00026346932,"about_ca_system_score_gemma":0.00023701391,"threshold_uncertainty_score":0.009656072},"labels":[],"label_agreement":null},{"id":"W2122096478","doi":"10.1016/j.msard.2015.10.005","title":"Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; University of British Columbia; Hotchkiss Brain Institute; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Cholesterol; Multiple sclerosis; Medicine; Apolipoprotein B; Pathogenesis; Myelin; Internal medicine; Apolipoprotein E; Cerebrospinal fluid; Disease; Lipoprotein; Endocrinology; Central nervous system; Immunology","score_opus":0.10506030241656844,"score_gpt":0.31284291299262385,"score_spread":0.2077826105760554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122096478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027804222,0.99953747,0.000020218635,0.000055422603,0.000027694012,0.000002720934,0.000023057662,8.8733725e-7,0.000054446347],"genre_scores_gemma":[0.0027360613,0.9969194,0.00011265675,0.000085669686,0.00006813645,0.0000065095883,0.000033761815,3.746345e-7,0.00003741293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926406,0.00017739803,0.0002273851,0.00010178712,0.00019595913,0.00003340577],"domain_scores_gemma":[0.99756384,0.0015721344,0.0005670127,0.000030454337,0.00022091197,0.00004564845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001774013,0.0009043438,0.003745246,0.0035720398,0.0002092004,0.0014453991,0.0008767595,0.0012415543,0.0019509614],"category_scores_gemma":[0.004006703,0.00047282333,0.0020775434,0.005216873,0.00047222045,0.0009914336,0.0007593633,0.0015590176,0.00025859723],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010580277,0.00021727702,0.0135508515,0.24606891,0.01555664,0.00031958614,0.00022526323,0.00044097815,0.0006984165,0.0014196535,0.008306016,0.71213835],"study_design_scores_gemma":[0.001289902,0.0012292074,0.15762778,0.28990006,0.14126147,0.0048194444,0.0015723136,0.0011409408,0.0016489731,0.0075967074,0.39147002,0.00044321446],"about_ca_topic_score_codex":0.003918555,"about_ca_topic_score_gemma":0.007859461,"teacher_disagreement_score":0.003918555,"about_ca_system_score_codex":0.00057653314,"about_ca_system_score_gemma":0.0015769235,"threshold_uncertainty_score":0.0093820095},"labels":[],"label_agreement":null},{"id":"W2123705151","doi":"10.1016/j.msard.2015.06.004","title":"Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"Fogarty International Center; IC Design Education Center; Biogen","keywords":"Medicine; Multiple sclerosis; Placebo; Quality of life (healthcare); Internal medicine; Expanded Disability Status Scale; Post-hoc analysis; Clinical endpoint; Physical therapy; Clinical trial; Pathology; Psychiatry","score_opus":0.14454473885104863,"score_gpt":0.331492370615714,"score_spread":0.1869476317646654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123705151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896466,0.009104469,0.000035407273,0.00026076098,0.000024359371,0.000010008437,0.0002021651,0.0000015417975,0.00071466767],"genre_scores_gemma":[0.99850637,0.0010927899,0.000050074916,0.000068188056,0.000021776073,0.00000590193,0.00013147666,7.692882e-7,0.00012257391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850273,0.0008637249,0.00013682811,0.0001094651,0.0001985928,0.00018872648],"domain_scores_gemma":[0.99738425,0.0010225205,0.00085699867,0.00011803544,0.00019262444,0.00042557993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024638681,0.000317878,0.0006812938,0.00073273375,0.00037271957,0.00080846256,0.00027692647,0.0005158955,0.0011409759],"category_scores_gemma":[0.004734124,0.00017031922,0.0018206104,0.00117213,0.00035188333,0.00060273544,0.00056580367,0.0008144322,0.00007849535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007019756,0.00087806594,0.96328187,0.0002083806,0.00437047,0.000087775064,0.00014290887,0.00029719988,0.00022715937,0.00006641888,0.00021447249,0.023205543],"study_design_scores_gemma":[0.00012895743,0.0007108502,0.99763,0.00003961657,0.00084709574,0.00004681365,0.00011416859,0.00014849339,0.000056834775,0.00004818388,0.00022017992,0.000008851597],"about_ca_topic_score_codex":0.007846566,"about_ca_topic_score_gemma":0.009138604,"teacher_disagreement_score":0.007846566,"about_ca_system_score_codex":0.0009104282,"about_ca_system_score_gemma":0.00072123104,"threshold_uncertainty_score":0.015601754},"labels":[],"label_agreement":null},{"id":"W2126814542","doi":"10.1016/j.msard.2013.06.013","title":"A review of the anterior visual pathway model and the study of vitamin D in demyelinating disease","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Multiple sclerosis; Demyelinating disease; Neuroprotection; Neurodegeneration; Neuroscience; Disease; Vitamin D and neurology; Lesion; Demyelinating Disorder; Pathology; Internal medicine; Immunology; Psychology","score_opus":0.05033969121749002,"score_gpt":0.32295917023734727,"score_spread":0.2726194790198573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126814542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002325648,0.9996754,0.000022440681,0.000099275494,0.00005168462,0.0000021801702,0.000012532418,0.0000011068297,0.00011226999],"genre_scores_gemma":[0.00018367308,0.99950147,0.00007175634,0.00010081872,0.00006741918,0.0000029332264,0.000012116448,3.2483854e-7,0.000059370544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948967,0.00010306867,0.00016318029,0.00008064479,0.0001358988,0.000027449574],"domain_scores_gemma":[0.99856204,0.0010081333,0.00018585855,0.000023427387,0.00017755477,0.00004293786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012974308,0.0010625386,0.0030379002,0.00637463,0.00038582407,0.0014388168,0.0013124294,0.0016699345,0.0039947876],"category_scores_gemma":[0.0025568777,0.00048196616,0.0012122685,0.0069738408,0.0007854054,0.0016867033,0.001023256,0.0015990874,0.00086116075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002345066,0.00008784056,0.0003129311,0.162105,0.000528746,0.0003211379,0.00011280727,0.00028740408,0.00087944424,0.0028224231,0.031128358,0.8011794],"study_design_scores_gemma":[0.000099687946,0.00016827822,0.0017369505,0.049606398,0.0016195395,0.0018032687,0.00019700566,0.00011607095,0.00033683435,0.0029813526,0.9412784,0.000056162993],"about_ca_topic_score_codex":0.0043853563,"about_ca_topic_score_gemma":0.0072767115,"teacher_disagreement_score":0.00637463,"about_ca_system_score_codex":0.0010410715,"about_ca_system_score_gemma":0.0027305863,"threshold_uncertainty_score":0.013363898},"labels":[],"label_agreement":null},{"id":"W2131152693","doi":"10.1016/j.msard.2015.03.006","title":"Systematic review of efficacy of TENS for management of central pain in people with multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Central pain; Pain management; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.08999826284677248,"score_gpt":0.30954718935544195,"score_spread":0.21954892650866947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131152693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091556634,0.99835265,0.00008030598,0.00009010636,0.000082585684,0.00014237134,0.0001633708,0.000005219457,0.00016784725],"genre_scores_gemma":[0.011837854,0.9870488,0.00035974407,0.0003286339,0.000066619046,0.00013888614,0.00011488597,0.000002765499,0.0001019372],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99764663,0.00063820055,0.0010599053,0.0002075563,0.00035684256,0.00009094128],"domain_scores_gemma":[0.9943141,0.0040326864,0.0011288892,0.000074514566,0.00035921435,0.00009062884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034136907,0.0013690419,0.007974852,0.0041840514,0.00043778116,0.0016131619,0.0016284945,0.0016117118,0.0045666904],"category_scores_gemma":[0.013070294,0.0007029143,0.007871034,0.004172465,0.0006184278,0.00135204,0.0011525863,0.0012380707,0.00019965942],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006661027,0.0000256912,0.0002911751,0.94507664,0.019560728,0.00009925828,0.00008649365,0.00010154983,0.00023999566,0.000101694815,0.00095717376,0.032793477],"study_design_scores_gemma":[0.0022284293,0.00092034024,0.0068491334,0.57455105,0.38507187,0.0006849675,0.00027633493,0.00014718156,0.00037489156,0.00046832854,0.02834559,0.000081831975],"about_ca_topic_score_codex":0.006834489,"about_ca_topic_score_gemma":0.019296853,"teacher_disagreement_score":0.007974852,"about_ca_system_score_codex":0.0015119086,"about_ca_system_score_gemma":0.004274363,"threshold_uncertainty_score":0.018053532},"labels":[],"label_agreement":null},{"id":"W2133260093","doi":"10.1016/j.msard.2014.06.006","title":"First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Discontinuation; Palpitations; Internal medicine; Concomitant; Population; Asymptomatic; Bradycardia; Multiple sclerosis; Hazard ratio; Randomized controlled trial; Anesthesia; Heart rate; Blood pressure; Confidence interval","score_opus":0.03996981292271586,"score_gpt":0.28837461309460405,"score_spread":0.24840480017188818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133260093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751425,0.0010170889,0.00010189466,0.00016908646,0.00009454393,0.00018938592,0.0003628725,0.00002308095,0.00052781875],"genre_scores_gemma":[0.9971825,0.0005292201,0.00032579032,0.00029098932,0.00019607437,0.0002673657,0.0005383475,0.000011875823,0.00065796025],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986511,0.0007216549,0.000066021654,0.00020899698,0.00009906903,0.00025316892],"domain_scores_gemma":[0.9978028,0.0007919837,0.00056505005,0.00023891272,0.00009261775,0.00050858234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002530602,0.00114521,0.0027720989,0.00036579501,0.00045099691,0.0011739637,0.0007568193,0.0015560093,0.0023373498],"category_scores_gemma":[0.0032201568,0.00041495048,0.0020239651,0.0003674501,0.000864813,0.001214358,0.00048712967,0.0037851878,0.00029479153],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9791469,0.0052786083,0.0022327215,0.00010568558,0.0009884001,0.000027677796,0.000044460787,0.000241928,0.0013454398,0.0000561187,0.00035016204,0.010181836],"study_design_scores_gemma":[0.8646739,0.100229956,0.030117452,0.00004702369,0.002295433,0.000059040805,0.00007401704,0.0006805941,0.0010184,0.00024655624,0.00052479457,0.00003283403],"about_ca_topic_score_codex":0.0018035079,"about_ca_topic_score_gemma":0.002352005,"teacher_disagreement_score":0.0027720989,"about_ca_system_score_codex":0.0007869498,"about_ca_system_score_gemma":0.0010499532,"threshold_uncertainty_score":0.013383269},"labels":[],"label_agreement":null},{"id":"W2134894009","doi":"10.1016/j.msard.2015.10.004","title":"Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba","funders":"Canadian Institutes of Health Research; Dalhousie University; Multiple Sclerosis Society of Canada; Research Manitoba","keywords":"Medicine; Anxiety; Meta-analysis; Depression (economics); PsycINFO; CINAHL; MEDLINE; Population; Psychological intervention; Randomized controlled trial; Clinical trial; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.18421839617710947,"score_gpt":0.36616257904167976,"score_spread":0.1819441828645703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134894009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003587579,0.9946926,0.0004044088,0.00012760391,0.00017962733,0.0005097268,0.00025525322,0.000024362344,0.00021873417],"genre_scores_gemma":[0.10117167,0.89322346,0.00273647,0.0008114951,0.00017875926,0.0011924691,0.00032571238,0.000020891372,0.00033906975],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9923035,0.0032484117,0.0026436588,0.00063700206,0.00087129907,0.00029607248],"domain_scores_gemma":[0.9899569,0.007181896,0.0016621439,0.00031553608,0.00070008606,0.00018343024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009129273,0.0030268752,0.021544665,0.005703056,0.00080641935,0.0027595912,0.0021941033,0.0023628438,0.004999333],"category_scores_gemma":[0.030486982,0.001703028,0.024566857,0.005996483,0.00086875097,0.0020042972,0.0022187098,0.0026097256,0.0002802735],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00232214,0.000052488445,0.0008983388,0.6352551,0.34439954,0.0001006526,0.00012650288,0.0002514709,0.00023122726,0.00011823322,0.0004860048,0.015758326],"study_design_scores_gemma":[0.0019742087,0.00031125866,0.0019876899,0.046676297,0.9465329,0.000085173684,0.00007157755,0.00008836945,0.00010724025,0.0001902289,0.0019484443,0.000026567554],"about_ca_topic_score_codex":0.011942037,"about_ca_topic_score_gemma":0.03017817,"teacher_disagreement_score":0.021544665,"about_ca_system_score_codex":0.003270518,"about_ca_system_score_gemma":0.005199759,"threshold_uncertainty_score":0.048280776},"labels":[],"label_agreement":null},{"id":"W2143842592","doi":"10.1016/j.msard.2015.06.011","title":"Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; McGill University","keywords":"Telerehabilitation; Psychological intervention; Medicine; Observational study; Physical therapy; Quality of life (healthcare); Physical medicine and rehabilitation; Intervention (counseling); MEDLINE; Randomized controlled trial; Telemedicine; Systematic review; Evidence-based medicine; Health care; Alternative medicine; Nursing","score_opus":0.09180659834877229,"score_gpt":0.3407987065212382,"score_spread":0.24899210817246592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143842592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023450914,0.99694115,0.00008878095,0.000086475586,0.000076587545,0.00017750493,0.00014132196,0.000006409913,0.00013655955],"genre_scores_gemma":[0.034091737,0.9644822,0.00055647036,0.00033988024,0.000064839696,0.00024655793,0.00012060153,0.0000040832447,0.00009359945],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959787,0.001255642,0.0014307029,0.00037859418,0.0007756671,0.00018066929],"domain_scores_gemma":[0.99029595,0.0069972132,0.0017818263,0.00012596845,0.0006211941,0.00017773974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051717455,0.0014701841,0.010229755,0.004853388,0.00055955304,0.002110221,0.0017122541,0.0020744966,0.0037077633],"category_scores_gemma":[0.019911533,0.0011072366,0.009691377,0.0051086177,0.0007359458,0.0017432792,0.0015239314,0.0017382634,0.00018511576],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010626231,0.00007299405,0.00095011503,0.9159158,0.042267624,0.00010220369,0.00016651144,0.00014045372,0.0001762906,0.00010099372,0.00069215643,0.03835221],"study_design_scores_gemma":[0.0027033822,0.00093430973,0.009523972,0.4933662,0.4827398,0.00042469517,0.00048161016,0.00019763027,0.00031967336,0.00028044012,0.00895145,0.00007682278],"about_ca_topic_score_codex":0.010105291,"about_ca_topic_score_gemma":0.029663462,"teacher_disagreement_score":0.010229755,"about_ca_system_score_codex":0.0029390599,"about_ca_system_score_gemma":0.005649546,"threshold_uncertainty_score":0.027351141},"labels":[],"label_agreement":null},{"id":"W2144456095","doi":"10.1016/j.msard.2014.10.001","title":"The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)","year":2014,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"IC Design Education Center; Teva Pharmaceutical Industries; Canadian Institutes of Health Research; Biogen","keywords":"Medicine; Pregnancy; Multiple sclerosis; Epidemiology; Gestation; Disease; Obstetrics; Disease registry; Pediatrics; Internal medicine; Immunology","score_opus":0.05401995808955339,"score_gpt":0.2536066723674934,"score_spread":0.19958671427794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144456095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006653983,0.98872185,0.0013060234,0.006132445,0.0010279755,0.000033206008,0.00017354044,0.000040864856,0.0018987231],"genre_scores_gemma":[0.0070314547,0.98357403,0.0032148059,0.003461424,0.0013700306,0.000061859064,0.00051313255,0.000008311803,0.00076490757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990889,0.0003491971,0.00015308674,0.00014086076,0.00019014908,0.00007778529],"domain_scores_gemma":[0.996181,0.0021919282,0.0004506898,0.00012690909,0.0007219356,0.0003276375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031407946,0.00048022647,0.001270003,0.0019153102,0.00033295737,0.0011057868,0.0011806907,0.0016474796,0.002811506],"category_scores_gemma":[0.0051147263,0.00022733623,0.0006715693,0.0012689577,0.0004678997,0.0021081986,0.0012866227,0.0022543739,0.0008356399],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006601964,0.000073588584,0.0045255707,0.0073489984,0.000080232836,0.00026335375,0.00007737588,0.00022035821,0.00030939138,0.0032049567,0.037463907,0.9463663],"study_design_scores_gemma":[0.00009556883,0.00019843041,0.025365604,0.035117365,0.0006744495,0.0036440666,0.0007208801,0.0003919473,0.00049615576,0.0048968517,0.928335,0.00006375036],"about_ca_topic_score_codex":0.0032201798,"about_ca_topic_score_gemma":0.0036295904,"teacher_disagreement_score":0.0032201798,"about_ca_system_score_codex":0.00079102826,"about_ca_system_score_gemma":0.005148093,"threshold_uncertainty_score":0.016610324},"labels":[],"label_agreement":null},{"id":"W2148777218","doi":"10.1016/j.msard.2015.07.008","title":"Causes of death among persons with multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Pharmaceuticals Bayer","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.071921140258111,"score_gpt":0.27006203358034037,"score_spread":0.19814089332222937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148777218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824212,0.008264991,0.00010298885,0.00039562618,0.00010316619,0.000017036788,0.005466537,0.000016053864,0.003212355],"genre_scores_gemma":[0.9924321,0.0038521797,0.00005900394,0.000108657114,0.00011537075,0.000020094369,0.0025055413,0.0000033436045,0.00090370874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966455,0.00009376837,0.00005433718,0.00004784518,0.00005771065,0.00008178639],"domain_scores_gemma":[0.9990945,0.0001526207,0.00037541304,0.00007288098,0.00016312512,0.00014148248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039977065,0.00030425165,0.000460811,0.0020282404,0.0004995639,0.00059460633,0.0003164348,0.0006489049,0.0016976764],"category_scores_gemma":[0.0017951175,0.00025546586,0.0010346672,0.0023792179,0.0001593012,0.00062977,0.0004981044,0.0007202866,0.00025185393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021273384,0.000031838867,0.9955937,0.00007117371,0.00021882607,0.00012390243,0.00012889552,0.00003730742,0.00006295354,0.00005946344,0.00070102245,0.002758114],"study_design_scores_gemma":[0.000009784151,0.000029079556,0.99892634,0.000026015563,0.00009471172,0.00012451081,0.00026431514,0.000050003186,0.000021059646,0.000055639135,0.0003949221,0.0000036455697],"about_ca_topic_score_codex":0.019138098,"about_ca_topic_score_gemma":0.020070959,"teacher_disagreement_score":0.019138098,"about_ca_system_score_codex":0.00040703634,"about_ca_system_score_gemma":0.00053071004,"threshold_uncertainty_score":0.038053393},"labels":[],"label_agreement":null},{"id":"W2150598981","doi":"10.1016/j.msard.2012.06.002","title":"Treatment of neuromyelitis optica: Review and recommendations","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":263,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Neuromyelitis optica; Medicine; Azathioprine; Rituximab; Multiple sclerosis; Mitoxantrone; Natalizumab; Prednisone; Optic neuritis; Methotrexate; Disease; Demyelinating disease; Immunology; Intensive care medicine; Dermatology; Internal medicine; Lymphoma; Chemotherapy","score_opus":0.05910238043995268,"score_gpt":0.30503082558224137,"score_spread":0.24592844514228868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150598981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007846182,0.9973652,0.00007466457,0.0017570682,0.00043780642,0.000033826524,0.000054300257,0.0000048255342,0.00019379485],"genre_scores_gemma":[0.0006606801,0.99643743,0.0005693787,0.0017148526,0.0003825246,0.00004631504,0.00004975773,0.0000019161455,0.00013714151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982071,0.00044939943,0.0006973999,0.00020682834,0.00035165309,0.000087627755],"domain_scores_gemma":[0.9938356,0.003625565,0.0012426527,0.00007469745,0.0009966324,0.00022477824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044390117,0.0014097159,0.0066655274,0.0033564637,0.000644331,0.0022151857,0.0033950147,0.0035809032,0.006468051],"category_scores_gemma":[0.008642854,0.00069599313,0.0034034112,0.0031547546,0.0009507653,0.0023467992,0.0010596773,0.0031936502,0.001223493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011153489,0.00020938658,0.00080886774,0.30903637,0.0029290894,0.00043507243,0.00014348097,0.00043324134,0.00064991,0.0014191266,0.05919937,0.62362075],"study_design_scores_gemma":[0.0017402373,0.0006700472,0.00414955,0.5095568,0.01910903,0.0013928392,0.0005731433,0.0003237369,0.00044545677,0.0035802182,0.45834333,0.00011564714],"about_ca_topic_score_codex":0.006877336,"about_ca_topic_score_gemma":0.01938095,"teacher_disagreement_score":0.006877336,"about_ca_system_score_codex":0.0017869362,"about_ca_system_score_gemma":0.0046506203,"threshold_uncertainty_score":0.023476005},"labels":[],"label_agreement":null},{"id":"W2150843744","doi":"10.1016/j.msard.2015.03.005","title":"Impact of multiple sclerosis relapse: The NARCOMS participant perspective","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; University of Alabama at Birmingham; Cleveland Clinic","keywords":"Medicine; Weakness; Adverse effect; Socioeconomic status; Multiple sclerosis; Physical therapy; Pediatrics; Internal medicine; Psychiatry; Population; Surgery; Environmental health","score_opus":0.11985218648706887,"score_gpt":0.32715469634648775,"score_spread":0.2073025098594189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150843744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62064296,0.0070701675,0.00028710894,0.28939322,0.0024349452,0.00016839252,0.0032339536,0.000041719046,0.07672756],"genre_scores_gemma":[0.95334625,0.0065350155,0.00047609743,0.0271441,0.0020845176,0.00014874172,0.0008990177,0.00003885625,0.009327382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482334,0.0033221927,0.0001929157,0.0002349496,0.00066037814,0.000766226],"domain_scores_gemma":[0.9911951,0.001958816,0.0018087835,0.00026225945,0.0019747685,0.0028002337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008108493,0.0002769806,0.00043319748,0.00069350237,0.0026095293,0.0032487372,0.00076273753,0.0015640097,0.012251543],"category_scores_gemma":[0.014837774,0.00013567595,0.00043206706,0.00070893124,0.00089358917,0.0030331742,0.0030632375,0.0020392393,0.00081340264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070412864,0.00064545503,0.606572,0.0014131997,0.00029289926,0.0041103303,0.08978361,0.00016650489,0.0010891405,0.0070770825,0.17188476,0.11626085],"study_design_scores_gemma":[0.00009048912,0.0014936295,0.3365233,0.0030906354,0.00021193728,0.005423427,0.3430436,0.00025851376,0.0004650508,0.0032892849,0.30598763,0.00012256535],"about_ca_topic_score_codex":0.009402396,"about_ca_topic_score_gemma":0.019514188,"teacher_disagreement_score":0.012251543,"about_ca_system_score_codex":0.0012481718,"about_ca_system_score_gemma":0.0028477653,"threshold_uncertainty_score":0.042882323},"labels":[],"label_agreement":null},{"id":"W2153660935","doi":"10.1016/j.msard.2013.05.001","title":"Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study","year":2013,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Ottawa; Ottawa Hospital","funders":"Multiple Sclerosis Society of Canada; Ottawa Hospital Research Institute","keywords":"Medicine; Brain size; Multiple sclerosis; Hematopoietic stem cell transplantation; Cognitive decline; Neuropsychology; Cognition; Neuroimaging; Transplantation; White matter; Internal medicine; Immunosuppression; Stem cell; Stem-cell therapy; Magnetic resonance imaging; Psychiatry; Dementia; Radiology; Disease","score_opus":0.10941312305433593,"score_gpt":0.27682485745710045,"score_spread":0.16741173440276452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153660935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995573,0.00008673823,0.000014378276,0.000019908779,0.000004576172,0.000044970417,0.000032427724,0.0000011642168,0.00023858603],"genre_scores_gemma":[0.9991953,0.00014495368,0.00007504902,0.000042697953,0.000032409644,0.000098434866,0.00013373104,0.0000012329342,0.0002761762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993856,0.00029099602,0.000050326395,0.00007450596,0.00010225378,0.00009640196],"domain_scores_gemma":[0.9979469,0.00052917824,0.0004998578,0.00020289325,0.00023145517,0.0005896135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014400649,0.0006844283,0.0010711097,0.0007677535,0.0011260331,0.0006198307,0.0007147814,0.00097149843,0.0011483354],"category_scores_gemma":[0.0029843098,0.0003300772,0.0008615732,0.0008155253,0.0010548664,0.0009071231,0.0006141505,0.0012830036,0.00025620862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07538061,0.09161524,0.78397936,0.0002832724,0.0013683034,0.0061534797,0.0030889877,0.00034018717,0.008155842,0.00018809015,0.0006369176,0.028809784],"study_design_scores_gemma":[0.003091591,0.043366905,0.948979,0.00001707801,0.00045422753,0.001234483,0.0011575299,0.00027686436,0.0008321662,0.00015317487,0.00039193025,0.00004496505],"about_ca_topic_score_codex":0.010486618,"about_ca_topic_score_gemma":0.009700681,"teacher_disagreement_score":0.010486618,"about_ca_system_score_codex":0.0007834108,"about_ca_system_score_gemma":0.001188163,"threshold_uncertainty_score":0.020851135},"labels":[],"label_agreement":null},{"id":"W2155985098","doi":"10.1016/j.msard.2012.12.008","title":"The case for vitamin D supplementation in multiple sclerosis","year":2013,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Northeast Agricultural University","keywords":"Multiple sclerosis; Medicine; Vitamin D and neurology; Vitamin; Dermatology; Immunology; Internal medicine","score_opus":0.09870726692141728,"score_gpt":0.32930019459119186,"score_spread":0.23059292766977457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155985098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026953403,0.9993418,0.000017937313,0.0003583308,0.00009972518,0.0000012272104,0.0000052187415,0.0000010826253,0.00014778187],"genre_scores_gemma":[0.0005517857,0.9983987,0.00011165081,0.0006738535,0.0001478164,0.0000032586618,0.00000790378,5.965207e-7,0.00010448469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992512,0.0002104191,0.00021823296,0.000110671055,0.00017519949,0.000034284585],"domain_scores_gemma":[0.9973533,0.00208469,0.00024922975,0.00005318902,0.00021702392,0.00004266206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020288725,0.00064202555,0.0023288778,0.0037738483,0.0003998579,0.0016237498,0.0009994402,0.0026390837,0.0036259035],"category_scores_gemma":[0.0040968754,0.00037698954,0.0012123315,0.00413735,0.0010498691,0.0020568105,0.0011529404,0.0026396182,0.0006107745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025876774,0.00005361876,0.00048318642,0.12027173,0.0010088951,0.00063747895,0.00020540337,0.000128464,0.0011102435,0.0039379895,0.037655532,0.83424866],"study_design_scores_gemma":[0.00017203113,0.00010680526,0.0019994108,0.08356306,0.0024424756,0.00276005,0.00032998712,0.000068561734,0.00037659972,0.0038982606,0.90424037,0.00004251836],"about_ca_topic_score_codex":0.0029381688,"about_ca_topic_score_gemma":0.007141004,"teacher_disagreement_score":0.0037738483,"about_ca_system_score_codex":0.0008848221,"about_ca_system_score_gemma":0.0021695243,"threshold_uncertainty_score":0.012129843},"labels":[],"label_agreement":null},{"id":"W2157274485","doi":"10.1016/j.msard.2012.05.002","title":"Cognitive impact of anticholinergic medication in MS: Adding insult to injury?","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Anticholinergic; Cognition; Multiple sclerosis; Context (archaeology); Beck Depression Inventory; Depression (economics); Population; Effects of sleep deprivation on cognitive performance; Clinical psychology; Psychiatry; Internal medicine; Anxiety","score_opus":0.041557110188370765,"score_gpt":0.3309136278458142,"score_spread":0.2893565176574434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157274485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84334433,0.1278324,0.00024875216,0.012123709,0.0012614527,0.000083688654,0.00067605014,0.000015120559,0.014414524],"genre_scores_gemma":[0.9651428,0.027992718,0.00045411958,0.0027683305,0.002557849,0.000032160264,0.0002870314,0.000004873776,0.0007600163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980661,0.00068097084,0.00037902166,0.00015222811,0.0004888057,0.00023280406],"domain_scores_gemma":[0.9877599,0.005376552,0.003558537,0.0006134798,0.0019942936,0.0006972791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031672148,0.00059039606,0.0012984923,0.0018334831,0.0009808686,0.0028066533,0.0009504641,0.0016696547,0.0038979203],"category_scores_gemma":[0.021994814,0.00027228982,0.001380757,0.0026670978,0.0008133701,0.0026327958,0.0011290981,0.0017878687,0.0002761487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040857196,0.00087241776,0.78689986,0.0033155933,0.00432135,0.0016552446,0.0013473885,0.00015272775,0.00031446794,0.00091847155,0.002939933,0.1931768],"study_design_scores_gemma":[0.00016477496,0.001014942,0.98658866,0.0013359106,0.003146114,0.0010458283,0.0018261613,0.00015240602,0.0001795811,0.0010227553,0.0034747063,0.000048251524],"about_ca_topic_score_codex":0.013812048,"about_ca_topic_score_gemma":0.027951043,"teacher_disagreement_score":0.013812048,"about_ca_system_score_codex":0.00088514347,"about_ca_system_score_gemma":0.0019082958,"threshold_uncertainty_score":0.027463257},"labels":[],"label_agreement":null},{"id":"W2157932760","doi":"10.1016/j.msard.2015.06.012","title":"Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis","year":2015,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Sarcoidosis and Beryllium Toxicity Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Neurosarcoidosis; Medicine; Multiple sclerosis; Sarcoidosis; Differential diagnosis; Brain biopsy; Presentation (obstetrics); Intensive care medicine; Pathology; Biopsy; Radiology; Immunology","score_opus":0.242094896031619,"score_gpt":0.4067767959533758,"score_spread":0.1646818999217568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157932760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044798344,0.99934095,0.000029156425,0.00031532784,0.000110618945,0.0000017315193,0.0000061668875,0.0000013642352,0.00014990054],"genre_scores_gemma":[0.0011171105,0.99772114,0.00020384605,0.0006218074,0.00020525802,0.0000033683486,0.000015048386,0.0000011315021,0.00011129362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990343,0.00031651073,0.00020626883,0.00010305718,0.00029879372,0.000041083647],"domain_scores_gemma":[0.9967603,0.0023822784,0.0003529039,0.00005662597,0.00037801065,0.00006986781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002253025,0.0007185014,0.00348457,0.0024126905,0.00031211224,0.0018157882,0.0010644976,0.0021866113,0.002837308],"category_scores_gemma":[0.004490859,0.00032795614,0.0010391729,0.0018736887,0.0008666517,0.002120431,0.0007509739,0.0030215671,0.0006626681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002458836,0.000053427517,0.00057959167,0.05989784,0.0008237839,0.0003579472,0.000109740584,0.00022561802,0.00061790546,0.0046215644,0.030160813,0.9023057],"study_design_scores_gemma":[0.0002270491,0.00020075074,0.0024682651,0.07692869,0.002549593,0.0052761757,0.00047981815,0.000267145,0.00048231552,0.007949476,0.90308046,0.00009029459],"about_ca_topic_score_codex":0.0021884525,"about_ca_topic_score_gemma":0.0055563156,"teacher_disagreement_score":0.00348457,"about_ca_system_score_codex":0.00091811875,"about_ca_system_score_gemma":0.0021223642,"threshold_uncertainty_score":0.0119152665},"labels":[],"label_agreement":null},{"id":"W2171984869","doi":"10.1016/j.msard.2014.09.213","title":"CD20+ T cells in multiple sclerosis","year":2014,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; CD8; Medicine; Cytotoxic T cell; Immunology; Rituximab; Web of science; T cell; Antibody; Pathology; Biology; Antigen; Immune system; Meta-analysis; In vitro; Biochemistry","score_opus":0.044285024032432965,"score_gpt":0.25267670031417616,"score_spread":0.2083916762817432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171984869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936739,0.0041802907,0.000034831897,0.00013594427,0.000021043286,0.0000061998917,0.000044085427,0.0000027318301,0.0019009421],"genre_scores_gemma":[0.9980149,0.0009580484,0.000053857653,0.00008872938,0.00006650589,0.000011023878,0.00005094984,0.0000012237497,0.0007547858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968386,0.0001538593,0.000027974655,0.000032124437,0.000039037935,0.00006309876],"domain_scores_gemma":[0.9994554,0.00018402579,0.00012315369,0.000022941149,0.00007942132,0.00013497658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078195264,0.00018987214,0.00025324375,0.0014668998,0.00041785437,0.00046260536,0.00024281254,0.0005731032,0.0032688612],"category_scores_gemma":[0.0015017457,0.00013098284,0.00011611869,0.0010297917,0.00025262713,0.00056149025,0.00037805666,0.00028412355,0.00025820133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004642949,0.0010113958,0.9104193,0.0003948052,0.00023438192,0.0025292207,0.0010054099,0.000129048,0.017904587,0.0006573084,0.0011593787,0.05991207],"study_design_scores_gemma":[0.00013945022,0.0010579868,0.9890493,0.00008050819,0.00012732773,0.00323062,0.0010468771,0.00017518905,0.0012596746,0.0005950645,0.003229811,0.000008105837],"about_ca_topic_score_codex":0.0011379333,"about_ca_topic_score_gemma":0.0017233283,"teacher_disagreement_score":0.0032688612,"about_ca_system_score_codex":0.0002508479,"about_ca_system_score_gemma":0.0002299634,"threshold_uncertainty_score":0.010935426},"labels":[],"label_agreement":null},{"id":"W2175178720","doi":"10.1016/j.msard.2015.10.007","title":"Spasticity in multiple sclerosis: Associations with impairments and overall quality of life","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux; Biogen","keywords":"Spasticity; Medicine; Depression (economics); Anxiety; Quality of life (healthcare); Multiple sclerosis; Physical therapy; Hospital Anxiety and Depression Scale; Mood; Physical medicine and rehabilitation; Visual analogue scale; Psychiatry","score_opus":0.10090376673045053,"score_gpt":0.2992243905898357,"score_spread":0.19832062385938515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175178720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641466,0.0028479528,0.000029357514,0.00006999321,0.000008101005,0.000004922278,0.00015354478,0.0000012642973,0.00047016348],"genre_scores_gemma":[0.9987387,0.0008774432,0.00005583086,0.000019000747,0.000016336144,0.000004635032,0.00016790337,4.5445955e-7,0.00011976509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994068,0.00024149421,0.00011196987,0.00007230793,0.00009174745,0.00007563027],"domain_scores_gemma":[0.99745256,0.0006190326,0.0013446037,0.00007860185,0.00019942055,0.0003057766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011490237,0.00038984665,0.0005343441,0.0014862863,0.00045960347,0.0007628076,0.0003434321,0.0005796095,0.0014906725],"category_scores_gemma":[0.0034728798,0.00025736517,0.0008353517,0.0022190572,0.00037363925,0.00054859684,0.0007320804,0.0007409383,0.00011527131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018723046,0.00007614991,0.99701726,0.000046178888,0.0003704235,0.000049876224,0.0000753973,0.000043873457,0.00008255226,0.000013413881,0.00003696623,0.0020006478],"study_design_scores_gemma":[0.00000411056,0.000084221654,0.99956685,0.000011650414,0.000068337074,0.000060253962,0.000098587894,0.000044981356,0.000008773,0.00001349998,0.00003635167,0.000002392965],"about_ca_topic_score_codex":0.00893945,"about_ca_topic_score_gemma":0.0130228875,"teacher_disagreement_score":0.00893945,"about_ca_system_score_codex":0.0003800421,"about_ca_system_score_gemma":0.00039532786,"threshold_uncertainty_score":0.01777482},"labels":[],"label_agreement":null},{"id":"W2188134163","doi":"10.1016/j.msard.2015.11.007","title":"Reducing clinical trial risk in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; St. Michael's Hospital; Toronto Rehabilitation Institute; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Clinical trial; Multiple sclerosis; Drug; Population; Phases of clinical research; Pharmaceutical industry; Clinical research; Internal medicine; Intensive care medicine; Pharmacology; Immunology; Environmental health","score_opus":0.172068959375452,"score_gpt":0.3449676101354311,"score_spread":0.1728986507599791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188134163","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49258268,0.36507717,0.016681397,0.061066158,0.0055256938,0.006155345,0.001697123,0.00047228843,0.05074228],"genre_scores_gemma":[0.95129675,0.025556438,0.0079314,0.007970653,0.002299767,0.002486865,0.00036148127,0.00007221942,0.0020243528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.81191057,0.17057201,0.009327055,0.002245168,0.0047270013,0.0012181114],"domain_scores_gemma":[0.6389397,0.29253262,0.037401844,0.01543654,0.008263716,0.0074256817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09217026,0.0006783673,0.0028025378,0.0017678466,0.0009979274,0.0026387186,0.00097521755,0.0030925765,0.0063454546],"category_scores_gemma":[0.31701067,0.00061448454,0.002184126,0.0024303915,0.0013683263,0.002847492,0.001996978,0.004153515,0.00069986156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32406977,0.0047525237,0.07639041,0.020156741,0.04571896,0.0004384491,0.0027605118,0.001364707,0.0010682807,0.013574311,0.023762295,0.48594308],"study_design_scores_gemma":[0.34376562,0.08524757,0.25971508,0.021288544,0.08439207,0.0011475348,0.0020102176,0.008502747,0.0028011128,0.082451515,0.10833264,0.00034526165],"about_ca_topic_score_codex":0.0009465321,"about_ca_topic_score_gemma":0.0016383943,"teacher_disagreement_score":0.09217026,"about_ca_system_score_codex":0.000994993,"about_ca_system_score_gemma":0.0035798552,"threshold_uncertainty_score":0.48744875},"labels":[],"label_agreement":null},{"id":"W2195362151","doi":"10.1016/j.msard.2015.11.006","title":"Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Teriflunomide; Medicine; Tolerability; Discontinuation; Adverse effect; Placebo; Internal medicine; Clinical trial; Nausea; Multiple sclerosis; Fingolimod; Immunology; Pathology; Alternative medicine","score_opus":0.12482319335835053,"score_gpt":0.3203329941100626,"score_spread":0.1955098007517121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2195362151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7132451,0.24571666,0.009314808,0.0005959223,0.00072007714,0.0062130676,0.015981462,0.0006137182,0.0075992267],"genre_scores_gemma":[0.9618032,0.02348991,0.0025162655,0.0006142807,0.0003729461,0.002634109,0.006702961,0.00009522881,0.0017710833],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.991882,0.0042378344,0.0019081272,0.00075452094,0.00083723,0.00038017097],"domain_scores_gemma":[0.9864972,0.0073259147,0.0032692293,0.0014169195,0.0011285382,0.0003621633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015560023,0.0025545354,0.008589728,0.0021371942,0.0005314509,0.0020907312,0.0009817105,0.0016121822,0.004490895],"category_scores_gemma":[0.0165061,0.0011069562,0.01772582,0.0017798844,0.0007965223,0.0020257593,0.0011475972,0.0021726524,0.0005883558],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6220185,0.00062370213,0.010098137,0.02430076,0.27584574,0.00023612117,0.00028578687,0.0021628977,0.009101902,0.00018965885,0.0016150562,0.053521745],"study_design_scores_gemma":[0.24511041,0.039750617,0.08628966,0.001921721,0.6113791,0.0005870668,0.000299534,0.0010361333,0.0059651574,0.0009911786,0.0064362166,0.0002333047],"about_ca_topic_score_codex":0.000801459,"about_ca_topic_score_gemma":0.0013698302,"teacher_disagreement_score":0.015560023,"about_ca_system_score_codex":0.0008380049,"about_ca_system_score_gemma":0.0008819187,"threshold_uncertainty_score":0.08229023},"labels":[],"label_agreement":null},{"id":"W2219352761","doi":"10.1016/j.msard.2015.05.002","title":"Corrigendum to “Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis” [Mult. Scler. Relat. Disord. 4 (2015) 104–111]","year":2015,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Dysautonomia; Regret; Spelling; Internal medicine; Cardiology; Psychiatry; Disease","score_opus":0.08134465008097701,"score_gpt":0.24602184000507774,"score_spread":0.16467718992410074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219352761","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000099419616,0.008890423,0.0003255094,0.057515692,0.9289962,0.0000763721,0.0024901184,0.00019010148,0.001416252],"genre_scores_gemma":[0.008701159,0.02537137,0.0028386095,0.26260853,0.5821356,0.00084236264,0.007885872,0.00064772397,0.108968824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99383587,0.001469547,0.0013827517,0.00075998093,0.002115276,0.00043657806],"domain_scores_gemma":[0.96330816,0.013919063,0.003259306,0.001841897,0.016269542,0.0014021001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0088623585,0.0027951356,0.004420094,0.006027403,0.0019668075,0.0031649843,0.0034569453,0.0062998105,0.07395155],"category_scores_gemma":[0.09442419,0.0014084318,0.006044387,0.004789718,0.0011629809,0.0019807732,0.0025476909,0.0067034285,0.020836161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058562175,0.0000070221645,0.00014087376,0.0007201478,0.00011820231,0.00018806352,0.000012124398,0.000030073781,0.00002002318,0.00010566888,0.99512994,0.003469224],"study_design_scores_gemma":[0.0007017933,0.000113424474,0.006677197,0.006221295,0.0021850986,0.0010875616,0.0000921258,0.0005714853,0.00046531533,0.0020802647,0.9796545,0.00014995023],"about_ca_topic_score_codex":0.020303845,"about_ca_topic_score_gemma":0.03952252,"teacher_disagreement_score":0.07395155,"about_ca_system_score_codex":0.0036035022,"about_ca_system_score_gemma":0.0055638957,"threshold_uncertainty_score":0.24739254},"labels":[],"label_agreement":null},{"id":"W2269092789","doi":"10.1016/j.msard.2016.02.001","title":"Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"Biogen","keywords":"Medicine; Daclizumab; Multiple sclerosis; Disease; Ocrelizumab; Relapsing remitting; Physical therapy; Clinical trial; Internal medicine; Natalizumab; Dimethyl fumarate; Alemtuzumab; Intensive care medicine; Immunology; Rituximab; Transplantation","score_opus":0.08869802365204665,"score_gpt":0.32983019147040266,"score_spread":0.241132167818356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269092789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850973,0.010946619,0.00023125963,0.00048550993,0.00016144093,0.00027316748,0.0013749503,0.000016729577,0.0014129373],"genre_scores_gemma":[0.9927249,0.0035236673,0.0004118901,0.00040775293,0.0003409949,0.0004956599,0.0013399572,0.000008918551,0.00074631575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974732,0.0016073914,0.00026199335,0.00020683993,0.00028933305,0.0001613574],"domain_scores_gemma":[0.99407274,0.002987105,0.0018119253,0.00030840648,0.00029144503,0.0005284847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004169617,0.0011105351,0.002925324,0.0004098606,0.0004514709,0.0012925331,0.00047625726,0.0011661057,0.0024941475],"category_scores_gemma":[0.0062771766,0.00026262415,0.004220369,0.0007658372,0.00072722766,0.0010286116,0.0007898968,0.0016704004,0.00027222],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90398544,0.0017258745,0.03690018,0.0021953972,0.025952661,0.00007433016,0.00014659703,0.0006660441,0.0013276709,0.00022833962,0.0010267722,0.025770681],"study_design_scores_gemma":[0.56171894,0.12680802,0.24515617,0.0007454753,0.056815952,0.00030391323,0.00051919196,0.001218414,0.0013942793,0.00095205713,0.0042255805,0.0001420522],"about_ca_topic_score_codex":0.0013480335,"about_ca_topic_score_gemma":0.0026013597,"teacher_disagreement_score":0.004169617,"about_ca_system_score_codex":0.0006140317,"about_ca_system_score_gemma":0.00090860954,"threshold_uncertainty_score":0.022051275},"labels":[],"label_agreement":null},{"id":"W2284283107","doi":"10.1016/j.msard.2016.02.012","title":"Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life – A post hoc analysis of the TEMSO and TOWER studies","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare; Sanofi Genzyme; Sanofi; Genzyme","keywords":"Post-hoc analysis; Medicine; Multiple sclerosis; Post hoc; Quality of life (healthcare); Health related quality of life; Physical medicine and rehabilitation; Physical therapy; Internal medicine; Disease; Immunology","score_opus":0.09871362279575006,"score_gpt":0.3100903200121196,"score_spread":0.21137669721636954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2284283107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938431,0.003939574,0.0004634537,0.00007100778,0.000050856466,0.00014515761,0.0009994502,0.000016577986,0.00047079087],"genre_scores_gemma":[0.99804115,0.00025087778,0.00033126416,0.00004642959,0.000052740525,0.00013613193,0.00087074057,0.0000125414135,0.00025820642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920223,0.004904313,0.0008131881,0.0011063518,0.0006817857,0.00047210106],"domain_scores_gemma":[0.9866621,0.0075451927,0.0030474202,0.0013424688,0.0007916352,0.00061124365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011449157,0.0008235469,0.0020167506,0.0011193255,0.00036100572,0.0010826313,0.0006581393,0.00054208573,0.0033756273],"category_scores_gemma":[0.0074556237,0.0003016056,0.008209126,0.0009839146,0.00036774692,0.00065371464,0.00093628594,0.00094317616,0.00021590435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110722974,0.00044846578,0.74782425,0.002086694,0.11446858,0.0008003414,0.00032981674,0.0009102082,0.004906154,0.00011357287,0.0016641588,0.015724761],"study_design_scores_gemma":[0.002480072,0.010293571,0.9550744,0.00013217269,0.027812649,0.000545247,0.00027201464,0.0013143836,0.00064992625,0.00007256895,0.0013114982,0.000041557272],"about_ca_topic_score_codex":0.0008886382,"about_ca_topic_score_gemma":0.0017639827,"teacher_disagreement_score":0.011449157,"about_ca_system_score_codex":0.0002430824,"about_ca_system_score_gemma":0.0005366126,"threshold_uncertainty_score":0.060549676},"labels":[],"label_agreement":null},{"id":"W2346221108","doi":"10.1016/j.msard.2016.05.006","title":"Adherence and persistence to drug therapies for multiple sclerosis: A population-based study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Quality Council; University of British Columbia Hospital; Health Sciences Centre; Manitoba Health; University of Manitoba; University of Saskatchewan","funders":"Ministry of Health, British Columbia; National Multiple Sclerosis Society","keywords":"Medicine; Discontinuation; Persistence (discontinuity); Glatiramer acetate; Population; Multiple sclerosis; Demography; Internal medicine; Socioeconomic status; Pediatrics; Disease; Immunology; Environmental health","score_opus":0.06897687515609541,"score_gpt":0.2839010022949514,"score_spread":0.214924127138856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346221108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992799,0.0002846675,0.000053479223,0.000044320655,0.0000075739654,0.000013406898,0.00010957653,0.0000018349004,0.00020513961],"genre_scores_gemma":[0.99938583,0.00016491702,0.000064909385,0.00007027614,0.000015336002,0.00001862502,0.000136693,0.0000020772866,0.00014127509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978636,0.0009509287,0.00026190473,0.0004112316,0.00027984727,0.00023240614],"domain_scores_gemma":[0.99626666,0.0009206778,0.0012219674,0.0004285038,0.00045832715,0.0007038814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022778746,0.00065066887,0.0011162237,0.001471231,0.0015933424,0.0016756122,0.00087521004,0.002211702,0.0017002805],"category_scores_gemma":[0.0052574817,0.001218368,0.0019151552,0.0031425045,0.00090838317,0.0019297777,0.0010049978,0.002281103,0.0003048899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004373341,0.00047170505,0.99706477,0.00001992878,0.00061546493,0.000090404996,0.00036672244,0.000016524029,0.00012962052,0.000015165254,0.00005912806,0.00071337464],"study_design_scores_gemma":[0.00006476152,0.00057710154,0.99775046,0.000012395804,0.00031717328,0.00016643332,0.00087890663,0.00010421509,0.000018652334,0.000022306767,0.00007613531,0.000011458846],"about_ca_topic_score_codex":0.013395056,"about_ca_topic_score_gemma":0.013570713,"teacher_disagreement_score":0.013395056,"about_ca_system_score_codex":0.0005808912,"about_ca_system_score_gemma":0.0005714407,"threshold_uncertainty_score":0.026634216},"labels":[],"label_agreement":null},{"id":"W2359083594","doi":"10.1016/j.msard.2016.05.009","title":"Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Manitoba Health; University of British Columbia; University of Alberta; University of Manitoba; Ministry of Health; McGill University; University of Calgary","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Department of Health and Wellness; Multiple Sclerosis Society; University of Alberta; Department of Health, Western Cape Government; Research Manitoba; Multiple Sclerosis Society of Canada; McGill University","keywords":"Medicine; Incidence (geometry); Population; Poisson regression; Epidemiology; Cohort; Asthma; Multiple sclerosis; Demography; Internal medicine; Pediatrics; Immunology; Environmental health","score_opus":0.03066636304140985,"score_gpt":0.2657576412911219,"score_spread":0.23509127824971204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2359083594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97461545,0.008691905,0.0008455827,0.0005952269,0.000021254134,0.00007080362,0.012345468,0.00004567607,0.0027685836],"genre_scores_gemma":[0.9912957,0.0027697592,0.00094527454,0.000067014174,0.000034518256,0.00003601822,0.0045032036,0.0000043939644,0.00034412224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906725,0.0001133406,0.00010704777,0.00019956364,0.00038962913,0.00012325401],"domain_scores_gemma":[0.9980616,0.00015164897,0.00085114717,0.00005685139,0.0007538787,0.00012482908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012213419,0.0002797561,0.00031128732,0.0029566316,0.00044117722,0.0008093922,0.00069118076,0.0003483036,0.0006520701],"category_scores_gemma":[0.0026666918,0.0001731742,0.00033968515,0.0057101995,0.00031656394,0.00054903916,0.00045357097,0.00042610732,0.00012064182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024881774,0.0000110492365,0.9953395,0.00007391283,0.000091685506,0.00002341335,0.00007140835,0.000109747634,0.00008722093,0.000033911125,0.00017554154,0.003957731],"study_design_scores_gemma":[0.0000025151292,0.000013717331,0.9991043,0.000022388753,0.00003619302,0.00008701095,0.000077275865,0.00020854716,0.00003208641,0.00001704597,0.00039665206,0.000002249434],"about_ca_topic_score_codex":0.6055763,"about_ca_topic_score_gemma":0.5856782,"teacher_disagreement_score":0.6055763,"about_ca_system_score_codex":0.0033179244,"about_ca_system_score_gemma":0.005193286,"threshold_uncertainty_score":0.79349315},"labels":[],"label_agreement":null},{"id":"W2463810424","doi":"10.1016/j.msard.2016.07.003","title":"Brain health: time matters in multiple sclerosis","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":451,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Actelion Pharmaceuticals; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Università degli Studi di Firenze; Karolinska Institutet; Multiple Sclerosis Society; Multiple Sclerosis Trust; Universität Basel; Univerzita Karlova v Praze; Sanofi Genzyme; F. Hoffmann-La Roche; Sanofi; AbbVie; Biogen; Royal Holloway, University of London; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Cognition; Action (physics); Health care; Intensive care medicine; Psychiatry; Pathology","score_opus":0.08942027039325148,"score_gpt":0.320134813110155,"score_spread":0.23071454271690353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463810424","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000332194,0.99965453,0.000012358648,0.00013565924,0.00006155532,0.000001413268,0.000009053861,8.1292865e-7,0.00009141537],"genre_scores_gemma":[0.00055156514,0.9990194,0.000056036264,0.00020257736,0.00010005266,0.0000030885412,0.000008655983,4.817364e-7,0.00005816245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99926823,0.00022662508,0.00021821503,0.00009724443,0.00015030059,0.00003928191],"domain_scores_gemma":[0.9970235,0.0022405724,0.00044141643,0.000036016896,0.00019715381,0.00006131363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018233939,0.0011376999,0.0034425703,0.0045017935,0.0003515549,0.0019489056,0.0008506281,0.0020463266,0.0052427496],"category_scores_gemma":[0.004600405,0.00049562147,0.0012245977,0.006520213,0.0009409555,0.002256652,0.0013659345,0.0015934091,0.00065088784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022302088,0.00005713983,0.00067142287,0.2758731,0.0017386964,0.0001903811,0.00029459735,0.00021214275,0.00034494087,0.0033990592,0.022065438,0.6949301],"study_design_scores_gemma":[0.00022542292,0.00021157005,0.0074452283,0.2585118,0.010401154,0.0017115183,0.00086120644,0.00015569222,0.0003135923,0.006759796,0.7133014,0.00010159503],"about_ca_topic_score_codex":0.003960603,"about_ca_topic_score_gemma":0.011975905,"teacher_disagreement_score":0.0052427496,"about_ca_system_score_codex":0.0011626076,"about_ca_system_score_gemma":0.0035869137,"threshold_uncertainty_score":0.017538667},"labels":[],"label_agreement":null},{"id":"W2468098431","doi":"10.1016/j.msard.2016.07.001","title":"Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Multiple sclerosis; Quality of life (healthcare); Internal medicine; Body mass index; Physical therapy; Expanded Disability Status Scale; Psychological intervention; Hyperlipidemia; Disease; Diabetes mellitus; Endocrinology; Psychiatry","score_opus":0.037044732526616615,"score_gpt":0.2556401940503584,"score_spread":0.21859546152374182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468098431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641013,0.016215544,0.0009867166,0.001550028,0.0015242778,0.012747957,0.0012515842,0.00014407348,0.0014784872],"genre_scores_gemma":[0.9628593,0.007244044,0.0026482265,0.0020372095,0.0011219338,0.020609818,0.00086885836,0.000017854094,0.0025928637],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976706,0.0012558573,0.0002972557,0.0003971503,0.00018201594,0.00019717417],"domain_scores_gemma":[0.997343,0.00097312656,0.0006687148,0.0002041705,0.00022990866,0.0005810477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00426192,0.0013036876,0.005574107,0.0007193824,0.0008965826,0.0013747737,0.0010952855,0.0032523244,0.0076232017],"category_scores_gemma":[0.004695753,0.0008087931,0.0027513902,0.00091110973,0.0016283063,0.0014105707,0.0006897867,0.0021761886,0.0007082418],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99068564,0.0025475249,0.0005387823,0.0010929061,0.0012027052,0.000021694215,0.000024641351,0.00006187902,0.0003597243,0.00003707864,0.00016783786,0.0032595675],"study_design_scores_gemma":[0.9823393,0.015640987,0.00083929417,0.00007158811,0.000762278,0.000009652485,0.000011471785,0.00009107003,0.000052538264,0.000047634465,0.00012882221,0.000005388596],"about_ca_topic_score_codex":0.0017234588,"about_ca_topic_score_gemma":0.0026691863,"teacher_disagreement_score":0.0076232017,"about_ca_system_score_codex":0.00091832,"about_ca_system_score_gemma":0.0020530156,"threshold_uncertainty_score":0.025502145},"labels":[],"label_agreement":null},{"id":"W2511874025","doi":"10.1016/j.msard.2016.08.010","title":"Physical activity in pediatric onset multiple sclerosis: Validating a questionnaire for clinical practice and research","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Medicine; Physical activity; Physical therapy; Multiple sclerosis; Clinical Practice; Psychiatry","score_opus":0.14804708776579145,"score_gpt":0.40799472083657845,"score_spread":0.259947633070787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511874025","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940169,0.0005303058,0.0013159048,0.00028830714,0.000054245284,0.0010644293,0.0005536299,0.000023483159,0.0021528427],"genre_scores_gemma":[0.98723793,0.00074399327,0.0085652545,0.0002382566,0.000032624204,0.0017043508,0.0009595032,0.00001820414,0.000499935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99193007,0.0036033595,0.0017964442,0.0005085085,0.0017435687,0.00041812577],"domain_scores_gemma":[0.9777533,0.008530815,0.0066288314,0.001208282,0.0047703194,0.0011084462],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013933615,0.0004977692,0.000877238,0.0015465505,0.0007313127,0.001103355,0.00070428784,0.0009440027,0.00084329816],"category_scores_gemma":[0.028418437,0.00043833087,0.001133408,0.0015098074,0.0006112019,0.00087007094,0.0012691572,0.0010180542,0.00030086667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011302467,0.00038856384,0.98411685,0.00010493415,0.00007807361,0.000045003835,0.0009338565,0.000156713,0.0003996263,0.000052056763,0.00041720443,0.013194242],"study_design_scores_gemma":[0.000048543472,0.00078460644,0.9966538,0.000069809794,0.000045957277,0.00013586855,0.0007830045,0.0005118858,0.0002114331,0.000033098087,0.00071211765,0.000009914401],"about_ca_topic_score_codex":0.0040462743,"about_ca_topic_score_gemma":0.00783745,"teacher_disagreement_score":0.9860664,"about_ca_system_score_codex":0.0010920194,"about_ca_system_score_gemma":0.001779024,"threshold_uncertainty_score":0.073688865},"labels":[],"label_agreement":null},{"id":"W2523998887","doi":"10.1016/j.msard.2016.09.008","title":"Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Cannabis; Psychiatry","score_opus":0.03496767093008995,"score_gpt":0.24539567766059045,"score_spread":0.2104280067305005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523998887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954503,0.00060109055,0.000020728758,0.0006748634,0.00001761997,0.000019990088,0.0005460787,0.0000017460017,0.0026676909],"genre_scores_gemma":[0.9976515,0.0007180473,0.00006334325,0.0003296901,0.00001098178,0.0000084186095,0.00025072487,0.0000023231044,0.00096497854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909234,0.0000993564,0.000060363134,0.00007625305,0.0003063792,0.0003653442],"domain_scores_gemma":[0.996942,0.0003029145,0.00072742655,0.00005767243,0.0011524206,0.00081752223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080916396,0.00029268782,0.00033655742,0.0019896918,0.0049980567,0.0019289514,0.0007912778,0.00090409565,0.0040714],"category_scores_gemma":[0.0038100665,0.00039440635,0.00077063125,0.004190607,0.0011727996,0.00072354206,0.00070082536,0.001487917,0.00025455048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103992345,0.00013382814,0.99113595,0.000033440323,0.000050302664,0.00011717614,0.004850895,0.000025544132,0.00014117366,0.00011301263,0.0005230236,0.0027716062],"study_design_scores_gemma":[0.000010467743,0.000051134288,0.98196906,0.00006718515,0.000033395725,0.00014088178,0.016373549,0.00007369197,0.000041170315,0.00003419284,0.0011802284,0.000025195679],"about_ca_topic_score_codex":0.9791252,"about_ca_topic_score_gemma":0.98413795,"teacher_disagreement_score":0.020874798,"about_ca_system_score_codex":0.009428154,"about_ca_system_score_gemma":0.012348731,"threshold_uncertainty_score":0.0684064},"labels":[],"label_agreement":null},{"id":"W2524490682","doi":"10.1016/j.msard.2016.09.006","title":"The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Effective diffusion coefficient; Diffusion MRI; Gadolinium; Nuclear medicine; Magnetic resonance imaging; Asymptomatic; White matter; Lesion; Hyperintensity; Radiology; Pathology","score_opus":0.08899565199143981,"score_gpt":0.31462113734651614,"score_spread":0.22562548535507632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524490682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881391,0.00785275,0.000302444,0.000079531506,0.000017542361,0.000023695935,0.000110290384,0.0000076286524,0.003467042],"genre_scores_gemma":[0.99725085,0.0018820616,0.000433481,0.000014390261,0.00002938484,0.000008357629,0.00007269864,0.000002376528,0.0003063145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945015,0.0002460564,0.00012233519,0.00004325813,0.000095777425,0.00004238836],"domain_scores_gemma":[0.99817574,0.00066800613,0.0005360541,0.00007178106,0.00037527,0.00017317601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021386896,0.00039400824,0.00029913054,0.0031896238,0.00029594498,0.0008619689,0.0003167167,0.00042016685,0.00084378896],"category_scores_gemma":[0.0053616785,0.00017988404,0.00019711754,0.0011460044,0.00046933847,0.0011589371,0.00033935596,0.00032013556,0.00019150999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042731166,0.0004163586,0.8514186,0.0011721891,0.00048225056,0.0019146953,0.0013544671,0.00026940557,0.04776369,0.0006253651,0.0005183569,0.089791544],"study_design_scores_gemma":[0.00007759471,0.0014382477,0.97651184,0.00015017031,0.00029096977,0.006200744,0.0013354437,0.0005710331,0.010891147,0.0005113599,0.0019905872,0.000030788255],"about_ca_topic_score_codex":0.0011836529,"about_ca_topic_score_gemma":0.0012812341,"teacher_disagreement_score":0.0031896238,"about_ca_system_score_codex":0.00022756089,"about_ca_system_score_gemma":0.00031442236,"threshold_uncertainty_score":0.011310577},"labels":[],"label_agreement":null},{"id":"W2526902842","doi":"10.1016/j.msard.2016.09.005","title":"Language disorders in multiple sclerosis: A systematic review","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Université Laval","funders":"","keywords":"PsycINFO; Multiple sclerosis; Medicine; Cognition; MEDLINE; English language; Psychology; Psychiatry","score_opus":0.062424120586532385,"score_gpt":0.31179313993916813,"score_spread":0.24936901935263575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526902842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082813477,0.9985066,0.000057249734,0.0001136799,0.000068045614,0.000110612105,0.00020503189,0.0000046876667,0.00010595677],"genre_scores_gemma":[0.0137070725,0.9851142,0.00034887542,0.0004248201,0.000062951105,0.00016904189,0.00008835678,0.0000027844176,0.00008195047],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995086,0.0013919001,0.0022168742,0.00043927107,0.0006249043,0.00024106963],"domain_scores_gemma":[0.988326,0.007236569,0.0032914614,0.00015082447,0.000761018,0.00023416718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048690964,0.0021051492,0.01076692,0.010741723,0.00062950654,0.0028349767,0.0014471421,0.0023717089,0.00562226],"category_scores_gemma":[0.018447625,0.0014436742,0.008246383,0.011444808,0.0010361859,0.0027798938,0.0026302114,0.0016116827,0.00029872442],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025392065,0.000023833501,0.00094206753,0.9588311,0.020344755,0.00017025655,0.00020204259,0.00007585765,0.00017363376,0.00011994682,0.0010227953,0.01783983],"study_design_scores_gemma":[0.00089420343,0.00029528068,0.007900754,0.69957566,0.2737441,0.00071290514,0.000557992,0.000077898956,0.000154789,0.00031653958,0.015684748,0.00008517264],"about_ca_topic_score_codex":0.0114280535,"about_ca_topic_score_gemma":0.044995163,"teacher_disagreement_score":0.0114280535,"about_ca_system_score_codex":0.0030694997,"about_ca_system_score_gemma":0.008756511,"threshold_uncertainty_score":0.025750577},"labels":[],"label_agreement":null},{"id":"W2548126365","doi":"10.1016/j.msard.2016.10.010","title":"Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi Genzyme; Sanofi","keywords":"Fingolimod; Teriflunomide; Medicine; Dimethyl fumarate; Number needed to harm; Multiple sclerosis; Number needed to treat; Placebo; Absolute risk reduction; Relative risk; Internal medicine; Confidence interval; Immunology; Alternative medicine","score_opus":0.22080275257219195,"score_gpt":0.40229793219424764,"score_spread":0.1814951796220557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548126365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87645775,0.09713296,0.015844336,0.0009774477,0.0020634288,0.0017932064,0.0028436822,0.0001005526,0.0027865893],"genre_scores_gemma":[0.98906136,0.0030330312,0.0041425377,0.0004221079,0.00031703367,0.0015270263,0.0009725986,0.00003108268,0.000493308],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.88635796,0.08110861,0.01661684,0.0071245306,0.007004509,0.0017875071],"domain_scores_gemma":[0.8601407,0.11946637,0.01172547,0.0048398785,0.0024916003,0.001335926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07262084,0.0024251207,0.011006629,0.0037319225,0.00065983314,0.0025041027,0.002431232,0.0034785548,0.0030860633],"category_scores_gemma":[0.076349795,0.0010736536,0.023688223,0.002682007,0.0019859748,0.0043770387,0.0036102931,0.0039495467,0.00016711839],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3236997,0.0006114328,0.090079345,0.01466665,0.54138863,0.00034479238,0.000586762,0.0021399981,0.0018002167,0.0009831644,0.00082736876,0.022871912],"study_design_scores_gemma":[0.11907884,0.059762232,0.24308477,0.002305558,0.54635185,0.00085435144,0.0020084279,0.011204059,0.0028488922,0.007092387,0.005010984,0.00039755917],"about_ca_topic_score_codex":0.0006724858,"about_ca_topic_score_gemma":0.0010772732,"teacher_disagreement_score":0.07262084,"about_ca_system_score_codex":0.0010658036,"about_ca_system_score_gemma":0.0007265564,"threshold_uncertainty_score":0.38406032},"labels":[],"label_agreement":null},{"id":"W2548283306","doi":"10.1016/j.msard.2016.10.011","title":"The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Placebo; Crossover study; Randomized controlled trial; Physical therapy; Multiple sclerosis; Paced Auditory Serial Addition Test; Cognition; Physical medicine and rehabilitation; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.034565119169412295,"score_gpt":0.2910974223698583,"score_spread":0.256532303200446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548283306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958254,0.0055331266,0.0006457775,0.00043060415,0.0007673443,0.0014944705,0.00048154098,0.0001123191,0.0009522054],"genre_scores_gemma":[0.99206346,0.0021880076,0.0012810404,0.0005822228,0.0006574802,0.0017285249,0.00043662378,0.000021260703,0.001041386],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983779,0.0009107875,0.00017542306,0.00027022607,0.000077320634,0.00018823467],"domain_scores_gemma":[0.9980915,0.0007524062,0.00030555957,0.00020906223,0.00014355309,0.00049780385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028675771,0.0016701618,0.0065064575,0.00062049064,0.0007576066,0.0010961546,0.0011507636,0.0027156828,0.005780123],"category_scores_gemma":[0.003821912,0.0012305499,0.0023677328,0.00064438995,0.0017635049,0.002035642,0.00054554903,0.002845965,0.0008420475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9931678,0.0016064555,0.00017471425,0.00023217838,0.0003871094,0.000015116934,0.000028158378,0.000078405545,0.0008433592,0.000021172273,0.000095100986,0.0033503878],"study_design_scores_gemma":[0.9601153,0.03803235,0.0009384471,0.000014854246,0.00037563563,0.00001272655,0.000014773508,0.00017699803,0.00015445595,0.000028910368,0.00012353461,0.000012018304],"about_ca_topic_score_codex":0.0014866464,"about_ca_topic_score_gemma":0.0019506207,"teacher_disagreement_score":0.0065064575,"about_ca_system_score_codex":0.0007595996,"about_ca_system_score_gemma":0.0010930649,"threshold_uncertainty_score":0.019336462},"labels":[],"label_agreement":null},{"id":"W2559196805","doi":"10.1016/j.msard.2016.11.012","title":"Processing speed and distractibility in multiple sclerosis: the role of sleep","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Carleton University; Sunnybrook Health Science Centre; Ottawa Hospital; Health Sciences Centre","funders":"Multiple Sclerosis Society","keywords":"Epworth Sleepiness Scale; Excessive daytime sleepiness; Somnolence; Psychology; Cognition; Audiology; Multiple sclerosis; Mood; Alertness; Distraction; Anxiety; Effects of sleep deprivation on cognitive performance; Medicine; Clinical psychology; Polysomnography; Psychiatry; Sleep disorder; Electroencephalography; Cognitive psychology","score_opus":0.04020565677912618,"score_gpt":0.2619082070018374,"score_spread":0.22170255022271124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559196805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318577,0.0146009475,0.00010684426,0.00029494034,0.000041610212,0.000010241883,0.00013000173,0.000001964417,0.0016276429],"genre_scores_gemma":[0.99671066,0.002513386,0.00012519171,0.000080117956,0.00007684885,0.000009457941,0.00008598312,0.0000029236476,0.000395406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995425,0.00020162541,0.00005659237,0.00006442013,0.00008056449,0.000054375272],"domain_scores_gemma":[0.9936114,0.0035347776,0.0016903904,0.00031418144,0.0003935556,0.0004557056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015347053,0.0004271525,0.0004488591,0.0014351917,0.00058338774,0.0013581546,0.0005674327,0.00066549936,0.0027472875],"category_scores_gemma":[0.0061160526,0.00023831506,0.00063221465,0.0017809429,0.0007742063,0.0011108943,0.00062626106,0.0008736732,0.00013624197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026663821,0.00050870504,0.9670311,0.00038429772,0.001111802,0.0003469176,0.0016984438,0.0002769656,0.0013010745,0.0004981032,0.0002180219,0.023958208],"study_design_scores_gemma":[0.000021081061,0.00016855386,0.99844885,0.000046051944,0.00014829841,0.000102303406,0.00052090565,0.00011469879,0.000058762642,0.00019457315,0.00016765481,0.000008162086],"about_ca_topic_score_codex":0.023750374,"about_ca_topic_score_gemma":0.023838261,"teacher_disagreement_score":0.023750374,"about_ca_system_score_codex":0.00051776675,"about_ca_system_score_gemma":0.000832687,"threshold_uncertainty_score":0.047224224},"labels":[],"label_agreement":null},{"id":"W2566431041","doi":"10.1016/j.msard.2016.12.007","title":"From bugs to brains: The microbiome in neurological health","year":2016,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Simon Fraser University; University of British Columbia","funders":"Health Canada; University of British Columbia; Canada Research Chairs","keywords":"Microbiome; Gut microbiome; Multiple sclerosis; Medicine; Discipline; Engineering ethics; Neuroscience; Data science; Bioinformatics; Biology; Sociology; Immunology; Computer science; Social science; Engineering","score_opus":0.009993076417919413,"score_gpt":0.24453742194585226,"score_spread":0.23454434552793285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566431041","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031519136,0.014400275,0.00010205959,0.029679574,0.9552995,0.0000076180927,0.000030005609,0.000029003384,0.0004204279],"genre_scores_gemma":[0.00027118184,0.005902915,0.000055085424,0.010496773,0.98080796,0.000009939561,0.000010269826,0.000013664303,0.0024322618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952863,0.0012170561,0.00067732466,0.00061301456,0.0018677007,0.00033857478],"domain_scores_gemma":[0.98312163,0.008954258,0.0010406023,0.000497543,0.0037777126,0.002608253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008660906,0.005214211,0.004261123,0.0035376593,0.0028226317,0.008993321,0.0038920525,0.016789764,0.008171383],"category_scores_gemma":[0.021746382,0.0013232562,0.0026467585,0.0013730949,0.0038009176,0.006492842,0.0032566402,0.025020316,0.0050289864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008073416,0.000017456658,0.00004631524,0.00039182339,0.000035458128,0.00015189324,0.00002737393,0.000026980808,0.000094399584,0.0004987955,0.9913186,0.007310141],"study_design_scores_gemma":[0.000117082534,0.000066552,0.00048653764,0.000919513,0.00013612428,0.0005942861,0.00013607806,0.00025263047,0.00019280962,0.003616363,0.99344033,0.000041764466],"about_ca_topic_score_codex":0.001411955,"about_ca_topic_score_gemma":0.0043983962,"teacher_disagreement_score":0.016789764,"about_ca_system_score_codex":0.0026313686,"about_ca_system_score_gemma":0.0032217153,"threshold_uncertainty_score":0.045803845},"labels":[],"label_agreement":null},{"id":"W2590528884","doi":"10.1016/j.msard.2017.02.013","title":"Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Alabama at Birmingham","keywords":"Upper limb; Physical medicine and rehabilitation; Medicine; Multiple sclerosis; Logistic regression; Physical therapy; Rehabilitation; Ambulatory; Association (psychology); Psychology; Psychiatry; Surgery","score_opus":0.07439613338366442,"score_gpt":0.28050667862031614,"score_spread":0.20611054523665173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590528884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983974,0.0008764622,0.000019818732,0.00005768061,0.0000065943564,0.0000022445497,0.00005811133,0.0000010832941,0.0005805782],"genre_scores_gemma":[0.99933475,0.00037854954,0.000023312297,0.000020936566,0.000014378667,0.0000023382981,0.000064265005,6.530505e-7,0.00016077248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994042,0.00017973324,0.00010885488,0.00006858768,0.00009342391,0.0001451464],"domain_scores_gemma":[0.99748766,0.0004163152,0.0014093436,0.0000804996,0.0001947603,0.00041145008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052020577,0.00026446392,0.00042303037,0.0011525145,0.0008701975,0.00083607796,0.0002826195,0.00070179807,0.0022750078],"category_scores_gemma":[0.0028341988,0.0002589725,0.00075697183,0.0017216385,0.00041570218,0.0004419633,0.0007191899,0.00069275056,0.0002591417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106676096,0.00008196085,0.99822825,0.000020315405,0.00007193094,0.0001340648,0.00013110203,0.000013100446,0.0001265838,0.000009425897,0.000030019268,0.0010465545],"study_design_scores_gemma":[0.0000010100553,0.0000321692,0.99956375,0.0000074013433,0.000023234265,0.00011135072,0.00018691107,0.000016880655,0.000009270218,0.000007520235,0.00003893873,0.0000015271685],"about_ca_topic_score_codex":0.012461167,"about_ca_topic_score_gemma":0.016439524,"teacher_disagreement_score":0.012461167,"about_ca_system_score_codex":0.0002905512,"about_ca_system_score_gemma":0.00043342673,"threshold_uncertainty_score":0.024777234},"labels":[],"label_agreement":null},{"id":"W2591549758","doi":"10.1016/j.msard.2017.02.012","title":"Increased incidence and prevalence of psoriasis in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; McGill University; University of British Columbia; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Dalhousie University; Multiple Sclerosis Society of Canada; Public Health Agency of Canada; Multiple Sclerosis Trust; Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis; Crohn's and Colitis Canada; Dalhousie Medical Research Foundation; Multiple Sclerosis Scientific Research Foundation; U.S. Department of Veterans Affairs; Teva Pharmaceutical Industries; Sanofi; Public Health Agency; National Multiple Sclerosis Society; Michael Smith Health Research BC; Biogen","keywords":"Psoriasis; Medicine; Incidence (geometry); Population; Multiple sclerosis; Cohort; Demography; Medical prescription; Internal medicine; Dermatology; Immunology; Environmental health","score_opus":0.030879322888268362,"score_gpt":0.22577340154250602,"score_spread":0.19489407865423766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591549758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199307,0.0035620485,0.00037703488,0.00024348055,0.000016352911,0.000017473365,0.0016175912,0.000031831605,0.0021411146],"genre_scores_gemma":[0.99811745,0.0009417326,0.0002733573,0.000027206013,0.000022224964,0.000004493415,0.00049197103,0.0000017361415,0.00011983313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909043,0.00013327193,0.00007042279,0.00018616983,0.0004342417,0.00008555946],"domain_scores_gemma":[0.99844056,0.00014499055,0.00082677044,0.000059414466,0.00037875512,0.00014955382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006115043,0.00014719016,0.00022764641,0.0017536886,0.0002852029,0.0005399843,0.00036883165,0.00025152517,0.0014373822],"category_scores_gemma":[0.0018021642,0.00014241964,0.00028504277,0.0022412112,0.00025620178,0.00023123465,0.0003097172,0.00042682627,0.00016503649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034834244,0.00001138703,0.9957806,0.000038415805,0.00006642987,0.000081763545,0.000053412838,0.00006274333,0.00030250594,0.000026093378,0.00020634387,0.0033355802],"study_design_scores_gemma":[0.0000015774121,0.000010426271,0.9993642,0.00000779084,0.000016516695,0.00024962748,0.00002722818,0.0000790844,0.000026322741,0.000019749014,0.00019616782,0.0000012296548],"about_ca_topic_score_codex":0.083634496,"about_ca_topic_score_gemma":0.09141328,"teacher_disagreement_score":0.083634496,"about_ca_system_score_codex":0.0013232216,"about_ca_system_score_gemma":0.00090253266,"threshold_uncertainty_score":0.16629535},"labels":[],"label_agreement":null},{"id":"W2603876309","doi":"10.1016/j.msard.2017.03.009","title":"Hospitalization is associated with subsequent disability in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Manitoba; Hotchkiss Brain Institute; Manitoba Health","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; AbbVie Canada; Crohn's and Colitis Canada; Research Manitoba; Multiple Sclerosis Society; Takeda Canada; Mylan; Multiple Sclerosis Scientific Research Foundation; Pfizer Canada; Janssen Canada; Sanofi; Pfizer","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Disease; Cohort; Pediatrics; Cohort study; Population; Young adult; Proportional hazards model; Physical therapy; Internal medicine; Psychiatry","score_opus":0.05859635771339704,"score_gpt":0.2757565066892163,"score_spread":0.21716014897581926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603876309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774027,0.00071690005,0.00007925902,0.00019969966,0.000010968209,0.000008430134,0.00070974394,0.000010997431,0.0005237458],"genre_scores_gemma":[0.9992061,0.00018745531,0.000066755354,0.000019236508,0.000011533141,0.000004254548,0.00043027967,0.0000016894459,0.000072666604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923277,0.00015743374,0.00010193527,0.00015031791,0.0001694781,0.00018796405],"domain_scores_gemma":[0.9952062,0.0006513156,0.0029850316,0.00018073742,0.00035788672,0.00061881525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006443758,0.00021574773,0.0002469589,0.00091637566,0.00049884745,0.0006612517,0.00053267035,0.0004313111,0.0025308006],"category_scores_gemma":[0.0050127856,0.00019404174,0.00064205186,0.0013254168,0.00035617044,0.000267977,0.00063974544,0.0008361055,0.0001626407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004346219,0.000012030736,0.99879825,0.000010192413,0.000040351853,0.000058924987,0.00002305978,0.000038335536,0.000028937764,0.00001141372,0.00008550998,0.0008494797],"study_design_scores_gemma":[0.0000017131441,0.000019757046,0.99947137,0.000009621537,0.000014758208,0.00019960744,0.000041689513,0.00014491742,0.00001184386,0.000021431595,0.00006136658,0.0000018750078],"about_ca_topic_score_codex":0.053056125,"about_ca_topic_score_gemma":0.05265379,"teacher_disagreement_score":0.053056125,"about_ca_system_score_codex":0.0011713788,"about_ca_system_score_gemma":0.0015298657,"threshold_uncertainty_score":0.10549462},"labels":[],"label_agreement":null},{"id":"W2610278979","doi":"10.1016/j.msard.2017.05.001","title":"Prehistoric enemies within: The contribution of human endogenous retroviruses to neurological diseases. Meeting report: “Second International Workshop on Human Endogenous Retroviruses and Disease”, Washington DC, March 13th and 14th 2017","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Servier; Advanced Foods and Materials Canada","keywords":"Endogenous retrovirus; Multiple sclerosis; Endogeny; Disease; Human disease; Medicine; Virology; Immunology; Biology; Genetics; Pathology","score_opus":0.06138738554699816,"score_gpt":0.25136995078566166,"score_spread":0.1899825652386635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610278979","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06286355,0.6195162,0.0022966056,0.24591297,0.027482172,0.000053446278,0.0010953452,0.000074343065,0.04070535],"genre_scores_gemma":[0.3554451,0.4814,0.0028936863,0.04549051,0.028002098,0.000070525144,0.0014567267,0.0000815054,0.085159756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997843,0.00006172816,0.000012660332,0.000033425524,0.00004592242,0.00006199388],"domain_scores_gemma":[0.9994,0.0002340767,0.000082970495,0.000034335833,0.00010544939,0.00014325438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016685796,0.00025479135,0.0002334626,0.0005665138,0.0009914109,0.0019661214,0.00034697712,0.0013019635,0.005516534],"category_scores_gemma":[0.0011183077,0.0001873744,0.0001555939,0.00040777444,0.001153304,0.0021269722,0.0014820168,0.003148343,0.00060508813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092835794,0.00015340456,0.021843052,0.0017129757,0.00012679442,0.0026670103,0.008210548,0.00030904726,0.020020919,0.0208587,0.3049831,0.61818606],"study_design_scores_gemma":[0.000016070377,0.0000898271,0.041709114,0.0011928381,0.000053993725,0.0014481856,0.004484338,0.000040989853,0.0031573053,0.008482328,0.9392933,0.00003159947],"about_ca_topic_score_codex":0.0040510544,"about_ca_topic_score_gemma":0.014541325,"teacher_disagreement_score":0.005516534,"about_ca_system_score_codex":0.0007093009,"about_ca_system_score_gemma":0.001057215,"threshold_uncertainty_score":0.018454611},"labels":[],"label_agreement":null},{"id":"W2615643304","doi":"10.1016/j.msard.2017.05.006","title":"Cognitive impairment in Chinese IIDDs revealed by MoCA and P300","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Audiology; Multiple sclerosis; Cognition; Depression (economics); Internal medicine; Psychiatry","score_opus":0.026365294199694158,"score_gpt":0.29376505214153686,"score_spread":0.26739975794184273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615643304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987533,0.00023301656,0.000028398355,0.000059197642,0.0000069699104,0.0000063287694,0.000051995306,0.000001612563,0.0008591921],"genre_scores_gemma":[0.9993735,0.00016989086,0.000028759943,0.000048433623,0.000016739825,0.0000036856002,0.00008663871,0.0000011225491,0.00027111586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982965,0.000018448478,0.000033189564,0.00003857473,0.000031416806,0.00004873105],"domain_scores_gemma":[0.99973994,0.0000474585,0.000105994106,0.000015389838,0.000040423274,0.00005085236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019075823,0.00052406633,0.00044088042,0.0016252649,0.00085297535,0.0004928699,0.00027204177,0.0002486484,0.0017666414],"category_scores_gemma":[0.00078807847,0.00015378924,0.00029228683,0.0012820831,0.00046543308,0.00047656245,0.000358266,0.00033660766,0.00014759057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003712492,0.00019545482,0.97808313,0.00006080513,0.00009758449,0.008719167,0.0019809827,0.00004191113,0.00405109,0.00020537358,0.00030407615,0.005889312],"study_design_scores_gemma":[0.0000108814465,0.00007001268,0.99423486,0.000009343565,0.00006448935,0.003939731,0.0010367329,0.00008983172,0.00016608414,0.00014193484,0.00022831734,0.00000786234],"about_ca_topic_score_codex":0.022179032,"about_ca_topic_score_gemma":0.015213869,"teacher_disagreement_score":0.022179032,"about_ca_system_score_codex":0.0003850073,"about_ca_system_score_gemma":0.00054938934,"threshold_uncertainty_score":0.044099867},"labels":[],"label_agreement":null},{"id":"W2625299651","doi":"10.1016/j.msard.2017.06.003","title":"The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Expanded Disability Status Scale; Medicine; Multiple sclerosis; Physical therapy; Physical medicine and rehabilitation; Physical disability; MEDLINE; Inclusion (mineral); Psychology; Psychiatry","score_opus":0.08286083481255867,"score_gpt":0.3428479991164018,"score_spread":0.2599871643038431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625299651","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006861734,0.99894935,0.000030738225,0.00008088618,0.00007137615,0.00003569817,0.00007038023,0.000001912268,0.00007351249],"genre_scores_gemma":[0.016046634,0.98285055,0.00029649638,0.00047351775,0.000102368824,0.00008599808,0.0000768722,0.0000023649573,0.000065080014],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99734396,0.00080437865,0.0009861151,0.0003555545,0.000370086,0.00013987166],"domain_scores_gemma":[0.9917903,0.006470726,0.0011512006,0.000084350846,0.0003852518,0.000118177406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004443648,0.0013469876,0.008881956,0.003746871,0.00042585883,0.002222528,0.0014929447,0.0027024997,0.0047048456],"category_scores_gemma":[0.016608747,0.0009047333,0.010358577,0.004249255,0.000676525,0.001620154,0.0012226071,0.0020211807,0.00021770566],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088730577,0.000059327976,0.001302647,0.9151766,0.040825207,0.000079090205,0.0001242921,0.00012194714,0.00018192334,0.00017739923,0.0009196463,0.04014467],"study_design_scores_gemma":[0.0019592948,0.00061582495,0.013591458,0.54363394,0.4231736,0.00031198873,0.00046198163,0.0001577013,0.00019667334,0.00056020985,0.015259102,0.00007821588],"about_ca_topic_score_codex":0.011442138,"about_ca_topic_score_gemma":0.034608737,"teacher_disagreement_score":0.011442138,"about_ca_system_score_codex":0.0018302378,"about_ca_system_score_gemma":0.004268034,"threshold_uncertainty_score":0.023500502},"labels":[],"label_agreement":null},{"id":"W2724713160","doi":"10.1016/j.msard.2017.06.016","title":"Human glutathione s-transferase enzyme gene variations and risk of multiple sclerosis in Iranian population cohort","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Genotype; Multiple sclerosis; Oxidative stress; Glutathione S-transferase; Glutathione; Medicine; Population; GSTP1; Expanded Disability Status Scale; Etiology; Internal medicine; Immunology; Physiology; Biology; Gene; Enzyme; Genetics; Biochemistry","score_opus":0.01666816719396034,"score_gpt":0.2230700579039939,"score_spread":0.20640189071003356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2724713160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991177,0.00021674042,0.00010993731,0.0000503563,0.000010969271,0.0000042835118,0.00019931275,0.000004663594,0.0002861069],"genre_scores_gemma":[0.9992582,0.0001251006,0.00009591861,0.000026450445,0.000016706652,0.0000070753845,0.00020276556,0.0000027543629,0.00026509626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997663,0.000050833816,0.000020254454,0.000081332124,0.000036547244,0.00004469244],"domain_scores_gemma":[0.99970883,0.00004228603,0.00007796944,0.000039744693,0.00005928401,0.0000719197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042128767,0.00044383763,0.00045556272,0.0009833046,0.0006761289,0.00047819674,0.00034045274,0.0003941275,0.001855784],"category_scores_gemma":[0.00079544145,0.00036028217,0.00072686456,0.0013376826,0.00024570402,0.0002990496,0.00025603207,0.0005966011,0.00018988844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048253083,0.000062774714,0.9953307,0.000011067118,0.00031071124,0.00024378125,0.00022595953,0.00008282572,0.0009806599,0.0000678851,0.00021438165,0.001986866],"study_design_scores_gemma":[0.000019891542,0.00010843849,0.99861,0.0000032983255,0.00016027073,0.00033577095,0.00018467677,0.0001793349,0.00008409563,0.00004813517,0.00026116127,0.00000491196],"about_ca_topic_score_codex":0.011159241,"about_ca_topic_score_gemma":0.006325507,"teacher_disagreement_score":0.011159241,"about_ca_system_score_codex":0.00027470884,"about_ca_system_score_gemma":0.0004455141,"threshold_uncertainty_score":0.022188604},"labels":[],"label_agreement":null},{"id":"W2737064420","doi":"10.1016/j.msard.2017.07.020","title":"Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Meta-analysis; Multiple sclerosis; Cochrane Library; Internal medicine; MEDLINE; Relative risk; Causality (physics); Clinically isolated syndrome; CINAHL; Physical therapy; Psychiatry; Confidence interval","score_opus":0.344363908382509,"score_gpt":0.4033033450547217,"score_spread":0.058939436672212686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737064420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035559821,0.99139696,0.002411087,0.00021544509,0.00031088246,0.0010971858,0.00074254593,0.000040833387,0.00022916369],"genre_scores_gemma":[0.20691855,0.76712143,0.014384712,0.0016302641,0.00054420624,0.0066450704,0.0015729554,0.000110348694,0.0010724952],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96800405,0.0147797065,0.010160472,0.0033016517,0.0029540954,0.00080006],"domain_scores_gemma":[0.96906674,0.023158723,0.00475641,0.0014449905,0.0012854813,0.00028769835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024758412,0.0044659986,0.030232714,0.010198632,0.0015168635,0.00523908,0.0037877618,0.0048632827,0.0070749815],"category_scores_gemma":[0.058863103,0.0026936259,0.06439646,0.011081547,0.0014873105,0.0044892393,0.0031722167,0.0036884204,0.00060682016],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001409805,0.000026528698,0.0039968328,0.23501311,0.75154376,0.00015764248,0.00009126771,0.00033577695,0.00013660944,0.00027385852,0.0004458483,0.0065689604],"study_design_scores_gemma":[0.0008906183,0.00013506222,0.0025790872,0.016126554,0.97815585,0.000101694546,0.000058345933,0.00017471501,0.000059789178,0.00046981795,0.001216862,0.000031617932],"about_ca_topic_score_codex":0.008431606,"about_ca_topic_score_gemma":0.02147068,"teacher_disagreement_score":0.030232714,"about_ca_system_score_codex":0.0032021864,"about_ca_system_score_gemma":0.005967571,"threshold_uncertainty_score":0.13093656},"labels":[],"label_agreement":null},{"id":"W2745955927","doi":"10.1016/j.msard.2017.08.006","title":"Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Carleton University; Ottawa Hospital; University of Ottawa; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada","keywords":"Numerical digit; Medicine; Multiple sclerosis; Symbol (formal); Modalities; Test (biology); Arithmetic; Psychiatry; Computer science; Biology","score_opus":0.044818295759184515,"score_gpt":0.25957459600032845,"score_spread":0.21475630024114395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745955927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97841996,0.013042866,0.0006821588,0.0008344401,0.000111773574,0.000035959296,0.00016035947,0.0000088896495,0.006703751],"genre_scores_gemma":[0.9956862,0.0026966718,0.0005567655,0.00019557544,0.000110477784,0.000019134972,0.00011248027,0.000004089708,0.00061862386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976981,0.0012213541,0.00025546036,0.00016227196,0.0005517438,0.00011098347],"domain_scores_gemma":[0.9867683,0.008660375,0.002368065,0.0008172996,0.0010622682,0.0003237173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004764357,0.00071834534,0.0007379337,0.0027910897,0.00033252154,0.0021266856,0.0011964759,0.0009329062,0.0009928519],"category_scores_gemma":[0.0219211,0.00016055377,0.00038904438,0.0018965437,0.0016033364,0.0025686875,0.0010700842,0.0010939133,0.0001763583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030016555,0.0010863928,0.80555713,0.00048403695,0.0006484723,0.0006301477,0.0015192375,0.00068013254,0.0017871638,0.0025912821,0.00093465764,0.18107976],"study_design_scores_gemma":[0.00009942271,0.0013450354,0.9864168,0.00037087992,0.00038599558,0.0010038777,0.0014349698,0.0010352889,0.0014264624,0.0044694,0.0019656694,0.000046249523],"about_ca_topic_score_codex":0.005225611,"about_ca_topic_score_gemma":0.0067295744,"teacher_disagreement_score":0.005225611,"about_ca_system_score_codex":0.0004887606,"about_ca_system_score_gemma":0.0016741356,"threshold_uncertainty_score":0.025196671},"labels":[],"label_agreement":null},{"id":"W2761661211","doi":"10.1016/j.msard.2017.10.004","title":"Treating depression in multiple sclerosis with antidepressants: A brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions","year":2017,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Depression (economics); Multiple sclerosis; Medicine; Antidepressant; Clinical trial; Disease; Comorbidity; Quality of life (healthcare); Randomized controlled trial; Psychiatry; Internal medicine; Anxiety","score_opus":0.5195576048701573,"score_gpt":0.510673184639342,"score_spread":0.00888442023081537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761661211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053676642,0.99961036,0.000038209917,0.00013576829,0.000043840024,0.000017678056,0.000026640957,0.0000018548602,0.00007202174],"genre_scores_gemma":[0.0006794957,0.9986199,0.00024404001,0.0003072843,0.000056123205,0.00002249685,0.00002707243,8.0248765e-7,0.000042767802],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979219,0.00054692524,0.00085382053,0.00018681471,0.00042165036,0.00006901526],"domain_scores_gemma":[0.99321485,0.0050197598,0.0010637569,0.00007250786,0.00053522456,0.00009403854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041621057,0.001555116,0.0055268975,0.0045938636,0.00040767805,0.0020436884,0.0019277785,0.0020001584,0.003174381],"category_scores_gemma":[0.009344679,0.0007309801,0.0037879744,0.004664131,0.00063032244,0.0019826528,0.0011128543,0.0021027434,0.0004408607],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041072446,0.000072419505,0.00034099387,0.46437415,0.0031692397,0.00011270948,0.00012855488,0.00026508528,0.00043284716,0.0010983603,0.008998637,0.52059644],"study_design_scores_gemma":[0.0009360893,0.0008351783,0.0055536004,0.5809976,0.034267057,0.0016088822,0.00041499216,0.00044177182,0.00059720245,0.0027880592,0.3714131,0.00014644043],"about_ca_topic_score_codex":0.0032650759,"about_ca_topic_score_gemma":0.013791258,"teacher_disagreement_score":0.0055268975,"about_ca_system_score_codex":0.001424266,"about_ca_system_score_gemma":0.0041747224,"threshold_uncertainty_score":0.022011578},"labels":[],"label_agreement":null},{"id":"W2763071712","doi":"10.1016/j.msard.2017.10.001","title":"The impact of treatment adherence on clinical and economic outcomes in multiple sclerosis: Real world evidence from Alberta, Canada","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Alberta Health Services; Université de Montréal; Hôpital Notre-Dame; University of Calgary","funders":"EMD Serono; Novartis Pharmaceuticals Canada; Multiple Sclerosis Society of Canada; Government of Alberta; Alberta Health Services; Genzyme; F. Hoffmann-La Roche; Teva Canada Innovation; Biogen Idec; Canadian Institutes of Health Research; Novartis","keywords":"Multiple sclerosis; Medicine; Real world evidence; Intensive care medicine; Psychiatry; Internal medicine","score_opus":0.12576575454439287,"score_gpt":0.356829119700862,"score_spread":0.23106336515646914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763071712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89540684,0.07719456,0.00030955096,0.007331296,0.00025030674,0.00023414113,0.00727492,0.000017261546,0.0119811],"genre_scores_gemma":[0.98253524,0.013687312,0.00041025766,0.0007714466,0.000048660168,0.000056763223,0.0015537544,0.0000078002,0.00092879793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906895,0.003412872,0.0007998549,0.0004547162,0.0029654102,0.0016776178],"domain_scores_gemma":[0.9752147,0.0070580873,0.004129598,0.0008005549,0.009981498,0.0028155288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009187099,0.0005178768,0.0015092856,0.0023119508,0.003156907,0.003236794,0.0022298086,0.0010833513,0.00258113],"category_scores_gemma":[0.024229623,0.0004162262,0.0016668093,0.008990496,0.0020486515,0.00062256743,0.0015156658,0.0019567767,0.000107225365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057658935,0.00076778495,0.90443766,0.0031340576,0.0060194484,0.0004915405,0.0024614003,0.0026259657,0.00015238218,0.002367344,0.009213973,0.06256254],"study_design_scores_gemma":[0.00095046754,0.00022289844,0.9850545,0.002546113,0.003358162,0.000092633614,0.0024899852,0.0008558728,0.00008117376,0.0003487292,0.003913557,0.0000859564],"about_ca_topic_score_codex":0.9956915,"about_ca_topic_score_gemma":0.9970036,"teacher_disagreement_score":0.05320453,"about_ca_system_score_codex":0.05320453,"about_ca_system_score_gemma":0.08576629,"threshold_uncertainty_score":0.3860277},"labels":[],"label_agreement":null},{"id":"W2765282886","doi":"10.1016/j.msard.2017.11.003","title":"The prevalence of anxiety and associated factors in persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions; Canada Research Chairs; Alberta Health; Cumming School of Medicine, University of Calgary; University of Calgary; Alberta Health Services","keywords":"Anxiety; Hospital Anxiety and Depression Scale; Medicine; Depression (economics); Quality of life (healthcare); Confounding; Odds ratio; Cross-sectional study; Psychiatry; Population; Multiple sclerosis; Logistic regression; Clinical psychology; Odds; Internal medicine; Environmental health; Pathology","score_opus":0.036971088562393006,"score_gpt":0.2572941627361175,"score_spread":0.2203230741737245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765282886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99824333,0.0010467597,0.00002127759,0.000057617173,0.0000067485757,0.0000034748462,0.00010559992,0.0000013300842,0.0005139001],"genre_scores_gemma":[0.9994393,0.00036357105,0.000026222287,0.000023000233,0.000012971484,0.0000025861743,0.000070403265,3.2437535e-7,0.00006161077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995535,0.0001591241,0.00007431238,0.00004541533,0.000083937404,0.00008366519],"domain_scores_gemma":[0.9986463,0.00028846008,0.0006651812,0.000054120457,0.000121101184,0.00022482697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044353373,0.00018056919,0.00029347438,0.0012196051,0.0005119313,0.00081224355,0.0001842701,0.00047205485,0.0012108611],"category_scores_gemma":[0.002487689,0.00023121416,0.0005085255,0.0012088312,0.00024202067,0.0005056978,0.00037743044,0.0005910258,0.00008115354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006754311,0.000045546705,0.99837685,0.000018473009,0.00007681013,0.0000684721,0.00019185666,0.000005878965,0.000120520155,0.000010863584,0.00003323851,0.0009838793],"study_design_scores_gemma":[0.0000013105894,0.0000348686,0.999446,0.0000049575224,0.000017821372,0.00012889472,0.00031144833,0.000010125021,0.000008040194,0.00000622019,0.000028986893,0.0000014031905],"about_ca_topic_score_codex":0.008565427,"about_ca_topic_score_gemma":0.010183179,"teacher_disagreement_score":0.008565427,"about_ca_system_score_codex":0.00023486516,"about_ca_system_score_gemma":0.00024127582,"threshold_uncertainty_score":0.017031133},"labels":[],"label_agreement":null},{"id":"W2765634741","doi":"10.1016/j.msard.2017.11.001","title":"Can falling infection rates in one country explain rising incidence of autoimmune and allergic diseases in other countries? Caution when (over) interpreting ecological data from disparate areas","year":2017,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of British Columbia; Vancouver Coastal Health Research Institute","funders":"","keywords":"Scopus; Mythology; Falling (accident); Web of science; Medicine; Incidence (geometry); MEDLINE; Environmental ethics; Data science; History; Environmental health; Political science; Classics; Law; Computer science; Philosophy","score_opus":0.060061046519949715,"score_gpt":0.27902149463649284,"score_spread":0.21896044811654314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765634741","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068334147,0.0011108824,0.00023033498,0.9868858,0.0101320185,0.000005828139,0.00004752877,0.000016004096,0.00088833005],"genre_scores_gemma":[0.010477851,0.0014318607,0.0005787538,0.9366145,0.049599648,0.000025553067,0.00003463276,0.000020072062,0.0012171234],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9930999,0.0034601106,0.0012155318,0.0005747157,0.0011959272,0.00045376687],"domain_scores_gemma":[0.9477928,0.038935076,0.0032266064,0.0017883057,0.006334595,0.0019226125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010294561,0.00054684194,0.0016503432,0.00096732733,0.0021861775,0.0031009568,0.0021974423,0.028691275,0.004911729],"category_scores_gemma":[0.093158826,0.0006669333,0.0012189815,0.001030483,0.0042131566,0.0063725766,0.0023637817,0.038118478,0.005524694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001355633,0.000078142075,0.014034697,0.00023951073,0.00012504979,0.007396118,0.0018727316,0.00017576938,0.00025974805,0.0074351416,0.92712176,0.04112589],"study_design_scores_gemma":[0.0002065345,0.00016338225,0.0076684463,0.0014388611,0.00017168323,0.008878493,0.0057081156,0.0014581904,0.00051054393,0.07912926,0.89446056,0.00020595566],"about_ca_topic_score_codex":0.0070380326,"about_ca_topic_score_gemma":0.008652251,"teacher_disagreement_score":0.028691275,"about_ca_system_score_codex":0.0025495745,"about_ca_system_score_gemma":0.0029965832,"threshold_uncertainty_score":0.05444348},"labels":[],"label_agreement":null},{"id":"W2770280018","doi":"10.1016/j.msard.2017.11.013","title":"Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Deutsche Stiftung Neurologie; Biogen Idec; Merck KGaA; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Novartis; Bayer","keywords":"Multiple sclerosis; Medicine; Perspective (graphical); Physical therapy; Physical medicine and rehabilitation; Psychiatry","score_opus":0.05478649989018387,"score_gpt":0.26781902990872924,"score_spread":0.21303253001854539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770280018","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044519007,0.014956828,0.00205707,0.9171059,0.007720529,0.00045137372,0.0006879779,0.000044432833,0.012456917],"genre_scores_gemma":[0.65848434,0.04369945,0.006578892,0.264192,0.0060238997,0.004557035,0.0021067928,0.00024629763,0.014111315],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9128735,0.07190708,0.0034451727,0.0012218608,0.0047712484,0.005781222],"domain_scores_gemma":[0.900191,0.04680252,0.003460143,0.0014826825,0.016267654,0.03179606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10127438,0.00089117175,0.0010305081,0.0018197568,0.0073479684,0.0103623215,0.0028455618,0.01053929,0.0034590815],"category_scores_gemma":[0.069137506,0.0006209476,0.0014424778,0.001956202,0.0044384087,0.006383791,0.018657358,0.014479697,0.0008499435],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055496837,0.00038448736,0.02086807,0.0037369393,0.0002634075,0.0010173256,0.38826966,0.0009930133,0.0013158851,0.029439138,0.42586327,0.12729384],"study_design_scores_gemma":[0.0001894005,0.0006254062,0.008265738,0.007840597,0.00010381894,0.0008315291,0.35601223,0.00057383307,0.00061077916,0.011485849,0.613221,0.00023988793],"about_ca_topic_score_codex":0.016402462,"about_ca_topic_score_gemma":0.01513502,"teacher_disagreement_score":0.10127438,"about_ca_system_score_codex":0.011583902,"about_ca_system_score_gemma":0.047983035,"threshold_uncertainty_score":0.5355965},"labels":[],"label_agreement":null},{"id":"W2771416990","doi":"10.1016/j.msard.2017.12.006","title":"Treatment satisfaction and bothersome bladder, bowel, sexual symptoms in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Quality of life (healthcare); Multiple sclerosis; Logistic regression; Patient satisfaction; Internal medicine; Disease; Physical therapy; Psychiatry; Surgery","score_opus":0.054119972625521116,"score_gpt":0.28039351043484706,"score_spread":0.22627353780932594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771416990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947509,0.003414843,0.000043845423,0.0002311685,0.000015212981,0.000013807907,0.00019164084,0.000001660984,0.001336937],"genre_scores_gemma":[0.9991171,0.00047194716,0.000036900437,0.00008168112,0.000019031671,0.00000976402,0.00009334569,6.457861e-7,0.0001694664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975068,0.0015328277,0.0003049405,0.000087673994,0.00037613264,0.00019176168],"domain_scores_gemma":[0.99316216,0.0031029226,0.002660356,0.00014919566,0.00039603576,0.00052942504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028786531,0.00015782134,0.0005760978,0.0010296328,0.0005658145,0.0009546657,0.00022218193,0.0006863402,0.0034154058],"category_scores_gemma":[0.008040673,0.0001698447,0.0012685782,0.0020423224,0.00043699998,0.00065003824,0.00056808756,0.00073882134,0.00012560995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012663974,0.00047309085,0.98239213,0.00026399083,0.00079753617,0.00004992022,0.00066869607,0.000064179454,0.00014187585,0.00006942254,0.0002608919,0.013551929],"study_design_scores_gemma":[0.000055940905,0.00055532815,0.99772555,0.00006167418,0.00022338537,0.000106073894,0.0007550784,0.00009703191,0.000054200602,0.000037678346,0.00031998113,0.000008255022],"about_ca_topic_score_codex":0.0036383057,"about_ca_topic_score_gemma":0.0056984103,"teacher_disagreement_score":0.0036383057,"about_ca_system_score_codex":0.0004292015,"about_ca_system_score_gemma":0.0004951627,"threshold_uncertainty_score":0.01522392},"labels":[],"label_agreement":null},{"id":"W2771966364","doi":"10.1016/j.msard.2017.12.007","title":"The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Nova Scotia Health Authority; Dalhousie University; University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Heart and Stroke Foundation of Canada","keywords":"Multiple sclerosis; Medicine; Anxiety; Depression (economics); Reliability (semiconductor); Clinical psychology; Psychiatry; Validity; Psychometrics","score_opus":0.0754390113063081,"score_gpt":0.2944983733866809,"score_spread":0.2190593620803728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771966364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934482,0.0033177887,0.0013474573,0.00018598093,0.0000641696,0.00010197437,0.00040577192,0.000026801963,0.0011018986],"genre_scores_gemma":[0.9976432,0.00032550909,0.0015629205,0.000036517726,0.00003790958,0.00007316341,0.00021353982,0.0000027430906,0.0001044861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99304456,0.003169665,0.0009703547,0.0007210101,0.0018730261,0.00022136746],"domain_scores_gemma":[0.97198224,0.015041653,0.007291131,0.0009712746,0.004163422,0.00055039336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0127883395,0.0006434387,0.00074278814,0.0021349925,0.0003421484,0.0009106216,0.00065309776,0.00073570077,0.00075258646],"category_scores_gemma":[0.037498944,0.0002880583,0.00082887616,0.0012229595,0.00061052135,0.0007207728,0.0009567847,0.0006260984,0.00024749065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003908961,0.00017299355,0.97173136,0.00018518463,0.00035626983,0.000029629371,0.00017082281,0.0002550277,0.000547053,0.000034708464,0.00018388638,0.02594212],"study_design_scores_gemma":[0.000057391622,0.0009336495,0.9952283,0.00012937955,0.00019728437,0.00033432132,0.00012482172,0.0018732894,0.00068745104,0.000098924014,0.0003216477,0.000013536437],"about_ca_topic_score_codex":0.0010500527,"about_ca_topic_score_gemma":0.0016054056,"teacher_disagreement_score":0.0127883395,"about_ca_system_score_codex":0.00042900475,"about_ca_system_score_gemma":0.0005640564,"threshold_uncertainty_score":0.06763202},"labels":[],"label_agreement":null},{"id":"W2775283417","doi":"10.1016/j.msard.2017.11.022","title":"Validation of an algorithm to detect severe MS relapses in administrative health databases","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Dalhousie University","keywords":"Medicine; Prednisone; Medical prescription; Diagnosis code; Database; Methylprednisolone; Population; Record linkage; Pediatrics; Algorithm; Outpatient clinic; Pharmacoepidemiology; Internal medicine","score_opus":0.09317554801030638,"score_gpt":0.35737687175260124,"score_spread":0.2642013237422949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775283417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85580367,0.0013128797,0.12056892,0.0014201031,0.00017970678,0.0017115686,0.013522995,0.00308618,0.0023941468],"genre_scores_gemma":[0.7636949,0.00027705866,0.21659003,0.00029410364,0.0000815484,0.0004831019,0.018106248,0.00008361581,0.00038939124],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99046636,0.004165886,0.0020251432,0.0017295557,0.0012046939,0.00040837994],"domain_scores_gemma":[0.96101516,0.028386982,0.002543405,0.0022841198,0.005152476,0.00061791716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01827478,0.0010105878,0.0017861786,0.005923276,0.0011839337,0.0042772195,0.0020932476,0.0018845183,0.0013480387],"category_scores_gemma":[0.047055315,0.0006020657,0.001661336,0.003220699,0.00041593824,0.001985697,0.0018808757,0.0011018105,0.0004977408],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003347433,0.0015619302,0.7460644,0.0006365431,0.002121601,0.0003222764,0.0003876796,0.039547533,0.0034426064,0.0017442869,0.009557982,0.19126575],"study_design_scores_gemma":[0.0011565367,0.0006616473,0.17843583,0.0002739745,0.001167599,0.0009121951,0.00041749494,0.80339926,0.0054508583,0.0038061994,0.004241561,0.00007687275],"about_ca_topic_score_codex":0.010251586,"about_ca_topic_score_gemma":0.010048203,"teacher_disagreement_score":0.01827478,"about_ca_system_score_codex":0.0012864395,"about_ca_system_score_gemma":0.003864331,"threshold_uncertainty_score":0.09664744},"labels":[],"label_agreement":null},{"id":"W2776489476","doi":"10.1016/j.msard.2017.12.012","title":"Paraneoplastic Neuromyelitis Optica Spectrum Disorder: A single center cohort description with two cases of histological validation","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of British Columbia","funders":"","keywords":"Medicine; Neuromyelitis optica; Cancer; Serous fluid; Pathology; Serous carcinoma; Ovarian cancer; Serology; Oncology; Multiple sclerosis; Internal medicine; Antibody; Immunology","score_opus":0.03205792600054316,"score_gpt":0.2312441609377451,"score_spread":0.19918623493720194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776489476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779606,0.00010604922,0.00048825465,0.00009372021,0.000022345432,0.00006246346,0.0002192265,0.000015472988,0.0011963883],"genre_scores_gemma":[0.9988489,0.00006773647,0.00040386783,0.00007301332,0.000031687254,0.000018220318,0.0002597382,0.00002434152,0.0002724155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988285,0.000116748684,0.00016751107,0.00040313,0.00020824597,0.00027589817],"domain_scores_gemma":[0.9963691,0.00074224354,0.0007488483,0.0007996599,0.0007205362,0.00061957503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009554264,0.0010319597,0.0005940656,0.0026355844,0.002930575,0.0016709729,0.0012701324,0.0013078015,0.0038760318],"category_scores_gemma":[0.007094352,0.0008729745,0.0007047081,0.0010307649,0.001305335,0.0012514527,0.0016850028,0.00085055927,0.00086123985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021340889,0.00026530825,0.7844223,0.00003150824,0.00006483544,0.20534714,0.0015558547,0.000077270866,0.003682125,0.0003420911,0.00060242094,0.0033958599],"study_design_scores_gemma":[0.00003030914,0.00024788952,0.32396045,0.000041184707,0.00007045204,0.6697753,0.002413246,0.00038119845,0.001216281,0.00036484428,0.0014450108,0.000053851523],"about_ca_topic_score_codex":0.0066414527,"about_ca_topic_score_gemma":0.0065382463,"teacher_disagreement_score":0.0066414527,"about_ca_system_score_codex":0.0008593926,"about_ca_system_score_gemma":0.0010970227,"threshold_uncertainty_score":0.013205588},"labels":[],"label_agreement":null},{"id":"W2787300357","doi":"10.1016/j.msard.2018.02.005","title":"The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Age of onset; Multiple sclerosis; Young adult; Penetrance; Disease; Demography; Internal medicine; Immunology; Phenotype; Biology","score_opus":0.10358821818861248,"score_gpt":0.2749136728281766,"score_spread":0.1713254546395641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787300357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946603,0.001331093,0.0009597897,0.00007493195,0.000022399057,0.000010177948,0.0013332159,0.000014222304,0.0015938621],"genre_scores_gemma":[0.99823534,0.0003510393,0.0006855194,0.000016904312,0.000013124951,0.0000060582897,0.0004716424,0.0000032271676,0.00021723098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987551,0.00073331944,0.00014774753,0.00014700543,0.00015396503,0.00006286819],"domain_scores_gemma":[0.9897245,0.004741764,0.0037182828,0.00079548167,0.0007251392,0.00029484712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002045431,0.00036777006,0.00024653072,0.0019741294,0.00027213906,0.000676057,0.0003188985,0.0003220614,0.0011602499],"category_scores_gemma":[0.00791545,0.00020780739,0.0004899237,0.0025461146,0.00026326394,0.00058413413,0.0004038829,0.00044454177,0.00016892121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100789366,0.00002036307,0.9958742,0.000026895355,0.00015593319,0.000030466463,0.00008705474,0.00013807761,0.0006343377,0.00004157871,0.000031492807,0.0028588679],"study_design_scores_gemma":[0.0000029669732,0.00013486003,0.99843246,0.000013249013,0.00007103508,0.00024761376,0.00016227357,0.0002732827,0.0003134591,0.0000665697,0.0002783707,0.000003879406],"about_ca_topic_score_codex":0.0061606774,"about_ca_topic_score_gemma":0.0060761455,"teacher_disagreement_score":0.0061606774,"about_ca_system_score_codex":0.0001874795,"about_ca_system_score_gemma":0.00029905327,"threshold_uncertainty_score":0.012249649},"labels":[],"label_agreement":null},{"id":"W2787385618","doi":"10.1016/j.msard.2018.02.009","title":"Factors associated with excessive sitting time in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Alabama at Birmingham; National Multiple Sclerosis Society","keywords":"Medicine; Sitting; Ambulatory; Multiple sclerosis; Logistic regression; Population; Percentile; Psychological intervention; Odds ratio; Physical therapy; Odds; Demography; Gerontology; Environmental health; Psychiatry; Internal medicine","score_opus":0.07177685466909786,"score_gpt":0.26636156601682015,"score_spread":0.1945847113477223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787385618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788636,0.001204413,0.000046825502,0.00007012648,0.000013394394,0.0000029645162,0.0001513444,0.000002427162,0.000622011],"genre_scores_gemma":[0.9994154,0.0002707265,0.00005596142,0.0000157599,0.000018027404,0.000002566709,0.00010693546,0.0000012569365,0.00011343277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951243,0.00014338025,0.000113817965,0.000059923426,0.000088375884,0.000082019025],"domain_scores_gemma":[0.99673045,0.0007472248,0.0017237935,0.00013332104,0.00021450409,0.00045073996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039972016,0.00029145202,0.00035210748,0.0012575412,0.0006107137,0.00077618205,0.0002823957,0.0005559137,0.002464214],"category_scores_gemma":[0.003382317,0.00020692559,0.0006046598,0.0022649113,0.00024433344,0.0003162707,0.00036959845,0.00060331996,0.00016737753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102643746,0.000033741442,0.9981457,0.000030130992,0.000119607495,0.00015446729,0.000122012025,0.000018391589,0.00017263489,0.0000113208025,0.00004472019,0.0010446637],"study_design_scores_gemma":[0.0000011648275,0.000027913475,0.9995553,0.0000070881733,0.000034476136,0.00011024369,0.00017872316,0.000023625262,0.000012758713,0.000009365843,0.000037586226,0.0000017733468],"about_ca_topic_score_codex":0.011014402,"about_ca_topic_score_gemma":0.016385108,"teacher_disagreement_score":0.011014402,"about_ca_system_score_codex":0.00023625583,"about_ca_system_score_gemma":0.00037518403,"threshold_uncertainty_score":0.021900594},"labels":[],"label_agreement":null},{"id":"W2787599611","doi":"10.1016/j.msard.2018.01.021","title":"Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011–2016)","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Physical therapy; Physical medicine and rehabilitation; Adverse effect; Rehabilitation; MEDLINE; Balance (ability); Multiple sclerosis","score_opus":0.09789177387970635,"score_gpt":0.3365683771397416,"score_spread":0.23867660326003523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787599611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011657854,0.99818254,0.00005753548,0.00009170919,0.00006265145,0.00008890777,0.00025551784,0.0000040264017,0.000091296955],"genre_scores_gemma":[0.013253654,0.98588437,0.00025171306,0.00022005048,0.000043434273,0.00015447398,0.00012191041,0.0000020174525,0.00006842455],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.995417,0.0010337118,0.0022245261,0.00040812552,0.0007008433,0.00021577271],"domain_scores_gemma":[0.9921606,0.0047003287,0.0022415076,0.00011330146,0.00061123975,0.00017293109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049818163,0.0016078982,0.009554809,0.008039114,0.0005321035,0.0026192875,0.001391142,0.0018963126,0.0036742804],"category_scores_gemma":[0.017983701,0.0011811154,0.010988372,0.009919925,0.0007300434,0.0022014084,0.0024327186,0.001508634,0.00026411997],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033643702,0.000020260133,0.0014723383,0.94688827,0.024372188,0.0001065899,0.0001577773,0.00008289016,0.00015176709,0.000118325006,0.0008601972,0.025432922],"study_design_scores_gemma":[0.0007248807,0.00029466933,0.014750814,0.65350485,0.3150106,0.0005798094,0.0004204065,0.00008189566,0.00019588087,0.00030363575,0.014057846,0.00007466554],"about_ca_topic_score_codex":0.012480945,"about_ca_topic_score_gemma":0.03921064,"teacher_disagreement_score":0.012480945,"about_ca_system_score_codex":0.0025821123,"about_ca_system_score_gemma":0.007655421,"threshold_uncertainty_score":0.026346684},"labels":[],"label_agreement":null},{"id":"W2788304256","doi":"10.1016/j.msard.2018.02.019","title":"A survey of dietary characteristics in a large population of people with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Multiple sclerosis; Medicine; Population; Environmental health; Gerontology; Immunology","score_opus":0.048489580740819535,"score_gpt":0.2718305457115136,"score_spread":0.22334096497069406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788304256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992094,0.00010133766,0.00005452444,0.00003698005,0.000004001344,0.000012670742,0.0002960689,0.0000018066855,0.00028318472],"genre_scores_gemma":[0.99895155,0.0001383204,0.00011214429,0.00009756711,0.000010600909,0.00002557458,0.00041007577,0.000001927879,0.00025219645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947673,0.00016350111,0.00009738465,0.000109552966,0.00009032575,0.00006255954],"domain_scores_gemma":[0.99898034,0.00019507835,0.00034333378,0.00007929709,0.00018776896,0.0002141783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005955836,0.0003470403,0.0006082492,0.0015999104,0.001017266,0.00079222466,0.00026933764,0.0007452534,0.001256006],"category_scores_gemma":[0.0018100111,0.00040717874,0.0005998042,0.0024282618,0.0003424666,0.0008690908,0.0006542952,0.00059879775,0.00031422637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000663919,0.000085342435,0.99797136,0.000016888178,0.00007319488,0.00008597291,0.00046008176,0.000007989012,0.00039817384,0.0000054941775,0.00006579788,0.00076340244],"study_design_scores_gemma":[0.0000046221558,0.000119159806,0.9985416,0.000004594258,0.000024621435,0.0001425097,0.0010016683,0.000024584715,0.000018710165,0.000004607685,0.000109963556,0.0000033042227],"about_ca_topic_score_codex":0.016695283,"about_ca_topic_score_gemma":0.020466512,"teacher_disagreement_score":0.016695283,"about_ca_system_score_codex":0.0003553351,"about_ca_system_score_gemma":0.00035426882,"threshold_uncertainty_score":0.03319621},"labels":[],"label_agreement":null},{"id":"W2797993398","doi":"10.1016/j.msard.2018.04.006","title":"Frequent retinal ganglion cell damage after acute optic neuritis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Ophthalmology; Ganglion; Retinal ganglion cell; Visual acuity; Optic nerve; Anatomy","score_opus":0.019517482726725325,"score_gpt":0.2536248396638929,"score_spread":0.23410735693716755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797993398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99594647,0.0029060636,0.000036402882,0.00006703815,0.000015089187,0.0000056363906,0.00007321564,0.0000021505853,0.0009480493],"genre_scores_gemma":[0.9991233,0.0006053478,0.00002388672,0.000027592841,0.00003995488,0.0000022962797,0.0000709818,7.6056324e-7,0.00010585661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983308,0.00058707834,0.00026692363,0.00021451846,0.0002853531,0.00031528412],"domain_scores_gemma":[0.99362963,0.0016087774,0.0030469573,0.00048330796,0.00061575265,0.0006155201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013242484,0.00023452929,0.0004196353,0.002972461,0.000935228,0.0010838442,0.00040712307,0.00088523707,0.0018574604],"category_scores_gemma":[0.005393876,0.00019210913,0.000354838,0.0017738813,0.0006558348,0.0013445395,0.00079089485,0.00067238905,0.00023744481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008148335,0.00011545956,0.9867619,0.00013310052,0.00013956624,0.0034857441,0.0004850318,0.000021428483,0.0014651212,0.00008557647,0.00015027905,0.006341936],"study_design_scores_gemma":[0.000008842525,0.00014121766,0.99583507,0.000018969933,0.000037933474,0.002971567,0.00057184784,0.000013058835,0.00013532766,0.000057530546,0.0002045512,0.000004088525],"about_ca_topic_score_codex":0.0036874744,"about_ca_topic_score_gemma":0.0034778903,"teacher_disagreement_score":0.0036874744,"about_ca_system_score_codex":0.000595813,"about_ca_system_score_gemma":0.00050430733,"threshold_uncertainty_score":0.007332027},"labels":[],"label_agreement":null},{"id":"W2799999954","doi":"10.1016/j.msard.2018.04.008","title":"Severe aseptic temporal lobe encephalitis on fingolimod","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Fingolimod; Medicine; Etiology; Multiple sclerosis; Aseptic meningitis; Encephalitis; Viral encephalitis; Temporal lobe; Immunology; Pediatrics; Pathology; Virus; Cerebrospinal fluid; Psychiatry","score_opus":0.014247635459749435,"score_gpt":0.21929233576179605,"score_spread":0.2050447003020466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799999954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9160241,0.009853761,0.0030756553,0.012453268,0.0011113109,0.00028000007,0.0010388634,0.00029730168,0.055865806],"genre_scores_gemma":[0.9901764,0.002250321,0.00042012593,0.0028212487,0.0004126785,0.000022459022,0.00033775502,0.000016739912,0.0035421734],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99981636,0.00003222683,0.000026782596,0.000025200336,0.000047293277,0.000052090025],"domain_scores_gemma":[0.99957865,0.00014649854,0.00006302183,0.000040944527,0.000047089212,0.00012381143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000303754,0.0008578075,0.0006492154,0.00037945202,0.00068292156,0.0004056449,0.0004612087,0.0014104418,0.0016527105],"category_scores_gemma":[0.0012089078,0.00025792868,0.00067441445,0.00035729288,0.00046511262,0.0006123214,0.00026928165,0.0021586746,0.0004910027],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009448237,0.0006233295,0.029037414,0.00030874016,0.00035345793,0.85415703,0.00035233216,0.00079129747,0.039664816,0.0012281766,0.006179307,0.057855934],"study_design_scores_gemma":[0.0012875039,0.006035863,0.18491879,0.00021161608,0.00091537007,0.7424338,0.0004915864,0.0031638134,0.021408953,0.004433991,0.034577634,0.000121012614],"about_ca_topic_score_codex":0.0018294138,"about_ca_topic_score_gemma":0.0032792636,"teacher_disagreement_score":0.0018294138,"about_ca_system_score_codex":0.0005564192,"about_ca_system_score_gemma":0.00080749625,"threshold_uncertainty_score":0.0055288672},"labels":[],"label_agreement":null},{"id":"W2801839118","doi":"10.1016/j.msard.2018.04.007","title":"Autonomic dysreflexia following acute myelitis due to neuromyelitis optica","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Autonomic dysreflexia; Tetraplegia; Medicine; Spinal cord injury; Blood pressure; Neuromyelitis optica; Anesthesia; Myelitis; Spinal cord; Surgery; Internal medicine; Multiple sclerosis","score_opus":0.03398605089543806,"score_gpt":0.30694777614924745,"score_spread":0.2729617252538094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801839118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871905,0.0015351558,0.00053291034,0.00032601831,0.0001467719,0.0000753411,0.000060356342,0.000045803055,0.008558611],"genre_scores_gemma":[0.99883085,0.00031984685,0.000055202665,0.00024713235,0.00008827057,0.0000074937016,0.000029854045,0.0000031282432,0.00041829253],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996699,0.00006797769,0.000050099814,0.000044967168,0.000071718205,0.00009538569],"domain_scores_gemma":[0.9989048,0.00038278857,0.000291356,0.00007029352,0.00008884289,0.00026183747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039184542,0.00047925563,0.00086504704,0.00084786303,0.0007686232,0.0005446294,0.0004934046,0.00097044837,0.0016170378],"category_scores_gemma":[0.004336996,0.00022281453,0.0003484629,0.0005791001,0.00081099727,0.0006077813,0.00056594686,0.0015064204,0.0003417748],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041189664,0.0007136799,0.22591281,0.00033647995,0.00027869016,0.72332156,0.0012413459,0.0004362777,0.011888605,0.0003003517,0.0007752687,0.030675972],"study_design_scores_gemma":[0.0002276495,0.0025594137,0.72449577,0.000101569574,0.00017148312,0.2673014,0.0008093721,0.0008999505,0.0017093165,0.00038814958,0.0012904407,0.000045583292],"about_ca_topic_score_codex":0.0025884877,"about_ca_topic_score_gemma":0.0032668621,"teacher_disagreement_score":0.0025884877,"about_ca_system_score_codex":0.0006761605,"about_ca_system_score_gemma":0.00036806625,"threshold_uncertainty_score":0.0054095387},"labels":[],"label_agreement":null},{"id":"W2808932716","doi":"10.1016/j.msard.2018.06.010","title":"Radiologically isolated syndrome in children: Current knowledge and future directions","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Mental Health Research Canada; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Ontario Institute for Regenerative Medicine; Stem Cell Network; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Magnetic resonance imaging; Observational study; Clinical significance; Psychological intervention; McDonald criteria; Demyelinating disease; Disease; Clinical Practice; Pediatrics; Intensive care medicine; Pathology; Physical therapy; Radiology; Psychiatry","score_opus":0.04744703907342532,"score_gpt":0.3147260977311121,"score_spread":0.26727905865768675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808932716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009297524,0.99962354,0.000017328028,0.00011053094,0.000035271558,0.0000010280208,0.000015776386,0.0000011643983,0.00010233501],"genre_scores_gemma":[0.0009801541,0.9987172,0.00008169298,0.0001046379,0.000065531196,0.0000017451985,0.000015534992,4.747211e-7,0.000032969107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994624,0.000088622466,0.00018040178,0.00012231346,0.00011109367,0.000035242003],"domain_scores_gemma":[0.9977398,0.0015746868,0.0004063557,0.000023744497,0.00019239419,0.00006298789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010698544,0.000749714,0.0025019408,0.0036880143,0.000309233,0.00200082,0.000983537,0.0014306967,0.0034439855],"category_scores_gemma":[0.0029948,0.0003576151,0.0009962958,0.0046021873,0.00085898285,0.0019719377,0.0009012595,0.0012770474,0.0003981715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018495404,0.00007983075,0.0051927944,0.16116159,0.0009856565,0.0010559304,0.00041390417,0.00033261706,0.0007542984,0.0028349573,0.016116476,0.810887],"study_design_scores_gemma":[0.00013583273,0.00017184939,0.022621464,0.17509511,0.0070488215,0.013683437,0.0019907528,0.00024512762,0.0004987515,0.0050206115,0.77334374,0.00014462574],"about_ca_topic_score_codex":0.0031536915,"about_ca_topic_score_gemma":0.0072744587,"teacher_disagreement_score":0.0036880143,"about_ca_system_score_codex":0.0007006169,"about_ca_system_score_gemma":0.003127861,"threshold_uncertainty_score":0.01152128},"labels":[],"label_agreement":null},{"id":"W2856119501","doi":"10.1016/j.msard.2018.07.012","title":"Use of the new oral disease-modifying therapies for multiple sclerosis in British Columbia, Canada: the first five-years","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Teriflunomide; Fingolimod; Medicine; Multiple sclerosis; Glatiramer acetate; Natalizumab; Medical prescription; Poisson regression; Internal medicine; Pediatrics; Pharmacology; Environmental health; Population; Immunology","score_opus":0.056556920343223197,"score_gpt":0.24977946225881328,"score_spread":0.19322254191559007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2856119501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260795,0.04333953,0.00023581198,0.006625928,0.000261567,0.00018276645,0.012910966,0.000047230493,0.010316772],"genre_scores_gemma":[0.9719121,0.0166551,0.00039944207,0.0011065392,0.00006272562,0.00006355586,0.0043226313,0.0000150134865,0.0054630516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969758,0.00025594843,0.00028575122,0.00023069492,0.0013510251,0.00090077356],"domain_scores_gemma":[0.989734,0.00054463896,0.0017269637,0.00018056901,0.0058648516,0.0019490463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022904496,0.0005267858,0.0011124345,0.0021511149,0.0034668928,0.0029950736,0.0022030324,0.0017209215,0.0018962556],"category_scores_gemma":[0.0073355483,0.00051407726,0.0011590746,0.006239653,0.0010135855,0.0013394782,0.0017226016,0.0030526011,0.00026923648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007433182,0.00026377058,0.9540765,0.0005432342,0.00032842715,0.00031117405,0.0026486772,0.0001997113,0.0002912524,0.00041629045,0.005268895,0.034908816],"study_design_scores_gemma":[0.000027771392,0.0001139933,0.9904242,0.00035347728,0.00019886928,0.00011306629,0.003027527,0.00019872158,0.00010220096,0.00005115292,0.0053506135,0.000038480208],"about_ca_topic_score_codex":0.9957623,"about_ca_topic_score_gemma":0.9973116,"teacher_disagreement_score":0.046627123,"about_ca_system_score_codex":0.046627123,"about_ca_system_score_gemma":0.08507087,"threshold_uncertainty_score":0.338305},"labels":[],"label_agreement":null},{"id":"W2884191823","doi":"10.1016/j.msard.2018.07.019","title":"Perceived cognitive deficits and depressive symptoms in patients with multiple sclerosis: Perceived stress and sleep quality as mediators","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Perceived Stress Scale; Medicine; Mediation; Pittsburgh Sleep Quality Index; Center for Epidemiologic Studies Depression Scale; Clinical psychology; Cognition; Depression (economics); Multiple sclerosis; Psychiatry; Depressive symptoms; Sleep quality; Stress (linguistics)","score_opus":0.023452416125247358,"score_gpt":0.2642543371818235,"score_spread":0.24080192105657616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884191823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982828,0.0012284573,0.000023237819,0.00010326329,0.000007763174,0.0000053302724,0.000060042537,7.164793e-7,0.00028847472],"genre_scores_gemma":[0.999579,0.00021950348,0.000027522912,0.00003757239,0.000012522655,0.000004556014,0.000050640538,2.8510632e-7,0.000068348665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944955,0.00024521883,0.00007406298,0.00005431114,0.00007648354,0.000100294965],"domain_scores_gemma":[0.9976501,0.00084529753,0.0008784604,0.00007440026,0.00013478997,0.00041705344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010354646,0.0003605562,0.0005528469,0.0008062084,0.00049927825,0.0010630089,0.00037351032,0.0009065843,0.0017476035],"category_scores_gemma":[0.004156664,0.000292074,0.0008675651,0.0010865527,0.0004383898,0.00059845945,0.00066504255,0.00096900476,0.000104659084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033817164,0.00018759175,0.9972127,0.00003594761,0.00031600715,0.00005961264,0.00019677155,0.000040917363,0.00008339725,0.000016988597,0.000036140522,0.0014757867],"study_design_scores_gemma":[0.000022612328,0.00018053559,0.9989864,0.000014004636,0.00012722705,0.000061842045,0.00041848057,0.000092533264,0.000020359686,0.000031201682,0.0000402592,0.000004497618],"about_ca_topic_score_codex":0.0065381066,"about_ca_topic_score_gemma":0.009708779,"teacher_disagreement_score":0.0065381066,"about_ca_system_score_codex":0.000352743,"about_ca_system_score_gemma":0.0005819341,"threshold_uncertainty_score":0.013000071},"labels":[],"label_agreement":null},{"id":"W2887080097","doi":"10.1016/j.msard.2018.08.007","title":"Mining healthcare data for markers of the multiple sclerosis prodrome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; University of Manitoba; Health Sciences Centre; Dalhousie University; University of Saskatchewan; Manitoba Health; University of British Columbia Hospital; Saskatchewan Health Quality Council; University of British Columbia","funders":"","keywords":"Medicine; Logistic regression; Medical prescription; Multiple sclerosis; Prodrome; Cohort; Odds ratio; Diagnosis code; Internal medicine; Population; Predictive analytics; Psychiatry; Statistics; Environmental health","score_opus":0.11055498326435126,"score_gpt":0.31147776379333775,"score_spread":0.2009227805289865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887080097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95465297,0.005200986,0.0033177382,0.0011963362,0.0000908564,0.000094884555,0.03352526,0.000073533556,0.0018475372],"genre_scores_gemma":[0.96843463,0.0010869156,0.004807238,0.00018892599,0.000070773705,0.00006453724,0.025044631,0.000008557695,0.0002936472],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998912,0.00028065447,0.00029312228,0.00024104431,0.00016666933,0.000106419226],"domain_scores_gemma":[0.9942708,0.0029092212,0.0016280803,0.00046678298,0.00048108428,0.00024403264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012460349,0.00036667412,0.0007327701,0.004911946,0.0002856072,0.0011614077,0.0004929138,0.0007090796,0.0012841161],"category_scores_gemma":[0.007773369,0.00015745158,0.0009722039,0.0041943537,0.00018302281,0.00061342685,0.0005861352,0.00053858693,0.0003241409],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010610692,0.00020510312,0.9495852,0.0008071415,0.0008016943,0.0008898591,0.00021346234,0.001064434,0.0028879417,0.00052845763,0.0038458302,0.038109727],"study_design_scores_gemma":[0.000099505305,0.0004892687,0.964733,0.00060485746,0.0013501814,0.002175548,0.0016583347,0.009603685,0.0043240017,0.0026818728,0.012236455,0.00004328783],"about_ca_topic_score_codex":0.004512649,"about_ca_topic_score_gemma":0.0071884464,"teacher_disagreement_score":0.004911946,"about_ca_system_score_codex":0.00029247024,"about_ca_system_score_gemma":0.00084075873,"threshold_uncertainty_score":0.008972764},"labels":[],"label_agreement":null},{"id":"W2887090343","doi":"10.1016/j.msard.2018.08.004","title":"Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agence Nationale de la Recherche; Ministère de la Santé et des Services sociaux","keywords":"Medicine; Multiple sclerosis; Retrospective cohort study; Natural history; Disease; Pediatrics; Epidemiology; Cohort study; Age of onset; Cohort; Internal medicine; Psychiatry","score_opus":0.06813667192759514,"score_gpt":0.3001277340746917,"score_spread":0.23199106214709653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887090343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977186,0.00103576,0.00008140073,0.00011574707,0.0000090068415,0.000008510681,0.0005905555,0.000004028205,0.0004364347],"genre_scores_gemma":[0.99855655,0.0003575385,0.000070630675,0.00006088564,0.000019991154,0.000010859584,0.0007520697,0.0000030960764,0.00016844831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877983,0.00034480498,0.00015024634,0.00033063226,0.00012539192,0.00026910118],"domain_scores_gemma":[0.9971431,0.00047159902,0.0011855258,0.00027198216,0.00048244413,0.0004453283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013474245,0.0006233396,0.0007409797,0.0024395264,0.0015103293,0.0016750386,0.000674698,0.0012959483,0.0017150701],"category_scores_gemma":[0.0035112933,0.0004834093,0.0012231965,0.0027840105,0.0005963314,0.001001521,0.0006438632,0.00083479355,0.00023991732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109644294,0.000053248088,0.99866474,0.000009418433,0.00013615242,0.00015710734,0.00015170213,0.000024835694,0.000066708744,0.000023608492,0.00009652739,0.00050628226],"study_design_scores_gemma":[0.0000085513175,0.00010412552,0.9983809,0.000014249525,0.000090446156,0.0004919395,0.0005091253,0.00007460495,0.000019743135,0.000025105619,0.00027113318,0.00001004776],"about_ca_topic_score_codex":0.058585007,"about_ca_topic_score_gemma":0.035837684,"teacher_disagreement_score":0.058585007,"about_ca_system_score_codex":0.001884711,"about_ca_system_score_gemma":0.0013252641,"threshold_uncertainty_score":0.11648804},"labels":[],"label_agreement":null},{"id":"W2887342729","doi":"10.1016/j.msard.2018.07.043","title":"Factors associated with perceived need for mental health care in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; Nova Scotia Health Authority; Dalhousie University; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada","keywords":"Multiple sclerosis; Medicine; Mental health; Psychiatry","score_opus":0.07561283902120947,"score_gpt":0.29159784607455835,"score_spread":0.2159850070533489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887342729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981812,0.0007762392,0.000023356446,0.00021541062,0.000007860224,0.000008954017,0.00010030372,6.954471e-7,0.0006860022],"genre_scores_gemma":[0.99958175,0.00019118555,0.00004099611,0.000040799572,0.000009471879,0.0000052095957,0.000055251116,5.175672e-7,0.000074811025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981173,0.0009552942,0.0003190206,0.00010191456,0.00027892264,0.00022753085],"domain_scores_gemma":[0.98976094,0.0030905937,0.004468906,0.00030781643,0.0007755311,0.0015961974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018652563,0.00019834981,0.0003600341,0.0011735421,0.00086890656,0.0014499438,0.00036698906,0.0007107594,0.0025136408],"category_scores_gemma":[0.012604762,0.00022180242,0.00089819176,0.0016070902,0.00048901944,0.00063551794,0.00082735234,0.0011705423,0.00010342935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007382605,0.00014561013,0.99768984,0.00003963928,0.00015016826,0.00005325321,0.0004714287,0.000019796282,0.000045435172,0.000026844822,0.00004695489,0.0012371822],"study_design_scores_gemma":[0.0000052990486,0.00006158801,0.9981615,0.000029290612,0.000054509816,0.000065494736,0.0014309315,0.000052716714,0.000014833457,0.00002133182,0.00009788476,0.0000045886436],"about_ca_topic_score_codex":0.0181071,"about_ca_topic_score_gemma":0.026050478,"teacher_disagreement_score":0.0181071,"about_ca_system_score_codex":0.00069177983,"about_ca_system_score_gemma":0.000856988,"threshold_uncertainty_score":0.03600341},"labels":[],"label_agreement":null},{"id":"W2887465886","doi":"10.1016/j.msard.2018.08.013","title":"Identifying optic neuritis and transverse myelitis using administrative data","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Dalhousie University; University of British Columbia Hospital; Vancouver Coastal Health; University of Manitoba; University of British Columbia; Manitoba Health","funders":"National Multiple Sclerosis Society","keywords":"Transverse myelitis; Optic neuritis; Medicine; Multiple sclerosis; Myelitis; Acute Transverse Myelitis; Dermatology; Spinal cord; Immunology; Psychiatry","score_opus":0.18617264876897346,"score_gpt":0.3586782497665155,"score_spread":0.17250560099754206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887465886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975694,0.0020234755,0.00077308714,0.00027767802,0.000042066164,0.00008892762,0.019079939,0.000017360668,0.0020034148],"genre_scores_gemma":[0.9876551,0.0007493213,0.0011572642,0.00009008829,0.0000386724,0.00010782269,0.009949704,0.0000055801147,0.00024643372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99033594,0.0039978283,0.0025237477,0.00093915785,0.0013131065,0.00089020043],"domain_scores_gemma":[0.97261614,0.0074316724,0.013642501,0.002828597,0.0026202756,0.0008607837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052071987,0.0005253707,0.0007534049,0.005845791,0.0009553777,0.0016561955,0.0014014796,0.00094073627,0.0014454853],"category_scores_gemma":[0.026163766,0.00056951935,0.001969506,0.0099389665,0.00048304308,0.0017040304,0.0015119007,0.0009258311,0.0003673629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007733661,0.00004204262,0.9972785,0.0000872739,0.0003527123,0.000047030568,0.000087320936,0.00007711692,0.00006354781,0.000106503074,0.0003581606,0.0014224062],"study_design_scores_gemma":[0.000022830787,0.000095309624,0.9968695,0.00011341778,0.00035051504,0.00018708028,0.0006180618,0.0004748834,0.00016235627,0.00017206559,0.00091899646,0.000015036387],"about_ca_topic_score_codex":0.045242824,"about_ca_topic_score_gemma":0.047244333,"teacher_disagreement_score":0.045242824,"about_ca_system_score_codex":0.0009026702,"about_ca_system_score_gemma":0.0026727314,"threshold_uncertainty_score":0.089958966},"labels":[],"label_agreement":null},{"id":"W2888242617","doi":"10.1016/j.msard.2018.08.019","title":"No association between socioeconomic status and risk of multiple sclerosis: A population-based incident case-control study in a developing country","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Association (psychology); Environmental health; Population; Developing country; Case-control study; Demography; Immunology; Internal medicine; Economic growth","score_opus":0.02864059619302026,"score_gpt":0.2720505355833588,"score_spread":0.24340993939033853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888242617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993876,0.00014037619,0.00007147172,0.00002411461,0.0000059663485,0.000004276879,0.00010650849,0.0000016219878,0.00025807758],"genre_scores_gemma":[0.9996184,0.00009311781,0.000059267342,0.000022466253,0.0000065715276,0.000004326465,0.000114750284,0.0000018476613,0.00007929796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889225,0.00042706114,0.00013364856,0.00025914673,0.00012021919,0.00016770304],"domain_scores_gemma":[0.99761933,0.00066826504,0.0005949287,0.00030591525,0.00031838464,0.0004931121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013978353,0.00047159565,0.000758344,0.0013687088,0.0014484051,0.0015349633,0.00070848037,0.0006905773,0.0015972226],"category_scores_gemma":[0.0030812144,0.0007975781,0.0007332426,0.0022395123,0.0010696087,0.0008330644,0.00061252195,0.00089873833,0.00021089653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022950345,0.00006642052,0.9987482,0.00000926109,0.00016105814,0.0001532013,0.00012191313,0.000011161786,0.00020994004,0.000018732873,0.00002931487,0.00024128973],"study_design_scores_gemma":[0.000022822825,0.00017717121,0.9987882,0.000005428656,0.00014170236,0.00026830574,0.00040332868,0.000074611686,0.000037615526,0.000018285931,0.00005772994,0.0000048310826],"about_ca_topic_score_codex":0.022534326,"about_ca_topic_score_gemma":0.021134103,"teacher_disagreement_score":0.022534326,"about_ca_system_score_codex":0.00045164075,"about_ca_system_score_gemma":0.0006976354,"threshold_uncertainty_score":0.0448063},"labels":[],"label_agreement":null},{"id":"W2888696829","doi":"10.1016/j.msard.2018.08.022","title":"Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Université de Sherbrooke; University of Calgary","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Comorbidity; PsycINFO; Observational study; Physical therapy; CINAHL; MEDLINE; Type 2 diabetes; Population; Diabetes mellitus; Intensive care medicine; Internal medicine; Psychiatry; Environmental health; Psychological intervention","score_opus":0.11759941515899497,"score_gpt":0.31535378527287294,"score_spread":0.19775437011387798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888696829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012385663,0.9995821,0.000027175585,0.0000862056,0.00004928391,0.000019673664,0.000026795786,9.911374e-7,0.0000839001],"genre_scores_gemma":[0.0011305695,0.9985049,0.000109378205,0.0001432282,0.000034245393,0.000026452868,0.000022438808,6.014318e-7,0.000028284272],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971015,0.0007861845,0.0011515304,0.0002815745,0.00055950775,0.00011973434],"domain_scores_gemma":[0.9883034,0.009623354,0.0013003142,0.00009309865,0.00057323795,0.00010654022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005395703,0.0015095846,0.005610297,0.007531343,0.0005846976,0.003278974,0.0016725113,0.002919633,0.0037190716],"category_scores_gemma":[0.01930732,0.00085444126,0.0055358107,0.007846503,0.00088706386,0.0022460213,0.0017385673,0.0019871783,0.00033544045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018067974,0.000059950115,0.0007610939,0.7980131,0.005812418,0.00013057832,0.00028679043,0.00017286086,0.00020676607,0.0006557546,0.0026847299,0.19103533],"study_design_scores_gemma":[0.00015178054,0.00013982011,0.0032328567,0.91019326,0.03234182,0.0004186209,0.000469377,0.00009931235,0.0001410641,0.00071159814,0.052050132,0.000050361745],"about_ca_topic_score_codex":0.010082155,"about_ca_topic_score_gemma":0.022767372,"teacher_disagreement_score":0.010082155,"about_ca_system_score_codex":0.0019594426,"about_ca_system_score_gemma":0.0077926675,"threshold_uncertainty_score":0.028535485},"labels":[],"label_agreement":null},{"id":"W2889718825","doi":"10.1016/j.msard.2018.08.020","title":"Pilot randomized controlled trial of functional electrical stimulation cycling exercise in people with multiple sclerosis with mobility disability","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Cycling; Physical medicine and rehabilitation; Functional electrical stimulation; Randomized controlled trial; Physical therapy; Stimulation; Internal medicine; Psychiatry","score_opus":0.03322548054890444,"score_gpt":0.26492313228075803,"score_spread":0.23169765173185358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889718825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979603,0.0017758721,0.00090063096,0.00091361674,0.0010411382,0.012167676,0.0012537582,0.00018169984,0.0021624938],"genre_scores_gemma":[0.9739973,0.001012944,0.0019831876,0.0011542393,0.00066737575,0.016849484,0.00093916827,0.000023645161,0.0033726569],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986603,0.00066316675,0.00012838835,0.00024637624,0.00006919753,0.0002326365],"domain_scores_gemma":[0.9977926,0.00079011184,0.00032501927,0.00018888152,0.00019600078,0.00070739567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025300703,0.0026082438,0.0044276547,0.0008228497,0.000994558,0.0011728711,0.001533945,0.0032689294,0.015925772],"category_scores_gemma":[0.0036091392,0.0010985453,0.002159356,0.00068234064,0.0021784534,0.0016847549,0.0009497576,0.0035613296,0.0014984815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99143136,0.0056044348,0.0001542832,0.00020353208,0.00027768433,0.000018933239,0.00002464504,0.00007023953,0.0003769918,0.000035551693,0.00015196647,0.0016502875],"study_design_scores_gemma":[0.9623334,0.03666506,0.0005865105,0.000011659394,0.00015008578,0.000004223409,0.000015609417,0.00007203158,0.00004254596,0.000035315665,0.000079254394,0.000004280845],"about_ca_topic_score_codex":0.004479083,"about_ca_topic_score_gemma":0.004575013,"teacher_disagreement_score":0.015925772,"about_ca_system_score_codex":0.0009747345,"about_ca_system_score_gemma":0.0018342277,"threshold_uncertainty_score":0.053277016},"labels":[],"label_agreement":null},{"id":"W2889883532","doi":"10.1016/j.msard.2018.09.004","title":"Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple sclerosis; Medicine; Mitochondrial DNA; DNA; Genetics; Immunology; Gene; Biology","score_opus":0.011477791379696616,"score_gpt":0.19424484342829393,"score_spread":0.1827670520485973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889883532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982254,0.0006749497,0.000108501285,0.00012767421,0.000023640543,0.0000056682406,0.00021556792,0.000007767645,0.0006108748],"genre_scores_gemma":[0.9992448,0.00014096218,0.00007732957,0.00003976874,0.000020297826,0.00000510509,0.00012561407,0.0000049250298,0.0003413112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956673,0.00007690798,0.000091815695,0.00015201983,0.000066531655,0.000045927798],"domain_scores_gemma":[0.99923503,0.00024085268,0.00030013415,0.00003995973,0.000080851845,0.0001031009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025213312,0.00075257715,0.0006911557,0.0020953135,0.0009475969,0.00047325328,0.0006004654,0.0012832828,0.004983442],"category_scores_gemma":[0.002165493,0.00027952951,0.0004621798,0.0016967286,0.00047743224,0.00045362438,0.000519517,0.0005667658,0.0005268669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027085075,0.0002930317,0.9339813,0.00016055435,0.00069483445,0.019648923,0.0011863853,0.00045454924,0.025882104,0.00032709728,0.0006987784,0.013963905],"study_design_scores_gemma":[0.00008657075,0.00039527676,0.9706595,0.000060128266,0.0004052259,0.02344513,0.000862742,0.00057939184,0.0015413039,0.0007482259,0.0011824352,0.000034078155],"about_ca_topic_score_codex":0.0023274347,"about_ca_topic_score_gemma":0.0015908404,"teacher_disagreement_score":0.004983442,"about_ca_system_score_codex":0.00029761976,"about_ca_system_score_gemma":0.00018239669,"threshold_uncertainty_score":0.0166713},"labels":[],"label_agreement":null},{"id":"W2890102036","doi":"10.1016/j.msard.2018.09.008","title":"Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; Dalhousie University; University of Calgary; University of Manitoba; University of Toronto","funders":"Crohn's and Colitis Canada; Canadian Institutes of Health Research; Dalhousie University; Research Manitoba","keywords":"Medicine; Fingolimod; Adverse effect; Natalizumab; Psychiatry; Depression (economics); Anxiety; Meta-analysis; Relative risk; Incidence (geometry); Systematic review; Observational study; MEDLINE; Internal medicine; Multiple sclerosis; Confidence interval","score_opus":0.06242617778613777,"score_gpt":0.3091988898515426,"score_spread":0.24677271206540483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890102036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011147268,0.9984138,0.000052435178,0.00006160088,0.000049990642,0.00006621578,0.00014150249,0.000003037893,0.00009678148],"genre_scores_gemma":[0.017823527,0.98123646,0.0003066751,0.00031707337,0.00006105478,0.00009034659,0.00009948965,0.0000018743132,0.000063518164],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99717784,0.0008384219,0.0010870508,0.00028412257,0.0004992778,0.00011325071],"domain_scores_gemma":[0.990234,0.0069820117,0.0020548091,0.00011403936,0.00047900312,0.00013606097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038326818,0.0011808297,0.0068081478,0.0038095724,0.00041539993,0.0017967519,0.0014172265,0.0016349956,0.0036598968],"category_scores_gemma":[0.015670635,0.00081499154,0.008004584,0.0050369906,0.0005766126,0.0014818693,0.0013422614,0.0014265418,0.00015748161],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069340353,0.000039151695,0.0016325602,0.91590357,0.04172558,0.00013532832,0.00013906742,0.00013050839,0.00017906986,0.00012435939,0.0011275053,0.038169898],"study_design_scores_gemma":[0.001490906,0.00052002433,0.01764405,0.46775603,0.49415866,0.00063985045,0.00039531893,0.00016568703,0.0002343911,0.0004137397,0.016480882,0.00010042403],"about_ca_topic_score_codex":0.008916202,"about_ca_topic_score_gemma":0.032628305,"teacher_disagreement_score":0.008916202,"about_ca_system_score_codex":0.001864699,"about_ca_system_score_gemma":0.0039363904,"threshold_uncertainty_score":0.020269394},"labels":[],"label_agreement":null},{"id":"W2890349017","doi":"10.1016/j.msard.2018.09.002","title":"Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Multiple sclerosis; Family medicine; MEDLINE; Health care; Psychiatry","score_opus":0.06507269190061979,"score_gpt":0.28866250422135786,"score_spread":0.22358981232073807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890349017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914219,0.00019644925,0.000078561905,0.0008811612,0.0000102018785,0.000047498666,0.005984278,0.000008569518,0.0013714833],"genre_scores_gemma":[0.99402547,0.00039091226,0.00016325156,0.00030777333,0.000020604706,0.00010699154,0.0046784603,0.0000050154317,0.0003015316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987311,0.00048172515,0.00020053858,0.00009768931,0.00024398131,0.00024500862],"domain_scores_gemma":[0.9966677,0.00047733853,0.0014903876,0.000115698276,0.00065345375,0.00059542945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017814619,0.00015754769,0.00028503896,0.00091083854,0.00039656577,0.00067171425,0.0003613566,0.00043486527,0.0013567242],"category_scores_gemma":[0.0039878665,0.00015693206,0.00042216468,0.0014722772,0.00024066812,0.0007896722,0.0014955613,0.0008133875,0.00033991807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029684668,0.000048637958,0.99502593,0.00003079625,0.000025845098,0.000026576146,0.0007190987,0.000037886177,0.000049469047,0.000020249056,0.0015489198,0.0024370116],"study_design_scores_gemma":[0.00000437935,0.000048077225,0.99563354,0.000037389556,0.000012476689,0.000078761004,0.002885488,0.00010431391,0.00004092576,0.000019825313,0.0011298893,0.0000049377777],"about_ca_topic_score_codex":0.024606602,"about_ca_topic_score_gemma":0.035927117,"teacher_disagreement_score":0.024606602,"about_ca_system_score_codex":0.00072969834,"about_ca_system_score_gemma":0.0011771265,"threshold_uncertainty_score":0.04892677},"labels":[],"label_agreement":null},{"id":"W2894796500","doi":"10.1016/j.msard.2018.09.036","title":"Use of eHealth and mHealth technology by persons with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Canon Foundation for Scientific Research; National Multiple Sclerosis Society; Research Manitoba; Biogen; Canadian Institutes of Health Research; Novartis","keywords":"eHealth; mHealth; Telehealth; Telemedicine; Health Information National Trends Survey; Medicine; The Internet; Health informatics; Health care; Health information technology; Patient portal; Descriptive statistics; Internet privacy; Family medicine; Medical education; Nursing; World Wide Web; Health information; Computer science; Public health; Psychological intervention","score_opus":0.05599073180113199,"score_gpt":0.2815563722829021,"score_spread":0.2255656404817701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894796500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945431,0.002140547,0.00004228319,0.0003755374,0.00001789922,0.000014549256,0.00043196566,0.0000024453143,0.002431621],"genre_scores_gemma":[0.996852,0.002002175,0.000081001126,0.00020278181,0.00003536424,0.000015632142,0.00017871655,0.0000012493202,0.0006310059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999119,0.00031416654,0.00013130489,0.00007726543,0.00025199133,0.00010626278],"domain_scores_gemma":[0.99734205,0.0009330217,0.0011290963,0.00009689458,0.0002752292,0.00022369511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005455275,0.00013968242,0.00028882775,0.0010631416,0.0005756535,0.00083314255,0.00018053355,0.0006882603,0.0024097795],"category_scores_gemma":[0.0046989494,0.00017720701,0.0005319643,0.0013865854,0.0002223939,0.0010646695,0.00056687975,0.0005495792,0.00023865636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013545179,0.00019070439,0.9841256,0.000090436406,0.00009195094,0.00015666088,0.0018978552,0.000019309527,0.00021748447,0.000039333627,0.00026955977,0.012765686],"study_design_scores_gemma":[0.0000072824732,0.00022154229,0.9952107,0.00006726312,0.000056525267,0.00031367052,0.0034863253,0.00005022621,0.000083086044,0.000031903834,0.0004649178,0.000006604513],"about_ca_topic_score_codex":0.009612353,"about_ca_topic_score_gemma":0.011853847,"teacher_disagreement_score":0.009612353,"about_ca_system_score_codex":0.00027899645,"about_ca_system_score_gemma":0.00043579526,"threshold_uncertainty_score":0.019112825},"labels":[],"label_agreement":null},{"id":"W2894945114","doi":"10.1016/j.msard.2018.09.033","title":"Cardiorespiratory fitness and cognitive processing speed in multiple sclerosis: The possible roles of psychological symptoms","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Cardiorespiratory fitness; Aerobic exercise; Cognition; Medicine; Anxiety; Depression (economics); Physical therapy; Confounding; Physical fitness; Physical medicine and rehabilitation; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.0617102155698691,"score_gpt":0.3063507402815769,"score_spread":0.24464052471170777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894945114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995587,0.0031889342,0.000053592503,0.00015864387,0.000013942533,0.000006546036,0.00005244418,0.00000124014,0.0009376585],"genre_scores_gemma":[0.9991788,0.00046896684,0.00006111732,0.00004691182,0.000030060524,0.0000059273348,0.000042752006,0.0000010034863,0.0001645194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951935,0.00023673705,0.00004248114,0.00008213826,0.000055145654,0.00006411788],"domain_scores_gemma":[0.99693656,0.0018247091,0.00064978324,0.00017278263,0.00014155789,0.00027457238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013323702,0.00047706606,0.000446192,0.00089774735,0.0005393966,0.001188567,0.00045341128,0.00088299747,0.0027940948],"category_scores_gemma":[0.004968646,0.0003145093,0.0005663705,0.0010147827,0.0007835485,0.0009177156,0.00054750853,0.0008803399,0.00012710132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014759017,0.00056889653,0.98517495,0.000142495,0.00059989543,0.00029486706,0.0006702364,0.00015490048,0.0010375956,0.0002668097,0.000082628794,0.009530737],"study_design_scores_gemma":[0.000016764125,0.00012945401,0.9991611,0.0000142587705,0.000090140304,0.000077440054,0.00020047,0.000084158004,0.000050973926,0.00010732904,0.00006408195,0.000003831041],"about_ca_topic_score_codex":0.004362997,"about_ca_topic_score_gemma":0.0042549586,"teacher_disagreement_score":0.004362997,"about_ca_system_score_codex":0.00021646274,"about_ca_system_score_gemma":0.00042831438,"threshold_uncertainty_score":0.009347141},"labels":[],"label_agreement":null},{"id":"W2897403748","doi":"10.1016/j.msard.2018.10.013","title":"Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Isfahan University of Medical Sciences","keywords":"Myelin oligodendrocyte glycoprotein; Medicine; Optic neuritis; Multiple sclerosis; Immunology; Oligodendrocyte; Antibody; Myelin; Pathology; Internal medicine; Central nervous system; Experimental autoimmune encephalomyelitis","score_opus":0.07496108249906837,"score_gpt":0.35103774748402017,"score_spread":0.2760766649849518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897403748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982179,0.001135059,0.000032411062,0.0000350259,0.000018272527,0.000021654077,0.000086701846,9.92506e-7,0.00045200344],"genre_scores_gemma":[0.9989956,0.0003506085,0.000045475856,0.000044519657,0.000036184563,0.00001766671,0.0003010026,0.0000012429224,0.00020771212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835473,0.0008268938,0.00020509124,0.0002239372,0.00018687986,0.00020252929],"domain_scores_gemma":[0.9972699,0.0009907591,0.00084012613,0.00012949445,0.00029206162,0.0004775969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023477662,0.0003537784,0.00092610146,0.00080747664,0.00045441964,0.0006824128,0.0004696713,0.0008775088,0.001303872],"category_scores_gemma":[0.0039084326,0.00020590627,0.0010790018,0.00093985384,0.0004887662,0.0010579177,0.00057053566,0.0006890246,0.00023952057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03889712,0.002060775,0.9398268,0.00021410386,0.0018206759,0.00033714148,0.00032432136,0.00016769503,0.0019020475,0.00006043219,0.00022215303,0.014166715],"study_design_scores_gemma":[0.0014986013,0.012715377,0.9827685,0.000047199985,0.00092366175,0.00040082852,0.00055533537,0.00030965713,0.00033525468,0.00011562835,0.00029904518,0.00003098206],"about_ca_topic_score_codex":0.0031970218,"about_ca_topic_score_gemma":0.0040258267,"teacher_disagreement_score":0.0031970218,"about_ca_system_score_codex":0.00082487665,"about_ca_system_score_gemma":0.00067926035,"threshold_uncertainty_score":0.012416303},"labels":[],"label_agreement":null},{"id":"W2897720855","doi":"10.1016/j.msard.2018.10.018","title":"Diabetes and anxiety adversely affect cognition in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; Health Sciences Centre; University of Manitoba","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Nova Scotia Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Natural Sciences and Engineering Research Council of Canada; Fondation Brain Canada; Health Sciences Centre Foundation; Brain and Behavior Research Foundation","keywords":"Medicine; Multiple sclerosis; Affect (linguistics); Cognition; Anxiety; Diabetes mellitus; Clinical psychology; Psychiatry; Endocrinology; Psychology","score_opus":0.04239819271777926,"score_gpt":0.25914880637747495,"score_spread":0.2167506136596957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897720855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957339,0.003005094,0.000010596736,0.00013231898,0.000016449902,0.0000037230511,0.000071102586,0.0000014830928,0.0010253934],"genre_scores_gemma":[0.99886477,0.00075004774,0.000029959649,0.00007624985,0.000026984046,0.000002959865,0.00006909115,7.2034965e-7,0.00017922604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992467,0.00038979112,0.00007591499,0.00006461608,0.00010334692,0.00011958115],"domain_scores_gemma":[0.99738246,0.00080285507,0.0011526225,0.00014886967,0.00013452319,0.00037878915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009495015,0.0004206835,0.00045325098,0.0007603441,0.0006886599,0.0013958054,0.00028854454,0.00062615273,0.001594766],"category_scores_gemma":[0.0048605115,0.0003270379,0.0009079285,0.00096557644,0.00036853744,0.0006170012,0.0007928828,0.0008149275,0.00012143403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021657213,0.0007244502,0.98347765,0.00015578327,0.0015324315,0.00021181474,0.00065273687,0.000062835796,0.00038648915,0.00008254366,0.0001914567,0.010356089],"study_design_scores_gemma":[0.000027577995,0.00018125764,0.999041,0.000016920343,0.00024290159,0.00006265249,0.00020079182,0.00002044663,0.0000347789,0.00007187605,0.00009401405,0.0000057920406],"about_ca_topic_score_codex":0.013605962,"about_ca_topic_score_gemma":0.025781075,"teacher_disagreement_score":0.013605962,"about_ca_system_score_codex":0.0005599964,"about_ca_system_score_gemma":0.00054150634,"threshold_uncertainty_score":0.027053535},"labels":[],"label_agreement":null},{"id":"W2898257974","doi":"10.1016/j.msard.2018.10.109","title":"Coexistence of Multiple Sclerosis and Alzheimer's disease: A review","year":2018,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; International Collaboration On Repair Discoveries; Vancouver Coastal Health; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Genentech; Multiple Sclerosis Society; Michael Smith Health Research BC; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Novartis; Multiple Sclerosis Society of Canada; American Academy of Neurology; National Multiple Sclerosis Society Michigan Chapter; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Disease; Alzheimer's disease; Neuroscience; Dermatology; Pathology; Immunology","score_opus":0.12690580694838247,"score_gpt":0.3355699256097763,"score_spread":0.2086641186613938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898257974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000098834746,0.9997253,0.000013683851,0.000042724183,0.000038709706,0.0000034945883,0.000018713168,8.9726706e-7,0.00005764985],"genre_scores_gemma":[0.00080076745,0.9989102,0.00009097911,0.00008934646,0.000057019126,0.00000453705,0.000020213656,3.245006e-7,0.000026672715],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992323,0.00013296762,0.00032222495,0.00012504274,0.00015420555,0.00003328584],"domain_scores_gemma":[0.99729794,0.0018551098,0.00056733855,0.000026879152,0.00019676359,0.00005599831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012622367,0.00095876807,0.002886424,0.0069494164,0.00040539773,0.0017418186,0.0012683675,0.0014647152,0.003628854],"category_scores_gemma":[0.0039334134,0.0005941214,0.0018893597,0.008469131,0.0005925789,0.0022365279,0.001106419,0.0010520061,0.00029141674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003039073,0.00010646735,0.0028348817,0.5602229,0.0038522447,0.000733825,0.00043487857,0.0002795203,0.0007976178,0.0015261364,0.012715321,0.4161923],"study_design_scores_gemma":[0.00032246116,0.00042800212,0.020090248,0.39008144,0.0372472,0.009580099,0.0018263557,0.00024917617,0.0004937447,0.0032083448,0.53623354,0.00023935232],"about_ca_topic_score_codex":0.004484538,"about_ca_topic_score_gemma":0.011199423,"teacher_disagreement_score":0.0069494164,"about_ca_system_score_codex":0.00076344615,"about_ca_system_score_gemma":0.0028673904,"threshold_uncertainty_score":0.012139738},"labels":[],"label_agreement":null},{"id":"W2898436682","doi":"10.1016/j.msard.2018.10.112","title":"Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Cognition; Multiple sclerosis; Audiology; Medicine; Association (psychology); Depression (economics); Montreal Cognitive Assessment; Analysis of variance; Physical medicine and rehabilitation; Physical therapy; Psychology; Psychiatry; Cognitive impairment; Internal medicine","score_opus":0.08145335485976651,"score_gpt":0.29633660455167227,"score_spread":0.21488324969190575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898436682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978059,0.00046967185,0.0007451354,0.000066968554,0.000010687709,0.000022806207,0.00006561454,0.0000059965764,0.00080723356],"genre_scores_gemma":[0.9989015,0.0001397513,0.00064041256,0.000021473312,0.000013854351,0.00001763105,0.00006867712,0.0000022220574,0.00019448303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987865,0.00059478404,0.00009533304,0.00019235592,0.00020328832,0.00012777302],"domain_scores_gemma":[0.9938664,0.0042076907,0.0008077471,0.00046019326,0.00038307765,0.00027495908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041637225,0.00060643366,0.00045874278,0.0019788577,0.00059657043,0.0013078675,0.0006496654,0.00056013226,0.0010691278],"category_scores_gemma":[0.013338659,0.00018477134,0.0007540682,0.0014658051,0.0005214921,0.0007550558,0.00072224246,0.00064246904,0.00007201729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008220171,0.00075933535,0.9662167,0.00012392133,0.0011327246,0.00006200195,0.0009689552,0.00063292345,0.0015985926,0.00038595215,0.000110768706,0.02718617],"study_design_scores_gemma":[0.000029738494,0.00038821704,0.9960167,0.00002438805,0.00045047433,0.000030363231,0.00038947733,0.0018265005,0.00024255064,0.0004061521,0.00018270867,0.000012738691],"about_ca_topic_score_codex":0.026560085,"about_ca_topic_score_gemma":0.02320643,"teacher_disagreement_score":0.026560085,"about_ca_system_score_codex":0.00043615705,"about_ca_system_score_gemma":0.0007435091,"threshold_uncertainty_score":0.052811027},"labels":[],"label_agreement":null},{"id":"W2900371473","doi":"10.1016/j.msard.2018.11.004","title":"Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Manitoba; University of British Columbia Hospital; Manitoba Health; University of British Columbia","funders":"Crohn's and Colitis Canada; University of British Columbia; MedImmune; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Ministry of Health, British Columbia; Saskatchewan Health Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Guthy-Jackson Charitable Foundation","keywords":"Medicine; Fingolimod; Odds ratio; Discontinuation; Population; Internal medicine; Medical prescription; Teriflunomide; Persistence (discontinuity); Logistic regression; Confidence interval; Comorbidity; Multiple sclerosis; Pediatrics; Demography; Psychiatry; Environmental health","score_opus":0.11230498106763695,"score_gpt":0.3148480857448274,"score_spread":0.20254310467719047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900371473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99916935,0.00039608573,0.000049344577,0.00004207006,0.00000852534,0.000010885094,0.00010960014,0.0000018474584,0.00021241093],"genre_scores_gemma":[0.9993505,0.00018542809,0.000055579378,0.00005954477,0.000017910412,0.00001534516,0.00014907426,0.0000021352557,0.00016450186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981729,0.00071718794,0.00024750453,0.00038911888,0.0002667417,0.00020647558],"domain_scores_gemma":[0.996219,0.0009652645,0.0013349577,0.00045470893,0.00042056572,0.0006055459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023129147,0.00064312055,0.0011386746,0.0011505543,0.0012820043,0.0017307616,0.0008049484,0.0020216396,0.0018719604],"category_scores_gemma":[0.005354967,0.0011117386,0.0019229904,0.0024302157,0.0008052993,0.0017569229,0.0008530823,0.0020886012,0.00031356205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068591454,0.0004712794,0.9964065,0.000023730547,0.00084314146,0.00008119102,0.00029866074,0.000018965853,0.0001644221,0.000016405065,0.000059593658,0.00093023584],"study_design_scores_gemma":[0.00008215486,0.0007115881,0.9976252,0.00001277106,0.00042827087,0.0001786869,0.0006844365,0.00011635076,0.000025017425,0.000028665308,0.00009520021,0.000011766935],"about_ca_topic_score_codex":0.0073367604,"about_ca_topic_score_gemma":0.006851207,"teacher_disagreement_score":0.0073367604,"about_ca_system_score_codex":0.00042886002,"about_ca_system_score_gemma":0.00044554638,"threshold_uncertainty_score":0.014588118},"labels":[],"label_agreement":null},{"id":"W2900596677","doi":"10.1016/j.msard.2018.11.021","title":"Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Tolerability; Adverse effect; Placebo; Internal medicine; Multiple sclerosis; Clinical trial; Cohort; Gastroenterology; Immunology; Pathology","score_opus":0.03259422897934258,"score_gpt":0.2599261944930275,"score_spread":0.22733196551368492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900596677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686952,0.018437024,0.0034679072,0.00013205886,0.000020446412,0.0006564907,0.0072940444,0.00005736937,0.0012395921],"genre_scores_gemma":[0.9881841,0.0026386187,0.0012502511,0.00008061077,0.00006955912,0.00022125964,0.007279216,0.000013423602,0.0002629283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99109834,0.00384254,0.0010012113,0.0011345173,0.0025015192,0.00042189835],"domain_scores_gemma":[0.9866794,0.0047081867,0.0052147736,0.0010215233,0.0018675241,0.0005087359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009571927,0.0007503805,0.002355398,0.002089639,0.0001781758,0.0013713503,0.000620645,0.00045996203,0.0013758753],"category_scores_gemma":[0.00798035,0.0003373335,0.0055015488,0.002506314,0.00025792402,0.00061895786,0.001454815,0.0007117023,0.00012866645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03425117,0.00062890665,0.813197,0.0027924841,0.05073863,0.00016703596,0.00024502358,0.0051570786,0.0032006449,0.00021282656,0.000799429,0.088609636],"study_design_scores_gemma":[0.0011247556,0.005264234,0.9706016,0.00016920762,0.015388454,0.00013524751,0.00006919265,0.004705367,0.00078157656,0.0001196783,0.001609679,0.000031019208],"about_ca_topic_score_codex":0.0018931824,"about_ca_topic_score_gemma":0.0027160714,"teacher_disagreement_score":0.009571927,"about_ca_system_score_codex":0.0010189367,"about_ca_system_score_gemma":0.0010638468,"threshold_uncertainty_score":0.050621808},"labels":[],"label_agreement":null},{"id":"W2901626095","doi":"10.1016/j.msard.2018.11.015","title":"Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"University of British Columbia; Michael Smith Health Research BC; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Institutes of Health; Bayer HealthCare; European Committee for Treatment and Research in Multiple Sclerosis; Michael J. Fox Foundation for Parkinson's Research; American Academy of Neurology; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Life course approach; Course (navigation); Case-control study; Gerontology; Environmental health; Demography; Internal medicine; Psychiatry; Developmental psychology; Psychology","score_opus":0.024671919138558557,"score_gpt":0.2652599387456144,"score_spread":0.2405880196070558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901626095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99938965,0.00017590287,0.00011143606,0.000017279523,0.0000062023178,0.000014841216,0.00010814038,0.0000021294377,0.00017443961],"genre_scores_gemma":[0.9991678,0.00014075801,0.00011199168,0.00003397837,0.000008760229,0.000022434357,0.00018419685,0.0000032338069,0.00032669218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992085,0.00027350293,0.00006377503,0.00024393527,0.00007910994,0.00013123202],"domain_scores_gemma":[0.99888057,0.00023163369,0.00031471133,0.00024014075,0.0001422308,0.00019075105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008189006,0.00065765646,0.00055052474,0.0010042269,0.0013902441,0.001026813,0.0005731428,0.0009731681,0.0014289191],"category_scores_gemma":[0.0019682166,0.000889431,0.0009013201,0.0013871632,0.00071601226,0.0006672824,0.0006538112,0.0008158513,0.00027378483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012898253,0.00040033323,0.994619,0.000018714354,0.00038908602,0.00023519904,0.0007195944,0.000021466185,0.0013522365,0.000049583068,0.000101990234,0.0008029375],"study_design_scores_gemma":[0.000062870815,0.0006360324,0.9973699,0.000009135509,0.0002733227,0.00031368237,0.00077290245,0.000089554596,0.00013672294,0.00003563673,0.00029072748,0.000009443757],"about_ca_topic_score_codex":0.020816874,"about_ca_topic_score_gemma":0.01980617,"teacher_disagreement_score":0.020816874,"about_ca_system_score_codex":0.00044583765,"about_ca_system_score_gemma":0.00044871532,"threshold_uncertainty_score":0.041391373},"labels":[],"label_agreement":null},{"id":"W2903804915","doi":"10.1016/j.msard.2018.10.103","title":"Sustained Reduction in Confirmed Disability Progression in Patients with Primary Progressive Multiple Sclerosis Treated with Ocrelizumab in the Open-label Extension Period of the Phase III ORATORIO trial","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Placebo; Myelofibrosis; Oratorio; Open label; Internal medicine; Clinical trial; Immunology; Pathology; Alternative medicine","score_opus":0.04062952160412597,"score_gpt":0.3035690542692676,"score_spread":0.26293953266514164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903804915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183637,0.0048969146,0.00018888887,0.00037058996,0.00014772412,0.00028485514,0.000645158,0.000042206655,0.0015872784],"genre_scores_gemma":[0.99644667,0.0010108658,0.00027286142,0.000346679,0.00015947789,0.00027170512,0.00070993626,0.00000733876,0.0007744027],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99910104,0.00042228188,0.000050401246,0.00013141539,0.000079893005,0.00021501917],"domain_scores_gemma":[0.99889225,0.00027731922,0.00028544012,0.00012000991,0.000086022796,0.00033901053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027806433,0.0011883926,0.0024442773,0.00021154157,0.00042076028,0.0010263738,0.00057601137,0.0010518794,0.0016501271],"category_scores_gemma":[0.0020371112,0.00025412271,0.001930203,0.0002805074,0.0005898173,0.0008934678,0.0003978725,0.0024815234,0.00035515105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9207583,0.0051285676,0.00729526,0.0006603075,0.0019964152,0.00011315824,0.00016696214,0.00060500106,0.0053067137,0.0001507835,0.001793395,0.056025203],"study_design_scores_gemma":[0.6941764,0.21379974,0.082894094,0.00015972747,0.0026441398,0.0002712623,0.00013927426,0.00092905975,0.0018417747,0.00037566703,0.0027181325,0.000050817638],"about_ca_topic_score_codex":0.0015109666,"about_ca_topic_score_gemma":0.0028063408,"teacher_disagreement_score":0.0027806433,"about_ca_system_score_codex":0.000595211,"about_ca_system_score_gemma":0.0010376213,"threshold_uncertainty_score":0.014705658},"labels":[],"label_agreement":null},{"id":"W2903866675","doi":"10.1016/j.msard.2018.10.105","title":"Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Opera; Multiple sclerosis; Clinical trial; Internal medicine; Surgery; Oncology; Immunology","score_opus":0.01277753586088721,"score_gpt":0.2321336456996975,"score_spread":0.2193561098388103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903866675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980433,0.0013786228,0.00003516043,0.00004277924,0.000014646077,0.00000796071,0.000095233394,0.000006007529,0.00037635735],"genre_scores_gemma":[0.99954504,0.00012509369,0.000022432834,0.000021978663,0.000011634415,0.000005473333,0.00013594521,6.7600723e-7,0.00013161605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995529,0.00010723328,0.000055723438,0.000077477736,0.00008512942,0.00012155504],"domain_scores_gemma":[0.9989976,0.00022630543,0.000362054,0.00006249313,0.00011502031,0.00023652322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009098953,0.00029419435,0.00083535095,0.00032873562,0.0003840769,0.00047542562,0.0002600835,0.00052610936,0.00077715673],"category_scores_gemma":[0.0018170876,0.0001052301,0.00087447936,0.00029259018,0.00017988918,0.0004027942,0.0002868866,0.00070447783,0.0001492105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03919004,0.0018859761,0.8825483,0.00025461454,0.001251334,0.00059383933,0.00048023043,0.0007751369,0.004011395,0.000069406226,0.0005354724,0.06840424],"study_design_scores_gemma":[0.00033650623,0.0046009338,0.99310076,0.000023342405,0.0004396407,0.00032098123,0.00011344636,0.000408951,0.0002441526,0.000032044794,0.00036480319,0.000014521396],"about_ca_topic_score_codex":0.0020277915,"about_ca_topic_score_gemma":0.0028018316,"teacher_disagreement_score":0.0020277915,"about_ca_system_score_codex":0.00033647867,"about_ca_system_score_gemma":0.00039107297,"threshold_uncertainty_score":0.004812062},"labels":[],"label_agreement":null},{"id":"W2903995358","doi":"10.1016/j.msard.2018.10.035","title":"Impact of Gadolinium-enhancing (GD+) Lesions on No Evidence of Disease Activity (NEDA) Status in Subcutaneous Interferon Beta-1a (SC IFNβ-1a)-treated Patients","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Gadolinium; Interferon beta-1a; Internal medicine; Interferon; BETA (programming language); Gastroenterology; Interferon beta; Pathology; Immunology","score_opus":0.040974278351388844,"score_gpt":0.31022498245071906,"score_spread":0.2692507040993302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903995358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988526,0.00047602234,0.000009817226,0.000051680407,0.000008944287,0.000002715706,0.000024128607,9.994802e-7,0.00057313277],"genre_scores_gemma":[0.99975675,0.00008999101,0.000010626476,0.000024884983,0.000008287969,0.0000011232335,0.00002970992,4.546786e-7,0.00007818919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998287,0.00007113272,0.000018271094,0.00002679253,0.000017319753,0.000037887155],"domain_scores_gemma":[0.99941885,0.0002232853,0.00011320643,0.000020053574,0.00002897417,0.00019563804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031287433,0.00014848764,0.00028583742,0.00011187668,0.00019883833,0.00038918343,0.00010726944,0.00023100109,0.0008852033],"category_scores_gemma":[0.0012276564,0.00007089585,0.00035127718,0.00015398189,0.00016846697,0.00021247548,0.00013954796,0.00037574687,0.000086582506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042030327,0.0008787109,0.91021127,0.000079080586,0.0004129443,0.0006876402,0.00018927924,0.0003201214,0.005592795,0.00009112185,0.00038215736,0.0391246],"study_design_scores_gemma":[0.0005193359,0.0048028976,0.9923344,0.000022606519,0.00039030437,0.00052909425,0.00018557075,0.00035936586,0.00039184227,0.00008847602,0.0003662773,0.000009789495],"about_ca_topic_score_codex":0.0015807081,"about_ca_topic_score_gemma":0.0022640915,"teacher_disagreement_score":0.0015807081,"about_ca_system_score_codex":0.00021240237,"about_ca_system_score_gemma":0.0002495552,"threshold_uncertainty_score":0.0031430125},"labels":[],"label_agreement":null},{"id":"W2904219708","doi":"10.1016/j.msard.2018.10.087","title":"Alemtuzumab Improves Clinical and Radiological Outcomes in Patients with Relapsing-remitting Multiple Sclerosis Over 8 Years: Care-MS I Follow-up (topaz Study)","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Radiological weapon; Clinical trial; Internal medicine; Physical therapy; Surgery; Psychiatry","score_opus":0.03784702482552056,"score_gpt":0.28934184226628107,"score_spread":0.2514948174407605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904219708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976338,0.0017848851,0.000022090102,0.0000725443,0.000017439332,0.000019607474,0.00021196561,0.000009000099,0.0002285519],"genre_scores_gemma":[0.99812347,0.0007878637,0.000086986314,0.00011817205,0.00006296273,0.00002126023,0.000569141,0.000002239688,0.0002279673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996884,0.00008640646,0.000031821557,0.00007067526,0.000052824853,0.00006991872],"domain_scores_gemma":[0.9993617,0.00007727602,0.00028016962,0.000042541407,0.00007094872,0.00016725337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007718803,0.00073171046,0.0014449622,0.00041570433,0.0004128115,0.0007713204,0.0004483647,0.00076228916,0.0007125244],"category_scores_gemma":[0.0011977267,0.00024727767,0.0010980288,0.0005124518,0.00029017468,0.0006199988,0.00036975334,0.00077779684,0.00020346267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16395283,0.0056254654,0.7119884,0.0006270904,0.008696118,0.0006781301,0.00038310004,0.0009783156,0.008601398,0.00006298597,0.0024654525,0.095940635],"study_design_scores_gemma":[0.012119161,0.022105828,0.95978236,0.00005609936,0.0034003973,0.00050939847,0.00012643596,0.0004220763,0.0006314272,0.000073225645,0.0007344585,0.000039258273],"about_ca_topic_score_codex":0.0023349025,"about_ca_topic_score_gemma":0.0031182587,"teacher_disagreement_score":0.0023349025,"about_ca_system_score_codex":0.00038587523,"about_ca_system_score_gemma":0.00042522902,"threshold_uncertainty_score":0.004642606},"labels":[],"label_agreement":null},{"id":"W2904422419","doi":"10.1016/j.msard.2018.10.037","title":"Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) Score Predicts Long-term Clinical Disease Activity (CDA)-free Status and Disability Progression in Subcutaneous Interferon Beta-1a (scifnβ-1a)-treated Patients","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Internal medicine; Disease; Post-hoc analysis; Interferon beta-1a; Interferon beta; BETA (programming language); Oncology; Pathology; Immunology; Radiology","score_opus":0.041922100974179345,"score_gpt":0.2947016932364096,"score_spread":0.25277959226223023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904422419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99926597,0.00026882143,0.000019740331,0.000047369995,0.00000804772,0.0000025088857,0.00003382331,0.0000023716573,0.00035131947],"genre_scores_gemma":[0.9996475,0.00008159,0.000028912555,0.000023599227,0.000017148755,0.0000023528157,0.00008167914,5.989803e-7,0.000116682284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998204,0.000054369495,0.000027951035,0.000027623473,0.000032087002,0.000037590067],"domain_scores_gemma":[0.9989549,0.00026753664,0.00038125133,0.000037043017,0.000064464286,0.00029480242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041417792,0.00040783177,0.00039908013,0.0003977413,0.00030054356,0.0005421444,0.00022536475,0.00055256713,0.0010949789],"category_scores_gemma":[0.0017589511,0.00018861571,0.00037444118,0.00032899334,0.00023980024,0.00036908084,0.00023908819,0.00055456767,0.00022738847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013460026,0.00016841704,0.9934049,0.000013446425,0.00010999176,0.00017402686,0.00004814753,0.0000792897,0.001007108,0.000014577232,0.00012873817,0.0035053606],"study_design_scores_gemma":[0.000046129077,0.0004915328,0.9982601,0.000006637359,0.00008419027,0.00058304553,0.000056172204,0.0002347004,0.00010954574,0.000027538888,0.00009671564,0.0000036062409],"about_ca_topic_score_codex":0.000947382,"about_ca_topic_score_gemma":0.0014326015,"teacher_disagreement_score":0.0010949789,"about_ca_system_score_codex":0.00018132299,"about_ca_system_score_gemma":0.00018601547,"threshold_uncertainty_score":0.0036630034},"labels":[],"label_agreement":null},{"id":"W2904733418","doi":"10.1016/j.msard.2018.10.093","title":"Pregnancy Outcomes During the Clinical Development of Cladribine in Multiple Sclerosis: An Integrated Analysis of Safety","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Pregnancy; Clinical trial; Pediatrics; Internal medicine; Immunology","score_opus":0.05563929869226659,"score_gpt":0.2898989886019169,"score_spread":0.2342596899096503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904733418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936458,0.0036171973,0.0003748878,0.00017054784,0.0000130668495,0.000047292262,0.00080999633,0.0000067163733,0.0013145781],"genre_scores_gemma":[0.9981791,0.00091706385,0.00013679682,0.000068982576,0.000012344173,0.000026148819,0.0004631982,0.0000032526923,0.0001931088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973296,0.0011078882,0.00030324305,0.0002597766,0.000738642,0.00026077518],"domain_scores_gemma":[0.98914015,0.0048186495,0.004298552,0.000416426,0.0007289299,0.00059720024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045491643,0.0002120794,0.00068102084,0.00076777185,0.00031017195,0.0008354278,0.0003209916,0.000434127,0.00073025],"category_scores_gemma":[0.012126994,0.0001798283,0.0011510481,0.0010929779,0.00043281855,0.00058356515,0.00070475345,0.0011854684,0.00012458052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011012579,0.0002384459,0.9478593,0.00021839348,0.0010875599,0.00023593506,0.0003852522,0.0008044387,0.0007695193,0.0002822623,0.000255668,0.036850505],"study_design_scores_gemma":[0.00007751909,0.0029405416,0.99302703,0.00009321509,0.00065049337,0.00043920366,0.00031230605,0.0010024401,0.0004922267,0.00021178996,0.00072702236,0.000026186573],"about_ca_topic_score_codex":0.0032888567,"about_ca_topic_score_gemma":0.0035014083,"teacher_disagreement_score":0.0045491643,"about_ca_system_score_codex":0.0012460937,"about_ca_system_score_gemma":0.001478252,"threshold_uncertainty_score":0.02405852},"labels":[],"label_agreement":null},{"id":"W2905125234","doi":"10.1016/j.msard.2018.10.026","title":"Long-term Disease Control with Fingolimod in RRMS Patients with Active Disease","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Relapsing remitting; Disease; Term (time); Pediatrics; Internal medicine; Physical therapy; Immunology","score_opus":0.015689631620237655,"score_gpt":0.24222356630056663,"score_spread":0.22653393468032898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905125234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234617,0.0064753103,0.000039847502,0.00010788077,0.000027630475,0.000011434415,0.000198282,0.0000043790164,0.0007889991],"genre_scores_gemma":[0.9983365,0.0008230955,0.000031616193,0.00007408421,0.000056337347,0.000010104565,0.0004094904,0.0000012436125,0.0002577125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992606,0.00023902391,0.000115171344,0.000116689305,0.00011928007,0.00014919738],"domain_scores_gemma":[0.99860954,0.00033189758,0.00053422584,0.00009638343,0.00015888759,0.00026893805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015975633,0.00026714004,0.0008690689,0.0005122901,0.0005675669,0.0008143379,0.00029337927,0.0006353378,0.0008988853],"category_scores_gemma":[0.0025498546,0.00013168552,0.0008571551,0.0006329185,0.00027255295,0.0008298027,0.0003705803,0.00079841603,0.000154499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03932504,0.0016279704,0.9093393,0.00037014994,0.0022063449,0.00047183383,0.0005813463,0.00026954032,0.0028479032,0.00011321096,0.0005689332,0.04227833],"study_design_scores_gemma":[0.00063696085,0.0040683546,0.99298334,0.00003948183,0.0007979486,0.00024610062,0.0001772755,0.0001194309,0.00019637475,0.000051939034,0.0006685626,0.000014175123],"about_ca_topic_score_codex":0.0029833124,"about_ca_topic_score_gemma":0.0034513562,"teacher_disagreement_score":0.0029833124,"about_ca_system_score_codex":0.00046317562,"about_ca_system_score_gemma":0.00044468677,"threshold_uncertainty_score":0.008448839},"labels":[],"label_agreement":null},{"id":"W2905179560","doi":"10.1016/j.msard.2018.10.084","title":"Long-term Efficacy and Safety of Teriflunomide: An Analysis of Pooled Clinical Trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Clinical trial; Pooled analysis; Multiple sclerosis; Safety profile; Internal medicine; Adverse effect; Immunology; Fingolimod; Meta-analysis","score_opus":0.0638662203504422,"score_gpt":0.35010310544773837,"score_spread":0.28623688509729617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905179560","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40296516,0.5881179,0.0029384291,0.0003787779,0.0003377286,0.00056971924,0.0030743822,0.00009299791,0.0015249364],"genre_scores_gemma":[0.939358,0.05402271,0.0014763558,0.00047938712,0.00039564888,0.00036844396,0.0033874013,0.000055685367,0.00045641907],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9866107,0.0067259376,0.00292137,0.0019604978,0.0013715547,0.00040984136],"domain_scores_gemma":[0.97651654,0.014033354,0.00589333,0.0018912877,0.0011814593,0.0004840203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022327596,0.0018309514,0.009952348,0.002148426,0.0004391554,0.0024304504,0.00089412986,0.0012435309,0.0016039601],"category_scores_gemma":[0.018815687,0.00080014917,0.017209705,0.0030927556,0.00075614237,0.0020231958,0.0010718579,0.0015284219,0.00024159969],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11282734,0.00016412605,0.045899253,0.011828018,0.7919063,0.0001426572,0.00008831681,0.0013858923,0.0020910571,0.0001001233,0.00059223507,0.032974653],"study_design_scores_gemma":[0.021970078,0.0074162236,0.12732072,0.0011075044,0.83673054,0.00043555026,0.00012946561,0.00086349435,0.0010469384,0.00043723205,0.0024376872,0.000104475745],"about_ca_topic_score_codex":0.0005839388,"about_ca_topic_score_gemma":0.0010924356,"teacher_disagreement_score":0.022327596,"about_ca_system_score_codex":0.0009488369,"about_ca_system_score_gemma":0.00074831955,"threshold_uncertainty_score":0.11808103},"labels":[],"label_agreement":null},{"id":"W29055455","doi":"10.1016/j.msard.2017.08.006","title":"¿Es la aplicación de las técnicas administrativas, un elemento determinante que garantiza el éxito en los microempresarios de la ciudad de Quito?","year":2012,"lang":"es","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Business, Innovation, and Economy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Society of Canada","keywords":"Humanities; Art","score_opus":0.017069567541204336,"score_gpt":0.23634664728017613,"score_spread":0.2192770797389718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W29055455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472519,0.0010405921,0.005782595,0.007183092,0.0001652211,0.000086984415,0.00023782313,0.00012408276,0.038127705],"genre_scores_gemma":[0.9869876,0.0010306025,0.0033596589,0.00077571586,0.0001364842,0.000058176083,0.00011245154,0.00006336823,0.007475994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974564,0.0007945194,0.00012644238,0.000212603,0.0009226646,0.00048740927],"domain_scores_gemma":[0.9640456,0.016312217,0.007280665,0.0030298952,0.0042308453,0.005100814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008835935,0.00025224348,0.00055410294,0.0009087849,0.0009166682,0.00469375,0.0010808752,0.0014875109,0.0076900627],"category_scores_gemma":[0.037354674,0.00025187962,0.00036956673,0.000769444,0.0022993267,0.002474588,0.0010029183,0.0025541831,0.002047363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084474316,0.0023527404,0.6253563,0.00054248143,0.00018403218,0.0004351167,0.021350274,0.0005087367,0.0072139655,0.021567086,0.004198659,0.3154459],"study_design_scores_gemma":[0.00010691301,0.0007313575,0.93097305,0.00048387074,0.000109609246,0.000544276,0.016754877,0.0009671815,0.0029000025,0.014093811,0.03224496,0.00009010314],"about_ca_topic_score_codex":0.008081531,"about_ca_topic_score_gemma":0.010809221,"teacher_disagreement_score":0.008835935,"about_ca_system_score_codex":0.001297542,"about_ca_system_score_gemma":0.0032041688,"threshold_uncertainty_score":0.046729505},"labels":[],"label_agreement":null},{"id":"W2905645019","doi":"10.1016/j.msard.2018.12.028","title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Neuromyelitis optica; Myasthenia gravis; Spectrum disorder; Immunology; Sarcoidosis; Autoimmunity; Autoimmune disease; Multiple sclerosis; Optic neuritis; Antibody; Dermatology","score_opus":0.013989571030606461,"score_gpt":0.22072613800697308,"score_spread":0.2067365669763666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905645019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9086204,0.009195702,0.001545349,0.0033536095,0.0005400147,0.00020582206,0.0008881627,0.00017435072,0.07547648],"genre_scores_gemma":[0.992215,0.00215216,0.00089470204,0.0011378203,0.0010884048,0.000026910184,0.0003229612,0.000020626892,0.0021413974],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993795,0.000053486085,0.00012239398,0.0001216397,0.000083788516,0.00023924939],"domain_scores_gemma":[0.998406,0.00045826804,0.00046723947,0.00011625464,0.00017095172,0.0003813616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003542492,0.002010432,0.00095556397,0.003239732,0.0032448005,0.0017340339,0.0008330874,0.0024698947,0.0064610406],"category_scores_gemma":[0.0030311302,0.00061620644,0.00079203665,0.003021426,0.0014517612,0.0018654127,0.0015541331,0.0016588026,0.0014812449],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017437518,0.000066393404,0.03657058,0.00008018012,0.00003880483,0.95728785,0.00017866418,0.000053382802,0.0018747341,0.00034417803,0.0006292405,0.002701631],"study_design_scores_gemma":[0.0000314671,0.00005689018,0.02140787,0.000034791963,0.000049759965,0.9758813,0.0002156066,0.0001457617,0.0003098482,0.0005266452,0.0013255583,0.000014534838],"about_ca_topic_score_codex":0.0046673263,"about_ca_topic_score_gemma":0.0068281577,"teacher_disagreement_score":0.0064610406,"about_ca_system_score_codex":0.00109984,"about_ca_system_score_gemma":0.0017804286,"threshold_uncertainty_score":0.021614373},"labels":[],"label_agreement":null},{"id":"W2906242579","doi":"10.1016/j.msard.2018.12.030","title":"MRI utilization during the diagnostic and post-diagnostic phases in multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Saskatchewan; Memorial University of Newfoundland; University of Manitoba; Manitoba Health; University of British Columbia; Dalhousie University; University of British Columbia Hospital","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Dalhousie Medical Research Foundation","keywords":"Medicine; Multiple sclerosis; Diagnostic test; Magnetic resonance imaging; Radiology; Pathology; Pediatrics; Psychiatry","score_opus":0.052010026890492715,"score_gpt":0.27606046027123377,"score_spread":0.22405043338074104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906242579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948486,0.0032428338,0.000046343703,0.00014185866,0.000014104421,0.000008346899,0.00018037172,0.0000027426056,0.0015147718],"genre_scores_gemma":[0.9978604,0.0014669909,0.000073893825,0.00004157217,0.000025571871,0.000008672036,0.00016258759,0.0000025623342,0.00035777746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935085,0.00023312596,0.000076294746,0.000060574497,0.0000815304,0.00019775654],"domain_scores_gemma":[0.9980527,0.0005555552,0.00064978097,0.000050873936,0.00036532842,0.00032574305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095633446,0.00020143624,0.00030494572,0.0018173886,0.00044435516,0.0008476203,0.00035877374,0.0005619727,0.0013739537],"category_scores_gemma":[0.0059171524,0.00020674276,0.00023308318,0.0012830066,0.00024967443,0.00066183147,0.0004681437,0.00046494996,0.00027455177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002127086,0.0002983016,0.97626275,0.00017772579,0.00007338415,0.0008301168,0.0013961509,0.000075222044,0.0017927301,0.00010382295,0.00035886874,0.016503664],"study_design_scores_gemma":[0.000008063483,0.00037337918,0.9955237,0.00006586852,0.000063714106,0.0009375256,0.0015756389,0.000075261094,0.0005558799,0.00004355803,0.0007671567,0.000010241878],"about_ca_topic_score_codex":0.0135030905,"about_ca_topic_score_gemma":0.016753945,"teacher_disagreement_score":0.0135030905,"about_ca_system_score_codex":0.0006292933,"about_ca_system_score_gemma":0.00082455284,"threshold_uncertainty_score":0.026849031},"labels":[],"label_agreement":null},{"id":"W2906840863","doi":"10.1016/j.msard.2019.01.003","title":"Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Hospitalier de l’Université de Montréal","funders":"National Medical Research Council; National Health and Medical Research Council","keywords":"Medicine; Multiple sclerosis; Incidence (geometry); Cohort; Pregnancy; Disease; Cohort study; Pediatrics; Environmental health; Demography; Internal medicine; Immunology","score_opus":0.04406432906042038,"score_gpt":0.270324932803981,"score_spread":0.22626060374356063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906840863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986076,0.00034696562,0.00006426119,0.000033199965,0.0000047099734,0.0000048660418,0.00064109144,0.0000030800395,0.00029426572],"genre_scores_gemma":[0.9990514,0.00024197466,0.000055497283,0.000022717619,0.00000640871,0.000008380308,0.00042696585,0.0000026923522,0.00018395018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995159,0.00010813053,0.000051282193,0.00017241431,0.000053052092,0.00009928313],"domain_scores_gemma":[0.99891543,0.0001916238,0.00042799843,0.00017225521,0.00012631482,0.00016638912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006900971,0.0002654633,0.000409384,0.00094667106,0.0006525963,0.0008526451,0.00050723075,0.0007040124,0.0012363761],"category_scores_gemma":[0.0021607976,0.0005020942,0.000713337,0.0021006973,0.00029449182,0.0008032075,0.0005336956,0.0008439742,0.00023196227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013361945,0.000027809549,0.9989624,0.0000043654973,0.00008405482,0.000050357885,0.00011810772,0.00001315985,0.00009106626,0.000012996193,0.000051438008,0.00045055363],"study_design_scores_gemma":[0.0000067930196,0.00007077976,0.99910337,0.0000053963686,0.00006107878,0.00017160825,0.00033140052,0.00008251304,0.000023443754,0.000013277098,0.00012607333,0.0000042084157],"about_ca_topic_score_codex":0.024794925,"about_ca_topic_score_gemma":0.015158132,"teacher_disagreement_score":0.024794925,"about_ca_system_score_codex":0.0004419157,"about_ca_system_score_gemma":0.00050492154,"threshold_uncertainty_score":0.049301207},"labels":[],"label_agreement":null},{"id":"W2907887556","doi":"10.1016/j.msard.2019.01.009","title":"Body composition and disability in people with multiple sclerosis: A dual-energy x-ray absorptiometry study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Hologic; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Lean body mass; Bone mineral; Physical therapy; Internal medicine; Dual-energy X-ray absorptiometry; Fat mass; Body mass index; Osteoporosis; Body weight","score_opus":0.021643538902952206,"score_gpt":0.2502054367341004,"score_spread":0.2285618978311482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907887556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931026,0.00018763349,0.0000301132,0.00004248493,0.000007760485,0.000009227378,0.00016185698,0.0000014972964,0.00024923103],"genre_scores_gemma":[0.99908304,0.00013117075,0.000048779904,0.000051721672,0.000015496626,0.000014822166,0.00023128594,0.0000012660256,0.0004223218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954283,0.00012675062,0.000069573995,0.000086337386,0.00008364723,0.000090934605],"domain_scores_gemma":[0.9992993,0.00008324546,0.00021206186,0.00005347934,0.00010725076,0.0002446734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008267345,0.0006324183,0.0008182232,0.0015589806,0.0013127876,0.0009682097,0.00043356538,0.0011050091,0.0013388251],"category_scores_gemma":[0.0014590542,0.0007987375,0.001063291,0.002106081,0.00044831794,0.0010383007,0.001197084,0.0012262804,0.00042279775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040196578,0.00033043145,0.99722457,0.000015851878,0.00021944723,0.00014828985,0.00038467918,0.000020970147,0.00028643024,0.000010013713,0.000050901723,0.00090640725],"study_design_scores_gemma":[0.00002021614,0.00026830746,0.9986708,0.000005227148,0.000097026634,0.00017857882,0.00057402917,0.000047676065,0.000027601212,0.000009878168,0.000096351105,0.000004295833],"about_ca_topic_score_codex":0.013715772,"about_ca_topic_score_gemma":0.014795316,"teacher_disagreement_score":0.013715772,"about_ca_system_score_codex":0.00039921748,"about_ca_system_score_gemma":0.00034062073,"threshold_uncertainty_score":0.027271867},"labels":[],"label_agreement":null},{"id":"W2909559055","doi":"10.1016/j.msard.2019.01.022","title":"Factors associated with receiving bone mineral density screening among people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Manitoba Health; Queen's University","funders":"Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Health Sciences Centre Foundation; Health Sciences Centre Research Foundation","keywords":"Medicine; Multiple sclerosis; Bone mineral; Environmental health; Internal medicine; Osteoporosis; Immunology","score_opus":0.04228576874004348,"score_gpt":0.23608740750738025,"score_spread":0.19380163876733678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909559055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968681,0.001014591,0.00004721218,0.0003070367,0.000027713137,0.000011644805,0.0003032308,0.0000046654463,0.0014157809],"genre_scores_gemma":[0.9991167,0.00024869916,0.00004654639,0.00011574071,0.00003252618,0.000007444738,0.00015130082,0.0000014107455,0.00027966723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989184,0.00030706025,0.00016758242,0.00012915538,0.00019447168,0.00028339212],"domain_scores_gemma":[0.99684274,0.00089025387,0.001251358,0.00016337252,0.00031307945,0.0005392391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073809864,0.00028808357,0.0005433873,0.0013144241,0.00097576453,0.0011801191,0.0004288854,0.0012844494,0.003138535],"category_scores_gemma":[0.005425173,0.0003542541,0.0009860458,0.0026660832,0.00043657134,0.0006349691,0.000530937,0.001713262,0.0002664075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012496661,0.00014481555,0.9983821,0.00001425536,0.000081287086,0.00008160936,0.0001039418,0.000012822588,0.000061711755,0.000015485812,0.0000746634,0.00090243225],"study_design_scores_gemma":[0.000011777884,0.00011966365,0.9988668,0.000015037832,0.00009212413,0.00016433008,0.00047231742,0.000054511616,0.00002285847,0.0000271235,0.00014865691,0.0000047833605],"about_ca_topic_score_codex":0.031512838,"about_ca_topic_score_gemma":0.021477636,"teacher_disagreement_score":0.031512838,"about_ca_system_score_codex":0.00044059491,"about_ca_system_score_gemma":0.0007740987,"threshold_uncertainty_score":0.06265879},"labels":[],"label_agreement":null},{"id":"W2912026765","doi":"10.1016/j.msard.2019.01.044","title":"Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Schweizerische Multiple Sklerose Gesellschaft; European Commission; Universitätsspital Basel; Bayer HealthCare; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Novartis Foundation; F. Hoffmann-La Roche","keywords":"Medicine; Ocrelizumab; Oratorio; Multiple sclerosis; Opera; Internal medicine; Literature; Psychiatry; Musical; Art","score_opus":0.0340385116582444,"score_gpt":0.2778177616240176,"score_spread":0.24377924996577321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912026765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99501485,0.0035754913,0.000115906194,0.00019278361,0.000065582935,0.00020369582,0.00023451015,0.000010175577,0.00058706343],"genre_scores_gemma":[0.9962733,0.0015711889,0.00033792152,0.00049497327,0.00017258732,0.0002642071,0.0005265482,0.000006161833,0.0003531012],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987828,0.0006626487,0.00009569083,0.00015579465,0.00010518738,0.00019785686],"domain_scores_gemma":[0.99785125,0.00065388234,0.0006274619,0.00015831002,0.00010860221,0.00060046266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027570808,0.00083022506,0.0023314396,0.00025452767,0.00047247394,0.0009644533,0.00049488357,0.000905318,0.0011806941],"category_scores_gemma":[0.0022800083,0.00036580913,0.0020814736,0.00042862378,0.0008973356,0.0010637469,0.00046021902,0.0022662557,0.00023238751],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9161382,0.0106862215,0.016752083,0.0006407346,0.0031646877,0.00010603757,0.00025108608,0.00042161078,0.0039376556,0.00014285826,0.00083249377,0.046926476],"study_design_scores_gemma":[0.73585397,0.20009182,0.05594615,0.0001007716,0.0041757417,0.00021945398,0.00019856803,0.00039635907,0.00092303345,0.00025912232,0.0017876731,0.000047365527],"about_ca_topic_score_codex":0.00083942554,"about_ca_topic_score_gemma":0.0014100543,"teacher_disagreement_score":0.0027570808,"about_ca_system_score_codex":0.0005839176,"about_ca_system_score_gemma":0.001109624,"threshold_uncertainty_score":0.014581025},"labels":[],"label_agreement":null},{"id":"W2913554609","doi":"10.1016/j.msard.2019.01.031","title":"Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Medicine; Multiple sclerosis; Medical physics; Intensive care medicine; Psychiatry","score_opus":0.03788694581344837,"score_gpt":0.27768644878981397,"score_spread":0.2397995029763656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913554609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92668986,0.0013905338,0.025217542,0.0009966744,0.00090781343,0.007911603,0.009034946,0.00029285537,0.02755815],"genre_scores_gemma":[0.9662469,0.00025521335,0.015902739,0.0004245485,0.00018035363,0.007076517,0.0058971797,0.00013587152,0.0038805546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96464276,0.01553352,0.0055184355,0.0037450083,0.008947141,0.0016131069],"domain_scores_gemma":[0.9105139,0.039165657,0.014979186,0.008794974,0.024362326,0.0021840641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046506513,0.0012771277,0.0015710008,0.002906007,0.0013372743,0.0030631893,0.001941413,0.0020937896,0.0041296203],"category_scores_gemma":[0.10888697,0.0004691643,0.0035182124,0.0016431622,0.0017744943,0.0034242298,0.0036183023,0.0019925958,0.0017557014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038772477,0.0022755263,0.9310372,0.0009504414,0.0022308882,0.00011020861,0.0020532815,0.0015336341,0.0014445606,0.0018730666,0.004904805,0.047709208],"study_design_scores_gemma":[0.0007286818,0.0046332083,0.9734744,0.0003860839,0.0008089799,0.00023066041,0.0011890141,0.004472689,0.001943509,0.0018831262,0.010143095,0.00010654147],"about_ca_topic_score_codex":0.0031058488,"about_ca_topic_score_gemma":0.0053767744,"teacher_disagreement_score":0.046506513,"about_ca_system_score_codex":0.0013240005,"about_ca_system_score_gemma":0.0030983384,"threshold_uncertainty_score":0.24595284},"labels":[],"label_agreement":null},{"id":"W2913597401","doi":"10.1016/j.msard.2019.02.007","title":"Time between expanded disability status scale (EDSS) scores","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Pharmaceuticals Bayer; National Institutes of Health; Multiple Sclerosis Society of Canada; Bayer; Celgene; Biogen; Nancy Davis Foundation for Multiple Sclerosis; EMD Serono; Novartis; Genentech; Multiple Sclerosis Society; Roche; University of Toronto; Genzyme; Sanofi; Merck","keywords":"Expanded Disability Status Scale; Medicine; Multiple sclerosis; Scale (ratio); Physical therapy; Physical medicine and rehabilitation; Gerontology; Psychiatry","score_opus":0.027496509609381728,"score_gpt":0.2690450577015438,"score_spread":0.24154854809216209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913597401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95352787,0.004919357,0.00082528935,0.00078249606,0.00055457046,0.0002711182,0.019785454,0.00010421691,0.019229596],"genre_scores_gemma":[0.9742594,0.00067724835,0.00031238465,0.00030080753,0.00022190865,0.00038524801,0.009246013,0.000019427069,0.014577559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984676,0.00028984313,0.00023111107,0.00034123444,0.000338484,0.00033162895],"domain_scores_gemma":[0.99663144,0.0009876968,0.0008578738,0.00018665445,0.0007296936,0.0006065533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014447077,0.00039631026,0.0011983654,0.0017604069,0.0011710286,0.0015627779,0.0005401601,0.000827171,0.010897634],"category_scores_gemma":[0.00685616,0.00028184915,0.0011970664,0.0014032759,0.00029728003,0.0011774366,0.0012183645,0.0021629536,0.001960787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008937825,0.00047018498,0.95999783,0.0002895828,0.00082741305,0.00048217582,0.0004527729,0.00015540804,0.00044048618,0.0007971197,0.004869281,0.022279963],"study_design_scores_gemma":[0.00020841736,0.0013520593,0.98669076,0.00009475906,0.00044110007,0.0004554114,0.0006324478,0.00022958577,0.00026484675,0.00062281097,0.008958835,0.00004895156],"about_ca_topic_score_codex":0.010619124,"about_ca_topic_score_gemma":0.012795939,"teacher_disagreement_score":0.010897634,"about_ca_system_score_codex":0.00092017464,"about_ca_system_score_gemma":0.001236902,"threshold_uncertainty_score":0.036456227},"labels":[],"label_agreement":null},{"id":"W2922410885","doi":"10.1016/j.msard.2019.03.009","title":"A case of concomitant psoriasis and multiple sclerosis: Secukinumab and rituximab exert dichotomous effects in two autoimmune conditions","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Novartis Pharmaceuticals Canada; Novartis Pharma; Mitsubishi Tanabe Pharma Corporation; European Commission; Biogen; Merck; Sanofi; Bayer Schering; Novartis","keywords":"Secukinumab; Medicine; Multiple sclerosis; Rituximab; Psoriasis; Concomitant; Immunology; Ixekizumab; Dermatology; Internal medicine; Antibody; Psoriatic arthritis","score_opus":0.01381924356041253,"score_gpt":0.22112681122446656,"score_spread":0.20730756766405403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922410885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598555,0.006611869,0.003237801,0.0091267945,0.000626264,0.00023193094,0.0004427423,0.00028580497,0.01958138],"genre_scores_gemma":[0.9907478,0.001007305,0.0019951994,0.001661402,0.0024606583,0.000052838357,0.00012360688,0.000049609596,0.0019015769],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.997632,0.00032415695,0.0003356748,0.00056905806,0.00025683237,0.0008821413],"domain_scores_gemma":[0.9921942,0.0039514694,0.00093364937,0.0008557196,0.00033219837,0.0017326307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010576643,0.002545104,0.0022491824,0.0049626785,0.004037,0.003346676,0.003480271,0.018759018,0.0064219045],"category_scores_gemma":[0.010407106,0.0032930265,0.0028317445,0.0022825045,0.003989528,0.004105135,0.0038751864,0.006451928,0.001998891],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013494397,0.000062841376,0.0018242497,0.000022842876,0.000009146117,0.996363,0.0001286272,0.000033416396,0.0005572372,0.00022008219,0.00010573848,0.0005378751],"study_design_scores_gemma":[0.000047108104,0.000071638766,0.0022182076,0.000008017466,0.000019065094,0.9966569,0.00007427964,0.0001736005,0.0003164808,0.00010835984,0.00029415987,0.000012175657],"about_ca_topic_score_codex":0.0034681438,"about_ca_topic_score_gemma":0.002464227,"teacher_disagreement_score":0.018759018,"about_ca_system_score_codex":0.00263233,"about_ca_system_score_gemma":0.001429678,"threshold_uncertainty_score":0.021483362},"labels":[],"label_agreement":null},{"id":"W2935354372","doi":"10.1016/j.msard.2019.04.003","title":"Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi; Genzyme","keywords":"Multiple sclerosis; Medicine; Pregnancy; Disease; Postpartum period; Intensive care medicine; Immunology; Pathology","score_opus":0.0732434747957501,"score_gpt":0.2737825918765738,"score_spread":0.20053911708082367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935354372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003776257,0.9997002,0.000027327278,0.000084709056,0.000055316294,0.0000036124181,0.000009115519,0.0000014216477,0.00008052412],"genre_scores_gemma":[0.00045684248,0.99916387,0.00010266079,0.00013696821,0.00007882453,0.000005302438,0.000013463057,3.9251705e-7,0.000041678755],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996443,0.00008903237,0.00009703437,0.000054432854,0.000090044916,0.000025113068],"domain_scores_gemma":[0.9990427,0.0006290123,0.00018676322,0.000009586093,0.00009837385,0.000033592205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000875529,0.0010593936,0.002853773,0.0027465809,0.00031305006,0.0012660144,0.00134759,0.0014205999,0.0030614862],"category_scores_gemma":[0.0025015683,0.0003205066,0.001358423,0.0017987791,0.00033399285,0.0011661996,0.0006876044,0.001391419,0.00046529734],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023097478,0.000093030605,0.0004432815,0.13937777,0.00086520764,0.00040157637,0.000086374675,0.00047781193,0.00041262383,0.0010348739,0.022649016,0.8339275],"study_design_scores_gemma":[0.0005043621,0.00053389044,0.0053954567,0.27444032,0.009477073,0.0075601526,0.0005290037,0.00053130666,0.0004820162,0.0036081127,0.6968045,0.00013377386],"about_ca_topic_score_codex":0.0019725328,"about_ca_topic_score_gemma":0.0042677075,"teacher_disagreement_score":0.0030614862,"about_ca_system_score_codex":0.0005689345,"about_ca_system_score_gemma":0.0015050876,"threshold_uncertainty_score":0.010241628},"labels":[],"label_agreement":null},{"id":"W2937440369","doi":"10.1016/j.msard.2019.04.014","title":"The association of fatigue and social participation in multiple sclerosis as assessed using two different instruments","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institutes of Health; Crohn's and Colitis Canada; Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Centers for Disease Control and Prevention; University of Alabama at Birmingham; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Association (psychology); Physical medicine and rehabilitation; Physical therapy; Immunology; Psychology; Psychotherapist","score_opus":0.07673923869246745,"score_gpt":0.3188534154269969,"score_spread":0.24211417673452945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937440369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99868065,0.00030167747,0.0000717552,0.00003398928,0.000009698813,0.000027853695,0.00020945512,0.0000015731613,0.0006634143],"genre_scores_gemma":[0.9985851,0.00018676565,0.00033945247,0.000035258814,0.000020467318,0.00008099545,0.00036898718,0.000001121086,0.00038188003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725986,0.0014912866,0.00040973048,0.00018842543,0.00041681377,0.00023385025],"domain_scores_gemma":[0.9900006,0.0039152326,0.0042979117,0.00029030375,0.0007883722,0.00070749474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030706045,0.0006004637,0.00052911195,0.0018662536,0.00058417756,0.00090231164,0.0005330195,0.001157413,0.0013354148],"category_scores_gemma":[0.011384302,0.00020385822,0.0012775852,0.0013673778,0.00043731043,0.0006558726,0.0013209078,0.00077262986,0.00017370124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037672563,0.00021635348,0.9946517,0.00005894408,0.00034045006,0.000026236119,0.00037400678,0.00006525062,0.00033232576,0.000023302353,0.00004149303,0.0034932322],"study_design_scores_gemma":[0.0000100763245,0.00023578074,0.9992217,0.000008703698,0.000037216774,0.000035046847,0.00023303981,0.00007959463,0.000041449908,0.000014409078,0.00007740415,0.0000055762243],"about_ca_topic_score_codex":0.0031049957,"about_ca_topic_score_gemma":0.008266952,"teacher_disagreement_score":0.0031049957,"about_ca_system_score_codex":0.0004544149,"about_ca_system_score_gemma":0.00035081615,"threshold_uncertainty_score":0.016239107},"labels":[],"label_agreement":null},{"id":"W2945447515","doi":"10.1016/j.msard.2019.05.014","title":"Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study★★","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Medicine; Teriflunomide; Multiple sclerosis; Term (time); Extension (predicate logic); Pediatrics; Dermatology; Internal medicine; Intensive care medicine; Immunology; Fingolimod","score_opus":0.024814999333749276,"score_gpt":0.2686279693662391,"score_spread":0.24381297003248983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945447515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960794,0.002948483,0.0000904458,0.000059171052,0.0000150353335,0.00012325805,0.00026163,0.0000051624847,0.00041733822],"genre_scores_gemma":[0.99753964,0.0009840516,0.00020455496,0.00011406074,0.0000792622,0.00015169373,0.0006558884,0.000003755004,0.0002669806],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99891376,0.0007126442,0.00008766688,0.00009991041,0.00010394212,0.00008210071],"domain_scores_gemma":[0.9963168,0.0010024995,0.0012546292,0.00035988947,0.00036113992,0.0007050452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040741293,0.00060639984,0.0013125108,0.00024344723,0.00027221613,0.000511015,0.00030951557,0.0006324195,0.0013335833],"category_scores_gemma":[0.0032280763,0.00018454315,0.0015493783,0.00032502905,0.0003523961,0.00051149336,0.00039794535,0.0009791842,0.00021989361],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.75092405,0.009011929,0.14557835,0.0011748543,0.00912283,0.00045323532,0.00048577567,0.0006808895,0.010447393,0.000092141476,0.0012647116,0.07076377],"study_design_scores_gemma":[0.15365249,0.31262428,0.5190927,0.00024408012,0.007770044,0.0009970061,0.00019690041,0.00076129,0.0020988393,0.00016575611,0.0023319381,0.00006468386],"about_ca_topic_score_codex":0.00055354263,"about_ca_topic_score_gemma":0.00085323106,"teacher_disagreement_score":0.0040741293,"about_ca_system_score_codex":0.00028722844,"about_ca_system_score_gemma":0.00058098504,"threshold_uncertainty_score":0.021546304},"labels":[],"label_agreement":null},{"id":"W2947604924","doi":"10.1016/j.msard.2019.05.027","title":"Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics","keywords":"Exon; Multiple sclerosis; Missense mutation; Immunology; TLR3; Gene; Sanger sequencing; Medicine; Allele; TLR7; Mutation; Biology; Toll-like receptor; Genetics; Innate immune system; Immune system","score_opus":0.021063925953333475,"score_gpt":0.21247428652853748,"score_spread":0.191410360575204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947604924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960104,0.00064862106,0.0005875511,0.000042818752,0.000016940143,0.000034597695,0.0019510915,0.000016161375,0.000691778],"genre_scores_gemma":[0.9943598,0.00024479878,0.0012957725,0.0000892661,0.000013433626,0.000053891592,0.0032390265,0.000010250452,0.0006939641],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99982774,0.000018906516,0.000027101296,0.000056907746,0.000046358997,0.00002297146],"domain_scores_gemma":[0.99982977,0.000049220536,0.00003897343,0.000013281887,0.000041094878,0.00002762618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009609655,0.000174543,0.00025200046,0.00070145377,0.0002442943,0.00018959172,0.00015748235,0.00031646708,0.0021998063],"category_scores_gemma":[0.00044508663,0.00006787322,0.00032965234,0.0005060259,0.000121846504,0.00006460576,0.00014191656,0.00019072712,0.0005194967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038748432,0.00019196623,0.45792866,0.0004420479,0.00022981639,0.010797519,0.0013118911,0.00059105403,0.47268438,0.00023830168,0.001704635,0.050004825],"study_design_scores_gemma":[0.000112087895,0.00066979683,0.9426938,0.000059025464,0.00018323386,0.016536318,0.0004484258,0.0009519906,0.030202296,0.00023475941,0.007886502,0.000021845235],"about_ca_topic_score_codex":0.0011056978,"about_ca_topic_score_gemma":0.0010806044,"teacher_disagreement_score":0.0021998063,"about_ca_system_score_codex":0.000146096,"about_ca_system_score_gemma":0.00015302202,"threshold_uncertainty_score":0.0073590875},"labels":[],"label_agreement":null},{"id":"W2947723815","doi":"10.1016/j.msard.2019.05.028","title":"Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Globus pallidus; Putamen; Medicine; Caudate nucleus; Atrophy; Thalamus; Grey matter; Internal medicine; Gastroenterology; Basal ganglia; White matter; Nuclear medicine; Magnetic resonance imaging; Central nervous system; Radiology","score_opus":0.031792684736056655,"score_gpt":0.2664433048164932,"score_spread":0.23465062008043655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947723815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99972934,0.000083784835,0.000009498318,0.0000053326025,0.0000029122214,0.0000022993165,0.000033139866,0.0000016155172,0.00013201497],"genre_scores_gemma":[0.99948907,0.000036065012,0.000014078387,0.000007108655,0.0000031897741,0.0000027536069,0.00007353579,7.1292567e-7,0.00037350255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998989,0.000019861203,0.000010537126,0.000027421454,0.000012553164,0.000030788313],"domain_scores_gemma":[0.999652,0.000051663304,0.00011869382,0.000019083274,0.000048029455,0.00011045443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023406507,0.00030651444,0.00044829038,0.00076044555,0.0003006155,0.00027923728,0.0001451904,0.00046089577,0.0015414417],"category_scores_gemma":[0.00079830876,0.00012962206,0.00019108209,0.00025832147,0.00020465223,0.00029677906,0.0002459628,0.0003101409,0.00020923451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0403794,0.0029988023,0.88556105,0.00013268257,0.0004509287,0.0047904206,0.0014075426,0.00027403547,0.04535836,0.00012721878,0.00048612064,0.01803351],"study_design_scores_gemma":[0.000055082,0.0016217765,0.99714965,0.0000023706893,0.000045970446,0.00035037822,0.00020063944,0.00007996573,0.00037850087,0.000023152434,0.00008859616,0.000003946402],"about_ca_topic_score_codex":0.005696571,"about_ca_topic_score_gemma":0.0034413189,"teacher_disagreement_score":0.005696571,"about_ca_system_score_codex":0.00024222843,"about_ca_system_score_gemma":0.00012056349,"threshold_uncertainty_score":0.01132679},"labels":[],"label_agreement":null},{"id":"W2948027444","doi":"10.1016/j.msard.2019.06.001","title":"Multiple Sclerosis and psychosis: A case report","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; University of Toronto","funders":"","keywords":"Multiple sclerosis; Paranoia; Psychosis; Medicine; Psychiatry; Context (archaeology); Acute Psychosis","score_opus":0.042994523681006494,"score_gpt":0.2781926257522483,"score_spread":0.2351981020712418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948027444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9244589,0.020838514,0.0049418034,0.012820361,0.0019080159,0.0006412424,0.001107874,0.00053056044,0.03275273],"genre_scores_gemma":[0.98125607,0.004753073,0.0027670192,0.002750506,0.003933331,0.00011933679,0.00025907144,0.000079930134,0.0040816837],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99821556,0.00020441615,0.00024548266,0.0003925756,0.00026300325,0.00067899487],"domain_scores_gemma":[0.9957022,0.0011814667,0.00080180797,0.00040697985,0.0002748254,0.001632734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072746124,0.004521872,0.0023555793,0.0069845114,0.009904159,0.0048472816,0.004258362,0.015388192,0.006836205],"category_scores_gemma":[0.005968951,0.0037022843,0.0034188384,0.0053361575,0.00481107,0.006217296,0.0072918762,0.0062626246,0.003598764],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019666997,0.000037571637,0.0012484735,0.000021059563,0.0000064891688,0.99783593,0.00010878838,0.000022058575,0.00018009257,0.00006834513,0.000121126104,0.0003305312],"study_design_scores_gemma":[0.000008868856,0.000026641188,0.0011195824,0.000009935917,0.000013183805,0.9981225,0.00016160433,0.000077214434,0.000107299915,0.00011324001,0.00022808126,0.0000116806605],"about_ca_topic_score_codex":0.005689218,"about_ca_topic_score_gemma":0.006671156,"teacher_disagreement_score":0.015388192,"about_ca_system_score_codex":0.0038458745,"about_ca_system_score_gemma":0.0023981004,"threshold_uncertainty_score":0.027903855},"labels":[],"label_agreement":null},{"id":"W2948265715","doi":"10.1016/j.msard.2019.05.029","title":"Emotional expressions associated with therapeutic inertia in multiple sclerosis care","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Roche (Canada); St. Michael's Hospital","funders":"National Science Foundation of Sri Lanka; F. Hoffmann-La Roche","keywords":"Multiple sclerosis; Medicine; Inertia; Physical medicine and rehabilitation; Psychiatry","score_opus":0.044756782169413215,"score_gpt":0.25680202929845997,"score_spread":0.21204524712904677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948265715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607533,0.000530051,0.00008130534,0.00039368813,0.000027500324,0.000016110384,0.000021664817,0.000001246062,0.0028530413],"genre_scores_gemma":[0.99937505,0.00018338366,0.00010135601,0.00012875118,0.00002203049,0.000014291654,0.000021653083,0.0000018356913,0.00015165274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963421,0.0024536625,0.00024057695,0.00012903352,0.00048533521,0.00034920647],"domain_scores_gemma":[0.9818386,0.00915776,0.006667879,0.0004092802,0.0008168219,0.001109616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032192632,0.00014032214,0.0002770429,0.00096691865,0.0016410508,0.0022457778,0.0002988857,0.0004761445,0.0018280805],"category_scores_gemma":[0.02716287,0.00012696722,0.00027038172,0.0008837845,0.0013057304,0.0007506169,0.0017353484,0.001268144,0.00008280028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018228538,0.00081311207,0.8332266,0.00046976854,0.00032504342,0.0012467118,0.11048495,0.00022165634,0.0026152097,0.0031859335,0.0012686286,0.044319555],"study_design_scores_gemma":[0.000035213347,0.00017859734,0.93376285,0.00014616447,0.00008696307,0.0004851974,0.06252415,0.0001751884,0.00023726081,0.00047982513,0.00186127,0.00002723974],"about_ca_topic_score_codex":0.002237179,"about_ca_topic_score_gemma":0.0029316354,"teacher_disagreement_score":0.0032192632,"about_ca_system_score_codex":0.0015098347,"about_ca_system_score_gemma":0.0009954191,"threshold_uncertainty_score":0.017025292},"labels":[],"label_agreement":null},{"id":"W2953858782","doi":"10.1016/j.msard.2019.07.002","title":"Higher health care use before a clinically isolated syndrome with or without subsequent MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Saskatchewan; Saskatchewan Health Quality Council; University of British Columbia Hospital; Manitoba Health; University of British Columbia; Vancouver Coastal Health; University of Manitoba","funders":"Nova Scotia Department of Health and Wellness; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Dalhousie University; Michael Smith Health Research BC; Saskatchewan Health Research Foundation; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Research Manitoba; Dalhousie Medical Research Foundation; Health Research","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Internal medicine; Intensive care medicine; Pediatrics; Psychiatry","score_opus":0.04474073713536785,"score_gpt":0.30133620566208963,"score_spread":0.25659546852672177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953858782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908121,0.0016529202,0.000069591704,0.00042971913,0.000077747325,0.000019674819,0.0017663267,0.000011643656,0.0051601324],"genre_scores_gemma":[0.99748945,0.0003180125,0.00004475246,0.00016347025,0.00007663158,0.000010563772,0.0007325194,0.0000038472685,0.0011607624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988274,0.00030055898,0.0001279768,0.00017693284,0.00015592008,0.00041124463],"domain_scores_gemma":[0.99458486,0.0016310968,0.0018842544,0.00029456432,0.0003742409,0.0012311426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005338317,0.00029141616,0.0006308589,0.0016306372,0.0011437028,0.0014742314,0.0004495633,0.000921874,0.00982394],"category_scores_gemma":[0.004997654,0.00017849395,0.00094030617,0.0018368949,0.00028463922,0.00091134803,0.0007511993,0.0018865122,0.00055231724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048405206,0.00019095543,0.9949065,0.000066372515,0.00019067536,0.0002620839,0.00022890801,0.00002121994,0.00023516272,0.00010239576,0.00034711254,0.00296447],"study_design_scores_gemma":[0.000012084724,0.0001370017,0.998623,0.000028385715,0.00006397626,0.00020480718,0.00036190718,0.000043713142,0.000051275973,0.000053976517,0.00041391433,0.0000058789565],"about_ca_topic_score_codex":0.026226101,"about_ca_topic_score_gemma":0.026158698,"teacher_disagreement_score":0.026226101,"about_ca_system_score_codex":0.0007756837,"about_ca_system_score_gemma":0.0011227893,"threshold_uncertainty_score":0.05214691},"labels":[],"label_agreement":null},{"id":"W2971720933","doi":"10.1016/j.msard.2019.101387","title":"Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; University of Calgary; McGill University; Mental Health Research Canada; Hospital for Sick Children","funders":"Sickkids Research Institute; Ontario Institute for Regenerative Medicine; Stem Cell Network; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation","keywords":"Medicine; Optic neuritis; Multiple sclerosis; Physical medicine and rehabilitation; Dermatology; Immunology","score_opus":0.03143187486149151,"score_gpt":0.2884065385178837,"score_spread":0.2569746636563922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971720933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961397,0.0013904332,0.000103449245,0.00007164469,0.000014302588,0.000018367951,0.00009412902,0.00000603644,0.0021619683],"genre_scores_gemma":[0.99827766,0.0010502731,0.00016700441,0.00003472079,0.000031081603,0.000010392959,0.00014538043,0.0000021853907,0.00028131471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950814,0.00009817848,0.00006167476,0.000052003,0.00010976045,0.00017024658],"domain_scores_gemma":[0.9979121,0.0003385752,0.00101824,0.000060441507,0.00035963373,0.0003110113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005589912,0.0003173345,0.00041217837,0.0015899143,0.0005199532,0.00071049394,0.00025759765,0.00054462114,0.0024000509],"category_scores_gemma":[0.002760325,0.00020787159,0.0002795948,0.0011890301,0.0005159943,0.00097028574,0.00048296573,0.00053720264,0.00033091722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049695483,0.00014505867,0.9811849,0.00012651613,0.00002746105,0.0056852615,0.0005124573,0.000033063185,0.0031949617,0.000096253534,0.00021042825,0.008286622],"study_design_scores_gemma":[0.000004812523,0.0001402117,0.9927759,0.00003682309,0.000014040004,0.00523908,0.0009265379,0.000015776754,0.00042382185,0.000029430672,0.00038937156,0.000004209243],"about_ca_topic_score_codex":0.0047493316,"about_ca_topic_score_gemma":0.0043223747,"teacher_disagreement_score":0.0047493316,"about_ca_system_score_codex":0.0004466109,"about_ca_system_score_gemma":0.0006381828,"threshold_uncertainty_score":0.009443343},"labels":[],"label_agreement":null},{"id":"W2971886490","doi":"10.1016/j.msard.2019.101383","title":"Predictors of people's perceptions of second hand smoke exposure as a risk factor for multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan; University of Toronto","funders":"","keywords":"Medicine; Residence; Environmental health; Logistic regression; Risk factor; Risk perception; Demography; Odds; Odds ratio; Smoke; Passive smoking; Perception; Psychology; Geography","score_opus":0.03035046052589006,"score_gpt":0.25872396651358864,"score_spread":0.2283735059876986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971886490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985946,0.00016610995,0.000037408023,0.00009700063,0.000011971064,0.000008383524,0.000095254014,0.0000014240951,0.0009878027],"genre_scores_gemma":[0.9996295,0.000066421395,0.000043671276,0.000026360382,0.000011282192,0.0000033728288,0.000051081686,6.6250834e-7,0.00016763789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999156,0.00031381226,0.00010324741,0.000057569127,0.0002067022,0.0001627442],"domain_scores_gemma":[0.99447626,0.0016472694,0.0020652423,0.00022685331,0.0005435859,0.0010408536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011838947,0.00021441701,0.0003044182,0.0008035459,0.00065260846,0.0012248054,0.00022486958,0.00066720863,0.0035904145],"category_scores_gemma":[0.005573613,0.00025681953,0.0008633466,0.000675667,0.0003546192,0.0005232827,0.0006445195,0.0013126839,0.00028125106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081025,0.00013513488,0.99806386,0.000013287972,0.000058926427,0.00003474107,0.0005108699,0.000016588436,0.0001020254,0.000015630665,0.000040405102,0.0009274341],"study_design_scores_gemma":[0.000005089358,0.00012453266,0.9974318,0.00001449833,0.00003543658,0.000064465756,0.0020524869,0.00010025643,0.000047793987,0.000024040439,0.00009503337,0.000004587052],"about_ca_topic_score_codex":0.012096653,"about_ca_topic_score_gemma":0.01142501,"teacher_disagreement_score":0.012096653,"about_ca_system_score_codex":0.00026248096,"about_ca_system_score_gemma":0.00059401715,"threshold_uncertainty_score":0.024052441},"labels":[],"label_agreement":null},{"id":"W2973460607","doi":"10.1016/j.msard.2019.101407","title":"Long noncoding RNAs associated with phenotypic severity in multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hotchkiss Brain Institute; University of Calgary","funders":"Canada Foundation for Innovation; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Hotchkiss Brain Institute; Cumming School of Medicine, University of Calgary; School of Medicine; University of Calgary","keywords":"Multiple sclerosis; Phenotype; Medicine; Genetics; Gene; Immunology; Biology","score_opus":0.019158470407961432,"score_gpt":0.2202551167887921,"score_spread":0.20109664638083066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973460607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643826,0.001116325,0.000941044,0.00009978036,0.0000132871955,0.000014734231,0.0009111713,0.00002911316,0.00043632672],"genre_scores_gemma":[0.99757093,0.00018117604,0.0011681104,0.00006473796,0.000018771794,0.00002144203,0.0006606975,0.00000815665,0.0003058257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973136,0.000045934834,0.00003831621,0.000106060936,0.00005836799,0.000019865585],"domain_scores_gemma":[0.9988024,0.000313808,0.0005954627,0.000060421862,0.00013270538,0.000095190015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005417531,0.0003195446,0.00025071017,0.0006568437,0.00023997681,0.0004525261,0.00016576938,0.0002990838,0.0015837468],"category_scores_gemma":[0.0012379627,0.00009341929,0.0002350919,0.0006855328,0.00024825803,0.00019053536,0.0003755793,0.00034695907,0.00028979674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016514973,0.000082545135,0.8617754,0.00034851505,0.00027835535,0.00062854367,0.0003190395,0.00057188416,0.10990954,0.00015915469,0.00052696344,0.023748472],"study_design_scores_gemma":[0.000020727395,0.00026626984,0.9885557,0.000030272207,0.000111488655,0.0016420006,0.00011150428,0.00065793114,0.0072531174,0.00034809238,0.00098808,0.000014815731],"about_ca_topic_score_codex":0.00039776653,"about_ca_topic_score_gemma":0.0005675031,"teacher_disagreement_score":0.0015837468,"about_ca_system_score_codex":0.0001636556,"about_ca_system_score_gemma":0.00015971367,"threshold_uncertainty_score":0.0052981973},"labels":[],"label_agreement":null},{"id":"W2974551108","doi":"10.1016/j.msard.2019.101402","title":"Rituximab-induced serum sickness in multiple sclerosis patients","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada; Genentech; National Institutes of Health; Patient-Centered Outcomes Research Institute; Biogen; University of Rochester; Novartis; Joint Research Centre; Genzyme; EMD Serono; National Multiple Sclerosis Society","keywords":"Rituximab; Medicine; Serum sickness; Multiple sclerosis; Immunology; CD20; Rash; Rheumatoid arthritis; Monoclonal antibody; Monoclonal; Population; Antibody; Internal medicine","score_opus":0.023964275356999545,"score_gpt":0.21103659235023065,"score_spread":0.1870723169932311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974551108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956968,0.0016156634,0.000048717182,0.000095530086,0.000013242482,0.000009403446,0.000074711046,0.000009181499,0.002436741],"genre_scores_gemma":[0.9995634,0.00017440873,0.00002223357,0.000040843475,0.000019061757,0.0000024258816,0.00006008769,9.89118e-7,0.00011654669],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99964166,0.000101588135,0.000057596837,0.00004355971,0.000069895716,0.000085717445],"domain_scores_gemma":[0.99935275,0.00019827491,0.00024013768,0.00002354071,0.00006258203,0.00012266144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003472723,0.00031955985,0.00033454734,0.000708889,0.0003995289,0.00051502854,0.00020401222,0.0005102149,0.001709731],"category_scores_gemma":[0.0021617694,0.00013872063,0.00028862682,0.00047817212,0.00023327637,0.00032755808,0.00027324999,0.0003790863,0.00025729206],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028269715,0.0002453548,0.965416,0.00011899849,0.00013399291,0.011572572,0.00037274676,0.00011959509,0.004745241,0.00016260326,0.000606747,0.01367919],"study_design_scores_gemma":[0.000074607546,0.0008792423,0.97570145,0.000044665998,0.00013721708,0.020797089,0.0003008394,0.00035545102,0.00058647944,0.000117362964,0.0009934562,0.000012287872],"about_ca_topic_score_codex":0.0017849266,"about_ca_topic_score_gemma":0.0012989505,"teacher_disagreement_score":0.0017849266,"about_ca_system_score_codex":0.00039770984,"about_ca_system_score_gemma":0.00031644292,"threshold_uncertainty_score":0.005719602},"labels":[],"label_agreement":null},{"id":"W2975742859","doi":"10.1016/j.msard.2019.101411","title":"Predictors of vocational status among persons with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parkwood Institute; Western University; Lawson Health Research Institute; London Health Sciences Centre","funders":"EMD Serono; AbbVie; Biogen Idec; Genzyme; Roche; Novartis","keywords":"Multiple sclerosis; Medicine; Vocational education; Physical therapy; Gerontology; Physical medicine and rehabilitation; Psychiatry; Psychology","score_opus":0.025891768759914176,"score_gpt":0.2385197626102714,"score_spread":0.21262799385035724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2975742859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987262,0.00028200023,0.000020597457,0.00010064804,0.00000917542,0.0000035897276,0.0001413865,0.0000015236698,0.0007147842],"genre_scores_gemma":[0.99954176,0.00010161471,0.000016245689,0.000019208208,0.0000108704435,0.0000026843286,0.000110390116,6.0212295e-7,0.00019661814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994475,0.00018520925,0.000053051503,0.000044373093,0.0000823449,0.00018756498],"domain_scores_gemma":[0.9981943,0.0004220731,0.000520354,0.00009020856,0.0002032831,0.00056985463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006266189,0.00022523868,0.00032927256,0.0010454531,0.0010375956,0.00088164856,0.00034008763,0.00077112194,0.002682035],"category_scores_gemma":[0.0036819777,0.0002752046,0.0004902969,0.0011883198,0.00035100314,0.0005542643,0.00070201384,0.00096637435,0.00032556523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081332,0.00006275273,0.99904996,0.0000035960318,0.00001939726,0.000046898527,0.000053432814,0.000013354191,0.000038570022,0.000011412667,0.00004220785,0.000576993],"study_design_scores_gemma":[0.0000025168906,0.000038279326,0.99952364,0.0000046876366,0.000009008416,0.00005670784,0.00024179254,0.00005098245,0.0000087353465,0.000015572929,0.000046874204,0.0000013142873],"about_ca_topic_score_codex":0.017872944,"about_ca_topic_score_gemma":0.020746179,"teacher_disagreement_score":0.017872944,"about_ca_system_score_codex":0.00033133136,"about_ca_system_score_gemma":0.00057451753,"threshold_uncertainty_score":0.03553778},"labels":[],"label_agreement":null},{"id":"W2978655339","doi":"10.1016/j.msard.2019.101427","title":"The multiple sclerosis gut microbiota: A systematic review","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Toronto; University of Manitoba; Public Health Agency of Canada; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Society; Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Gut flora; Neuroscience; Immunology; Biology","score_opus":0.04001760140771747,"score_gpt":0.26519320139091923,"score_spread":0.22517559998320175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978655339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018794385,0.99937505,0.000035071622,0.00009147509,0.000056726396,0.000018216326,0.00015416452,0.0000025591705,0.000078794896],"genre_scores_gemma":[0.0014599222,0.9979995,0.000107998094,0.0002190465,0.00004688855,0.000026444372,0.00008507976,0.0000011342502,0.00005399639],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99888545,0.00025685725,0.00038957997,0.00016947107,0.000221246,0.00007740075],"domain_scores_gemma":[0.9964862,0.0023259253,0.0007566849,0.000048613874,0.00027767126,0.00010500386],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0020385096,0.0014129141,0.005604663,0.007458878,0.00032922113,0.0019711393,0.0014068392,0.0016155043,0.004628914],"category_scores_gemma":[0.006665713,0.0005546329,0.0033218358,0.009081244,0.00046743787,0.001642148,0.0015680925,0.00095533585,0.0004546235],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033369046,0.000030390001,0.0007461595,0.86274886,0.007057477,0.00024303993,0.0001196365,0.00019596363,0.00042028268,0.00036622942,0.0095583135,0.11818013],"study_design_scores_gemma":[0.00060496683,0.0002766522,0.009365796,0.75191015,0.099973306,0.0015074356,0.00044155677,0.00015497544,0.00031010716,0.00097137305,0.13435781,0.00012587332],"about_ca_topic_score_codex":0.005406864,"about_ca_topic_score_gemma":0.017967783,"teacher_disagreement_score":0.9943953,"about_ca_system_score_codex":0.0013606973,"about_ca_system_score_gemma":0.0050996877,"threshold_uncertainty_score":0.015485287},"labels":[],"label_agreement":null},{"id":"W2980183442","doi":"10.1016/j.msard.2019.101440","title":"Gender identity and sexual orientation affect health care satisfaction, but not utilization, in persons with Multiple Sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Sexual orientation; Medicine; Transgender; Logistic regression; Confounding; Affect (linguistics); Sexual identity; Health care; Clinical psychology; Gender identity; Demography; Human sexuality; Psychology; Social psychology; Internal medicine","score_opus":0.06639426740800924,"score_gpt":0.3086385789962187,"score_spread":0.24224431158820947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980183442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924505,0.0002106921,0.00001201764,0.00007158013,0.0000053132057,0.000001963535,0.000039190483,4.4106176e-7,0.00041369448],"genre_scores_gemma":[0.99968123,0.00008723007,0.000016606464,0.00004028651,0.0000051947086,0.0000016575127,0.000027474875,3.5957777e-7,0.00013986265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994549,0.00025342708,0.000051717292,0.000035089848,0.00007678066,0.00012811279],"domain_scores_gemma":[0.9980533,0.0006018758,0.0007872472,0.00007823312,0.00014678716,0.00033249057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070471456,0.00016234166,0.0003133448,0.00048676622,0.000673383,0.0009218011,0.0001726909,0.00051661266,0.0020029377],"category_scores_gemma":[0.0037124201,0.00023497108,0.0007288012,0.0007004407,0.00033713118,0.00046034757,0.0004977066,0.0006471691,0.00015990568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016462509,0.0001288806,0.9968168,0.000010513396,0.00006935586,0.000052023126,0.00043666028,0.000015337526,0.000083003986,0.0000174315,0.000052268097,0.0021529496],"study_design_scores_gemma":[0.0000047634653,0.00010871342,0.9984445,0.000008178756,0.000034236527,0.000066212706,0.001159997,0.000052617426,0.000024519271,0.000023371722,0.00007053416,0.0000022589363],"about_ca_topic_score_codex":0.010815413,"about_ca_topic_score_gemma":0.018075746,"teacher_disagreement_score":0.010815413,"about_ca_system_score_codex":0.0002885063,"about_ca_system_score_gemma":0.00035789167,"threshold_uncertainty_score":0.021504939},"labels":[],"label_agreement":null},{"id":"W2981054419","doi":"10.1016/j.msard.2019.101448","title":"Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Berlin Institute of Health; NeuroCure Exzellenzcluster; Tohoku University; Stanford University","keywords":"Medicine; Serostatus; Neuromyelitis optica; Rituximab; Cohort; Pediatrics; Transverse myelitis; Optic neuritis; Azathioprine; Myelitis; Internal medicine; Multiple sclerosis; Surgery; Disease; Immunology","score_opus":0.0147594950965529,"score_gpt":0.23692000474149674,"score_spread":0.22216050964494385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981054419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982362,0.000576599,0.0011574989,0.000614756,0.000049194754,0.0017880432,0.008680672,0.000027162641,0.0047440506],"genre_scores_gemma":[0.96504575,0.001653488,0.006932982,0.00055741315,0.00011343007,0.0027259693,0.020359185,0.00002773691,0.0025840173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982986,0.0004611469,0.0005624291,0.0001998173,0.00024921415,0.00022885735],"domain_scores_gemma":[0.9916082,0.0010868185,0.0022132625,0.0011083501,0.0029783412,0.0010049952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037408152,0.00026920286,0.00029115123,0.0035970395,0.0015114032,0.0009730611,0.000989427,0.00052369933,0.0015796489],"category_scores_gemma":[0.0074900785,0.00026262715,0.00020235602,0.0027118332,0.0004009446,0.0009937416,0.0016282798,0.000637443,0.0006489742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020441576,0.00027530792,0.9810625,0.00008370138,0.000016631797,0.0005361276,0.0018480065,0.000091926144,0.00087823387,0.0006628714,0.002740839,0.011599495],"study_design_scores_gemma":[0.000057698475,0.00025924342,0.981857,0.0001575426,0.000022939226,0.00082963833,0.0035622376,0.00038315306,0.0007420118,0.0001286986,0.011983701,0.000016282767],"about_ca_topic_score_codex":0.026424846,"about_ca_topic_score_gemma":0.019776518,"teacher_disagreement_score":0.026424846,"about_ca_system_score_codex":0.0013402023,"about_ca_system_score_gemma":0.0060700923,"threshold_uncertainty_score":0.05254209},"labels":[],"label_agreement":null},{"id":"W2981920413","doi":"10.1016/j.msard.2019.101441","title":"Physician referral improves adherence to the physical activity guidelines for adults with MS: A randomized controlled trial","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Physical Activity and Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Referral; Randomized controlled trial; Physical therapy; Multiple sclerosis; Physical activity; Clinical trial; Internal medicine; Family medicine; Psychiatry","score_opus":0.056240014693024795,"score_gpt":0.31583561787921305,"score_spread":0.25959560318618824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981920413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96828777,0.01905234,0.0005370244,0.002113354,0.0017358718,0.0048490535,0.0007719129,0.00014150616,0.0025111504],"genre_scores_gemma":[0.9835173,0.0060849846,0.00143738,0.002268114,0.0011371538,0.0033012903,0.0004896015,0.000013410783,0.0017506805],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984653,0.0007058425,0.0001924199,0.00031445813,0.0001235501,0.00019839303],"domain_scores_gemma":[0.9973744,0.001135325,0.0006468834,0.00012358707,0.00017413053,0.0005455581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016829025,0.0013828218,0.0047609983,0.0005356909,0.0008112093,0.00122001,0.0011238257,0.0052000405,0.008493672],"category_scores_gemma":[0.005354652,0.0009482747,0.0030570305,0.00079308345,0.0010606666,0.0011608353,0.0005697246,0.0042272657,0.0007772808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9648806,0.012505566,0.0015972485,0.0023939153,0.0038671463,0.000049992832,0.000101312326,0.00015322612,0.0003630034,0.00005411456,0.0008955481,0.013138364],"study_design_scores_gemma":[0.965943,0.027214132,0.0034049647,0.00018201415,0.002678239,0.000014971668,0.00003966229,0.00021765968,0.00004580618,0.000054651864,0.00019239896,0.000012526404],"about_ca_topic_score_codex":0.0050644292,"about_ca_topic_score_gemma":0.0066819517,"teacher_disagreement_score":0.008493672,"about_ca_system_score_codex":0.00091156265,"about_ca_system_score_gemma":0.0014574039,"threshold_uncertainty_score":0.02841413},"labels":[],"label_agreement":null},{"id":"W2987685056","doi":"10.1016/j.msard.2019.101516","title":"Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cannabis; Legalization; Medicine; Recreation; Family medicine; Demographics; Principle of legality; Psychiatry; Cross-sectional study; Demography; Environmental health; Law; Pathology; Political science","score_opus":0.03910574055481355,"score_gpt":0.25931294236243807,"score_spread":0.22020720180762451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987685056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532795,0.00060539815,0.00004466358,0.000316974,0.000012243948,0.000040593917,0.0020646153,0.0000059173203,0.0015816601],"genre_scores_gemma":[0.99810314,0.00054728787,0.0000664883,0.00016082448,0.000005769295,0.000011690576,0.0005354589,0.000004545315,0.0005647818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906904,0.00009182479,0.000082038794,0.000114081355,0.00033811343,0.00030496434],"domain_scores_gemma":[0.9976978,0.00015382096,0.00064374536,0.000048921764,0.00072316756,0.00073261576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048585096,0.00023612457,0.00042347945,0.0012456415,0.0021330593,0.0014066637,0.0012254671,0.0007235838,0.0027609107],"category_scores_gemma":[0.0019723368,0.0004976483,0.0006901858,0.004082176,0.0007922511,0.0006640624,0.000987862,0.0010335157,0.00029444296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004276273,0.00005280739,0.9973604,0.000024331543,0.000046587473,0.00006506455,0.00070408883,0.000024324676,0.00012334585,0.000033322358,0.00038713458,0.0011358586],"study_design_scores_gemma":[0.000003142624,0.000014519392,0.99765176,0.000018284383,0.000012197938,0.000043619762,0.0019164055,0.00007343814,0.000017188551,0.000006142002,0.00023711029,0.0000060801444],"about_ca_topic_score_codex":0.98118305,"about_ca_topic_score_gemma":0.9885805,"teacher_disagreement_score":0.018816948,"about_ca_system_score_codex":0.010440503,"about_ca_system_score_gemma":0.01218913,"threshold_uncertainty_score":0.07575148},"labels":[],"label_agreement":null},{"id":"W2988939654","doi":"10.1016/j.msard.2019.101511","title":"Factors associated with health care utilization in pediatric multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; Institute for Clinical Evaluative Sciences; University of Waterloo; York University; Hospital for Sick Children; Montreal Neurological Institute and Hospital; University of Toronto; SickKids Foundation; University of Manitoba; Manitoba Health","funders":"Canadian Institutes of Health Research; National Institutes of Health; Crohn's and Colitis Canada; University of Waterloo; Multiple Sclerosis Society of Canada; Physicians' Services Incorporated Foundation; Institute for Clinical Evaluative Sciences; Multiple Sclerosis Scientific Research Foundation; McMaster University; Dalhousie University; Hamilton Health Sciences; Ontario Ministry of Health and Long-Term Care; National Multiple Sclerosis Society; Research Manitoba; Royal Bank of Canada; University of Windsor","keywords":"Medicine; Odds ratio; Multiple sclerosis; Generalized estimating equation; Ambulatory; Neurocognitive; Quality of life (healthcare); Odds; Population; Cognition; Cohort; Pediatrics; Socioeconomic status; Physical therapy; Internal medicine; Logistic regression; Psychiatry","score_opus":0.08005793607646335,"score_gpt":0.2844188698074197,"score_spread":0.20436093373095637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988939654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983903,0.00078062824,0.000022635268,0.00009012944,0.0000047457274,0.0000031089187,0.00028956874,0.0000013958576,0.00041749363],"genre_scores_gemma":[0.9990571,0.00053588056,0.000058157882,0.00002611485,0.000008753053,0.000006267779,0.00023505317,0.0000014185845,0.00007139604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897313,0.00034858836,0.00015570267,0.00009065269,0.000167692,0.0002642685],"domain_scores_gemma":[0.9961442,0.00091372215,0.002042691,0.00011902197,0.00033269048,0.00044757812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074931106,0.00021495148,0.00027846443,0.0012563008,0.00046314648,0.0008593816,0.00028967357,0.0004141807,0.0013935594],"category_scores_gemma":[0.0049329177,0.00017483266,0.00074553647,0.0029731577,0.00025174613,0.00042369205,0.00047896657,0.000827945,0.00009253384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017201604,0.000030542036,0.9990675,0.000008817287,0.0000333992,0.000054179225,0.000066265144,0.000018617524,0.000022962226,0.000018610279,0.00004020503,0.0006216669],"study_design_scores_gemma":[8.266933e-7,0.000022232585,0.9992561,0.000014360762,0.00002184407,0.00013007496,0.00036278856,0.00005053118,0.000028758184,0.0000068019667,0.0001042166,0.0000013807811],"about_ca_topic_score_codex":0.035334837,"about_ca_topic_score_gemma":0.032250583,"teacher_disagreement_score":0.035334837,"about_ca_system_score_codex":0.00068023824,"about_ca_system_score_gemma":0.001206307,"threshold_uncertainty_score":0.07025832},"labels":[],"label_agreement":null},{"id":"W2989533252","doi":"10.1016/j.msard.2019.101493","title":"Effects of Mindfulness-based interventions on physical symptoms in people with multiple sclerosis – a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Meta-analysis; Mindfulness; Medicine; Psychological intervention; Psychotherapist; Systematic review; Physical therapy; MEDLINE; Clinical psychology; Physical medicine and rehabilitation; Psychology; Psychiatry; Internal medicine","score_opus":0.07933472634197179,"score_gpt":0.33076535588822503,"score_spread":0.2514306295462532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989533252","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0113870045,0.9872754,0.00034174402,0.0001005946,0.0001616358,0.00033170872,0.00017968057,0.000021676102,0.00020056727],"genre_scores_gemma":[0.17331634,0.822586,0.0019004302,0.000648204,0.00019469575,0.0006369482,0.00031275346,0.000016999189,0.00038756113],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975183,0.00089961063,0.00076624256,0.00032274678,0.00036356883,0.0001296038],"domain_scores_gemma":[0.99470866,0.0038317624,0.0008788713,0.00016742291,0.000302802,0.00011033628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048346426,0.002093199,0.01307116,0.0028279272,0.00056270993,0.0018511745,0.0015851688,0.0018683536,0.003305701],"category_scores_gemma":[0.012493493,0.0011906157,0.020373473,0.002784626,0.00068775774,0.0012697019,0.0013783342,0.0021140822,0.00019038809],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007078616,0.00021435216,0.0017200306,0.5250728,0.428743,0.00010409129,0.00020386995,0.000370732,0.0006091644,0.000119059325,0.00044205753,0.035322145],"study_design_scores_gemma":[0.0028587878,0.00079127925,0.004948265,0.03493413,0.9543682,0.00007760311,0.00010249366,0.00014508545,0.00019491676,0.00014207205,0.0014052925,0.000031840296],"about_ca_topic_score_codex":0.0075688157,"about_ca_topic_score_gemma":0.019591266,"teacher_disagreement_score":0.01307116,"about_ca_system_score_codex":0.0015486932,"about_ca_system_score_gemma":0.0020842052,"threshold_uncertainty_score":0.025568306},"labels":[],"label_agreement":null},{"id":"W2994623253","doi":"10.1016/j.msard.2019.101891","title":"No evidence of disease activity status in patients treated with early vs. delayed subcutaneous interferon β-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Actelion Pharmaceuticals; Schweizerische Multiple Sklerose Gesellschaft; Sanofi; European Commission; Bayer HealthCare; Universitätsspital Basel; Acorda Therapeutics; Merck KGaA; Merck; AbbVie; Bayer Schering; Teva Pharmaceutical Industries; EMD Serono; Novartis","keywords":"Medicine; Multiple sclerosis; Disease; Interferon; Internal medicine; Immunology; Dermatology; Gastroenterology","score_opus":0.021164755843350862,"score_gpt":0.25052083811436027,"score_spread":0.2293560822710094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994623253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982474,0.00093458494,0.0000746539,0.00005375247,0.000049033748,0.00009270408,0.000090880945,0.0000048897373,0.00045217716],"genre_scores_gemma":[0.9990037,0.00023437737,0.00014807604,0.0000866326,0.00004808449,0.00013218122,0.00014505116,0.0000016197575,0.00020036352],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99931073,0.00035258417,0.00006184608,0.00011947322,0.000053618864,0.00010178993],"domain_scores_gemma":[0.9980697,0.0009135705,0.00029717505,0.000111696856,0.000072410905,0.00053537794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017490775,0.00035914656,0.0015545995,0.0002104169,0.00017450539,0.00040342793,0.0003143906,0.00047140144,0.0019965493],"category_scores_gemma":[0.0018344817,0.00015459256,0.0011050043,0.00015245982,0.00039206046,0.00043102074,0.0002494441,0.0010499735,0.00021042631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95154744,0.0058088754,0.007427033,0.00021666854,0.0005159573,0.00010379574,0.000060642393,0.00036871768,0.006148273,0.00006662716,0.00018490345,0.027551001],"study_design_scores_gemma":[0.14939216,0.7796523,0.06421146,0.000062285086,0.001308935,0.000212381,0.00010833693,0.0012591585,0.0026122972,0.0003107283,0.0008352052,0.00003476467],"about_ca_topic_score_codex":0.00031907854,"about_ca_topic_score_gemma":0.000658191,"teacher_disagreement_score":0.0019965493,"about_ca_system_score_codex":0.00032929957,"about_ca_system_score_gemma":0.00071352196,"threshold_uncertainty_score":0.009250164},"labels":[],"label_agreement":null},{"id":"W2995378675","doi":"10.1016/j.msard.2019.101887","title":"Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Roche (Canada); St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Multiple sclerosis; Inertia; Physical medicine and rehabilitation; Psychiatry","score_opus":0.06129911747051195,"score_gpt":0.26937376181334854,"score_spread":0.2080746443428366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995378675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978047,0.0006202204,0.00003063018,0.0004364809,0.000013797891,0.000024230838,0.00004929166,0.0000012293177,0.0010193916],"genre_scores_gemma":[0.9992304,0.00029695113,0.00011002964,0.00017965845,0.000022569198,0.000010000429,0.000046977148,0.0000012119119,0.00010234649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666864,0.0010701083,0.00069763284,0.00023377826,0.0008367475,0.0004930125],"domain_scores_gemma":[0.9750958,0.008257582,0.012182229,0.0005216733,0.0019897823,0.0019528285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019513115,0.00016531463,0.00041704334,0.0012295722,0.0013802771,0.0016116136,0.00039114585,0.0010372858,0.002693607],"category_scores_gemma":[0.028094558,0.0003168372,0.000770512,0.0015756523,0.00042934844,0.0008317857,0.00090410945,0.0015120736,0.0001531236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007200332,0.00015155293,0.9967277,0.000034784876,0.000054348522,0.00010169233,0.0005791915,0.000009302895,0.00004473739,0.000022327382,0.000081331134,0.0021210394],"study_design_scores_gemma":[0.000015238856,0.00011600327,0.9961427,0.00006705391,0.00006081201,0.0002839305,0.002905541,0.000085697204,0.000025781148,0.000029432329,0.00026016813,0.000007629801],"about_ca_topic_score_codex":0.017007593,"about_ca_topic_score_gemma":0.022406261,"teacher_disagreement_score":0.017007593,"about_ca_system_score_codex":0.0009101072,"about_ca_system_score_gemma":0.002442147,"threshold_uncertainty_score":0.033817172},"labels":[],"label_agreement":null},{"id":"W2997666549","doi":"10.1016/j.msard.2020.101928","title":"Predictive medicine in multiple sclerosis: A systematic review","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; Sanofi Genzyme; Merck; MedDay Pharmaceuticals; Roche; Agence Nationale de la Recherche; National Security Agency; Biogen; Sanofi; Genzyme; Teva Pharmaceutical Industries; Novartis","keywords":"Multiple sclerosis; Medicine; MEDLINE; Intensive care medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.09322648895263447,"score_gpt":0.3149819086856666,"score_spread":0.22175541973303214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997666549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028012044,0.99918526,0.0000806047,0.00009780451,0.00006170789,0.00008258601,0.00010124992,0.000004593753,0.00010601585],"genre_scores_gemma":[0.005888751,0.99313813,0.00035322498,0.00034268879,0.00005200007,0.00011171007,0.00006054429,0.0000025631873,0.00005032642],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99506724,0.0020736197,0.0014748309,0.00041978454,0.0007615715,0.00020295494],"domain_scores_gemma":[0.98237926,0.013929877,0.0023712348,0.00021172086,0.00088012585,0.00022792733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007528021,0.0018227918,0.0097032,0.007241788,0.0005471444,0.003010465,0.0018375079,0.00242549,0.0070431535],"category_scores_gemma":[0.025207713,0.0013115522,0.0077181137,0.009479604,0.00089169876,0.0031260652,0.0022508276,0.002310685,0.00047771743],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002939908,0.000025467898,0.000578775,0.945762,0.020386651,0.000091068374,0.00011347431,0.00011811317,0.00009701345,0.00024747584,0.0013923697,0.030893544],"study_design_scores_gemma":[0.0010401645,0.0002105325,0.004656078,0.7717859,0.20523506,0.00031785425,0.00026535426,0.00014005428,0.000104948536,0.0006644741,0.01551414,0.000065547596],"about_ca_topic_score_codex":0.009941777,"about_ca_topic_score_gemma":0.0338923,"teacher_disagreement_score":0.009941777,"about_ca_system_score_codex":0.0029330603,"about_ca_system_score_gemma":0.008883023,"threshold_uncertainty_score":0.039812446},"labels":[],"label_agreement":null},{"id":"W2998846246","doi":"10.1016/j.msard.2020.101940","title":"Reliability and validity of a novel device for quantifying ankle dorsiflexion force in persons with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Mount Royal University","funders":"EMD Serono","keywords":"Medicine; Ankle dorsiflexion; Physical medicine and rehabilitation; Reliability (semiconductor); Physical therapy; Ankle; Limits of agreement; Modalities; Range of motion; Nuclear medicine; Surgery","score_opus":0.14934964528465736,"score_gpt":0.3106397778474063,"score_spread":0.16129013256274896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998846246","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733824,0.00024188407,0.0012866228,0.000049951075,0.00006971977,0.00006867959,0.00012471661,0.000013971267,0.0008062118],"genre_scores_gemma":[0.99729127,0.000109043845,0.0019414454,0.000051810177,0.00002821753,0.00006558721,0.0001556684,0.000005681843,0.0003513348],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967392,0.0012848492,0.0004294784,0.000493956,0.0008890635,0.00016344702],"domain_scores_gemma":[0.9858618,0.008299642,0.0017883725,0.00069519755,0.003054412,0.00030058177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00597681,0.0005701116,0.0005345626,0.0012693772,0.000490164,0.0009559637,0.0005518429,0.0011940348,0.0006527067],"category_scores_gemma":[0.01616137,0.00049341726,0.00096167775,0.0005537861,0.0006224557,0.0008195997,0.0009412528,0.0006418845,0.00029896776],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011665459,0.00045917672,0.9737172,0.00008878333,0.0003634594,0.000058780777,0.0009502936,0.00042515533,0.0032432931,0.00011035953,0.00025948236,0.019157492],"study_design_scores_gemma":[0.00011926644,0.0013941439,0.9930999,0.00004528152,0.00013626748,0.0001929543,0.00052672735,0.0032060726,0.0007267724,0.00009700021,0.00043379277,0.000021849484],"about_ca_topic_score_codex":0.0029282141,"about_ca_topic_score_gemma":0.0055204593,"teacher_disagreement_score":0.00597681,"about_ca_system_score_codex":0.00044774183,"about_ca_system_score_gemma":0.00040823864,"threshold_uncertainty_score":0.03160876},"labels":[],"label_agreement":null},{"id":"W2999802292","doi":"10.1016/j.msard.2020.101950","title":"Evaluation of ethnicity as a predictor of diagnostic phenotype and prognosis in neuromyelitis optica spectrum disorder in Toronto, Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Biogen; Roche; Novartis","keywords":"Medicine; Neuromyelitis optica; Spectrum disorder; Ethnic group; Phenotype; Multiple sclerosis; Pediatrics; Immunology; Psychiatry; Genetics; Gene","score_opus":0.0373750766326049,"score_gpt":0.2759022954175594,"score_spread":0.2385272187849545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999802292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544936,0.00039876983,0.000070213144,0.00045606573,0.000020257383,0.000023707165,0.0012625084,0.000005593384,0.0023133522],"genre_scores_gemma":[0.99859995,0.0002284791,0.00010705638,0.00006351743,0.0000069933203,0.000010025402,0.00039897635,0.0000045641746,0.00058048917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998938,0.00017371813,0.000099896446,0.00012202285,0.00030001262,0.0003663773],"domain_scores_gemma":[0.99534273,0.0003178384,0.0006917555,0.00010678243,0.0022628196,0.001278081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008139284,0.00032843548,0.0004388932,0.0017669197,0.004358958,0.0016965113,0.0013498932,0.000489316,0.001977649],"category_scores_gemma":[0.0037540386,0.00031189955,0.00046633635,0.0036737951,0.000978413,0.00037496554,0.0010451986,0.0007177725,0.00023334556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007231985,0.000022231228,0.9966807,0.00001118478,0.00002216146,0.00018182388,0.0008122068,0.00006711809,0.000106375206,0.000084642284,0.00049092236,0.0014482688],"study_design_scores_gemma":[0.000009743428,0.000021400787,0.9962591,0.000032553322,0.00002564888,0.00013778497,0.0027889805,0.0002381687,0.00005105561,0.000033103537,0.000392148,0.00001030488],"about_ca_topic_score_codex":0.991719,"about_ca_topic_score_gemma":0.9950023,"teacher_disagreement_score":0.02369117,"about_ca_system_score_codex":0.02369117,"about_ca_system_score_gemma":0.032322384,"threshold_uncertainty_score":0.17189229},"labels":[],"label_agreement":null},{"id":"W2999863154","doi":"10.1016/j.msard.2019.101919","title":"Under-treated depression negatively impacts lifestyle behaviors, participation and health-related quality of life among older people with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Physiotherapy Foundation of Canada","keywords":"Medicine; Depression (economics); Psychosocial; Quality of life (healthcare); Multiple sclerosis; Depressive symptoms; Anxiety; Internal medicine; Psychiatry","score_opus":0.08415249453143177,"score_gpt":0.3146048150547855,"score_spread":0.23045232052335374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999863154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984131,0.00076498976,0.000017878001,0.00011402929,0.000016599606,0.000005403776,0.00014942825,0.0000012849802,0.0005172124],"genre_scores_gemma":[0.99915457,0.00035324454,0.000028718565,0.0000848438,0.000019942801,0.0000056765803,0.000119495104,6.2572303e-7,0.00023292439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994597,0.00019009833,0.000082318744,0.000059522095,0.00008991066,0.00011836186],"domain_scores_gemma":[0.9986098,0.0002138911,0.0006017271,0.000059096517,0.0002051763,0.0003101904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064682594,0.00024621078,0.00055494596,0.0005805004,0.0006193423,0.0008904821,0.00021875519,0.00058941636,0.0013286137],"category_scores_gemma":[0.0033584596,0.00023326415,0.00086348486,0.00085681817,0.00021919675,0.00047301492,0.0005389518,0.0007702466,0.0001520278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019568858,0.00013331864,0.9951749,0.00003518213,0.00020835451,0.00004476433,0.00021997347,0.000013815071,0.0001177084,0.0000064028536,0.00009501749,0.0037549355],"study_design_scores_gemma":[0.000007767245,0.00010974248,0.9993303,0.0000117613,0.00009700148,0.000039664832,0.0002751243,0.000027697251,0.000015812377,0.000010218725,0.00007279849,0.0000022853565],"about_ca_topic_score_codex":0.014962425,"about_ca_topic_score_gemma":0.02926667,"teacher_disagreement_score":0.014962425,"about_ca_system_score_codex":0.00031935822,"about_ca_system_score_gemma":0.00036386246,"threshold_uncertainty_score":0.029750705},"labels":[],"label_agreement":null},{"id":"W3002536563","doi":"10.1016/j.msard.2020.101964","title":"Anti-CV2/CRMP5 antibody-associated hemorrhagic leukoencephalomyelitis treated with steroids, intravenous immunoglobulin, plasmapheresis, and cyclophosphamide","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Plasmapheresis; Cyclophosphamide; Autoantibody; Malignancy; Antibody; Acute disseminated encephalomyelitis; Encephalomyelitis; Immunoglobulin G; Multiple sclerosis; Immunology; Internal medicine; Gastroenterology; Chemotherapy","score_opus":0.013408963881945504,"score_gpt":0.20622574861666548,"score_spread":0.19281678473471997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002536563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417739,0.0116908355,0.0046110577,0.0063670664,0.001211982,0.00079803076,0.0003593442,0.00047135522,0.03271642],"genre_scores_gemma":[0.9916249,0.0016770285,0.0011311708,0.0022932186,0.00045761984,0.00008648708,0.00026813318,0.000016465598,0.0024450598],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997961,0.000033958517,0.00002584973,0.00003847219,0.00003730432,0.000068283094],"domain_scores_gemma":[0.9997731,0.000052617146,0.000018588751,0.000018705337,0.00003201057,0.000105003164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034976672,0.00093165145,0.0010134088,0.0005190025,0.0011619626,0.00033732757,0.00056852575,0.0012283295,0.00093814376],"category_scores_gemma":[0.0007746104,0.00019617834,0.00067051983,0.0003758221,0.00045615237,0.00043865212,0.00030342984,0.0017420282,0.0002758879],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009361031,0.004171034,0.043404825,0.00088830665,0.0009490038,0.78352773,0.00050724816,0.002731549,0.033580933,0.0023266186,0.008815682,0.10973601],"study_design_scores_gemma":[0.0065815914,0.01572353,0.24883159,0.0005578806,0.001339681,0.6535701,0.0004970574,0.016928714,0.024079353,0.004685964,0.026975794,0.00022862993],"about_ca_topic_score_codex":0.004987596,"about_ca_topic_score_gemma":0.00652329,"teacher_disagreement_score":0.004987596,"about_ca_system_score_codex":0.0011659797,"about_ca_system_score_gemma":0.0010134706,"threshold_uncertainty_score":0.00991714},"labels":[],"label_agreement":null},{"id":"W3002578671","doi":"10.1016/j.msard.2020.101955","title":"Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Saskatchewan; Health Sciences Centre; Manitoba Health","funders":"Saskatchewan Health Research Foundation","keywords":"Comorbidity; Medicine; Population; Odds ratio; Odds; Internal medicine; Logistic regression; Pediatrics","score_opus":0.06059881887132283,"score_gpt":0.29942472329734876,"score_spread":0.23882590442602591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002578671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991122,0.00030485887,0.000035851008,0.00005666574,0.000010687524,0.000004018576,0.0002852028,0.000002151904,0.00018824705],"genre_scores_gemma":[0.9994506,0.00011949598,0.000030155514,0.000025898134,0.000011866022,0.000004442249,0.00026692532,0.000001021201,0.000089581015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878055,0.0004377726,0.00013935947,0.0002448472,0.00014789295,0.0002496664],"domain_scores_gemma":[0.9973436,0.00035450395,0.0010771052,0.0002536262,0.00028215957,0.0006891179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010411494,0.00046712157,0.0006120399,0.0011671253,0.0010949773,0.0011696005,0.00057794683,0.0011694563,0.0010523249],"category_scores_gemma":[0.0038245493,0.00058207195,0.0015029773,0.0019863888,0.00043653496,0.0011614951,0.0009946267,0.0014028944,0.00017102895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014958021,0.00006620013,0.99916446,0.0000037852508,0.00015435238,0.000050868763,0.00004956596,0.00001454407,0.000059662994,0.0000065017566,0.000028164774,0.000252294],"study_design_scores_gemma":[0.000004616934,0.000062837236,0.9995789,0.0000024879616,0.000042619657,0.00007006912,0.00013952224,0.000055943627,0.000007976555,0.00000751814,0.00002445684,0.0000031535901],"about_ca_topic_score_codex":0.03081413,"about_ca_topic_score_gemma":0.03679846,"teacher_disagreement_score":0.03081413,"about_ca_system_score_codex":0.0006978379,"about_ca_system_score_gemma":0.0008047708,"threshold_uncertainty_score":0.06126958},"labels":[],"label_agreement":null},{"id":"W3003639437","doi":"10.1016/j.msard.2020.101973","title":"Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Hemophagocytosis; Alemtuzumab; Medicine; Multiple sclerosis; Clinically isolated syndrome; Jaundice; Differential diagnosis; Pathology; Gastroenterology; Immunology; Bone marrow; Antibody; Pancytopenia","score_opus":0.06086326959752518,"score_gpt":0.2738405279115333,"score_spread":0.2129772583140081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003639437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95120645,0.016003566,0.0063910624,0.0063766334,0.0009458588,0.0004189097,0.00038736424,0.00037220956,0.017898053],"genre_scores_gemma":[0.98973876,0.003224329,0.0017641196,0.0012787402,0.0019473716,0.000057145153,0.00012687035,0.000035607995,0.0018271013],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991124,0.00011536267,0.00010994953,0.00021045309,0.00012231087,0.00032952172],"domain_scores_gemma":[0.99745494,0.00091332564,0.0005055952,0.0003045486,0.00013848723,0.0006830904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005242704,0.0027803672,0.0019163378,0.0031804119,0.003925362,0.0026745154,0.002108906,0.009560677,0.0023378213],"category_scores_gemma":[0.0039701555,0.0017155013,0.00241423,0.0021495894,0.0029495193,0.0033477973,0.0022491608,0.004814996,0.0012222781],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021157997,0.000024049277,0.0013336116,0.0000144858,0.0000074285294,0.9977452,0.0000545204,0.000026638281,0.00021703777,0.00005349235,0.000099538425,0.00040274157],"study_design_scores_gemma":[0.0000124599965,0.000029600833,0.0014620657,0.000008266628,0.000020272619,0.9977325,0.00005553291,0.00014437448,0.00021302582,0.00008359309,0.00023043249,0.000007786878],"about_ca_topic_score_codex":0.0024674842,"about_ca_topic_score_gemma":0.0027387477,"teacher_disagreement_score":0.009560677,"about_ca_system_score_codex":0.0022552642,"about_ca_system_score_gemma":0.0013809727,"threshold_uncertainty_score":0.016363144},"labels":[],"label_agreement":null},{"id":"W3005047919","doi":"10.1016/j.msard.2020.101987","title":"Management of diabetes and hypertension in people with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Research Manitoba; International Business Machines Corporation","keywords":"Medicine; Diabetes mellitus; Odds ratio; Body mass index; Logistic regression; Internal medicine; Univariate analysis; Multiple sclerosis; Blood pressure; Depression (economics); Case-control study; Comorbidity; Physical therapy; Multivariate analysis; Endocrinology; Psychiatry","score_opus":0.035704120419214204,"score_gpt":0.22812043413442892,"score_spread":0.19241631371521473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005047919","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452085,0.04301417,0.00011191896,0.0032052388,0.00028268402,0.00008905955,0.00042507064,0.00000959516,0.007653764],"genre_scores_gemma":[0.98187673,0.015106692,0.00038350458,0.0012831837,0.00036284231,0.00009885512,0.0002545859,0.0000018383481,0.0006318268],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855024,0.0006636364,0.0002401282,0.000073669624,0.0003305676,0.00014174645],"domain_scores_gemma":[0.99840945,0.00046793005,0.0006243624,0.00005343223,0.00018563689,0.0002591836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013242175,0.00017053942,0.00061032525,0.0011460584,0.0008310292,0.00085143297,0.00031032015,0.00079428486,0.0011467257],"category_scores_gemma":[0.0054337373,0.00022500129,0.00071411446,0.0021279876,0.00019781683,0.00074782484,0.0004531762,0.0009199471,0.00014874937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091131503,0.0020540962,0.9331777,0.00077468785,0.0006906647,0.00046085496,0.0011704623,0.000044579207,0.0002848226,0.00011892981,0.0015486408,0.05876318],"study_design_scores_gemma":[0.0002004208,0.0012550934,0.99370146,0.0003345805,0.0005208405,0.00046740388,0.0015351636,0.0000670639,0.00008607267,0.00016071276,0.001656217,0.000015026845],"about_ca_topic_score_codex":0.008949193,"about_ca_topic_score_gemma":0.013841273,"teacher_disagreement_score":0.008949193,"about_ca_system_score_codex":0.0004787253,"about_ca_system_score_gemma":0.00085952075,"threshold_uncertainty_score":0.017794192},"labels":[],"label_agreement":null},{"id":"W3008711629","doi":"10.1016/j.msard.2020.102016","title":"Non-compliance with disease modifying therapies in patients with Multiple Sclerosis: A qualitative analysis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Disease; Cohort; Compliance (psychology); Adverse effect; Medical advice; Physical therapy; Internal medicine; Pediatrics; Psychiatry","score_opus":0.07107569053112676,"score_gpt":0.29799759777328194,"score_spread":0.22692190724215516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008711629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516594,0.0004718133,0.00047658,0.0018385109,0.000029878383,0.00021626665,0.0004462127,0.000004238501,0.0013505443],"genre_scores_gemma":[0.9971993,0.00032247807,0.00062647666,0.00084258843,0.000010104033,0.00039387742,0.00019614163,0.000008079835,0.00040092072],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9733901,0.020218631,0.0018699775,0.0008655276,0.0015744108,0.002081405],"domain_scores_gemma":[0.90411514,0.07828802,0.0073394617,0.00143657,0.005721855,0.0030989929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02738804,0.00031435525,0.00095105526,0.002337727,0.005623507,0.0033584358,0.0016218224,0.0013877214,0.0028277955],"category_scores_gemma":[0.07078135,0.00071485934,0.00089144433,0.0030315567,0.0036831133,0.0034965815,0.0050872024,0.0026568489,0.00016021],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018746256,0.00016498579,0.065851495,0.0005961163,0.00006919381,0.00023229656,0.92472607,0.000055360902,0.00029736382,0.0008029283,0.00052844937,0.0064883586],"study_design_scores_gemma":[0.00001857042,0.000106589345,0.024612218,0.00044866055,0.000024826397,0.000118778094,0.9722859,0.00011834482,0.00013581572,0.00027891822,0.001820646,0.000030705345],"about_ca_topic_score_codex":0.023433357,"about_ca_topic_score_gemma":0.039377194,"teacher_disagreement_score":0.02738804,"about_ca_system_score_codex":0.008810685,"about_ca_system_score_gemma":0.01236343,"threshold_uncertainty_score":0.14484352},"labels":[],"label_agreement":null},{"id":"W3009008098","doi":"10.1016/j.msard.2020.102028","title":"Predictors of hospitalization in a Canadian MS population: A matched cohort study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health; University of Saskatchewan","funders":"Saskatchewan Health Research Foundation","keywords":"Medicine; Comorbidity; Odds ratio; Population; Odds; Logistic regression; Cohort; Demography; Retrospective cohort study; Cohort study; Diagnosis code; Pediatrics; Internal medicine; Environmental health","score_opus":0.02436139598120182,"score_gpt":0.2527734395428892,"score_spread":0.2284120435616874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009008098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721634,0.000244323,0.00005192113,0.00015554036,0.00001774626,0.000029881612,0.001441261,0.0000063084026,0.0008366431],"genre_scores_gemma":[0.9978461,0.00031889346,0.00012628037,0.000093015056,0.000017337812,0.000022339926,0.001066959,0.0000055294195,0.00050357514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987501,0.00010477824,0.0000657208,0.0002731041,0.0002631373,0.00054314785],"domain_scores_gemma":[0.99817586,0.00010211423,0.00030676328,0.00013262237,0.00062117697,0.0006614577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008435762,0.00096524163,0.000866442,0.0022060175,0.0049576135,0.001990128,0.001954065,0.0013097634,0.002614399],"category_scores_gemma":[0.0022787286,0.0009749635,0.0013325397,0.0048666294,0.0010023783,0.0008834894,0.0011170347,0.0017834303,0.00036124428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028902656,0.00013991936,0.9966731,0.000011659517,0.00013009904,0.00022945338,0.00048421122,0.000050742314,0.00023009542,0.000071202645,0.00062570046,0.0010648773],"study_design_scores_gemma":[0.000022845572,0.000048347567,0.9981184,0.00000878475,0.00005707236,0.00012913959,0.0010579828,0.00018834877,0.00002253383,0.000024795205,0.0003050216,0.000016637761],"about_ca_topic_score_codex":0.96967196,"about_ca_topic_score_gemma":0.96989125,"teacher_disagreement_score":0.030328035,"about_ca_system_score_codex":0.014207559,"about_ca_system_score_gemma":0.017985199,"threshold_uncertainty_score":0.10308355},"labels":[],"label_agreement":null},{"id":"W3009562967","doi":"10.1016/j.msard.2020.102039","title":"Corticospinal inhibition and alexithymia in multiple sclerosis patients–An exploratory study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Biogen; Novartis","keywords":"Alexithymia; GABAergic; Toronto Alexithymia Scale; Multiple sclerosis; Transcranial magnetic stimulation; Neuropsychology; Medicine; Psychology; Neuroscience; Clinical psychology; Psychiatry; Stimulation; Cognition; Inhibitory postsynaptic potential","score_opus":0.04563936652360001,"score_gpt":0.23778593884008226,"score_spread":0.19214657231648224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009562967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994272,0.000108262495,0.000013280781,0.000007189035,0.0000013960232,0.000024760966,0.000024758298,6.540577e-7,0.0003925535],"genre_scores_gemma":[0.99942386,0.00010520902,0.000054817407,0.000021311043,0.000009718174,0.000031773507,0.0000931583,6.257425e-7,0.00025953702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996402,0.0001353065,0.000034475375,0.0000668106,0.000057500107,0.00006567632],"domain_scores_gemma":[0.9994357,0.0001743138,0.0001456956,0.000033620552,0.000046459587,0.00016415684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005241303,0.00078476575,0.00084206404,0.0009570732,0.0014441265,0.0007338253,0.00037061726,0.00071543123,0.0026089414],"category_scores_gemma":[0.0011104024,0.00038903955,0.0006613129,0.0008510152,0.00071924645,0.00056453637,0.00066634465,0.00060392806,0.00045178368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008020378,0.0074493643,0.96291554,0.00014294445,0.0004471155,0.003651552,0.002960788,0.00015307633,0.005013905,0.00013407033,0.00013198849,0.008979262],"study_design_scores_gemma":[0.00029906462,0.005957582,0.9896373,0.000010439217,0.00013982377,0.0017209029,0.0016146434,0.00012591506,0.00019579442,0.00006863971,0.00021173271,0.000018171486],"about_ca_topic_score_codex":0.004179576,"about_ca_topic_score_gemma":0.0048784073,"teacher_disagreement_score":0.004179576,"about_ca_system_score_codex":0.0005713636,"about_ca_system_score_gemma":0.000577158,"threshold_uncertainty_score":0.0087278485},"labels":[],"label_agreement":null},{"id":"W3010847380","doi":"10.1016/j.msard.2019.11.078","title":"Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Patients with Relapsing Multiple Sclerosis Over 48 Weeks: A Randomized, Placebo-Controlled, Phase 2 Study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of Toronto; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Gastroenterology; Internal medicine; Randomized controlled trial; Confidence interval; Adverse effect; Dimethyl fumarate; Multiple sclerosis; Immunology; Pathology","score_opus":0.017050431650200808,"score_gpt":0.2431664878634373,"score_spread":0.2261160562132365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010847380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926636,0.0042168684,0.00027426303,0.00028708685,0.00021284107,0.0008200478,0.00043324934,0.00006553976,0.0010264004],"genre_scores_gemma":[0.99330103,0.001849065,0.0005805709,0.0006523732,0.0003753153,0.0011453454,0.00064449094,0.000019746187,0.0014319753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992655,0.00033725266,0.000043380758,0.00014384974,0.00006461408,0.00014551931],"domain_scores_gemma":[0.99908745,0.00023346249,0.00021813686,0.000071473085,0.00006376437,0.0003257544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017576589,0.0019319179,0.0037556507,0.0005343902,0.00057871523,0.0011263046,0.00084117823,0.002196994,0.0041193455],"category_scores_gemma":[0.0014732582,0.0009219056,0.0018638863,0.0004448875,0.0013283753,0.0015242021,0.0003797578,0.003162595,0.0006945623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9677913,0.008340363,0.0010713891,0.0003866547,0.00090101094,0.000048812144,0.000053815933,0.00031425705,0.00443943,0.00005085874,0.0004040185,0.01619801],"study_design_scores_gemma":[0.8939353,0.09938384,0.004569621,0.000023648574,0.00054121,0.000046209996,0.000024801344,0.00032927806,0.0005632631,0.000100454934,0.00045981907,0.000022410442],"about_ca_topic_score_codex":0.0007054923,"about_ca_topic_score_gemma":0.0014411432,"teacher_disagreement_score":0.0041193455,"about_ca_system_score_codex":0.0007366872,"about_ca_system_score_gemma":0.0007341257,"threshold_uncertainty_score":0.013780534},"labels":[],"label_agreement":null},{"id":"W3010981054","doi":"10.1016/j.msard.2020.102053","title":"Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Ahvaz Jundishapur University of Medical Sciences","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Lower limb; Physical therapy; Surgery; Psychiatry","score_opus":0.03655006522001114,"score_gpt":0.27805290895111584,"score_spread":0.2415028437311047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010981054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942064,0.00006305996,0.000032151376,0.0000069730845,0.000003601973,0.0000040248074,0.00012565391,0.0000018329445,0.0003420569],"genre_scores_gemma":[0.999493,0.000026088723,0.000028341386,0.0000054296484,0.000004568923,0.0000042417655,0.00018200425,7.205182e-7,0.0002556833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998264,0.000024283152,0.000026182955,0.00005284424,0.00002633803,0.00004400169],"domain_scores_gemma":[0.99967384,0.00008228142,0.0000632908,0.00001403388,0.00006516916,0.00010137355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020167358,0.0003006043,0.0004172756,0.0011342339,0.00038018776,0.0004121236,0.00014819483,0.0003402903,0.0020172717],"category_scores_gemma":[0.00095455203,0.0001237751,0.0002745434,0.00052099576,0.00021548418,0.00027197876,0.00039350917,0.00020256103,0.00021388775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036646551,0.00029608796,0.9786162,0.00007428407,0.00026223337,0.00063655677,0.0012071319,0.00010206299,0.0055894163,0.000041597243,0.00016047212,0.0093492465],"study_design_scores_gemma":[0.000010034347,0.00023892266,0.99912506,0.0000015184023,0.000024308945,0.00015375437,0.00025827272,0.000061529594,0.00006633257,0.000015856904,0.000042505144,0.000001940124],"about_ca_topic_score_codex":0.009272139,"about_ca_topic_score_gemma":0.010671241,"teacher_disagreement_score":0.009272139,"about_ca_system_score_codex":0.00018740461,"about_ca_system_score_gemma":0.00014545575,"threshold_uncertainty_score":0.018436313},"labels":[],"label_agreement":null},{"id":"W3011079219","doi":"10.1016/j.msard.2019.11.051","title":"Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Neuromyelitis optica; Placebo; Internal medicine; Serostatus; Clinical endpoint; Hazard ratio; Gastroenterology; Multiple sclerosis; Confidence interval; Clinical trial; Immunology; Pathology; Viral load","score_opus":0.029854584990562663,"score_gpt":0.2756057949033446,"score_spread":0.24575120991278193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011079219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926086,0.0040730373,0.00028059058,0.0003062369,0.00024621942,0.00091396814,0.0004249141,0.00010501857,0.0010414005],"genre_scores_gemma":[0.9945557,0.0014821753,0.000590197,0.0004858496,0.00021467448,0.00091616414,0.00066897343,0.00001761275,0.0010686087],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99959975,0.0001685701,0.000039553237,0.00007858932,0.000030239504,0.000083334926],"domain_scores_gemma":[0.9994186,0.00013099924,0.00010992146,0.000046287245,0.000052232583,0.00024202274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012673065,0.0013299007,0.0030303723,0.00044250776,0.0004827427,0.0008078842,0.00084804074,0.0013818245,0.0035052036],"category_scores_gemma":[0.00088372856,0.00054068526,0.001869566,0.0003061234,0.00088294875,0.000838118,0.00031432556,0.0025737176,0.0008052721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95532024,0.0072826366,0.001224096,0.00052438985,0.0008740389,0.000060020328,0.00007935198,0.00027960815,0.010208216,0.000053103056,0.00062659156,0.02346763],"study_design_scores_gemma":[0.783062,0.20574524,0.007711724,0.000032683743,0.00071232225,0.00006975684,0.00005758286,0.00044364002,0.0013804665,0.00008405851,0.0006763793,0.00002412544],"about_ca_topic_score_codex":0.00083280326,"about_ca_topic_score_gemma":0.0018878236,"teacher_disagreement_score":0.0035052036,"about_ca_system_score_codex":0.0005527676,"about_ca_system_score_gemma":0.0010645575,"threshold_uncertainty_score":0.011726081},"labels":[],"label_agreement":null},{"id":"W3011509562","doi":"10.1016/j.msard.2019.11.013","title":"Motor Skill Acquisition Through Virtual Reality in People with Multiple Sclerosis: The Impact of Cognitive Function and Related Biomarkers","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Multiple sclerosis; Neurorehabilitation; Dreyfus model of skill acquisition; Physical medicine and rehabilitation; Montreal Cognitive Assessment; Virtual reality; Medicine; Motor skill; Rehabilitation; Psychology; Physical therapy; Neuroscience; Cognitive impairment; Computer science; Psychiatry; Artificial intelligence","score_opus":0.03593337758143836,"score_gpt":0.27321952247038317,"score_spread":0.2372861448889448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011509562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871564,0.00050587626,0.000060833583,0.0000274951,0.0000036014374,0.0000071986547,0.00005601773,0.0000026090504,0.00062087254],"genre_scores_gemma":[0.9994179,0.00021229526,0.00006612189,0.000013754639,0.000004492927,0.000006042471,0.000051066683,7.1697525e-7,0.00022751924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996125,0.00014254884,0.000036243837,0.000061093415,0.00007430911,0.00007333966],"domain_scores_gemma":[0.99912137,0.00029550432,0.0002736588,0.000051604373,0.00012467023,0.00013316933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057183515,0.00053408876,0.0006388729,0.0005867662,0.00036667136,0.0012238025,0.0002697182,0.0006221727,0.0016677903],"category_scores_gemma":[0.003017707,0.00017980688,0.0004952672,0.0005141253,0.0002556842,0.0008272869,0.00073412043,0.0005226939,0.0002260558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003991774,0.001965313,0.9421393,0.0004071227,0.0009632225,0.0005076198,0.0016598001,0.0007342731,0.0025051157,0.00011288227,0.0002464743,0.044766966],"study_design_scores_gemma":[0.000025319781,0.001496732,0.99628544,0.00003053103,0.00020257285,0.00021695782,0.00064746133,0.0005028321,0.0002654633,0.00013038075,0.0001800686,0.000016144824],"about_ca_topic_score_codex":0.006525333,"about_ca_topic_score_gemma":0.0066659497,"teacher_disagreement_score":0.006525333,"about_ca_system_score_codex":0.00023940661,"about_ca_system_score_gemma":0.00022979749,"threshold_uncertainty_score":0.012974739},"labels":[],"label_agreement":null},{"id":"W3011573122","doi":"10.1016/j.msard.2019.11.060","title":"Efficacy of a Fourth Alemtuzumab Course in RRMS Patients from CARE-MS II Who Experienced Disease Activity After Three Prior Courses","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Relapsing remitting; Physical therapy; Surgery; Immunology","score_opus":0.019191281974147045,"score_gpt":0.24445241318072583,"score_spread":0.22526113120657879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011573122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998906,0.00045197003,0.000026746857,0.000092288145,0.00003112324,0.000034338176,0.000045044442,0.0000059364065,0.00040657312],"genre_scores_gemma":[0.9993297,0.00008592162,0.000032589283,0.000088068475,0.000037829042,0.000025751966,0.00013214898,9.4517117e-7,0.00026692916],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996499,0.00008791323,0.000025423295,0.00006248433,0.00003667765,0.00013759991],"domain_scores_gemma":[0.9988771,0.0002499252,0.00017620392,0.00008188142,0.000056091052,0.0005587261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076259795,0.00036023013,0.0011614376,0.0002548008,0.00047997595,0.0006258484,0.00040306462,0.00084028865,0.0012591016],"category_scores_gemma":[0.001853398,0.00012809696,0.0010550859,0.00015047412,0.0003559878,0.00043128745,0.0002875641,0.0015138672,0.00023185767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69769764,0.018274443,0.1322988,0.00019981335,0.0011263199,0.00089840405,0.0005238898,0.0028754813,0.014030549,0.00021748482,0.0014239212,0.13043326],"study_design_scores_gemma":[0.05184262,0.3512916,0.5841366,0.00011074924,0.0015257328,0.0006826718,0.00031945307,0.0027994171,0.004500313,0.00025727806,0.002461241,0.000072330164],"about_ca_topic_score_codex":0.0019086873,"about_ca_topic_score_gemma":0.0020380565,"teacher_disagreement_score":0.0019086873,"about_ca_system_score_codex":0.0007079236,"about_ca_system_score_gemma":0.00069312507,"threshold_uncertainty_score":0.0051363707},"labels":[],"label_agreement":null},{"id":"W3012117463","doi":"10.1016/j.msard.2019.11.072","title":"Efficacy of Subcutaneous Interferon Β-1a in Patients with a First Clinical Demyelinating Event in REFLEX is Maintained After Application of the 2017 McDonald Criteria","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; McDonald criteria; Placebo; Internal medicine; Multiple sclerosis; Hazard ratio; Population; Gastroenterology; Confidence interval; Pathology; Immunology","score_opus":0.03302231902226241,"score_gpt":0.30542888989398465,"score_spread":0.27240657087172226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012117463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349594,0.004739213,0.00006881416,0.0001622042,0.000062881794,0.000035903122,0.000062812396,0.000010269871,0.001361963],"genre_scores_gemma":[0.99869376,0.0007067646,0.00010142466,0.00012461843,0.000051134422,0.000015333277,0.000117939446,0.0000018780426,0.00018702983],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996493,0.00014119162,0.000056835004,0.000043143795,0.000045744666,0.00006375364],"domain_scores_gemma":[0.99892247,0.00043193257,0.00030064982,0.00007099095,0.00007856372,0.00019534405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011861331,0.00023377445,0.0009103436,0.0002470453,0.00023493839,0.00039439794,0.00021954271,0.00040801396,0.0011206334],"category_scores_gemma":[0.0022181694,0.00011013137,0.0005673395,0.00025994817,0.00021409607,0.00038090517,0.00013847467,0.00057964347,0.00023694253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3070553,0.008581321,0.31863558,0.0012467337,0.0021714983,0.0013347124,0.00044732195,0.0006792685,0.02863714,0.0003024488,0.0017440792,0.32916477],"study_design_scores_gemma":[0.024852052,0.09240872,0.87081385,0.00041836264,0.001463786,0.0020491465,0.00029429115,0.0008729069,0.0037609304,0.00030391559,0.0027232608,0.00003874552],"about_ca_topic_score_codex":0.00065886095,"about_ca_topic_score_gemma":0.00095592457,"teacher_disagreement_score":0.0011861331,"about_ca_system_score_codex":0.00030734402,"about_ca_system_score_gemma":0.00046105747,"threshold_uncertainty_score":0.0062729716},"labels":[],"label_agreement":null},{"id":"W3021383321","doi":"10.1016/j.msard.2012.10.004","title":"Book review","year":2012,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.040784689367329145,"score_gpt":0.28791073046248217,"score_spread":0.24712604109515302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021383321","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003697681,0.15158795,0.0017687093,0.055885658,0.15912357,0.00017301436,0.0009514311,0.00067106326,0.6294688],"genre_scores_gemma":[0.00086839526,0.033340424,0.0005150705,0.013396575,0.023212163,0.0000616564,0.00038925363,0.00017468419,0.9280418],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993395,0.000076941695,0.000021968825,0.00006740454,0.00043594226,0.000058313297],"domain_scores_gemma":[0.99780446,0.00045913376,0.00010382927,0.00014161385,0.0010305449,0.0004604183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007470844,0.0008004096,0.0008294884,0.0027451015,0.0010755479,0.003533471,0.0012517346,0.0023046394,0.29225364],"category_scores_gemma":[0.004507086,0.00038200538,0.0004990877,0.0021705632,0.0006380368,0.0021575985,0.0016997261,0.0029057774,0.2481909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003788887,0.000005326931,0.000015448173,0.00004892831,0.0000010810022,0.000019518116,0.0000059507993,0.000015625963,0.000025206798,0.0007383154,0.96760625,0.03151454],"study_design_scores_gemma":[0.0000022148474,0.000003030382,0.00004154172,0.000070867376,0.0000012191533,0.00005243874,0.000009019619,0.000006621684,0.000012442269,0.00042286346,0.9993761,0.0000015726782],"about_ca_topic_score_codex":0.0029055441,"about_ca_topic_score_gemma":0.009034873,"teacher_disagreement_score":0.29225364,"about_ca_system_score_codex":0.0015063243,"about_ca_system_score_gemma":0.002342401,"threshold_uncertainty_score":0.9776858},"labels":[],"label_agreement":null},{"id":"W3021487116","doi":"10.1016/j.msard.2020.102075","title":"Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Genzyme; Novartis Pharmaceuticals Canada; Teva Pharmaceutical Industries; Roche; Merck; Bayer","keywords":"Multiple sclerosis; Medicine; Encephalitis; Pathophysiology; Anti-NMDA receptor encephalitis; Autoimmune encephalitis; NMDA receptor; Disease; Relapsing remitting; Immunology; Neuroscience; Pediatrics; Receptor; Pathology; Internal medicine; Psychology; Virus","score_opus":0.050210539531408645,"score_gpt":0.2862886915107945,"score_spread":0.23607815197938586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021487116","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014474734,0.9971132,0.0001214507,0.00021551922,0.000117514064,0.000006769255,0.000045936078,0.0000079432775,0.0009241042],"genre_scores_gemma":[0.007201234,0.9911543,0.0004722261,0.0004210505,0.00032962655,0.00000584542,0.00008160199,0.0000025888603,0.00033154752],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99967813,0.000043391883,0.00012359487,0.000060169306,0.00006608627,0.000028558172],"domain_scores_gemma":[0.9993563,0.0003462052,0.0001854099,0.000015847225,0.00005720438,0.000039019113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033320347,0.0008505936,0.0014224504,0.0045926645,0.00042624056,0.0013437971,0.0010142458,0.0013431329,0.003101647],"category_scores_gemma":[0.0011382657,0.00033505837,0.00068035786,0.0040716436,0.0006195874,0.0019974757,0.0007394415,0.0008792593,0.0008823949],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027296916,0.00018446728,0.008366717,0.077924185,0.0008562787,0.16997425,0.00078433286,0.0005538303,0.005796326,0.0020294527,0.032440208,0.700817],"study_design_scores_gemma":[0.000046393525,0.0001360656,0.012208632,0.022390638,0.002054221,0.5875362,0.0012550604,0.00020683934,0.0010105026,0.0017398278,0.37130103,0.000114615024],"about_ca_topic_score_codex":0.0014447456,"about_ca_topic_score_gemma":0.003222789,"teacher_disagreement_score":0.0045926645,"about_ca_system_score_codex":0.0004295529,"about_ca_system_score_gemma":0.0011696356,"threshold_uncertainty_score":0.010376036},"labels":[],"label_agreement":null},{"id":"W3022456477","doi":"10.1016/j.msard.2020.102086","title":"Alemtuzumab and prescription medication use in the MS population","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Marshall-Smith Syndroom Research Foundation; Multiple Sclerosis International Federation; Stichting MS Research; American Academy of Neurology; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Canada Foundation for Innovation; National Multiple Sclerosis Society","keywords":"Alemtuzumab; Medicine; Medical prescription; Polypharmacy; Multiple sclerosis; Population; Drug; Adverse effect; Pediatrics; Internal medicine; Psychiatry; Pharmacology; Environmental health","score_opus":0.06380809541472414,"score_gpt":0.2727158265422622,"score_spread":0.20890773112753802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022456477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977119,0.0014548025,0.000022447988,0.000099266064,0.000007958939,0.0000021591757,0.00022829464,0.0000022660358,0.00047083417],"genre_scores_gemma":[0.99921083,0.00044778353,0.0000141906185,0.000045880104,0.000021134245,0.000003572221,0.00010531377,0.000001198793,0.0001501742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992254,0.0003688505,0.00009560459,0.00011530686,0.00010371092,0.00009109231],"domain_scores_gemma":[0.9983032,0.00051966787,0.00078126416,0.00011249598,0.000100651276,0.00018273348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074431865,0.00016940024,0.00041632616,0.0008687281,0.00031631626,0.00095617917,0.0002439484,0.0005397409,0.0011710542],"category_scores_gemma":[0.0043908,0.00022259138,0.00059550384,0.0014954659,0.00023300985,0.0005127652,0.00032574375,0.0005678777,0.00015836372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044857097,0.000070647955,0.9969139,0.000021492948,0.00028095508,0.000110867586,0.00010228192,0.000023168981,0.00021142536,0.00002900974,0.00010017809,0.0016874266],"study_design_scores_gemma":[0.0000146215125,0.00011793883,0.9988029,0.000011315948,0.00013445925,0.00028898666,0.00022320685,0.000084211715,0.000054693817,0.00002698724,0.0002367242,0.000003938526],"about_ca_topic_score_codex":0.006413777,"about_ca_topic_score_gemma":0.0049462253,"teacher_disagreement_score":0.006413777,"about_ca_system_score_codex":0.00029153124,"about_ca_system_score_gemma":0.0003269163,"threshold_uncertainty_score":0.012752891},"labels":[],"label_agreement":null},{"id":"W3023209915","doi":"10.1016/j.msard.2020.102146","title":"Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Bayer HealthCare; Sanofi","keywords":"Alemtuzumab; Medicine; Pregnancy; Multiple sclerosis; Pediatrics; Obstetrics; Internal medicine; Gynecology; Immunology","score_opus":0.032012514851661844,"score_gpt":0.3002381336431129,"score_spread":0.26822561879145107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023209915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985328,0.00059680827,0.00002801553,0.00011180997,0.0000074665018,0.0000058540054,0.00023013551,0.000002379413,0.00048471027],"genre_scores_gemma":[0.99907553,0.00036082216,0.000026778198,0.000046160196,0.000007258359,0.0000086206655,0.00018873664,0.0000015700086,0.0002844242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995628,0.00012261902,0.000050583436,0.00006322285,0.000068803514,0.00013194402],"domain_scores_gemma":[0.99850214,0.0003364857,0.00080123194,0.000049832317,0.00009853135,0.00021180803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009928979,0.00016015548,0.00028468293,0.0005770169,0.00035470052,0.00066503685,0.00026491794,0.0004820964,0.0010697243],"category_scores_gemma":[0.0047091166,0.00018569312,0.0004941961,0.0008112167,0.00022170685,0.0006041739,0.00049614,0.0009276483,0.0001517833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010911452,0.00012658502,0.99185044,0.000015205308,0.00007866793,0.00016440458,0.00024347342,0.00007871686,0.000115420735,0.000033993718,0.00012162304,0.006080216],"study_design_scores_gemma":[0.000018570265,0.00040653517,0.9981828,0.00002379794,0.00007605804,0.00032856176,0.00043732516,0.00019066888,0.00007327374,0.00003726807,0.0002185894,0.0000065794343],"about_ca_topic_score_codex":0.008599157,"about_ca_topic_score_gemma":0.0064316816,"teacher_disagreement_score":0.008599157,"about_ca_system_score_codex":0.0004906027,"about_ca_system_score_gemma":0.00057529175,"threshold_uncertainty_score":0.017098248},"labels":[],"label_agreement":null},{"id":"W3023765813","doi":"10.1016/j.msard.2020.102078","title":"From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Hemiparesis; Lesion; Magnetic resonance imaging; Radiology; Pediatrics; Surgery; Psychiatry","score_opus":0.04924135507317509,"score_gpt":0.24627939858889356,"score_spread":0.19703804351571846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023765813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963284,0.0007034203,0.00014491183,0.00025616135,0.000081797756,0.000044530512,0.00007416981,0.000007811619,0.0023586326],"genre_scores_gemma":[0.9980692,0.0003611546,0.00012959243,0.00030188754,0.00015635155,0.000024194745,0.00015884009,0.000007705601,0.0007910502],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9994475,0.00005927903,0.00007023746,0.00012934057,0.00009179091,0.00020175571],"domain_scores_gemma":[0.99918634,0.00014778679,0.00017424104,0.000050509538,0.0000886039,0.0003525208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027641025,0.0009604229,0.00087276037,0.0016415392,0.0038239334,0.0010702193,0.00059085374,0.0014142912,0.0026378767],"category_scores_gemma":[0.0018757202,0.0006198909,0.00066154264,0.0011937454,0.001004882,0.0009844946,0.0011626795,0.0015455642,0.0006719256],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005171824,0.0012012129,0.64543056,0.00005487176,0.00006590988,0.34190634,0.0023260815,0.00006517171,0.001664153,0.00023833933,0.00071094505,0.0058192895],"study_design_scores_gemma":[0.000147598,0.0010221105,0.39922634,0.0000664139,0.00011524272,0.59012216,0.0054948595,0.00020083015,0.00067080464,0.00037051004,0.002490607,0.00007253975],"about_ca_topic_score_codex":0.0028330064,"about_ca_topic_score_gemma":0.002833854,"teacher_disagreement_score":0.0038239334,"about_ca_system_score_codex":0.0007160304,"about_ca_system_score_gemma":0.0008236525,"threshold_uncertainty_score":0.008824527},"labels":[],"label_agreement":null},{"id":"W3025106536","doi":"10.1016/j.msard.2020.102158","title":"Teriflunomide vs injectable disease modifying therapies for relapsing forms of MS","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Actelion Pharmaceuticals; Genentech; Bayer Schering; IC Design Education Center; Alkermes; Alexion Pharmaceuticals; Genzyme; Biogen Idec; Patient-Centered Outcomes Research Institute; Celgene; Bayer; Biogen; Bayer HealthCare; Sanofi; Almirall; MedDay Pharmaceuticals; Merck; National Institute of Neurological Disorders and Stroke; Teva Pharmaceutical Industries; EMD Serono; Novartis; Roche; Pfizer","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Tolerability; Adverse effect; Disease; Fingolimod; Intensive care medicine; Natalizumab; Internal medicine; Immunology","score_opus":0.0781052675865193,"score_gpt":0.3177968576131146,"score_spread":0.2396915900265953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025106536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000078093624,0.99971443,0.000014782562,0.000031785803,0.000040566403,0.000003831894,0.000011093294,0.0000014631053,0.000103935294],"genre_scores_gemma":[0.001250901,0.99837744,0.000082633516,0.00011489433,0.000053171934,0.0000071110835,0.000019752955,7.3550945e-7,0.000093271155],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99971956,0.00007572778,0.00007404852,0.000041107003,0.00006631649,0.0000232984],"domain_scores_gemma":[0.99936634,0.00043392193,0.00012852666,0.00000883358,0.00004206933,0.00002030498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009777527,0.0008183553,0.003140642,0.0025140545,0.00018134977,0.0009435181,0.0009640892,0.0009841134,0.0048388704],"category_scores_gemma":[0.0015158658,0.00029487838,0.0015739608,0.0022819638,0.0003435277,0.00088057277,0.00054154865,0.0012393078,0.0005046726],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008633353,0.00007907404,0.00024039239,0.19373153,0.002123363,0.00015915476,0.00007763355,0.00024478027,0.0010483514,0.0012165097,0.010417412,0.7897985],"study_design_scores_gemma":[0.0026254964,0.0015456637,0.0065650903,0.21091627,0.031266615,0.002772585,0.00037660508,0.0004325858,0.0013793315,0.0033079623,0.73869926,0.0001125265],"about_ca_topic_score_codex":0.0020502156,"about_ca_topic_score_gemma":0.0043066386,"teacher_disagreement_score":0.0048388704,"about_ca_system_score_codex":0.00058912346,"about_ca_system_score_gemma":0.0009081829,"threshold_uncertainty_score":0.016187668},"labels":[],"label_agreement":null},{"id":"W3033837102","doi":"10.1016/j.msard.2020.102260","title":"Epidemiology of pediatric multiple sclerosis: A systematic literature review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epidemiology; MEDLINE; Meta-analysis; Systematic review; Incidence (geometry); Disease; Data extraction; Multiple sclerosis; Pediatrics; Pathology; Immunology","score_opus":0.1753109828645792,"score_gpt":0.35202856237591224,"score_spread":0.17671757951133304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033837102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030922587,0.99590474,0.00029008483,0.00007924414,0.00007023488,0.00012683627,0.00033123326,0.0000106021525,0.000094859286],"genre_scores_gemma":[0.06900955,0.9275583,0.0017243252,0.0004991525,0.00012962408,0.00043242404,0.0004640244,0.000016022372,0.00016662467],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99208707,0.0027025323,0.0030827222,0.00093898945,0.00085873646,0.00032998773],"domain_scores_gemma":[0.9851055,0.0103623485,0.0028448778,0.00047868496,0.0010165824,0.00019198823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009698757,0.0025383015,0.01592276,0.008011122,0.00064975367,0.003226983,0.0022079875,0.0024428533,0.004476809],"category_scores_gemma":[0.02408816,0.0017881365,0.025516449,0.0106017385,0.00071424304,0.0025473163,0.0022242037,0.0017900731,0.00038733432],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009648848,0.000040034916,0.0076186024,0.58198446,0.39358702,0.00021926606,0.0001491448,0.0003297546,0.00020922435,0.00013712647,0.0006725249,0.014087932],"study_design_scores_gemma":[0.00041229287,0.00013050699,0.007463012,0.05105016,0.93825316,0.00019892729,0.00012979774,0.00011707969,0.00008154452,0.00016022808,0.0019670753,0.00003626095],"about_ca_topic_score_codex":0.006957009,"about_ca_topic_score_gemma":0.022985078,"teacher_disagreement_score":0.01592276,"about_ca_system_score_codex":0.0022090382,"about_ca_system_score_gemma":0.004431613,"threshold_uncertainty_score":0.0512926},"labels":[],"label_agreement":null},{"id":"W3034107318","doi":"10.1016/j.msard.2020.102276","title":"Characteristics of COVID-19 disease in multiple sclerosis patients","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Immunosuppression; Disease; Coronavirus disease 2019 (COVID-19); Pandemic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.057502380615398065,"score_gpt":0.2742256895401938,"score_spread":0.21672330892479572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034107318","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812305,0.0011846111,0.00012880044,0.0052190386,0.00013792874,0.00004368408,0.0010472097,0.000019132323,0.0109891435],"genre_scores_gemma":[0.9945748,0.0004917968,0.00011507532,0.0024101576,0.00044992453,0.00004387279,0.0007514889,0.000009345778,0.0011534528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929786,0.00014929687,0.00012136767,0.00008218007,0.00012484993,0.0002243778],"domain_scores_gemma":[0.99700433,0.0007577805,0.00075840007,0.00011081865,0.00034088094,0.0010277674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044247424,0.00030610646,0.00068778923,0.0011674355,0.0010528113,0.00095353305,0.00040209576,0.0016716596,0.0036943126],"category_scores_gemma":[0.004016261,0.00024718218,0.00042874392,0.0020924879,0.00037990246,0.00079370337,0.00037756827,0.0012732223,0.00078448467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004294159,0.00010449415,0.98466796,0.000022605494,0.00003054565,0.0084741395,0.00029886488,0.0000732497,0.00059687847,0.00014167861,0.0023963747,0.00276386],"study_design_scores_gemma":[0.00003523897,0.00027282984,0.97115684,0.00004122038,0.000035850953,0.024198746,0.0008756274,0.00030577413,0.0001128695,0.00027899287,0.0026613767,0.000024683957],"about_ca_topic_score_codex":0.0039954023,"about_ca_topic_score_gemma":0.0036652563,"teacher_disagreement_score":0.0039954023,"about_ca_system_score_codex":0.0006616032,"about_ca_system_score_gemma":0.00064761244,"threshold_uncertainty_score":0.012358725},"labels":[],"label_agreement":null},{"id":"W3035682087","doi":"10.1016/j.msard.2020.102283","title":"FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis With Seizures (FLAMES): Is immunotherapy always needed to put out the fire?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Fluid-attenuated inversion recovery; Medicine; Immunotherapy; Encephalitis; Hyperintensity; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Pathology; Immunology; Magnetic resonance imaging; Radiology; Immune system","score_opus":0.02941443017098383,"score_gpt":0.23175377045992404,"score_spread":0.2023393402889402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035682087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8823431,0.03852303,0.0026010917,0.036029816,0.00087682257,0.00014182186,0.00016798596,0.00019774753,0.039118536],"genre_scores_gemma":[0.9845781,0.0065464955,0.0010402587,0.005348582,0.001233379,0.000011741132,0.00007239841,0.000015712958,0.001153405],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9997423,0.000043200514,0.00004206517,0.000031624804,0.000044457352,0.0000962795],"domain_scores_gemma":[0.99922216,0.0002702988,0.0002326786,0.000037331363,0.00009595623,0.00014155387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081895606,0.0007232716,0.00062430964,0.00076955033,0.0005103873,0.00064778375,0.0005601499,0.0023625956,0.0016219598],"category_scores_gemma":[0.002686121,0.00025753505,0.00036026686,0.00043647707,0.001165022,0.0019815103,0.00036238742,0.0013140242,0.0005221845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002912553,0.0003375165,0.14613278,0.0006579558,0.00030287722,0.68141574,0.0006061147,0.00062207325,0.011498523,0.0026414802,0.015633732,0.13723864],"study_design_scores_gemma":[0.00029611128,0.0007831216,0.11786387,0.00068505487,0.00034934384,0.848694,0.0018695729,0.001877165,0.004373429,0.007151768,0.015962204,0.000094220886],"about_ca_topic_score_codex":0.0024161339,"about_ca_topic_score_gemma":0.0030771508,"teacher_disagreement_score":0.0024161339,"about_ca_system_score_codex":0.0005640061,"about_ca_system_score_gemma":0.00049436354,"threshold_uncertainty_score":0.0054259896},"labels":[],"label_agreement":null},{"id":"W3039192476","doi":"10.1016/j.msard.2020.102354","title":"Therapeutic status quo in patients with relapsing-remitting multiple sclerosis: A sign of poor self-perception of their clinical status?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Universität Zürich","keywords":"Multiple sclerosis; Medicine; Relapsing remitting; Status quo; Perception; Expanded Disability Status Scale; Sign (mathematics); Psychiatry; Psychology; Neuroscience","score_opus":0.053129104798496175,"score_gpt":0.2769729555080532,"score_spread":0.223843850709557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039192476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990876,0.00034021927,0.00004167299,0.00015780829,0.000005053439,0.0000047070316,0.000029639905,0.0000012819913,0.0003320188],"genre_scores_gemma":[0.9998412,0.000046853027,0.00003444599,0.00003076106,0.000005728262,0.0000023272175,0.000017130827,2.9903146e-7,0.00002119573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985469,0.0006830802,0.00014897228,0.00013623599,0.00037437363,0.00011045128],"domain_scores_gemma":[0.9863517,0.0030615774,0.008966597,0.0002307812,0.0005118701,0.00087745034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025596018,0.00018085747,0.0003239407,0.00064078916,0.00041866978,0.00081338175,0.0002470922,0.00056873524,0.0012168788],"category_scores_gemma":[0.014389563,0.00011903129,0.00034332226,0.0005586937,0.00082606403,0.00059104525,0.0005506877,0.00074649794,0.0001652278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021594015,0.00006794152,0.9955844,0.00003365788,0.000056352797,0.00007372282,0.0005008435,0.000053505755,0.00013552321,0.00002270813,0.00008051092,0.0031749655],"study_design_scores_gemma":[0.000022974258,0.000531896,0.99656796,0.00004073654,0.00004033604,0.000533037,0.00127795,0.00048491845,0.00008764838,0.00016032324,0.00023861614,0.00001353594],"about_ca_topic_score_codex":0.0010770161,"about_ca_topic_score_gemma":0.0011630025,"teacher_disagreement_score":0.0025596018,"about_ca_system_score_codex":0.00039348987,"about_ca_system_score_gemma":0.00035985993,"threshold_uncertainty_score":0.013536632},"labels":[],"label_agreement":null},{"id":"W3042093824","doi":"10.1016/j.msard.2020.102382","title":"Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Company; Life Sciences Institute; Novartis Pharmaceuticals Canada; Eisai; Asahi Kasei Pharma Corporation; Genzyme; Takeda Pharmaceutical Company; Novartis; Teva Pharmaceutical Industries; Bayer; Biogen; Astellas Pharma; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation","keywords":"Medicine; Multiple sclerosis; Intrathecal; Immunology; Pediatrics; Anesthesia","score_opus":0.04270201954177836,"score_gpt":0.25925508698195204,"score_spread":0.2165530674401737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042093824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805176,0.0010219945,0.00001675778,0.00006141878,0.000008291275,0.00000473946,0.000046232053,0.0000016071484,0.0007872896],"genre_scores_gemma":[0.9996057,0.00015262266,0.00001484856,0.0000237397,0.000010289838,0.0000024941007,0.000043567034,3.929956e-7,0.00014639959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964297,0.00017272592,0.000027218377,0.000038892787,0.0000546141,0.00006366866],"domain_scores_gemma":[0.99884486,0.00042023702,0.0003776347,0.000050306364,0.00012912137,0.00017791071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051987416,0.00023185082,0.0003108629,0.0003305218,0.00032998627,0.0005115133,0.0001459537,0.0004255788,0.0010092306],"category_scores_gemma":[0.0025657217,0.0000919084,0.00032137436,0.0003239231,0.00028811296,0.00031364665,0.00028443712,0.00043917948,0.00012390393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0114115225,0.0008652153,0.9634808,0.00013623285,0.00057580334,0.00047916934,0.00028017352,0.0001919997,0.002956685,0.000043135606,0.0002113534,0.019368017],"study_design_scores_gemma":[0.00009395717,0.0017223611,0.9970036,0.000013996661,0.0001766748,0.00022722324,0.0001671891,0.0000791564,0.00032871836,0.000028169039,0.00015244777,0.000006402323],"about_ca_topic_score_codex":0.003952151,"about_ca_topic_score_gemma":0.0036491875,"teacher_disagreement_score":0.003952151,"about_ca_system_score_codex":0.0004524653,"about_ca_system_score_gemma":0.00043591057,"threshold_uncertainty_score":0.007858276},"labels":[],"label_agreement":null},{"id":"W3042866786","doi":"10.1016/j.msard.2020.102401","title":"The effects of high-dose corticosteroids for multiple sclerosis relapse on blood pressure: A pilot study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"AbbVie; Sanofi Genzyme; Biogen Idec; Roche; Novartis","keywords":"Medicine; Family history; Blood pressure; Multiple sclerosis; Corticosteroid; Internal medicine; Immunology","score_opus":0.04704076254261353,"score_gpt":0.26115315599435457,"score_spread":0.21411239345174105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042866786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889815,0.00037167256,0.00003904167,0.00005444703,0.000024746938,0.00027669925,0.000058984348,0.0000056095305,0.00027069476],"genre_scores_gemma":[0.99795604,0.0005531453,0.0002365589,0.0001681389,0.00020309197,0.0003722075,0.00014255916,0.0000040787386,0.00036414937],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984535,0.0009493831,0.000093911105,0.00012345325,0.00015613099,0.00022362085],"domain_scores_gemma":[0.9964644,0.0015917264,0.00027022714,0.00033309433,0.00018584507,0.0011546169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029111884,0.0008699259,0.0020978246,0.00054730475,0.0010358129,0.0006312407,0.0007614274,0.0014495717,0.0021149404],"category_scores_gemma":[0.003103172,0.00036735254,0.0015718567,0.0006217014,0.0012801393,0.0007265977,0.0005165346,0.0019785273,0.00033064254],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6946672,0.19206515,0.02766037,0.00067169464,0.0010998895,0.0011443014,0.001053475,0.00040312458,0.03265992,0.00011995973,0.00051388337,0.04794107],"study_design_scores_gemma":[0.07667646,0.8390843,0.08039439,0.00002793528,0.0006423743,0.0001946196,0.00027244282,0.00020658156,0.0020240906,0.000050127182,0.00039704857,0.000029584684],"about_ca_topic_score_codex":0.0035416165,"about_ca_topic_score_gemma":0.003785357,"teacher_disagreement_score":0.0035416165,"about_ca_system_score_codex":0.0005280932,"about_ca_system_score_gemma":0.0014703458,"threshold_uncertainty_score":0.015396059},"labels":[],"label_agreement":null},{"id":"W3044867607","doi":"10.1016/j.msard.2020.102418","title":"Functioning Profiles of Young People with MS in Inpatient Rehabilitation: Data from the National Rehabilitation Reporting System in Canada","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rehabilitation; Functional Independence Measure; Medicine; Latent class model; Logistic regression; Young adult; Gerontology; Barthel index; Physical therapy; Physical medicine and rehabilitation","score_opus":0.029642577909029598,"score_gpt":0.22631381648668542,"score_spread":0.1966712385776558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044867607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788862,0.0008776983,0.000070752634,0.000300982,0.000013193842,0.000051360905,0.017838966,0.000012946673,0.0019479647],"genre_scores_gemma":[0.99112564,0.00070599304,0.0001078041,0.00012719496,0.0000054605134,0.000028515353,0.007247364,0.000005298809,0.0006467136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982717,0.0001465697,0.0003045533,0.00017290814,0.00053056976,0.0005737664],"domain_scores_gemma":[0.995849,0.00021225595,0.0009250223,0.00007593827,0.0021161193,0.0008217163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097035454,0.00034935414,0.0007580251,0.0027941335,0.0018066955,0.0014943314,0.0012432637,0.0005826487,0.0013895709],"category_scores_gemma":[0.0041136607,0.00036365175,0.0011185549,0.0080661075,0.0005345359,0.00073133956,0.0013201287,0.00064921885,0.00030291043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024675965,0.0000123046875,0.99802727,0.000026103686,0.00003329945,0.000032757067,0.00030602512,0.0000506177,0.000035302994,0.00003244127,0.00047329106,0.0009459373],"study_design_scores_gemma":[0.0000018685853,0.000008204958,0.99899036,0.000018443192,0.000010213886,0.000026819436,0.0006404695,0.000081777776,0.000014572771,0.0000066317584,0.00019669041,0.000003854682],"about_ca_topic_score_codex":0.9878974,"about_ca_topic_score_gemma":0.9919835,"teacher_disagreement_score":0.01779076,"about_ca_system_score_codex":0.01779076,"about_ca_system_score_gemma":0.02141708,"threshold_uncertainty_score":0.1290816},"labels":[],"label_agreement":null},{"id":"W3045561006","doi":"10.1016/j.msard.2020.102429","title":"African Americans experience disproportionate neurodegenerative changes in the medulla and upper cervical spinal cord in early multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Spinal cord; Medulla; Multiple sclerosis; White matter; Expanded Disability Status Scale; Atrophy; Cord; Anatomy; Dorsum; Internal medicine; Pathology; Magnetic resonance imaging; Surgery; Radiology","score_opus":0.07829156025219836,"score_gpt":0.2939585029981723,"score_spread":0.21566694274597392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045561006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881834,0.00027945012,0.000015815267,0.00005852506,0.0000041686103,0.0000018910146,0.00003850684,4.774704e-7,0.0007828689],"genre_scores_gemma":[0.99937063,0.00022583189,0.000030109364,0.000039973653,0.0000120901395,0.0000017667436,0.000030001276,7.595591e-7,0.00028885106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997819,0.000059485716,0.000015422718,0.00003780944,0.00004093235,0.00006456159],"domain_scores_gemma":[0.99937856,0.00010742398,0.0003241202,0.00002433511,0.00008589944,0.00007961138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444709,0.00017880772,0.00020585072,0.0009930999,0.0007264079,0.0005334965,0.00014823131,0.0003951278,0.0026506092],"category_scores_gemma":[0.0016229491,0.00012684525,0.0001326753,0.0009942581,0.0002571751,0.000564735,0.00034960156,0.00037442974,0.00018526602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017854647,0.00008028088,0.9928619,0.000017435765,0.000032711236,0.00049939746,0.0007151196,0.000013177141,0.0013800535,0.00006415853,0.00010726778,0.00404997],"study_design_scores_gemma":[9.871326e-7,0.000024413726,0.99861455,0.0000068690756,0.000011568766,0.0003406728,0.00077089784,0.0000099723475,0.00006613645,0.00002953723,0.00012273916,0.0000015702244],"about_ca_topic_score_codex":0.011436918,"about_ca_topic_score_gemma":0.019509833,"teacher_disagreement_score":0.011436918,"about_ca_system_score_codex":0.00021884906,"about_ca_system_score_gemma":0.00023667069,"threshold_uncertainty_score":0.022740662},"labels":[],"label_agreement":null},{"id":"W3045636730","doi":"10.1016/j.msard.2020.102432","title":"The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; University College London Hospitals NHS Foundation Trust; Rosetrees Trust; Health Technology Assessment Programme; MicroResearch; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Multiple Sclerosis Society","keywords":"Medicine; Urinary system; Multiple sclerosis; Pediatrics; Medical record; Emergency department; Emergency medicine; Intensive care medicine; Internal medicine; Immunology","score_opus":0.032087401716870946,"score_gpt":0.25971834472882266,"score_spread":0.22763094301195172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045636730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774571,0.018472472,0.00008126729,0.0015211437,0.00011362697,0.000040595427,0.00018855966,0.00000797839,0.002117225],"genre_scores_gemma":[0.9954918,0.0037025644,0.0001754253,0.00022651353,0.00011563443,0.000026288022,0.00012634096,0.0000010010045,0.00013441335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874485,0.0006808999,0.00019539073,0.000052701915,0.00018610188,0.00014005009],"domain_scores_gemma":[0.9976376,0.00086118886,0.000765668,0.000062755644,0.00024672906,0.00042602187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010452524,0.00024225317,0.0006754073,0.000882902,0.0009016409,0.0007595761,0.00044265963,0.00089680904,0.0008111993],"category_scores_gemma":[0.009806348,0.00022392905,0.00066844525,0.0011676485,0.00019919567,0.00079364405,0.00042518767,0.0009150041,0.00009133282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000948885,0.0011057914,0.96798193,0.00026146325,0.00028167956,0.00017584543,0.00033295547,0.000098293,0.000105632855,0.00006582956,0.00067299017,0.027968703],"study_design_scores_gemma":[0.00008150901,0.0008134202,0.9972752,0.00014891045,0.0001330784,0.0002636855,0.0006013472,0.0001871564,0.000039947245,0.000090399066,0.00035626363,0.000009156079],"about_ca_topic_score_codex":0.007598851,"about_ca_topic_score_gemma":0.008667673,"teacher_disagreement_score":0.007598851,"about_ca_system_score_codex":0.000568181,"about_ca_system_score_gemma":0.0013109416,"threshold_uncertainty_score":0.015109241},"labels":[],"label_agreement":null},{"id":"W3046717098","doi":"10.1016/j.msard.2020.102438","title":"Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Sanofi","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Term (time); Tower; Extension (predicate logic); Physical medicine and rehabilitation; Physical therapy; Immunology; Fingolimod; Structural engineering","score_opus":0.03951284863092202,"score_gpt":0.25038511289518445,"score_spread":0.21087226426426242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046717098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704033,0.0020592401,0.00005528509,0.000062529114,0.000014297741,0.000038821803,0.000377702,0.0000067302226,0.00034504267],"genre_scores_gemma":[0.9981194,0.0006234442,0.00013817158,0.00011132287,0.000045210258,0.00004463014,0.00062957016,0.0000034365676,0.00028487673],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99943227,0.00027203726,0.000066091445,0.00007722982,0.00008824853,0.000064087595],"domain_scores_gemma":[0.997783,0.00054946874,0.0008163958,0.00024918118,0.00019058779,0.00041132138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021498175,0.0005809756,0.0011878522,0.00031570677,0.00042364924,0.000544179,0.0003920263,0.00058375904,0.0009776466],"category_scores_gemma":[0.0024280977,0.00023272233,0.0012136272,0.00038424335,0.00038360944,0.0008431355,0.00028028365,0.00092103815,0.0002422959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5975998,0.0061909202,0.28509644,0.0009064882,0.007337547,0.0006448232,0.0006373296,0.0011446679,0.017446665,0.00011928178,0.0014988156,0.081377216],"study_design_scores_gemma":[0.08467271,0.10431906,0.79950035,0.00013590413,0.0055913706,0.00077461,0.00026205904,0.00069552625,0.0019935803,0.0001294002,0.0018338872,0.000091482194],"about_ca_topic_score_codex":0.0014113272,"about_ca_topic_score_gemma":0.0022735915,"teacher_disagreement_score":0.0021498175,"about_ca_system_score_codex":0.00045647298,"about_ca_system_score_gemma":0.00046672192,"threshold_uncertainty_score":0.011369467},"labels":[],"label_agreement":null},{"id":"W3048326791","doi":"10.1016/j.msard.2020.102446","title":"Concentrations of plasma-borne extracellular particles differ between multiple sclerosis disease courses and compared to healthy controls","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; University of Newcastle Australia; Multiple Sclerosis Australia","keywords":"Multiple sclerosis; Extracellular; Medicine; Extracellular vesicle; Immunology; Myelin; Central nervous system; Neutrophil extracellular traps; Pathology; Inflammation; Microvesicles; Internal medicine; Biology; Cell biology; Biochemistry","score_opus":0.032327830128448455,"score_gpt":0.23816828763479952,"score_spread":0.20584045750635108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048326791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999358,0.00018440947,0.00004872771,0.000010635891,0.0000036453227,0.0000025150628,0.00010280998,0.000004502661,0.0002847044],"genre_scores_gemma":[0.9992306,0.00007212791,0.000057405712,0.000011668397,0.000008372759,0.0000055013516,0.00016818354,0.0000037327673,0.000442344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982786,0.000027988695,0.000020554053,0.00006027326,0.000022393238,0.000040965162],"domain_scores_gemma":[0.9993467,0.00019490828,0.0002125015,0.000039556347,0.00006333064,0.00014291596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014276498,0.00027066463,0.00043495442,0.00091363385,0.00029682321,0.0005762148,0.00015081067,0.00054780237,0.0029088461],"category_scores_gemma":[0.0008880405,0.00016175512,0.00019451967,0.0004038086,0.00024738308,0.00039317002,0.00030060404,0.00032039266,0.00040100596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011761249,0.00030923396,0.87680197,0.000090660884,0.00027951042,0.0014372742,0.0011248667,0.0001029373,0.093517475,0.00014508417,0.00027392962,0.014155791],"study_design_scores_gemma":[0.000020078744,0.0002857639,0.9966749,0.0000037100165,0.00004188231,0.000791045,0.00030935742,0.00010538354,0.0014748733,0.000082611165,0.00020410845,0.000006232259],"about_ca_topic_score_codex":0.0011846771,"about_ca_topic_score_gemma":0.00067229645,"teacher_disagreement_score":0.0029088461,"about_ca_system_score_codex":0.00018279957,"about_ca_system_score_gemma":0.00008259981,"threshold_uncertainty_score":0.009731114},"labels":[],"label_agreement":null},{"id":"W3055474239","doi":"10.1016/j.msard.2020.102456","title":"Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba","funders":"","keywords":"Optic neuritis; Medicine; Multiple sclerosis; Optic nerve; Blurred vision; Visual acuity; Visual field; Ophthalmology; Magnetic resonance imaging; Myelin oligodendrocyte glycoprotein; Radiology; Immunology","score_opus":0.04149403892279723,"score_gpt":0.26275226853954425,"score_spread":0.22125822961674702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3055474239","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20685495,0.028937528,0.0042390474,0.5954477,0.037725467,0.00045143857,0.00036552144,0.00029538127,0.12568292],"genre_scores_gemma":[0.6212421,0.008847389,0.002402023,0.27565706,0.045065444,0.00016746904,0.000255799,0.000070036745,0.046292733],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987225,0.00044089023,0.00020388978,0.00010463765,0.00029695142,0.00023108322],"domain_scores_gemma":[0.99636334,0.002325286,0.0002859714,0.00023653843,0.00033115863,0.00045771332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016900235,0.0005230852,0.0009767007,0.00074716774,0.0015148101,0.0008029018,0.0011386632,0.012553098,0.0018642294],"category_scores_gemma":[0.009586579,0.0003132083,0.00094039575,0.00050549896,0.0013034529,0.0013111258,0.00051257905,0.005255612,0.0010176775],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00364379,0.0013614737,0.015563342,0.0006587218,0.00022175904,0.77538687,0.0006707489,0.0002949811,0.006364325,0.0078109936,0.12090774,0.0671153],"study_design_scores_gemma":[0.0033578593,0.0036989686,0.04011221,0.00073252566,0.00039702913,0.64895964,0.00074928685,0.0021342256,0.0062199607,0.011615786,0.28186682,0.00015568545],"about_ca_topic_score_codex":0.0032491002,"about_ca_topic_score_gemma":0.0041104797,"teacher_disagreement_score":0.012553098,"about_ca_system_score_codex":0.0015166597,"about_ca_system_score_gemma":0.0015397655,"threshold_uncertainty_score":0.01100415},"labels":[],"label_agreement":null},{"id":"W3083641055","doi":"10.1016/j.msard.2020.102488","title":"Lymphomatosis cerebri masquerading as the Marburg variant of multiple sclerosis","year":2020,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Multiple sclerosis; Brain biopsy; Lymphoma; Biopsy; Cyclophosphamide; Pseudotumor cerebri; Presentation (obstetrics); Pathology; Stereotactic biopsy; Radiology; Chemotherapy; Internal medicine; Immunology; Intracranial pressure","score_opus":0.027886593350609862,"score_gpt":0.21407756233865427,"score_spread":0.1861909689880444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083641055","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11771043,0.018508937,0.0019451891,0.68319994,0.027451107,0.00023296267,0.0002746388,0.00021649292,0.1504603],"genre_scores_gemma":[0.66125256,0.009412572,0.002399707,0.17317821,0.12556565,0.00013481831,0.00016323196,0.00009708701,0.027796213],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99919647,0.0002366653,0.000089277084,0.00010827633,0.00017361285,0.0001956447],"domain_scores_gemma":[0.99842656,0.0007759625,0.00020067961,0.00007869211,0.00018909112,0.000328992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007696889,0.0010963962,0.00095370435,0.0011185489,0.0025750692,0.0016710686,0.0012050793,0.017240684,0.0032036223],"category_scores_gemma":[0.007936251,0.00056645524,0.0009108407,0.0009375223,0.0019982546,0.0022747265,0.00076148077,0.008233131,0.0013357621],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020341435,0.00009714973,0.0076534413,0.00008708013,0.000027794178,0.93494844,0.00026370888,0.00022213969,0.00079807476,0.0044241394,0.045946423,0.0053283153],"study_design_scores_gemma":[0.00033827894,0.00016967917,0.010184835,0.00029532748,0.000072775576,0.9173397,0.00072004006,0.0027218638,0.0007433047,0.010613499,0.056737095,0.00006359499],"about_ca_topic_score_codex":0.0044171913,"about_ca_topic_score_gemma":0.006384454,"teacher_disagreement_score":0.017240684,"about_ca_system_score_codex":0.0025910877,"about_ca_system_score_gemma":0.0017573962,"threshold_uncertainty_score":0.018799722},"labels":[],"label_agreement":null},{"id":"W3087826157","doi":"10.1016/j.msard.2020.102526","title":"Anemia and sarcoidosis following treatment with alemtuzumab","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Autoimmune hemolytic anemia; Anemia; Adverse effect; Natalizumab; Internal medicine; Dermatology; Immunology","score_opus":0.03810727548125019,"score_gpt":0.2572866105682099,"score_spread":0.2191793350869597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087826157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943989,0.0028746233,0.00006486696,0.0002351387,0.000026391695,0.000020966738,0.000043918986,0.000004254548,0.0023308867],"genre_scores_gemma":[0.9991762,0.0003615309,0.000028427863,0.00007763667,0.000054705233,0.0000040465547,0.000042701817,6.4727953e-7,0.00025415744],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9991429,0.0004158682,0.00009706065,0.00006667936,0.00015051625,0.00012694155],"domain_scores_gemma":[0.99624807,0.0015048196,0.0013440077,0.00021948967,0.000238492,0.00044517012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014407638,0.00015827964,0.0004815141,0.0007642028,0.0005483329,0.00048218743,0.00028253385,0.00082535035,0.0009582384],"category_scores_gemma":[0.0052517047,0.00013612263,0.00048802336,0.0008450405,0.000364367,0.0004028192,0.00028138194,0.0007432672,0.00011015257],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006959514,0.000719515,0.9632139,0.000097318945,0.00029099797,0.012389537,0.00032733122,0.00008424101,0.0017917687,0.00013565549,0.00028008068,0.013710083],"study_design_scores_gemma":[0.00012339468,0.0012552602,0.9871689,0.00002216224,0.00020991023,0.009758819,0.00017309627,0.00012606071,0.00035242754,0.00009367707,0.00070808665,0.000008238751],"about_ca_topic_score_codex":0.0025209207,"about_ca_topic_score_gemma":0.002737779,"teacher_disagreement_score":0.0025209207,"about_ca_system_score_codex":0.00054669526,"about_ca_system_score_gemma":0.0005194363,"threshold_uncertainty_score":0.0076195598},"labels":[],"label_agreement":null},{"id":"W3088332612","doi":"10.1016/j.msard.2020.102492","title":"Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Teva Pharmaceutical Industries; Bayer; Celgene; Biogen; Sanofi Genzyme; F. Hoffmann-La Roche; Agence Nationale de la Recherche; Roche; PTC Therapeutics; UCB","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Randomized controlled trial; Anesthesia; Clinical endpoint; Volunteer; Surgery; Internal medicine","score_opus":0.0457979791972268,"score_gpt":0.24637228151121252,"score_spread":0.2005743023139857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088332612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948026,0.003465919,0.00027334836,0.000109213914,0.00009273038,0.0003475049,0.0005017639,0.000026028847,0.00038087004],"genre_scores_gemma":[0.9950486,0.0016303314,0.00081921514,0.00033654732,0.0002532193,0.0006565021,0.00097263424,0.000010022383,0.0002727815],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981857,0.001071268,0.00021500418,0.0002722603,0.00013462435,0.00012113135],"domain_scores_gemma":[0.9973652,0.000748383,0.0010102815,0.00035269803,0.00018564585,0.0003378985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043003764,0.0010222758,0.0025079264,0.00030496984,0.00031367474,0.0006481752,0.0005393236,0.0009672895,0.0017724786],"category_scores_gemma":[0.0033673726,0.00044006793,0.002025688,0.00042969338,0.0007035167,0.001005571,0.00043792574,0.0015003991,0.00025205285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95333564,0.0041395565,0.008562073,0.00066677586,0.0045332066,0.00003453378,0.00009608987,0.0004378018,0.003507657,0.00004705394,0.00058803096,0.0240515],"study_design_scores_gemma":[0.7410631,0.19292726,0.050426316,0.0001239994,0.010381725,0.00021580327,0.00007517667,0.00093932985,0.0019134525,0.00016625535,0.0017004369,0.000067052584],"about_ca_topic_score_codex":0.00059835246,"about_ca_topic_score_gemma":0.0016628141,"teacher_disagreement_score":0.0043003764,"about_ca_system_score_codex":0.00048666808,"about_ca_system_score_gemma":0.00054162013,"threshold_uncertainty_score":0.022742808},"labels":[],"label_agreement":null},{"id":"W3088933202","doi":"10.1016/j.msard.2020.102525","title":"The relationship between dimensions of mental health and alexithymia in multiple sclerosis patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Feeling; Multiple sclerosis; Anxiety; Mental health; Psychopathology; Clinical psychology; Psychology; Depression (economics); Psychiatry; Medicine; Social psychology","score_opus":0.06091234496272073,"score_gpt":0.2599911727729702,"score_spread":0.19907882781024944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088933202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890685,0.00015621856,0.000016119597,0.000054587108,0.000004963919,0.0000031089967,0.00006176852,0.0000013255604,0.0007949735],"genre_scores_gemma":[0.9997924,0.00004539825,0.000018945879,0.000013368959,0.0000053426006,0.0000014402623,0.000048478374,4.5381407e-7,0.000074109295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995926,0.00014239682,0.00006124556,0.000048237293,0.00007492179,0.000080536105],"domain_scores_gemma":[0.99788517,0.0006499511,0.0008516292,0.00006137708,0.00013475667,0.00041709936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003722984,0.00022645661,0.0003580615,0.0010813314,0.0006586199,0.0009988786,0.00025758636,0.00049037125,0.002153129],"category_scores_gemma":[0.0032049518,0.00023290457,0.0004930593,0.0011906793,0.00044781718,0.0004583767,0.0007074047,0.0008540482,0.00013615158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016225314,0.000040403756,0.9981468,0.0000071171603,0.000078467754,0.00012500808,0.00010910565,0.000031277184,0.0001580553,0.000020808666,0.00002740671,0.0010934216],"study_design_scores_gemma":[0.0000037338705,0.000041354408,0.99946886,0.0000024340638,0.000016275175,0.00015464477,0.00019316646,0.000056757697,0.00001530865,0.0000208437,0.000024124482,0.000002591428],"about_ca_topic_score_codex":0.0057803756,"about_ca_topic_score_gemma":0.010285728,"teacher_disagreement_score":0.0057803756,"about_ca_system_score_codex":0.00043639992,"about_ca_system_score_gemma":0.0003420736,"threshold_uncertainty_score":0.011493444},"labels":[],"label_agreement":null},{"id":"W3089633237","doi":"10.1016/j.msard.2020.102555","title":"Does age at diagnosis influence the use of health services for multiple sclerosis?","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Université de Montréal; Centre Hospitalier de l’Université de Montréal; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.09078395452362052,"score_gpt":0.28712956418233837,"score_spread":0.19634560965871783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089633237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847307,0.0067420057,0.0001413772,0.0026502009,0.00021737427,0.000016882715,0.0009892245,0.000009327825,0.004502802],"genre_scores_gemma":[0.9979527,0.0008918296,0.000069215464,0.00025068695,0.00012994892,0.000004531076,0.00023823619,0.000006024683,0.00045683232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965597,0.0014727921,0.00044524882,0.0004181934,0.0004536685,0.0006504097],"domain_scores_gemma":[0.9736528,0.0122509515,0.008348721,0.0013010063,0.0016627205,0.0027838636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029557731,0.0003182249,0.0008549917,0.0015550576,0.00096393615,0.0020446419,0.0008608798,0.002059215,0.005476833],"category_scores_gemma":[0.028821796,0.00042343826,0.0021423043,0.0028871598,0.0006567536,0.0015918177,0.0006820149,0.0018353051,0.00057808426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018197625,0.00007458298,0.99723154,0.000023792181,0.0002146977,0.00008076334,0.00014647424,0.00002120674,0.000032909797,0.000046660818,0.00019115287,0.0017542344],"study_design_scores_gemma":[0.000009414719,0.000072997784,0.9987841,0.000036186182,0.0001221392,0.00014316119,0.0003094491,0.00006591807,0.000022685997,0.00006280386,0.00036495223,0.000006249178],"about_ca_topic_score_codex":0.045148604,"about_ca_topic_score_gemma":0.03628492,"teacher_disagreement_score":0.045148604,"about_ca_system_score_codex":0.0008164583,"about_ca_system_score_gemma":0.001572293,"threshold_uncertainty_score":0.08977163},"labels":[],"label_agreement":null},{"id":"W3092309860","doi":"10.1016/j.msard.2020.102566","title":"Safety of dimethyl fumarate for multiple sclerosis: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; Chrest Foundation","keywords":"Medicine; Dimethyl fumarate; Internal medicine; Adverse effect; Discontinuation; Nausea; Placebo; Randomized controlled trial; Relative risk; Meta-analysis; Confidence interval; Observational study; Cochrane Library; Multiple sclerosis; Gastroenterology; Pathology; Immunology","score_opus":0.1500865941086234,"score_gpt":0.3385283172169947,"score_spread":0.18844172310837132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092309860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006223543,0.9926225,0.00033819315,0.00011051126,0.0001159796,0.00015671519,0.00024390729,0.000017452683,0.00017135737],"genre_scores_gemma":[0.19359885,0.80226076,0.0016983298,0.000979014,0.00021784879,0.00038766034,0.00044590782,0.000021110693,0.0003905417],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99561864,0.0018944588,0.0012921527,0.000534929,0.00047046036,0.00018931304],"domain_scores_gemma":[0.99121547,0.0061534657,0.0016847115,0.0002745769,0.0005298736,0.0001418329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007194619,0.0022424485,0.014618088,0.0028635443,0.00053433265,0.002209937,0.0017767637,0.0025449246,0.0040437696],"category_scores_gemma":[0.016984306,0.0012710855,0.024063617,0.0035631675,0.00068852736,0.0017484282,0.0014409765,0.0020485704,0.0002998418],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005658358,0.00005496201,0.0031563144,0.40877485,0.5648821,0.00014275174,0.00009786645,0.00039489818,0.00040111635,0.00010968825,0.000563153,0.015763875],"study_design_scores_gemma":[0.0016905909,0.0003741892,0.003597331,0.016206896,0.976185,0.000085230145,0.000058367088,0.00012279791,0.00012700586,0.00013299174,0.001390204,0.000029376482],"about_ca_topic_score_codex":0.005628562,"about_ca_topic_score_gemma":0.0150636835,"teacher_disagreement_score":0.014618088,"about_ca_system_score_codex":0.0018940496,"about_ca_system_score_gemma":0.0022290132,"threshold_uncertainty_score":0.03804928},"labels":[],"label_agreement":null},{"id":"W3093167267","doi":"10.1016/j.msard.2020.102579","title":"Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Seventh Framework Programme; Schweizerische Multiple Sklerose Gesellschaft; Shire; Guthy-Jackson Charitable Foundation; Arthur Arnstein Stiftung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; MedImmune; Deutsche Forschungsgemeinschaft; Universität Basel; Novartis; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Bayer; Biogen; F. Hoffmann-La Roche; Roche","keywords":"Medicine; Neuropathic pain; Spinal cord; Neuromyelitis optica; Multiple sclerosis; Lesion; Intensity (physics); Spinothalamic tract; Anesthesia; Internal medicine; Pathology; Nociception; Immunology; Psychiatry","score_opus":0.01542098351110319,"score_gpt":0.1935555819865361,"score_spread":0.17813459847543292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093167267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99790025,0.00064692885,0.00019321362,0.00006151373,0.000009664561,0.0000038848334,0.0001450115,0.0000067629658,0.0010327842],"genre_scores_gemma":[0.9992107,0.00014376656,0.00012834645,0.000023138487,0.000009218226,0.0000037483028,0.00010773504,0.000002933134,0.00037040122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989724,0.00001880999,0.0000100984,0.000026493775,0.000026844089,0.000020519265],"domain_scores_gemma":[0.99937254,0.00012695765,0.0003539415,0.000020533253,0.000047019286,0.000078958685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014596595,0.00025474833,0.00019947925,0.0004918391,0.00019226912,0.0005762236,0.00029919902,0.0002923696,0.0027020255],"category_scores_gemma":[0.0008716194,0.00013784654,0.00024574267,0.00043131976,0.00037938348,0.00030104484,0.000360828,0.00030771724,0.00014636344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018236483,0.00013687409,0.9590923,0.00013557343,0.0005123885,0.0011096767,0.0003253427,0.00045876144,0.019998249,0.00030005505,0.00038485488,0.015722211],"study_design_scores_gemma":[0.0000066908215,0.000045129575,0.99843544,0.000008040357,0.000037706734,0.00062707585,0.0001087394,0.00019934637,0.00026433996,0.00017525659,0.00008807144,0.0000040425366],"about_ca_topic_score_codex":0.0037345455,"about_ca_topic_score_gemma":0.0049699573,"teacher_disagreement_score":0.0037345455,"about_ca_system_score_codex":0.00028004273,"about_ca_system_score_gemma":0.00017081382,"threshold_uncertainty_score":0.009039164},"labels":[],"label_agreement":null},{"id":"W3104936044","doi":"10.1016/j.msard.2020.102621","title":"Serum Tumor Necrosis Factor-Alpha Levels Correlate with Cognitive Function Scales Scores in Multiple Sclerosis Patients","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Jordan University of Science and Technology","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Cognition; Internal medicine; Montreal Cognitive Assessment; Neurology; Physical therapy; Cohort; Correlation; Disease; Cognitive impairment; Immunology; Psychiatry","score_opus":0.06140002202102085,"score_gpt":0.25031624152786947,"score_spread":0.18891621950684861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104936044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992818,0.00025326214,0.00003356582,0.000028769979,0.0000069366533,0.0000014979279,0.00005228115,0.0000042703173,0.00033758773],"genre_scores_gemma":[0.99961287,0.00007134426,0.000027118558,0.0000146279135,0.0000114911,0.0000021286746,0.00007492739,8.840424e-7,0.00018469078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997534,0.000055410583,0.00004288901,0.000047535057,0.000050241368,0.000050410017],"domain_scores_gemma":[0.99805045,0.00044325672,0.001004617,0.000072168354,0.00017848099,0.0002510218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031352317,0.00035043576,0.00038300597,0.00088575843,0.0004182866,0.0007779225,0.00020007756,0.00048340604,0.0015688617],"category_scores_gemma":[0.0027630408,0.000285396,0.000338143,0.00072913634,0.0002732867,0.00033417283,0.00028039617,0.00055002625,0.00030270373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056905654,0.00007681729,0.99691415,0.000009763548,0.00009385024,0.0001757371,0.00009003842,0.000033822613,0.0006593439,0.000009797407,0.00006123374,0.0013063927],"study_design_scores_gemma":[0.000010192713,0.00010673374,0.99884856,0.000003997402,0.000045751287,0.0004964522,0.00011858089,0.00012716292,0.00014003938,0.000031490465,0.00006758005,0.0000034205123],"about_ca_topic_score_codex":0.0019940292,"about_ca_topic_score_gemma":0.001570576,"teacher_disagreement_score":0.0019940292,"about_ca_system_score_codex":0.00023427428,"about_ca_system_score_gemma":0.0002484183,"threshold_uncertainty_score":0.005248368},"labels":[],"label_agreement":null},{"id":"W3112161524","doi":"10.1016/j.msard.2020.102673","title":"Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Celgene; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Medicine; Numerical digit; Test (biology); Symbol (formal); Modalities; Multiple sclerosis; Audiology; Dermatology; Arithmetic; Psychiatry; Mathematics","score_opus":0.02851786071263102,"score_gpt":0.25636851520807774,"score_spread":0.22785065449544673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112161524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892247,0.0004037033,0.000038380844,0.000066847235,0.000044821325,0.000020895937,0.000076240955,0.00001247625,0.0004141567],"genre_scores_gemma":[0.998582,0.00038926888,0.00011075516,0.000044496217,0.000044823017,0.000021518012,0.00012719035,0.0000044324197,0.0006754729],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99964213,0.0001637882,0.00003965077,0.00004177465,0.000027235881,0.00008535676],"domain_scores_gemma":[0.9990602,0.00042758576,0.00006970959,0.000055246623,0.00004682098,0.00034044817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005307351,0.00065879413,0.0016148231,0.00022720556,0.00035301884,0.00036445347,0.00050357985,0.0008379879,0.002708316],"category_scores_gemma":[0.0020887037,0.00026593803,0.00037360072,0.00028578102,0.00074399175,0.00058154325,0.000408342,0.0011347997,0.00039254513],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91558677,0.011652662,0.0041703824,0.00028970078,0.00033420415,0.00021895225,0.0002767103,0.00035776276,0.032608494,0.000098589044,0.00031122242,0.034094535],"study_design_scores_gemma":[0.09304695,0.7011817,0.14363828,0.00011276114,0.0013908608,0.0004069458,0.001118919,0.0031423115,0.053117007,0.00029251195,0.0024287228,0.00012300136],"about_ca_topic_score_codex":0.0034335717,"about_ca_topic_score_gemma":0.0033058801,"teacher_disagreement_score":0.0034335717,"about_ca_system_score_codex":0.00023403115,"about_ca_system_score_gemma":0.00072705373,"threshold_uncertainty_score":0.009060204},"labels":[],"label_agreement":null},{"id":"W3120661261","doi":"10.1016/j.msard.2021.102740","title":"Predicting falls and injuries in people with multiple sclerosis using machine learning algorithms","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Machine learning; Decision tree; Medicine; Artificial intelligence; Algorithm; Falling (accident); Confusion; Multiple sclerosis; Recall; Scale (ratio); Expanded Disability Status Scale; Computer science; Psychology; Psychiatry; Cognitive psychology","score_opus":0.029015828797109244,"score_gpt":0.2763994065536786,"score_spread":0.24738357775656938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120661261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201185,0.0006487046,0.005392224,0.00032535777,0.00003792952,0.00004350773,0.0008073567,0.000069265996,0.000663826],"genre_scores_gemma":[0.9954567,0.0002844557,0.0030330627,0.000036658676,0.000038086724,0.000023893735,0.0008301169,0.000003032728,0.00029397773],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99965346,0.0000693247,0.00006935314,0.000067367604,0.00008593364,0.000054616237],"domain_scores_gemma":[0.99894303,0.00050758955,0.00021408065,0.000034587294,0.0002136713,0.00008703541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007356773,0.00056215585,0.00073520065,0.0026851213,0.00038226438,0.0008444931,0.00035127916,0.00087460806,0.00088908494],"category_scores_gemma":[0.003907942,0.00019170347,0.0008045128,0.0010274173,0.00016068397,0.00051978324,0.0005083387,0.000629404,0.00023627093],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003256218,0.00045536377,0.9359968,0.000047359914,0.0002406748,0.000118941716,0.000037094072,0.018804042,0.0002706888,0.00008771642,0.0007539177,0.042861868],"study_design_scores_gemma":[0.000058779162,0.00043092846,0.49875346,0.00010025925,0.00021206813,0.00041639924,0.0003354994,0.49653903,0.00050550984,0.002235314,0.00038864423,0.000024034009],"about_ca_topic_score_codex":0.009355992,"about_ca_topic_score_gemma":0.009423777,"teacher_disagreement_score":0.009355992,"about_ca_system_score_codex":0.00036407774,"about_ca_system_score_gemma":0.0005058296,"threshold_uncertainty_score":0.018603086},"labels":[],"label_agreement":null},{"id":"W3124448270","doi":"10.1016/j.msard.2021.102770","title":"Does cognitive training improve attention/working memory in persons with MS? A pilot study using the Cogmed Working Memory Training program","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Parkwood Institute; Ontario Shores Centre for Mental Health Sciences; London Health Sciences Centre; Lawson Health Research Institute","funders":"Lawson Health Research Institute","keywords":"Working memory training; Training (meteorology); Cognitive training; Working memory; Medicine; Cognition; Multiple sclerosis; Physical medicine and rehabilitation; Psychiatry","score_opus":0.11161438053650526,"score_gpt":0.3095001542378981,"score_spread":0.19788577370139288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124448270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995403,0.00012187364,0.000023424811,0.000043779717,0.000009444517,0.0000943659,0.00002230518,0.0000020431921,0.00014255242],"genre_scores_gemma":[0.998787,0.00022406,0.00027715595,0.000106636406,0.00004899741,0.00022057237,0.000070459915,9.070679e-7,0.00026405428],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969256,0.00013367682,0.000027915203,0.000048837224,0.00003228535,0.00006476073],"domain_scores_gemma":[0.9993555,0.00026020498,0.00007142955,0.000048549566,0.00005738749,0.00020689456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010516769,0.00043866088,0.0007633246,0.00030451806,0.0006793571,0.00036207572,0.00047412835,0.0008294038,0.0013674638],"category_scores_gemma":[0.0014925253,0.00022611527,0.0007209669,0.00029454404,0.00031073816,0.00043875145,0.0003161028,0.00079940114,0.00019008425],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26222923,0.39001542,0.0976374,0.0012139375,0.0012660641,0.0008514215,0.0027275812,0.0008007302,0.023503201,0.00009797928,0.0007082213,0.21894878],"study_design_scores_gemma":[0.026734954,0.612882,0.353767,0.00008301295,0.001007063,0.00018688732,0.0008262401,0.0006027739,0.0030801655,0.00007831347,0.000720808,0.000030739557],"about_ca_topic_score_codex":0.00390787,"about_ca_topic_score_gemma":0.004421152,"teacher_disagreement_score":0.00390787,"about_ca_system_score_codex":0.00030984948,"about_ca_system_score_gemma":0.00069599884,"threshold_uncertainty_score":0.0077702403},"labels":[],"label_agreement":null},{"id":"W3124748247","doi":"10.1016/j.msard.2021.102790","title":"MAGNIMS score predicts long-term clinical disease activity-free status and confirmed disability progression in patients treated with subcutaneous interferon beta-1a","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Merck KGaA","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Multiple sclerosis; Gastroenterology; Immunology","score_opus":0.04136060337065636,"score_gpt":0.3052844282943865,"score_spread":0.2639238249237301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124748247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877006,0.00075248344,0.00006691874,0.000043249478,0.0000057123757,0.0000069190514,0.00009281952,0.0000040208984,0.00025776515],"genre_scores_gemma":[0.9995505,0.00012039987,0.0000642107,0.000014629569,0.000015499263,0.0000045810148,0.00014295235,8.8492015e-7,0.0000862569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997371,0.000100088924,0.000025073088,0.000054695603,0.00004630619,0.000036705173],"domain_scores_gemma":[0.9981812,0.0004911533,0.0008945509,0.00007880306,0.00008101204,0.00027320508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009136712,0.00030234206,0.0004906939,0.00021507406,0.000121527635,0.00034232737,0.00019465346,0.00029233503,0.0012585166],"category_scores_gemma":[0.0017282589,0.00017774903,0.0006275223,0.00021378235,0.00016355388,0.00017149908,0.00026265244,0.00054624677,0.00011721282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00825701,0.00011114625,0.980493,0.000062655614,0.0006812752,0.00006328268,0.000030233019,0.0003431541,0.0011363719,0.000016719983,0.0001863646,0.008618797],"study_design_scores_gemma":[0.00017145519,0.0011452781,0.997375,0.000012000585,0.00024277745,0.00018466309,0.000017465913,0.0005677554,0.00011910677,0.000032124757,0.0001275247,0.000004708891],"about_ca_topic_score_codex":0.00044665352,"about_ca_topic_score_gemma":0.0009615486,"teacher_disagreement_score":0.0012585166,"about_ca_system_score_codex":0.00013190633,"about_ca_system_score_gemma":0.00016493612,"threshold_uncertainty_score":0.0048319697},"labels":[],"label_agreement":null},{"id":"W3125090708","doi":"10.1016/j.msard.2021.102795","title":"Physical Activity in Youth with Multiple Sclerosis receiving the ATOMIC intervention: Social connectedness above all else","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University; Hospital for Sick Children","funders":"","keywords":"Social connectedness; Medicine; Intervention (counseling); Social cognitive theory; Multiple sclerosis; Coaching; Population; Physical activity; Conversation; Physical therapy; Psychology; Developmental psychology; Psychiatry; Psychotherapist","score_opus":0.055066123820854754,"score_gpt":0.2850375983763357,"score_spread":0.22997147455548095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125090708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895716,0.00039206515,0.000016759488,0.00011729464,0.000015538444,0.000015172129,0.000051817195,0.0000014454107,0.00043271587],"genre_scores_gemma":[0.99948275,0.00018437514,0.000034669934,0.00003237642,0.000012634155,0.000014133898,0.00006782459,5.5893923e-7,0.0001705689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957985,0.00015274058,0.00002803413,0.000047976,0.00004892201,0.0001424913],"domain_scores_gemma":[0.99937075,0.000104682,0.00017931187,0.00002057224,0.0000651466,0.0002595992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006375086,0.00032692536,0.0005192249,0.000550248,0.00077061914,0.00064597395,0.00025201752,0.000633388,0.0015248647],"category_scores_gemma":[0.0019607414,0.00019183384,0.00071944005,0.0008619361,0.00024444528,0.00044559565,0.00078877603,0.0008262537,0.00008973828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016710516,0.0019313872,0.97872263,0.00009075447,0.0002809447,0.000084044455,0.00060310453,0.000035794834,0.00025990623,0.0000784098,0.00025452793,0.01598741],"study_design_scores_gemma":[0.00007847021,0.00092322176,0.99751955,0.00003533538,0.00022676938,0.00002803115,0.0008584729,0.000069169924,0.000059777147,0.000028011615,0.00016972696,0.0000034775464],"about_ca_topic_score_codex":0.024402356,"about_ca_topic_score_gemma":0.03622441,"teacher_disagreement_score":0.024402356,"about_ca_system_score_codex":0.0005617895,"about_ca_system_score_gemma":0.00097221875,"threshold_uncertainty_score":0.048520625},"labels":[],"label_agreement":null},{"id":"W3127226135","doi":"10.1016/j.msard.2021.102800","title":"COVID-19 and disease-modifying therapies in patients with demyelinating diseases of the central nervous system: A systematic review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Neuromyelitis optica; Multiple sclerosis; Demyelinating disease; Rituximab; Pandemic; Disease; Coronavirus disease 2019 (COVID-19); Demyelinating Disorder; Natalizumab; Intensive care medicine; Pediatrics; Immunology; Internal medicine; Infectious disease (medical specialty); Antibody","score_opus":0.044586138807301445,"score_gpt":0.29848279129229943,"score_spread":0.253896652484998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127226135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006825613,0.9987914,0.00004462659,0.00006370604,0.00006494214,0.00006243788,0.00019153752,0.000003869551,0.000095002775],"genre_scores_gemma":[0.00972624,0.9894447,0.00020525242,0.00028014524,0.000049619997,0.000091978494,0.00012591336,0.0000023502096,0.000073772295],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9978771,0.00057303393,0.00082399783,0.0002497824,0.0003537359,0.00012226978],"domain_scores_gemma":[0.9945123,0.0036869717,0.0012597687,0.00007125401,0.00035312088,0.000116519564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002960158,0.0013500076,0.0091397,0.005108492,0.00041111867,0.0020832275,0.001479156,0.0018365355,0.0048153503],"category_scores_gemma":[0.011421536,0.0008643862,0.00892776,0.0066193896,0.00060992636,0.0013915945,0.0012906202,0.0013772971,0.00028207412],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000684802,0.000033049648,0.0008703758,0.9295651,0.03573776,0.00009688621,0.00008854799,0.00013885021,0.00021585428,0.00013639555,0.0015801261,0.030852411],"study_design_scores_gemma":[0.0018485589,0.00046754803,0.00926978,0.50866246,0.45727608,0.0004422508,0.00029512643,0.000144126,0.00023854933,0.0003530278,0.020904735,0.00009773674],"about_ca_topic_score_codex":0.012592584,"about_ca_topic_score_gemma":0.035397466,"teacher_disagreement_score":0.012592584,"about_ca_system_score_codex":0.0022210905,"about_ca_system_score_gemma":0.00464938,"threshold_uncertainty_score":0.0250386},"labels":[],"label_agreement":null},{"id":"W3127586358","doi":"10.1016/j.msard.2021.102809","title":"Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hotchkiss Brain Institute; University of Alberta; University of Calgary","funders":"Government of Alberta","keywords":"Medicine; Multiple sclerosis; Peripheral; Biomarker; Clinically isolated syndrome; Biomarker discovery; Pathology; Immunology; Internal medicine; Proteomics","score_opus":0.040716207046802504,"score_gpt":0.28157708864407954,"score_spread":0.24086088159727703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127586358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952998,0.0034332108,0.00025956827,0.000074525306,0.000024689865,0.000022628275,0.00015697538,0.000009235621,0.0007192908],"genre_scores_gemma":[0.9986046,0.00054184115,0.0003440498,0.00007385153,0.000031037565,0.000025950225,0.00013913111,0.0000027795784,0.0002367876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991223,0.00036311412,0.00013283156,0.00014579696,0.00012808737,0.00010793962],"domain_scores_gemma":[0.9981598,0.0006467791,0.0006243111,0.00008059557,0.00024176309,0.00024670243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014543945,0.00072005054,0.0008454827,0.0022730022,0.0005563041,0.0013593906,0.00035364725,0.0008295177,0.0012669088],"category_scores_gemma":[0.00459984,0.0002176245,0.00042813562,0.0012136954,0.0004992996,0.0009496048,0.00092511554,0.00058661104,0.00022974623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063287243,0.00047317529,0.9572376,0.00031883488,0.00050459255,0.0016337296,0.0005792231,0.00014360274,0.009488855,0.00017434258,0.00037977073,0.0227375],"study_design_scores_gemma":[0.00011082434,0.0017178057,0.9892841,0.00012184959,0.00032123705,0.002744016,0.00082752336,0.0007411228,0.0028441723,0.0003882911,0.00086799124,0.000031045474],"about_ca_topic_score_codex":0.0017349834,"about_ca_topic_score_gemma":0.0017895995,"teacher_disagreement_score":0.0022730022,"about_ca_system_score_codex":0.00048368605,"about_ca_system_score_gemma":0.00073369,"threshold_uncertainty_score":0.0076916814},"labels":[],"label_agreement":null},{"id":"W3130955693","doi":"10.1016/j.msard.2021.102854","title":"Challenges in multiple sclerosis care: Results from an international mixed-methods study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; Axdev Group (Canada)","funders":"Merck KGaA","keywords":"Medicine; Multiple sclerosis; Immunology","score_opus":0.11404897795377365,"score_gpt":0.3523979306294212,"score_spread":0.23834895267564754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130955693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881892,0.002292443,0.002032319,0.0008162526,0.0000529729,0.0035492037,0.000909754,0.000012721974,0.0021450918],"genre_scores_gemma":[0.97914106,0.0022173559,0.0055254973,0.0017141827,0.000049363585,0.009746997,0.00097577664,0.000040392104,0.00058942905],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9442406,0.042047065,0.0059857094,0.0020422658,0.0032666703,0.002417667],"domain_scores_gemma":[0.8798741,0.08633008,0.013789295,0.004983991,0.012377052,0.0026455645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08913531,0.00090838457,0.0018903195,0.0030678397,0.0039037906,0.0059708646,0.0025461705,0.0019924992,0.0028757271],"category_scores_gemma":[0.10765391,0.0011371559,0.0025867906,0.005706113,0.002509719,0.004806558,0.0071321176,0.0019916156,0.00051474705],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012975623,0.0033571783,0.5225493,0.004677048,0.0012562858,0.0009241371,0.40799233,0.0002407693,0.00030138786,0.0010033987,0.0018282164,0.054572444],"study_design_scores_gemma":[0.00043644855,0.0025347287,0.30833393,0.0050697625,0.00091349886,0.0007234477,0.67454845,0.0010518153,0.0003120865,0.0007090897,0.0051687243,0.00019801265],"about_ca_topic_score_codex":0.016141396,"about_ca_topic_score_gemma":0.025078967,"teacher_disagreement_score":0.08913531,"about_ca_system_score_codex":0.005934185,"about_ca_system_score_gemma":0.008423087,"threshold_uncertainty_score":0.47139823},"labels":[],"label_agreement":null},{"id":"W3131487333","doi":"10.1016/j.msard.2021.102844","title":"Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Sanofi Genzyme; Allergan; EMD Serono; MedDay Pharmaceuticals; Innosuisse - Schweizerische Agentur für Innovationsförderung; Schweizerische Multiple Sklerose Gesellschaft; Eisai; Alexion Pharmaceuticals; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Multiple Sclerosis Society; Ministerstvo Školství, Mládeže a Tělovýchovy; Atara Biotherapeutics; Mylan; Baxalta; TG Therapeutics; National Research Foundation; F. Hoffmann-La Roche; Novartis; Celgene; Bayer; Pfizer; Biogen; Roche; Teva Pharmaceutical Industries; Bayer HealthCare; European Commission; Multiple Sclerosis International Federation; Sanofi; Genentech; National Multiple Sclerosis Society; Merck; CSL Behring; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; MedDRA; Population; Adverse effect; Placebo; Clinical trial; Incidence (geometry); Phases of clinical research; Pathology; Pharmacovigilance","score_opus":0.08706421045346827,"score_gpt":0.316655371971675,"score_spread":0.22959116151820672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131487333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8936208,0.08293091,0.0051819785,0.0007602344,0.00015734976,0.0029149714,0.010083868,0.00023644886,0.0041133272],"genre_scores_gemma":[0.97502714,0.013677982,0.0021994384,0.00046992712,0.00024552018,0.0011108164,0.0065657096,0.000043666576,0.00065973215],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922218,0.0047967024,0.0008866062,0.0007319774,0.0011515797,0.00021133525],"domain_scores_gemma":[0.9886827,0.004031113,0.0049235555,0.0008475611,0.0011571989,0.00035779562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019095095,0.0009843174,0.0024298632,0.0012067058,0.00021212368,0.0009950456,0.0006398799,0.0007663099,0.0024198869],"category_scores_gemma":[0.01621519,0.00036373257,0.004844028,0.0014961154,0.00040609104,0.00068369816,0.00088345946,0.0008552901,0.00033310978],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5428771,0.0015959443,0.07101963,0.009531872,0.107227184,0.00021943891,0.0002574223,0.004331073,0.0068561584,0.00022563146,0.0058964156,0.2499623],"study_design_scores_gemma":[0.25857696,0.10242533,0.42225137,0.0013930706,0.18531038,0.0011812564,0.00019690696,0.0046141506,0.006705766,0.00089179305,0.016270181,0.0001827283],"about_ca_topic_score_codex":0.0005637019,"about_ca_topic_score_gemma":0.0008767391,"teacher_disagreement_score":0.019095095,"about_ca_system_score_codex":0.00058857625,"about_ca_system_score_gemma":0.0010983422,"threshold_uncertainty_score":0.100985706},"labels":[],"label_agreement":null},{"id":"W3133335727","doi":"10.1016/j.msard.2021.102840","title":"Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerische Multiple Sklerose Gesellschaft; ZonMw; Health~Holland; European Commission; EU Joint Programme – Neurodegenerative Disease Research; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Weston Brain Institute","keywords":"Medicine; Multiple sclerosis; Biomarker; Immunoassay; Internal medicine; Gastroenterology; Cerebrospinal fluid; Expanded Disability Status Scale; Pathology; Amyotrophic lateral sclerosis; Oncology; Immunology; Disease; Antibody; Biology","score_opus":0.06168818904227556,"score_gpt":0.2546800506918796,"score_spread":0.19299186164960402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133335727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95892864,0.004227039,0.034288142,0.00011240461,0.000085403946,0.00007674025,0.00054422795,0.00038405013,0.0013533141],"genre_scores_gemma":[0.97338253,0.000655185,0.02440826,0.00010407484,0.000056495912,0.000086790096,0.0005177773,0.000013670056,0.0007751649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986363,0.00042951992,0.0001101563,0.00032835547,0.0004161325,0.000079446334],"domain_scores_gemma":[0.9986312,0.0005152296,0.000466732,0.00011460394,0.00021282722,0.000059304315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013547706,0.00067018665,0.00032797147,0.0007863835,0.000120836165,0.0004118797,0.00030653985,0.00044942336,0.0008531933],"category_scores_gemma":[0.0022927336,0.00021390835,0.0002841853,0.00051429955,0.00030143082,0.00023201891,0.00029119232,0.0005063487,0.00041618454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018172348,0.0004599349,0.35416383,0.00029716763,0.00024294989,0.00017098918,0.00024816196,0.00095593836,0.57049125,0.00026530278,0.00071057735,0.07017667],"study_design_scores_gemma":[0.00014663108,0.003092572,0.4028383,0.000083998304,0.00036543317,0.0041321805,0.0001709183,0.014499612,0.5689587,0.0006289554,0.0050304793,0.000052136784],"about_ca_topic_score_codex":0.00026604757,"about_ca_topic_score_gemma":0.00036249883,"teacher_disagreement_score":0.0013547706,"about_ca_system_score_codex":0.00026277942,"about_ca_system_score_gemma":0.00015582716,"threshold_uncertainty_score":0.0071647763},"labels":[],"label_agreement":null},{"id":"W3134164674","doi":"10.1016/j.msard.2021.102882","title":"Fulminant ADEM treated with cyclophosphamide: Case report and review of the literature","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Acute disseminated encephalomyelitis; Medicine; Fulminant; Multiple sclerosis; Cyclophosphamide; Pediatrics; Intensive care unit; Intensive care medicine; Immunology; Internal medicine; Chemotherapy","score_opus":0.038288022934512285,"score_gpt":0.3028962195589655,"score_spread":0.26460819662445323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134164674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011468503,0.9978497,0.00007854118,0.00018102025,0.000107718886,0.00000778662,0.000032208165,0.000005645309,0.00059057854],"genre_scores_gemma":[0.007641674,0.99118316,0.00022941492,0.00040709795,0.00027376626,0.0000065102345,0.00004969026,0.0000019771426,0.00020677934],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99963534,0.00006203077,0.00013990626,0.000062828076,0.00007048971,0.000029327175],"domain_scores_gemma":[0.99931645,0.00038749047,0.00018989098,0.000021124144,0.000051882966,0.00003307088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003749148,0.001048251,0.0020681748,0.003781638,0.00048025805,0.0014187767,0.0012072875,0.0014859876,0.0022343965],"category_scores_gemma":[0.0013337014,0.00032029705,0.00085402734,0.0042741275,0.0007693417,0.0018358616,0.0006140305,0.00094926596,0.0006099176],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037799124,0.0002768739,0.0059402045,0.11543521,0.0014899516,0.16121039,0.0007937349,0.00068768923,0.004293234,0.0019955616,0.030356845,0.6771423],"study_design_scores_gemma":[0.00016818804,0.00024818847,0.012169863,0.03936172,0.003988109,0.62550175,0.0014019548,0.00030189718,0.0015218691,0.0019460928,0.31323656,0.0001536529],"about_ca_topic_score_codex":0.0011546637,"about_ca_topic_score_gemma":0.002771962,"teacher_disagreement_score":0.003781638,"about_ca_system_score_codex":0.00045732313,"about_ca_system_score_gemma":0.0012481088,"threshold_uncertainty_score":0.0074748397},"labels":[],"label_agreement":null},{"id":"W3134385846","doi":"10.1016/j.msard.2021.102883","title":"Corpus callosum lesions are not inextricably linked to CNS symptoms in reported cases of susac syndrome","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Corpus callosum; Encephalopathy; Disease; Presentation (obstetrics); Pediatrics; Multiple sclerosis; Pathology; Surgery; Internal medicine","score_opus":0.037418966524798807,"score_gpt":0.2536817145676341,"score_spread":0.2162627480428353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134385846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963972,0.0003597037,0.00011156574,0.00007092003,0.000017286833,0.000007968801,0.000102288206,0.000021393387,0.002911696],"genre_scores_gemma":[0.9994568,0.00010507551,0.00014882362,0.000024431614,0.000020027008,0.000004068551,0.000084834755,0.0000049197083,0.0001511266],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99953544,0.000065547996,0.000091775706,0.00010290662,0.00011141713,0.00009294028],"domain_scores_gemma":[0.99733776,0.0009908236,0.00090670463,0.00026071587,0.00020248958,0.00030156013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031669525,0.0009449035,0.0004818722,0.0030690983,0.0011123196,0.0007509832,0.0008140892,0.0015913032,0.004069036],"category_scores_gemma":[0.004545378,0.00032441452,0.00027124071,0.0016792718,0.0019725638,0.00057000644,0.00070529233,0.00043986033,0.00045503624],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006284814,0.00010304104,0.54045475,0.00023546079,0.00015415307,0.4179744,0.0018847241,0.00029368527,0.027618771,0.001221011,0.00069764623,0.008733845],"study_design_scores_gemma":[0.000041800708,0.00025267806,0.32497942,0.000059550617,0.00011719509,0.6673757,0.0009432004,0.00045686332,0.0036198227,0.00074410666,0.0013684917,0.00004110758],"about_ca_topic_score_codex":0.0027252352,"about_ca_topic_score_gemma":0.0034789033,"teacher_disagreement_score":0.004069036,"about_ca_system_score_codex":0.00024729347,"about_ca_system_score_gemma":0.0005705256,"threshold_uncertainty_score":0.01361227},"labels":[],"label_agreement":null},{"id":"W3134686384","doi":"10.1016/j.msard.2021.102884","title":"Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health; University of Victoria","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Depression (economics); Medicine; Relapsing remitting; Depressive symptoms; Beck Depression Inventory; Population; Placebo; Cognition; Internal medicine; Clinical psychology; Psychiatry; Anxiety","score_opus":0.057897969849158765,"score_gpt":0.26517419472930365,"score_spread":0.20727622488014488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134686384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992855,0.0001091515,0.000019655206,0.000025589523,0.000007726206,0.000002304573,0.00007496587,8.313356e-7,0.00047435166],"genre_scores_gemma":[0.9994394,0.00004634784,0.00001094825,0.000026340242,0.000013650602,0.0000024378858,0.000100491365,0.0000014292091,0.0003588602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997708,0.000055899112,0.00002329213,0.000045656343,0.000038743747,0.00006569455],"domain_scores_gemma":[0.99927956,0.00019331322,0.00021754221,0.000033186807,0.00006445013,0.00021204352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026169408,0.00020351601,0.00036628405,0.000668986,0.00032798963,0.00043765304,0.00014226722,0.00032884092,0.0046559144],"category_scores_gemma":[0.0016265993,0.00017268266,0.0002734702,0.00041468223,0.00022062928,0.00043040197,0.00028536172,0.00035070462,0.0005150025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007314452,0.000104836356,0.99384296,0.00001009335,0.00007631897,0.00015280113,0.0005158767,0.000009242309,0.001282008,0.000033129494,0.00010406546,0.0031372842],"study_design_scores_gemma":[0.000008975895,0.00009805683,0.9991755,0.0000015518522,0.000009993654,0.00016288432,0.00042755698,0.0000152207385,0.000033346285,0.00001245607,0.00005329885,0.0000012312025],"about_ca_topic_score_codex":0.0021040638,"about_ca_topic_score_gemma":0.0036183365,"teacher_disagreement_score":0.0046559144,"about_ca_system_score_codex":0.00012327568,"about_ca_system_score_gemma":0.00009865044,"threshold_uncertainty_score":0.015575647},"labels":[],"label_agreement":null},{"id":"W3138262194","doi":"10.1016/j.msard.2021.102911","title":"A mixed-methods study of cognitive performance in persons with multiple sclerosis: Association between neuropsychological test performance and interviews about daily cognitive functioning","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Multiple Sclerosis Society","keywords":"Neuropsychology; Cognition; Clinical psychology; Psychology; Neuropsychological assessment; Neuropsychological test; Thematic analysis; Effects of sleep deprivation on cognitive performance; Test (biology); Qualitative research; Medicine; Developmental psychology; Psychiatry","score_opus":0.06402109757871173,"score_gpt":0.31462114225491045,"score_spread":0.25060004467619873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138262194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99900645,0.0002424879,0.0002464393,0.000018930843,0.000011153434,0.00019931642,0.00011391679,0.000003228955,0.0001580925],"genre_scores_gemma":[0.9969111,0.00019153954,0.0010345271,0.00012067237,0.000034295135,0.0008397638,0.00029444147,0.000003972991,0.0005696377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99400747,0.004077859,0.00054487726,0.0005505541,0.000544231,0.00027497922],"domain_scores_gemma":[0.993486,0.003171962,0.0013495128,0.00076737325,0.00073335675,0.0004918456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064713857,0.0011716528,0.0012431986,0.0019443026,0.0025139446,0.0016174498,0.0010838454,0.0012956719,0.001685655],"category_scores_gemma":[0.010934218,0.0011264404,0.0011937727,0.0018549946,0.0008687373,0.0014761926,0.0013720439,0.0009326093,0.000521604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006606723,0.0053023743,0.97522163,0.00022616051,0.0011723657,0.00032586593,0.0044897594,0.000102521546,0.0009171625,0.00012315804,0.00015821165,0.005353973],"study_design_scores_gemma":[0.0017960465,0.022576885,0.9613775,0.00007604359,0.0008712386,0.00086591975,0.009989223,0.00094860647,0.0005213369,0.00021265556,0.00068205805,0.00008252965],"about_ca_topic_score_codex":0.010254016,"about_ca_topic_score_gemma":0.016779076,"teacher_disagreement_score":0.010254016,"about_ca_system_score_codex":0.0011128231,"about_ca_system_score_gemma":0.0011024284,"threshold_uncertainty_score":0.03422433},"labels":[],"label_agreement":null},{"id":"W3138588637","doi":"10.1016/j.msard.2021.102910","title":"Obesity is associated with the Optic Neuritis severity in Male patients with Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Sucampo Pharmaceuticals; U.S. Department of Defense","keywords":"Medicine; Internal medicine; Optic neuritis; Leptin; Body mass index; Logistic regression; Multiple sclerosis; Obesity; Estrogen; Sex hormone-binding globulin; Endocrinology; Hormone; Testosterone (patch); Gastroenterology; Immunology; Androgen","score_opus":0.023611548390920726,"score_gpt":0.22450663378391855,"score_spread":0.20089508539299783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138588637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983254,0.0006928214,0.000060398306,0.00011486719,0.000025020974,0.0000029265693,0.000116369265,0.0000026750909,0.0006595469],"genre_scores_gemma":[0.9991744,0.00022325155,0.00005401822,0.000044133394,0.00004931599,0.0000031517068,0.000093667535,0.0000017796328,0.00035625175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997377,0.00006527153,0.00003745656,0.000050218783,0.00004881149,0.000060491704],"domain_scores_gemma":[0.9988539,0.00016908409,0.00065941166,0.000050024842,0.000081474325,0.00018614049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025639994,0.0003374535,0.00038477228,0.0011934254,0.00052501407,0.0006630326,0.00021126463,0.00043388145,0.003317338],"category_scores_gemma":[0.0013978493,0.00027260804,0.00077715825,0.001269547,0.0002571231,0.00038279773,0.0003235133,0.00073963247,0.0002388913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018240185,0.00004799285,0.9975211,0.000013176087,0.00013037687,0.00017858735,0.000070741575,0.000011020967,0.00048092523,0.000020742758,0.000061511295,0.0012813413],"study_design_scores_gemma":[0.0000037559691,0.00004030034,0.9992617,0.000004811941,0.000059202644,0.0003228949,0.00012317058,0.00003650066,0.000033024633,0.000020705662,0.00009060074,0.0000032187168],"about_ca_topic_score_codex":0.0033156797,"about_ca_topic_score_gemma":0.0036888572,"teacher_disagreement_score":0.003317338,"about_ca_system_score_codex":0.00017456831,"about_ca_system_score_gemma":0.00025223193,"threshold_uncertainty_score":0.01109755},"labels":[],"label_agreement":null},{"id":"W3149959926","doi":"10.1016/j.msard.2021.102931","title":"Can serum glial fibrillary acidic protein (GFAP) solve the longstanding problem of diagnosis and monitoring progressive multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; McDonald criteria; Medical diagnosis; Cerebrospinal fluid; Magnetic resonance imaging; Lumbar; Lumbar puncture; Pathology; Radiology; Psychiatry","score_opus":0.04665116888110507,"score_gpt":0.2674648555797023,"score_spread":0.22081368669859722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149959926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85119057,0.06878854,0.019157667,0.03312064,0.007951548,0.00012020938,0.00076411007,0.0009372078,0.017969541],"genre_scores_gemma":[0.9641769,0.016443972,0.01227067,0.0028231533,0.0021980607,0.0000286944,0.00029218703,0.00007476103,0.0016916916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990614,0.0004227168,0.00011587721,0.00009501904,0.00021030332,0.00009467378],"domain_scores_gemma":[0.9929639,0.0035664223,0.0007613357,0.00030539557,0.0018831599,0.000519763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003677644,0.0008511725,0.0018496625,0.0015856646,0.00041635497,0.0012621159,0.0005971535,0.002062995,0.000698096],"category_scores_gemma":[0.018662348,0.00025928378,0.0004712936,0.000930951,0.000640999,0.0021776324,0.00041287308,0.0013900038,0.00084205513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006486182,0.0012121192,0.56032336,0.0011993957,0.00069850095,0.0022977951,0.0004666585,0.0015175438,0.017557094,0.0012088298,0.014923337,0.3921092],"study_design_scores_gemma":[0.0017718326,0.011329605,0.6999473,0.0022261771,0.0064244857,0.019612985,0.004451359,0.032960635,0.088393345,0.032323927,0.100090005,0.00046831014],"about_ca_topic_score_codex":0.003214181,"about_ca_topic_score_gemma":0.0038850985,"teacher_disagreement_score":0.003677644,"about_ca_system_score_codex":0.00032797773,"about_ca_system_score_gemma":0.0011797195,"threshold_uncertainty_score":0.019449532},"labels":[],"label_agreement":null},{"id":"W3154761299","doi":"10.1016/j.msard.2021.102945","title":"A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Cladribine; Medicine; Alemtuzumab; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Adverse effect; Regimen; Clinical trial; Transplantation; Immunology","score_opus":0.061552138367007236,"score_gpt":0.279093176129514,"score_spread":0.21754103776250677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154761299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974808,0.0013889908,0.00015202686,0.00008146822,0.000013755225,0.000029696217,0.00069318264,0.0000062682293,0.00015372754],"genre_scores_gemma":[0.9988355,0.00013435876,0.0001937778,0.00006902853,0.000016062284,0.000016031678,0.00068767776,0.0000056835956,0.00004188537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99460196,0.0027117874,0.0005266096,0.0012742514,0.00046592916,0.00041956903],"domain_scores_gemma":[0.986403,0.0046136943,0.004511127,0.0018551414,0.0013384561,0.0012784951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034180407,0.0006248912,0.0016043199,0.0008208969,0.0006071693,0.0015893914,0.0008647648,0.0011895513,0.001459478],"category_scores_gemma":[0.010788444,0.00057669147,0.002785304,0.0017161409,0.00084739976,0.0006778522,0.0010886478,0.0009191178,0.0002526411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026807921,0.00039790993,0.9483324,0.0007406723,0.011331443,0.00091294467,0.00052377005,0.0009374899,0.0021771647,0.00012536635,0.0010714892,0.006641459],"study_design_scores_gemma":[0.0012988596,0.002022663,0.990293,0.000069511865,0.0031251197,0.0008015331,0.00049823144,0.0008380343,0.00021959085,0.000049070946,0.0007313924,0.000052913925],"about_ca_topic_score_codex":0.0126638105,"about_ca_topic_score_gemma":0.014634505,"teacher_disagreement_score":0.0126638105,"about_ca_system_score_codex":0.0019922915,"about_ca_system_score_gemma":0.0012651809,"threshold_uncertainty_score":0.02518022},"labels":[],"label_agreement":null},{"id":"W3155780952","doi":"10.1016/j.msard.2021.102966","title":"Longitudinal analysis of disability outcomes among young people with MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Cognition; Physical medicine and rehabilitation; Longitudinal study; Physical therapy; Expanded Disability Status Scale; Gait; Young adult; Pediatrics; Gerontology; Psychiatry","score_opus":0.029299423419740667,"score_gpt":0.27336809062288925,"score_spread":0.24406866720314857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155780952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898905,0.00030710775,0.000042974498,0.000058221067,0.0000069404764,0.000005403032,0.00040660013,0.0000019335785,0.00018186859],"genre_scores_gemma":[0.99922204,0.00013849225,0.000027648279,0.00002333963,0.000006200047,0.00001052407,0.00037543022,7.264905e-7,0.0001955859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990196,0.000327743,0.000106207015,0.00011662734,0.00013444417,0.00029527652],"domain_scores_gemma":[0.9965347,0.0005543356,0.0013220338,0.00023575207,0.00061444705,0.0007386754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023656636,0.00022751187,0.00032508234,0.001388924,0.00090836815,0.0008052779,0.0003540127,0.0006712321,0.0008596674],"category_scores_gemma":[0.005741875,0.00028674555,0.00080581906,0.0014669271,0.00025628775,0.00084516814,0.0008533762,0.0008971294,0.00021196983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015535335,0.000055731907,0.9984396,0.0000070488327,0.000060525268,0.00003075197,0.0002029938,0.00001605454,0.000062731626,0.000015446893,0.000053252184,0.000900567],"study_design_scores_gemma":[0.0000058602873,0.00015402099,0.9991248,0.000007526164,0.00003889302,0.00004242167,0.0004208757,0.000055957156,0.00002515835,0.000017487346,0.000104123836,0.0000028963861],"about_ca_topic_score_codex":0.037049755,"about_ca_topic_score_gemma":0.03301589,"teacher_disagreement_score":0.037049755,"about_ca_system_score_codex":0.0006459631,"about_ca_system_score_gemma":0.0012096064,"threshold_uncertainty_score":0.07366824},"labels":[],"label_agreement":null},{"id":"W3155910301","doi":"10.1016/j.msard.2021.102967","title":"Socioeconomic status and access to multiple sclerosis treatment in Mexico","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Multiple sclerosis; Socioeconomic status; Neurology; Neurosurgery; Pediatrics; Expanded Disability Status Scale; Internal medicine; Physical therapy; Surgery; Population; Environmental health; Immunology","score_opus":0.05984559780417387,"score_gpt":0.2989172757336982,"score_spread":0.23907167792952433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155910301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979961,0.0004859731,0.000014321305,0.000310163,0.0000062828894,0.0000032564224,0.00021163913,8.9939846e-7,0.0009713828],"genre_scores_gemma":[0.9989773,0.00044889346,0.000022295933,0.000062012645,0.000011194176,0.0000057030707,0.00016250758,0.0000012172103,0.00030892008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996247,0.00012300212,0.000030418287,0.000038708324,0.000034901088,0.00014819679],"domain_scores_gemma":[0.99864584,0.00020912288,0.0007818746,0.00004616649,0.00007964205,0.00023729677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044351094,0.00014215967,0.00024232152,0.00096429494,0.0010409233,0.001058273,0.0003503484,0.00039079846,0.0029389146],"category_scores_gemma":[0.0022776795,0.0001975437,0.00035605027,0.0016306466,0.00035520794,0.00052165694,0.00090425333,0.0005800475,0.00010910791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015218896,0.00014278953,0.9963804,0.000021406575,0.000098278106,0.0001288007,0.0007391932,0.00003501635,0.0000561528,0.00024852235,0.00025884018,0.0017386031],"study_design_scores_gemma":[0.0000130556355,0.00004005672,0.99739754,0.0000336521,0.00004489307,0.000070927075,0.0016968955,0.0000558389,0.000014560919,0.000054164084,0.00057471974,0.0000036292447],"about_ca_topic_score_codex":0.11983377,"about_ca_topic_score_gemma":0.13089612,"teacher_disagreement_score":0.11983377,"about_ca_system_score_codex":0.0010375155,"about_ca_system_score_gemma":0.00075804634,"threshold_uncertainty_score":0.23827249},"labels":[],"label_agreement":null},{"id":"W3157740433","doi":"10.1016/j.msard.2021.102990","title":"A pilot trial of autologous hematopoietic stem cell transplant in neuromyelitis optic spectrum disorder","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Neuromyelitis optica; Rituximab; Multiple sclerosis; Spectrum disorder; Expanded Disability Status Scale; Hematopoietic stem cell transplantation; Cyclophosphamide; Pediatrics; Internal medicine; Transplantation; Surgery; Lymphoma; Immunology; Chemotherapy; Psychiatry","score_opus":0.03200563233889158,"score_gpt":0.24937753894676243,"score_spread":0.21737190660787084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157740433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967044,0.00074797025,0.00019365779,0.0004560606,0.00021408954,0.00071479793,0.0002465559,0.000019280504,0.00070313975],"genre_scores_gemma":[0.99694115,0.00047843513,0.00041154475,0.00040031498,0.00022047867,0.00062795024,0.00035037412,0.000006207666,0.00056354754],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99891126,0.00066578924,0.00006470654,0.00014255838,0.000049744263,0.00016593334],"domain_scores_gemma":[0.99808526,0.00075249444,0.00012783027,0.0001999471,0.00009873662,0.0007357976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002188388,0.0010022479,0.0020037766,0.0003946971,0.00086442125,0.00088581844,0.00081158045,0.0016628332,0.004018087],"category_scores_gemma":[0.0021023965,0.00036169364,0.0012774987,0.0004886732,0.001937186,0.00094382325,0.00061853474,0.0026302827,0.0005985304],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9605457,0.018160706,0.0016060275,0.0001548793,0.0004357451,0.0002458816,0.000089940295,0.0004103261,0.0037685146,0.00021458857,0.0004595969,0.013908192],"study_design_scores_gemma":[0.6306435,0.36275315,0.004295069,0.000020338235,0.0002715758,0.000118390846,0.000063459986,0.0003084979,0.0008254336,0.00020443292,0.00048318968,0.00001298499],"about_ca_topic_score_codex":0.0015595566,"about_ca_topic_score_gemma":0.0014874947,"teacher_disagreement_score":0.004018087,"about_ca_system_score_codex":0.00063518184,"about_ca_system_score_gemma":0.0016357282,"threshold_uncertainty_score":0.013441861},"labels":[],"label_agreement":null},{"id":"W3161653279","doi":"10.1016/j.msard.2021.103009","title":"Transcutaneous spinal cord stimulation improves postural stability in individuals with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Glenrose Rehabilitation Hospital; Alberta Health Services; Women and Children’s Health Research Institute; University of Alberta Hospital; University of Alberta","funders":"Houston Methodist Hospital","keywords":"Medicine; Multiple sclerosis; Stimulation; Center of pressure (fluid mechanics); Physical medicine and rehabilitation; Proprioception; Spinal cord; Functional electrical stimulation; Internal medicine","score_opus":0.040851118059993086,"score_gpt":0.29294306247146235,"score_spread":0.25209194441146926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161653279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910754,0.00043405723,0.00015077599,0.000026279793,0.000004778271,0.000007826838,0.000013668574,0.0000104754645,0.00024456746],"genre_scores_gemma":[0.99936014,0.00019534094,0.00028293833,0.000019844067,0.0000080963555,0.0000076005795,0.00002091359,9.113144e-7,0.00010416514],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99994123,0.000015056319,0.000007804065,0.000010373193,0.000017338893,0.00000834347],"domain_scores_gemma":[0.9998523,0.000048731592,0.00003567633,0.000007782293,0.000027963524,0.000027483558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012760432,0.00027429222,0.00022196026,0.0001818965,0.00014244312,0.00010208244,0.000083576015,0.00021702876,0.0010476271],"category_scores_gemma":[0.00052303454,0.000043505006,0.00009922536,0.00009634263,0.00014276635,0.00008229507,0.00012951852,0.00012655795,0.00009837744],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008221996,0.002521258,0.20942694,0.001018519,0.00057342596,0.0012825495,0.0009893088,0.0008442942,0.48087248,0.000030268371,0.00063059834,0.29358834],"study_design_scores_gemma":[0.00019531346,0.013738835,0.9724018,0.000040520037,0.00016368102,0.0018288493,0.00019887263,0.0005413745,0.010417314,0.000057832254,0.00040725112,0.000008352553],"about_ca_topic_score_codex":0.00039630005,"about_ca_topic_score_gemma":0.0010629208,"teacher_disagreement_score":0.0010476271,"about_ca_system_score_codex":0.00006810039,"about_ca_system_score_gemma":0.00007576649,"threshold_uncertainty_score":0.0035046935},"labels":[],"label_agreement":null},{"id":"W3162915930","doi":"10.1016/j.msard.2021.103012","title":"The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cegep de Saint Jerome; Université de Montréal; Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; Centre Hospitalier Universitaire de Rennes; Sanofi Genzyme; Multiple Sclerosis Society; Centre Hospitalier Universitaire de Nice; Sanofi; Université Claude Bernard Lyon 1; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Toulouse; Multiple Sclerosis Society of Canada; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; Merck; Teva Pharmaceutical Industries; Université de Lorraine; Centre Hospitalier Universitaire de Bordeaux; Hospices Civils de Lyon; Agence Nationale de la Recherche; Roche","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Hazard ratio; Internal medicine; Immunology; Confidence interval","score_opus":0.04998136824734042,"score_gpt":0.33259484200560463,"score_spread":0.28261347375826423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162915930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7695534,0.19362044,0.0072743203,0.0024092179,0.0007781958,0.001696735,0.013767462,0.00015657021,0.01074363],"genre_scores_gemma":[0.97172683,0.015987525,0.0021652677,0.0004985764,0.00035831705,0.0012904257,0.0075579486,0.00013077683,0.00028438217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7962865,0.1427955,0.035858724,0.011755915,0.011049371,0.0022540488],"domain_scores_gemma":[0.6244022,0.2048845,0.1123203,0.035509907,0.020531537,0.0023515243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.17339502,0.0014024429,0.005453499,0.009131624,0.00065404247,0.00581292,0.0026053083,0.0016721387,0.0039242213],"category_scores_gemma":[0.27190563,0.0010959525,0.0116709,0.012206464,0.0014690763,0.004580921,0.0036043017,0.0014632165,0.0004984608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10674091,0.000516099,0.5554369,0.022156408,0.22081138,0.0004261284,0.002507002,0.0019944438,0.0008655086,0.0027397973,0.0038093315,0.08199609],"study_design_scores_gemma":[0.015190307,0.009122343,0.60644835,0.011913683,0.32895318,0.0017806648,0.0036797016,0.002376102,0.0023774824,0.0023032255,0.015475443,0.00037951375],"about_ca_topic_score_codex":0.0013882417,"about_ca_topic_score_gemma":0.001507381,"teacher_disagreement_score":0.17339502,"about_ca_system_score_codex":0.0015062784,"about_ca_system_score_gemma":0.0019384328,"threshold_uncertainty_score":0.9170115},"labels":[],"label_agreement":null},{"id":"W3162935255","doi":"10.1016/j.msard.2021.103006","title":"Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network; University of British Columbia; Memorial University of Newfoundland","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Biomarker; Interleukin 1 receptor antagonist; Microglia; Receptor antagonist; Expanded Disability Status Scale; Immunology; Cerebrospinal fluid; Interleukin; Pathology; Internal medicine; Receptor; Antagonist; Inflammation; Cytokine; Biology","score_opus":0.05859214145914149,"score_gpt":0.25994149441028497,"score_spread":0.20134935295114348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162935255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965803,0.001781869,0.0003927476,0.00008976199,0.000020323321,0.000030131172,0.00026677092,0.000020251038,0.000817895],"genre_scores_gemma":[0.9981067,0.00039262132,0.00080066605,0.00009864161,0.000050566723,0.00003136826,0.00026272066,0.0000036539277,0.00025312795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995552,0.00019381961,0.000042723026,0.00007554995,0.00008447437,0.000048209644],"domain_scores_gemma":[0.9990972,0.00024681076,0.00035624532,0.000050015748,0.000111719324,0.00013800326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008230272,0.00053095067,0.00059498806,0.00087786716,0.00038506676,0.0008095557,0.00019966591,0.00073552487,0.0006938583],"category_scores_gemma":[0.0021263692,0.00016751052,0.00023867072,0.0006861423,0.00022622007,0.00046103704,0.00031567007,0.00055330683,0.00022525864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043039634,0.0004934669,0.9269928,0.00020070319,0.00056630996,0.0007963996,0.00041813502,0.00024270594,0.04015292,0.00013754667,0.0004949766,0.02520005],"study_design_scores_gemma":[0.00012498596,0.002308484,0.9884133,0.00004428575,0.00029197673,0.0027138703,0.0002826704,0.00079251814,0.0038859344,0.00020852989,0.000909121,0.000024356317],"about_ca_topic_score_codex":0.0004631386,"about_ca_topic_score_gemma":0.0007356685,"teacher_disagreement_score":0.00087786716,"about_ca_system_score_codex":0.00016017823,"about_ca_system_score_gemma":0.00034702607,"threshold_uncertainty_score":0.004352629},"labels":[],"label_agreement":null},{"id":"W3163139312","doi":"10.1016/j.msard.2021.103016","title":"A mindfulness group intervention in newly diagnosed persons with multiple sclerosis: A pilot study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Parkwood Institute; London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Lawson Health Research Institute","keywords":"Medicine; Physical therapy; Mindfulness; Anxiety; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Psychological intervention; Repeated measures design; Coping (psychology); Clinical psychology; Psychiatry","score_opus":0.048685031934047635,"score_gpt":0.2722002085374608,"score_spread":0.22351517660341316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163139312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990915,0.00005914037,0.000065405635,0.000025926383,0.000011467596,0.0005598516,0.000018630457,0.0000043119044,0.0001637812],"genre_scores_gemma":[0.9960616,0.00028965418,0.001169275,0.00012414226,0.00005012979,0.0018037212,0.00008924474,0.00000218504,0.0004099839],"study_design_codex":"nonrandomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941254,0.00023964277,0.000046935686,0.00008977652,0.00007789862,0.00013318998],"domain_scores_gemma":[0.9988217,0.00036634196,0.0001011708,0.00009950138,0.000096420816,0.0005148644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011259565,0.00070372265,0.0013283145,0.00057628314,0.0014321036,0.00044225095,0.00076616864,0.001032894,0.0017953234],"category_scores_gemma":[0.0014400423,0.0004980716,0.00088528387,0.00037525108,0.000700457,0.0005484965,0.00071503245,0.0011975968,0.00020872065],"study_design_candidate":"nonrandomized_trial","study_design_consensus":"nonrandomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13109612,0.65058196,0.03633283,0.0013706471,0.0007892506,0.0010730838,0.008344886,0.0005534393,0.037473988,0.00016997075,0.00050541305,0.13170828],"study_design_scores_gemma":[0.07669122,0.71544397,0.20031966,0.000095948286,0.0007400244,0.00030907453,0.002821255,0.0007377371,0.0021178531,0.00012740184,0.0005419147,0.000053917152],"about_ca_topic_score_codex":0.00573478,"about_ca_topic_score_gemma":0.0075918166,"teacher_disagreement_score":0.00573478,"about_ca_system_score_codex":0.00046163602,"about_ca_system_score_gemma":0.001614285,"threshold_uncertainty_score":0.011402786},"labels":[],"label_agreement":null},{"id":"W3163435887","doi":"10.1016/j.msard.2021.103003","title":"Cross-sectional analysis of peripheral blood mononuclear cells in lymphopenic and non-lymphopenic relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate.","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Government of Alberta; Biogen","keywords":"Immunophenotyping; Medicine; Peripheral blood mononuclear cell; CD8; Multiple sclerosis; Population; Immunology; Monocyte; Internal medicine; CD16; Immune system; Flow cytometry; Gastroenterology; CD3; Biology; In vitro","score_opus":0.023190131559225682,"score_gpt":0.24941706729005644,"score_spread":0.22622693573083075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163435887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992223,0.00027694248,0.000027959419,0.000012201701,0.000004334949,0.0000069959906,0.00021361894,0.0000016909594,0.00023403796],"genre_scores_gemma":[0.9995468,0.00006663168,0.00003286083,0.000024748066,0.0000051243564,0.0000090154845,0.00018175472,6.0098097e-7,0.00013238002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975425,0.00009328389,0.000027230028,0.000058844405,0.0000292276,0.000037264104],"domain_scores_gemma":[0.99928904,0.00016165701,0.00024386281,0.000035485602,0.000109267385,0.00016075425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003649077,0.00014520189,0.000249879,0.0003826983,0.0002249009,0.00026928808,0.0001359037,0.000314626,0.0012501188],"category_scores_gemma":[0.0009925975,0.0001576864,0.0001842555,0.0003902414,0.00009654091,0.00017308077,0.00012693091,0.00030358176,0.00016785093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018746393,0.00015504038,0.9945057,0.000020188407,0.00011549202,0.0001104839,0.00010000007,0.000018411984,0.0017746926,0.000009979423,0.00007319664,0.0012423177],"study_design_scores_gemma":[0.000017124601,0.00038360473,0.9991128,0.000002191729,0.000036915237,0.00013074165,0.00010949553,0.0000337752,0.00008577665,0.000004947303,0.00008106005,0.0000015993584],"about_ca_topic_score_codex":0.0024035377,"about_ca_topic_score_gemma":0.0025586404,"teacher_disagreement_score":0.0024035377,"about_ca_system_score_codex":0.0001375397,"about_ca_system_score_gemma":0.0001232805,"threshold_uncertainty_score":0.00477916},"labels":[],"label_agreement":null},{"id":"W3164228261","doi":"10.1016/j.msard.2021.103041","title":"Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Corporation; American University of Beirut","keywords":"Fingolimod; Medicine; Multiple sclerosis; Retinal; Montreal Cognitive Assessment; Cognition; Cognitive decline; Internal medicine; Audiology; Ophthalmology; Disease; Immunology; Cognitive impairment; Psychiatry; Dementia","score_opus":0.048822441238611604,"score_gpt":0.2905171473254759,"score_spread":0.2416947060868643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164228261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978084,0.0014593552,0.000027968255,0.00006745015,0.00004502392,0.000017498147,0.00011895881,0.0000037133825,0.00045160844],"genre_scores_gemma":[0.99896514,0.000340961,0.00008060316,0.000056493755,0.00007194088,0.000025420712,0.00013054829,0.0000024420888,0.0003264428],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987237,0.00064895616,0.00013662224,0.00017464104,0.00013399187,0.00018202397],"domain_scores_gemma":[0.9981627,0.0010192702,0.00034024162,0.0001502519,0.00009448781,0.0002331412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002477041,0.0005787952,0.0019933213,0.00035249506,0.00031605217,0.0006206923,0.0003788262,0.00086435577,0.001781667],"category_scores_gemma":[0.0036159393,0.00023869984,0.0017307106,0.00041803985,0.00033183402,0.00066459645,0.00030863218,0.0012538155,0.00016933243],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9383467,0.0038356055,0.029255394,0.00020262042,0.002702853,0.000083063474,0.000104182946,0.00033152607,0.0027200943,0.000047778693,0.00020458775,0.02216557],"study_design_scores_gemma":[0.057934694,0.21587902,0.7061072,0.00015673322,0.010827239,0.0002709339,0.00037342947,0.0018005335,0.0046838573,0.0004400364,0.0014210307,0.00010524015],"about_ca_topic_score_codex":0.0023537322,"about_ca_topic_score_gemma":0.0023999242,"teacher_disagreement_score":0.002477041,"about_ca_system_score_codex":0.00046052007,"about_ca_system_score_gemma":0.0006718974,"threshold_uncertainty_score":0.013099968},"labels":[],"label_agreement":null},{"id":"W3166952808","doi":"10.1016/j.msard.2021.103249","title":"Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Nova Scotia Health Research Foundation; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society; Dalhousie Medical Research Foundation; U.S. Department of Defense","keywords":"Discontinuation; Comorbidity; Medicine; Glatiramer acetate; Internal medicine; Proportional hazards model; Hazard ratio; Physical therapy; Disease; Psychiatry; Pediatrics; Confidence interval","score_opus":0.12828306854256744,"score_gpt":0.2860483914292349,"score_spread":0.15776532288666745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166952808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697375,0.002298115,0.000035340672,0.000060607945,0.000010904963,0.000003356123,0.00025129394,0.000002593065,0.00036396115],"genre_scores_gemma":[0.99926764,0.00033555916,0.00003740783,0.000021331298,0.000020245318,0.0000037975597,0.00022647891,0.00000127655,0.00008627131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979857,0.00086541224,0.00046004937,0.00021292103,0.0002471197,0.00022877516],"domain_scores_gemma":[0.9901265,0.0027465844,0.0051089386,0.00057695014,0.00046467222,0.00097643054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017394704,0.00029660566,0.00086819154,0.0017621289,0.00082660804,0.0012143037,0.0004404131,0.0008414312,0.0017742435],"category_scores_gemma":[0.01072594,0.00031005312,0.0010744946,0.0028152703,0.00035014522,0.0009867775,0.00086725026,0.00095613266,0.00018196624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003772567,0.000058473164,0.9977804,0.000019079596,0.00028060106,0.000051042272,0.00008426674,0.000022194037,0.00008751248,0.000013481226,0.000029144398,0.0011966154],"study_design_scores_gemma":[0.000008048092,0.00011744536,0.9992835,0.0000127563135,0.00008108983,0.00017092763,0.00015126722,0.00007075411,0.000020779424,0.000015002699,0.000064232234,0.0000042419524],"about_ca_topic_score_codex":0.007746629,"about_ca_topic_score_gemma":0.007958825,"teacher_disagreement_score":0.007746629,"about_ca_system_score_codex":0.0004414008,"about_ca_system_score_gemma":0.0005187975,"threshold_uncertainty_score":0.015403092},"labels":[],"label_agreement":null},{"id":"W3170288888","doi":"10.1016/j.msard.2021.103050","title":"A non-parametric propensity score for estimating the effect of interferon-beta or glatiramer acetate on long-term outcomes of multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Armand-Frappier Foundation; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Glatiramer acetate; Medicine; Multiple sclerosis; Internal medicine; Confounding; Logistic regression; Propensity score matching; Hazard ratio; Proportional hazards model; Interferon beta-1a; Interferon beta-1b; Interferon beta; Immunology; Confidence interval","score_opus":0.0967418744945849,"score_gpt":0.3135608160988775,"score_spread":0.21681894160429258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170288888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77968013,0.001911716,0.21330848,0.0005975155,0.00031518462,0.0007313175,0.0021196587,0.00042262144,0.00091347366],"genre_scores_gemma":[0.97474366,0.00026479323,0.022188423,0.00009193443,0.00007569535,0.0004899493,0.001306007,0.000032332337,0.000807287],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9762171,0.019327337,0.0011751578,0.0018629312,0.00095244363,0.00046515043],"domain_scores_gemma":[0.92585146,0.058962133,0.0061754687,0.006729002,0.001565469,0.00071643695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03473888,0.000910884,0.0025682626,0.0024286797,0.00051537476,0.0015437353,0.0016688069,0.0018636261,0.0044236234],"category_scores_gemma":[0.07331003,0.0005273143,0.0045638946,0.0024493018,0.0010352253,0.0015941026,0.0017558126,0.0021134797,0.00041409186],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024794329,0.00086862035,0.70862466,0.0007225344,0.026011033,0.0005847248,0.0003201601,0.06734734,0.002761776,0.00938225,0.004363403,0.1542192],"study_design_scores_gemma":[0.0035617866,0.007846587,0.36744425,0.00021085102,0.008675425,0.0010961432,0.00040040855,0.5888116,0.0012065812,0.017191269,0.003343448,0.00021165528],"about_ca_topic_score_codex":0.001916025,"about_ca_topic_score_gemma":0.0011245158,"teacher_disagreement_score":0.03473888,"about_ca_system_score_codex":0.0005864369,"about_ca_system_score_gemma":0.0013386244,"threshold_uncertainty_score":0.18371898},"labels":[],"label_agreement":null},{"id":"W3173562773","doi":"10.1016/j.msard.2021.103088","title":"Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; St. Francis Xavier University; University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Research Manitoba","keywords":"Medicine; Brain size; Framingham Risk Score; Framingham Heart Study; Percentile; Internal medicine; Multiple sclerosis; Cardiology; Disease; Magnetic resonance imaging","score_opus":0.030160773771186908,"score_gpt":0.23914466033544274,"score_spread":0.20898388656425582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173562773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792576,0.0009563016,0.00022159232,0.00014011325,0.000016894139,0.0000050264216,0.00018086407,0.000011315491,0.0005421381],"genre_scores_gemma":[0.9993337,0.00019534938,0.00014208745,0.000023381495,0.00003095058,0.000004188059,0.00012494254,0.0000027809658,0.0001424364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999468,0.0001668286,0.000040789873,0.00014001271,0.00010434671,0.000080062106],"domain_scores_gemma":[0.9947259,0.0013852444,0.0029378613,0.00031161832,0.00027107506,0.00036828395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001669634,0.0003595825,0.00037865108,0.0010229279,0.00032499773,0.00057531754,0.00032931875,0.00059314055,0.0021838052],"category_scores_gemma":[0.006136571,0.0002445693,0.00060364034,0.0008204827,0.00034973086,0.0003948759,0.00041090418,0.00096610974,0.00016269855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002455999,0.000031397267,0.99567115,0.000012280346,0.00013960364,0.00009740125,0.000096457545,0.00011441013,0.00020061767,0.000046065776,0.00010722203,0.00323774],"study_design_scores_gemma":[0.0000022745085,0.00004669845,0.9995055,0.000004188436,0.000028641112,0.00009880737,0.000021248228,0.00013545984,0.000020321117,0.000076463395,0.00005813889,0.0000022822853],"about_ca_topic_score_codex":0.0041931467,"about_ca_topic_score_gemma":0.0030199557,"teacher_disagreement_score":0.0041931467,"about_ca_system_score_codex":0.0002167936,"about_ca_system_score_gemma":0.00021116696,"threshold_uncertainty_score":0.008829951},"labels":[],"label_agreement":null},{"id":"W3173632496","doi":"10.1016/j.msard.2021.103105","title":"Cannabinoids and bladder symptoms in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Department of Obstetrics and Gynecology, University of Wisconsin-Madison","keywords":"Cannabis; Medicine; Logistic regression; Cross-sectional study; Environmental health; Consumption (sociology); Psychiatry; Internal medicine","score_opus":0.024350194998976758,"score_gpt":0.24067593192462036,"score_spread":0.2163257369256436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173632496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.932019,0.06369456,0.00008254859,0.0008806291,0.00008068674,0.000019353627,0.00011444802,0.000006686381,0.003102139],"genre_scores_gemma":[0.9871535,0.011552632,0.00011047192,0.00017360241,0.00008745634,0.000006962033,0.00006901095,0.0000014551273,0.00084508845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998721,0.000043995977,0.000018393712,0.000009966402,0.000030505074,0.000025070878],"domain_scores_gemma":[0.99941576,0.00024037989,0.00016381154,0.000016852018,0.000052713087,0.000110511755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037422578,0.00023882093,0.00045561284,0.0011308985,0.0006560926,0.0006014535,0.00027478614,0.00075217243,0.0021792443],"category_scores_gemma":[0.0013771121,0.00015678878,0.0003688371,0.00095746864,0.00046450406,0.00045171412,0.00048620233,0.00056761235,0.00009538362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023670377,0.0020537928,0.79147595,0.0025695984,0.0013466686,0.016133497,0.0012746841,0.0004950695,0.020194238,0.0015734365,0.0017067028,0.13750604],"study_design_scores_gemma":[0.00021222902,0.00096754316,0.9868721,0.00025321083,0.00041048118,0.0049457583,0.00092053926,0.00037588566,0.0010761569,0.0012590538,0.0026750965,0.0000319253],"about_ca_topic_score_codex":0.007339091,"about_ca_topic_score_gemma":0.009625217,"teacher_disagreement_score":0.007339091,"about_ca_system_score_codex":0.0005416914,"about_ca_system_score_gemma":0.0006250738,"threshold_uncertainty_score":0.014592767},"labels":[],"label_agreement":null},{"id":"W3174727609","doi":"10.1016/j.msard.2021.103124","title":"Susceptibility weighted imaging detects prominent veins that precede or coincide with maximal motor disability in a model of multiple sclerosis: A pilot study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research; Alberta Innovates - Health Solutions; Multiple Sclerosis Society of Canada; Canada Foundation for Innovation; Canadian Institutes of Health Research","keywords":"Susceptibility weighted imaging; Multiple sclerosis; Medicine; Experimental autoimmune encephalomyelitis; Spinal cord; Pathology; Magnetic resonance imaging; White matter; Immunology; Radiology","score_opus":0.0739931107559621,"score_gpt":0.276170572251512,"score_spread":0.20217746149554988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174727609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992824,0.000059749418,0.00028330294,0.000040093626,0.000011697882,0.00009145109,0.00005820091,0.000009542172,0.00016351313],"genre_scores_gemma":[0.9981993,0.00016675018,0.00065035716,0.000053721436,0.000041710216,0.00010982221,0.00016901518,0.0000094843235,0.0005998126],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995844,0.00015858727,0.00002196595,0.000083003615,0.000044169785,0.00010787621],"domain_scores_gemma":[0.9985781,0.00040788375,0.00024946916,0.00020137499,0.0001229575,0.0004401812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012973085,0.0012199199,0.0007258927,0.0009487577,0.0005394845,0.00041573605,0.00061453343,0.0007914994,0.0015107263],"category_scores_gemma":[0.0011557218,0.00037005483,0.000531926,0.0003548375,0.0012191063,0.00080045534,0.0004252712,0.001280834,0.00023402556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08205711,0.06130174,0.02903236,0.00021486674,0.0003204083,0.0043114396,0.0006559553,0.0005917872,0.8111768,0.00043595952,0.0005776842,0.009323925],"study_design_scores_gemma":[0.008555388,0.58430576,0.18685111,0.00004154957,0.0006812271,0.008366899,0.0011919237,0.0051568802,0.20304643,0.00053202576,0.0011657923,0.00010495238],"about_ca_topic_score_codex":0.0012865639,"about_ca_topic_score_gemma":0.0016413236,"teacher_disagreement_score":0.0015107263,"about_ca_system_score_codex":0.00035076984,"about_ca_system_score_gemma":0.00042630333,"threshold_uncertainty_score":0.006860912},"labels":[],"label_agreement":null},{"id":"W31758784","doi":"10.1016/j.msard.2011.07.002","title":"Multiple sclerosis in children","year":2011,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Multiple Sclerosis Society of Canada; Multiple Sclerosis Scientific Research Foundation","keywords":"Multiple sclerosis; Medicine; Neuroimaging; Pediatrics; Epidemiology; Psychiatry; Family medicine; Pathology","score_opus":0.0325694220883064,"score_gpt":0.25639660886621696,"score_spread":0.22382718677791055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31758784","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004798589,0.022605369,0.00007857772,0.048782554,0.9275671,0.000017053171,0.000048336977,0.000031343756,0.0008217384],"genre_scores_gemma":[0.000480458,0.013563467,0.000110950365,0.04813139,0.9346097,0.000037609505,0.000034363416,0.000020299432,0.0030117948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905912,0.0026039227,0.0021744652,0.0008858721,0.0030620515,0.0006824468],"domain_scores_gemma":[0.9620591,0.019377531,0.0036203978,0.0011066542,0.009465756,0.004370483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014763868,0.0041227075,0.00683735,0.0053287945,0.0031913328,0.006866141,0.0042039743,0.030345486,0.0066159633],"category_scores_gemma":[0.040986508,0.0021401239,0.003898937,0.002554228,0.0030877301,0.004567655,0.0035724537,0.030454105,0.004664733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005319836,0.000011206805,0.00009739161,0.00071732025,0.00008255514,0.00034507652,0.000028248669,0.000020611935,0.000041193987,0.00023758484,0.98942125,0.0089442935],"study_design_scores_gemma":[0.0002433031,0.000056080396,0.0014690039,0.0027898282,0.00047614364,0.0011402126,0.00010410525,0.00010350553,0.000097493605,0.00051502406,0.99296653,0.000038775433],"about_ca_topic_score_codex":0.0056911795,"about_ca_topic_score_gemma":0.01268552,"teacher_disagreement_score":0.030345486,"about_ca_system_score_codex":0.0055989283,"about_ca_system_score_gemma":0.0060209986,"threshold_uncertainty_score":0.0780797},"labels":[],"label_agreement":null},{"id":"W3179310843","doi":"10.1016/j.msard.2021.103130","title":"Cognitive fatigability in multiple sclerosis: How does performance decline over time on the Paced Auditory Serial Addition Test?","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Carleton University; Ottawa Hospital","funders":"Multiple Sclerosis Society of Canada; University of Ottawa","keywords":"Paced Auditory Serial Addition Test; Audiology; Cognition; Analysis of variance; Neuropsychology; Mixed-design analysis of variance; Stimulus (psychology); Task (project management); Multiple sclerosis; Neuropsychological test; Medicine; Repeated measures design; Psychology; Effects of sleep deprivation on cognitive performance; Developmental psychology; Physical medicine and rehabilitation; Cognitive psychology; Psychiatry; Statistics","score_opus":0.0385241016422043,"score_gpt":0.25206659613563487,"score_spread":0.21354249449343057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179310843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964709,0.00127661,0.00020024854,0.00021215995,0.000030534964,0.000019456445,0.00025160643,0.000013503035,0.0015250524],"genre_scores_gemma":[0.9984276,0.0004550788,0.00014966803,0.00007878065,0.000054761298,0.000021362082,0.00031538145,0.000006191297,0.0004911686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994273,0.00015395482,0.00008226961,0.000119111144,0.00014910803,0.00006821151],"domain_scores_gemma":[0.99599636,0.0013179682,0.0014942065,0.00023937706,0.00057797605,0.00037411155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001502003,0.0006876149,0.0007312922,0.0015977557,0.00039991093,0.0008088409,0.00074878935,0.0014032185,0.0012795451],"category_scores_gemma":[0.0099799605,0.00021789795,0.00061571354,0.0012125687,0.00056409376,0.001343751,0.00044504978,0.0009240597,0.0004622311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090655254,0.00056500355,0.9779468,0.00007946396,0.00029974093,0.0003517361,0.00047573712,0.00032908045,0.0012498297,0.000051986226,0.00034082815,0.017403178],"study_design_scores_gemma":[0.00000932693,0.00032588808,0.998558,0.000011525099,0.0000578501,0.00021718701,0.00016441043,0.00027227172,0.00011957259,0.00007254561,0.00018311423,0.000008359586],"about_ca_topic_score_codex":0.010439366,"about_ca_topic_score_gemma":0.01053478,"teacher_disagreement_score":0.010439366,"about_ca_system_score_codex":0.00030301415,"about_ca_system_score_gemma":0.00033462935,"threshold_uncertainty_score":0.020757198},"labels":[],"label_agreement":null},{"id":"W3182293793","doi":"10.1016/j.msard.2021.103149","title":"Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital; University of British Columbia; McGill University","funders":"National Institutes of Health; Fonds de recherche du Québec; Government of South Australia; National Institute of Allergy and Infectious Diseases; Immune Tolerance Network","keywords":"Medicine; Multiple sclerosis; White matter; Transplantation; Immunosuppression; Brain size; Nuclear medicine; Grey matter; Hematopoietic cell; Internal medicine; Magnetic resonance imaging; Oncology; Stem cell; Haematopoiesis; Radiology; Immunology; Biology","score_opus":0.03345681017649542,"score_gpt":0.2550159212055808,"score_spread":0.22155911102908538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182293793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990953,0.00052588794,0.000033016233,0.000017435656,0.000013611719,0.000009018926,0.000032392993,0.0000040345903,0.00026942277],"genre_scores_gemma":[0.99957913,0.00012516348,0.000019277046,0.000015417474,0.00002057649,0.000006902095,0.000059834623,0.0000017258183,0.00017198642],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99967,0.000129386,0.000018228724,0.000031574662,0.00007926946,0.00007159576],"domain_scores_gemma":[0.99944514,0.00021389617,0.00013845899,0.0000456178,0.000048113718,0.000108764696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055966823,0.00026472198,0.00069004967,0.00043473576,0.00020137575,0.00031381176,0.00039881506,0.00038393433,0.0011153595],"category_scores_gemma":[0.0012477647,0.00009049113,0.000351249,0.00041217115,0.0005057243,0.00042050466,0.0002502896,0.00064447254,0.00012801123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47509575,0.019978674,0.21439964,0.000572576,0.0020979554,0.006118463,0.0009263744,0.0035020837,0.115087666,0.00040833306,0.0012752538,0.16053714],"study_design_scores_gemma":[0.0037401714,0.09552072,0.86744016,0.000028938182,0.0008274822,0.0026202577,0.00037466653,0.002077051,0.025517622,0.00049134495,0.0012948512,0.00006671654],"about_ca_topic_score_codex":0.0025553436,"about_ca_topic_score_gemma":0.0018524836,"teacher_disagreement_score":0.0025553436,"about_ca_system_score_codex":0.0003550876,"about_ca_system_score_gemma":0.0004342462,"threshold_uncertainty_score":0.005080998},"labels":[],"label_agreement":null},{"id":"W3186473405","doi":"10.1016/j.msard.2021.103159","title":"High-dose biotin for multiple sclerosis: A systematic review and meta-analyses of randomized controlled trials","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Biotin and Related Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Relative risk; Placebo; MEDLINE; Meta-analysis; Internal medicine; Systematic review; Multiple sclerosis; Pathology; Confidence interval; Psychiatry; Alternative medicine","score_opus":0.13169344900408472,"score_gpt":0.33982951166033093,"score_spread":0.2081360626562462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186473405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026045141,0.996402,0.00027427997,0.00009159241,0.000088351175,0.00014591854,0.00026844544,0.000013970964,0.00011095828],"genre_scores_gemma":[0.08535253,0.9104403,0.0019020396,0.00094442244,0.00017786089,0.0004102971,0.0004967432,0.000021365902,0.00025437144],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953687,0.0020933168,0.0013243349,0.0005887891,0.00042692866,0.00019792172],"domain_scores_gemma":[0.9920813,0.005686466,0.0015049591,0.00022990939,0.00035382327,0.00014355729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075571015,0.0025063953,0.018365229,0.002947963,0.00048402642,0.0025748217,0.0021570483,0.0023212323,0.0051326817],"category_scores_gemma":[0.015813373,0.0011882581,0.019476002,0.004692745,0.00070580264,0.0017777077,0.001578703,0.002195905,0.00032933257],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005714857,0.000057664,0.0020074842,0.5146608,0.4542073,0.00009883516,0.00008076698,0.00039455868,0.0003381534,0.00014801779,0.0008112188,0.02148047],"study_design_scores_gemma":[0.0033849657,0.00037772142,0.0036698368,0.02990715,0.95918804,0.000091605274,0.00007461113,0.0001366823,0.00011803097,0.00032260703,0.002689202,0.000039393042],"about_ca_topic_score_codex":0.0046646465,"about_ca_topic_score_gemma":0.014221664,"teacher_disagreement_score":0.018365229,"about_ca_system_score_codex":0.0017031465,"about_ca_system_score_gemma":0.0023589334,"threshold_uncertainty_score":0.039966285},"labels":[],"label_agreement":null},{"id":"W3188046047","doi":"10.1016/j.msard.2021.103206","title":"Longitudinally extensive transverse myelitis with positive aquaporin-4 IgG associated with dengue infection: a case report and systematic review of cases","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; University of Calgary; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Neuromyelitis optica; Medicine; Transverse myelitis; Dengue fever; Serology; Rituximab; Immunology; Multiple sclerosis; Pediatrics; Antibody","score_opus":0.05147709847104438,"score_gpt":0.3069706806845038,"score_spread":0.2554935822134594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188046047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032341043,0.995821,0.00008995719,0.00010712961,0.000043594646,0.00007525766,0.00043438168,0.0000036695512,0.00019090962],"genre_scores_gemma":[0.023557294,0.97505206,0.0004574437,0.00037778265,0.000041584637,0.00007356029,0.00035287935,0.0000035095923,0.00008389959],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976998,0.00027988807,0.0014115615,0.00025278598,0.0002773794,0.000078663026],"domain_scores_gemma":[0.9941865,0.0035003172,0.001712488,0.00012997474,0.00038418866,0.00008650863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018348441,0.0007380845,0.0033822223,0.0077231987,0.0004993789,0.0015861569,0.001262975,0.0013000093,0.0021935126],"category_scores_gemma":[0.007887326,0.0006166867,0.0033324347,0.008030969,0.0006813146,0.001656283,0.0010149862,0.0006559466,0.00023370047],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005970759,0.00008141319,0.018949382,0.81048876,0.015789526,0.0061112996,0.0009673392,0.00024270813,0.0015833155,0.000558564,0.0057009254,0.13892974],"study_design_scores_gemma":[0.00039030795,0.00034249524,0.069589816,0.67047065,0.13615614,0.038063977,0.0026859224,0.00016796734,0.0010372677,0.0008975935,0.07992281,0.00027502663],"about_ca_topic_score_codex":0.005139845,"about_ca_topic_score_gemma":0.01743282,"teacher_disagreement_score":0.0077231987,"about_ca_system_score_codex":0.0010826472,"about_ca_system_score_gemma":0.00407943,"threshold_uncertainty_score":0.010219872},"labels":[],"label_agreement":null},{"id":"W3192175397","doi":"10.1016/j.msard.2021.103165","title":"The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Medicine; Physical disability; Physical therapy; Cohort; Physical medicine and rehabilitation; Cross-sectional study; Internal medicine; Pathology; Psychiatry","score_opus":0.24547990116250468,"score_gpt":0.3614456529966943,"score_spread":0.11596575183418961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192175397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903886,0.0027891065,0.0023796584,0.0002301984,0.000117549636,0.00021841064,0.0015254787,0.00002875501,0.0023222046],"genre_scores_gemma":[0.9955123,0.00047952624,0.00261286,0.00009691025,0.000044701083,0.00018498034,0.00083514734,0.0000052926716,0.00022819641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98915136,0.007380373,0.0011230068,0.00064835267,0.0014412757,0.00025556065],"domain_scores_gemma":[0.963175,0.021315092,0.009215556,0.0013633653,0.0040650684,0.00086595013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017716024,0.0007518947,0.0012460283,0.002430353,0.00058312673,0.0015202037,0.00062808144,0.0009421787,0.0005938434],"category_scores_gemma":[0.030269824,0.00021169413,0.0015048684,0.0015828384,0.00039311644,0.0016141935,0.0011013115,0.0012065576,0.00017000543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014677477,0.00043979974,0.9705151,0.00026328923,0.0014750368,0.000031431173,0.0002071984,0.00071118743,0.00062480586,0.00013212868,0.00032849447,0.023803925],"study_design_scores_gemma":[0.000082755665,0.00216867,0.9928428,0.000078532816,0.000526761,0.00010638175,0.00026103167,0.00272688,0.00045176124,0.00020573728,0.0005181832,0.000030577317],"about_ca_topic_score_codex":0.002332133,"about_ca_topic_score_gemma":0.003727245,"teacher_disagreement_score":0.017716024,"about_ca_system_score_codex":0.00047419366,"about_ca_system_score_gemma":0.00078659336,"threshold_uncertainty_score":0.09369236},"labels":[],"label_agreement":null},{"id":"W3193852454","doi":"10.1016/j.msard.2021.103213","title":"Cognitive fatigue interventions for people with multiple sclerosis: A scoping review","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint Mary's University; Queen's University; Dalhousie University","funders":"","keywords":"CINAHL; Psychological intervention; PsycINFO; Medicine; MEDLINE; Randomized controlled trial; Cognition; Physical therapy; Systematic review; Intervention (counseling); Physical medicine and rehabilitation; Psychiatry","score_opus":0.19057575724056594,"score_gpt":0.38981919471859955,"score_spread":0.1992434374780336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193852454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030291086,0.99929917,0.000043376756,0.0000660863,0.000060582635,0.00008391164,0.000036577367,0.000003344997,0.000103999875],"genre_scores_gemma":[0.004172474,0.9949968,0.00026738693,0.0002509222,0.00004484429,0.00015199982,0.00003905708,0.0000020365637,0.000074474054],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.998243,0.00052271865,0.0005896779,0.00018651978,0.00033956068,0.00011869529],"domain_scores_gemma":[0.9940619,0.0047417427,0.0007243159,0.000057293808,0.0003223381,0.00009249058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004568941,0.0015187634,0.0074786125,0.0041110325,0.0005992188,0.0024344155,0.0018811991,0.0030946485,0.0050273812],"category_scores_gemma":[0.0132935755,0.0008352689,0.0061911326,0.003707378,0.000633885,0.0016490952,0.0014523864,0.002189221,0.00033518582],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006205698,0.000106539,0.00022875078,0.8547843,0.0070709037,0.00007002555,0.00020207584,0.0001417561,0.00023847644,0.00022752737,0.0018727097,0.13443643],"study_design_scores_gemma":[0.0012414928,0.00055934855,0.0030293341,0.89812005,0.069972284,0.0002468816,0.00036449762,0.00013745553,0.00021843062,0.0004065885,0.025655968,0.00004774202],"about_ca_topic_score_codex":0.009636741,"about_ca_topic_score_gemma":0.024700899,"teacher_disagreement_score":0.009636741,"about_ca_system_score_codex":0.0021131118,"about_ca_system_score_gemma":0.0052479343,"threshold_uncertainty_score":0.024163127},"labels":[],"label_agreement":null},{"id":"W3194345549","doi":"10.1016/j.msard.2021.103152","title":"Corrigendum to “Does Age at Diagnosis Influence the Use of Health Services for Multiple Sclerosis?” [Multiple Sclerosis and Related Disorders 46 (2020), 102555]","year":2021,"lang":"en","type":"erratum","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; University of Manitoba; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Multiple sclerosis; Regret; Medicine; Pediatrics; Psychiatry; Statistics","score_opus":0.06268593145955087,"score_gpt":0.27863871155058934,"score_spread":0.21595278009103847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194345549","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005003357,0.0010711742,0.000099622615,0.09390374,0.89618355,0.00003997326,0.002826745,0.00018470745,0.0056404085],"genre_scores_gemma":[0.00301248,0.00802095,0.0011222601,0.3172345,0.3406404,0.00056719757,0.008896272,0.00073188747,0.31977412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948809,0.00091367285,0.00096006657,0.00067536626,0.0019879749,0.0005819884],"domain_scores_gemma":[0.960269,0.0096417805,0.0016325932,0.0015209693,0.02484253,0.0020931487],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062761027,0.0025493575,0.0039994917,0.005512423,0.005137588,0.0059169475,0.003932259,0.010828572,0.14206536],"category_scores_gemma":[0.065463796,0.0016923228,0.0035512382,0.004371274,0.0016760317,0.0023497527,0.00273905,0.010625258,0.10503869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005671771,0.0000030017786,0.00002705858,0.000020024927,0.000003103212,0.000024076433,0.000003173847,0.0000059754343,0.0000019960205,0.000050952065,0.99907374,0.00078124786],"study_design_scores_gemma":[0.00010866197,0.00003385956,0.0035302367,0.00085344067,0.00009515113,0.0001606194,0.000119323384,0.0002095753,0.000054715372,0.0011031384,0.9936603,0.0000710023],"about_ca_topic_score_codex":0.122607455,"about_ca_topic_score_gemma":0.17835924,"teacher_disagreement_score":0.98917145,"about_ca_system_score_codex":0.0068838755,"about_ca_system_score_gemma":0.010659996,"threshold_uncertainty_score":0.47525597},"labels":[],"label_agreement":null},{"id":"W3194500955","doi":"10.1016/j.msard.2021.103224","title":"In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"Janssen Pharmaceuticals; Ministero della Salute; University of Brighton; Wellcome Trust; University of Sussex; Academy of Medical Sciences; Motor Neurone Disease Association; Biogen","keywords":"Monoaminergic; Neuroscience; Ventral tegmental area; Raphe; Raphe nuclei; Medicine; Brainstem; Locus coeruleus; Multiple sclerosis; Default mode network; Thalamus; Dopaminergic; Internal medicine; Dopamine; Psychology; Serotonin; Serotonergic; Central nervous system; Functional magnetic resonance imaging","score_opus":0.06970972282189908,"score_gpt":0.27162528061441155,"score_spread":0.20191555779251247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194500955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937895,0.0025944752,0.0017768155,0.00013010076,0.000022067268,0.000011308195,0.000104078725,0.000010784677,0.0015608838],"genre_scores_gemma":[0.9979189,0.0005497246,0.0005386447,0.0000379031,0.000014324786,0.00002097256,0.00011205679,0.000005457689,0.00080205745],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999088,0.000032466953,0.000006325604,0.000019334708,0.00001638421,0.000016736034],"domain_scores_gemma":[0.99956113,0.00018529744,0.00008898515,0.000057986246,0.000049585684,0.00005704899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039043967,0.00028411188,0.0002470552,0.00036462935,0.00038325196,0.0002641157,0.00029382264,0.00045249588,0.0034495988],"category_scores_gemma":[0.0007033511,0.00024043578,0.00010402559,0.00020518838,0.0009445209,0.0005309866,0.0003604376,0.000756542,0.00029527617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077081416,0.00034731833,0.011987828,0.00031326112,0.00021812037,0.0013018416,0.0004599935,0.00030177872,0.9652202,0.0010568239,0.00016250067,0.010922221],"study_design_scores_gemma":[0.0008391766,0.006189636,0.4875912,0.00012853387,0.00053639855,0.010994246,0.002059962,0.0027655642,0.48090684,0.0036576765,0.004293062,0.000037586746],"about_ca_topic_score_codex":0.0012059497,"about_ca_topic_score_gemma":0.001454497,"teacher_disagreement_score":0.0034495988,"about_ca_system_score_codex":0.00015735492,"about_ca_system_score_gemma":0.0001771472,"threshold_uncertainty_score":0.011539996},"labels":[],"label_agreement":null},{"id":"W3194875566","doi":"10.1016/j.msard.2021.103221","title":"Vitamin D3 and estradiol alter PAD2 expression and activity levels in C6 glioma cells","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Iran University of Medical Sciences","keywords":"Multiple sclerosis; Endocrinology; Internal medicine; Citrullination; Vitamin D and neurology; Gene expression; Glioma; Medicine; Citrulline; Arginine; Biology; Cancer research; Immunology; Gene; Biochemistry","score_opus":0.03887625733290314,"score_gpt":0.27204124274272923,"score_spread":0.23316498540982608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194875566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583983,0.001070555,0.0005418075,0.00009296651,0.00003373883,0.0000054924594,0.001053536,0.000036650825,0.0013254532],"genre_scores_gemma":[0.9897765,0.0006540715,0.00077812665,0.00004538701,0.000006961273,0.000018659755,0.0015212687,0.000014432334,0.007184584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997906,0.000019468556,0.000017859116,0.00004674497,0.000049438586,0.00007583616],"domain_scores_gemma":[0.9999193,0.000015447096,0.000013271857,0.000011993943,0.000017341059,0.00002276832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010207261,0.00017383396,0.00025002175,0.00038388986,0.00029095617,0.00047771566,0.00017428091,0.0002115541,0.002103507],"category_scores_gemma":[0.000108691704,0.00011802426,0.00030457004,0.00058686495,0.00019487314,0.0001961299,0.0001562701,0.00037400844,0.0005288271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011470516,0.000082007435,0.0014177206,0.000047372047,0.000018993896,0.00010149617,0.00009480163,0.00007256621,0.9943137,0.0001566508,0.00015728237,0.0023904955],"study_design_scores_gemma":[0.000051977448,0.00043951918,0.024816254,0.0000046485206,0.000048848317,0.00027751713,0.00039070475,0.00064507616,0.9665045,0.00009233634,0.0067132185,0.00001527828],"about_ca_topic_score_codex":0.0060408786,"about_ca_topic_score_gemma":0.004697057,"teacher_disagreement_score":0.0060408786,"about_ca_system_score_codex":0.00030723066,"about_ca_system_score_gemma":0.0002870111,"threshold_uncertainty_score":0.012011409},"labels":[],"label_agreement":null},{"id":"W3196748365","doi":"10.1016/j.msard.2021.103253","title":"High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Multiple Sclerosis International Federation","keywords":"Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Optic neuritis; Immunology; Demyelinating disease; Titer; Immunoglobulin G; Antibody; Internal medicine; Experimental autoimmune encephalomyelitis","score_opus":0.05868217488618522,"score_gpt":0.3223163125145612,"score_spread":0.263634137628376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3196748365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961888,0.0009415799,0.00031950013,0.000071253075,0.000023316497,0.00001890433,0.00035462505,0.000023438313,0.0020586257],"genre_scores_gemma":[0.99910164,0.00034070786,0.00018834938,0.00002290173,0.000020691174,0.000006917336,0.00025761552,0.000004764324,0.000056482568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881977,0.0002780395,0.00016738953,0.0002606997,0.00023794707,0.00023610095],"domain_scores_gemma":[0.99347126,0.0016822643,0.0034862575,0.0001847145,0.0004765224,0.00069896324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075257,0.00040546575,0.0004360105,0.0014024329,0.00065342686,0.00092192314,0.00046379416,0.00057923124,0.0030693058],"category_scores_gemma":[0.0056717014,0.00029237295,0.00025468107,0.0015411489,0.00086830196,0.00061805686,0.00070786156,0.00068099453,0.00048890524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008874343,0.000018983936,0.9959726,0.000026583426,0.000011518512,0.0014697551,0.00006359578,0.000024895153,0.00037672496,0.000031023912,0.00015165591,0.001764019],"study_design_scores_gemma":[0.000007208506,0.00017886925,0.9810168,0.00003968537,0.000032692464,0.016867077,0.00040085183,0.000080755504,0.000587696,0.00009637923,0.00068619504,0.0000056981357],"about_ca_topic_score_codex":0.0016683239,"about_ca_topic_score_gemma":0.001481376,"teacher_disagreement_score":0.0030693058,"about_ca_system_score_codex":0.00046563783,"about_ca_system_score_gemma":0.00066143106,"threshold_uncertainty_score":0.010267854},"labels":[],"label_agreement":null},{"id":"W3200291571","doi":"10.1016/j.msard.2021.103269","title":"Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes","year":2021,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Biogen; Multiple Sclerosis Society of Canada; Roche; Sanofi Genzyme; VGH and UBC Hospital Foundation; Novartis","keywords":"Multiple sclerosis; Medicine; Immunology; Disease; Antigen; Clinically isolated syndrome; Internal medicine","score_opus":0.050564636669196625,"score_gpt":0.2591225114763988,"score_spread":0.20855787480720217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200291571","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06770546,0.0034739326,0.00040723546,0.8811774,0.01773632,0.000070602364,0.0002319738,0.00005196978,0.029145032],"genre_scores_gemma":[0.4445027,0.003843194,0.0015999395,0.4506773,0.07450892,0.0001500107,0.0003126426,0.00004788178,0.02435744],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999091,0.00032767022,0.0001652821,0.0000689022,0.00017925675,0.00016784907],"domain_scores_gemma":[0.99655557,0.0018714939,0.00024138328,0.00014512411,0.0005866878,0.0005996538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012908962,0.00042654542,0.00085086474,0.0008073028,0.0016730195,0.0012044498,0.00068817707,0.01143155,0.0025564365],"category_scores_gemma":[0.010228818,0.0003139551,0.0003780718,0.0005989379,0.0010805632,0.0012074059,0.00045847043,0.0053577283,0.0013994557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00100661,0.0003795129,0.12893094,0.00023322199,0.000088622524,0.13808566,0.0011009339,0.00017294091,0.0023974006,0.0051768497,0.67297524,0.049452078],"study_design_scores_gemma":[0.0010828591,0.00079588476,0.1876096,0.0010560746,0.00023509083,0.2857606,0.0052756197,0.0046262476,0.0018529659,0.020034524,0.4914908,0.00017963073],"about_ca_topic_score_codex":0.0046176855,"about_ca_topic_score_gemma":0.0076469304,"teacher_disagreement_score":0.01143155,"about_ca_system_score_codex":0.0014519582,"about_ca_system_score_gemma":0.001067045,"threshold_uncertainty_score":0.010534704},"labels":[],"label_agreement":null},{"id":"W3200387566","doi":"10.1016/j.msard.2021.103237","title":"Dietary intake and characteristics in persons with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut du Savoir Montfort; Niagara Health System; University of Ottawa","funders":"","keywords":"Medicine; Micronutrient; Vitamin B12; Dietary Reference Intake; Food group; Multiple sclerosis; Food science; Vitamin; Environmental health; Nutrient; Population; Physiology; Internal medicine; Biology","score_opus":0.0452704021666997,"score_gpt":0.253101953925558,"score_spread":0.2078315517588583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200387566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820495,0.0007730212,0.000023810206,0.000052252304,0.000009004324,0.000003868762,0.00037131316,0.0000025140398,0.00055927347],"genre_scores_gemma":[0.9986815,0.00036806642,0.000068596746,0.00004288987,0.000013650894,0.000006841188,0.0003568562,0.0000016947993,0.0004597541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997718,0.0000669674,0.000044719203,0.00003983064,0.000035380897,0.000041327276],"domain_scores_gemma":[0.99937505,0.0001255811,0.00027829356,0.000044998123,0.000065207925,0.0001108964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034155822,0.00028725585,0.00053329446,0.0013381393,0.0007591401,0.0006894827,0.00021866405,0.0006779682,0.0023212424],"category_scores_gemma":[0.0014461584,0.00034448566,0.00063853996,0.0024911608,0.00018243861,0.0005909537,0.00043123402,0.00056035974,0.00030024885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044530418,0.00018389498,0.99703383,0.00003125068,0.00025528757,0.000105085324,0.0001390379,0.000021772075,0.0003993177,0.000012362342,0.0000655684,0.0013072469],"study_design_scores_gemma":[0.000005749569,0.000108003704,0.9993486,0.0000048187244,0.00004631058,0.00011399906,0.00021582651,0.000025242723,0.00002811237,0.000010841158,0.00008948307,0.000002949793],"about_ca_topic_score_codex":0.010192353,"about_ca_topic_score_gemma":0.011028435,"teacher_disagreement_score":0.010192353,"about_ca_system_score_codex":0.0002510455,"about_ca_system_score_gemma":0.00019148516,"threshold_uncertainty_score":0.020266056},"labels":[],"label_agreement":null},{"id":"W3202953604","doi":"10.1016/j.msard.2021.103286","title":"Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Institute for Regenerative Medicine; Canadian Society of Nephrology; Rare Disease Foundation; Biogen; National Multiple Sclerosis Society","keywords":"Medicine; Incidence (geometry); Pediatrics; Exact test; Cohort; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunology; Internal medicine","score_opus":0.05706248991232948,"score_gpt":0.31724374599329713,"score_spread":0.26018125608096765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202953604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826324,0.003936944,0.00013991802,0.0024949163,0.00014844436,0.00006868709,0.006139241,0.000027515152,0.00441206],"genre_scores_gemma":[0.99630344,0.0012884984,0.00026462637,0.00026577464,0.000045635927,0.000053467804,0.0012612891,0.0000048146453,0.0005125112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964361,0.0016847682,0.0002902313,0.0002987682,0.00055322587,0.000737028],"domain_scores_gemma":[0.994718,0.0012642964,0.0021105504,0.00022792259,0.00082915655,0.00085010903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036159034,0.0004576203,0.0005503892,0.0011912028,0.00055402424,0.00097603415,0.00063645834,0.000720575,0.001962856],"category_scores_gemma":[0.010333959,0.00021648729,0.0011991748,0.0014663921,0.00046075167,0.0006197123,0.0013800294,0.00085044163,0.00012925967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078613486,0.00046312588,0.9810161,0.00022836706,0.0004561632,0.00011569901,0.00021684112,0.00038180474,0.00013358518,0.0003077,0.001350014,0.014544481],"study_design_scores_gemma":[0.000049138747,0.0005295071,0.9971284,0.00012328727,0.00025688906,0.00003775393,0.00038100235,0.00009526004,0.00019626429,0.00003711243,0.001160164,0.000005193624],"about_ca_topic_score_codex":0.10192459,"about_ca_topic_score_gemma":0.09697431,"teacher_disagreement_score":0.10192459,"about_ca_system_score_codex":0.0027101869,"about_ca_system_score_gemma":0.006448979,"threshold_uncertainty_score":0.20266265},"labels":[],"label_agreement":null},{"id":"W3203041565","doi":"10.1016/j.msard.2021.103277","title":"Current international trends in the treatment of multiple sclerosis in children—Impact of the COVID-19 pandemic","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Stockholms Läns Landsting; Kommunfullmäktige, Stockholms Stad","keywords":"Medicine; Fingolimod; Pandemic; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Disease; Family medicine; Pediatrics; Intensive care medicine; Infectious disease (medical specialty); Psychiatry; Internal medicine","score_opus":0.08959931482317973,"score_gpt":0.3420050974423322,"score_spread":0.2524057826191525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203041565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7840397,0.09969832,0.000564263,0.085940465,0.00051109394,0.000056351473,0.0034257362,0.000043061827,0.025721064],"genre_scores_gemma":[0.9334905,0.055145994,0.0013991577,0.0067079207,0.00051253685,0.000052575375,0.0015708036,0.0000164359,0.0011040701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973545,0.0010547013,0.00046924542,0.00026570202,0.0005100302,0.000345736],"domain_scores_gemma":[0.98941517,0.0029915152,0.0045929058,0.0001809393,0.0012888459,0.0015306518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003907766,0.0001284687,0.00022622525,0.0011896709,0.0003763497,0.0012357662,0.000322273,0.00064360985,0.0041654254],"category_scores_gemma":[0.00735348,0.00009459512,0.00027256957,0.002297305,0.00047172082,0.0014147365,0.0006944097,0.0009462427,0.00039466046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017721624,0.0000948354,0.89798474,0.0008758809,0.00005085108,0.00026235633,0.0032704659,0.00015939707,0.00052746636,0.0014703706,0.009083272,0.08604316],"study_design_scores_gemma":[0.000011652081,0.00011873351,0.94722956,0.0007371998,0.000029258455,0.0011602106,0.0087493025,0.00010846738,0.00018052425,0.00018449497,0.041477256,0.000013373287],"about_ca_topic_score_codex":0.010673155,"about_ca_topic_score_gemma":0.01459937,"teacher_disagreement_score":0.010673155,"about_ca_system_score_codex":0.0016351271,"about_ca_system_score_gemma":0.001931322,"threshold_uncertainty_score":0.021222055},"labels":[],"label_agreement":null},{"id":"W3203218405","doi":"10.1016/j.msard.2021.103309","title":"Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Mitacs","keywords":"Multiple sclerosis; Magnetization transfer; Medicine; Myelin; Saturation (graph theory); Differential (mechanical device); Nuclear magnetic resonance; Water saturation; Fraction (chemistry); Materials science; Chromatography; Magnetic resonance imaging; Chemistry; Composite material; Internal medicine; Central nervous system; Physics; Immunology; Thermodynamics; Porosity; Radiology","score_opus":0.040991019132828994,"score_gpt":0.297303901788054,"score_spread":0.256312882655225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203218405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95374,0.007101128,0.03612899,0.00019571336,0.000043663058,0.00007580013,0.00017774181,0.00017990696,0.002357061],"genre_scores_gemma":[0.9798043,0.0018810973,0.01725542,0.00009112116,0.000021539148,0.00005205919,0.000084592895,0.000037273174,0.00077263755],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99965084,0.00017277818,0.00001779793,0.00005220139,0.00007196836,0.000034449222],"domain_scores_gemma":[0.9992175,0.0004731558,0.00008113955,0.000049967606,0.00012881083,0.000049444843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001979617,0.0005582737,0.00026930735,0.0011335069,0.00029842698,0.00078249414,0.00032976925,0.0012484916,0.0008456301],"category_scores_gemma":[0.0032744561,0.00040111493,0.0001736567,0.0003926155,0.00038197625,0.00093457435,0.00039473872,0.00054274,0.00023225395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033908847,0.00014691852,0.025682237,0.00041060906,0.00015819282,0.00019272666,0.00022707492,0.0032215447,0.8987317,0.0006406595,0.00024698777,0.06695044],"study_design_scores_gemma":[0.00007563729,0.0014834683,0.09263538,0.00007826261,0.00046286202,0.0018364586,0.00027445328,0.059681255,0.84030193,0.0014866237,0.0015944825,0.00008926184],"about_ca_topic_score_codex":0.00126119,"about_ca_topic_score_gemma":0.0028262953,"teacher_disagreement_score":0.001979617,"about_ca_system_score_codex":0.00022842825,"about_ca_system_score_gemma":0.00036679982,"threshold_uncertainty_score":0.010469377},"labels":[],"label_agreement":null},{"id":"W3204407904","doi":"10.1016/j.msard.2021.103283","title":"Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Merck","keywords":"Medicine; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Interferon beta; Interferon beta-1b; Interferon beta-1a; BETA (programming language); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Interferon; Virology; Immunology; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty)","score_opus":0.0468734160230599,"score_gpt":0.27978921761934517,"score_spread":0.23291580159628528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204407904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822694,0.0004902522,0.00008384806,0.000058280824,0.000004602518,0.000017869213,0.00071083,0.0000032723883,0.00040410683],"genre_scores_gemma":[0.9990275,0.0001276191,0.00003544956,0.000024754461,0.000011792334,0.000011014203,0.00072762964,0.0000010355172,0.000033212942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906856,0.00027293363,0.0001833818,0.00016499333,0.00017975172,0.00013045664],"domain_scores_gemma":[0.99357986,0.0010079051,0.0044155684,0.0001599627,0.00032966706,0.0005070599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013377157,0.00019265668,0.00035105954,0.00046003482,0.00026049372,0.0005453029,0.00020736502,0.00020463837,0.0011992251],"category_scores_gemma":[0.0038862682,0.000085718755,0.0005849846,0.000681249,0.00022895986,0.00042797948,0.00052581937,0.0005803906,0.00010372248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004983015,0.0000240065,0.9968143,0.00002876042,0.00008518579,0.000076785785,0.00004222556,0.00008612215,0.00009192212,0.000013224678,0.00013417348,0.0021049865],"study_design_scores_gemma":[0.000030040734,0.0004064715,0.9986058,0.00001877914,0.000055259214,0.00034734604,0.00008769939,0.00017710018,0.000087497465,0.00003310411,0.00014685035,0.0000039078795],"about_ca_topic_score_codex":0.0012134613,"about_ca_topic_score_gemma":0.001694654,"teacher_disagreement_score":0.0013377157,"about_ca_system_score_codex":0.0004109022,"about_ca_system_score_gemma":0.00041862123,"threshold_uncertainty_score":0.007074654},"labels":[],"label_agreement":null},{"id":"W3206377547","doi":"10.1016/j.msard.2021.103316","title":"Predictors of cognitive fatigue and fatigability in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Sanofi Genzyme; AbbVie; Roche; EMD Serono; Novartis","keywords":"Medicine; Anxiety; Cognition; Paced Auditory Serial Addition Test; Depression (economics); Effects of sleep deprivation on cognitive performance; Multiple sclerosis; Hospital Anxiety and Depression Scale; Physical therapy; Quality of life (healthcare); Audiology; Physical medicine and rehabilitation; Psychiatry; Cognitive impairment","score_opus":0.0680018828208656,"score_gpt":0.2814320459272793,"score_spread":0.21343016310641366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206377547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987656,0.0006687544,0.000027068118,0.00005169833,0.000006787537,0.0000035554842,0.000067286725,0.0000013816613,0.00040789868],"genre_scores_gemma":[0.9995994,0.00016150685,0.000030772193,0.000010721614,0.000017156077,0.000003174106,0.00006847264,5.5650344e-7,0.000108168024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943167,0.00024923705,0.00007360959,0.000052214837,0.00008340796,0.0001098466],"domain_scores_gemma":[0.99595636,0.001528122,0.0015384953,0.00017442142,0.00032925987,0.00047342668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013386919,0.0003442724,0.000415108,0.0010599656,0.0004949765,0.00072253094,0.0003134846,0.0007461044,0.0018284059],"category_scores_gemma":[0.006840962,0.0002677076,0.00069675635,0.0011180494,0.00031570886,0.00053794147,0.0005270309,0.0008013177,0.00013911855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016882452,0.00007044852,0.998454,0.000013531172,0.000094412055,0.0000482823,0.000074986914,0.000035530447,0.00005818966,0.000010460009,0.000030829993,0.0009406384],"study_design_scores_gemma":[0.0000034614816,0.000054425833,0.9996326,0.000006303601,0.000030106747,0.00005032429,0.0001121265,0.00005766106,0.0000119928945,0.00001198752,0.000027316753,0.0000017570767],"about_ca_topic_score_codex":0.009625031,"about_ca_topic_score_gemma":0.009596069,"teacher_disagreement_score":0.009625031,"about_ca_system_score_codex":0.00023749848,"about_ca_system_score_gemma":0.0004297204,"threshold_uncertainty_score":0.019137979},"labels":[],"label_agreement":null},{"id":"W3206988781","doi":"10.1016/j.msard.2021.103322","title":"Age differences in trajectories of self-rated health of young people with Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University Health Centre; McGill University","funders":"Royal Children's Hospital Foundation","keywords":"Medicine; Multiple sclerosis; Prodrome; Young adult; Demography; Ordinal regression; Pediatrics; Gerontology; Psychiatry; Psychosis","score_opus":0.038346679308120094,"score_gpt":0.25835720257810446,"score_spread":0.22001052326998438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206988781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907815,0.00021121494,0.000028167336,0.00004860061,0.000005452588,0.0000038352337,0.00029779892,0.00000156745,0.0003251951],"genre_scores_gemma":[0.999225,0.00015599316,0.000024284636,0.000015726033,0.0000041597336,0.0000034446027,0.0002888164,7.1618973e-7,0.0002817004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968195,0.00006415388,0.000030235962,0.00006140469,0.00004119297,0.000121049314],"domain_scores_gemma":[0.99872583,0.00023537983,0.00040787098,0.00006865096,0.00018604776,0.000376147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007036434,0.00017547548,0.00027485975,0.00071529,0.0004986654,0.0007512165,0.00018970692,0.00056594313,0.0017548734],"category_scores_gemma":[0.0031860222,0.00023240059,0.00065114436,0.00071770995,0.00018344841,0.0006583576,0.00069612585,0.0006805235,0.00028353848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013700574,0.00003704523,0.99747413,0.000008454853,0.000044658405,0.000038659982,0.00057669386,0.000041308103,0.00015582988,0.000034111068,0.00005409762,0.0013980063],"study_design_scores_gemma":[0.0000013008492,0.000049596667,0.9993383,0.000004038432,0.000008602637,0.000025509004,0.0004406552,0.000043807326,0.000013329082,0.000015710575,0.000057304853,0.0000018238941],"about_ca_topic_score_codex":0.026847422,"about_ca_topic_score_gemma":0.030705512,"teacher_disagreement_score":0.026847422,"about_ca_system_score_codex":0.00034329607,"about_ca_system_score_gemma":0.0003969366,"threshold_uncertainty_score":0.053382277},"labels":[],"label_agreement":null},{"id":"W3207337634","doi":"10.1016/j.msard.2021.103338","title":"A systematic review of the effects of cannabis on cognition in people with multiple sclerosis","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Dalhousie University; Nova Scotia Health Authority","funders":"Dalhousie Medical Research Foundation","keywords":"Cannabis; Cognition; Medicine; Context (archaeology); Effects of cannabis; Multiple sclerosis; Cannabinoid; Psychiatry; Cannabidiol; Clinical psychology","score_opus":0.02089277612849307,"score_gpt":0.26244785426701756,"score_spread":0.24155507813852448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207337634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068079785,0.9987909,0.00003809959,0.00007946493,0.000059514554,0.0000669287,0.00015628744,0.0000028851919,0.00012512825],"genre_scores_gemma":[0.0073564667,0.9919892,0.00017251151,0.00021667733,0.000040515435,0.000068157475,0.00007702048,0.0000015746813,0.000077881414],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99783176,0.0006309004,0.00087895186,0.00020778198,0.0003514679,0.00009909392],"domain_scores_gemma":[0.9934402,0.0047450475,0.0011431563,0.000081648664,0.0004828694,0.00010704567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027722071,0.0013330259,0.0079281395,0.005475809,0.0005397921,0.0020265672,0.0012369244,0.0016920022,0.004281602],"category_scores_gemma":[0.012850802,0.00074355194,0.0073605487,0.006570086,0.00058283977,0.0012944827,0.0012953096,0.0012763239,0.00022961528],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004243768,0.00002035195,0.00048757604,0.9446507,0.018293792,0.00011288737,0.0001244781,0.000083079474,0.00017388126,0.00011047243,0.0010349075,0.034483477],"study_design_scores_gemma":[0.00084634864,0.00040713203,0.00801446,0.69318974,0.26905015,0.0005903428,0.00032614684,0.00009507545,0.0002143202,0.00040892474,0.026776478,0.00008087075],"about_ca_topic_score_codex":0.018289613,"about_ca_topic_score_gemma":0.053583056,"teacher_disagreement_score":0.018289613,"about_ca_system_score_codex":0.0023327135,"about_ca_system_score_gemma":0.007011593,"threshold_uncertainty_score":0.036366343},"labels":[],"label_agreement":null},{"id":"W3208607270","doi":"10.1016/j.msard.2021.103366","title":"Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; White matter; Multiple sclerosis; Fractional anisotropy; Myelin; Magnetic resonance imaging; Expanded Disability Status Scale; Pathology; Diffusion MRI; Lesion; Internal medicine; Radiology; Central nervous system","score_opus":0.021924225447769768,"score_gpt":0.2247373587507246,"score_spread":0.20281313330295483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208607270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991916,0.00039261163,0.000046295972,0.000024732428,0.0000060561174,0.000002201665,0.000028825218,0.0000029573655,0.00030467936],"genre_scores_gemma":[0.9996105,0.000095862604,0.000055768538,0.000016201655,0.000012276557,0.0000022983065,0.000046769583,0.0000011724951,0.00015919465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951804,0.00017664146,0.000067217305,0.000077430785,0.00008922077,0.000071464485],"domain_scores_gemma":[0.99713564,0.0007794602,0.0012496948,0.00015027418,0.00035548143,0.00032944704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008662665,0.00047745867,0.00034314833,0.0013232416,0.00038611313,0.00074437255,0.0002981582,0.0005962418,0.0010672255],"category_scores_gemma":[0.0038899896,0.00036463264,0.00024525626,0.0011324524,0.00040618435,0.00063765905,0.00035788162,0.0005874909,0.00022745135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005218967,0.00012127613,0.9957332,0.000014920797,0.000117319185,0.00015994029,0.00011001533,0.000032460048,0.0016236852,0.000016442706,0.00003982425,0.0015089432],"study_design_scores_gemma":[0.000006930033,0.00015982123,0.9986738,0.000004635314,0.00005138496,0.0004339333,0.00013325766,0.00009400873,0.000333661,0.000031215663,0.000074488395,0.0000029403386],"about_ca_topic_score_codex":0.0018942928,"about_ca_topic_score_gemma":0.0018564765,"teacher_disagreement_score":0.0018942928,"about_ca_system_score_codex":0.00026975395,"about_ca_system_score_gemma":0.00028629508,"threshold_uncertainty_score":0.0045812726},"labels":[],"label_agreement":null},{"id":"W3208727480","doi":"10.1016/j.msard.2021.103367","title":"Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup analyses of ADVANCE and ATTAIN","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Atrophy; Disease; Clinical trial; Pediatrics; Immunology","score_opus":0.0799425548653229,"score_gpt":0.33092033841724955,"score_spread":0.2509777835519267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208727480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970054,0.0018377008,0.000132769,0.000080604994,0.000033146003,0.000048944028,0.0005459547,0.0000066322673,0.0003088188],"genre_scores_gemma":[0.99883443,0.00017177733,0.00009632169,0.000035090543,0.00004457254,0.000047803715,0.000601489,0.000004436717,0.00016417688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982899,0.00050547434,0.00031047012,0.0004279595,0.0002210694,0.00024502445],"domain_scores_gemma":[0.9968657,0.0009013177,0.0011679673,0.00048690423,0.00014381568,0.00043438683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034159366,0.0007247529,0.0018128261,0.0008499038,0.00036819666,0.0009796246,0.00056915364,0.00073320384,0.0012487135],"category_scores_gemma":[0.003205226,0.0002970749,0.006272357,0.0007256216,0.0003029584,0.0007177547,0.000908733,0.0010572246,0.0001397084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11938599,0.000450111,0.84384364,0.00034535045,0.01973521,0.00029360328,0.00026964906,0.0006398917,0.002776732,0.00013267549,0.0006423971,0.011484772],"study_design_scores_gemma":[0.0022040957,0.004724185,0.9826569,0.00004530127,0.0071139,0.00036555,0.0002772156,0.0011607021,0.0004371011,0.00023321909,0.00075011177,0.000031810745],"about_ca_topic_score_codex":0.00094642036,"about_ca_topic_score_gemma":0.002114018,"teacher_disagreement_score":0.0034159366,"about_ca_system_score_codex":0.0003768187,"about_ca_system_score_gemma":0.00052549044,"threshold_uncertainty_score":0.018065453},"labels":[],"label_agreement":null},{"id":"W3210963379","doi":"10.1016/j.msard.2021.103336","title":"The impact of brain lesions on sexual dysfunction in patients with multiple sclerosis: A systematic review of magnetic resonance imaging studies","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Cognitive Sciences and Technologies Council; Iran University of Medical Sciences","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Functional magnetic resonance imaging; Sexual dysfunction; Pathology; Radiology; Psychiatry","score_opus":0.059033434765610085,"score_gpt":0.3213234260537245,"score_spread":0.2622899912881144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210963379","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001329576,0.99826884,0.000040220002,0.000057132373,0.00003354705,0.000040677576,0.00016890143,0.000002393386,0.00005864244],"genre_scores_gemma":[0.018896261,0.98033834,0.00025648694,0.00021233482,0.000050571398,0.00006493812,0.0001355774,0.0000023666073,0.00004308051],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967213,0.0008168885,0.0014809329,0.0003839931,0.0004805699,0.000116265204],"domain_scores_gemma":[0.98806375,0.008789552,0.0022265834,0.00013994884,0.00064530404,0.00013469392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039173216,0.0012908895,0.008419162,0.007036263,0.0004619853,0.0021893168,0.0013194197,0.0018150684,0.0027041528],"category_scores_gemma":[0.01625098,0.0009913038,0.007879062,0.008526072,0.00073474617,0.0016126343,0.0015388158,0.0010871461,0.00016022268],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046101116,0.000022569424,0.0038581586,0.9126899,0.047614675,0.00016638261,0.00017810441,0.00012138243,0.00029109442,0.00010659907,0.0009987076,0.033491354],"study_design_scores_gemma":[0.00067267223,0.00029607813,0.0279945,0.49373809,0.46208093,0.000887383,0.0005339054,0.00014059775,0.0002494698,0.00036883855,0.012931348,0.00010625544],"about_ca_topic_score_codex":0.008123641,"about_ca_topic_score_gemma":0.028757676,"teacher_disagreement_score":0.008419162,"about_ca_system_score_codex":0.0013991839,"about_ca_system_score_gemma":0.003771778,"threshold_uncertainty_score":0.020717025},"labels":[],"label_agreement":null},{"id":"W3211797748","doi":"10.1016/j.msard.2021.103404","title":"Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche","keywords":"Medicine; Multiple sclerosis; De-escalation; Family medicine; Psychiatry; Intensive care medicine","score_opus":0.07930803957407116,"score_gpt":0.29542118526838634,"score_spread":0.21611314569431517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211797748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888927,0.00038239476,0.000021982687,0.00007474723,0.000006513754,0.0000118954,0.00018986882,0.0000011744078,0.00042210802],"genre_scores_gemma":[0.9993104,0.0001448833,0.000043629327,0.000083692,0.000015490856,0.000015511567,0.0002538282,0.0000016515576,0.00013093735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839765,0.0006633689,0.00023345041,0.00024580996,0.00020047219,0.00025935337],"domain_scores_gemma":[0.9948139,0.0013128298,0.0023741273,0.00025000217,0.00043834152,0.0008108661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015055966,0.00033035802,0.0005566236,0.0011290073,0.0008275305,0.0012226973,0.0004991143,0.0010592176,0.0014230852],"category_scores_gemma":[0.005961815,0.0003751538,0.0010839878,0.0023902024,0.00034019543,0.00069078564,0.00073978864,0.0010833984,0.00015295068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016857882,0.00009987307,0.9987833,0.0000093889685,0.0001045685,0.000025087587,0.00017276773,0.000011449057,0.000045026452,0.0000058475166,0.00006689914,0.0005072169],"study_design_scores_gemma":[0.000022099282,0.00007422157,0.99915504,0.000005364582,0.00007738407,0.00003575987,0.0005042766,0.000029853829,0.0000118661565,0.000003954369,0.00007743109,0.000002703095],"about_ca_topic_score_codex":0.024019351,"about_ca_topic_score_gemma":0.023970183,"teacher_disagreement_score":0.024019351,"about_ca_system_score_codex":0.00070366863,"about_ca_system_score_gemma":0.0007863332,"threshold_uncertainty_score":0.047759116},"labels":[],"label_agreement":null},{"id":"W3211811792","doi":"10.1016/j.msard.2021.103384","title":"Relationship between lymphopenia and disease activity in persons with multiple sclerosis treated with dimethyl fumarate","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; Memorial University of Newfoundland","funders":"","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Discontinuation; Adverse effect; Internal medicine; Mallinckrodt; Disease; Glatiramer acetate; Lymphocyte; Lymphocytopenia; Gastroenterology; Oncology; Immunology","score_opus":0.05995907752777968,"score_gpt":0.2702331384550504,"score_spread":0.21027406092727075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211811792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878687,0.0006604839,0.000028771501,0.00003739511,0.0000069264966,0.000004433697,0.00008895523,0.000002265671,0.00038390877],"genre_scores_gemma":[0.9996063,0.00012771324,0.000023998326,0.00002030118,0.000009564455,0.0000035326173,0.00007056972,5.2395916e-7,0.00013751756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948394,0.00025087842,0.000062524385,0.000053512897,0.00007032675,0.00007877492],"domain_scores_gemma":[0.99783117,0.0007085631,0.00082261104,0.000089862224,0.00019243419,0.0003552727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069117086,0.00027480474,0.00048305548,0.00086145615,0.00047524873,0.0005544075,0.00028250125,0.0005255478,0.0012628692],"category_scores_gemma":[0.0029893422,0.0002705604,0.0005922136,0.0009940801,0.00022951698,0.00030673077,0.000310258,0.00073000055,0.00013267707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011968676,0.00015768886,0.9969614,0.000015178397,0.00016175258,0.00006636843,0.00006579884,0.000027674712,0.00021787579,0.000006201467,0.000026547841,0.0010965774],"study_design_scores_gemma":[0.000025993242,0.000585581,0.99882144,0.00000571164,0.00011193236,0.00012075507,0.00011922889,0.000072911316,0.00005853183,0.000007822477,0.000067301655,0.0000028102886],"about_ca_topic_score_codex":0.0062517286,"about_ca_topic_score_gemma":0.0065491577,"teacher_disagreement_score":0.0062517286,"about_ca_system_score_codex":0.00028693667,"about_ca_system_score_gemma":0.0002548866,"threshold_uncertainty_score":0.012430668},"labels":[],"label_agreement":null},{"id":"W3211966991","doi":"10.1016/j.msard.2021.103395","title":"The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Multiple sclerosis; Simvastatin; Internal medicine; Statin; Meta-analysis; Randomized controlled trial; Odds ratio; Confidence interval; Clinically isolated syndrome; HMG-CoA reductase; Clinical trial; Oncology; Reductase; Immunology","score_opus":0.09112487645957563,"score_gpt":0.32131188854862053,"score_spread":0.2301870120890449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211966991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004262406,0.99468756,0.000305505,0.00009069065,0.00013087617,0.00013509813,0.00024200161,0.000017560724,0.00012836671],"genre_scores_gemma":[0.1181169,0.87818843,0.0015502268,0.0007464536,0.00022061716,0.0003828065,0.00042432506,0.000021145896,0.00034909157],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950723,0.0019977393,0.0014998871,0.00060803036,0.0005823516,0.00023972972],"domain_scores_gemma":[0.99166226,0.0060464325,0.0013400264,0.00026472582,0.0005294054,0.00015717368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007843909,0.002818931,0.021356735,0.0041320683,0.00063572265,0.0029697518,0.0022281439,0.0028530415,0.0041368823],"category_scores_gemma":[0.01627659,0.0017350444,0.029148791,0.0056901816,0.0008173823,0.0019503634,0.0018336881,0.0025337155,0.00035749632],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030052934,0.000044503868,0.0026549445,0.34849253,0.63285464,0.00013091696,0.000090062116,0.00034753483,0.00031294455,0.00008817356,0.00048664145,0.011491773],"study_design_scores_gemma":[0.0009046778,0.00017497993,0.0028105802,0.012816959,0.9819334,0.00005890866,0.000046205405,0.00008982824,0.00007854282,0.000097320706,0.0009650402,0.000023514402],"about_ca_topic_score_codex":0.0075336522,"about_ca_topic_score_gemma":0.019611849,"teacher_disagreement_score":0.021356735,"about_ca_system_score_codex":0.0019501157,"about_ca_system_score_gemma":0.002651774,"threshold_uncertainty_score":0.041483045},"labels":[],"label_agreement":null},{"id":"W3212518353","doi":"10.1016/j.msard.2021.103389","title":"Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Pregnancy; Family medicine; Psychiatry","score_opus":0.07045415638180676,"score_gpt":0.30617203998382925,"score_spread":0.2357178836020225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212518353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666166,0.00047084838,0.000023493893,0.0010939428,0.000025663134,0.000011548775,0.000071849434,0.000001477992,0.0016396119],"genre_scores_gemma":[0.99925345,0.00014274845,0.000041713072,0.00023970017,0.000016690377,0.000006792874,0.00004667434,0.0000018262315,0.00025042266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99628025,0.002314123,0.0002671916,0.00028191844,0.00036616193,0.00049029524],"domain_scores_gemma":[0.95443255,0.03459364,0.0051057325,0.0007277958,0.0006178567,0.004522402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040156944,0.00014099611,0.00050694414,0.00048846065,0.00091786037,0.001840489,0.00073590485,0.0016280875,0.006273558],"category_scores_gemma":[0.045167282,0.00037786714,0.0011902994,0.0006007302,0.000899248,0.0012102869,0.0010921698,0.0025926607,0.00028016983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054342356,0.001468465,0.9800235,0.00006110353,0.00038583425,0.00018651588,0.0020299025,0.00019015702,0.00012675261,0.00029872623,0.0004879924,0.009306928],"study_design_scores_gemma":[0.0002733353,0.0012432782,0.99182606,0.00008161104,0.00018757503,0.00016299491,0.0047135632,0.0006786114,0.000048891106,0.00031487772,0.00044613014,0.000023064678],"about_ca_topic_score_codex":0.016477693,"about_ca_topic_score_gemma":0.02243067,"teacher_disagreement_score":0.016477693,"about_ca_system_score_codex":0.0012256188,"about_ca_system_score_gemma":0.002197848,"threshold_uncertainty_score":0.0327636},"labels":[],"label_agreement":null},{"id":"W3216053749","doi":"10.1016/j.msard.2021.103408","title":"Response to treatment in NMOSD: the Australasian experience","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; University of British Columbia; University of Sydney; Brain Foundation; Multiple Sclerosis Australia; NIHR Oxford Biomedical Research Centre; Star Scientific Foundation; Petre Foundation; Guthy-Jackson Charitable Foundation","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.046378994448420155,"score_gpt":0.30434004320411007,"score_spread":0.2579610487556899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216053749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793226,0.0037669358,0.0000913788,0.0034033556,0.00008928645,0.000028397899,0.0001152491,0.0000026354326,0.004570546],"genre_scores_gemma":[0.99663,0.0019447735,0.000096506614,0.00079422194,0.00006766158,0.000015508398,0.00005363642,0.0000032654712,0.00039429578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780613,0.001140444,0.0002690761,0.00014030744,0.00037892206,0.0002651471],"domain_scores_gemma":[0.99416876,0.0013866302,0.0017130462,0.0002133212,0.0009855194,0.0015327813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038545155,0.00010185443,0.00041790196,0.0005824582,0.00084935734,0.0010397785,0.0002558271,0.00052850856,0.0012266536],"category_scores_gemma":[0.009605178,0.000097271295,0.00018043081,0.0014516439,0.0006861345,0.00068556546,0.0008029569,0.0007720414,0.00011428094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011746588,0.00067234464,0.90982515,0.0003147939,0.00014761834,0.0024722104,0.01695152,0.000093824405,0.0012698419,0.0006733636,0.0029157398,0.063489],"study_design_scores_gemma":[0.000108102875,0.00078763574,0.9652438,0.00035624194,0.00008253615,0.0031919042,0.017954353,0.00012829492,0.00019539092,0.00020604691,0.011715957,0.000029768637],"about_ca_topic_score_codex":0.020140026,"about_ca_topic_score_gemma":0.028238343,"teacher_disagreement_score":0.020140026,"about_ca_system_score_codex":0.0013756151,"about_ca_system_score_gemma":0.0017059516,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W3216860585","doi":"10.1016/j.msard.2021.103426","title":"It is time to move to alternative clinical trial designs: Reconsidering the holy grail of trial methodology","year":2021,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Clinical endpoint; Placebo; Multiple sclerosis; Frequentist inference; Holy Grail; Intensive care medicine; Clinical study design; Neurology; Physical therapy; Alternative medicine; Internal medicine; Psychiatry; Bayesian probability; Statistics; Pathology","score_opus":0.32618042834971345,"score_gpt":0.4114681794528889,"score_spread":0.08528775110317544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216860585","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021891423,0.010316954,0.00073850487,0.08317478,0.9050411,0.000038461192,0.00003897339,0.000092804206,0.00053657993],"genre_scores_gemma":[0.00043571583,0.0047266725,0.0015636461,0.104415484,0.8865531,0.00009512041,0.00001969153,0.000095161515,0.0020953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8929214,0.050330922,0.01677959,0.005173944,0.03312257,0.0016716227],"domain_scores_gemma":[0.4575425,0.41043207,0.017754415,0.012682666,0.08609745,0.015490885],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14758128,0.0054242103,0.013321951,0.007033925,0.0069750925,0.024993336,0.012794699,0.055453364,0.008452366],"category_scores_gemma":[0.34127367,0.0033865324,0.006548274,0.0052737864,0.01349547,0.016407195,0.0035247314,0.07792357,0.00969911],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009793771,0.00002204413,0.000043117157,0.0012303621,0.00022971585,0.00008147237,0.00008137399,0.00004906064,0.00004984164,0.0021955606,0.9862645,0.009654972],"study_design_scores_gemma":[0.0005992115,0.00013102245,0.000395129,0.0045175976,0.0007213261,0.00031410303,0.0002414532,0.00087321893,0.0001612309,0.019409612,0.9724495,0.00018669984],"about_ca_topic_score_codex":0.0036395246,"about_ca_topic_score_gemma":0.011953431,"teacher_disagreement_score":0.8524187,"about_ca_system_score_codex":0.008969112,"about_ca_system_score_gemma":0.012856563,"threshold_uncertainty_score":0.78049374},"labels":[],"label_agreement":null},{"id":"W3217203738","doi":"10.1016/j.msard.2021.103422","title":"Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels","year":2021,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Clinically isolated syndrome; White matter; Lesion; Pathology; Neurofilament; Parenchyma; Magnetic resonance imaging; Immunology; Radiology; Immunohistochemistry","score_opus":0.06470887912743513,"score_gpt":0.3081831803335818,"score_spread":0.24347430120614666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217203738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012343681,0.99959236,0.00002040807,0.00006635448,0.000036038444,0.000002035812,0.000016640877,0.0000017154181,0.00014100649],"genre_scores_gemma":[0.0015832054,0.9979437,0.00011244861,0.00015154779,0.000083081264,0.000004375877,0.000030100256,5.8674624e-7,0.00009087878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973375,0.00005251211,0.00008893188,0.000047732956,0.00006216468,0.000014880048],"domain_scores_gemma":[0.9991242,0.00050151895,0.00023431804,0.00001324212,0.00010155405,0.00002519305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006796107,0.0008791366,0.002446891,0.0038275844,0.00016569022,0.0008695957,0.00061287347,0.0008733128,0.0028115297],"category_scores_gemma":[0.0018446557,0.0002984264,0.0008074328,0.0035413844,0.00042619486,0.00081664,0.0005385166,0.00074057374,0.0004912358],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036649875,0.000060750528,0.0023089624,0.13827576,0.0024479139,0.00066550367,0.00010056959,0.00016792725,0.0012517759,0.00089614297,0.017393796,0.8360644],"study_design_scores_gemma":[0.00057891017,0.0004555933,0.032521106,0.1707587,0.030253861,0.01370858,0.00061839697,0.0002969598,0.0015941187,0.0032974647,0.745723,0.00019335221],"about_ca_topic_score_codex":0.0021497193,"about_ca_topic_score_gemma":0.0052126427,"teacher_disagreement_score":0.0038275844,"about_ca_system_score_codex":0.00040722766,"about_ca_system_score_gemma":0.0011965972,"threshold_uncertainty_score":0.009405494},"labels":[],"label_agreement":null},{"id":"W34627003","doi":"10.1016/j.msard.2021.103286","title":"Mura urbane di Busca","year":2010,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Ancient Mediterranean Archaeology and History","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health; Ontario Institute for Regenerative Medicine; Canadian Society of Nephrology; Rare Disease Foundation; Biogen","keywords":"Mura; Geography; Computer science","score_opus":0.022563031573890262,"score_gpt":0.18525322085241958,"score_spread":0.16269018927852932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W34627003","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1572352,0.11102784,0.0043014446,0.058081638,0.012031065,0.0005693225,0.011812481,0.0021721432,0.6427688],"genre_scores_gemma":[0.2338547,0.026827008,0.0080236485,0.0036108042,0.0028144368,0.000431041,0.0035304395,0.00050619117,0.7204017],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996282,0.000087985965,0.000014923184,0.00009426581,0.00007404825,0.000100591096],"domain_scores_gemma":[0.9996797,0.000056877725,0.000043095966,0.000027102764,0.000088402565,0.000104768005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004400354,0.0010516971,0.0007140882,0.001283443,0.0017271084,0.0015303523,0.0006808995,0.0011025165,0.097558826],"category_scores_gemma":[0.000919321,0.0003044359,0.00039851898,0.00093817996,0.00051158306,0.00048158038,0.0017515728,0.0014269501,0.0165581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015690996,0.00051591726,0.021484762,0.0020503108,0.00017381829,0.006111208,0.0025876693,0.0008986947,0.00972764,0.033633146,0.4000503,0.52119744],"study_design_scores_gemma":[0.00007739492,0.00010883438,0.020897731,0.0002741623,0.000021770156,0.0014331711,0.0005949927,0.00023733107,0.0007327531,0.0013481467,0.97425205,0.000021749198],"about_ca_topic_score_codex":0.020834887,"about_ca_topic_score_gemma":0.043207586,"teacher_disagreement_score":0.097558826,"about_ca_system_score_codex":0.002033938,"about_ca_system_score_gemma":0.0018411794,"threshold_uncertainty_score":0.32636678},"labels":[],"label_agreement":null},{"id":"W4200360730","doi":"10.1016/j.msard.2021.103468","title":"Pandemic-associated mental health changes in youth with neuroinflammatory disorders","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; SickKids Foundation; University of Toronto","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Pandemic; Mental health; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Neuroinflammation; Psychiatry; 2019-20 coronavirus outbreak; Virology; Immunology; Disease; Inflammation; Pathology","score_opus":0.01782153277906568,"score_gpt":0.24075697291892958,"score_spread":0.2229354401398639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200360730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957873,0.001041797,0.000036045076,0.0005869088,0.000056350415,0.000018066445,0.00072182855,0.0000051423854,0.0017465112],"genre_scores_gemma":[0.99860746,0.00049794104,0.000046453013,0.000100780904,0.00003611439,0.000009345217,0.00042126275,0.0000010812676,0.00027965425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963474,0.00008098963,0.000028253966,0.000040660732,0.00004915587,0.00016628187],"domain_scores_gemma":[0.9990489,0.00007561826,0.00043830884,0.00002234711,0.00011350325,0.00030141193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003698515,0.0001701595,0.0002525508,0.00044878872,0.00076472695,0.0007799489,0.00025383433,0.00044910217,0.0023016646],"category_scores_gemma":[0.002271281,0.00012437483,0.00058145256,0.00058066315,0.00024863466,0.00060188153,0.00095112505,0.0012784323,0.00014366656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018051795,0.00019062877,0.99138194,0.00003228909,0.00009721946,0.00016702458,0.00025195366,0.000043280448,0.000087315915,0.0000704763,0.0004400258,0.007057306],"study_design_scores_gemma":[0.0000037927048,0.00005858773,0.99896526,0.000019703175,0.000023413388,0.000078509256,0.00055360014,0.00004520014,0.000015740308,0.000033414643,0.00020003332,0.0000026595887],"about_ca_topic_score_codex":0.035088345,"about_ca_topic_score_gemma":0.07097122,"teacher_disagreement_score":0.035088345,"about_ca_system_score_codex":0.00097077666,"about_ca_system_score_gemma":0.0010750783,"threshold_uncertainty_score":0.06976825},"labels":[],"label_agreement":null},{"id":"W4200548123","doi":"10.1016/j.msard.2021.103467","title":"Feasibility of a theory-informed mobile app for changing physical activity in youth with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Social cognitive theory; Intervention (counseling); Medicine; Physical therapy; Cardiorespiratory fitness; Depression (economics); Psychology; Psychiatry; Developmental psychology","score_opus":0.061819206001710966,"score_gpt":0.2981677991008056,"score_spread":0.23634859309909462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200548123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737483,0.00020983051,0.009449662,0.0017582128,0.0003643268,0.0063913306,0.0008245278,0.0006504106,0.00660336],"genre_scores_gemma":[0.92009616,0.00039747314,0.060183696,0.0010247292,0.00010904185,0.013659179,0.00042516252,0.000045396708,0.004059168],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982285,0.0009252053,0.00013031015,0.00021321507,0.00026875496,0.00023415821],"domain_scores_gemma":[0.9936014,0.004940874,0.0001616579,0.0002344901,0.0004735209,0.00058805745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00391308,0.0006280868,0.00056456734,0.00060601044,0.00073400466,0.0012854702,0.00095909147,0.0013128108,0.009586765],"category_scores_gemma":[0.01325257,0.0003632547,0.0009906915,0.00017175241,0.00033895764,0.0010342854,0.001691746,0.0010632423,0.0016945371],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014961945,0.070405126,0.07914159,0.0037709,0.00035976587,0.0018171127,0.021098249,0.0016780897,0.008921644,0.0016086303,0.015808433,0.78042865],"study_design_scores_gemma":[0.03878706,0.28044355,0.40294355,0.009302216,0.00522803,0.0037667041,0.06427005,0.052765388,0.026214883,0.014430904,0.10057042,0.0012772239],"about_ca_topic_score_codex":0.0013430357,"about_ca_topic_score_gemma":0.0021783786,"teacher_disagreement_score":0.009586765,"about_ca_system_score_codex":0.00047077975,"about_ca_system_score_gemma":0.002050407,"threshold_uncertainty_score":0.032070875},"labels":[],"label_agreement":null},{"id":"W4205747186","doi":"10.1016/j.msard.2021.103479","title":"Comparing diagnostic criteria for the diagnosis of neurocognitive disorders in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Eurostars; Amsterdam Neuroscience; ZonMw; Multiple Sclerosis Society of Canada; National Institutes of Health; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Atara Biotherapeutics; Celgene; Biogen; National Multiple Sclerosis Society; MedDay Pharmaceuticals; Sanofi","keywords":"McNemar's test; Medicine; Neurocognitive; Cognition; Multiple sclerosis; Cognitive impairment; Clinical psychology; Normative; Cognitive test; Psychiatry; Physical therapy","score_opus":0.08991184375142688,"score_gpt":0.2969553129104668,"score_spread":0.2070434691590399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205747186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478626,0.0022624142,0.0004035721,0.0001417624,0.00007491022,0.0001226035,0.00044841366,0.0000049452906,0.0017550437],"genre_scores_gemma":[0.9981974,0.00023535133,0.00041390106,0.0000717603,0.000024506706,0.00010938655,0.0008260762,0.0000033342546,0.00011840304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878621,0.007046048,0.0023220668,0.00061617995,0.001494075,0.0006595177],"domain_scores_gemma":[0.95989984,0.02532545,0.0071403314,0.0014966676,0.004539437,0.0015982286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010378901,0.00046666362,0.0010625316,0.0051467502,0.0011389077,0.0014586201,0.0013213942,0.0012476393,0.0015913752],"category_scores_gemma":[0.04601837,0.00031209408,0.0014523821,0.0022186022,0.000738991,0.0011600074,0.0019709535,0.0008316122,0.00021318796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024557998,0.00025734954,0.9876387,0.00019036613,0.00090220495,0.00015737808,0.0008782028,0.00012521839,0.0004675873,0.00039540537,0.0006059766,0.005925817],"study_design_scores_gemma":[0.00043348133,0.0007949007,0.9932301,0.00013014476,0.0004233372,0.0007466893,0.002176179,0.00046606408,0.00029648186,0.00053720386,0.00074298057,0.000022308013],"about_ca_topic_score_codex":0.012693757,"about_ca_topic_score_gemma":0.014754342,"teacher_disagreement_score":0.012693757,"about_ca_system_score_codex":0.0014584735,"about_ca_system_score_gemma":0.0016133953,"threshold_uncertainty_score":0.0548895},"labels":[],"label_agreement":null},{"id":"W4205816563","doi":"10.1016/j.msard.2022.103516","title":"Wilcoxon-Mann-Whitney odds ratio: A statistical measure for ordinal outcomes such as EDSS","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Manitoba","funders":"","keywords":"Ordinal Scale; Ordinal data; Medicine; Odds ratio; Expanded Disability Status Scale; Ordinal regression; Confidence interval; Wilcoxon signed-rank test; Odds; Statistics; Mann–Whitney U test; Ordered logit; Multiple sclerosis; Physical therapy; Internal medicine; Mathematics; Logistic regression; Psychiatry","score_opus":0.042497542601688205,"score_gpt":0.2986033938349913,"score_spread":0.2561058512333031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205816563","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13120587,0.0077025914,0.8035407,0.0023113834,0.003517919,0.002487634,0.023927074,0.0050250273,0.020281881],"genre_scores_gemma":[0.6032788,0.0016689728,0.3680415,0.0006873295,0.0011905466,0.005537945,0.009300836,0.0012020943,0.009091983],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97419816,0.013964341,0.0034375936,0.0020130838,0.0056018257,0.00078510214],"domain_scores_gemma":[0.94875884,0.035027064,0.0074089584,0.004135865,0.0036679716,0.001001188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016484525,0.0010150645,0.002235752,0.0044305436,0.0006054796,0.0018176836,0.0018959084,0.0012192427,0.011808947],"category_scores_gemma":[0.08286559,0.00030721308,0.0015659335,0.0049987277,0.0013931587,0.003119126,0.001883122,0.0019703824,0.0012580724],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009135216,0.0008574276,0.14790504,0.0045071254,0.0048961584,0.0014216485,0.0011185763,0.0041201627,0.0062018624,0.065820046,0.07371081,0.6803059],"study_design_scores_gemma":[0.0025983325,0.015656304,0.39532772,0.0023316815,0.0026096266,0.01481082,0.0033489806,0.069154486,0.01892197,0.24696797,0.22732794,0.0009441964],"about_ca_topic_score_codex":0.00067041157,"about_ca_topic_score_gemma":0.00071560097,"teacher_disagreement_score":0.016484525,"about_ca_system_score_codex":0.0008128304,"about_ca_system_score_gemma":0.0016445004,"threshold_uncertainty_score":0.08717954},"labels":[],"label_agreement":null},{"id":"W4206195605","doi":"10.1016/j.msard.2022.103539","title":"Remyelination trial failures: Repercussions of ignoring neurorehabilitation and exercise in repair","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Memorial University of Newfoundland","funders":"","keywords":"Remyelination; Medicine; Psychological intervention; Clinical trial; Neuroscience; Multiple sclerosis; Physical medicine and rehabilitation; Bioinformatics; Internal medicine; Psychology; Immunology; Central nervous system; Biology","score_opus":0.07760768729359606,"score_gpt":0.3295857761311949,"score_spread":0.2519780888375988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206195605","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003684462,0.9991472,0.000030461044,0.00014014327,0.00008389608,0.000015088763,0.00003162148,0.0000017951606,0.0001812895],"genre_scores_gemma":[0.011678142,0.98669887,0.00028548486,0.0008462498,0.00019872775,0.00006386884,0.000057557405,0.0000031974248,0.00016787222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979697,0.0009892589,0.00050173764,0.00020221193,0.00026203404,0.000075013675],"domain_scores_gemma":[0.9886121,0.0094298525,0.0013792666,0.00010367957,0.00034128633,0.00013379414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006657412,0.0006702601,0.004290116,0.0012509193,0.00018774801,0.001440783,0.0012848795,0.0018043116,0.0054847756],"category_scores_gemma":[0.012903237,0.0003153422,0.0025557494,0.0017181246,0.0004894858,0.00082462124,0.000645977,0.002098779,0.00033137592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049906136,0.000120957906,0.0008729524,0.38065764,0.012000136,0.00019443569,0.00026709517,0.00034268512,0.00049071555,0.0020458458,0.010208315,0.5878087],"study_design_scores_gemma":[0.020913195,0.0041844132,0.01713167,0.50037265,0.12148122,0.0011869157,0.0008438104,0.0007260212,0.0008568541,0.005345358,0.32678124,0.0001767266],"about_ca_topic_score_codex":0.0018088948,"about_ca_topic_score_gemma":0.006979063,"teacher_disagreement_score":0.006657412,"about_ca_system_score_codex":0.0009458137,"about_ca_system_score_gemma":0.0022203012,"threshold_uncertainty_score":0.035208166},"labels":[],"label_agreement":null},{"id":"W4206552172","doi":"10.1016/j.msard.2022.103509","title":"Clinical characteristics and outcomes of multiple sclerosis patients with COVID-19 in Toronto, Canada","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Coronavirus disease 2019 (COVID-19); Ocrelizumab; Retrospective cohort study; Population; Disease; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pediatrics; Internal medicine; Infectious disease (medical specialty); Immunology","score_opus":0.0455873167147681,"score_gpt":0.29016341688653996,"score_spread":0.24457610017177187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206552172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725418,0.0021161917,0.000077241086,0.0066393535,0.00013596707,0.00006812199,0.006767575,0.000016667016,0.011636986],"genre_scores_gemma":[0.9945739,0.0008151546,0.000072430026,0.0009188427,0.00006590119,0.000020583562,0.0017697396,0.000007621658,0.0017557697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989029,0.00008431658,0.0001009198,0.000109582106,0.00026533226,0.0005369012],"domain_scores_gemma":[0.9964071,0.00014445439,0.0005236696,0.00006870478,0.0015188835,0.0013371549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037951532,0.00035769984,0.00063875143,0.00093223085,0.0033824134,0.0015271608,0.0010746993,0.000775234,0.0037296058],"category_scores_gemma":[0.0022836123,0.00034644592,0.00043379003,0.0046468102,0.00074164686,0.0004566314,0.000799965,0.0011525879,0.00042173953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022964751,0.00005544754,0.9867943,0.000042075393,0.00006070175,0.0013113798,0.0009534752,0.000093475464,0.00028917595,0.00020818277,0.0068416265,0.0031206117],"study_design_scores_gemma":[0.00003468633,0.000037313715,0.9952395,0.00007059821,0.00004067226,0.00052569737,0.0022995211,0.00013445363,0.00004045845,0.000046490088,0.00150984,0.000020854903],"about_ca_topic_score_codex":0.98136526,"about_ca_topic_score_gemma":0.99071467,"teacher_disagreement_score":0.027913949,"about_ca_system_score_codex":0.027913949,"about_ca_system_score_gemma":0.030294258,"threshold_uncertainty_score":0.20253086},"labels":[],"label_agreement":null},{"id":"W4206573422","doi":"10.1016/j.msard.2022.103535","title":"High or increasing serum NfL is predictive of impending multiple sclerosis relapses","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; University of Manitoba; Ottawa Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Biomarker; Proportional hazards model; Internal medicine; Oncology; McDonald criteria; Immunology","score_opus":0.04458607865476119,"score_gpt":0.26482515623061537,"score_spread":0.22023907757585418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206573422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985421,0.000369568,0.000068394475,0.00006372592,0.00000603793,0.000008154366,0.00021440492,0.000010130558,0.0007173893],"genre_scores_gemma":[0.9994553,0.00007389886,0.000088084336,0.000013344151,0.0000085559,0.0000039605393,0.00016156089,0.0000015535795,0.00019374258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997737,0.00003985454,0.00001544323,0.00005277402,0.00007272778,0.000045535242],"domain_scores_gemma":[0.99830616,0.00032784176,0.0007292379,0.00007136122,0.00022634602,0.0003390117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000713504,0.00030919173,0.00026951358,0.0005116421,0.00035525823,0.00049284054,0.00032682627,0.000392716,0.0025314149],"category_scores_gemma":[0.0027864103,0.00012486774,0.0002522221,0.00041387242,0.00032764894,0.00019821632,0.00020607794,0.0005570103,0.00033022827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004071603,0.000024966792,0.996863,0.000009434881,0.000026132006,0.000041298154,0.000025238072,0.000047100053,0.00040424088,0.000008531048,0.00010021024,0.0020427709],"study_design_scores_gemma":[0.000009351614,0.00010915386,0.99885833,0.000007801905,0.000040265517,0.00023504965,0.000047700574,0.00033016794,0.00015015759,0.000025761969,0.00018316564,0.000003108564],"about_ca_topic_score_codex":0.019643018,"about_ca_topic_score_gemma":0.028604932,"teacher_disagreement_score":0.019643018,"about_ca_system_score_codex":0.0006456536,"about_ca_system_score_gemma":0.0007078875,"threshold_uncertainty_score":0.039057374},"labels":[],"label_agreement":null},{"id":"W4207014326","doi":"10.1016/j.msard.2022.103557","title":"Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Exercise and Physiological Responses","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Hyperthermia; Coronavirus; Disease; Thermoregulation; Coronavirus disease 2019 (COVID-19); Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.03433131098261919,"score_gpt":0.25183533815478676,"score_spread":0.21750402717216757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4207014326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013141781,0.9993795,0.000036332658,0.00011791422,0.00008107419,0.0000028253203,0.00001264377,0.0000020910632,0.00023621459],"genre_scores_gemma":[0.0014817807,0.99786735,0.000086929926,0.00014002275,0.00019444314,0.000010628152,0.000033976667,8.12162e-7,0.00018410858],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984765,0.000041181727,0.000030796306,0.000027668491,0.00003478319,0.000017891402],"domain_scores_gemma":[0.99975246,0.00014404838,0.000039666756,0.000005143857,0.0000439409,0.000014635818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043011588,0.00088298443,0.0020734644,0.0011944256,0.00020287279,0.0007676028,0.00064088963,0.0009997397,0.0022604505],"category_scores_gemma":[0.0005707956,0.00018455142,0.00083674066,0.0009610357,0.00034417218,0.00056668796,0.0005855148,0.0012831533,0.00088341907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037171345,0.00011500002,0.00054598413,0.031302325,0.00041700702,0.000224801,0.00006278081,0.00027514895,0.0012681572,0.0012292045,0.0135286795,0.95065916],"study_design_scores_gemma":[0.0003668948,0.00092879415,0.01782135,0.035176463,0.0017704174,0.0058084005,0.00028829504,0.0005232765,0.0012864114,0.0045888433,0.9313254,0.00011537966],"about_ca_topic_score_codex":0.0009110763,"about_ca_topic_score_gemma":0.0016765727,"teacher_disagreement_score":0.0022604505,"about_ca_system_score_codex":0.0003125705,"about_ca_system_score_gemma":0.0005005145,"threshold_uncertainty_score":0.007561922},"labels":[],"label_agreement":null},{"id":"W4210367898","doi":"10.1016/j.msard.2022.103638","title":"Medical cannabis use in Canadians with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University Hospital Foundation; University of Alberta","keywords":"Multiple sclerosis; Medicine; Cannabis; Medical cannabis; Dermatology; Psychiatry","score_opus":0.02305351732865284,"score_gpt":0.23123587740021656,"score_spread":0.2081823600715637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210367898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735676,0.004879722,0.00008214178,0.0027482123,0.00013693528,0.00005125478,0.0050101387,0.00001208048,0.013511858],"genre_scores_gemma":[0.9938116,0.0025966442,0.00012743607,0.00052372756,0.00005681342,0.000015101293,0.0011105901,0.000004811837,0.001753127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915123,0.000054742588,0.000059601865,0.000075863376,0.00034351388,0.0003150792],"domain_scores_gemma":[0.99781895,0.00013185358,0.0005114294,0.000028471968,0.001012776,0.00049657066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004099835,0.00032000314,0.00046057164,0.002629551,0.004630854,0.0014768351,0.00093446655,0.0009141994,0.0056540025],"category_scores_gemma":[0.0029196478,0.0003183268,0.0007690383,0.005666791,0.0006453023,0.00055631786,0.00063272426,0.0012330561,0.0002715274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001699154,0.00010390425,0.9895817,0.0001205276,0.00009685209,0.0005153014,0.0011976797,0.000055381523,0.00018765172,0.00024451956,0.0024919074,0.0052345893],"study_design_scores_gemma":[0.000020342764,0.000034887824,0.99064916,0.0001496205,0.000086790045,0.00064464356,0.0047836704,0.00018632755,0.000047521793,0.00008074014,0.0032803959,0.000035814588],"about_ca_topic_score_codex":0.9883582,"about_ca_topic_score_gemma":0.9903452,"teacher_disagreement_score":0.013855424,"about_ca_system_score_codex":0.013855424,"about_ca_system_score_gemma":0.022442466,"threshold_uncertainty_score":0.10052866},"labels":[],"label_agreement":null},{"id":"W4212804224","doi":"10.1016/j.msard.2022.103689","title":"Cognitive function in pediatric-onset relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; University of Manitoba; Hospital for Sick Children; York University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Neurocognitive; Cognition; Disease; Pediatrics; Neurology; Immunology; Internal medicine; Psychiatry","score_opus":0.026719595333692538,"score_gpt":0.2718255498147476,"score_spread":0.24510595448105507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212804224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984413,0.0006304005,0.000026229403,0.000033407436,0.000007934418,0.0000036448384,0.0001797842,0.0000035558148,0.00067361456],"genre_scores_gemma":[0.99912876,0.00038119734,0.000044479206,0.000023014762,0.000008246537,0.000005763636,0.000244662,0.0000017301481,0.00016204409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955183,0.00012898943,0.000053882286,0.000066810746,0.000093765586,0.00010475262],"domain_scores_gemma":[0.99850476,0.00028486634,0.0006366714,0.00006323403,0.00025199712,0.000258471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011283971,0.0007896477,0.00046408517,0.0015043791,0.00042143065,0.0009180024,0.00038178093,0.00037555795,0.0007982],"category_scores_gemma":[0.004398177,0.00015485873,0.0005008713,0.0013720049,0.0004257354,0.0006084455,0.0006324156,0.0006252409,0.00018221313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000360058,0.00028896536,0.99155164,0.00005821181,0.00011681047,0.0006945752,0.00037274923,0.00010600677,0.00034452337,0.000047199344,0.00021040026,0.0058489544],"study_design_scores_gemma":[0.000006444584,0.00021372571,0.998543,0.0000109338625,0.00005432686,0.0005968924,0.0002485417,0.00005261665,0.0001311066,0.000023003638,0.00011602537,0.0000033447168],"about_ca_topic_score_codex":0.020703621,"about_ca_topic_score_gemma":0.0123333875,"teacher_disagreement_score":0.020703621,"about_ca_system_score_codex":0.000694939,"about_ca_system_score_gemma":0.0007898735,"threshold_uncertainty_score":0.041166186},"labels":[],"label_agreement":null},{"id":"W4220661846","doi":"10.1016/j.msard.2022.103761","title":"Progressive retinal changes in pediatric multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; McGill University; SickKids Foundation; University of Toronto; Montreal Neurological Institute and Hospital; Hospital for Sick Children","funders":"Multiple Sclerosis Society of Canada; Ontario Institute for Regenerative Medicine; Stem Cell Network; Multiple Sclerosis Scientific Research Foundation; National Multiple Sclerosis Society","keywords":"Medicine; Optic neuritis; Nerve fiber layer; Retinal; Multiple sclerosis; Ophthalmology; Inner plexiform layer","score_opus":0.04306767492897136,"score_gpt":0.26523303964532513,"score_spread":0.22216536471635379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220661846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956501,0.0017295376,0.00006862732,0.00007806945,0.0000068503573,0.000012370194,0.0001568407,0.0000068620475,0.0022906556],"genre_scores_gemma":[0.998073,0.0014751094,0.00013745952,0.000020988227,0.000012209537,0.000007801454,0.000103496706,0.0000018247038,0.0001680996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995322,0.00016463097,0.000063581334,0.000057481335,0.00010012665,0.00008193903],"domain_scores_gemma":[0.9986639,0.00027946688,0.000654604,0.000051198473,0.0001936586,0.00015703784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091891165,0.00027242096,0.00023005795,0.0021633324,0.00041222712,0.00050506403,0.00017328074,0.00024736254,0.0013941295],"category_scores_gemma":[0.00261672,0.00013731275,0.00018868479,0.0015433596,0.00040835736,0.00057576987,0.0003767957,0.00036039107,0.0001346897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003403714,0.00020603187,0.96871537,0.00021445531,0.00004756445,0.005031743,0.0007911367,0.00017065158,0.0021484334,0.00045687155,0.0005341945,0.021343108],"study_design_scores_gemma":[0.0000110901055,0.00020265693,0.9911814,0.000049388284,0.000033693857,0.006264249,0.0007816437,0.000074633135,0.0006068349,0.00006268757,0.00072913687,0.000002607306],"about_ca_topic_score_codex":0.0067531792,"about_ca_topic_score_gemma":0.006528905,"teacher_disagreement_score":0.0067531792,"about_ca_system_score_codex":0.00046893762,"about_ca_system_score_gemma":0.00059830403,"threshold_uncertainty_score":0.013427734},"labels":[],"label_agreement":null},{"id":"W4220761486","doi":"10.1016/j.msard.2022.103779","title":"Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University; University of Manitoba; Ottawa Hospital; University of Ottawa","funders":"Multiple Sclerosis Society of Canada","keywords":"Mesenchymal stem cell; Medicine; Multiple sclerosis; Clinical trial; Cognition; Stem-cell therapy; Cell therapy; Stem cell; Oncology; Internal medicine; Pathology; Immunology; Psychiatry; Biology","score_opus":0.10661464198893725,"score_gpt":0.3299668980979571,"score_spread":0.22335225610901985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220761486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758951,0.017344885,0.00045279207,0.0020475504,0.0003648914,0.00064621394,0.0007856312,0.0000915306,0.0023713624],"genre_scores_gemma":[0.9832146,0.0099934805,0.0008477491,0.001870976,0.0006511433,0.00075384334,0.0008670646,0.000019909276,0.00178132],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996346,0.00017437359,0.000023407281,0.00004574094,0.000041277726,0.00008069772],"domain_scores_gemma":[0.99907637,0.00036510063,0.00011785462,0.000045389148,0.000062351195,0.00033280032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014845323,0.0012901668,0.0026908095,0.00036358833,0.00048290656,0.0011335231,0.0005992436,0.0016828335,0.003200686],"category_scores_gemma":[0.0014917871,0.00021975611,0.0017737766,0.00052375894,0.00095070736,0.0006924625,0.0003292136,0.0031632532,0.00047189984],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77546126,0.03298759,0.0037169652,0.0023815043,0.0046679196,0.00032044423,0.00032404318,0.0014561029,0.017060505,0.00040175274,0.0043958114,0.15682605],"study_design_scores_gemma":[0.6351818,0.33158204,0.021214798,0.00025687082,0.0029860488,0.00025350583,0.00014065776,0.00077455275,0.0026531722,0.0009948086,0.003904043,0.00005778571],"about_ca_topic_score_codex":0.0013862752,"about_ca_topic_score_gemma":0.0030140036,"teacher_disagreement_score":0.003200686,"about_ca_system_score_codex":0.0005797954,"about_ca_system_score_gemma":0.0011236635,"threshold_uncertainty_score":0.010707319},"labels":[],"label_agreement":null},{"id":"W4220808026","doi":"10.1016/j.msard.2022.103745","title":"Structural visual metrics associate with moderate to vigorous physical activity in youth with pediatric onset neuroinflammatory disorders","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Mental Health Research Canada; Hospital for Sick Children","funders":"","keywords":"Medicine; Optic neuritis; Multiple sclerosis; Neuromyelitis optica; Retinal; Cohort; Myelin oligodendrocyte glycoprotein; Pediatrics; Ophthalmology; Internal medicine; Psychiatry; Experimental autoimmune encephalomyelitis","score_opus":0.02681956103543183,"score_gpt":0.2625453185428964,"score_spread":0.2357257575074646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220808026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977665,0.0004222758,0.00012879231,0.00008529083,0.000009362377,0.0000053913327,0.0003271715,0.0000062706586,0.0012490309],"genre_scores_gemma":[0.9991892,0.00014874448,0.0001014262,0.00001288006,0.000009963995,0.000004188308,0.00020896846,0.000003416905,0.0003210712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996419,0.00007059552,0.000036179183,0.00007850754,0.00007611889,0.00009661068],"domain_scores_gemma":[0.9972608,0.00034159012,0.0016949186,0.000115368275,0.0002765193,0.00031076325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038373985,0.00039084503,0.00021881108,0.0012810096,0.00034839395,0.0010294798,0.0003859655,0.000428906,0.00335613],"category_scores_gemma":[0.0040167607,0.0001847865,0.00041512403,0.0012453384,0.00036087856,0.0004971417,0.0007560678,0.00059383095,0.00022705246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035404715,0.000019006035,0.9975828,0.000008385691,0.00003512983,0.000055517798,0.00008646574,0.00003138614,0.00010783334,0.0000332129,0.00010448656,0.0019002773],"study_design_scores_gemma":[7.4013667e-7,0.000018280416,0.99940634,0.000007683623,0.000012820965,0.00014112378,0.00017422307,0.000070005466,0.0000345236,0.000027961209,0.00010497145,0.0000013759591],"about_ca_topic_score_codex":0.018613262,"about_ca_topic_score_gemma":0.024252303,"teacher_disagreement_score":0.018613262,"about_ca_system_score_codex":0.00040340214,"about_ca_system_score_gemma":0.00044110068,"threshold_uncertainty_score":0.037009835},"labels":[],"label_agreement":null},{"id":"W4220867349","doi":"10.1016/j.msard.2022.103757","title":"The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada","funders":"Multiple Sclerosis International Federation; Multiple Sclerosis Trust; Fondazione Italiana Sclerosi Multipla","keywords":"Medicine; Patient-reported outcome; Agency (philosophy); Multiple sclerosis; Stakeholder; Public relations; Quality of life (healthcare); Nursing; Political science; Sociology; Psychiatry","score_opus":0.08853545093438485,"score_gpt":0.3245907632389557,"score_spread":0.23605531230457083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220867349","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005353051,0.052200697,0.0013339123,0.93625885,0.0082869325,0.000048311947,0.00036039663,0.00005441004,0.00092117523],"genre_scores_gemma":[0.032428578,0.14574169,0.029733839,0.71382797,0.07198963,0.0014517402,0.002690329,0.00022969692,0.0019065703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8860482,0.063710324,0.014252187,0.0067429487,0.01874796,0.010498386],"domain_scores_gemma":[0.40354466,0.4206088,0.021153983,0.011406945,0.07295769,0.07032796],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29961866,0.0031122952,0.015076684,0.0051160413,0.009915073,0.028847734,0.011810522,0.06284874,0.0151691465],"category_scores_gemma":[0.27636075,0.002209735,0.005146208,0.006302647,0.024719698,0.05521615,0.026310913,0.06575184,0.00446186],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018166585,0.0011456517,0.006299051,0.010843681,0.0007362097,0.00049640815,0.0032026537,0.0018030526,0.00091081846,0.28650436,0.50173914,0.18450233],"study_design_scores_gemma":[0.0008249809,0.00068773853,0.008980617,0.03611228,0.00053646124,0.00035381177,0.012791156,0.0032129874,0.00034587606,0.30227742,0.6333323,0.0005443906],"about_ca_topic_score_codex":0.018779881,"about_ca_topic_score_gemma":0.016127067,"teacher_disagreement_score":0.70038134,"about_ca_system_score_codex":0.019178651,"about_ca_system_score_gemma":0.12445799,"threshold_uncertainty_score":0.8636949},"labels":[],"label_agreement":null},{"id":"W4220874346","doi":"10.1016/j.msard.2021.103478","title":"Multimodal emotion perception in young and elderly patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Perception; Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology","score_opus":0.0218561860423329,"score_gpt":0.2332730679329121,"score_spread":0.21141688189057922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220874346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930096,0.00021657311,0.000020130801,0.000023218125,0.000005334951,0.000002183654,0.000024542787,5.417545e-7,0.00040645857],"genre_scores_gemma":[0.9996088,0.00011371154,0.000014431524,0.000034546803,0.0000075396406,0.0000023959133,0.000028062093,3.3970971e-7,0.00019015932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998945,0.00002746389,0.000011564112,0.000017930672,0.00001843928,0.000030071473],"domain_scores_gemma":[0.9995146,0.00013818195,0.0001424422,0.000012614788,0.00005487223,0.00013729962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026632677,0.00016799856,0.0003774808,0.00033553818,0.0003555991,0.00066732336,0.00006973817,0.00028861113,0.0016775955],"category_scores_gemma":[0.0016895939,0.00007791203,0.00019755369,0.0002269131,0.00018460616,0.00032978907,0.0003139548,0.00029406478,0.00016489223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012872415,0.00024324807,0.9688826,0.000081365615,0.0001250963,0.0010122228,0.011269704,0.000062629406,0.0040931134,0.00006131143,0.00037312036,0.012508436],"study_design_scores_gemma":[0.000010988718,0.00022886528,0.99339455,0.0000081696735,0.000032248085,0.0004999597,0.0054369294,0.000054077842,0.000083418694,0.00004016701,0.00020417837,0.0000063165635],"about_ca_topic_score_codex":0.0028682125,"about_ca_topic_score_gemma":0.0037745202,"teacher_disagreement_score":0.0028682125,"about_ca_system_score_codex":0.00019413483,"about_ca_system_score_gemma":0.00012928629,"threshold_uncertainty_score":0.0057030916},"labels":[],"label_agreement":null},{"id":"W4221056406","doi":"10.1016/j.msard.2022.103746","title":"Implications of Low-Titer MOG Antibodies","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Titer; Antibody; Immunology; Virology","score_opus":0.02598116198887592,"score_gpt":0.28753402267878825,"score_spread":0.26155286068991235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221056406","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052227555,0.005990655,0.000102105936,0.06625624,0.9265423,0.000015913003,0.00005830579,0.000038259066,0.0009440595],"genre_scores_gemma":[0.0005096057,0.0021029084,0.00008526116,0.049186986,0.94575006,0.000019520821,0.000019368836,0.000020942643,0.0023053417],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98765194,0.003805742,0.0021416598,0.0011383169,0.004568391,0.0006938777],"domain_scores_gemma":[0.91915596,0.051175512,0.0043554245,0.002043833,0.016772686,0.006496626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021173676,0.0046341037,0.006816061,0.0043621934,0.004635072,0.00966091,0.005706627,0.038406923,0.0086340625],"category_scores_gemma":[0.06809287,0.0025669632,0.0036659215,0.0020187537,0.00452726,0.0057087564,0.002672077,0.03247823,0.0062980196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000948128,0.000013392717,0.00008939806,0.00035521638,0.00007782014,0.0003294863,0.000019856698,0.00001819151,0.000052947405,0.0003097862,0.99496305,0.0036760478],"study_design_scores_gemma":[0.0004961722,0.00008517011,0.001609081,0.0014750452,0.0006170332,0.0011287077,0.00013801553,0.00045267577,0.00024034965,0.0027957584,0.99088484,0.00007727165],"about_ca_topic_score_codex":0.0030536968,"about_ca_topic_score_gemma":0.0068587745,"teacher_disagreement_score":0.038406923,"about_ca_system_score_codex":0.00555027,"about_ca_system_score_gemma":0.0036883436,"threshold_uncertainty_score":0.11197841},"labels":[],"label_agreement":null},{"id":"W4223433487","doi":"10.1016/j.msard.2022.103790","title":"Do we need more clinical trials in secondary progressive MS?","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Alliance; Medicine; Multiple sclerosis; Clinical trial; Disease; Progressive disease; Alternative medicine; Psychiatry; Internal medicine; Pathology; Political science; Law","score_opus":0.08613404031667447,"score_gpt":0.38649021531601185,"score_spread":0.30035617499933737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223433487","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003111519,0.013284586,0.00012810213,0.083011135,0.9026548,0.000042963908,0.00007032389,0.00004589673,0.00073103],"genre_scores_gemma":[0.000396747,0.007132234,0.0002667851,0.09198052,0.89743847,0.00009520693,0.00003907661,0.000035136345,0.0026158048],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.970616,0.012707443,0.0057099517,0.0017431732,0.00808811,0.0011352752],"domain_scores_gemma":[0.8326338,0.099439606,0.010294997,0.004212397,0.038656846,0.014762451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05760225,0.00524077,0.011317675,0.0055180746,0.0049996814,0.011274118,0.0068309843,0.046411917,0.013024872],"category_scores_gemma":[0.12427615,0.00286674,0.0062986673,0.0034164786,0.0045408905,0.009845318,0.003040284,0.04094559,0.010364307],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016567855,0.000019700732,0.000044554152,0.0010499579,0.00015311688,0.00008434019,0.000016976423,0.00002247113,0.00004372074,0.00033540404,0.9913208,0.0067432337],"study_design_scores_gemma":[0.0014173662,0.00016169126,0.0006531173,0.0038595072,0.001131961,0.00036822402,0.000121151505,0.0003879506,0.00013031073,0.0036782126,0.98800695,0.00008351442],"about_ca_topic_score_codex":0.002721327,"about_ca_topic_score_gemma":0.008230557,"teacher_disagreement_score":0.05760225,"about_ca_system_score_codex":0.0064990977,"about_ca_system_score_gemma":0.0075701377,"threshold_uncertainty_score":0.30463344},"labels":[],"label_agreement":null},{"id":"W4224249334","doi":"10.1016/j.msard.2022.103792","title":"Pregnancy outcomes of women with multiple sclerosis treated with ocrelizumab in Canada: A descriptive analysis of real-world data","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Medicine; Pregnancy; Ocrelizumab; Pediatrics; Retrospective cohort study; Live birth; Obstetrics; Prospective cohort study; Reproductive medicine; Surgery; Internal medicine","score_opus":0.05787079466661044,"score_gpt":0.2619896650254949,"score_spread":0.20411887035888449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224249334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840042,0.0014779998,0.00014692075,0.0001942595,0.0000042891734,0.00006495947,0.012725698,0.00001226929,0.0013693415],"genre_scores_gemma":[0.99415225,0.00119757,0.00020134584,0.00007378405,0.0000041779467,0.000043611002,0.0041908287,0.0000046538366,0.00013182337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849784,0.00015833588,0.00023150588,0.0002303031,0.00060619815,0.00027581528],"domain_scores_gemma":[0.9946126,0.0008221089,0.0027859262,0.00018545159,0.0012751817,0.00031867443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010250839,0.00022068986,0.00034099535,0.0028447367,0.00090867275,0.0009125094,0.0006893694,0.00030799402,0.00062388845],"category_scores_gemma":[0.006594312,0.00022602691,0.0003472483,0.005736202,0.0005424592,0.00031410687,0.000650743,0.00036551352,0.00007579721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053793032,0.000006493144,0.9975383,0.00003940979,0.000041360152,0.00008508912,0.00023222338,0.00006933667,0.000043345193,0.000033130305,0.000249334,0.001608056],"study_design_scores_gemma":[0.000004752486,0.000023252562,0.9978974,0.000046471723,0.000028704622,0.00026902504,0.00070889236,0.00025218967,0.000060478902,0.000012714867,0.0006875694,0.0000085317515],"about_ca_topic_score_codex":0.8974918,"about_ca_topic_score_gemma":0.86343086,"teacher_disagreement_score":0.10250819,"about_ca_system_score_codex":0.008387113,"about_ca_system_score_gemma":0.011463349,"threshold_uncertainty_score":0.20622373},"labels":[],"label_agreement":null},{"id":"W4224299660","doi":"10.1016/j.msard.2022.103816","title":"High efficacy treatment is not enough in MS: Socioeconomic factors are key to improving outcomes","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Fingolimod; Teriflunomide; Medicine; Multiple sclerosis; Clinical trial; Natalizumab; Internal medicine; Immunology","score_opus":0.03196315494529688,"score_gpt":0.2812564293762534,"score_spread":0.2492932744309565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224299660","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034856846,0.01016211,0.0001022923,0.048730835,0.94042903,0.000019265923,0.000062979125,0.000034752356,0.00042386993],"genre_scores_gemma":[0.0003324696,0.005566963,0.000088946275,0.027464846,0.9652102,0.00002953899,0.0000247116,0.000020578667,0.0012617226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98356473,0.005219412,0.0035645422,0.0014913211,0.0053623915,0.0007975847],"domain_scores_gemma":[0.8700296,0.09002706,0.00619365,0.0022941239,0.023605103,0.007850461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030633189,0.0061304024,0.01138639,0.0051947427,0.005039933,0.011511275,0.006190484,0.035040542,0.00966681],"category_scores_gemma":[0.08255533,0.0026689959,0.0053516887,0.0037504702,0.0049328054,0.007852939,0.0025182324,0.04367461,0.00743431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012837032,0.000028292308,0.00008549349,0.00092106033,0.00018693737,0.00012431368,0.000022348555,0.000029866682,0.000033005595,0.00032860888,0.9926145,0.005497055],"study_design_scores_gemma":[0.0011968388,0.00019754197,0.0025844742,0.0066301557,0.0019287309,0.00093567173,0.00033565774,0.0009032046,0.00021148803,0.0075450786,0.97731096,0.00022026432],"about_ca_topic_score_codex":0.0043788073,"about_ca_topic_score_gemma":0.011491047,"teacher_disagreement_score":0.035040542,"about_ca_system_score_codex":0.005577373,"about_ca_system_score_gemma":0.0070612603,"threshold_uncertainty_score":0.16200578},"labels":[],"label_agreement":null},{"id":"W4224980576","doi":"10.1016/j.msard.2022.103829","title":"The metabolic potential of the paediatric-onset multiple sclerosis gut microbiome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; SickKids Foundation; University of Saskatchewan; Simon Fraser University; University of Manitoba; Saskatchewan Disease Control Laboratory; Public Health Agency of Canada; Hospital for Sick Children; University of British Columbia","funders":"Janssen Canada; Canadian Institutes of Health Research; Institute for Translational Neuroscience; National Institutes of Health; Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; University of Manitoba; Emerald Publishing; Multiple Sclerosis Scientific Research Foundation; Takeda Canada; Immune Tolerance Network; Public Health Agency of Canada; Biogen; Patient-Centered Outcomes Research Institute; American Academy of Neurology; U.S. Department of Defense; Genome Canada; Novartis; Erasmus Medisch Centrum; National Multiple Sclerosis Society; Pfizer Canada; Alexion Pharmaceuticals; Roche; University of British Columbia","keywords":"Multiple sclerosis; Interquartile range; Medicine; Microbiome; Internal medicine; Feces; Physiology; Immunology; Gastroenterology; Biology; Bioinformatics; Microbiology","score_opus":0.010469934062647861,"score_gpt":0.19686297299030714,"score_spread":0.18639303892765927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224980576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9698638,0.023494646,0.0018873865,0.0014552311,0.00010055367,0.000008048824,0.00041909516,0.000018670546,0.0027526536],"genre_scores_gemma":[0.99313366,0.005366252,0.00092236017,0.00011039674,0.00004943391,0.000006962432,0.00010519573,0.000005289646,0.00030033453],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99962115,0.0001665729,0.000015768648,0.00005361312,0.00006531212,0.00007758048],"domain_scores_gemma":[0.99965036,0.00008558962,0.00012138663,0.000024883639,0.00004489614,0.00007278354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040182524,0.000241599,0.0003122581,0.00043646144,0.00026037454,0.0011481068,0.00015961775,0.00060577947,0.0008273165],"category_scores_gemma":[0.0011969979,0.00017154487,0.00023788099,0.0003837898,0.00040884677,0.000618464,0.00082718366,0.000629857,0.000112059155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003027436,0.00014136273,0.36948147,0.0008250842,0.00047617644,0.004129365,0.0016171938,0.001803458,0.4776791,0.014152673,0.0016231408,0.12504359],"study_design_scores_gemma":[0.000058227055,0.0009141974,0.91712075,0.000500384,0.00027007057,0.010601346,0.0021672756,0.0027418116,0.027925715,0.013000678,0.024629423,0.000070235095],"about_ca_topic_score_codex":0.0007625187,"about_ca_topic_score_gemma":0.00096937513,"teacher_disagreement_score":0.0011481068,"about_ca_system_score_codex":0.00033392024,"about_ca_system_score_gemma":0.00036376328,"threshold_uncertainty_score":0.0027676225},"labels":[],"label_agreement":null},{"id":"W4225165339","doi":"10.1016/j.msard.2022.103820","title":"Quality of life in pediatric-onset multiple sclerosis: Different disease course, different impact, different measurement approach needed","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Shriners Hospitals for Children - Canada; Montreal Children's Hospital; Santé Montérégie; McGill University; McGill University Health Centre","funders":"Fondation de l'Hôpital de Montréal pour enfants","keywords":"Medicine; Multiple sclerosis; Quality of life (healthcare); Disease; Pediatrics; Immunology; Internal medicine","score_opus":0.09692189695966878,"score_gpt":0.29395803414480987,"score_spread":0.19703613718514107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225165339","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9272075,0.053465698,0.003235306,0.0073521677,0.0006820426,0.00025819775,0.0018436854,0.000021457861,0.005933796],"genre_scores_gemma":[0.98965096,0.005941904,0.0025268185,0.0004886465,0.0001520178,0.00015128369,0.0009468862,0.000015680635,0.00012574122],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9937364,0.003568363,0.0009934581,0.00037671637,0.00092441257,0.00040070817],"domain_scores_gemma":[0.9853136,0.007463307,0.0027527993,0.0007568509,0.0028763886,0.0008370177],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0114774825,0.0004602122,0.0011653351,0.0017320745,0.00043864042,0.0016362508,0.00062600354,0.00049686007,0.0009771549],"category_scores_gemma":[0.024850657,0.00020386638,0.0019653488,0.0026414103,0.00079268456,0.0020588308,0.0011929736,0.0015306183,0.00010762528],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005153622,0.00021487776,0.91463643,0.0012253124,0.0013247011,0.000108623404,0.0014587723,0.0005885407,0.00038477982,0.0011265366,0.0011315121,0.077284515],"study_design_scores_gemma":[0.00004312336,0.00043784684,0.9923517,0.0010498893,0.00048418337,0.0002736041,0.0019082471,0.00037330427,0.00039789797,0.00050175504,0.002145944,0.000032566866],"about_ca_topic_score_codex":0.005894851,"about_ca_topic_score_gemma":0.007292029,"teacher_disagreement_score":0.9885225,"about_ca_system_score_codex":0.0015109825,"about_ca_system_score_gemma":0.0015307829,"threshold_uncertainty_score":0.060699463},"labels":[],"label_agreement":null},{"id":"W4253778485","doi":"10.1016/j.msard.2019.06.025","title":"Reply to letter to the editor","year":2019,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Multiple sclerosis; Medicine; Scopus; Epidemiology; MEDLINE; Immunology; Pathology","score_opus":0.017770295909726338,"score_gpt":0.22855712090753286,"score_spread":0.21078682499780652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253778485","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029954914,0.0013557776,0.00003706645,0.94524425,0.049801756,0.000009065368,0.000038243576,0.000017880699,0.0031964313],"genre_scores_gemma":[0.0040416345,0.001121279,0.000073593736,0.9279924,0.057389267,0.000027025128,0.000022086693,0.000023967334,0.0093086315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969317,0.0010376932,0.00033695664,0.00038369777,0.00076993374,0.0005400216],"domain_scores_gemma":[0.9937382,0.0031558047,0.00052449753,0.00019872039,0.0012130724,0.001169679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032443593,0.00091454526,0.0016865066,0.001063489,0.0042367,0.004272275,0.0019735696,0.05301308,0.009660111],"category_scores_gemma":[0.026034938,0.0008759592,0.0010516399,0.0008301293,0.0024916525,0.003387788,0.0018101747,0.030717175,0.0074495533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004282192,0.0000152231905,0.0003059456,0.000039800387,0.000010946861,0.002402491,0.00009847863,0.000033031352,0.000051348634,0.00096884253,0.9942326,0.0017985264],"study_design_scores_gemma":[0.00011113168,0.000058908616,0.0013250995,0.00042837134,0.000041392836,0.0035170459,0.0006954917,0.00035302303,0.00019850646,0.00599622,0.987188,0.000086816784],"about_ca_topic_score_codex":0.0047123358,"about_ca_topic_score_gemma":0.0064560715,"teacher_disagreement_score":0.05301308,"about_ca_system_score_codex":0.0038842068,"about_ca_system_score_gemma":0.0048565394,"threshold_uncertainty_score":0.032316327},"labels":[],"label_agreement":null},{"id":"W4280505911","doi":"10.1016/j.msard.2022.103606","title":"Cognitive Dual Tasking Impacts Lower Limbs Inter-Segmental Coordination During Walking in Patients with Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Physical medicine and rehabilitation; Gait; Cognition; Medicine; Treadmill; Preferred walking speed; Psychology; Physical therapy; Neuroscience","score_opus":0.020789962334015186,"score_gpt":0.24110602672869835,"score_spread":0.22031606439468315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280505911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953294,0.0001051876,0.000015174521,0.000016558773,0.000003072972,0.000002391335,0.000028343706,0.0000012545883,0.00029509875],"genre_scores_gemma":[0.9996604,0.000036635844,0.000016984573,0.000012045829,0.0000046069385,0.0000032713294,0.000041909647,5.402578e-7,0.00022363423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983704,0.00003733553,0.00002328399,0.00003351868,0.000024186478,0.000044698158],"domain_scores_gemma":[0.9995198,0.00012847802,0.00016673609,0.000024099474,0.000061064515,0.000099909266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026842984,0.00050690304,0.00039286207,0.00046228772,0.0003711186,0.0005339302,0.0002156009,0.0004893853,0.0021685637],"category_scores_gemma":[0.0017418705,0.00015038346,0.00029566267,0.00035274887,0.00022357193,0.00031645107,0.00047143854,0.00039076494,0.00028944414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007167689,0.0014035072,0.9629607,0.0001245863,0.0004821116,0.00075483945,0.0009509792,0.00036144667,0.0056850505,0.000031872907,0.0003492243,0.019728063],"study_design_scores_gemma":[0.0000310502,0.0005435549,0.9986338,0.0000075471844,0.000063358835,0.00012688327,0.00022308287,0.00016451893,0.00011237891,0.00002776029,0.00006183609,0.0000042504485],"about_ca_topic_score_codex":0.006863053,"about_ca_topic_score_gemma":0.010386427,"teacher_disagreement_score":0.006863053,"about_ca_system_score_codex":0.00021911653,"about_ca_system_score_gemma":0.00020285985,"threshold_uncertainty_score":0.013646245},"labels":[],"label_agreement":null},{"id":"W4280506672","doi":"10.1016/j.msard.2022.103865","title":"Validity and sensitivity of Canadian normative data for the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) battery","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Normative; Cognition; Multiple sclerosis; Cognitive impairment; Medicine; Clinical psychology; Discriminant function analysis; Discriminant validity; Cognitive Assessment System; Psychology; Audiology; Gerontology; Psychometrics; Psychiatry; Statistics","score_opus":0.12234202107696569,"score_gpt":0.3031837256084954,"score_spread":0.1808417045315297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280506672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94216603,0.0032817181,0.0030197117,0.0011652105,0.00065270293,0.0007080673,0.0126930475,0.00017670108,0.036136884],"genre_scores_gemma":[0.98441005,0.0006949601,0.0027286771,0.0003807515,0.000051024555,0.00044013862,0.008842726,0.0000792486,0.0023723475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97988254,0.0033700168,0.0021438114,0.002328698,0.010781776,0.0014931572],"domain_scores_gemma":[0.91647816,0.019948162,0.0051550954,0.003884498,0.052463334,0.0020706805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023149285,0.00089284184,0.0010716307,0.006467144,0.0043018507,0.0030889031,0.0046207965,0.0013170023,0.0027118628],"category_scores_gemma":[0.104851216,0.0006673895,0.0020285319,0.004239674,0.0022667914,0.0016274629,0.0029629022,0.0015168706,0.00062098756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009433258,0.00026712773,0.9439083,0.00023767192,0.0006774273,0.00013672153,0.0025953723,0.0015286296,0.00056740176,0.0028037387,0.012018089,0.034316264],"study_design_scores_gemma":[0.00007727806,0.00008826383,0.98912966,0.00020437133,0.00014590085,0.00016700516,0.00086610863,0.0014695706,0.0004241127,0.0006060109,0.006745412,0.00007628246],"about_ca_topic_score_codex":0.9255104,"about_ca_topic_score_gemma":0.9330761,"teacher_disagreement_score":0.07448959,"about_ca_system_score_codex":0.019538408,"about_ca_system_score_gemma":0.02745989,"threshold_uncertainty_score":0.14985651},"labels":[],"label_agreement":null},{"id":"W4280577718","doi":"10.1016/j.msard.2022.103875","title":"Onset of multiple sclerosis is preventable – time to act now!","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Immunology","score_opus":0.027734226203240266,"score_gpt":0.269489485070087,"score_spread":0.24175525886684676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280577718","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016611159,0.0077680387,0.00006869466,0.036583435,0.95489866,0.000011256148,0.000034354485,0.00003295996,0.0005859632],"genre_scores_gemma":[0.000177813,0.004271511,0.00006878904,0.02804192,0.9644046,0.000019000137,0.0000185736,0.000017369786,0.0029803887],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.986466,0.004148679,0.0023216817,0.0011067202,0.0052680443,0.0006888214],"domain_scores_gemma":[0.92428213,0.039239038,0.005577053,0.0020946444,0.020831523,0.007975598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02310579,0.0058964435,0.009298036,0.0056763934,0.004539246,0.0112343235,0.005183405,0.03144159,0.0152714],"category_scores_gemma":[0.06518132,0.0024229598,0.004321841,0.0027341908,0.0040024463,0.008895647,0.0026072776,0.0352954,0.013088735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097558855,0.000025757552,0.000053564094,0.00054409815,0.000077900375,0.000106675485,0.000015024148,0.000022869383,0.00003488801,0.0003106689,0.9930031,0.005708011],"study_design_scores_gemma":[0.00032087983,0.00010922635,0.0007720305,0.0017302899,0.00040685048,0.00049712823,0.00011676589,0.0002549988,0.00009659032,0.0024542287,0.9931716,0.000069535374],"about_ca_topic_score_codex":0.00295003,"about_ca_topic_score_gemma":0.0082238065,"teacher_disagreement_score":0.03144159,"about_ca_system_score_codex":0.0042322706,"about_ca_system_score_gemma":0.0054433392,"threshold_uncertainty_score":0.122196555},"labels":[],"label_agreement":null},{"id":"W4280578607","doi":"10.1016/j.msard.2022.103596","title":"Depression, Anxiety and Alexithymia in Tunisian Patients with Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Alexithymia; Multiple sclerosis; Hospital Anxiety and Depression Scale; Psychiatry; Cohort; Hamilton Anxiety Rating Scale; Toronto Alexithymia Scale; Population; Neurology; Medical record; Internal medicine","score_opus":0.022328708602535434,"score_gpt":0.23295339039517837,"score_spread":0.21062468179264293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280578607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864906,0.0006115345,0.000009072303,0.000097707,0.000010078515,0.000004408376,0.000051264306,6.4076164e-7,0.00056614896],"genre_scores_gemma":[0.99924266,0.00035387138,0.000022751914,0.000059776736,0.000017857996,0.000005962389,0.000058770336,3.4265102e-7,0.00023807844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998062,0.000052609554,0.000026803737,0.00002352109,0.00003325034,0.000057574027],"domain_scores_gemma":[0.99974436,0.000042109048,0.00010806617,0.000006108298,0.00003138008,0.000067990986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021023821,0.00022541913,0.00033440546,0.00086056115,0.0008294288,0.0005775443,0.00017396545,0.00038316243,0.001204494],"category_scores_gemma":[0.0008114525,0.00018387607,0.0003343267,0.0010103759,0.00026033432,0.00026367992,0.00029502012,0.000432635,0.00009556398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021862706,0.00017081256,0.993905,0.00003690025,0.00013825399,0.0007853652,0.00071921025,0.000028035976,0.00041308094,0.00003855087,0.00018769648,0.0033584253],"study_design_scores_gemma":[0.000012880202,0.00007109586,0.99814105,0.000011746507,0.000034867007,0.00060103723,0.0008979281,0.00003330369,0.000017716395,0.000017380058,0.00015739452,0.0000035772111],"about_ca_topic_score_codex":0.022854226,"about_ca_topic_score_gemma":0.031637277,"teacher_disagreement_score":0.022854226,"about_ca_system_score_codex":0.0005965002,"about_ca_system_score_gemma":0.0004049319,"threshold_uncertainty_score":0.045442402},"labels":[],"label_agreement":null},{"id":"W4281636901","doi":"10.1016/j.msard.2022.103937","title":"Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Barts Charity","keywords":"Medicine; Seroconversion; Vaccination; Immunology; Multiple sclerosis; Immune system; Coronavirus disease 2019 (COVID-19); Booster dose; Booster (rocketry); Virology; Antibody; Immunization; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.044040016839496765,"score_gpt":0.2844411345669836,"score_spread":0.24040111772748685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281636901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999424,0.00010620442,0.000015770212,0.000034753895,0.000008293906,0.000014685262,0.000058061894,0.0000028556426,0.00033536035],"genre_scores_gemma":[0.999595,0.000066007895,0.000033298587,0.000050067112,0.000010821692,0.00002086276,0.00006122019,6.111128e-7,0.00016212187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969196,0.000080363425,0.000031954325,0.00005641675,0.00007075436,0.00006855818],"domain_scores_gemma":[0.9990953,0.0002473105,0.00034700334,0.000037472142,0.0000905119,0.00018229758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087287684,0.0002924181,0.00038076233,0.00042374982,0.00032748719,0.00032206232,0.0001872035,0.0006710034,0.0022916866],"category_scores_gemma":[0.002858613,0.00017158643,0.0002557393,0.0002374122,0.00020279718,0.0003426245,0.00030217174,0.0004688518,0.00045664728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010424868,0.00032454898,0.9878807,0.00007295061,0.000040564733,0.00023701006,0.0006211633,0.00003589572,0.0018809733,0.000007692949,0.00023575754,0.007620191],"study_design_scores_gemma":[0.00004299147,0.0019561155,0.99676883,0.000020020994,0.000029540166,0.0004373761,0.00027768008,0.00006278956,0.00023008374,0.000015320735,0.00015615424,0.0000030305605],"about_ca_topic_score_codex":0.0012294902,"about_ca_topic_score_gemma":0.0012151379,"teacher_disagreement_score":0.0022916866,"about_ca_system_score_codex":0.00020783908,"about_ca_system_score_gemma":0.00015957683,"threshold_uncertainty_score":0.007666409},"labels":[],"label_agreement":null},{"id":"W4281640815","doi":"10.1016/j.msard.2022.103932","title":"Multiple sclerosis incidence: A systematic review of change over time by geographical region","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Incidence (geometry); Demography; Medicine; Population; Multiple sclerosis; Scopus; McDonald criteria; Systematic review; Pediatrics; MEDLINE; Geography; Environmental health","score_opus":0.11160084349357316,"score_gpt":0.31332506919185044,"score_spread":0.20172422569827728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281640815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019886678,0.9964581,0.00012801193,0.00013822012,0.000079660545,0.00022448182,0.00084929564,0.000008994579,0.00012449382],"genre_scores_gemma":[0.03381902,0.9637153,0.0008923505,0.0005332614,0.000054913395,0.00050292065,0.00037112014,0.000011282352,0.000099808596],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98593384,0.0044538095,0.0063639698,0.001228959,0.0015718458,0.0004475936],"domain_scores_gemma":[0.9727831,0.01794405,0.006715887,0.0004942862,0.0017302586,0.0003324556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011767275,0.0019407248,0.014513404,0.0116186105,0.000617516,0.0037428255,0.0022054203,0.0021066964,0.005048587],"category_scores_gemma":[0.045065906,0.001840518,0.016283562,0.017966295,0.001139274,0.003110232,0.0030823962,0.001837535,0.0003339817],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034997336,0.000011343441,0.002222291,0.9249622,0.060577437,0.00007666099,0.00020880433,0.00008838701,0.00010707351,0.00008595675,0.0007279658,0.010581859],"study_design_scores_gemma":[0.00083272177,0.0001894311,0.013823725,0.50400704,0.47116455,0.0003048975,0.00047965432,0.000080716236,0.0001269732,0.00023161799,0.008694419,0.00006425479],"about_ca_topic_score_codex":0.019885054,"about_ca_topic_score_gemma":0.06987771,"teacher_disagreement_score":0.019885054,"about_ca_system_score_codex":0.004437113,"about_ca_system_score_gemma":0.010367966,"threshold_uncertainty_score":0.062232018},"labels":[],"label_agreement":null},{"id":"W4281926010","doi":"10.1016/j.msard.2022.103916","title":"Sick leave and occupational burnout among nurses caring for patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Sick leave; Burnout; Logistic regression; Family medicine; Cross-sectional study; Emotional exhaustion; Nursing; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.030450100461458858,"score_gpt":0.2552692186853468,"score_spread":0.22481911822388795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281926010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886453,0.00048397624,0.000012360651,0.00014887535,0.000020063815,0.0000033066342,0.000015511108,2.7256928e-7,0.00045122087],"genre_scores_gemma":[0.99922717,0.00029040626,0.000021917534,0.00009820181,0.000019506597,0.000008748734,0.000029208875,6.8405245e-7,0.00030411803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848807,0.0007388867,0.00012463269,0.000074664844,0.00017432198,0.00039935074],"domain_scores_gemma":[0.99358964,0.002360655,0.0018208756,0.00014980548,0.00063659047,0.0014423777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018063439,0.0002156301,0.00031082466,0.0008250122,0.0017970051,0.0011101115,0.00037633823,0.0009449139,0.0023592901],"category_scores_gemma":[0.010425214,0.00030826573,0.0005710236,0.00075054105,0.00055321533,0.00077586627,0.0012657365,0.0011513914,0.00023711813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020506358,0.00039349328,0.9923779,0.00005150548,0.00006597573,0.0001159707,0.0035511155,0.000025134657,0.00009870345,0.000051279294,0.00017577008,0.0028880553],"study_design_scores_gemma":[0.000012979108,0.00019094716,0.98492,0.00007566983,0.00003072197,0.00011383972,0.014203786,0.00005207183,0.00002498965,0.00003382464,0.00033483328,0.0000063004786],"about_ca_topic_score_codex":0.014350877,"about_ca_topic_score_gemma":0.026979696,"teacher_disagreement_score":0.014350877,"about_ca_system_score_codex":0.0008193174,"about_ca_system_score_gemma":0.0014290587,"threshold_uncertainty_score":0.02853471},"labels":[],"label_agreement":null},{"id":"W4283516981","doi":"10.1016/j.msard.2022.103995","title":"Use of natalizumab in persons with multiple sclerosis: 2022 update","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Sherbrooke; University of British Columbia; Memorial University of Newfoundland; Western University","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Dosing; Adverse effect; Intensive care medicine; Internal medicine; Immunology","score_opus":0.07109589134726166,"score_gpt":0.2656694784780308,"score_spread":0.19457358713076914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091957,0.99894017,0.00004809679,0.00022811707,0.00021171129,0.000004805683,0.00006138944,0.0000069447315,0.0004068374],"genre_scores_gemma":[0.0006715555,0.998166,0.0001303122,0.0005239351,0.0002317777,0.000008212361,0.00007790652,0.0000018201429,0.00018857776],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995759,0.000089658315,0.00012602871,0.000049239214,0.00012879721,0.000030344512],"domain_scores_gemma":[0.9988142,0.0005570366,0.00034452692,0.000017894774,0.00021014204,0.000056103137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009182937,0.0008323614,0.0019223052,0.0025958738,0.0001635712,0.001075534,0.0009998584,0.0012364496,0.0046446095],"category_scores_gemma":[0.002219567,0.00036086174,0.0012704319,0.0020345799,0.0002788893,0.0010809597,0.00059233216,0.0014509368,0.001088499],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037520804,0.00006373498,0.00051543355,0.0491141,0.00072545465,0.00019147163,0.000042513617,0.00023302551,0.00073971215,0.0005538437,0.050449956,0.89699554],"study_design_scores_gemma":[0.00047746525,0.00034904134,0.0044161268,0.031646527,0.0041641155,0.0020149858,0.00006492119,0.00022005805,0.00035848832,0.0006195682,0.955614,0.000054638887],"about_ca_topic_score_codex":0.0025090182,"about_ca_topic_score_gemma":0.0075328397,"teacher_disagreement_score":0.0046446095,"about_ca_system_score_codex":0.0006603024,"about_ca_system_score_gemma":0.0016724691,"threshold_uncertainty_score":0.015537739},"labels":[],"label_agreement":null},{"id":"W4283746622","doi":"10.1016/j.msard.2022.104007","title":"EBV as the “gluten of MS” hypothesis provides a rationale for trialing antiviral therapies","year":2022,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"National Institute of General Medical Sciences","keywords":"Scopus; Multiple sclerosis; Medicine; Epstein–Barr virus; Web of science; Virus; MEDLINE; Immunology; Virology; Internal medicine; Meta-analysis; Law; Political science","score_opus":0.04901008463862364,"score_gpt":0.2853209897920375,"score_spread":0.23631090515341388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283746622","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048332164,0.0077533387,0.00019430589,0.050563138,0.9405219,0.00002942462,0.000038130762,0.0000403612,0.00081105495],"genre_scores_gemma":[0.0004388717,0.0029738937,0.00017214769,0.04535002,0.9487961,0.000034435645,0.000014312659,0.000024750063,0.002195441],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98682797,0.0053398027,0.0019960732,0.0011929297,0.004075555,0.000567578],"domain_scores_gemma":[0.9104161,0.065196656,0.0035314583,0.002054494,0.012528348,0.0062728454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027973745,0.0051071323,0.0063224,0.0038293337,0.0037460877,0.009703233,0.0054199244,0.03557258,0.006763841],"category_scores_gemma":[0.06307609,0.0018857348,0.0042953747,0.0017944921,0.005139808,0.006600059,0.0023213276,0.041026466,0.005729059],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021089449,0.00003195892,0.000059776175,0.0007618272,0.0001505909,0.0002066171,0.000030997395,0.00004691586,0.00009093689,0.0010893388,0.9897398,0.0075801923],"study_design_scores_gemma":[0.00071314437,0.00018354543,0.00054008956,0.001481408,0.0005372461,0.00050115,0.00010665704,0.00055418024,0.00023837438,0.006466708,0.98860335,0.00007402721],"about_ca_topic_score_codex":0.0013386371,"about_ca_topic_score_gemma":0.0031412886,"teacher_disagreement_score":0.03557258,"about_ca_system_score_codex":0.0035333098,"about_ca_system_score_gemma":0.003723661,"threshold_uncertainty_score":0.14794105},"labels":[],"label_agreement":null},{"id":"W4283797772","doi":"10.1016/j.msard.2022.104031","title":"Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"University of Bristol; Novartis Animal Health; Novartis","keywords":"Ocrelizumab; Medicine; Relapsing remitting; Ofatumumab; Multiple sclerosis; Internal medicine; Filgrastim; Oncology; Physical therapy; Dermatology; Rituximab; Immunology; Granulocyte colony-stimulating factor; Chemotherapy","score_opus":0.07481059588906752,"score_gpt":0.3151139462203904,"score_spread":0.24030335033132288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283797772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324846,0.0010244901,0.001531661,0.00029405855,0.00023424771,0.0005512305,0.001183313,0.00004214342,0.0018904419],"genre_scores_gemma":[0.99740297,0.00015142307,0.00066091906,0.00011463166,0.00005889151,0.00046246368,0.00074914476,0.0000055634423,0.0003940653],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956505,0.003127642,0.00021381973,0.00039557935,0.00019997777,0.0004125321],"domain_scores_gemma":[0.98030007,0.015115698,0.0020461455,0.000944932,0.0006029235,0.0009902888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070904307,0.0009495197,0.0025217575,0.0003678779,0.00024006744,0.0009294261,0.00086559,0.0012325516,0.0051651723],"category_scores_gemma":[0.019702774,0.0004250527,0.0033972403,0.00029899398,0.0008565456,0.0008691604,0.00071449025,0.0019444468,0.0003872481],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8586626,0.0076565226,0.0040221564,0.0006047292,0.0032918,0.00007883731,0.00010082859,0.10221936,0.0013299738,0.0015951772,0.0016230838,0.018814946],"study_design_scores_gemma":[0.30968615,0.3889095,0.0233935,0.00034832454,0.008918109,0.00017593497,0.00020572825,0.25492886,0.0047508925,0.005599922,0.0029019546,0.00018113274],"about_ca_topic_score_codex":0.0026696066,"about_ca_topic_score_gemma":0.0010864856,"teacher_disagreement_score":0.0070904307,"about_ca_system_score_codex":0.0015536967,"about_ca_system_score_gemma":0.0017811303,"threshold_uncertainty_score":0.037498236},"labels":[],"label_agreement":null},{"id":"W4283813348","doi":"10.1016/j.msard.2022.104028","title":"COVID-19 in the pregnant or postpartum MS patient: Symptoms and outcomes","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"COVID-19 Impact on Reproduction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; University of British Columbia","funders":"Alvin J. Siteman Cancer Center; National Cancer Institute; National Multiple Sclerosis Society; National Center for Advancing Translational Sciences; Multiple Sclerosis Society of Canada; U.S. Department of Defense","keywords":"Medicine; Pregnancy; Postpartum period; Multiple sclerosis; Obstetrics; Coronavirus disease 2019 (COVID-19); Propensity score matching; Young adult; Internal medicine; Disease; Infectious disease (medical specialty); Immunology","score_opus":0.034685802608223265,"score_gpt":0.27349131730230974,"score_spread":0.23880551469408648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283813348","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8475708,0.0073305354,0.00034845536,0.10323862,0.0009169883,0.000066566754,0.0009981114,0.000038051156,0.039491907],"genre_scores_gemma":[0.98512775,0.002147732,0.0001847685,0.009317173,0.0011041794,0.000025595176,0.00031353033,0.000009714907,0.0017696549],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9995776,0.000100943966,0.000040638555,0.000039534523,0.00007623277,0.00016503947],"domain_scores_gemma":[0.9988194,0.00031461226,0.00020474981,0.000029463468,0.00012590797,0.00050582975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004341121,0.00019085828,0.0004411993,0.00040466624,0.001211618,0.0009885851,0.00029595118,0.002329474,0.0018156231],"category_scores_gemma":[0.0050075916,0.0001541751,0.00031488677,0.0007223816,0.00036701476,0.0006605837,0.0004400581,0.0020362874,0.00034271844],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005964692,0.0002990322,0.7668952,0.00009473258,0.00007111469,0.19016203,0.0008150863,0.00039220823,0.0006878124,0.0010225803,0.016586905,0.02237688],"study_design_scores_gemma":[0.00014138654,0.0008056523,0.6305043,0.0006648026,0.00013949687,0.34466743,0.0054110037,0.001708932,0.00038365554,0.004877831,0.010607657,0.00008784701],"about_ca_topic_score_codex":0.005834169,"about_ca_topic_score_gemma":0.0053937254,"teacher_disagreement_score":0.005834169,"about_ca_system_score_codex":0.0010536772,"about_ca_system_score_gemma":0.0011405972,"threshold_uncertainty_score":0.011600435},"labels":[],"label_agreement":null},{"id":"W4284667846","doi":"10.1016/j.msard.2022.104030","title":"Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Innovative Medicines Canada; Dalhousie University","funders":"Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Regimen; Internal medicine; Oncology; Immunology; Transplantation","score_opus":0.02851383815231817,"score_gpt":0.24893150441573722,"score_spread":0.22041766626341905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284667846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997894,0.000065019376,0.000015866011,0.000004033487,0.0000012800712,0.000015124488,0.000045101824,9.399802e-7,0.00006319305],"genre_scores_gemma":[0.99965656,0.000038659455,0.00004780311,0.000017381597,0.000007797751,0.000016131311,0.00017375225,5.9796986e-7,0.00004136691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993794,0.00015981933,0.00007711888,0.00015328235,0.0001165528,0.00011385612],"domain_scores_gemma":[0.99856347,0.00019491866,0.00077622186,0.00012120181,0.00010977766,0.0002344216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072363036,0.00024875868,0.00052579504,0.00030869307,0.00034289833,0.00044446508,0.00023735833,0.00027044924,0.0006764608],"category_scores_gemma":[0.0013111244,0.00013400371,0.00047454273,0.00041777012,0.00023592314,0.00022920646,0.00032679137,0.00053813076,0.000095730524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010653105,0.0005462223,0.9797213,0.000041768635,0.00018740624,0.0003848977,0.00012718848,0.000121471785,0.0026219748,0.000015972153,0.000097887125,0.005480779],"study_design_scores_gemma":[0.00031921806,0.0086085005,0.98910856,0.000008869011,0.000143139,0.0006597522,0.00007929478,0.00026879806,0.0004805325,0.000014039862,0.00030215926,0.0000071337336],"about_ca_topic_score_codex":0.0016243482,"about_ca_topic_score_gemma":0.0017961313,"teacher_disagreement_score":0.0016243482,"about_ca_system_score_codex":0.00053956476,"about_ca_system_score_gemma":0.0005161527,"threshold_uncertainty_score":0.0039148927},"labels":[],"label_agreement":null},{"id":"W4285603485","doi":"10.1016/j.msard.2022.104062","title":"Saudi consensus recommendations on the management of Neuromyelitis Optica Spectrum Disorders (NMOSD)","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Biogen; Ministry of Health – Kingdom of Saudi Arabia; Merck","keywords":"Neuromyelitis optica; Medicine; Spectrum disorder; Multiple sclerosis; Demyelinating Disorder; Aquaporin 4; Immunology; Dermatology; Pathology; Psychiatry","score_opus":0.09081450929488182,"score_gpt":0.3154046180443192,"score_spread":0.22459010874943736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285603485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060033385,0.94490343,0.0015467827,0.020353347,0.0044358964,0.0002592908,0.0015340211,0.00013251072,0.026234409],"genre_scores_gemma":[0.0051151146,0.96544605,0.0063737575,0.010076635,0.0013216214,0.00033306834,0.0021497875,0.000038623893,0.0091453325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985266,0.00036748254,0.00040189605,0.00010345067,0.00047938272,0.000121223566],"domain_scores_gemma":[0.99776876,0.00059998693,0.00041037926,0.000041233776,0.0010315516,0.00014808027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021676735,0.0009518965,0.0013160005,0.003619267,0.00069967017,0.0014126147,0.0019771596,0.0030881604,0.014617181],"category_scores_gemma":[0.005025535,0.00031653707,0.0020409962,0.0025473684,0.000563319,0.0014522203,0.0011471534,0.0022500954,0.0070417263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014094535,0.00008845059,0.0005041061,0.023038263,0.00017627496,0.00048624177,0.00021461533,0.00036959958,0.0006518241,0.006221527,0.28803867,0.68006945],"study_design_scores_gemma":[0.00006249989,0.00004677027,0.0011702608,0.025076054,0.00023303808,0.0011697743,0.0001664943,0.000066874025,0.00022924166,0.0021063709,0.969649,0.000023659313],"about_ca_topic_score_codex":0.006482211,"about_ca_topic_score_gemma":0.0073450753,"teacher_disagreement_score":0.014617181,"about_ca_system_score_codex":0.0019623814,"about_ca_system_score_gemma":0.005653975,"threshold_uncertainty_score":0.048899293},"labels":[],"label_agreement":null},{"id":"W4285678970","doi":"10.1016/j.msard.2022.104061","title":"Saudi consensus recommendations on the management of multiple sclerosis: MS management in children and adolescents","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Ministry of Health – Kingdom of Saudi Arabia","keywords":"Glatiramer acetate; Medicine; Acute disseminated encephalomyelitis; Multiple sclerosis; Neuromyelitis optica; Pediatrics; Observational study; Demyelinating Disorder; Demyelinating disease; Randomized controlled trial; McDonald criteria; Intensive care medicine; Population; Disease; Pathology; Psychiatry","score_opus":0.08181320650427126,"score_gpt":0.3054345439414968,"score_spread":0.22362133743722556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285678970","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019416753,0.98787665,0.00035174188,0.007168291,0.001817229,0.00015188933,0.0005312233,0.000022079594,0.001886729],"genre_scores_gemma":[0.0016759706,0.99038386,0.0020981864,0.0038747473,0.00045114697,0.0001896756,0.0004157774,0.000004971323,0.0009055806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99680126,0.0008710632,0.0012186657,0.00018950953,0.00073961687,0.00017988644],"domain_scores_gemma":[0.99394834,0.002428217,0.001338387,0.000073983094,0.0019337367,0.00027729606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005782582,0.0013232316,0.0031819935,0.007699617,0.000688201,0.0021024432,0.002790624,0.0033687043,0.0070173754],"category_scores_gemma":[0.012786364,0.00059345044,0.0043306565,0.0049057594,0.00067918265,0.0016599338,0.0014762981,0.002543735,0.0016256789],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003939158,0.00014296241,0.0011867903,0.19998513,0.0016844809,0.00042875658,0.00041324744,0.0005215992,0.00056626915,0.00377179,0.15201047,0.6388946],"study_design_scores_gemma":[0.00038639692,0.00011422562,0.0037679095,0.32508916,0.0054188627,0.0007936645,0.00039874343,0.00013952931,0.00027313043,0.0023481282,0.6612027,0.00006755012],"about_ca_topic_score_codex":0.017339293,"about_ca_topic_score_gemma":0.022260968,"teacher_disagreement_score":0.017339293,"about_ca_system_score_codex":0.0032740312,"about_ca_system_score_gemma":0.014454583,"threshold_uncertainty_score":0.034476697},"labels":[],"label_agreement":null},{"id":"W4288455360","doi":"10.1016/j.msard.2022.104080","title":"Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Biogen","keywords":"Dimethyl fumarate; Discontinuation; Medicine; Term (time); Multiple sclerosis; Family medicine; Pediatrics; Internal medicine; Physical therapy; Psychiatry","score_opus":0.04220681545848206,"score_gpt":0.2868115921861847,"score_spread":0.24460477672770262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288455360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957065,0.0009367297,0.000057212037,0.00045258814,0.000014307839,0.000082870974,0.0011839437,0.000005684783,0.0015601825],"genre_scores_gemma":[0.9975872,0.0007503207,0.00010972223,0.00018558894,0.000016962527,0.000029446968,0.0008213447,0.0000033265871,0.00049605465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963414,0.00044816782,0.00025561097,0.0002846026,0.0019475471,0.0007227211],"domain_scores_gemma":[0.99127126,0.0007588657,0.0029491433,0.00022320899,0.0029023248,0.0018952744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031572415,0.00022056514,0.00049667206,0.0007140835,0.002521952,0.0013453106,0.000984329,0.0005706036,0.0012030923],"category_scores_gemma":[0.010325244,0.00019358972,0.00075187464,0.002386988,0.00047123028,0.00038803057,0.00074417045,0.0011753365,0.00013183792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004216361,0.00024067923,0.9803124,0.00006127731,0.00010068208,0.00007117654,0.00151601,0.00006356132,0.00007721764,0.000035725327,0.0008734062,0.016226215],"study_design_scores_gemma":[0.000021932348,0.0001637979,0.99797255,0.000037889957,0.000045130208,0.00005884955,0.00074770383,0.00015760209,0.00003741447,0.000006597707,0.0007400637,0.000010501091],"about_ca_topic_score_codex":0.8962344,"about_ca_topic_score_gemma":0.8912362,"teacher_disagreement_score":0.10376561,"about_ca_system_score_codex":0.015277174,"about_ca_system_score_gemma":0.018793697,"threshold_uncertainty_score":0.20875335},"labels":[],"label_agreement":null},{"id":"W4290098700","doi":"10.1016/j.msard.2022.104088","title":"Lessons learned from clinical trials of exercise and physical activity in people with MS – guidance for improving the quality of future research","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychological intervention; Randomized controlled trial; Fidelity; Physical medicine and rehabilitation; Multiple sclerosis; Physical therapy; Cognition; Applied psychology; Psychology; Nursing; Psychiatry","score_opus":0.4648288480510515,"score_gpt":0.508287043480823,"score_spread":0.04345819542977147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290098700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037998456,0.8259417,0.0031377187,0.1629587,0.005472498,0.0005879459,0.00019096659,0.00008441947,0.001246162],"genre_scores_gemma":[0.018672477,0.81255317,0.040827528,0.113246016,0.009542816,0.003786428,0.00036010274,0.00012907988,0.000882381],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.6832243,0.2238509,0.05668843,0.0067535588,0.02660245,0.002880342],"domain_scores_gemma":[0.31108826,0.5871271,0.023001205,0.01907175,0.053652532,0.006059034],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.38351625,0.0023945053,0.013349288,0.0050295973,0.002026825,0.013596468,0.007991177,0.014263812,0.0062110974],"category_scores_gemma":[0.5090235,0.0025628472,0.010219703,0.0068545626,0.0074560437,0.02843029,0.0067758136,0.019866228,0.0014451803],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014570908,0.00019379903,0.0014658584,0.18627357,0.003620249,0.00038779347,0.0030653358,0.0010228003,0.00043242905,0.025155202,0.1019283,0.6749975],"study_design_scores_gemma":[0.0017863008,0.00093467464,0.0026344897,0.5171987,0.0055908426,0.00060236995,0.0024564224,0.0009049627,0.00046118777,0.092820436,0.3744154,0.00019416978],"about_ca_topic_score_codex":0.009150134,"about_ca_topic_score_gemma":0.017194774,"teacher_disagreement_score":0.61648375,"about_ca_system_score_codex":0.011437619,"about_ca_system_score_gemma":0.047893852,"threshold_uncertainty_score":0.76023424},"labels":[],"label_agreement":null},{"id":"W4292166418","doi":"10.1016/j.msard.2022.104102","title":"Vaccine hesitancy in people with multiple sclerosis","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Virology; Dermatology; Immunology","score_opus":0.02122079986011625,"score_gpt":0.22079047415309308,"score_spread":0.19956967429297684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292166418","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062237162,0.0030492502,0.000047607788,0.91109633,0.0053363196,0.000026212954,0.00020781223,0.000018456174,0.017980812],"genre_scores_gemma":[0.29989082,0.0033478504,0.00016253679,0.666182,0.018826222,0.000069521,0.00013844279,0.000017018276,0.011365622],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9993162,0.0002652459,0.00008785539,0.00004650097,0.00013565419,0.00014857255],"domain_scores_gemma":[0.9959592,0.0017301678,0.00070159027,0.0000911235,0.0005070981,0.0010108047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010105377,0.00019447315,0.00041797207,0.0006282488,0.0028154014,0.0013339003,0.00039479084,0.010870525,0.0036243622],"category_scores_gemma":[0.010731385,0.00018543373,0.00038941263,0.00079587405,0.0011248994,0.0012328487,0.0008159688,0.0068637943,0.00063306896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039368286,0.00037523193,0.22786376,0.00024308235,0.0001454066,0.018301722,0.0042798556,0.00011329656,0.0005074845,0.0043937303,0.6990459,0.044336844],"study_design_scores_gemma":[0.00078021386,0.001080058,0.4650747,0.0023641998,0.00045717205,0.03423966,0.02365852,0.0021027387,0.00075953425,0.018128749,0.45115533,0.00019917665],"about_ca_topic_score_codex":0.019394321,"about_ca_topic_score_gemma":0.031968307,"teacher_disagreement_score":0.019394321,"about_ca_system_score_codex":0.0014924734,"about_ca_system_score_gemma":0.001921077,"threshold_uncertainty_score":0.038562834},"labels":[],"label_agreement":null},{"id":"W4292805718","doi":"10.1016/j.msard.2022.104138","title":"Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Celgene; Teva Pharmaceutical Industries; Biogen; Sanofi; Heart and Stroke Foundation of Canada; Roche","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Mood; Physical therapy; Cohort; Quality of life (healthcare); Cognition; Disease; Pediatrics; Internal medicine; Psychiatry","score_opus":0.08463754628614457,"score_gpt":0.29193224968933223,"score_spread":0.20729470340318767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292805718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984376,0.00035172387,0.000052288164,0.00008918079,0.000013124868,0.000008635001,0.000047210546,0.0000015370954,0.0009987092],"genre_scores_gemma":[0.9994741,0.000053301308,0.000048293983,0.00005551452,0.000021900238,0.0000053079298,0.00004059616,0.0000025524405,0.00029846263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990601,0.00042239827,0.00009765758,0.000141483,0.00017535368,0.00010311491],"domain_scores_gemma":[0.9798779,0.012112541,0.0053062374,0.0013597023,0.0008422592,0.00050149526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044532795,0.0003516184,0.00051895774,0.00080623344,0.0005695237,0.0014395487,0.0005879738,0.0009717289,0.0032366598],"category_scores_gemma":[0.028391894,0.00021129506,0.00039828217,0.00065827667,0.0007170584,0.0015064935,0.00049637957,0.0007720864,0.0002052277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014082029,0.0020820198,0.94571954,0.00027956144,0.0007399659,0.00034409363,0.0031340856,0.00036301702,0.0030136225,0.0009884186,0.0004929675,0.028760603],"study_design_scores_gemma":[0.00017091383,0.00081437634,0.9954079,0.00003062011,0.00016189205,0.00022774376,0.0004653014,0.00039976946,0.0005198575,0.0015128457,0.00027089898,0.000017874474],"about_ca_topic_score_codex":0.0046289274,"about_ca_topic_score_gemma":0.0043872017,"teacher_disagreement_score":0.0046289274,"about_ca_system_score_codex":0.0005483279,"about_ca_system_score_gemma":0.00066507293,"threshold_uncertainty_score":0.023551524},"labels":[],"label_agreement":null},{"id":"W4294842594","doi":"10.1016/j.msard.2022.104164","title":"Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Bruton's tyrosine kinase; Multiple sclerosis; Immunology; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Oncology; Receptor; Cancer","score_opus":0.050399819930991664,"score_gpt":0.2694452851222424,"score_spread":0.21904546519125076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294842594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013199837,0.9994444,0.000014185452,0.00016349612,0.00006842514,0.0000014938912,0.000015048652,0.000001371604,0.00015949078],"genre_scores_gemma":[0.0011739471,0.9983479,0.000035007986,0.00021983882,0.0001154796,0.00000255979,0.000022000942,5.4993836e-7,0.00008270139],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99980086,0.00004542102,0.000042449523,0.000030149457,0.00006250605,0.000018659373],"domain_scores_gemma":[0.9994979,0.00029022104,0.00012047888,0.000007541622,0.00006606049,0.000017819255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006444259,0.0004071669,0.002418125,0.0008911123,0.00012989389,0.0007154912,0.00083110953,0.00090421195,0.0027618061],"category_scores_gemma":[0.0013611758,0.00018088006,0.0012157758,0.0010883128,0.00028417664,0.0006484326,0.00028342038,0.0011081779,0.00063159486],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000583799,0.0000616177,0.00060938636,0.050790396,0.0014116281,0.00013274967,0.000035672438,0.00022596002,0.0010569656,0.0011408356,0.018960578,0.9249905],"study_design_scores_gemma":[0.0012928238,0.001244897,0.015528096,0.057372313,0.010693846,0.003054804,0.0002568789,0.00031899262,0.0012577253,0.003054258,0.90581024,0.000115097195],"about_ca_topic_score_codex":0.0015987114,"about_ca_topic_score_gemma":0.0043390454,"teacher_disagreement_score":0.0027618061,"about_ca_system_score_codex":0.00033620643,"about_ca_system_score_gemma":0.0008478711,"threshold_uncertainty_score":0.009239197},"labels":[],"label_agreement":null},{"id":"W4296741057","doi":"10.1016/j.msard.2022.104190","title":"Linking X to MS: Immunity and demyelination on the X-chromosome in MS","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Immunity; X chromosome; Chromosome; Immunology; Neuroscience; Genetics; Immune system; Biology; Gene","score_opus":0.0246551719435279,"score_gpt":0.21571332701721382,"score_spread":0.19105815507368593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296741057","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010329908,0.017114624,0.00039997787,0.9288956,0.03391164,0.000027104057,0.00003530723,0.000037215483,0.009248682],"genre_scores_gemma":[0.0892634,0.017024146,0.0004818683,0.432852,0.4477922,0.00005744053,0.000034725967,0.00003834116,0.012455806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896467,0.00049280556,0.00011986407,0.0001109562,0.00018181959,0.00012982725],"domain_scores_gemma":[0.99712294,0.0020943529,0.00017093617,0.00009464981,0.00021674877,0.00030039137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013820687,0.00083931716,0.0012237978,0.0007367251,0.0017840314,0.0018196608,0.0009939815,0.025586218,0.0034624657],"category_scores_gemma":[0.007150016,0.0004985841,0.0005704734,0.000518448,0.0019079727,0.0025385343,0.0007769364,0.011909354,0.0014888417],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00099317,0.0003403262,0.011804616,0.0005537014,0.00010486159,0.14732553,0.0007731527,0.0006645,0.0026508386,0.016497184,0.7696161,0.048676],"study_design_scores_gemma":[0.0014572948,0.0008717836,0.017416839,0.0015689285,0.00028187383,0.23937573,0.0023151233,0.006446901,0.0019614722,0.07940226,0.64865685,0.0002449483],"about_ca_topic_score_codex":0.0014388141,"about_ca_topic_score_gemma":0.0020074788,"teacher_disagreement_score":0.025586218,"about_ca_system_score_codex":0.0015589984,"about_ca_system_score_gemma":0.0009911121,"threshold_uncertainty_score":0.01158309},"labels":[],"label_agreement":null},{"id":"W4297311074","doi":"10.1016/j.msard.2022.104196","title":"The relationship between alexithymia, reading the mind in the eyes and cognition in patients with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Toronto Alexithymia Scale; Beck Depression Inventory; Cognition; Psychology; Trail Making Test; Anxiety; Clinical psychology; Verbal fluency test; Paced Auditory Serial Addition Test; Beck Anxiety Inventory; Medicine; Depression (economics); Psychiatry; Neuropsychology","score_opus":0.05847195435854977,"score_gpt":0.2659462954068055,"score_spread":0.2074743410482557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297311074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981067,0.0005485088,0.000020827447,0.000087977394,0.000012477337,0.0000041088133,0.000048837846,0.000002278763,0.0011681869],"genre_scores_gemma":[0.99964356,0.0001247147,0.000029157773,0.000022199121,0.000014929933,0.0000018553039,0.00004352408,5.773839e-7,0.00011957686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960214,0.00012690134,0.00006998434,0.00005495544,0.00008386731,0.000062144165],"domain_scores_gemma":[0.9981127,0.0006510426,0.0007384434,0.00008243114,0.00015732132,0.00025813922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005226334,0.0003304147,0.00046073718,0.0011837082,0.00085901597,0.0010436623,0.00027797505,0.00072213373,0.0017510852],"category_scores_gemma":[0.0038280548,0.00026189376,0.0005588889,0.0012165207,0.00056136824,0.0005376824,0.000533602,0.001117112,0.000118865595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024297317,0.000119632256,0.99688053,0.000020566238,0.00017795328,0.00019082736,0.00021946778,0.000044924862,0.00021815479,0.000035042416,0.000054432643,0.0017954118],"study_design_scores_gemma":[0.000007945981,0.00007195386,0.99921405,0.0000046303353,0.000043207343,0.00022730953,0.00023239708,0.00007764316,0.000020230202,0.000048486436,0.000048168833,0.0000040131795],"about_ca_topic_score_codex":0.008272838,"about_ca_topic_score_gemma":0.011346396,"teacher_disagreement_score":0.008272838,"about_ca_system_score_codex":0.00039252065,"about_ca_system_score_gemma":0.00039611955,"threshold_uncertainty_score":0.016449332},"labels":[],"label_agreement":null},{"id":"W4303446350","doi":"10.1016/j.msard.2022.104229","title":"The symbol digit modalities test and the paced auditory serial addition test involve more than processing speed","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Carleton University; University of Ottawa; St. Francis Xavier University; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"Numerical digit; Medicine; Test (biology); Audiology; Modalities; Symbol (formal); Arithmetic; Computer science","score_opus":0.023670388049836406,"score_gpt":0.24430650171116794,"score_spread":0.22063611366133154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303446350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644791,0.0026041837,0.005545431,0.00042086167,0.00023002793,0.0001407313,0.0013969134,0.00022070341,0.02496205],"genre_scores_gemma":[0.98661906,0.0012927561,0.0054324907,0.00050849287,0.00021120215,0.00012831685,0.0009452199,0.000059312777,0.004803165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874395,0.00017841229,0.00015455029,0.00022075669,0.00063921086,0.00006315774],"domain_scores_gemma":[0.9927723,0.0039013345,0.0018277165,0.00044186346,0.0008521041,0.00020469638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009359122,0.0012478995,0.0008438006,0.0019718497,0.0002461019,0.001055213,0.0006506366,0.00084948156,0.00421279],"category_scores_gemma":[0.008783716,0.00018471744,0.000490717,0.0017108871,0.0005409786,0.0021522802,0.00045225356,0.0006469477,0.0007686745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022301779,0.0014211866,0.71073574,0.00067990116,0.0010175421,0.0019603143,0.0007325052,0.0033029811,0.04022409,0.0017553479,0.0029197226,0.23302045],"study_design_scores_gemma":[0.0000648776,0.0013277486,0.9820219,0.000051614552,0.00020430134,0.0027477809,0.00021227678,0.001171832,0.00738766,0.0024660162,0.0022909893,0.000052987012],"about_ca_topic_score_codex":0.002329864,"about_ca_topic_score_gemma":0.0018376075,"teacher_disagreement_score":0.00421279,"about_ca_system_score_codex":0.00022373952,"about_ca_system_score_gemma":0.00050984224,"threshold_uncertainty_score":0.01409322},"labels":[],"label_agreement":null},{"id":"W4303446370","doi":"10.1016/j.msard.2022.104230","title":"Discussing the potential for progression with patients newly diagnosed with multiple sclerosis: When, how, and why?","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Medicine; Acknowledgement; Multiple sclerosis; Disease; Anxiety; Intensive care medicine; Progressive disease; Pediatrics; Psychiatry; Pathology","score_opus":0.053012340172682804,"score_gpt":0.28430436252011343,"score_spread":0.23129202234743063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303446370","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026248275,0.9992836,0.000010965184,0.0004920191,0.00010880085,0.0000015923139,0.0000067879437,7.995014e-7,0.00006923312],"genre_scores_gemma":[0.00042370913,0.9988563,0.00006196452,0.00044697325,0.00014974114,0.0000038462113,0.000010565292,4.0314774e-7,0.000046550904],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9986571,0.0006336893,0.00025539272,0.00012516865,0.00026686784,0.000061763734],"domain_scores_gemma":[0.9942011,0.0046998216,0.00049797137,0.00004695995,0.00045909587,0.000094888754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031286965,0.0009547594,0.0036987613,0.0029757484,0.00046328604,0.0023285344,0.0015268743,0.0037215687,0.0037832893],"category_scores_gemma":[0.008466165,0.00042965694,0.0019113346,0.0030035805,0.00079948985,0.002725549,0.00105272,0.0030975477,0.00068675727],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022745391,0.000050548566,0.0006906884,0.15257117,0.0013315399,0.00026429514,0.00038912537,0.00015926996,0.00027202736,0.0028808862,0.040912393,0.80025053],"study_design_scores_gemma":[0.00023144617,0.00019990839,0.0047476497,0.32946426,0.006036455,0.002676879,0.0011818246,0.00013141595,0.00033306392,0.005342043,0.64953953,0.0001155802],"about_ca_topic_score_codex":0.0046181874,"about_ca_topic_score_gemma":0.009571917,"teacher_disagreement_score":0.0046181874,"about_ca_system_score_codex":0.0011062919,"about_ca_system_score_gemma":0.0032863223,"threshold_uncertainty_score":0.016546309},"labels":[],"label_agreement":null},{"id":"W4306644982","doi":"10.1016/j.msard.2022.104250","title":"Trends in the environmental risks associated with earlier onset in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Margareta af Ugglas Foundation; Multiple Sclerosis Society; European Genomic Institute for Diabetes; Swedish Foundation for MS Research; HORIZON EUROPE Framework Programme; Multiple Sclerosis Society of Canada","keywords":"Medicine; Vitamin D and neurology; Age of onset; Body mass index; Disease; Cohort; Multiple sclerosis; Risk factor; Cohort study; vitamin D deficiency; Obesity; Pediatrics; Demography; Internal medicine; Immunology","score_opus":0.06341110857591195,"score_gpt":0.2640886501180761,"score_spread":0.20067754154216413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306644982","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11104428,0.8748566,0.00063061184,0.0021537193,0.00026733254,0.000056166762,0.008384945,0.000026518042,0.0025797735],"genre_scores_gemma":[0.36546278,0.62525105,0.0023803045,0.0009230547,0.00052216393,0.00011186023,0.0047373166,0.000020308415,0.000591218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790895,0.0003796386,0.0008446351,0.00045642364,0.00033629098,0.00007412293],"domain_scores_gemma":[0.97079706,0.014220307,0.011104683,0.00038401363,0.0031289882,0.00036494358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031428507,0.0002922314,0.00068651483,0.008987926,0.00024712965,0.0017290259,0.00044644004,0.00069510256,0.0022280717],"category_scores_gemma":[0.01470132,0.00022618622,0.0013350995,0.015732488,0.00040533434,0.0016984199,0.0005760781,0.00066083216,0.00020782564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009979925,0.000077883895,0.6132301,0.15659778,0.0077661164,0.0012581575,0.0032554069,0.0005904632,0.002838194,0.0026145473,0.0065204203,0.20425305],"study_design_scores_gemma":[0.00004291589,0.00030504755,0.91314644,0.03138549,0.006387684,0.003086706,0.002108559,0.00023914772,0.00088359567,0.0009030411,0.041457538,0.00005386602],"about_ca_topic_score_codex":0.004513084,"about_ca_topic_score_gemma":0.007499723,"teacher_disagreement_score":0.008987926,"about_ca_system_score_codex":0.0007557735,"about_ca_system_score_gemma":0.0010852091,"threshold_uncertainty_score":0.016621172},"labels":[],"label_agreement":null},{"id":"W4306664528","doi":"10.1016/j.msard.2022.104238","title":"A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; International Collaboration On Repair Discoveries; University of British Columbia","funders":"University of British Columbia","keywords":"Multiple sclerosis; White matter; Myelin; Medicine; Nuclear medicine; Binding potential; Pathology; Magnetic resonance imaging; Internal medicine; Positron emission tomography; Central nervous system; Radiology; Immunology","score_opus":0.12081709891831649,"score_gpt":0.27647721004989095,"score_spread":0.15566011113157446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306664528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741484,0.0018504428,0.0007435756,0.017045949,0.0015266533,0.00047009456,0.00038750694,0.00004118553,0.0037861972],"genre_scores_gemma":[0.9814299,0.00048496408,0.0011306399,0.013618307,0.0016359548,0.00033925404,0.00017458257,0.000016962978,0.0011694648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764204,0.0014767459,0.00028495622,0.00020243376,0.00020606881,0.00018777922],"domain_scores_gemma":[0.9884029,0.008405971,0.0004757624,0.00068437075,0.0011978948,0.000833067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005331601,0.00058543973,0.00094850425,0.0003756269,0.0011007792,0.000915363,0.00080788846,0.0044316924,0.0014154831],"category_scores_gemma":[0.015434259,0.00034184978,0.0005554405,0.000599473,0.000855347,0.000906235,0.00046213635,0.0016483983,0.00049456436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25792873,0.018915178,0.30598643,0.0012603085,0.0018998863,0.16603196,0.004091974,0.0004916954,0.057579175,0.0013474814,0.03375083,0.15071629],"study_design_scores_gemma":[0.055638243,0.21236974,0.5394741,0.000402576,0.0035279975,0.10392567,0.0046435236,0.003414675,0.025712391,0.0032006064,0.047409367,0.0002810409],"about_ca_topic_score_codex":0.0035076314,"about_ca_topic_score_gemma":0.0053518694,"teacher_disagreement_score":0.005331601,"about_ca_system_score_codex":0.0008783513,"about_ca_system_score_gemma":0.00091662764,"threshold_uncertainty_score":0.028196573},"labels":[],"label_agreement":null},{"id":"W4306709142","doi":"10.1016/j.msard.2022.104256","title":"The biological rabbit hole: Only for the blind","year":2022,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Rabbit (cipher); Medicine; Multiple sclerosis; Immunology; Statistics; Mathematics","score_opus":0.0712973415011136,"score_gpt":0.29138752437165694,"score_spread":0.22009018287054333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306709142","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049726776,0.0013130354,0.00006927539,0.97208947,0.02110492,0.000010585861,0.000017133214,0.000015629988,0.004882749],"genre_scores_gemma":[0.0060752803,0.0011545485,0.0002240908,0.9327912,0.039119814,0.00004159265,0.000012895523,0.00002537668,0.020555258],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778736,0.00077080337,0.00019908838,0.00028799466,0.00054578553,0.00040882634],"domain_scores_gemma":[0.9960531,0.0016425896,0.0002313345,0.00020379329,0.00059166254,0.0012775109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023368583,0.0010336643,0.0012904247,0.0007368557,0.008596797,0.00514571,0.0015309345,0.07085203,0.01102767],"category_scores_gemma":[0.0186713,0.00086642546,0.001264484,0.00048154828,0.0039808666,0.00660736,0.0022109572,0.060131736,0.006297614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009866124,0.000080641,0.00079390703,0.00004894278,0.000027801783,0.009098241,0.0003482185,0.00004795634,0.00026719828,0.0056917802,0.9778114,0.005685246],"study_design_scores_gemma":[0.00019764453,0.00011406424,0.0012010204,0.00030449373,0.00004164181,0.008093277,0.0018068723,0.00035905206,0.00018771538,0.019819291,0.9678044,0.000070600545],"about_ca_topic_score_codex":0.0067148623,"about_ca_topic_score_gemma":0.012461131,"teacher_disagreement_score":0.07085203,"about_ca_system_score_codex":0.0037886347,"about_ca_system_score_gemma":0.0041047507,"threshold_uncertainty_score":0.036891222},"labels":[],"label_agreement":null},{"id":"W4309479795","doi":"10.1016/j.msard.2022.104421","title":"Association between multiple sclerosis and epilepsy: A systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Epilepsy; Meta-analysis; Incidence (geometry); Multiple sclerosis; Confidence interval; Observational study; Population; Internal medicine; Relative risk; Pediatrics; Psychiatry; Environmental health","score_opus":0.15728198384027198,"score_gpt":0.3312605183813784,"score_spread":0.1739785345411064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309479795","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060901847,0.9922495,0.00051561795,0.0001348678,0.00013100513,0.00025217343,0.00043329748,0.000024671823,0.00016867949],"genre_scores_gemma":[0.15998513,0.83437264,0.0026733284,0.00094150385,0.00021739364,0.00071944215,0.0005992135,0.000033858876,0.00045750593],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99419576,0.002273709,0.0019548775,0.000715294,0.000586875,0.0002735685],"domain_scores_gemma":[0.98841316,0.008172227,0.002132204,0.0004140798,0.0006799774,0.0001883657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008400373,0.0027328026,0.01818583,0.0048051695,0.0007126399,0.0032601152,0.0024375396,0.002915119,0.00591001],"category_scores_gemma":[0.020892585,0.0019814633,0.026788644,0.0073085595,0.0008571522,0.0022718743,0.0021838767,0.0021633983,0.00048218857],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013541216,0.00003335608,0.004375848,0.39741322,0.5886658,0.00019722994,0.00013232138,0.00027564733,0.00025624322,0.00010373858,0.00052591786,0.006666577],"study_design_scores_gemma":[0.00057930127,0.00010395848,0.0034167941,0.015714495,0.97871804,0.00009764486,0.00006606881,0.00009110352,0.00005703456,0.00010871858,0.0010211578,0.000025672283],"about_ca_topic_score_codex":0.008263571,"about_ca_topic_score_gemma":0.029174935,"teacher_disagreement_score":0.01818583,"about_ca_system_score_codex":0.0021911145,"about_ca_system_score_gemma":0.0037843948,"threshold_uncertainty_score":0.044425905},"labels":[],"label_agreement":null},{"id":"W4310064348","doi":"10.1016/j.msard.2022.104433","title":"The nine hole peg test as an outcome measure in progressive MS trials","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"","keywords":"Medicine; Ambulatory; Clinical trial; Randomized controlled trial; Physical therapy; Test (biology); Surgery; Internal medicine","score_opus":0.08297419620756323,"score_gpt":0.33296610375509905,"score_spread":0.2499919075475358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310064348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.877979,0.091315165,0.0033909325,0.0039028109,0.002666291,0.0059654727,0.0041753575,0.00014464329,0.010460368],"genre_scores_gemma":[0.9820259,0.007106739,0.0027715664,0.00079679646,0.0004678609,0.0039254553,0.0015090591,0.000023175486,0.0013733661],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97036576,0.023682782,0.0022100313,0.0008755535,0.0022342154,0.00063172437],"domain_scores_gemma":[0.9822565,0.009735399,0.004764131,0.0008113707,0.0010945449,0.0013380239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021714892,0.0021058053,0.0060476996,0.0021657774,0.0007992115,0.0018297726,0.0013049745,0.0026340308,0.0028283899],"category_scores_gemma":[0.028023724,0.00046310166,0.0033888717,0.0021314977,0.001140413,0.0037951802,0.0016503322,0.0027715191,0.00042753603],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80057913,0.0032788604,0.039914306,0.00592996,0.023254337,0.00017285367,0.00027206136,0.002642178,0.0016651194,0.0017632857,0.0037758548,0.11675209],"study_design_scores_gemma":[0.5166721,0.21735649,0.20628728,0.0029687553,0.025357852,0.00047915566,0.0005789021,0.0077244313,0.002979704,0.007332494,0.01188598,0.0003768813],"about_ca_topic_score_codex":0.0013876773,"about_ca_topic_score_gemma":0.0019256859,"teacher_disagreement_score":0.021714892,"about_ca_system_score_codex":0.0014471291,"about_ca_system_score_gemma":0.002129586,"threshold_uncertainty_score":0.114840746},"labels":[],"label_agreement":null},{"id":"W4310731794","doi":"10.1016/j.msard.2022.104444","title":"Stroke Outcomes and Hyperacute Treatment Utilization in Multiple Sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Stroke (engine); Thrombolysis; Population; Odds ratio; Logistic regression; Multiple sclerosis; Emergency medicine; Internal medicine; Physical therapy; Myocardial infarction; Environmental health","score_opus":0.09061417699426802,"score_gpt":0.29001869555218024,"score_spread":0.19940451855791222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310731794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950381,0.0026109852,0.000029698313,0.00026210607,0.000014206515,0.0000072062157,0.00088927377,0.0000028419777,0.0011456137],"genre_scores_gemma":[0.9978854,0.0009163002,0.000024115063,0.000072045645,0.000039822462,0.000010129516,0.00078047754,0.0000019495262,0.00026970846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832803,0.0006493657,0.00034966302,0.00016105274,0.00018665382,0.0003253007],"domain_scores_gemma":[0.99395365,0.0012939381,0.0032966156,0.00027166345,0.0004769521,0.00070721726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016975479,0.00025465293,0.00063146517,0.00214506,0.00083524984,0.0017592115,0.0005008345,0.00088356726,0.0024718165],"category_scores_gemma":[0.008904967,0.00026009095,0.0011599306,0.0044075768,0.00033433439,0.0013175613,0.00093450834,0.0010380702,0.0002602125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054611266,0.00020236435,0.9956589,0.00007634111,0.0007010683,0.00006960974,0.00017694438,0.000064513144,0.000038573256,0.0000661459,0.0002537431,0.0021456762],"study_design_scores_gemma":[0.000026183152,0.00014397,0.99853694,0.00004695444,0.0002195069,0.00010686073,0.0004587044,0.00010402695,0.000034403256,0.00006220127,0.000251705,0.000008386223],"about_ca_topic_score_codex":0.034130916,"about_ca_topic_score_gemma":0.027851563,"teacher_disagreement_score":0.034130916,"about_ca_system_score_codex":0.0008046404,"about_ca_system_score_gemma":0.0011494363,"threshold_uncertainty_score":0.06786454},"labels":[],"label_agreement":null},{"id":"W4311086874","doi":"10.1016/j.msard.2022.104459","title":"Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Bayer Vital; EMD Serono; Deutsche Forschungsgemeinschaft; European Commission; Sanofi; Bayer HealthCare; Bristol-Myers Squibb; CSL Behring; Fresenius Medical Care North America; Biogen; Celgene; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Merck KGaA; Pfizer","keywords":"Cladribine; Medicine; Multiple sclerosis; Expert opinion; Term (time); Relapsing remitting; Dermatology; Systematic review; Alternative medicine; MEDLINE; Intensive care medicine; Medical physics; Immunology; Pathology; Internal medicine","score_opus":0.2194334906312244,"score_gpt":0.36579924789781365,"score_spread":0.14636575726658926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311086874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021970714,0.977416,0.0013974494,0.008953734,0.0017337216,0.0031781683,0.0031892627,0.00004023843,0.0018944637],"genre_scores_gemma":[0.022550745,0.9526174,0.0055796904,0.00989488,0.00091426354,0.006062941,0.0017613095,0.000029715931,0.0005889906],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.937574,0.020879308,0.029327769,0.0030090434,0.0080791395,0.0011307073],"domain_scores_gemma":[0.748668,0.16464527,0.053806055,0.0031641726,0.02741676,0.0022997737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06017679,0.0018154822,0.008102371,0.024722764,0.0012898037,0.0044138795,0.0040431437,0.004856659,0.0074746143],"category_scores_gemma":[0.19035204,0.0015006555,0.007939883,0.015810205,0.0023129298,0.0059099817,0.0036102694,0.0020208922,0.001000188],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014608736,0.000009335729,0.0006135252,0.960181,0.002823014,0.00016945458,0.00048561988,0.000076201206,0.00023055736,0.00032239585,0.005261899,0.02968077],"study_design_scores_gemma":[0.000106296284,0.00006533485,0.000926853,0.96346825,0.011572053,0.00018202096,0.00035990242,0.00004284474,0.0001426413,0.00034631733,0.022759613,0.00002776408],"about_ca_topic_score_codex":0.005725432,"about_ca_topic_score_gemma":0.01492617,"teacher_disagreement_score":0.06017679,"about_ca_system_score_codex":0.007005464,"about_ca_system_score_gemma":0.030961337,"threshold_uncertainty_score":0.3182491},"labels":[],"label_agreement":null},{"id":"W4312156836","doi":"10.1016/j.msard.2022.104482","title":"Cognitive reserve as a moderating factor between EDSS and cognition in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Montréal","funders":"Canadian Institutes of Health Research","keywords":"Multiple sclerosis; Cognitive reserve; Neuropsychology; Cognition; Medicine; Expanded Disability Status Scale; Population; Effects of sleep deprivation on cognitive performance; Clinical psychology; Physical medicine and rehabilitation; Audiology; Cognitive impairment; Psychiatry; Environmental health","score_opus":0.09531968446700659,"score_gpt":0.2968907295039255,"score_spread":0.2015710450369189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312156836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975776,0.0014418444,0.00004917434,0.00017122169,0.000026777729,0.0000047714457,0.00008437795,0.0000046881846,0.00063958636],"genre_scores_gemma":[0.99941087,0.00015379822,0.000057000772,0.000029600165,0.00003350066,0.0000036149113,0.000064907355,0.0000014986599,0.00024535225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932754,0.00025363802,0.00007896529,0.00012003942,0.00007744587,0.00014244407],"domain_scores_gemma":[0.9963695,0.0017168317,0.00093475124,0.00028095217,0.0001800479,0.0005179293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015548465,0.0007858464,0.00060520234,0.0008232241,0.0006382296,0.0013269754,0.00069525134,0.0010694524,0.00270494],"category_scores_gemma":[0.006509599,0.00036073342,0.0013525706,0.000728554,0.00049022824,0.0008079851,0.0007833757,0.0012596054,0.00015745412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019897644,0.00046685833,0.9905199,0.00007285818,0.0011978084,0.00023145229,0.0003439913,0.00016084853,0.00033974805,0.00012897933,0.00013890878,0.004408847],"study_design_scores_gemma":[0.000036171597,0.00026024753,0.99803966,0.000023846482,0.00056031946,0.00011216145,0.00022897634,0.0002828821,0.000090105095,0.0002072675,0.00014807994,0.000010160728],"about_ca_topic_score_codex":0.01328184,"about_ca_topic_score_gemma":0.012076127,"teacher_disagreement_score":0.01328184,"about_ca_system_score_codex":0.0004015446,"about_ca_system_score_gemma":0.0010157397,"threshold_uncertainty_score":0.02640909},"labels":[],"label_agreement":null},{"id":"W4312157419","doi":"10.1016/j.msard.2022.104477","title":"Switching to natalizumab or fingolimod in multiple sclerosis: Comparative effectiveness and effect of pre-switch disease activity","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"Sanofi Genzyme; Multiple Sclerosis Society; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Glatiramer acetate; Hazard ratio; Internal medicine; Confidence interval; Physical therapy; Immunology","score_opus":0.04864018171732619,"score_gpt":0.3034846335300865,"score_spread":0.2548444518127603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312157419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850367,0.012976221,0.00022148318,0.00019226687,0.000080476115,0.00015753362,0.00041316127,0.000009879655,0.0009123109],"genre_scores_gemma":[0.9974235,0.00184061,0.00015968995,0.00007627065,0.00007629043,0.000052271687,0.00027817217,0.0000025438926,0.00009045564],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99029505,0.007196048,0.00073239213,0.0007673892,0.00070258835,0.00030659317],"domain_scores_gemma":[0.9850465,0.009935768,0.003089873,0.00095800345,0.00024143662,0.00072836137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011746289,0.0006652641,0.0015360819,0.001086425,0.00020938119,0.0011668102,0.00082665967,0.0011577009,0.0019084585],"category_scores_gemma":[0.017426964,0.00031933602,0.004704198,0.0008339647,0.00082784053,0.000970342,0.0007205602,0.0012624183,0.00016486253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72953963,0.004157941,0.13020964,0.002320343,0.049315073,0.000113093985,0.00026307392,0.003387194,0.0010719288,0.00048842246,0.0004935165,0.07864008],"study_design_scores_gemma":[0.20248221,0.24155197,0.44686002,0.0010323176,0.08958571,0.00059333025,0.00044965104,0.009001103,0.0031949303,0.002182945,0.002917662,0.00014817885],"about_ca_topic_score_codex":0.0012207278,"about_ca_topic_score_gemma":0.0010604187,"teacher_disagreement_score":0.011746289,"about_ca_system_score_codex":0.00093718513,"about_ca_system_score_gemma":0.0005560115,"threshold_uncertainty_score":0.062121034},"labels":[],"label_agreement":null},{"id":"W4315884145","doi":"10.1016/j.msard.2023.104519","title":"Cancer risk and mortality in multiple sclerosis: The need for vigilance","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Mitoxantrone; Azathioprine; Multiple sclerosis; Cancer; Internal medicine; Population; Cyclophosphamide; Oncology; Disease; Chemotherapy; Immunology","score_opus":0.05518526377351195,"score_gpt":0.30802340309560955,"score_spread":0.2528381393220976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315884145","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024758632,0.014661712,0.00007212203,0.04165401,0.9431099,0.000012753661,0.00004697709,0.000029011047,0.00038876856],"genre_scores_gemma":[0.0002348578,0.0058265147,0.00009288793,0.02246591,0.97035044,0.000020835494,0.000018621256,0.000018431852,0.00097150216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9802238,0.007047286,0.003989792,0.0015919578,0.006476189,0.00067109725],"domain_scores_gemma":[0.837284,0.105197184,0.006335394,0.0037717805,0.03891957,0.008492049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03693705,0.005510238,0.011319937,0.0058994805,0.0050791455,0.015015643,0.006993724,0.035367172,0.009686514],"category_scores_gemma":[0.10656609,0.002585065,0.0056081563,0.004447286,0.004500988,0.009003952,0.0028958404,0.042351156,0.006807819],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010714197,0.000019537549,0.00008797739,0.0010287801,0.00018177328,0.000099952085,0.000032904856,0.000024003353,0.000030413654,0.00037944538,0.9922044,0.0058036987],"study_design_scores_gemma":[0.00064913597,0.00012786262,0.0017464187,0.006023415,0.0014122443,0.0005711108,0.00035869487,0.00063237344,0.00013352357,0.005856722,0.9823429,0.00014573781],"about_ca_topic_score_codex":0.0050672125,"about_ca_topic_score_gemma":0.01361347,"teacher_disagreement_score":0.03693705,"about_ca_system_score_codex":0.0056463694,"about_ca_system_score_gemma":0.006432532,"threshold_uncertainty_score":0.19534409},"labels":[],"label_agreement":null},{"id":"W4316035190","doi":"10.1016/j.msard.2023.104514","title":"Multiple sclerosis-related heat sensitivity linked to absence of DMT prescription and subjective hand impairment but not autonomic or corticospinal dysfunction","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Thermoregulation and physiological responses","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Depression (economics); Physical medicine and rehabilitation; Anxiety; Transcranial magnetic stimulation; Multiple sclerosis; Visual analogue scale; Physical therapy; Internal medicine; Cardiology; Psychiatry; Stimulation","score_opus":0.040208404117657075,"score_gpt":0.25003616870786555,"score_spread":0.20982776459020847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316035190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579805,0.00044908148,0.00030507732,0.00013273323,0.000017282586,0.000031943346,0.00017918363,0.000016986158,0.0030696408],"genre_scores_gemma":[0.9994597,0.000071230745,0.0000874055,0.000038771308,0.000013587547,0.000004805611,0.00007619834,0.000002096771,0.00024631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997665,0.00003985414,0.00003612732,0.000069328176,0.000038947634,0.000049223527],"domain_scores_gemma":[0.9987483,0.00027785343,0.00060689636,0.00007831492,0.0000954715,0.00019312184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023066567,0.0006583174,0.0005231824,0.00076352945,0.00053094735,0.00045496816,0.0002866884,0.00052646856,0.004623407],"category_scores_gemma":[0.0017147501,0.00017098214,0.00042389994,0.0006361673,0.0005765702,0.00033831276,0.00036113826,0.00079787185,0.0002141365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029793782,0.0005907348,0.9185752,0.00027806262,0.00042811816,0.041840795,0.00044122603,0.00029828664,0.025521724,0.00028502286,0.00030632573,0.008455248],"study_design_scores_gemma":[0.000012127822,0.00023187493,0.9795226,0.000019294343,0.000078915706,0.01895128,0.00009061088,0.00023543795,0.00058004155,0.00011777979,0.00015171255,0.000008424685],"about_ca_topic_score_codex":0.003248544,"about_ca_topic_score_gemma":0.002759035,"teacher_disagreement_score":0.004623407,"about_ca_system_score_codex":0.00030124007,"about_ca_system_score_gemma":0.0003776802,"threshold_uncertainty_score":0.015466869},"labels":[],"label_agreement":null},{"id":"W4318672184","doi":"10.1016/j.msard.2023.104542","title":"Specific alterations in NKG2D+ T lymphocytes in relapsing-remitting and progressive multiple sclerosis patients","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada","keywords":"Medicine; Relapsing remitting; Multiple sclerosis; NKG2D; Immunology; Cytotoxic T cell; Genetics","score_opus":0.04567342888861846,"score_gpt":0.2677340634801948,"score_spread":0.22206063459157632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318672184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990277,0.00025609197,0.000029327326,0.000011178759,0.0000041389544,0.0000064453147,0.00009163632,0.0000028854136,0.0005704243],"genre_scores_gemma":[0.9994911,0.00006361723,0.000028350521,0.000020469639,0.0000064638384,0.000006474709,0.000104229075,0.0000015685152,0.00027777883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985135,0.000025294135,0.00002451699,0.000042364714,0.00001836243,0.00003809373],"domain_scores_gemma":[0.9998393,0.000034511657,0.0000500008,0.000010798953,0.000025960688,0.000039302075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000111706446,0.0002158078,0.00032348058,0.00055970723,0.00033568247,0.00032809252,0.0001641086,0.00031397934,0.0017266974],"category_scores_gemma":[0.000556703,0.000119227036,0.000177571,0.00037245816,0.00015541523,0.0002187168,0.00019533394,0.00021580534,0.00025282617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048493627,0.00019078908,0.93423176,0.00011634685,0.0001739432,0.0036098098,0.0006456374,0.00015022281,0.03776984,0.00010042245,0.0003022941,0.017859684],"study_design_scores_gemma":[0.00004108213,0.0003486421,0.9941949,0.0000076075867,0.0000532216,0.003409421,0.00031249598,0.00009579175,0.0009493447,0.00006657924,0.0005161635,0.0000047085196],"about_ca_topic_score_codex":0.0010924564,"about_ca_topic_score_gemma":0.0010279245,"teacher_disagreement_score":0.0017266974,"about_ca_system_score_codex":0.00018627035,"about_ca_system_score_gemma":0.00010372496,"threshold_uncertainty_score":0.0057763457},"labels":[],"label_agreement":null},{"id":"W4319915130","doi":"10.1016/j.msard.2023.104561","title":"Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Medicine; Natalizumab; Dosing; Expanded Disability Status Scale; Physical therapy; Multiple sclerosis; Rating scale; Randomized controlled trial; Clinical trial; Internal medicine; Clinical endpoint; Progressive multifocal leukoencephalopathy; Disease","score_opus":0.08653767171726767,"score_gpt":0.30270793263833595,"score_spread":0.21617026092106828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813572,0.0052958042,0.0010496249,0.00050704024,0.0007435675,0.007393221,0.0015447132,0.00009416886,0.002014753],"genre_scores_gemma":[0.98145574,0.0012767682,0.0026450332,0.0008825858,0.000623019,0.010506005,0.0012466704,0.000021919415,0.0013421983],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992446,0.0048851506,0.0006462968,0.0009722668,0.00061084796,0.00043946478],"domain_scores_gemma":[0.9917675,0.0028231584,0.0029753856,0.0005122535,0.0005804405,0.0013411242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071191704,0.002259831,0.0040884465,0.00075278874,0.00065739296,0.0016285417,0.0013907499,0.0026524677,0.0047887657],"category_scores_gemma":[0.008086303,0.0007541904,0.0049612867,0.00057608413,0.0018915621,0.002086014,0.000903851,0.004241551,0.00062726036],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98894715,0.003873673,0.00081414916,0.00033741392,0.0016356274,0.000014795131,0.000021505697,0.00013918433,0.0005311801,0.0000505738,0.00013662665,0.0034980206],"study_design_scores_gemma":[0.90896696,0.08397222,0.004142543,0.000056960995,0.0014740381,0.000027087854,0.00002137305,0.00056986127,0.00023236904,0.00016793018,0.00034051994,0.000028270679],"about_ca_topic_score_codex":0.0006441259,"about_ca_topic_score_gemma":0.0011930509,"teacher_disagreement_score":0.0071191704,"about_ca_system_score_codex":0.0010420831,"about_ca_system_score_gemma":0.0014845344,"threshold_uncertainty_score":0.037650168},"labels":[],"label_agreement":null},{"id":"W4320921451","doi":"10.1016/j.msard.2023.104578","title":"Vascular function and cognition in persons with multiple sclerosis: Preliminary examination","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Cognition; Arterial stiffness; Multiple sclerosis; Population; Internal medicine; Trail Making Test; Comorbidity; Cardiology; Physical therapy; Cognitive impairment; Blood pressure; Psychiatry","score_opus":0.04080956677154136,"score_gpt":0.24474924242258678,"score_spread":0.20393967565104543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320921451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984799,0.0002897063,0.000024566909,0.000039597642,0.0000037225996,0.00001462317,0.00014303162,0.0000012670557,0.0010036187],"genre_scores_gemma":[0.99908936,0.00017335136,0.0000896823,0.000033807566,0.000011119967,0.00001356633,0.00022984124,7.164553e-7,0.00035861973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961483,0.00014334708,0.000046136076,0.000051738098,0.00007116968,0.00007280914],"domain_scores_gemma":[0.99866164,0.00038812315,0.0002971795,0.00009679746,0.00029047646,0.0002657655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015610065,0.0004818217,0.00048014912,0.0013877962,0.0010631462,0.00081405864,0.00038723738,0.00051628164,0.0021003135],"category_scores_gemma":[0.0030211434,0.00028108244,0.0008166859,0.0013981243,0.0003907845,0.00097470527,0.00074426545,0.00066730526,0.000275707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060362695,0.0004736935,0.99474925,0.000027372354,0.0001425793,0.00016897835,0.0006585169,0.000024817953,0.00028021564,0.000030301553,0.000080381185,0.002760188],"study_design_scores_gemma":[0.000014750913,0.00048079618,0.9984687,0.0000041626863,0.00005957211,0.00009513198,0.00067382195,0.000022151704,0.00004530586,0.000023926386,0.000108878754,0.0000027492063],"about_ca_topic_score_codex":0.021334417,"about_ca_topic_score_gemma":0.033696625,"teacher_disagreement_score":0.021334417,"about_ca_system_score_codex":0.0003791573,"about_ca_system_score_gemma":0.00059827435,"threshold_uncertainty_score":0.042420447},"labels":[],"label_agreement":null},{"id":"W4322011926","doi":"10.1016/j.msard.2023.104590","title":"Are we ready for CD19-targeted CAR T-cell therapies in MS?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chimeric antigen receptor; CD19; Medicine; Immunology; B cell; Antigen; T cell; Cancer research","score_opus":0.0493028518859097,"score_gpt":0.29498792866946655,"score_spread":0.24568507678355683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322011926","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045621444,0.015165872,0.00016550219,0.047656547,0.9355238,0.000024122339,0.000046099736,0.000052088206,0.0013204257],"genre_scores_gemma":[0.00057520065,0.011200273,0.00018433447,0.049318902,0.93129045,0.000038678198,0.00003213497,0.000032975076,0.007327111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962775,0.00088134233,0.0004572132,0.00035730362,0.0017211724,0.00030545803],"domain_scores_gemma":[0.9854976,0.0073679853,0.0007133693,0.00029912128,0.0037502097,0.0023717724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009979367,0.0030074597,0.0034972513,0.0021583254,0.0023650776,0.0057103755,0.0031777842,0.01934572,0.008862408],"category_scores_gemma":[0.018684788,0.0010543654,0.0025064382,0.0009260155,0.0021999488,0.004721707,0.001289771,0.02471867,0.006173671],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009382545,0.00002144337,0.0000176577,0.00028983108,0.000026474027,0.00008743751,0.000008322711,0.000030195642,0.0000835125,0.00041745286,0.9902907,0.008633112],"study_design_scores_gemma":[0.00021646444,0.0001040794,0.00021825978,0.00046200972,0.00012298934,0.00021906452,0.000033317654,0.0002504197,0.00017386027,0.0018673282,0.99630415,0.000027987919],"about_ca_topic_score_codex":0.0018936817,"about_ca_topic_score_gemma":0.0050192946,"teacher_disagreement_score":0.01934572,"about_ca_system_score_codex":0.002768916,"about_ca_system_score_gemma":0.0031312138,"threshold_uncertainty_score":0.052776575},"labels":[],"label_agreement":null},{"id":"W4323275977","doi":"10.1016/j.msard.2023.104606","title":"Mapping two decades of multiple sclerosis rehabilitation trials: A systematic scoping review and call to action to advance the study of race and ethnicity in rehabilitation research","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; Humber River Regional Hospital; Queen's University","funders":"","keywords":"Medicine; Multiple sclerosis; Rehabilitation; Ethnic group; Call to action; Race (biology); Physical medicine and rehabilitation; Physical therapy; Systematic review; Clinical trial; MEDLINE; Pathology; Gender studies; Psychiatry","score_opus":0.1981652630258297,"score_gpt":0.43172721773072936,"score_spread":0.23356195470489965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323275977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003125233,0.9689041,0.002923785,0.020265706,0.0025150287,0.0009854449,0.0007648983,0.0000607042,0.00045504535],"genre_scores_gemma":[0.11895757,0.77390873,0.03483591,0.05104424,0.0031002918,0.014406625,0.0027734034,0.0002812336,0.0006920369],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.57895833,0.18248512,0.1817206,0.016218772,0.036249645,0.004367539],"domain_scores_gemma":[0.1600951,0.65794855,0.09790924,0.027125763,0.05244338,0.0044779484],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43472436,0.0026914545,0.02757867,0.023045745,0.004307806,0.020559076,0.0075557465,0.013492849,0.0052714534],"category_scores_gemma":[0.66058,0.005030461,0.022666005,0.026595637,0.006118088,0.03533218,0.017059455,0.013208383,0.0007965318],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015205009,0.0001599106,0.012656017,0.77386606,0.072983675,0.0002569386,0.005738759,0.00057116174,0.0006062364,0.0053484207,0.011727103,0.1145653],"study_design_scores_gemma":[0.000791378,0.00038156443,0.012593316,0.85786176,0.083323166,0.0002642687,0.0031230254,0.00033477115,0.00028250949,0.006560748,0.034282777,0.00020061333],"about_ca_topic_score_codex":0.026000688,"about_ca_topic_score_gemma":0.0859903,"teacher_disagreement_score":0.56527567,"about_ca_system_score_codex":0.022971377,"about_ca_system_score_gemma":0.09012122,"threshold_uncertainty_score":0.6970855},"labels":[],"label_agreement":null},{"id":"W4323658077","doi":"10.1016/j.msard.2023.104612","title":"Multiple sclerosis in Indigenous Peoples of the Americas: A systematic review of incidence, prevalence, and outcomes","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia","funders":"","keywords":"Medicine; Incidence (geometry); Indigenous; Epidemiology; Multiple sclerosis; Demography; Confounding; Prevalence; Gerontology; Internal medicine; Immunology","score_opus":0.06653528153400365,"score_gpt":0.32205837874927107,"score_spread":0.25552309721526745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323658077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023244533,0.9969326,0.000060452017,0.000082658684,0.00004747871,0.00009062874,0.00038370639,0.0000038194025,0.000074103606],"genre_scores_gemma":[0.02378269,0.9752015,0.00033754855,0.00020760353,0.00004388615,0.00015562034,0.00022510084,0.0000026590374,0.0000432939],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99402505,0.0014019969,0.0029321413,0.00055181043,0.00088112813,0.00020798024],"domain_scores_gemma":[0.9844899,0.010156509,0.0036586134,0.00025257,0.0012093406,0.00023304726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064969156,0.0013790526,0.009840002,0.010725196,0.00064041186,0.0024073126,0.0014501468,0.0015816928,0.0020783858],"category_scores_gemma":[0.024009878,0.0010976733,0.009934955,0.012655044,0.0007763747,0.0016528819,0.0018974356,0.001236312,0.00013072255],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002887825,0.000025271103,0.0064462526,0.91790974,0.049747527,0.00010441838,0.00026307994,0.00009966209,0.00017755339,0.00010729853,0.0007512243,0.024079107],"study_design_scores_gemma":[0.00043401777,0.00024452366,0.03654257,0.5270705,0.42461953,0.0005269782,0.00075842644,0.000108714084,0.00017666277,0.00025594086,0.00918326,0.00007886574],"about_ca_topic_score_codex":0.020049198,"about_ca_topic_score_gemma":0.06034471,"teacher_disagreement_score":0.020049198,"about_ca_system_score_codex":0.0025735814,"about_ca_system_score_gemma":0.0088444,"threshold_uncertainty_score":0.039864957},"labels":[],"label_agreement":null},{"id":"W4323980898","doi":"10.1016/j.msard.2023.104614","title":"Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Spinal cord; Multiple sclerosis; Lesion; Corticospinal tract; Central nervous system disease; Demyelinating disease; Pathology; Magnetic resonance imaging; Radiology; Surgery","score_opus":0.06543710682518092,"score_gpt":0.3088262401795518,"score_spread":0.24338913335437087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323980898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990119,0.00048980507,0.00002193604,0.000019218083,0.0000027635808,0.0000026086202,0.00003094729,0.0000021844862,0.0004187801],"genre_scores_gemma":[0.99942976,0.00019559056,0.000039394738,0.000010543699,0.0000068890427,0.0000022579052,0.000063647436,7.433528e-7,0.00025109798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974734,0.00008646605,0.000030341525,0.00003956813,0.000055861557,0.00004029682],"domain_scores_gemma":[0.9984824,0.00026251617,0.0007793103,0.000058715657,0.00017918104,0.00023799465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005391699,0.00033385563,0.00036787335,0.0015234831,0.0005313924,0.00060892705,0.000305946,0.00064430764,0.0018351959],"category_scores_gemma":[0.0023874147,0.00018609795,0.00024485067,0.0012048923,0.0004894028,0.00048488236,0.00043605038,0.0005739026,0.00019156934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008539905,0.00018162717,0.98858297,0.000046668094,0.00014585623,0.00096986734,0.00036670314,0.000062406354,0.0039790696,0.00005396691,0.000065881824,0.0046909074],"study_design_scores_gemma":[0.0000037791085,0.00007479821,0.99912363,0.000004276235,0.000018772418,0.000495362,0.0001173444,0.000029327037,0.000063658226,0.000018746763,0.00004867593,0.0000016394868],"about_ca_topic_score_codex":0.006257285,"about_ca_topic_score_gemma":0.007976467,"teacher_disagreement_score":0.006257285,"about_ca_system_score_codex":0.00021653972,"about_ca_system_score_gemma":0.00031065464,"threshold_uncertainty_score":0.012441754},"labels":[],"label_agreement":null},{"id":"W4328097996","doi":"10.1016/j.msard.2023.104626","title":"The impact of cognitive impairment on disease burden in Chinese patients with multiple sclerosis: A model simulation study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"Bristol-Myers Squibb","keywords":"Multiple sclerosis; Medicine; Cognitive impairment; Disease; Cognition; Physical medicine and rehabilitation; Psychiatry; Internal medicine","score_opus":0.03516307136005028,"score_gpt":0.3039537774814197,"score_spread":0.26879070612136946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328097996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983303,0.000091119444,0.0004436832,0.00021068279,0.0000124074095,0.000026571899,0.0003087459,0.000012266952,0.00056436454],"genre_scores_gemma":[0.99883944,0.00008953861,0.0002304065,0.00004929142,0.000007969248,0.000050419345,0.00032232597,0.0000042582137,0.0004064414],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994991,0.00020868408,0.000024641426,0.000075626085,0.000026486583,0.00016552063],"domain_scores_gemma":[0.9965857,0.0022093637,0.00031175526,0.00017605037,0.00029323364,0.00042395742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014906235,0.0012778236,0.0019665612,0.0008555899,0.0009899744,0.0013180802,0.0017837826,0.0021085306,0.0037790183],"category_scores_gemma":[0.004334123,0.00067543716,0.0024452913,0.0010837647,0.00081203657,0.0009913519,0.0010869157,0.0014748247,0.00031189003],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033639057,0.0042444426,0.19780946,0.00021110827,0.0020311098,0.0013470837,0.0005896077,0.7813802,0.0007217585,0.002389884,0.0016683984,0.004243034],"study_design_scores_gemma":[0.00091208,0.0012790764,0.04099673,0.00003189305,0.00078187697,0.00013996454,0.00057149254,0.95399404,0.00017701124,0.000828585,0.0002156861,0.000071465285],"about_ca_topic_score_codex":0.19965616,"about_ca_topic_score_gemma":0.07256953,"teacher_disagreement_score":0.19965616,"about_ca_system_score_codex":0.0030221432,"about_ca_system_score_gemma":0.0036574253,"threshold_uncertainty_score":0.39698803},"labels":[],"label_agreement":null},{"id":"W4328110099","doi":"10.1016/j.msard.2023.104630","title":"Cognitive impairment, fatigue and depression in multiple sclerosis: Is there a difference between benign and non-benign MS?","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Multiple sclerosis; Expanded Disability Status Scale; Depression (economics); Medicine; Cognition; Anxiety; Physical therapy; Beck Depression Inventory; Physical medicine and rehabilitation; Audiology; Psychiatry","score_opus":0.0759929165356866,"score_gpt":0.2966199833045948,"score_spread":0.22062706676890823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328110099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731296,0.0020248077,0.000029050787,0.000077293276,0.000007788705,0.000011475645,0.00008917128,0.0000011403416,0.00044634967],"genre_scores_gemma":[0.9994836,0.0003369906,0.000027486343,0.000020162921,0.000018454548,0.000005179293,0.00005912832,2.9873013e-7,0.00004858372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995214,0.00014057034,0.00006532385,0.0000625049,0.00015048929,0.000059754075],"domain_scores_gemma":[0.99869114,0.00040092785,0.00057085976,0.00003196833,0.00010439515,0.00020067231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009763978,0.00017423638,0.0004235923,0.0012246304,0.00026899631,0.00042679821,0.0002331483,0.00041184397,0.0011006681],"category_scores_gemma":[0.0031685384,0.000111186455,0.00028381165,0.0009404168,0.00033532263,0.00048247018,0.0003643769,0.00030753657,0.00015569438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036149714,0.000079739744,0.99286014,0.000048018894,0.000036199686,0.00013339664,0.00013839145,0.000014762035,0.00008691202,0.000011714887,0.000066349734,0.006162874],"study_design_scores_gemma":[0.0000067969117,0.00013677988,0.99926025,0.000011676913,0.000011980415,0.0003562866,0.00009885229,0.00003199671,0.000013441404,0.000016463555,0.000054111908,0.0000013892826],"about_ca_topic_score_codex":0.0021211607,"about_ca_topic_score_gemma":0.0024052043,"teacher_disagreement_score":0.0021211607,"about_ca_system_score_codex":0.00023221056,"about_ca_system_score_gemma":0.00019552904,"threshold_uncertainty_score":0.005163729},"labels":[],"label_agreement":null},{"id":"W4353048131","doi":"10.1016/j.msard.2023.104655","title":"Inequality in accessing healthcare for people with MS","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Referral; Health care; Family medicine; Library science; Political science; Law; Computer science","score_opus":0.05714403381001097,"score_gpt":0.33444627715734765,"score_spread":0.27730224334733666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353048131","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064489126,0.012583036,0.0000658078,0.08687045,0.899463,0.0000204806,0.0001975137,0.000021444868,0.00071374926],"genre_scores_gemma":[0.0008175129,0.0075093755,0.00008056714,0.0396779,0.9497314,0.00005890641,0.000069693924,0.000033877404,0.002020847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9839968,0.005197489,0.0030907923,0.0013363083,0.0054209335,0.00095772126],"domain_scores_gemma":[0.8727348,0.095667206,0.0049043265,0.0021095802,0.01870921,0.005874874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027167385,0.00565799,0.007400082,0.007025973,0.006598065,0.012675806,0.005513325,0.031916875,0.013342388],"category_scores_gemma":[0.11316768,0.0024252154,0.004061057,0.006023356,0.004604219,0.0091792755,0.0036095849,0.033737633,0.0047278553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004467534,0.000012280353,0.000083584724,0.0006510494,0.00008296218,0.000053332846,0.000053548578,0.000019271129,0.000009687415,0.0003661058,0.99572206,0.002901507],"study_design_scores_gemma":[0.0005801874,0.00010399669,0.0037892358,0.011180708,0.0014461959,0.00047273905,0.0012850973,0.00064447784,0.00011318205,0.00775462,0.97249675,0.00013285557],"about_ca_topic_score_codex":0.016258262,"about_ca_topic_score_gemma":0.03367735,"teacher_disagreement_score":0.031916875,"about_ca_system_score_codex":0.007842699,"about_ca_system_score_gemma":0.010343874,"threshold_uncertainty_score":0.14367658},"labels":[],"label_agreement":null},{"id":"W4360999432","doi":"10.1016/j.msard.2023.104677","title":"Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Paced Auditory Serial Addition Test; Medicine; Neurocognitive; Depression (economics); Confidence interval; Population; Mallinckrodt; Expanded Disability Status Scale; Physical therapy; Cognition; Neuropsychology; Physical medicine and rehabilitation; Psychiatry; Internal medicine; Multiple sclerosis","score_opus":0.09938648461708932,"score_gpt":0.3662454622970719,"score_spread":0.26685897767998257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360999432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962758,0.000664312,0.0001417893,0.00012679717,0.000010765462,0.0002680083,0.0014999555,0.000024309094,0.000988376],"genre_scores_gemma":[0.99521303,0.00022431959,0.00061236095,0.00022424772,0.00003829178,0.0004583245,0.0027306825,0.000006179072,0.0004925665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877745,0.00056299893,0.00015386895,0.00020923163,0.00020024362,0.00009618493],"domain_scores_gemma":[0.99680734,0.00045699632,0.0011129008,0.00023109937,0.00075585186,0.000635794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005256183,0.0006437663,0.0007144173,0.00072341383,0.00058877346,0.00087377476,0.0005733578,0.00071814714,0.00090704695],"category_scores_gemma":[0.0057806163,0.00023498273,0.0010991477,0.0005647046,0.0002610753,0.00062118645,0.0008226152,0.00064835255,0.0004958877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012782558,0.0012215838,0.97128266,0.00013155318,0.0010987908,0.00009449819,0.0002645593,0.00018409602,0.0004244338,0.000033924745,0.00077132473,0.011709944],"study_design_scores_gemma":[0.0013684208,0.0044811936,0.99145013,0.000059538215,0.00075091474,0.00018226705,0.000103158796,0.00044563305,0.0002194532,0.000076945886,0.0008427549,0.000019533905],"about_ca_topic_score_codex":0.001951955,"about_ca_topic_score_gemma":0.0034543986,"teacher_disagreement_score":0.005256183,"about_ca_system_score_codex":0.0005789265,"about_ca_system_score_gemma":0.0008206071,"threshold_uncertainty_score":0.02779764},"labels":[],"label_agreement":null},{"id":"W4361268560","doi":"10.1016/j.msard.2023.104676","title":"ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Mayo Clinic","keywords":"Medicine; Multiple sclerosis; Therapeutic plasma exchange; Neuroscience; Internal medicine; Immunology","score_opus":0.12041235679416369,"score_gpt":0.33011883432682204,"score_spread":0.20970647753265836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361268560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984742,0.00033063383,0.00004172055,0.000047581747,0.000008053008,0.000006071511,0.000027215945,0.0000036131976,0.0010608694],"genre_scores_gemma":[0.99970657,0.000051572933,0.000022881182,0.000017768481,0.00001438613,0.000001978135,0.000051735842,0.0000013137106,0.0001317824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942136,0.000203021,0.00009154339,0.00006489845,0.000109329914,0.00010991453],"domain_scores_gemma":[0.990703,0.0034164614,0.0038150765,0.00063669466,0.0004449479,0.0009837813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008261253,0.00027795596,0.0005266989,0.00062170735,0.00047147853,0.00059232424,0.00052607455,0.00082619424,0.0022224265],"category_scores_gemma":[0.0076430566,0.0001569023,0.0003162864,0.00062906364,0.00062584813,0.00059654936,0.00029581747,0.0008681145,0.00041332358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007971837,0.00047960985,0.9761326,0.00005745417,0.00020065796,0.0025838541,0.00020050723,0.00006773876,0.006105286,0.0000612659,0.000116827294,0.0060223835],"study_design_scores_gemma":[0.00002962786,0.00083958165,0.9962967,0.000007983658,0.00004451895,0.0020559751,0.00009624928,0.00010726412,0.00031647112,0.00003602766,0.00016424587,0.0000053637073],"about_ca_topic_score_codex":0.0015200343,"about_ca_topic_score_gemma":0.0010398647,"teacher_disagreement_score":0.0022224265,"about_ca_system_score_codex":0.00026795018,"about_ca_system_score_gemma":0.00029508313,"threshold_uncertainty_score":0.0074347258},"labels":[],"label_agreement":null},{"id":"W4362472116","doi":"10.1016/j.msard.2022.104322","title":"Early onset of Action and Sustained Efficacy of MRI Outcomes during Cladribine Tablets Treatment in Highly Active Relapsing Multiple Sclerosis: Results of the 2-Year MAGNIFY-MS Study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Multiple sclerosis; Confidence interval; Magnetic resonance imaging; Cladribine; Clinical endpoint; Nuclear medicine; Lesion; Internal medicine; Poisson regression; Expanded Disability Status Scale; McDonald criteria; Clinical trial; Surgery; Radiology; Population","score_opus":0.04682843048370224,"score_gpt":0.2871072259003992,"score_spread":0.24027879541669697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362472116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989532,0.00056406495,0.000031282103,0.000021273116,0.0000062265153,0.000021674803,0.00016862484,0.000004002753,0.00022955891],"genre_scores_gemma":[0.99936014,0.00014303856,0.000041650423,0.000021250873,0.000019899557,0.0000146350285,0.00024361958,0.0000017197495,0.0001540783],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999263,0.00033582316,0.00005812395,0.00010121956,0.00012959976,0.00011227194],"domain_scores_gemma":[0.9975097,0.00053746643,0.0011051648,0.00021367769,0.00016165597,0.0004723917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019143233,0.0004970097,0.0012204847,0.00036043866,0.00028574886,0.0006522158,0.00033330132,0.0007334519,0.0007144967],"category_scores_gemma":[0.0025148261,0.00018957382,0.0008799285,0.00042174474,0.0003458033,0.0007361454,0.0003165498,0.0007626314,0.00016317847],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5245845,0.008388609,0.3592432,0.00043666136,0.002892966,0.00048196883,0.0006998001,0.0014778278,0.021469662,0.0001397589,0.00067982567,0.07950523],"study_design_scores_gemma":[0.0062483526,0.0392697,0.95121306,0.000022771226,0.0006975299,0.0001432957,0.000101429854,0.0005875328,0.0012999022,0.000044882436,0.0003322514,0.00003946232],"about_ca_topic_score_codex":0.0014999985,"about_ca_topic_score_gemma":0.001443167,"teacher_disagreement_score":0.0019143233,"about_ca_system_score_codex":0.0004302949,"about_ca_system_score_gemma":0.00034626797,"threshold_uncertainty_score":0.010124028},"labels":[],"label_agreement":null},{"id":"W4362472973","doi":"10.1016/j.msard.2022.104360","title":"MRI and Clinical Outcomes of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, in Relapsing Multiple Sclerosis Over 2.5 Years of the Open-Label Extension to a Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Multiple sclerosis; Double blind; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Tolerability; Gastroenterology; Adverse effect; Pathology; Immunology; Radiology","score_opus":0.09464708955712986,"score_gpt":0.3631750525634793,"score_spread":0.26852796300634946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362472973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974377,0.006643915,0.00015699532,0.00056285545,0.0001413309,0.000098948025,0.0009083762,0.00002383672,0.0017199214],"genre_scores_gemma":[0.99600357,0.0011950193,0.00011312555,0.00039133246,0.00015243422,0.00008878038,0.0013488687,0.000007498275,0.0006993818],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99930656,0.0003191154,0.000047598984,0.00009293016,0.00006112076,0.00017264999],"domain_scores_gemma":[0.9984902,0.00034022573,0.00044707285,0.0001093062,0.0001788739,0.00043429586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021191975,0.0008392232,0.001637574,0.0003077498,0.00039345174,0.0010115891,0.00044048595,0.0012111167,0.0020415927],"category_scores_gemma":[0.0028126545,0.00027619107,0.0013971912,0.00038101667,0.0006646449,0.0012379138,0.00031239566,0.0020771192,0.00041729092],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8417133,0.007493909,0.04144569,0.00078380725,0.005462953,0.0003921354,0.0002237253,0.0025894872,0.007871091,0.0002907269,0.005169375,0.086563826],"study_design_scores_gemma":[0.21500236,0.27824044,0.4739248,0.000436582,0.010637383,0.0016918866,0.00044825615,0.0041290433,0.0040370654,0.0023418637,0.008903186,0.00020716453],"about_ca_topic_score_codex":0.0015793488,"about_ca_topic_score_gemma":0.0022306948,"teacher_disagreement_score":0.0021191975,"about_ca_system_score_codex":0.00074639946,"about_ca_system_score_gemma":0.0005840211,"threshold_uncertainty_score":0.011207521},"labels":[],"label_agreement":null},{"id":"W4362474564","doi":"10.1016/j.msard.2022.104348","title":"Nurses' Knowledges on Multiple Sclerosis Disease in the Béni-Mellal Khénifra Region, Morocco","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Multiple sclerosis; Quarter (Canadian coin); Family medicine; Informed consent; Alternative medicine; Physical therapy; Internal medicine; Psychiatry; Pathology","score_opus":0.06290453222756454,"score_gpt":0.2853350518812402,"score_spread":0.22243051965367566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362474564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965791,0.0007997819,0.000008872818,0.00074788055,0.000015798272,0.000004649944,0.000058213034,4.278999e-7,0.0017851845],"genre_scores_gemma":[0.9985568,0.00075201533,0.000016184902,0.00016136224,0.000008165755,0.0000073901997,0.000025030593,3.4052124e-7,0.00047270808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995741,0.00013543776,0.000035090183,0.000034824683,0.000072488656,0.00014808714],"domain_scores_gemma":[0.998662,0.0004256828,0.00034061805,0.000017506469,0.00024911595,0.00030501283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007303419,0.0001320566,0.00027721256,0.00056073774,0.0013043458,0.000754452,0.00027519622,0.0003268297,0.002200401],"category_scores_gemma":[0.0025771668,0.00012331553,0.00016117346,0.0006005372,0.00047475196,0.0006119833,0.0008184766,0.00041858095,0.00014041021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001058996,0.0001356356,0.84739244,0.00037509415,0.00003860364,0.0012491064,0.13060933,0.000072974304,0.00054006185,0.00029996,0.0014283479,0.017752578],"study_design_scores_gemma":[0.0000075970784,0.00011315107,0.8330677,0.00049226,0.000029280816,0.00034362645,0.16115329,0.00006659222,0.00008091789,0.000096188545,0.0045353873,0.000014037864],"about_ca_topic_score_codex":0.1522152,"about_ca_topic_score_gemma":0.24083857,"teacher_disagreement_score":0.1522152,"about_ca_system_score_codex":0.0022435444,"about_ca_system_score_gemma":0.0034382183,"threshold_uncertainty_score":0.30265838},"labels":[],"label_agreement":null},{"id":"W4362583702","doi":"10.1016/j.msard.2023.104699","title":"Simple parameters from complete blood count predict lymphopenia, adverse effects and efficacy in people with MS treated with dimethyl fumarate","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Dimethyl fumarate; Multiple sclerosis; Adverse effect; Internal medicine; Eosinophil; Lymphocyte; Population; Blood count; Leukopenia; Complete blood count; Immunology; Toxicity; Asthma","score_opus":0.020948136710343533,"score_gpt":0.23896932388904996,"score_spread":0.21802118717870642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362583702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99832064,0.00087512244,0.000055277484,0.00005600882,0.00001132837,0.000009833439,0.000120134806,0.0000036267434,0.00054809375],"genre_scores_gemma":[0.99950683,0.00015352691,0.00006483545,0.00003052812,0.000012395334,0.0000058334713,0.00008859345,7.659311e-7,0.00013670708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995808,0.00017039524,0.00007012354,0.000043027194,0.000090645226,0.00004506778],"domain_scores_gemma":[0.9985501,0.0004230286,0.00064758107,0.000055797536,0.00016207383,0.00016138256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069391687,0.00034573954,0.0007009729,0.00072256156,0.0003184598,0.0005011745,0.0002048168,0.0004759854,0.00087826204],"category_scores_gemma":[0.0029156045,0.0001808559,0.00065377663,0.00070189073,0.0001732971,0.0003391039,0.00026084317,0.00049856916,0.00012654069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012087693,0.00018170322,0.99370146,0.000039141833,0.0002474083,0.000044033535,0.0000678182,0.000048755,0.0005304225,0.0000066622993,0.000060923012,0.003862934],"study_design_scores_gemma":[0.000042312502,0.000738405,0.9982887,0.000011559798,0.00021179367,0.00011515197,0.00010125037,0.00017030763,0.00018243013,0.000026457034,0.000106488216,0.000005097628],"about_ca_topic_score_codex":0.0024503586,"about_ca_topic_score_gemma":0.003992267,"teacher_disagreement_score":0.0024503586,"about_ca_system_score_codex":0.0002444821,"about_ca_system_score_gemma":0.000249544,"threshold_uncertainty_score":0.0048721433},"labels":[],"label_agreement":null},{"id":"W4372311940","doi":"10.1016/j.msard.2023.104749","title":"Equity, diversity and inclusion in academic publishing: Can we move the needle?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Equity (law); Medicine; Inclusion (mineral); Diversity (politics); Publishing; Social science; Sociology; Law; Political science","score_opus":0.05346566508976891,"score_gpt":0.2849824706272839,"score_spread":0.23151680553751497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4372311940","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025743146,0.0053773914,0.00005647654,0.06517201,0.9288341,0.0000117400095,0.000015102846,0.000019717409,0.00048776],"genre_scores_gemma":[0.0004022651,0.003751215,0.00007248179,0.019877115,0.97446036,0.000020629901,0.0000070261494,0.000014402281,0.0013946183],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9677665,0.008585636,0.0050737294,0.0022759684,0.014409469,0.0018887317],"domain_scores_gemma":[0.81616235,0.10524681,0.007070662,0.003724815,0.050056994,0.017738428],"candidate_categories":["metaresearch","open_science"],"consensus_categories":[],"category_scores_codex":[0.044753097,0.0045279656,0.0069092643,0.008338664,0.009805019,0.027450016,0.008263841,0.047432464,0.013171269],"category_scores_gemma":[0.12544088,0.0021781072,0.004425858,0.00515966,0.011014859,0.01415777,0.00416397,0.040354256,0.005107491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002540917,0.000019822584,0.00004464235,0.00047739776,0.000045091023,0.00006644368,0.00006457525,0.000020660325,0.000017766528,0.0008792923,0.99402606,0.004312808],"study_design_scores_gemma":[0.00018927093,0.000058840156,0.00080464047,0.0031168268,0.00024989745,0.00028753642,0.0007036267,0.00040295938,0.000086844746,0.0077188597,0.9862881,0.00009254429],"about_ca_topic_score_codex":0.006722569,"about_ca_topic_score_gemma":0.020186666,"teacher_disagreement_score":0.9917362,"about_ca_system_score_codex":0.010703311,"about_ca_system_score_gemma":0.018149804,"threshold_uncertainty_score":0.23667979},"labels":[],"label_agreement":null},{"id":"W4377826726","doi":"10.1016/j.msard.2023.104769","title":"Migraine and multiple sclerosis: The final answer?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Migraine; Dermatology; Neuroscience; Physical medicine and rehabilitation; Psychiatry; Psychology","score_opus":0.043647720067425656,"score_gpt":0.2545502412882075,"score_spread":0.21090252122078187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377826726","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018149993,0.013508225,0.00003940437,0.04786036,0.9379175,0.000013474995,0.000034972047,0.00001720299,0.0005907621],"genre_scores_gemma":[0.00020194658,0.006285826,0.000054621934,0.04467028,0.94645965,0.000024502124,0.000023990842,0.000015728718,0.0022634845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99192435,0.0025025224,0.0015482868,0.00088585966,0.0026796528,0.00045926793],"domain_scores_gemma":[0.96194065,0.018883096,0.0022977493,0.0008582108,0.01086984,0.005150444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0127993785,0.00460766,0.007404321,0.0048336494,0.004574229,0.010833667,0.005782091,0.030810295,0.014939912],"category_scores_gemma":[0.042722013,0.0020940537,0.0033652592,0.003027796,0.0035913356,0.0073554013,0.0029179784,0.024033781,0.011220956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047020785,0.000010799619,0.000036723028,0.00038626694,0.00004109636,0.00008018416,0.000010209859,0.00000892986,0.000019632553,0.00013479887,0.99653685,0.0026874663],"study_design_scores_gemma":[0.0004872155,0.0000706203,0.0008169002,0.002544394,0.0004086459,0.00058862794,0.00018003711,0.00021997331,0.000065387016,0.0017329223,0.9928213,0.00006399482],"about_ca_topic_score_codex":0.004142748,"about_ca_topic_score_gemma":0.012427354,"teacher_disagreement_score":0.030810295,"about_ca_system_score_codex":0.0040443363,"about_ca_system_score_gemma":0.0051379073,"threshold_uncertainty_score":0.06769043},"labels":[],"label_agreement":null},{"id":"W4378978155","doi":"10.1016/j.msard.2023.104786","title":"Beyond the B-cell as a treatment target in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Ofatumumab; Internal medicine; Natalizumab; Dermatology; CD20; Rituximab; Immunology; Lymphoma","score_opus":0.03763177313008521,"score_gpt":0.2723908189235822,"score_spread":0.234759045793497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378978155","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023865225,0.01574773,0.000100508165,0.029766513,0.9537438,0.00001814435,0.000032940698,0.00003155589,0.0005348421],"genre_scores_gemma":[0.00028403386,0.007124326,0.00008410257,0.024077695,0.96633244,0.000022208074,0.000013745691,0.000017277944,0.0020441974],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98639697,0.0045993878,0.0024062076,0.0010342413,0.0049346965,0.0006285285],"domain_scores_gemma":[0.9314347,0.045324676,0.0029202923,0.0012642803,0.013710069,0.0053460556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025745777,0.0058556455,0.009732303,0.005431745,0.004418185,0.010557684,0.0063444176,0.032455493,0.007494571],"category_scores_gemma":[0.045827508,0.002450784,0.0049810195,0.0026561613,0.0045392094,0.0072357976,0.0022468464,0.03596546,0.006015131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017794104,0.000026594691,0.00003520477,0.00085915305,0.00011426433,0.00015483276,0.000019981899,0.0000353221,0.00007025108,0.00045010584,0.9918412,0.00621501],"study_design_scores_gemma":[0.00071322307,0.0001797992,0.0008346346,0.0026855897,0.0007583156,0.0006986234,0.00012221863,0.0006775635,0.00023299365,0.004276315,0.9887322,0.00008851026],"about_ca_topic_score_codex":0.0034858088,"about_ca_topic_score_gemma":0.008090202,"teacher_disagreement_score":0.032455493,"about_ca_system_score_codex":0.005816341,"about_ca_system_score_gemma":0.005112885,"threshold_uncertainty_score":0.13615835},"labels":[],"label_agreement":null},{"id":"W4379375212","doi":"10.1016/j.msard.2023.104787","title":"Clinical course, imaging, and pathological features of 45 adult and pediatric cases of myelin oligodendrocyte glycoprotein antibody-associated disease","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Centre hospitalier de l'Université Laval; Hôpital Maisonneuve-Rosemont; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Ottawa; McGill University Health Centre; Montreal Neurological Institute and Hospital; Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Ottawa Hospital","funders":"","keywords":"Myelin oligodendrocyte glycoprotein; Medicine; Multiple sclerosis; Pathological; Myelin; Oligodendrocyte; Demyelinating disease; Disease; Pathology; Glycoprotein; Antibody; Immunology; Central nervous system; Internal medicine; Biology; Experimental autoimmune encephalomyelitis","score_opus":0.03267765359218974,"score_gpt":0.32343469081794196,"score_spread":0.2907570372257522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379375212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988859,0.00038932703,0.000082493585,0.000009444989,0.0000018473324,0.000006133084,0.00007799818,0.0000039662336,0.00054277387],"genre_scores_gemma":[0.99939895,0.0002576364,0.00012655844,0.000015771278,0.0000050789245,0.000005628369,0.00011424447,0.000003106837,0.00007303227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996946,0.000041997824,0.000055389257,0.00006542065,0.00005301818,0.00008957964],"domain_scores_gemma":[0.99932075,0.00016726501,0.00024991675,0.000032410408,0.000056302022,0.00017336538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034825248,0.00049655087,0.00041133646,0.0009934983,0.00045102806,0.00041293132,0.00019953783,0.00035418183,0.00096736784],"category_scores_gemma":[0.0016040571,0.00038364273,0.0002528657,0.0008099623,0.00063139957,0.00037181797,0.00040976994,0.00023738958,0.00017784702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027553423,0.00010737539,0.94971526,0.00003988827,0.000045572084,0.038816486,0.0010465789,0.00019063396,0.004381716,0.00009408669,0.00016400154,0.0051228674],"study_design_scores_gemma":[0.000012296302,0.00025633036,0.8947352,0.000012030627,0.00004943548,0.10283766,0.0006253347,0.00017453027,0.00059462764,0.00005356701,0.00063892046,0.000010062688],"about_ca_topic_score_codex":0.0023573493,"about_ca_topic_score_gemma":0.0020179267,"teacher_disagreement_score":0.0023573493,"about_ca_system_score_codex":0.00030702187,"about_ca_system_score_gemma":0.00023613965,"threshold_uncertainty_score":0.0046873093},"labels":[],"label_agreement":null},{"id":"W4379742832","doi":"10.1016/j.msard.2023.104788","title":"Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selection","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma; Novartis Animal Health; Novartis","keywords":"Clinical trial; Medicine; Protocol (science); Selection (genetic algorithm); Multiple sclerosis; Medical physics; MEDLINE; Alternative medicine; Pathology; Artificial intelligence; Psychiatry; Computer science","score_opus":0.42181555034574436,"score_gpt":0.4818763018958606,"score_spread":0.060060751550116254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379742832","genre_codex":"commentary","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010260081,0.3487373,0.046952453,0.54774946,0.008872618,0.018195475,0.002764081,0.00048434993,0.015984196],"genre_scores_gemma":[0.11527858,0.31283146,0.3312557,0.18808657,0.0060377996,0.039885875,0.0029577026,0.0007926288,0.0028736982],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.122124225,0.5492531,0.26206136,0.009329811,0.054866247,0.0023652848],"domain_scores_gemma":[0.02390887,0.8250014,0.06693735,0.01902974,0.06355663,0.0015659678],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.82260877,0.002360286,0.007007,0.03472289,0.005379516,0.023468377,0.011332127,0.014739841,0.0034531595],"category_scores_gemma":[0.9225415,0.0045781066,0.010379078,0.036888544,0.013542956,0.030884473,0.011991154,0.015826812,0.0017487088],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013412384,0.00017943587,0.013922855,0.21075062,0.0037106809,0.00070622645,0.028658325,0.0015464283,0.000732276,0.03801728,0.09165802,0.6087766],"study_design_scores_gemma":[0.0014942497,0.0005740898,0.012046642,0.5878451,0.004236936,0.000688942,0.01132902,0.0020553225,0.001348488,0.034614474,0.34325686,0.0005098198],"about_ca_topic_score_codex":0.008633633,"about_ca_topic_score_gemma":0.014565334,"teacher_disagreement_score":0.17739123,"about_ca_system_score_codex":0.027754394,"about_ca_system_score_gemma":0.08866812,"threshold_uncertainty_score":0.218755},"labels":[],"label_agreement":null},{"id":"W4382518072","doi":"10.1016/j.msard.2023.104862","title":"Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Meta-analysis; Medicine; Serology; Chlamydia; Internal medicine; Odds ratio; Confidence interval; Subgroup analysis; Chlamydophila pneumoniae; Logistic regression; Chlamydial infection; Multiple sclerosis; Immunology; Chlamydiales; Antibody","score_opus":0.13226761442951052,"score_gpt":0.31441393158809,"score_spread":0.18214631715857948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382518072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011263166,0.98716927,0.000547801,0.00015510841,0.00023271721,0.000031725613,0.0003810795,0.000029328583,0.00018985114],"genre_scores_gemma":[0.25386938,0.7413758,0.0016740443,0.000821214,0.00058104016,0.0001366031,0.0008729286,0.000032899756,0.0006361146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985625,0.0005686748,0.00028844664,0.00031234027,0.00014430565,0.00012372603],"domain_scores_gemma":[0.9974432,0.0017800007,0.00031474014,0.00015544523,0.00021549842,0.000091151065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003034592,0.0022854796,0.009046312,0.001523467,0.00039420644,0.0017134241,0.0015834211,0.0018574841,0.0033667805],"category_scores_gemma":[0.0048355693,0.0011453425,0.018868672,0.002964683,0.00030557142,0.00086628064,0.0009782359,0.0018498695,0.00034204812],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008180844,0.00009202426,0.020510452,0.08590537,0.8554928,0.0003775323,0.00006893876,0.0010782259,0.0007054376,0.00016028636,0.0020129017,0.025415195],"study_design_scores_gemma":[0.00090522633,0.00029371405,0.01663027,0.0037065325,0.97539425,0.00016358988,0.00004645069,0.00034942516,0.00012406711,0.00027955225,0.002065174,0.000041835476],"about_ca_topic_score_codex":0.0054166634,"about_ca_topic_score_gemma":0.0092235785,"teacher_disagreement_score":0.009046312,"about_ca_system_score_codex":0.0006746652,"about_ca_system_score_gemma":0.0011204649,"threshold_uncertainty_score":0.01604867},"labels":[],"label_agreement":null},{"id":"W4382883108","doi":"10.1016/j.msard.2023.104869","title":"Assessing the utility of magnetic resonance imaging-based “SuStaIn” disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"International Progressive MS Alliance; Biogen","keywords":"Subtyping; Natalizumab; Medicine; Multiple sclerosis; Magnetic resonance imaging; Oncology; Clinical trial; Disease; Internal medicine; Placebo; Progressive disease; Pathology; Immunology; Radiology","score_opus":0.04748384130623075,"score_gpt":0.3108504081322997,"score_spread":0.26336656682606896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382883108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900788,0.005536672,0.0018523098,0.00034744374,0.00007280733,0.00014510515,0.00028084737,0.000015083964,0.0016709171],"genre_scores_gemma":[0.9981713,0.00026712572,0.0011900361,0.000082746556,0.000036480516,0.000030609368,0.0001222551,0.0000031748411,0.00009628979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98484135,0.010686645,0.0014443386,0.0008355162,0.0018255592,0.0003665639],"domain_scores_gemma":[0.9409934,0.03837394,0.008704616,0.0057393326,0.005382023,0.00080672157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035615474,0.00081528403,0.0011255854,0.001992453,0.00077416614,0.0018648364,0.001029213,0.0013619064,0.00079605106],"category_scores_gemma":[0.07274347,0.000397457,0.0013904587,0.0013505194,0.0013126394,0.0024737243,0.0016394882,0.0007237663,0.0001814776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023031749,0.00063467,0.90160745,0.00076371257,0.0061041918,0.00016414392,0.0013426358,0.0015838693,0.0026026857,0.0008838275,0.00058835815,0.06069273],"study_design_scores_gemma":[0.0013603,0.018250164,0.9572176,0.0003872871,0.0064654336,0.000536162,0.0011427366,0.005991959,0.0036500485,0.0022190218,0.0026863972,0.00009304836],"about_ca_topic_score_codex":0.0033251734,"about_ca_topic_score_gemma":0.005920168,"teacher_disagreement_score":0.035615474,"about_ca_system_score_codex":0.00061122497,"about_ca_system_score_gemma":0.0012649201,"threshold_uncertainty_score":0.18835491},"labels":[],"label_agreement":null},{"id":"W4383164035","doi":"10.1016/j.msard.2023.104873","title":"Is using ChatGPT to help write papers and grants is useful, and ethical?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Spelling; Chatbot; Entertainment; Style (visual arts); Loneliness; Computer science; Singing; Grammar; Artificial intelligence; Psychology; Linguistics; Visual arts; Management; Social psychology","score_opus":0.12853420959720097,"score_gpt":0.37138628447698757,"score_spread":0.2428520748797866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383164035","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020067297,0.0014547112,0.000111494184,0.077034146,0.92033136,0.000023991497,0.00002773939,0.000052619886,0.0009438851],"genre_scores_gemma":[0.00026602758,0.001167695,0.00015312692,0.057953637,0.9349713,0.00006063664,0.00001946358,0.000048246657,0.005360027],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9726141,0.0067314547,0.0039178757,0.0019935977,0.012826517,0.0019164702],"domain_scores_gemma":[0.8488066,0.08218671,0.0072522345,0.003867926,0.039500624,0.018385842],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03559591,0.0036150373,0.0050315782,0.0055677043,0.007053245,0.021806402,0.0068333717,0.05417657,0.021367427],"category_scores_gemma":[0.15853108,0.0020486787,0.004860371,0.0026439326,0.0063587846,0.007561627,0.003787697,0.041770786,0.017304879],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002899053,0.00001016446,0.000019307694,0.00017210418,0.000021363905,0.00006494205,0.000023595154,0.00001356907,0.000026430838,0.00028622043,0.9961825,0.0031506042],"study_design_scores_gemma":[0.00016971967,0.00004146814,0.00024150065,0.0010440233,0.00011654621,0.000180727,0.00013745144,0.00021416879,0.00007448018,0.0021676477,0.9955674,0.000044793218],"about_ca_topic_score_codex":0.003758919,"about_ca_topic_score_gemma":0.012205309,"teacher_disagreement_score":0.9644041,"about_ca_system_score_codex":0.007979453,"about_ca_system_score_gemma":0.010272606,"threshold_uncertainty_score":0.18825144},"labels":[],"label_agreement":null},{"id":"W4384565171","doi":"10.1016/j.msard.2023.104894","title":"Beyond the simplicity of theory of mind deficit in multiple sclerosis: from kinetic perception to socio-emotional abstraction and mentalizing","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Personality Disorders and Psychopathology","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministero della Salute","keywords":"Mentalization; Theory of mind; Psychology; Social cognition; Intentionality; Cognition; Cognitive psychology; Perception; Cognitive deficit; Attribution; Developmental psychology; Neuroscience; Social psychology; Cognitive impairment","score_opus":0.04956715884096193,"score_gpt":0.27536030130426203,"score_spread":0.2257931424633001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384565171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934405,0.00008586486,0.00013456827,0.000020156165,0.0000016342265,0.0000049218706,0.000018020099,0.0000027767703,0.00038787903],"genre_scores_gemma":[0.99983096,0.000022442822,0.00007535209,0.0000042595716,0.0000016872168,0.0000022821903,0.000014198451,5.984747e-7,0.00004823122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980706,0.000045665794,0.00002386264,0.000037156242,0.00006280131,0.000023486164],"domain_scores_gemma":[0.99863464,0.00045722234,0.0005525288,0.00012019759,0.000095121395,0.00014036543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046485668,0.00034078135,0.00019777683,0.00086918555,0.000228707,0.00052055425,0.00017234118,0.00021057804,0.00204683],"category_scores_gemma":[0.0027248673,0.00009228912,0.00018373903,0.00028390015,0.00070314406,0.0003475918,0.00049655087,0.0003545744,0.00009349798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005252147,0.00023721179,0.9681234,0.00007497889,0.0000935776,0.0004705947,0.0014910793,0.00018706248,0.010269798,0.00021079351,0.00008113262,0.01823513],"study_design_scores_gemma":[0.0000061477263,0.00021916421,0.99727577,0.000008547522,0.000024465173,0.0006286533,0.00033422982,0.00026527926,0.0007313476,0.00042516855,0.000077079145,0.0000042250726],"about_ca_topic_score_codex":0.0013585647,"about_ca_topic_score_gemma":0.0017489659,"teacher_disagreement_score":0.00204683,"about_ca_system_score_codex":0.0002617687,"about_ca_system_score_gemma":0.00020896616,"threshold_uncertainty_score":0.006847322},"labels":[],"label_agreement":null},{"id":"W4385298954","doi":"10.1016/j.msard.2023.104911","title":"Is it ethical to use teriflunomide as an active comparator in phase 3 trials?","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Teriflunomide; Medicine; Clinical trial; Amyotrophic lateral sclerosis; Multiple sclerosis; Family medicine; Disease; Oncology; Fingolimod; Internal medicine; Psychiatry","score_opus":0.3638427763101612,"score_gpt":0.47076212204114004,"score_spread":0.10691934573097883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385298954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021428205,0.97016317,0.0015994109,0.01930294,0.00383449,0.00034385585,0.0002346184,0.000018096936,0.002360655],"genre_scores_gemma":[0.10389965,0.8063858,0.014499903,0.06272519,0.007822156,0.002388678,0.00040721794,0.000045800178,0.0018256314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9640834,0.026055207,0.005447374,0.0011435911,0.00287168,0.0003987616],"domain_scores_gemma":[0.9123957,0.07167889,0.010918659,0.0014603382,0.00262903,0.0009173972],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.052238967,0.00050524896,0.0053007607,0.0010645265,0.00045741204,0.0021913878,0.0014888509,0.004433628,0.004872247],"category_scores_gemma":[0.085695416,0.0005087376,0.0029495852,0.001175813,0.002402133,0.0028762715,0.0011684897,0.0049866065,0.00057883497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011068366,0.00016510517,0.001143497,0.15884967,0.007907356,0.000207831,0.00047614705,0.0003619863,0.0012448117,0.016294228,0.03285266,0.7694283],"study_design_scores_gemma":[0.04452997,0.004909109,0.0059901173,0.32059523,0.026244137,0.0016978821,0.0010560266,0.0009815264,0.0017511105,0.040808246,0.55126536,0.00017123332],"about_ca_topic_score_codex":0.0008057327,"about_ca_topic_score_gemma":0.0021649296,"teacher_disagreement_score":0.99556637,"about_ca_system_score_codex":0.0013753198,"about_ca_system_score_gemma":0.0037226935,"threshold_uncertainty_score":0.27626938},"labels":[],"label_agreement":null},{"id":"W4385694372","doi":"10.1016/j.msard.2023.104934","title":"Iron in multiple sclerosis – Neuropathology, immunology, and real-world considerations","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Queen's University; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Excitotoxicity; Multiple sclerosis; Neurotoxicity; Neuropathology; Medicine; Oxidative stress; Ferritin; Deferoxamine; Immunology; Immune system; Neuroprotection; Innate immune system; Central nervous system; Physiology; Neuroscience; Glutamate receptor; Toxicity; Pathology; Disease; Biology; Pharmacology; Endocrinology; Internal medicine","score_opus":0.05634555039097719,"score_gpt":0.2756353304680608,"score_spread":0.21928978007708363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385694372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020914931,0.99917465,0.000034942976,0.00028216318,0.00020627362,7.862627e-7,0.000004236239,0.0000024202388,0.00027353072],"genre_scores_gemma":[0.00033626435,0.9983026,0.00008913769,0.00032481717,0.00056134886,0.0000028080253,0.000011509445,0.0000010061311,0.00037046024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997938,0.00004637254,0.00002767946,0.000033349934,0.00007569515,0.0000231198],"domain_scores_gemma":[0.99949026,0.00027826568,0.00004980277,0.000015348405,0.00011149011,0.000054785505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010222212,0.00095333776,0.0018304872,0.0020410984,0.00033110369,0.001338117,0.0012763184,0.002024701,0.0026435393],"category_scores_gemma":[0.00095503643,0.00028843808,0.00036819102,0.0021085367,0.0009898131,0.0017741389,0.0009479035,0.0025409842,0.001729914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016227267,0.00006558022,0.00020824543,0.013937949,0.000107967506,0.00043133963,0.00006266236,0.0005242174,0.0012624648,0.010530247,0.11769599,0.85501105],"study_design_scores_gemma":[0.000026071362,0.000058960068,0.0005687237,0.004048203,0.00008538946,0.0014338095,0.000055267443,0.00013109249,0.00016499592,0.005043682,0.9883659,0.00001802856],"about_ca_topic_score_codex":0.0014326989,"about_ca_topic_score_gemma":0.0037013504,"teacher_disagreement_score":0.0026435393,"about_ca_system_score_codex":0.00094313925,"about_ca_system_score_gemma":0.0013794992,"threshold_uncertainty_score":0.008843482},"labels":[],"label_agreement":null},{"id":"W4385708421","doi":"10.1016/j.msard.2023.104933","title":"Randomized controlled trial of the behavioral intervention for physical activity in multiple sclerosis project: Social cognitive theory variables as mediators","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Randomized controlled trial; Medicine; Intervention (counseling); Social cognitive theory; Cognition; Physical therapy; Clinical psychology; Physical medicine and rehabilitation; Psychotherapist; Psychiatry; Psychology; Internal medicine","score_opus":0.06775457892095482,"score_gpt":0.3381902637466798,"score_spread":0.270435684825725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385708421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96805793,0.004876479,0.0019155546,0.0022389914,0.0030292643,0.014892606,0.0015140674,0.00028963195,0.0031853712],"genre_scores_gemma":[0.9640088,0.002027339,0.0033243361,0.0013126762,0.0010412773,0.023976337,0.0008039832,0.000035248,0.003469948],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99598604,0.002425779,0.0003034671,0.0005552144,0.00025985026,0.00046952444],"domain_scores_gemma":[0.9959247,0.0018666865,0.00069448305,0.0003049218,0.00026766717,0.00094139535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004466325,0.0028476908,0.0074207126,0.0010838881,0.001557694,0.0016652603,0.0017825518,0.004998937,0.013193978],"category_scores_gemma":[0.0077905557,0.0015279425,0.0030800032,0.0010088091,0.0029309287,0.0019357778,0.0015136595,0.006259228,0.0014493156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99168855,0.0044782483,0.0002525549,0.00026034235,0.0006586008,0.000007841725,0.000018095156,0.000106244996,0.00010632376,0.00008164106,0.00018536084,0.002156342],"study_design_scores_gemma":[0.9864428,0.012390793,0.0004102856,0.00001969062,0.00036185433,0.0000030907975,0.000011856693,0.00016232465,0.000043259894,0.0000759331,0.000073359406,0.0000047624812],"about_ca_topic_score_codex":0.0071820347,"about_ca_topic_score_gemma":0.004673504,"teacher_disagreement_score":0.013193978,"about_ca_system_score_codex":0.0016126083,"about_ca_system_score_gemma":0.0035019259,"threshold_uncertainty_score":0.044138193},"labels":[],"label_agreement":null},{"id":"W4385973218","doi":"10.1016/j.msard.2023.104937","title":"CNS resilience in the progression of MS","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Scopus; Genome-wide association study; Genomics; Genetics; Epigenetics; Resilience (materials science); Genome; Medicine; Biology; Computational biology; MEDLINE; Gene; Genotype; Psychiatry; Single-nucleotide polymorphism","score_opus":0.03206027442023911,"score_gpt":0.3117704720261226,"score_spread":0.2797101976058835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385973218","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039809787,0.011645742,0.000078238016,0.03370285,0.9539578,0.00001886565,0.000051717845,0.000029905941,0.00047503313],"genre_scores_gemma":[0.0003720159,0.0049136924,0.00005613063,0.013881447,0.9792196,0.000020275053,0.000015458138,0.000012503683,0.0015088356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99096245,0.003083087,0.0016142972,0.00079766125,0.0030535068,0.00048911653],"domain_scores_gemma":[0.93940544,0.038938038,0.00268,0.0012158338,0.012690078,0.005070539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020015161,0.0050888145,0.008131602,0.0052607725,0.0043595727,0.009431491,0.00579943,0.027850272,0.007927907],"category_scores_gemma":[0.05319043,0.0019061828,0.0039990735,0.0025864756,0.0038225402,0.0061814524,0.0027519437,0.02875682,0.005197481],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015955718,0.000026704329,0.000079619844,0.00092735613,0.00011263118,0.00019332748,0.00003550332,0.000035686116,0.000047303212,0.000471638,0.99028534,0.0076254196],"study_design_scores_gemma":[0.0007437607,0.00020111965,0.0025264649,0.0051220967,0.0010190562,0.0010225594,0.00029529707,0.0009643217,0.00023305693,0.0050882623,0.98265094,0.00013303888],"about_ca_topic_score_codex":0.0051200846,"about_ca_topic_score_gemma":0.012239096,"teacher_disagreement_score":0.027850272,"about_ca_system_score_codex":0.0053874003,"about_ca_system_score_gemma":0.005184327,"threshold_uncertainty_score":0.10585159},"labels":[],"label_agreement":null},{"id":"W4386012957","doi":"10.1016/j.msard.2023.104945","title":"Assessing the duration of EDSS improvement after a therapy start: A novel approach applied to the long-term extension of the PRISMS study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Merck KGaA; Merck; Merck Healthcare KGaA","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Regimen; Randomization; Placebo; Incidence (geometry); Internal medicine; Randomized controlled trial; Cumulative incidence; Surgery; Gastroenterology; Pediatrics; Cohort; Immunology","score_opus":0.06369443365532455,"score_gpt":0.3053357887524003,"score_spread":0.24164135509707574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386012957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7939962,0.0172062,0.17777102,0.00063658465,0.00039048993,0.0015496804,0.0039924304,0.00020967885,0.0042476146],"genre_scores_gemma":[0.9384147,0.0017438261,0.054518428,0.00025790717,0.00031251414,0.0014283439,0.0022296358,0.0000657078,0.0010289246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97234046,0.021057267,0.0016209149,0.0024140035,0.0023332073,0.00023412592],"domain_scores_gemma":[0.92059994,0.0543279,0.01656067,0.005597828,0.0019849553,0.00092873635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07105861,0.0008386296,0.0022173168,0.0017122438,0.00030208705,0.0012414225,0.0011780148,0.0007028486,0.0017068248],"category_scores_gemma":[0.062459495,0.00035820523,0.0019374581,0.001556056,0.0007480669,0.0014402213,0.0021014533,0.0018573224,0.00021797337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03851524,0.00087286637,0.6392569,0.0036551706,0.00993171,0.000381246,0.0013592129,0.013987455,0.0039399737,0.0040196907,0.0015746726,0.28250593],"study_design_scores_gemma":[0.004485328,0.030356806,0.8011436,0.00089953636,0.008165793,0.0027163906,0.00059945986,0.11325531,0.004746582,0.010452972,0.022810273,0.00036781776],"about_ca_topic_score_codex":0.00042938732,"about_ca_topic_score_gemma":0.00043109202,"teacher_disagreement_score":0.07105861,"about_ca_system_score_codex":0.00037706806,"about_ca_system_score_gemma":0.00078665407,"threshold_uncertainty_score":0.37579834},"labels":[],"label_agreement":null},{"id":"W4386257877","doi":"10.1016/j.msard.2023.104969","title":"Delayed oculomotor response associates with optic neuritis in youth with demyelinating disorders","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Queen's University","funders":"Ontario Institute for Regenerative Medicine; Stem Cell Network","keywords":"Optic neuritis; Medicine; Nerve fiber layer; Pupillary response; Optic nerve; Ophthalmology; Audiology; Retinal ganglion cell; Saccade; Visual acuity; Multiple sclerosis; Neuroscience; Pupil; Psychology; Eye movement","score_opus":0.02686891349310801,"score_gpt":0.25811592960853746,"score_spread":0.23124701611542944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386257877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99877065,0.00037098594,0.000025627707,0.000047108213,0.000007912714,0.0000038355597,0.00006411863,0.000003247142,0.0007065747],"genre_scores_gemma":[0.9995067,0.00018743482,0.000034260665,0.000019036734,0.000016524391,0.0000038466387,0.00007676781,0.000001674548,0.00015372643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942327,0.0001332688,0.000075643715,0.00010087439,0.00009638674,0.00017057893],"domain_scores_gemma":[0.9967289,0.000594462,0.0018679193,0.000083537605,0.00028319328,0.00044201929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005951222,0.0004495669,0.00040373625,0.0018548366,0.00062316825,0.00092869846,0.0004008766,0.00067844195,0.0025042016],"category_scores_gemma":[0.0041338424,0.0002731312,0.00038260766,0.0012396165,0.00061481964,0.0005430143,0.0006388768,0.00076601165,0.00027590842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012777762,0.00006030626,0.9970988,0.000014138224,0.000016428945,0.001024569,0.00012845622,0.000011010251,0.0003459765,0.000027971164,0.000056774727,0.001087732],"study_design_scores_gemma":[0.0000053022313,0.00009215559,0.99574053,0.000016232923,0.000022941616,0.0033130324,0.0004978282,0.00003808167,0.00011186103,0.000025962436,0.00013333911,0.0000027707872],"about_ca_topic_score_codex":0.0068485984,"about_ca_topic_score_gemma":0.0054432796,"teacher_disagreement_score":0.0068485984,"about_ca_system_score_codex":0.000410325,"about_ca_system_score_gemma":0.000695541,"threshold_uncertainty_score":0.013617456},"labels":[],"label_agreement":null},{"id":"W4386401846","doi":"10.1016/j.msard.2023.104966","title":"Multiple sclerosis and quality of life: The role of cognitive impairment on quality of life in people with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Expanded Disability Status Scale; Depression (economics); Quality of life (healthcare); Medicine; Multiple sclerosis; Cognition; Beck Depression Inventory; Physical disability; Executive dysfunction; Physical therapy; Physical medicine and rehabilitation; Clinical psychology; Psychiatry; Anxiety; Neuropsychology","score_opus":0.06909068961577618,"score_gpt":0.2983099691224767,"score_spread":0.2292192795067005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386401846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594924,0.034397148,0.000073434545,0.0014893289,0.0001064515,0.00001617507,0.0005502439,0.000002689338,0.0038719804],"genre_scores_gemma":[0.9954862,0.0038728311,0.000072149945,0.00016069585,0.00007401028,0.00000815034,0.00016302188,7.894236e-7,0.00016204937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990382,0.0004943859,0.000095605836,0.00007748986,0.00017803664,0.00011623267],"domain_scores_gemma":[0.9967057,0.001147374,0.0010322126,0.000121261284,0.00039681632,0.0005967008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022133116,0.0002928134,0.00065904344,0.0012867568,0.00055179186,0.0013237288,0.00046310984,0.0006972316,0.0017546663],"category_scores_gemma":[0.0064078122,0.00016717352,0.0011951494,0.002578101,0.00050820253,0.00096621603,0.00089497707,0.0012088076,0.0001212311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035849318,0.0002646414,0.9836257,0.00023986418,0.000680553,0.00007575836,0.0005253785,0.000072681294,0.000057225458,0.0001650181,0.0003704419,0.013564179],"study_design_scores_gemma":[0.00001023274,0.00012342565,0.9984617,0.000097487464,0.00018940859,0.000060671435,0.0005011398,0.000070191476,0.000015560774,0.00007714769,0.0003871016,0.000006025692],"about_ca_topic_score_codex":0.01616121,"about_ca_topic_score_gemma":0.023570063,"teacher_disagreement_score":0.01616121,"about_ca_system_score_codex":0.0005604132,"about_ca_system_score_gemma":0.00070353516,"threshold_uncertainty_score":0.032134295},"labels":[],"label_agreement":null},{"id":"W4386630159","doi":"10.1016/j.msard.2023.104998","title":"Are we there yet? The holy grail: A biomarker for Multiple Sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Holy Grail; Medicine; Multiple sclerosis; Biomarker; Immunology; World Wide Web; Genetics","score_opus":0.08516344769704169,"score_gpt":0.3031964610574046,"score_spread":0.2180330133603629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386630159","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002608378,0.012498145,0.0001051771,0.044362605,0.94246185,0.000021780641,0.000058542777,0.000035944333,0.00042987394],"genre_scores_gemma":[0.0002765557,0.00591398,0.00009932683,0.032719348,0.9587746,0.00003632232,0.000025915255,0.000021696333,0.00213216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881989,0.0039422764,0.0019430119,0.0011307901,0.0042672353,0.00051776797],"domain_scores_gemma":[0.9354347,0.03836189,0.003413853,0.0015154299,0.015537616,0.0057365135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022368388,0.0061693136,0.0100889485,0.0069029196,0.0049826666,0.012847404,0.0062051928,0.032682795,0.006904397],"category_scores_gemma":[0.06239376,0.0027637568,0.004726043,0.0031083315,0.0050710654,0.0076519144,0.0030882454,0.033274278,0.0073366496],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007885367,0.000012904995,0.000050990428,0.00052159023,0.000078692305,0.00009739422,0.000018657385,0.000016146712,0.00003054267,0.0002669682,0.9945479,0.004279486],"study_design_scores_gemma":[0.0005341089,0.00014894511,0.0010678984,0.0030269576,0.0008592601,0.0008163068,0.00018994586,0.0006242234,0.00020395363,0.0044408124,0.98796695,0.000120628734],"about_ca_topic_score_codex":0.0039263205,"about_ca_topic_score_gemma":0.008316812,"teacher_disagreement_score":0.032682795,"about_ca_system_score_codex":0.0051610284,"about_ca_system_score_gemma":0.0055757943,"threshold_uncertainty_score":0.11829674},"labels":[],"label_agreement":null},{"id":"W4386851210","doi":"10.1016/j.msard.2023.105008","title":"Admission and discharge profiles of people with MS accessing in-patient rehabilitation in Canada","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital; University of British Columbia; McGill University; McGill University Health Centre","funders":"","keywords":"Rehabilitation; Medicine; Odds; Cohort; Quality of life (healthcare); Latent class model; Functional Independence Measure; Stroke (engine); Multiple sclerosis; Logistic regression; Physical therapy; Acute care; Cognition; Odds ratio; Physical medicine and rehabilitation; Ordered logit; Gerontology; Health care; Psychiatry; Internal medicine","score_opus":0.019474239279034418,"score_gpt":0.2548042655903164,"score_spread":0.23533002631128197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386851210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995847,0.0006501032,0.000050967676,0.0006795139,0.000023640428,0.000056984434,0.0055296673,0.000008012199,0.0030425426],"genre_scores_gemma":[0.99557143,0.0005387713,0.00007335227,0.0002490323,0.0000097065895,0.00001902311,0.0024934255,0.0000062020113,0.0010391022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998028,0.00013302336,0.00022070787,0.00018302245,0.0004249086,0.0010104498],"domain_scores_gemma":[0.9941413,0.00027573216,0.0010896155,0.00008800767,0.0025105975,0.0018947205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005651628,0.00031378632,0.0008176145,0.001751151,0.0037793557,0.0024418207,0.001498752,0.00083006406,0.0043392084],"category_scores_gemma":[0.0050948584,0.0004242346,0.00091624336,0.0065611624,0.0008135391,0.0009910644,0.0018764518,0.0017251273,0.00036331272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022074931,0.0000919848,0.99186796,0.000060053546,0.00007067957,0.00015246258,0.0017937203,0.00013126961,0.00011744073,0.00019926747,0.0016858551,0.003608648],"study_design_scores_gemma":[0.000009732251,0.000033958015,0.9934342,0.000074401854,0.000020538124,0.000066256405,0.005457482,0.00017275788,0.000024392672,0.000047944224,0.00063910487,0.000019214292],"about_ca_topic_score_codex":0.988937,"about_ca_topic_score_gemma":0.99359787,"teacher_disagreement_score":0.02990734,"about_ca_system_score_codex":0.02990734,"about_ca_system_score_gemma":0.040258426,"threshold_uncertainty_score":0.21699393},"labels":[],"label_agreement":null},{"id":"W4386989266","doi":"10.1016/j.msard.2023.105025","title":"Sleep, physical activity, and psychological outcomes in children and adolescents with pediatric onset multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Queen's University; University of Toronto; Hospital for Sick Children","funders":"National Multiple Sclerosis Society","keywords":"Actigraphy; Medicine; Sleep onset latency; Sleep onset; Sleep (system call); Depression (economics); Physical therapy; Population; Quality of life (healthcare); Pediatrics; Psychiatry; Insomnia","score_opus":0.04539463137848946,"score_gpt":0.29314293247238826,"score_spread":0.2477483010938988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386989266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901557,0.0005332817,0.000008889508,0.000042903237,0.000005383728,0.0000040594355,0.0001472742,6.2313745e-7,0.00024207722],"genre_scores_gemma":[0.9990398,0.00053770165,0.000026269265,0.000027460204,0.0000071897725,0.000009591269,0.00023555131,6.9112673e-7,0.00011581395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972147,0.000071524366,0.000033537603,0.000037313628,0.00004910124,0.00008705142],"domain_scores_gemma":[0.99918777,0.00013561644,0.00039445268,0.000025173518,0.00007866848,0.00017826787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043424184,0.00023095813,0.0003622076,0.0005571653,0.0004019375,0.0005680061,0.00022354208,0.0003574687,0.0010031563],"category_scores_gemma":[0.0017661637,0.00017301476,0.0005373325,0.0010176338,0.00029729816,0.00042637877,0.0005229137,0.0007104774,0.000092142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007492723,0.0000765858,0.9985341,0.000016208876,0.000042302123,0.000065856584,0.00014506458,0.000017649038,0.000047755082,0.00001217026,0.00005664462,0.00091072096],"study_design_scores_gemma":[0.0000039190595,0.00007387435,0.99921036,0.000010752124,0.000020571706,0.000084927065,0.0004920851,0.000017584638,0.000015927431,0.0000055203386,0.00006346123,0.000001012624],"about_ca_topic_score_codex":0.022415398,"about_ca_topic_score_gemma":0.034552492,"teacher_disagreement_score":0.022415398,"about_ca_system_score_codex":0.00046825685,"about_ca_system_score_gemma":0.0005751599,"threshold_uncertainty_score":0.04456985},"labels":[],"label_agreement":null},{"id":"W4387101856","doi":"10.1016/j.msard.2023.105023","title":"A Canadian case control study investigating demographic and environmental factors associated with MOGAD","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of New Brunswick; Public Health Ontario; Western University; University of Toronto; Ottawa Hospital; Health Sciences Centre; London Health Sciences Centre; McGill University Health Centre; University of Ottawa; University of Manitoba; University of British Columbia; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Odds ratio; Logistic regression; Case-control study; Young adult; Pediatrics; Surgery; Internal medicine","score_opus":0.03753921952861682,"score_gpt":0.24289865967890595,"score_spread":0.20535944015028912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387101856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386877,0.0011037425,0.00025623347,0.00021683711,0.000036146757,0.000135973,0.0015003148,0.000011810176,0.0028700922],"genre_scores_gemma":[0.9963831,0.0007063031,0.00045451307,0.00019653473,0.000017448008,0.000070076145,0.000715645,0.000008539131,0.0014477322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977264,0.00030455308,0.00018940396,0.0004920567,0.0005510574,0.0007366731],"domain_scores_gemma":[0.9968701,0.00035532462,0.00052007433,0.00021913629,0.0013968892,0.0006384462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016568855,0.0010421745,0.0010283994,0.0035429713,0.00773503,0.0022906174,0.0019659156,0.0014007497,0.0042247837],"category_scores_gemma":[0.004247559,0.0012994331,0.0012850747,0.007184235,0.0017922488,0.0006931267,0.0011935845,0.0016182517,0.00039118913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053609675,0.00031002026,0.99207675,0.000069772155,0.00020772648,0.0012073157,0.0015977838,0.00004102139,0.00053376734,0.0003380525,0.000993611,0.0020880366],"study_design_scores_gemma":[0.00009080158,0.0001765017,0.9949825,0.00004956724,0.00016173985,0.00079821685,0.002189955,0.000117551484,0.000073817646,0.00005948182,0.0012726272,0.000027244996],"about_ca_topic_score_codex":0.9743859,"about_ca_topic_score_gemma":0.9720702,"teacher_disagreement_score":0.025614083,"about_ca_system_score_codex":0.015948312,"about_ca_system_score_gemma":0.019767495,"threshold_uncertainty_score":0.115713656},"labels":[],"label_agreement":null},{"id":"W4387108150","doi":"10.1016/j.msard.2023.105029","title":"The role of autophagy protein Atg5 in multiple sclerosis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Autophagy; ATG5; Multiple sclerosis; Biology; Cell biology; Immunology; Genetics; Apoptosis","score_opus":0.05367112339667342,"score_gpt":0.27502037442032273,"score_spread":0.22134925102364933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387108150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008966741,0.99893206,0.000052225285,0.00012584619,0.00009494794,0.0000021753915,0.000009124512,0.0000046100054,0.0006893623],"genre_scores_gemma":[0.0006039678,0.9987702,0.00009595061,0.000097525204,0.00006160865,0.0000029437651,0.000018655823,6.975218e-7,0.00034845536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998852,0.000018351588,0.000021574982,0.000018530634,0.000043761047,0.000012605946],"domain_scores_gemma":[0.9999018,0.000037126534,0.000017709723,0.000002981669,0.000028638098,0.00001168675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003081541,0.00057343236,0.0010361321,0.0022861168,0.000314626,0.00079497765,0.00052798673,0.00080307404,0.0026648636],"category_scores_gemma":[0.0003009616,0.00017689957,0.0003732654,0.0018299747,0.00032474994,0.0008807741,0.00064903166,0.0012179038,0.0015882833],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006782445,0.000044208053,0.00014908129,0.021621441,0.00009051642,0.0002915829,0.00008600814,0.0002821683,0.0029335099,0.004001135,0.02086887,0.94956356],"study_design_scores_gemma":[0.000011791716,0.00008715725,0.00089401414,0.0044723437,0.0001342492,0.0019088723,0.000058560774,0.000063178515,0.00067199516,0.002144059,0.98953784,0.000015983933],"about_ca_topic_score_codex":0.0010491387,"about_ca_topic_score_gemma":0.0017454422,"teacher_disagreement_score":0.0026648636,"about_ca_system_score_codex":0.0005402636,"about_ca_system_score_gemma":0.0009675523,"threshold_uncertainty_score":0.008914888},"labels":[],"label_agreement":null},{"id":"W4387189999","doi":"10.1016/j.msard.2023.105021","title":"Association between limbic system lesions and anxiety in persons with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Robarts Clinical Trials; Western University","funders":"American Academy of Neurology","keywords":"Medicine; Multiple sclerosis; Association (psychology); Anxiety; Limbic system; Pathology; Psychiatry; Internal medicine; Central nervous system; Psychotherapist; Psychology","score_opus":0.04590942316197807,"score_gpt":0.2575910237112579,"score_spread":0.21168160054927984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387189999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988834,0.00041032964,0.00001891182,0.00006007339,0.0000064155197,0.0000032419698,0.00006853076,0.0000013889255,0.000547764],"genre_scores_gemma":[0.9996062,0.00015132557,0.000018773228,0.000023540439,0.000013612705,0.000002004962,0.00005477493,3.369556e-7,0.00012950416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999726,0.000099229306,0.00002911916,0.000031661588,0.00004251538,0.00007148807],"domain_scores_gemma":[0.9989624,0.00024820893,0.00044084352,0.000056622568,0.00008927727,0.000202538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002864712,0.00023650331,0.00027359175,0.0008498807,0.00059209985,0.0007018867,0.00022652853,0.0005322772,0.0017892784],"category_scores_gemma":[0.0018592151,0.00021825329,0.0005393711,0.0008040203,0.00031793286,0.00032067928,0.00035772676,0.00074282807,0.00012310711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019412182,0.000106273554,0.99807465,0.000012831972,0.00011074491,0.00016909208,0.0001465964,0.000010657402,0.00023020506,0.000015994687,0.000044231245,0.0008845853],"study_design_scores_gemma":[0.000003654284,0.000054948592,0.99949765,0.0000029054083,0.00003078691,0.00013252307,0.00020525654,0.000018675733,0.000013590901,0.000009943724,0.000028234686,0.000001828201],"about_ca_topic_score_codex":0.015096829,"about_ca_topic_score_gemma":0.01901568,"teacher_disagreement_score":0.015096829,"about_ca_system_score_codex":0.00029438458,"about_ca_system_score_gemma":0.0002947095,"threshold_uncertainty_score":0.030017912},"labels":[],"label_agreement":null},{"id":"W4387363470","doi":"10.1016/j.msard.2023.105046","title":"Social network size and mental health outcomes in youth with neuroinflammatory disorders","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Anxiety; Depression (economics); Medicine; Mental health; Quality of life (healthcare); Psychiatry; Clinical psychology; Social support; Psychology","score_opus":0.015182002121924663,"score_gpt":0.25342710331180957,"score_spread":0.2382451011898849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387363470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823725,0.00050036865,0.000020702,0.0001768175,0.000019774454,0.0000049168652,0.0003712202,0.0000030628105,0.0006659338],"genre_scores_gemma":[0.99918026,0.00020155101,0.000017974464,0.000024258296,0.00002163885,0.00000498795,0.0002521178,0.0000010572886,0.00029603258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995407,0.00009283216,0.00003645525,0.00006553397,0.0000625268,0.00020198323],"domain_scores_gemma":[0.9980469,0.00019678146,0.0008139832,0.00005692428,0.00012547067,0.0007598704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004743372,0.00035460532,0.0003346102,0.0007894954,0.0007751461,0.0011227315,0.00045860547,0.00068981363,0.002785561],"category_scores_gemma":[0.0029108718,0.00023819853,0.00087718904,0.0009219592,0.0004066347,0.00081739476,0.0011398108,0.0014032138,0.00023075126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096902775,0.00010742733,0.9981086,0.000008226153,0.00008018229,0.00006709539,0.00009539707,0.000040438677,0.000039287846,0.000029737444,0.00011049613,0.0012160244],"study_design_scores_gemma":[0.0000023483076,0.000047440488,0.9994406,0.000006308741,0.000026318,0.000035056833,0.00026917653,0.00006684033,0.0000121016,0.000023173054,0.00006819779,0.000002456674],"about_ca_topic_score_codex":0.033126526,"about_ca_topic_score_gemma":0.049771573,"teacher_disagreement_score":0.033126526,"about_ca_system_score_codex":0.00073181087,"about_ca_system_score_gemma":0.00071855343,"threshold_uncertainty_score":0.065867424},"labels":[],"label_agreement":null},{"id":"W4387521237","doi":"10.1016/j.msard.2023.105066","title":"MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Neuroscience; Pathology; Immunology; Biology","score_opus":0.08503298338119988,"score_gpt":0.28026724385968815,"score_spread":0.19523426047848827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387521237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310595,0.0010341681,0.0010797268,0.00015157358,0.000021084496,0.00003021871,0.0010943251,0.00007284741,0.003410095],"genre_scores_gemma":[0.9974419,0.00039295372,0.0006885331,0.000025530233,0.000015570015,0.000017665125,0.00046615416,0.000021496291,0.0009302394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997671,0.00005449263,0.00003147881,0.000044854773,0.000072137394,0.000030019019],"domain_scores_gemma":[0.9962196,0.00068255677,0.0018193789,0.0002770405,0.0007665114,0.00023504635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007302653,0.0004137805,0.00024609274,0.0019585954,0.00032382554,0.0011947431,0.00034554544,0.00058004167,0.0029650398],"category_scores_gemma":[0.0060045067,0.00024369829,0.00023426533,0.0014618947,0.00033395973,0.0015692808,0.00035958595,0.0007221775,0.0005786182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001425549,0.000342332,0.946466,0.0001185098,0.00037273503,0.00022896798,0.0005876356,0.0007622573,0.0113329105,0.0002708208,0.00089855655,0.03719367],"study_design_scores_gemma":[0.0000067192705,0.00027051213,0.99598664,0.000018855158,0.00009031421,0.00028714308,0.00026322957,0.00058118015,0.001656522,0.00039497335,0.0004317609,0.000012171821],"about_ca_topic_score_codex":0.0055501196,"about_ca_topic_score_gemma":0.006719376,"teacher_disagreement_score":0.0055501196,"about_ca_system_score_codex":0.00030568067,"about_ca_system_score_gemma":0.00034887338,"threshold_uncertainty_score":0.011035621},"labels":[],"label_agreement":null},{"id":"W4387643059","doi":"10.1016/j.msard.2023.105060","title":"Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Retrospective cohort study; Cohort; Dementia; Cognition; Cognitive reserve; Multiple sclerosis; Audiology; Risk factor; Cohort study; Amyotrophic lateral sclerosis; Disease; Pediatrics; Physical therapy; Psychiatry; Internal medicine","score_opus":0.053211491535602604,"score_gpt":0.3083231252297077,"score_spread":0.25511163369410506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387643059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909925,0.00031247718,0.00006409717,0.00004117414,0.000011379158,0.0000055242326,0.00021373059,0.0000024229173,0.00024990595],"genre_scores_gemma":[0.9994924,0.00009595948,0.000047878653,0.000027740793,0.00001597471,0.0000060222674,0.00015033087,0.000002586635,0.00016108472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942195,0.00013421041,0.00007349707,0.0001973226,0.000052918516,0.00012011845],"domain_scores_gemma":[0.99840647,0.00019886493,0.00061623316,0.00031268396,0.00015805,0.00030770767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091378274,0.00044172487,0.00048304882,0.0008215444,0.0012310903,0.0011752297,0.0005303561,0.00091331615,0.0024192065],"category_scores_gemma":[0.002040906,0.0007112297,0.0010157054,0.0014465131,0.0005974544,0.0008714213,0.0006186421,0.0010649967,0.0003857349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040732897,0.00007821898,0.9982023,0.0000112270645,0.00021433667,0.00016744199,0.00018187898,0.000016717448,0.0002646475,0.000027311562,0.00006371706,0.00036499332],"study_design_scores_gemma":[0.000028494129,0.00032136185,0.99797195,0.000010228775,0.00024583336,0.0004321704,0.00054159237,0.00011296235,0.00007683128,0.000060565846,0.00018728574,0.0000107295955],"about_ca_topic_score_codex":0.010528778,"about_ca_topic_score_gemma":0.010543244,"teacher_disagreement_score":0.010528778,"about_ca_system_score_codex":0.00031871523,"about_ca_system_score_gemma":0.0005104737,"threshold_uncertainty_score":0.020934999},"labels":[],"label_agreement":null},{"id":"W4387653819","doi":"10.1016/j.msard.2023.105075","title":"Characteristics and predictors of disease course in children initially presenting with ADEM","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Disease; Pediatrics; Dermatology; Internal medicine; Immunology","score_opus":0.030131592056845766,"score_gpt":0.30371395674451623,"score_spread":0.27358236468767044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387653819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999041,0.00015404115,0.000023216202,0.000045952343,0.0000064443248,0.000003662622,0.00017452701,0.000002839788,0.00054829236],"genre_scores_gemma":[0.9995435,0.00008209427,0.000028389888,0.000016668144,0.000011852512,0.0000035506334,0.00021274657,0.0000019792237,0.00009930178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996735,0.0000459646,0.00004085838,0.00004807471,0.000045985693,0.00014560942],"domain_scores_gemma":[0.997945,0.00044515802,0.0007344429,0.00004940204,0.00014752438,0.00067843293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002804539,0.00033239694,0.00042620298,0.0011304406,0.00063486776,0.00075542904,0.00031720623,0.00065274624,0.002475922],"category_scores_gemma":[0.0025204434,0.0002518273,0.0005286454,0.0010772881,0.00041118806,0.00083003833,0.0005032667,0.0013239476,0.0003339419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005431563,0.000033375054,0.99895847,0.0000033564093,0.0000059482113,0.00041171443,0.00005023672,0.00002642204,0.00008903282,0.000009374374,0.00004418201,0.00031355725],"study_design_scores_gemma":[0.00000316531,0.00011646569,0.9974456,0.000006897045,0.0000082368315,0.0016742998,0.00049616117,0.00010153921,0.00004515717,0.000017574033,0.00008137047,0.0000034778056],"about_ca_topic_score_codex":0.006000711,"about_ca_topic_score_gemma":0.0056887413,"teacher_disagreement_score":0.006000711,"about_ca_system_score_codex":0.0004703711,"about_ca_system_score_gemma":0.0007549522,"threshold_uncertainty_score":0.011931539},"labels":[],"label_agreement":null},{"id":"W4387767261","doi":"10.1016/j.msard.2023.105086","title":"Can we improve outcomes in MS around the world? Access and global considerations across income strata","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Intervention (counseling); Intensive care medicine; Disease; Clinical Practice; Physical therapy; Pathology; Psychiatry","score_opus":0.04662434464144772,"score_gpt":0.3469727916802097,"score_spread":0.300348447038762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387767261","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042818487,0.01072712,0.00006635254,0.074353576,0.9140799,0.000016017946,0.00006620475,0.000025398598,0.000622667],"genre_scores_gemma":[0.00049525383,0.008584929,0.0000872334,0.03924447,0.94973785,0.000030883435,0.000021834156,0.000023767887,0.0017738029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9863923,0.00416813,0.0025763498,0.0010804039,0.00488545,0.0008973485],"domain_scores_gemma":[0.89048046,0.070120834,0.0044300915,0.0017658443,0.025486693,0.007716047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029857611,0.004444369,0.007633651,0.0049277265,0.005010339,0.011206369,0.0048027616,0.026653474,0.009697508],"category_scores_gemma":[0.089688376,0.0015895807,0.0041551664,0.0043118414,0.0040291604,0.008078519,0.0023096795,0.033120945,0.005066542],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006583122,0.000017904009,0.00008003698,0.0006894245,0.00008646429,0.00009083236,0.000044338336,0.000024949235,0.00002503991,0.00044402506,0.99285007,0.005581173],"study_design_scores_gemma":[0.0003836459,0.00011169238,0.002276216,0.0050577214,0.0007430549,0.000455774,0.0005207843,0.00042778678,0.00013771612,0.0055038976,0.98427767,0.00010410964],"about_ca_topic_score_codex":0.007472396,"about_ca_topic_score_gemma":0.020017482,"teacher_disagreement_score":0.029857611,"about_ca_system_score_codex":0.005714061,"about_ca_system_score_gemma":0.008160763,"threshold_uncertainty_score":0.15790397},"labels":[],"label_agreement":null},{"id":"W4387802367","doi":"10.1016/j.msard.2023.105093","title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Genentech","keywords":"Multiple sclerosis; Medicine; Neuromyelitis optica; Myelin oligodendrocyte glycoprotein; Spectrum disorder; Optic neuritis; Expanded Disability Status Scale; Relapsing remitting; Internal medicine; Gastroenterology; Immunology; Psychiatry; Experimental autoimmune encephalomyelitis","score_opus":0.02772519443667449,"score_gpt":0.2795204740821587,"score_spread":0.2517952796454842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387802367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970697,0.00066322973,0.000040958574,0.00006899599,0.000022348891,0.000012598605,0.000317622,0.000016944727,0.0017875901],"genre_scores_gemma":[0.9985291,0.00012463793,0.000023207778,0.00003037747,0.000019909307,0.000006322698,0.00033126972,0.0000031432048,0.00093202275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951136,0.00012127579,0.000027599004,0.000094399526,0.000068288784,0.00017705535],"domain_scores_gemma":[0.9983247,0.00023902286,0.00046701747,0.00018761012,0.00018408847,0.0005975774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001031971,0.0003630499,0.00050077075,0.0006844821,0.0009710325,0.0009828602,0.00040493114,0.0006289758,0.0029235205],"category_scores_gemma":[0.0022073174,0.00024110425,0.0008817078,0.0004891891,0.00032795305,0.000769532,0.0005442963,0.0014579048,0.00042111662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025221985,0.0014063065,0.94357,0.00007756258,0.00048636753,0.0009983405,0.00047170906,0.00024046461,0.0051532155,0.00029113848,0.0010905773,0.020992309],"study_design_scores_gemma":[0.00010770614,0.0010643124,0.99699354,0.00000802426,0.0001299023,0.00061648,0.00013132705,0.00023004651,0.00021141705,0.0001231846,0.00037388125,0.0000101992555],"about_ca_topic_score_codex":0.008072344,"about_ca_topic_score_gemma":0.006668148,"teacher_disagreement_score":0.008072344,"about_ca_system_score_codex":0.00045229407,"about_ca_system_score_gemma":0.0010858994,"threshold_uncertainty_score":0.016050696},"labels":[],"label_agreement":null},{"id":"W4387817166","doi":"10.1016/j.msard.2023.105091","title":"Cancer risk, disease-modifying therapy, and age in multiple sclerosis: A retrospective population-based cohort study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta; University of Toronto; St. Michael's Hospital; Centre for Advancing Health Outcomes; University of British Columbia; Foothills Medical Centre; University of Calgary","funders":"Alberta Health; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Government of Alberta; Biogen Idec; Biogen; Roche","keywords":"Medicine; Interquartile range; Population; Hazard ratio; Cancer; Internal medicine; Confidence interval; Cohort study; Environmental health","score_opus":0.06565235849740345,"score_gpt":0.3007560240838869,"score_spread":0.23510366558648346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387817166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864715,0.0004226606,0.000104475,0.000026862688,0.0000087154185,0.000009124904,0.0005634159,0.000004794264,0.00021286677],"genre_scores_gemma":[0.9991036,0.0002246699,0.00008605355,0.000025736565,0.000011067016,0.000010967014,0.00036411086,0.000003004254,0.00017069488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993393,0.00015888136,0.00007401068,0.00023790967,0.00009116684,0.00009884455],"domain_scores_gemma":[0.9988564,0.00014443172,0.00039200147,0.0002605947,0.00013494767,0.00021162974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083041686,0.00050637574,0.00075996853,0.0009026423,0.0009424225,0.0010859697,0.00049909524,0.000807412,0.0012812683],"category_scores_gemma":[0.001529302,0.0008919117,0.0012445576,0.0021861077,0.00038764847,0.0007457418,0.0005199844,0.00103755,0.00027595786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051221,0.00008284594,0.9979054,0.0000086534,0.00034802506,0.000099923745,0.0000805718,0.000032496628,0.00039933855,0.000016034399,0.00007634367,0.00043819522],"study_design_scores_gemma":[0.00002885668,0.00016053376,0.9988619,0.000004524542,0.00021326452,0.0002614482,0.00016581424,0.00011852233,0.00004706626,0.000017836743,0.00011329774,0.0000069055145],"about_ca_topic_score_codex":0.015901526,"about_ca_topic_score_gemma":0.013478677,"teacher_disagreement_score":0.015901526,"about_ca_system_score_codex":0.0003986632,"about_ca_system_score_gemma":0.00059341535,"threshold_uncertainty_score":0.03161794},"labels":[],"label_agreement":null},{"id":"W4388378419","doi":"10.1016/j.msard.2023.105125","title":"A comparison of measles-rubella-zoster reaction, oligoclonal IgG bands, oligoclonal kappa free light chains and kappa index in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Virology and Viral Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Ministerstvo Zdravotnictví Ceské Republiky","keywords":"Medicine; Kappa; Multiple sclerosis; Measles; Immunoglobulin light chain; Rubella; Virology; Immunology; Antibody; Vaccination","score_opus":0.04717166000694903,"score_gpt":0.2645785332423748,"score_spread":0.21740687323542576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388378419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709725,0.00069479464,0.00033051564,0.000013575639,0.000015614978,0.000008611296,0.00007159623,0.00001324147,0.0017548699],"genre_scores_gemma":[0.99927324,0.00012720619,0.00018445644,0.000010904794,0.000011516098,0.0000046876025,0.000061241,0.0000027878132,0.00032389324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996201,0.000100121215,0.00005396887,0.000070002076,0.00009589736,0.000059889313],"domain_scores_gemma":[0.99860364,0.0006578889,0.00022025613,0.00007038083,0.00023349278,0.0002143926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009391664,0.0003362752,0.0002796833,0.0019081596,0.00031596783,0.0005514617,0.00029021868,0.0004361406,0.0012232885],"category_scores_gemma":[0.0020844887,0.00022161346,0.00025352254,0.00083404966,0.0003769024,0.0005245466,0.0003249906,0.00041407725,0.00027922823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010204528,0.00040500556,0.8568097,0.00018035989,0.0002443837,0.0019664837,0.00090294145,0.00027738506,0.107062116,0.00029340285,0.00016295991,0.021490883],"study_design_scores_gemma":[0.000046030964,0.0010162789,0.98511106,0.000013169592,0.00011490421,0.0033878,0.00041783208,0.0006114765,0.008685311,0.00016234623,0.00042261404,0.000011148974],"about_ca_topic_score_codex":0.0014797519,"about_ca_topic_score_gemma":0.00096206635,"teacher_disagreement_score":0.0019081596,"about_ca_system_score_codex":0.00024573097,"about_ca_system_score_gemma":0.00019280426,"threshold_uncertainty_score":0.0049667954},"labels":[],"label_agreement":null},{"id":"W4388561368","doi":"10.1016/j.msard.2023.105123","title":"Brain volume increase after discontinuing natalizumab therapy: Evidence for reversible pseudoatrophy","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); University of British Columbia Hospital; Montreal Neurological Institute and Hospital","funders":"","keywords":"Natalizumab; Medicine; Multiple sclerosis; Placebo; Anesthesia; Brain size; Internal medicine; Magnetic resonance imaging; Pathology; Radiology; Immunology","score_opus":0.05864502814502363,"score_gpt":0.30231301892333684,"score_spread":0.24366799077831322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388561368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97044015,0.019409288,0.0005940066,0.0007071607,0.000081910555,0.00009926151,0.00023866273,0.000025548248,0.00840395],"genre_scores_gemma":[0.9968641,0.0022373605,0.00018402436,0.00014518316,0.000080893115,0.000016360214,0.00012306115,0.000004504697,0.00034453438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993148,0.0003492464,0.000052943273,0.000069268564,0.00015888338,0.000054895536],"domain_scores_gemma":[0.9913454,0.005170924,0.002342036,0.0006047749,0.00035093087,0.00018590488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012743117,0.00028162994,0.0005840837,0.0006073062,0.00030509196,0.00049497676,0.00072186854,0.0006737226,0.0034474586],"category_scores_gemma":[0.008934551,0.000116091695,0.0005745627,0.0005179689,0.0008519735,0.00064116763,0.00029927975,0.0008041779,0.00022533984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03464472,0.0022590028,0.55057096,0.0040158387,0.0053411527,0.038208295,0.0010583851,0.00092569174,0.058772717,0.0036403113,0.0022572079,0.29830578],"study_design_scores_gemma":[0.0006646136,0.006017296,0.95980275,0.00021883256,0.0010929208,0.018962163,0.00038913434,0.0006242604,0.005703781,0.0016031148,0.00488601,0.00003515165],"about_ca_topic_score_codex":0.0012408474,"about_ca_topic_score_gemma":0.0012807382,"teacher_disagreement_score":0.0034474586,"about_ca_system_score_codex":0.0003802853,"about_ca_system_score_gemma":0.0005132657,"threshold_uncertainty_score":0.011532962},"labels":[],"label_agreement":null},{"id":"W4388818948","doi":"10.1016/j.msard.2023.105144","title":"Long term effects of continuous positive airway pressure treatment of obstructive sleep apnea-hypopnea syndrome in multiple sclerosis patients","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Randomized controlled trial; Continuous positive airway pressure; Obstructive sleep apnea; Physical therapy; Hypopnea; Apnea–hypopnea index; Epworth Sleepiness Scale; Quality of life (healthcare); Depression (economics); Internal medicine; Apnea; Polysomnography","score_opus":0.020100198729553237,"score_gpt":0.240616953517221,"score_spread":0.22051675478766777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388818948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914756,0.0073032565,0.000020686904,0.00014971016,0.000064293694,0.000025687388,0.00015775612,0.000003679859,0.00079937075],"genre_scores_gemma":[0.9976646,0.001416885,0.00003823043,0.00011945764,0.00012512035,0.000034502205,0.00026908852,9.2526693e-7,0.00033121344],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99955744,0.00015919379,0.000058578982,0.000058303434,0.000072408824,0.00009398571],"domain_scores_gemma":[0.99875295,0.0003580623,0.00023686388,0.00004353709,0.000113811446,0.0004948055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083922595,0.00035581426,0.001525076,0.00030451862,0.00072923396,0.00052279007,0.00031486605,0.0009498608,0.0012511767],"category_scores_gemma":[0.0019854666,0.00013475689,0.0012581922,0.0004067993,0.00032214707,0.00046640792,0.00032802307,0.0012325053,0.0001341295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3985992,0.02193725,0.3690175,0.0015803729,0.00871347,0.002102029,0.00088565465,0.0010212017,0.015548586,0.00019587431,0.0013112678,0.17908761],"study_design_scores_gemma":[0.008134701,0.074451834,0.91156405,0.00014220437,0.0027390479,0.00048724026,0.00033094187,0.0002916832,0.00065606786,0.0000817034,0.001070434,0.000050152154],"about_ca_topic_score_codex":0.0035470508,"about_ca_topic_score_gemma":0.0059621823,"teacher_disagreement_score":0.0035470508,"about_ca_system_score_codex":0.00048240006,"about_ca_system_score_gemma":0.0006983562,"threshold_uncertainty_score":0.007052779},"labels":[],"label_agreement":null},{"id":"W4388818964","doi":"10.1016/j.msard.2023.105141","title":"Is multiple sclerosis a glymphaticopathy?","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Immunology","score_opus":0.031941161554268196,"score_gpt":0.24692528136007705,"score_spread":0.21498411980580884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388818964","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039346436,0.009850433,0.000072184645,0.04752346,0.94141436,0.000011912064,0.000025234991,0.000022446737,0.0010406543],"genre_scores_gemma":[0.00029002744,0.0036602833,0.00003888448,0.021818615,0.9722777,0.000010596264,0.000010715896,0.000008270571,0.0018849584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962681,0.0009474754,0.0006605405,0.00044455033,0.0013991086,0.0002802215],"domain_scores_gemma":[0.97972304,0.010207559,0.0016102705,0.0005831412,0.005151131,0.0027248922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071797976,0.0039772647,0.0048634396,0.0042905253,0.0037671903,0.007191486,0.003649177,0.03067715,0.009546342],"category_scores_gemma":[0.02556703,0.0016398348,0.0030297325,0.0019725666,0.0031539793,0.0046072537,0.0020779348,0.026069973,0.0077335583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007045415,0.00001596379,0.000073228104,0.00038951472,0.000049329563,0.00049732305,0.000014006304,0.000024876004,0.000050104667,0.0002958927,0.992935,0.0055843266],"study_design_scores_gemma":[0.00031714886,0.0000731662,0.00089855795,0.0013750081,0.00031513668,0.0018282395,0.0000940213,0.00032645976,0.0001195711,0.0020500007,0.99255556,0.000047154535],"about_ca_topic_score_codex":0.002429008,"about_ca_topic_score_gemma":0.007426643,"teacher_disagreement_score":0.03067715,"about_ca_system_score_codex":0.0040545687,"about_ca_system_score_gemma":0.0028159034,"threshold_uncertainty_score":0.03797084},"labels":[],"label_agreement":null},{"id":"W4388947332","doi":"10.1016/j.msard.2023.105138","title":"The influence of personality in persons with MS","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ontario Shores Centre for Mental Health Sciences; Lawson Health Research Institute; Western University","funders":"","keywords":"Conscientiousness; Neuroticism; Extraversion and introversion; Big Five personality traits; Personality; Clinical psychology; Psychological intervention; Anxiety; Medicine; Depression (economics); Psychology; Psychiatry; Social psychology","score_opus":0.034968413135310496,"score_gpt":0.27477086957793667,"score_spread":0.23980245644262618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388947332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719965,0.00063547643,0.000024423282,0.00019595267,0.000028505958,0.0000035105936,0.000066203225,0.0000014627021,0.0018448606],"genre_scores_gemma":[0.99953735,0.00020034114,0.000025404799,0.00003791992,0.00002037997,0.0000015150964,0.000027568525,8.74891e-7,0.00014860783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869895,0.00082320004,0.00008900162,0.00006845502,0.00013636384,0.00018404634],"domain_scores_gemma":[0.995067,0.001665868,0.0012445395,0.0002226786,0.0003508991,0.0014489872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007914357,0.00025164944,0.00035213333,0.0008967099,0.0013425236,0.0011142503,0.00025630245,0.00044525237,0.0011617878],"category_scores_gemma":[0.0066701225,0.00021262829,0.00062514225,0.0009914662,0.0004424829,0.00041672305,0.0007617761,0.0008712452,0.00015430657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031201777,0.0001208131,0.9934643,0.000016667622,0.00015603217,0.00030223865,0.00077024044,0.00004031398,0.00022154766,0.00006320072,0.000101235535,0.0044312533],"study_design_scores_gemma":[0.0000025106604,0.00005049298,0.99919504,0.00000450553,0.000020256806,0.00012246407,0.00046834472,0.000026725065,0.000015537787,0.000023103927,0.00006852769,0.000002431446],"about_ca_topic_score_codex":0.011710402,"about_ca_topic_score_gemma":0.01975539,"teacher_disagreement_score":0.011710402,"about_ca_system_score_codex":0.00064768584,"about_ca_system_score_gemma":0.0005711815,"threshold_uncertainty_score":0.023284495},"labels":[],"label_agreement":null},{"id":"W4389340890","doi":"10.1016/j.msard.2023.105356","title":"Exercise ventilatory (in)efficiency in multiple sclerosis: The missing factor?","year":2023,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Multiple sclerosis; Physical medicine and rehabilitation; Physical therapy; Immunology","score_opus":0.07526556728994567,"score_gpt":0.27366635115196103,"score_spread":0.19840078386201537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389340890","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015301203,0.009073991,0.00006671665,0.9760334,0.011910129,0.0000053981735,0.000048233676,0.0000071195923,0.0013248295],"genre_scores_gemma":[0.03496871,0.013140777,0.0003892143,0.7225685,0.22561182,0.000066862405,0.00007353582,0.000017555363,0.0031629626],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635255,0.0017875372,0.0007963217,0.00027110853,0.0005402584,0.0002522016],"domain_scores_gemma":[0.97940356,0.014592233,0.0013602539,0.00049923686,0.0022947686,0.0018498447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048750155,0.00053052674,0.0023763743,0.0008359605,0.001970571,0.0021106566,0.0014732393,0.02177589,0.0035700728],"category_scores_gemma":[0.029159306,0.0004264891,0.0006286372,0.0012700846,0.0025081434,0.0034996634,0.0010253716,0.015525657,0.0017692384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005390818,0.00017823391,0.016861055,0.0007253363,0.00013383022,0.00897045,0.00061190716,0.00007317936,0.00037588493,0.005063633,0.9226299,0.04383759],"study_design_scores_gemma":[0.0015388642,0.000586594,0.048464846,0.0052555273,0.0005026504,0.027137337,0.005677995,0.0016565616,0.000540656,0.046949722,0.8614447,0.00024459287],"about_ca_topic_score_codex":0.0052582254,"about_ca_topic_score_gemma":0.009708252,"teacher_disagreement_score":0.02177589,"about_ca_system_score_codex":0.0023434244,"about_ca_system_score_gemma":0.00286689,"threshold_uncertainty_score":0.02578187},"labels":[],"label_agreement":null},{"id":"W4389476706","doi":"10.1016/j.msard.2023.105365","title":"Comorbidity in the multiple sclerosis and neuromyelitis optica spectrum disorders population: findings from an underserved, low income country, Zambia","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Office of AIDS Research; Fogarty International Center; National Institute on Aging; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; American Academy of Neurology; National Multiple Sclerosis Society","keywords":"Neuromyelitis optica; Medicine; Multiple sclerosis; Spectrum disorder; Comorbidity; Population; Pediatrics; Environmental health; Psychiatry","score_opus":0.04766772374554182,"score_gpt":0.27204752992369746,"score_spread":0.22437980617815564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389476706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992077,0.0002561398,0.000022108583,0.00009355459,0.000003858566,0.000011113396,0.00017275495,7.2713095e-7,0.00023210676],"genre_scores_gemma":[0.9993581,0.000323968,0.000043569788,0.000055929137,0.0000036142378,0.00001547472,0.00011074138,9.383793e-7,0.00008765011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995295,0.000106686275,0.000065526605,0.000056356064,0.000055130226,0.000186812],"domain_scores_gemma":[0.999503,0.000053066487,0.00022960224,0.000021136975,0.000090909656,0.00010227586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050903007,0.00034605214,0.0004903867,0.0016357251,0.0017229969,0.0014260175,0.00050013344,0.00048064647,0.001333483],"category_scores_gemma":[0.0017359129,0.00047764162,0.00052973593,0.0029785947,0.00069735025,0.0005936623,0.0015412002,0.0007370706,0.00012271588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046786343,0.000044865224,0.99487865,0.000055179804,0.000054040076,0.00024172654,0.0029463868,0.000017085837,0.0002981513,0.00007211918,0.00013782702,0.0012071904],"study_design_scores_gemma":[0.00000383931,0.000030316965,0.99394625,0.00003644988,0.000035988898,0.00018066187,0.0055423616,0.00004321853,0.000016652886,0.0000149357675,0.00014560972,0.0000036590748],"about_ca_topic_score_codex":0.2230673,"about_ca_topic_score_gemma":0.310771,"teacher_disagreement_score":0.2230673,"about_ca_system_score_codex":0.0015514762,"about_ca_system_score_gemma":0.0018565826,"threshold_uncertainty_score":0.44353777},"labels":[],"label_agreement":null},{"id":"W4389513800","doi":"10.1016/j.msard.2023.105364","title":"Emboldened or not: The potential fall-out of a failed anti-EBV trial in multiple sclerosis","year":2023,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.051789653677591994,"score_gpt":0.2849057615460464,"score_spread":0.2331161078684544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389513800","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017441377,0.025487496,0.0003452775,0.103912294,0.8676454,0.000054905384,0.0001611231,0.000109973385,0.0021091532],"genre_scores_gemma":[0.0017966736,0.010002804,0.0002532963,0.09847273,0.8853927,0.00006928323,0.00004925339,0.00006368151,0.0038996416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99058354,0.0038889444,0.001531073,0.00072468584,0.0028081948,0.00046346133],"domain_scores_gemma":[0.9522301,0.03403231,0.0025701395,0.0009053343,0.0063333632,0.003928829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022289421,0.0032790205,0.0064234966,0.0020855137,0.0025372875,0.0063478905,0.005448678,0.027237702,0.0068247756],"category_scores_gemma":[0.059213653,0.0016646397,0.0036446827,0.0016236517,0.002354674,0.004078766,0.0012208709,0.034744155,0.004967057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004515655,0.000027257749,0.00007461963,0.0007556644,0.00019633405,0.0002582875,0.000022346772,0.000059027134,0.000081461396,0.0005768601,0.98705286,0.010443654],"study_design_scores_gemma":[0.0017492896,0.00036327375,0.0010585019,0.0026912568,0.0012844779,0.0006881389,0.00010091279,0.0010067604,0.00035580652,0.004517378,0.9860799,0.000104426865],"about_ca_topic_score_codex":0.002192901,"about_ca_topic_score_gemma":0.00669444,"teacher_disagreement_score":0.027237702,"about_ca_system_score_codex":0.0041132425,"about_ca_system_score_gemma":0.0035836468,"threshold_uncertainty_score":0.11787915},"labels":[],"label_agreement":null},{"id":"W4389866816","doi":"10.1016/j.msard.2023.105288","title":"Effect of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, on Patient-Reported Vitality and Mental Health in Patients with Relapsing Multiple Sclerosis in a Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Multiple sclerosis; Vitality; Internal medicine; Mental health; Tyrosine kinase; Oncology; Psychiatry; Genetics; Receptor","score_opus":0.022203950507527145,"score_gpt":0.2817896169211643,"score_spread":0.2595856664136371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389866816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910284,0.0070130522,0.00016739497,0.0006127788,0.00022455532,0.00036566347,0.00060764316,0.000060344253,0.0018457674],"genre_scores_gemma":[0.99336034,0.0026939965,0.0003546192,0.00075401785,0.00016790256,0.00053107314,0.00087228697,0.000012056367,0.0012536369],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997054,0.00014658783,0.00001568613,0.00003901521,0.000019526153,0.00007366465],"domain_scores_gemma":[0.9995677,0.00013401624,0.00007368605,0.000021646436,0.000029441622,0.00017355084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010798378,0.0010789632,0.0019488427,0.00021039361,0.0003289648,0.00078961055,0.00050526846,0.00096249627,0.0026816335],"category_scores_gemma":[0.0010737216,0.00028214595,0.0013325296,0.00027128184,0.0004894112,0.0006477102,0.0002283444,0.0031334457,0.0003560951],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8799251,0.009543523,0.0041724504,0.0012578393,0.003337521,0.00016022599,0.00016254924,0.0015428553,0.0076448545,0.00029136846,0.0036720894,0.088289686],"study_design_scores_gemma":[0.84845704,0.12498407,0.019167403,0.00013296264,0.0014925159,0.00021673793,0.0000988758,0.0013660726,0.0011036017,0.000404997,0.002535909,0.000039869432],"about_ca_topic_score_codex":0.00079025107,"about_ca_topic_score_gemma":0.002540733,"teacher_disagreement_score":0.0026816335,"about_ca_system_score_codex":0.0005244223,"about_ca_system_score_gemma":0.0005507804,"threshold_uncertainty_score":0.008970976},"labels":[],"label_agreement":null},{"id":"W4389878096","doi":"10.1016/j.msard.2023.105237","title":"Investigation of Changes in Lymphocyte Subset Counts and their Relationship with MRI Outcomes in the Magnify-MS Study","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple sclerosis; Medicine; Lymphocyte; Lymphocyte subsets; Immunology; Internal medicine; Pathology; Immune system; CD8","score_opus":0.05672076094658816,"score_gpt":0.2584236059101785,"score_spread":0.20170284496359034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389878096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992531,0.00016215393,0.000035588302,0.000034078792,0.0000041054395,0.0000040852,0.00014151857,0.0000017720012,0.00036356956],"genre_scores_gemma":[0.9995235,0.00006598228,0.0000383271,0.000016655145,0.000013185626,0.00000549925,0.00018903079,0.0000013892935,0.00014646769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997055,0.000098765704,0.0000355285,0.000060739945,0.00004686463,0.000052616346],"domain_scores_gemma":[0.99887687,0.00020197887,0.0004948511,0.00009878016,0.00012510011,0.00020236525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008252972,0.00032178854,0.0003819293,0.00060066057,0.00033829856,0.0007268819,0.00036365283,0.00043979974,0.00095436245],"category_scores_gemma":[0.0023442248,0.00017931548,0.00027911537,0.00075087085,0.0002750884,0.0005750473,0.00041052068,0.00054536184,0.00018189615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016082352,0.00007985377,0.9953928,0.000013409418,0.00012494836,0.00013031786,0.00009775783,0.000034203964,0.0005832713,0.000031947096,0.00010023771,0.0018029339],"study_design_scores_gemma":[0.00002498271,0.0003673879,0.9985341,0.000004386306,0.000068339614,0.00024243268,0.00022669173,0.00010890583,0.00016747288,0.000054783435,0.00019655484,0.0000039851943],"about_ca_topic_score_codex":0.0011192445,"about_ca_topic_score_gemma":0.0011973212,"teacher_disagreement_score":0.0011192445,"about_ca_system_score_codex":0.00018715515,"about_ca_system_score_gemma":0.0002001699,"threshold_uncertainty_score":0.0043646693},"labels":[],"label_agreement":null},{"id":"W4389883767","doi":"10.1016/j.msard.2023.105329","title":"Update on Long-Term Efficacy and Safety of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, Over 5 Years from an Ongoing Phase 2 Open-Label Extension","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tyrosine-kinase inhibitor; Bruton's tyrosine kinase; Open label; Term (time); Extension (predicate logic); Tyrosine kinase; Pharmacology; Oncology; Adverse effect; Internal medicine; Receptor; Cancer; Computer science","score_opus":0.047042485512655066,"score_gpt":0.33179932538169954,"score_spread":0.2847568398690445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389883767","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045525543,0.8899767,0.0047813444,0.02355679,0.005023155,0.00044440132,0.010529146,0.00048818038,0.019674731],"genre_scores_gemma":[0.21927978,0.66068476,0.010933636,0.05730112,0.009901257,0.0011126334,0.026613891,0.00030861772,0.013864369],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987118,0.00032812767,0.00030004568,0.000118469936,0.00043889682,0.000102670034],"domain_scores_gemma":[0.9935901,0.0030494668,0.0014463647,0.00018993157,0.001438239,0.00028593524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053048707,0.00063261273,0.002361171,0.0007596264,0.0003815321,0.0021649634,0.0014125091,0.0014327065,0.004558809],"category_scores_gemma":[0.006351227,0.0002971732,0.0021032868,0.0010080588,0.0003808567,0.0018821886,0.0005430215,0.003313695,0.001587921],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012824235,0.00047701548,0.003497405,0.0104434695,0.002112445,0.00039520508,0.00021738684,0.0008819777,0.007951813,0.0009992126,0.10583501,0.8543647],"study_design_scores_gemma":[0.008962835,0.010140417,0.0313306,0.0077830404,0.0110991215,0.0029934538,0.00020417193,0.0009958942,0.0060517834,0.002737589,0.91753924,0.00016182719],"about_ca_topic_score_codex":0.0013811574,"about_ca_topic_score_gemma":0.004318455,"teacher_disagreement_score":0.0053048707,"about_ca_system_score_codex":0.0011792077,"about_ca_system_score_gemma":0.0012666205,"threshold_uncertainty_score":0.028055191},"labels":[],"label_agreement":null},{"id":"W4389893007","doi":"10.1016/j.msard.2023.105328","title":"Design and Baseline Characteristics of Phase 3, Double-Blind, Randomised Trials Evaluating the Efficacy and Safety of Evobrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis (evolutionRMS 1 and 2)","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Internal medicine; Relapsing remitting; Clinical trial; Physical therapy; Oncology; Immunology; Fingolimod","score_opus":0.1882112032418722,"score_gpt":0.3692451553097669,"score_spread":0.18103395206789472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389893007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66534245,0.051418535,0.016892217,0.002881107,0.002847826,0.22183171,0.023215443,0.0005018375,0.0150688505],"genre_scores_gemma":[0.7070189,0.0053075105,0.013757363,0.004595829,0.00097620056,0.25580633,0.00735738,0.00010214505,0.005078418],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9854614,0.008571452,0.0018932415,0.0019974422,0.0009074292,0.0011690338],"domain_scores_gemma":[0.99104184,0.0035636676,0.0029915224,0.00076051045,0.0007532128,0.0008891951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019500384,0.003187025,0.0056648753,0.00095222355,0.0010722944,0.0018437754,0.0010812723,0.0029318877,0.012567647],"category_scores_gemma":[0.02013591,0.0011190595,0.0049237884,0.0012058722,0.002026799,0.0019641211,0.00071358756,0.0037942952,0.0016106379],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.980093,0.0016911672,0.0022710636,0.0014337722,0.0031760535,0.000039476894,0.000054669275,0.00043495191,0.0009111351,0.000417346,0.0010923897,0.008385038],"study_design_scores_gemma":[0.9266783,0.05058503,0.010292306,0.00028372687,0.00415528,0.000085160034,0.00005177068,0.0006837508,0.00069353275,0.0017166148,0.004698486,0.00007606213],"about_ca_topic_score_codex":0.00057508267,"about_ca_topic_score_gemma":0.0010079142,"teacher_disagreement_score":0.019500384,"about_ca_system_score_codex":0.0014279302,"about_ca_system_score_gemma":0.0024006034,"threshold_uncertainty_score":0.10312915},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4390084405","doi":"10.1016/j.msard.2023.105399","title":"Physical activity together for MS (PAT-MS): Secondary outcomes of a randomized controlled feasibility trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; McMaster University; University of Ottawa","funders":"","keywords":"Randomized controlled trial; Psychological intervention; Medicine; Coping (psychology); Multiple sclerosis; Clinical psychology; Context (archaeology); Caregiver burden; Physical therapy; Quality of life (healthcare); Psychiatry; Disease; Nursing; Internal medicine","score_opus":0.05611424981829161,"score_gpt":0.32623630047423813,"score_spread":0.2701220506559465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390084405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716206,0.0061676432,0.0015505158,0.0012255504,0.0009270874,0.014731353,0.0017499471,0.00014090799,0.0018863783],"genre_scores_gemma":[0.95936346,0.0029080892,0.0041432525,0.0013201194,0.0011917405,0.027344259,0.0016191131,0.00003103075,0.002078911],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948297,0.0033973868,0.00045870518,0.0005801918,0.0002845092,0.0004494876],"domain_scores_gemma":[0.9930391,0.002884041,0.0017683816,0.0006068082,0.00047584952,0.0012258084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073427083,0.002725505,0.006956638,0.0008975626,0.0011157863,0.0020313882,0.0014854055,0.004255183,0.009621985],"category_scores_gemma":[0.008648412,0.0011896975,0.0046787327,0.0012656866,0.0022779873,0.002659841,0.0015082426,0.0044277157,0.0012886537],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9913953,0.0030067714,0.00047954638,0.0005062462,0.0011777903,0.000021315995,0.000027727001,0.00009249176,0.0003154742,0.00006045868,0.00019494705,0.0027219488],"study_design_scores_gemma":[0.9713524,0.026323624,0.00090993865,0.000038764094,0.0009907518,0.0000116901965,0.000017301061,0.00009435575,0.000060580565,0.00007706985,0.00011563939,0.000008004299],"about_ca_topic_score_codex":0.0014260908,"about_ca_topic_score_gemma":0.0015848208,"teacher_disagreement_score":0.009621985,"about_ca_system_score_codex":0.0011500682,"about_ca_system_score_gemma":0.003054346,"threshold_uncertainty_score":0.038832426},"labels":[],"label_agreement":null},{"id":"W4390817041","doi":"10.1016/j.msard.2024.105444","title":"In the era of antiviral trials for MS, the answer lies in the details","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"Massachusetts General Hospital","keywords":"Multiple sclerosis; Epstein–Barr virus; Medicine; Virus; Disease; Immunology; Prodrug; Virology; Internal medicine; Pharmacology","score_opus":0.06197284138430743,"score_gpt":0.33140479392944644,"score_spread":0.269431952545139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390817041","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016206088,0.0045380984,0.00008520586,0.02988365,0.96481323,0.000014731768,0.00003155923,0.000031207237,0.00058617734],"genre_scores_gemma":[0.00018648838,0.0038569611,0.00012217432,0.02870317,0.96419996,0.000023304636,0.000015872234,0.000021699201,0.002870327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865159,0.0042574173,0.0023447494,0.0009528626,0.0054030675,0.0005259443],"domain_scores_gemma":[0.9032134,0.05991346,0.004384406,0.002304579,0.022905199,0.007279003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026832432,0.004354137,0.00784012,0.0043904204,0.0038998725,0.01120656,0.005096851,0.023248643,0.011247297],"category_scores_gemma":[0.07648934,0.001702113,0.004117204,0.0022056198,0.003661739,0.008083507,0.0015854826,0.03214103,0.010360316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112953145,0.000020375403,0.00003880506,0.00063337415,0.0000716752,0.00007473718,0.00001597031,0.00002932184,0.000045769655,0.00050725363,0.99226695,0.0061827735],"study_design_scores_gemma":[0.0003785681,0.00010679022,0.00053030316,0.0020800685,0.00038471897,0.00031387364,0.000117046206,0.0003973467,0.00015967438,0.0043480787,0.9910998,0.000083714825],"about_ca_topic_score_codex":0.0021862108,"about_ca_topic_score_gemma":0.005953036,"teacher_disagreement_score":0.026832432,"about_ca_system_score_codex":0.003708498,"about_ca_system_score_gemma":0.005398698,"threshold_uncertainty_score":0.14190513},"labels":[],"label_agreement":null},{"id":"W4390837701","doi":"10.1016/j.msard.2024.105434","title":"Predicting time to serologic diagnosis of AQP4+ NMOSD based on clinical factors and social determinants of health","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta; London Health Sciences Centre; University of Calgary; Ottawa Hospital; Health Sciences Centre; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Manitoba; University of Ottawa; University of Toronto; Western University","funders":"European Genomic Institute for Diabetes; Roche Canada","keywords":"Medicine; Serology; Neuromyelitis optica; Cohort; Ethnic group; Pediatrics; Cohort study; Spectrum disorder; Internal medicine; Demography; Multiple sclerosis; Antibody; Immunology; Psychiatry","score_opus":0.09374377842453142,"score_gpt":0.3560968428491834,"score_spread":0.262353064424652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390837701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986174,0.00015324086,0.00007824419,0.00012050621,0.00001808489,0.0000038468393,0.0001819258,0.0000036136055,0.0008231728],"genre_scores_gemma":[0.99963903,0.00004181721,0.00004288214,0.000015694424,0.000015721675,0.00000183807,0.00011430297,8.974087e-7,0.00012772862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995389,0.00018511407,0.000034735123,0.000057637288,0.00004656739,0.0001369675],"domain_scores_gemma":[0.9971474,0.0010877046,0.00080650504,0.0001123786,0.00021259027,0.0006334265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081828714,0.00030331704,0.00024923444,0.0006665422,0.00048430703,0.0006629195,0.0002902029,0.00063680485,0.003069698],"category_scores_gemma":[0.0038543546,0.00019966096,0.00070639444,0.00066592474,0.00029793943,0.0006408341,0.00039631687,0.00086591626,0.00029491156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007363614,0.000034130917,0.9993585,0.0000017014626,0.000021986447,0.000018493816,0.000013321384,0.000036783378,0.000029689023,0.000011076259,0.00003694975,0.00036379413],"study_design_scores_gemma":[0.000005385224,0.00012110234,0.998713,0.0000051702887,0.000033853634,0.00009161584,0.00016593536,0.00068463583,0.000038395745,0.000049090035,0.000088720684,0.000003050959],"about_ca_topic_score_codex":0.011373761,"about_ca_topic_score_gemma":0.009747885,"teacher_disagreement_score":0.011373761,"about_ca_system_score_codex":0.00033160913,"about_ca_system_score_gemma":0.00070024317,"threshold_uncertainty_score":0.022615135},"labels":[],"label_agreement":null},{"id":"W4391036856","doi":"10.1016/j.msard.2024.105457","title":"What is the role of diet for multiple sclerosis? Why epidemiological studies don't give the full answer","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Multiple sclerosis; Medicine; Epidemiology; Disease; Vitamin D and neurology; Immune system; Immunology; Environmental health; Gerontology; Internal medicine","score_opus":0.060783286783141495,"score_gpt":0.3166874655476032,"score_spread":0.2559041787644617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391036856","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018589739,0.009753675,0.00007367897,0.04047052,0.94929236,0.000012871578,0.000034903995,0.000028859236,0.00031440452],"genre_scores_gemma":[0.00026162982,0.006769371,0.0001150726,0.05061316,0.94024485,0.000026662376,0.000018360732,0.00002899981,0.0019218948],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847718,0.0046149553,0.0029465067,0.0014106733,0.0056223376,0.00063383],"domain_scores_gemma":[0.88085085,0.07266146,0.005011623,0.0021549265,0.032470882,0.0068502394],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029551294,0.0053034266,0.011041081,0.0056779003,0.0049998974,0.012498771,0.007481604,0.0343291,0.008187891],"category_scores_gemma":[0.08792273,0.0028186832,0.004345193,0.0030588445,0.0051590432,0.008614806,0.0027227986,0.04000836,0.008296286],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010181358,0.000019569265,0.00006869789,0.0011793653,0.00018337092,0.00009834496,0.000030895717,0.000028235047,0.00004675131,0.00045701474,0.9924286,0.005357289],"study_design_scores_gemma":[0.0007434254,0.00013284328,0.0009757308,0.0048367013,0.0012295507,0.000538932,0.00031246783,0.00055989355,0.0002073508,0.006008154,0.98431027,0.00014480624],"about_ca_topic_score_codex":0.004247478,"about_ca_topic_score_gemma":0.009230509,"teacher_disagreement_score":0.97044873,"about_ca_system_score_codex":0.0045381775,"about_ca_system_score_gemma":0.006119892,"threshold_uncertainty_score":0.1562841},"labels":[],"label_agreement":null},{"id":"W4391058228","doi":"10.1016/j.msard.2024.105454","title":"Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Saffron Plant Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Kashan University of Medical Sciences","keywords":"Medicine; Multiple sclerosis; Crocin; Double blinded; Randomized controlled trial; Clinical trial; Mental health; Physical therapy; Internal medicine; Psychiatry; Alternative medicine; Pathology; Pharmacology; Placebo","score_opus":0.03698428820916453,"score_gpt":0.30468759778925714,"score_spread":0.2677033095800926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391058228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819473,0.007264151,0.00086437346,0.00091152056,0.0010218393,0.005793049,0.0006676259,0.000114078204,0.0014160746],"genre_scores_gemma":[0.98569494,0.0037287462,0.0012576834,0.001366533,0.00087102107,0.004261675,0.000681592,0.000021859449,0.0021159507],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990421,0.00048637504,0.00007813933,0.00018305334,0.000056392542,0.00015392838],"domain_scores_gemma":[0.99836534,0.00046413438,0.0003466569,0.00014574056,0.00015927332,0.00051882374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00187875,0.0020936013,0.005914054,0.0005557535,0.0008005564,0.0011533079,0.0011125877,0.003596057,0.0077082706],"category_scores_gemma":[0.0025893138,0.0009346077,0.0026909115,0.00057450053,0.001896763,0.0014779284,0.0006252886,0.0034142665,0.000964164],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99202955,0.0026552235,0.00025611688,0.00041510232,0.00049894187,0.000017703336,0.000018327366,0.000049590944,0.001010712,0.000025760857,0.00013467096,0.002888325],"study_design_scores_gemma":[0.96688575,0.031430576,0.0007797997,0.000024670364,0.00044616376,0.000008369425,0.000014138626,0.00011195838,0.00012918348,0.000033614368,0.00012591708,0.000009789665],"about_ca_topic_score_codex":0.0011828447,"about_ca_topic_score_gemma":0.0018813325,"teacher_disagreement_score":0.0077082706,"about_ca_system_score_codex":0.0006417603,"about_ca_system_score_gemma":0.0010969442,"threshold_uncertainty_score":0.025786757},"labels":[],"label_agreement":null},{"id":"W4391289135","doi":"10.1016/j.msard.2024.105477","title":"Milk and multiple sclerosis: A possible link?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Milk Quality and Mastitis in Dairy Cows","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Immune system; Immunology; Vitamin D and neurology; Myelin oligodendrocyte glycoprotein; Myelin; Pathology; Endocrinology; Central nervous system","score_opus":0.03901879050953096,"score_gpt":0.21533598422582662,"score_spread":0.17631719371629567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391289135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8397712,0.12874267,0.0012688347,0.018241845,0.00082877994,0.000036946843,0.0005862675,0.000088630775,0.010434817],"genre_scores_gemma":[0.9698645,0.024065167,0.0007458093,0.0014467889,0.0014692104,0.000025249657,0.0001784369,0.000008301691,0.0021964845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967265,0.000104826235,0.000029428767,0.0000688607,0.000046410238,0.000077893106],"domain_scores_gemma":[0.9984535,0.000918316,0.00031168936,0.00006896858,0.00011408808,0.00013333517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070014974,0.0005864204,0.0007327596,0.0012189988,0.00048743273,0.0015546231,0.0009408843,0.002795356,0.011161863],"category_scores_gemma":[0.0028543046,0.0002984432,0.0004578461,0.0013437414,0.0011238015,0.0017817705,0.0007422213,0.0011399308,0.0006484666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011001228,0.001361361,0.84401816,0.0014959814,0.0020267447,0.027479554,0.00140762,0.00046575532,0.014089865,0.01056417,0.0041161506,0.081973456],"study_design_scores_gemma":[0.00058203016,0.0027034876,0.92783415,0.000700624,0.0016797971,0.029006196,0.00475402,0.0019147038,0.00239619,0.012155327,0.016148906,0.00012471197],"about_ca_topic_score_codex":0.0018530752,"about_ca_topic_score_gemma":0.0016804842,"teacher_disagreement_score":0.011161863,"about_ca_system_score_codex":0.00031992717,"about_ca_system_score_gemma":0.00049586507,"threshold_uncertainty_score":0.037340164},"labels":[],"label_agreement":null},{"id":"W4391430005","doi":"10.1016/j.msard.2024.105473","title":"The effect of exercise on mental health and health-related quality of life in individuals with multiple sclerosis: A Systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Medicine; Multiple sclerosis; Meta-analysis; Quality of life (healthcare); Mental health; Health related quality of life; Physical medicine and rehabilitation; Physical therapy; Psychiatry; Disease; Internal medicine; Nursing","score_opus":0.14298506852616397,"score_gpt":0.37479585313740427,"score_spread":0.2318107846112403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391430005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057273232,0.99326986,0.00026835164,0.000085390995,0.00013903233,0.00013624843,0.00021850901,0.00001534515,0.00013984203],"genre_scores_gemma":[0.13142686,0.8649889,0.0015457865,0.0006981903,0.00021907635,0.00040079915,0.00036927784,0.000020976573,0.00033018505],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963058,0.0013966751,0.0011550179,0.00051699515,0.00044238442,0.00018305336],"domain_scores_gemma":[0.992955,0.00518057,0.0010580574,0.00022505978,0.0004463503,0.00013488148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006421643,0.0025123726,0.017275784,0.003916211,0.00064604107,0.0028888518,0.001831457,0.0027654408,0.0037427135],"category_scores_gemma":[0.015859421,0.0017171099,0.030285085,0.0050629377,0.0007771641,0.0016605114,0.0019674788,0.0025015562,0.00028952252],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028118135,0.00006835242,0.003379047,0.36910683,0.60883963,0.00011609067,0.00011232316,0.00030605105,0.00032320624,0.00008548837,0.00042697537,0.014424159],"study_design_scores_gemma":[0.00078775233,0.0002015723,0.004291581,0.017423963,0.9759177,0.000054537708,0.000056911085,0.00008994106,0.00007201491,0.0000986054,0.0009797858,0.000025630365],"about_ca_topic_score_codex":0.010627012,"about_ca_topic_score_gemma":0.027058814,"teacher_disagreement_score":0.017275784,"about_ca_system_score_codex":0.0019128815,"about_ca_system_score_gemma":0.0025303073,"threshold_uncertainty_score":0.033961296},"labels":[],"label_agreement":null},{"id":"W4392202594","doi":"10.1016/j.msard.2024.105525","title":"Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Hotchkiss Brain Institute","keywords":"Medicine; Multiple sclerosis; Relapsing remitting; Domperidone; Lesion; Randomized controlled trial; Clinical trial; Expanded Disability Status Scale; Clinically isolated syndrome; Internal medicine; Oncology; Pathology; Psychiatry","score_opus":0.2042149628265359,"score_gpt":0.39370540783067104,"score_spread":0.18949044500413514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392202594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185366,0.0008612833,0.0009834536,0.00064424356,0.00042509957,0.012593802,0.0011937914,0.00009866707,0.0013458951],"genre_scores_gemma":[0.97562057,0.0007974154,0.0036403325,0.0007486032,0.0005753046,0.0153444335,0.0010013899,0.000032254262,0.0022396767],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99679923,0.0021229282,0.00017366042,0.0003601733,0.00021026943,0.00033366925],"domain_scores_gemma":[0.9946137,0.0019177923,0.0010005218,0.0005902117,0.0004934866,0.0013842694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049240924,0.002484638,0.004406535,0.0007955999,0.0010563184,0.0012051705,0.0016974556,0.0027361717,0.007884062],"category_scores_gemma":[0.005217967,0.0013820522,0.0022618705,0.00070542475,0.00251933,0.001944681,0.0011593164,0.003550852,0.0013180741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9817376,0.01290549,0.00047416912,0.00014736796,0.00030487802,0.000025753601,0.00004181789,0.00012040846,0.001353519,0.00005334418,0.00018138309,0.0026543224],"study_design_scores_gemma":[0.90142936,0.09640757,0.0013717647,0.0000081506605,0.00021070123,0.00001102228,0.000023415823,0.0001641688,0.00016347902,0.00006480855,0.00013520445,0.000010339269],"about_ca_topic_score_codex":0.0040346347,"about_ca_topic_score_gemma":0.0043063727,"teacher_disagreement_score":0.007884062,"about_ca_system_score_codex":0.0010164052,"about_ca_system_score_gemma":0.0035623075,"threshold_uncertainty_score":0.026374817},"labels":[],"label_agreement":null},{"id":"W4392302729","doi":"10.1016/j.msard.2024.105530","title":"Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Student Research Committee, Tabriz University of Medical Sciences; Tabriz University of Medical Sciences","keywords":"Medicine; Montreal Cognitive Assessment; Confounding; Cognition; Multiple sclerosis; Meta-analysis; Neuropsychology; Critical appraisal; Systematic review; Sample size determination; Bioinformatics; Clinical psychology; Internal medicine; MEDLINE; Psychiatry; Pathology; Cognitive impairment; Alternative medicine; Biology","score_opus":0.15382993898698422,"score_gpt":0.35155969091624795,"score_spread":0.19772975192926373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392302729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041823625,0.99487406,0.00027533816,0.00009169229,0.00009378296,0.00012385905,0.00023028742,0.000016892052,0.000111686546],"genre_scores_gemma":[0.12394963,0.8722064,0.0018057622,0.0006703729,0.00021506163,0.00048258982,0.0003421415,0.000019147004,0.00030891743],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99563134,0.0017307549,0.0013541209,0.00059052487,0.0004707702,0.00022252057],"domain_scores_gemma":[0.99145085,0.0058042062,0.0017567046,0.00027888405,0.0005385868,0.00017079247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008016952,0.0029026733,0.017584147,0.004516674,0.000697417,0.003227575,0.0020562606,0.002933967,0.0040637236],"category_scores_gemma":[0.019589018,0.002014046,0.025577273,0.00600581,0.0008404872,0.0020982088,0.0020898916,0.0025496266,0.00033773528],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023214186,0.00006101763,0.0043837754,0.38530973,0.5936449,0.00017486837,0.0001226288,0.00036405667,0.0002527179,0.000112008325,0.00064859865,0.012604301],"study_design_scores_gemma":[0.00093742163,0.00017218069,0.003947076,0.019042544,0.9741943,0.00008279974,0.00006380841,0.00011715675,0.000066015215,0.00013922612,0.0012079234,0.000029568635],"about_ca_topic_score_codex":0.0094478,"about_ca_topic_score_gemma":0.02655574,"teacher_disagreement_score":0.017584147,"about_ca_system_score_codex":0.0020205008,"about_ca_system_score_gemma":0.0035224962,"threshold_uncertainty_score":0.042398214},"labels":[],"label_agreement":null},{"id":"W4392545642","doi":"10.1016/j.msard.2024.105544","title":"Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background","year":2024,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Medical diagnosis; Inclusion and exclusion criteria; Intensive care medicine; Pathology; Alternative medicine","score_opus":0.045978867747604145,"score_gpt":0.2726277596016084,"score_spread":0.22664889185400425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392545642","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018201433,0.005276847,0.0009666169,0.9407653,0.0127614485,0.000034576024,0.00014896406,0.000039465973,0.021805234],"genre_scores_gemma":[0.2260689,0.0048330273,0.0037267685,0.6610425,0.092334695,0.0000880519,0.00027036943,0.00006481404,0.011570944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981153,0.00046388453,0.00035061117,0.00023285394,0.0004394849,0.00039781583],"domain_scores_gemma":[0.99429816,0.0030020317,0.0005744674,0.0002147319,0.00092644605,0.000984104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015696558,0.00051698484,0.000840504,0.0008710972,0.0027459164,0.0014829194,0.0015750756,0.02090011,0.0036479793],"category_scores_gemma":[0.014903689,0.0003855002,0.00074789824,0.0006652121,0.0018857123,0.0014634806,0.0010784756,0.011595307,0.0019996662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003125025,0.0001552223,0.029666694,0.0003734434,0.000054868233,0.350313,0.0009677258,0.00047716766,0.0020228026,0.01317786,0.55297583,0.049502857],"study_design_scores_gemma":[0.00024772724,0.00012757306,0.023022372,0.0018232071,0.000113315626,0.5379991,0.0017065961,0.0026237962,0.000971882,0.036215987,0.39501417,0.00013427553],"about_ca_topic_score_codex":0.0043269964,"about_ca_topic_score_gemma":0.010354344,"teacher_disagreement_score":0.02090011,"about_ca_system_score_codex":0.0025561275,"about_ca_system_score_gemma":0.0026857173,"threshold_uncertainty_score":0.018546104},"labels":[],"label_agreement":null},{"id":"W4392596335","doi":"10.1016/j.msard.2024.105542","title":"OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Nerve fiber layer; Subclinical infection; Multiple sclerosis; Retina; Inner plexiform layer; Ganglion; Optic nerve; Ophthalmology; Optical coherence tomography; Retinal; Optical coherence tomography angiography; Neuromyelitis optica; Ganglion cell layer; Pathology; Neuroscience; Anatomy; Immunology","score_opus":0.03709265859973692,"score_gpt":0.31035083546337,"score_spread":0.2732581768636331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392596335","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033318903,0.019292127,0.00062796305,0.06128646,0.9164225,0.000055976456,0.00007709568,0.00012001527,0.0017846803],"genre_scores_gemma":[0.0013939808,0.005957867,0.00033660379,0.034351148,0.9553776,0.000034234123,0.000025144054,0.000025980935,0.0024975745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965868,0.00061151176,0.0007511873,0.00047557752,0.001362902,0.00021199389],"domain_scores_gemma":[0.98332757,0.00933502,0.000729908,0.00039672127,0.0046270397,0.0015836853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006655217,0.0038601866,0.0045503257,0.0033423828,0.0016729723,0.004397755,0.0037706404,0.028214619,0.0024275237],"category_scores_gemma":[0.020878563,0.001701844,0.0031121667,0.000986634,0.0026867893,0.0039733,0.00097651966,0.027458197,0.0036067427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039538924,0.000075174336,0.0003447344,0.00092216436,0.00018965775,0.003384675,0.000030705836,0.00008570846,0.0004542813,0.00063239416,0.9728469,0.020638123],"study_design_scores_gemma":[0.0010342487,0.00039972778,0.0037688613,0.0025789656,0.001204249,0.01417044,0.000168497,0.0024112398,0.0015648184,0.002879137,0.96960527,0.00021446428],"about_ca_topic_score_codex":0.00181349,"about_ca_topic_score_gemma":0.0035639093,"teacher_disagreement_score":0.028214619,"about_ca_system_score_codex":0.0027499525,"about_ca_system_score_gemma":0.0013855386,"threshold_uncertainty_score":0.035196543},"labels":[],"label_agreement":null},{"id":"W4393386030","doi":"10.1016/j.msard.2024.105603","title":"Assessing multimodal emotion recognition in multiple sclerosis with a clinically accessible measure","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Carleton University; Ottawa Hospital; The Scarborough Hospital; University of Ottawa","funders":"","keywords":"Cognition; Mood; Multiple sclerosis; Social cognition; Emotion recognition; Psychology; Clinical psychology; Medicine; Developmental psychology; Psychiatry; Neuroscience","score_opus":0.114061484896842,"score_gpt":0.32434569209159947,"score_spread":0.2102842071947575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393386030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943311,0.00042985356,0.0015104369,0.00010143408,0.00003093417,0.00021068462,0.00015934507,0.000011371832,0.003214736],"genre_scores_gemma":[0.99592125,0.00023884092,0.002345177,0.00010031427,0.000042786185,0.0003090286,0.00017213782,0.0000053463223,0.0008651916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911696,0.0003941023,0.00009796631,0.0001181883,0.00019862855,0.0000740752],"domain_scores_gemma":[0.9980578,0.0007866646,0.00055434875,0.0001236517,0.00033587086,0.00014170115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016595735,0.0004072457,0.00038702905,0.00061462336,0.00036340728,0.0009484667,0.00026920927,0.0006284769,0.0022465163],"category_scores_gemma":[0.005851952,0.00010326811,0.00038313618,0.0003624655,0.00027240877,0.00067324477,0.00071390695,0.00056502625,0.0003475472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070029665,0.0028276606,0.7674118,0.00074404746,0.0009469914,0.0004916353,0.004725344,0.0008595771,0.046451777,0.0006371602,0.0023348776,0.16556606],"study_design_scores_gemma":[0.00013930327,0.0022313811,0.98985565,0.00005793914,0.00021790001,0.00036804785,0.0013957601,0.0010501079,0.0033471915,0.0004450526,0.0008495918,0.00004213346],"about_ca_topic_score_codex":0.0007470869,"about_ca_topic_score_gemma":0.0018048579,"teacher_disagreement_score":0.0022465163,"about_ca_system_score_codex":0.00033328292,"about_ca_system_score_gemma":0.00023868345,"threshold_uncertainty_score":0.008776784},"labels":[],"label_agreement":null},{"id":"W4393931160","doi":"10.1016/j.msard.2024.105599","title":"Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Public Health Agency of Canada; University of Manitoba; University of British Columbia","funders":"Hospital for Sick Children; University of Toronto; Multiple Sclerosis Society of Canada; McGill University; University of Pennsylvania","keywords":"Multiple sclerosis; Medicine; Pediatrics; Immunology","score_opus":0.032469404543208645,"score_gpt":0.269323689514796,"score_spread":0.23685428497158736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988506,0.0007765305,0.000053274205,0.000015235697,0.0000020909772,0.0000029259008,0.00013115123,0.00000219162,0.00016596472],"genre_scores_gemma":[0.99923074,0.00034576096,0.00019614349,0.000009120541,0.00000467423,0.0000051756383,0.00013978056,9.115736e-7,0.00006782909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965584,0.00014061794,0.00005047711,0.00006282181,0.000063981985,0.000026232274],"domain_scores_gemma":[0.99893266,0.00020804993,0.000671196,0.000042056527,0.00007838909,0.00006772975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059039553,0.0003124442,0.00033206787,0.0007562696,0.00022980514,0.00034883348,0.00013936059,0.00021705961,0.0008099052],"category_scores_gemma":[0.0021796944,0.0001633561,0.00023888085,0.0009662336,0.00015265403,0.0002545563,0.00027007383,0.0002510223,0.00008619795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017335695,0.000015325135,0.9982815,0.000017173224,0.00005884778,0.00002523978,0.000032369444,0.00001555859,0.00022153794,0.0000035725627,0.000015523197,0.0011401083],"study_design_scores_gemma":[0.0000034974275,0.00013998832,0.99932075,0.000006683114,0.00003337716,0.00021660693,0.000063526306,0.000037295613,0.00010549112,0.000005464059,0.00006621421,0.0000011359045],"about_ca_topic_score_codex":0.002139615,"about_ca_topic_score_gemma":0.002312195,"teacher_disagreement_score":0.002139615,"about_ca_system_score_codex":0.0001433327,"about_ca_system_score_gemma":0.00013279478,"threshold_uncertainty_score":0.004254341},"labels":[],"label_agreement":null},{"id":"W4394836657","doi":"10.1016/j.msard.2024.105625","title":"Open access publishing and the future of scientific communication","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Health Sciences Research and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Download; Publishing; Medicine; Scientific publishing; Scholarly communication; Internet privacy; World Wide Web; Library science; Computer science; Law; Political science","score_opus":0.11987495043826121,"score_gpt":0.44152962579027005,"score_spread":0.32165467535200887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394836657","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001811444,0.005320435,0.00008757621,0.029984623,0.9634396,0.000011439025,0.000023073246,0.000042650518,0.001072533],"genre_scores_gemma":[0.00019004969,0.0031627622,0.000073655174,0.0075109187,0.9862321,0.000013813842,0.000010737085,0.000019841269,0.0027861134],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9649159,0.007345156,0.0044968836,0.002070239,0.01950977,0.0016621398],"domain_scores_gemma":[0.79750574,0.101666674,0.011872609,0.005175207,0.06313744,0.020642279],"candidate_categories":["scholarly_communication","open_science"],"consensus_categories":[],"category_scores_codex":[0.035905942,0.004957404,0.0071228147,0.012913475,0.007230021,0.031288523,0.008094286,0.036589354,0.030465208],"category_scores_gemma":[0.11821369,0.002515063,0.004915366,0.0062262616,0.00845837,0.014084271,0.00457371,0.03074593,0.016488113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006283023,0.000027175787,0.00003683798,0.00082890166,0.000045296023,0.00010283625,0.000045812434,0.00004126878,0.00004544708,0.0017329836,0.98760104,0.009429624],"study_design_scores_gemma":[0.00014367161,0.000043526456,0.00021157529,0.001076314,0.000091337184,0.00017948082,0.00013574965,0.000260393,0.00005764174,0.0054237605,0.9923356,0.00004081152],"about_ca_topic_score_codex":0.0021758263,"about_ca_topic_score_gemma":0.0054193535,"teacher_disagreement_score":0.9919057,"about_ca_system_score_codex":0.008064532,"about_ca_system_score_gemma":0.010535168,"threshold_uncertainty_score":0.18989104},"labels":[],"label_agreement":null},{"id":"W4396656463","doi":"10.1016/j.msard.2024.105645","title":"Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Parkwood Institute; London Health Sciences Centre; Western University; St Joseph's Health Centre; University Health Network","funders":"Sanofi Genzyme; EMD Serono; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Cognition; Multiple sclerosis; Depression (economics); Mood; Mediation; Cognitive skill; Medicine; Clinical psychology; Effects of sleep deprivation on cognitive performance; Psychology; Psychiatry","score_opus":0.06891309897790426,"score_gpt":0.2852530187343158,"score_spread":0.21633991975641154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396656463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99857163,0.00043850474,0.00011078094,0.00018518005,0.000009804361,0.00001052323,0.00012414486,0.0000033482597,0.00054601295],"genre_scores_gemma":[0.9994073,0.00017609194,0.0001429256,0.0000349156,0.000008552642,0.000010112548,0.00009003378,9.75036e-7,0.00012916698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990941,0.00040096953,0.0000801044,0.00015965367,0.00012751337,0.00013757589],"domain_scores_gemma":[0.9949922,0.0024144733,0.0014977072,0.00032391676,0.0002987096,0.00047300084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019526567,0.00043691337,0.00035170492,0.0006801951,0.00049298996,0.0010895209,0.00057276705,0.0006025238,0.0029287962],"category_scores_gemma":[0.009568894,0.0003113259,0.0007495036,0.00056483946,0.00041947013,0.000504988,0.0010243776,0.0008549609,0.00026935045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009673755,0.00016965508,0.9956584,0.000028274093,0.00011628551,0.000046425324,0.0002632141,0.000065619846,0.000071412636,0.000042259013,0.000058943555,0.003382719],"study_design_scores_gemma":[0.000006313585,0.0001332735,0.9986278,0.000036089576,0.00006772936,0.00007881358,0.0003207473,0.0004224447,0.000046321424,0.000160601,0.000096013726,0.000003864728],"about_ca_topic_score_codex":0.0072199455,"about_ca_topic_score_gemma":0.009369406,"teacher_disagreement_score":0.0072199455,"about_ca_system_score_codex":0.0003135656,"about_ca_system_score_gemma":0.000711959,"threshold_uncertainty_score":0.014355838},"labels":[],"label_agreement":null},{"id":"W4396767444","doi":"10.1016/j.msard.2024.105643","title":"Effects of virtual reality-based rehabilitation on cognitive function and mood in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Multiple sclerosis; Medicine; Meta-analysis; Mood; Randomized controlled trial; Cognition; Rehabilitation; Physical medicine and rehabilitation; Cognitive rehabilitation therapy; Virtual reality; Physical therapy; Systematic review; MEDLINE; Clinical psychology; Psychiatry; Artificial intelligence; Internal medicine; Computer science","score_opus":0.105504400862463,"score_gpt":0.35057669958630444,"score_spread":0.24507229872384145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396767444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036577028,0.9946761,0.00048497465,0.00013284376,0.00013513329,0.0004486508,0.0002744809,0.000022243972,0.00016784812],"genre_scores_gemma":[0.1147094,0.87769127,0.0031812857,0.00078265514,0.000252191,0.0024839023,0.000613153,0.000028590815,0.0002575],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98639095,0.006975786,0.0039060966,0.0011518617,0.0012738365,0.0003014268],"domain_scores_gemma":[0.9737384,0.020056525,0.0039077965,0.0006217362,0.0014051982,0.0002703232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017088152,0.0030483839,0.022159949,0.0070007253,0.0007883046,0.0037817066,0.0026116301,0.002839214,0.003927828],"category_scores_gemma":[0.04175418,0.0016848887,0.041019075,0.0073171654,0.00088969036,0.0019060957,0.0017005606,0.002146754,0.0002726673],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026719857,0.00004611578,0.0014320405,0.5135559,0.4685829,0.000081524304,0.0000725593,0.00049233483,0.00017129908,0.0001254662,0.000364872,0.01240298],"study_design_scores_gemma":[0.0011067115,0.0003015536,0.0016875657,0.04015694,0.9551098,0.00007042066,0.000041496714,0.00016808254,0.00010854978,0.00017991706,0.0010446311,0.000024398358],"about_ca_topic_score_codex":0.0061033703,"about_ca_topic_score_gemma":0.010383061,"teacher_disagreement_score":0.022159949,"about_ca_system_score_codex":0.0032843284,"about_ca_system_score_gemma":0.004281106,"threshold_uncertainty_score":0.09037191},"labels":[],"label_agreement":null},{"id":"W4396789160","doi":"10.1016/j.msard.2024.105660","title":"Carotid intima media thickness in multiple sclerosis: A CLSA study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation; Government of Canada","keywords":"Medicine; Intima-media thickness; Multiple sclerosis; Internal medicine; Cardiology; Carotid arteries; Immunology","score_opus":0.05744580231679806,"score_gpt":0.2832099185957511,"score_spread":0.22576411627895307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396789160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815136,0.00037079662,0.00008975854,0.00006291305,0.000008478767,0.000051895473,0.0008191851,0.000005333959,0.00044020443],"genre_scores_gemma":[0.9983304,0.00019975907,0.00015514494,0.00006676494,0.000030789393,0.00005338817,0.0009179922,0.0000043517734,0.00024132984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998582,0.00034640392,0.00015519321,0.00040221532,0.00034521605,0.00016900162],"domain_scores_gemma":[0.9966775,0.0002619502,0.0007883416,0.00051015295,0.0009523122,0.00080983056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024622434,0.0011571969,0.0008304283,0.0018569768,0.0015096558,0.0011052517,0.0011730694,0.0013545016,0.0010181395],"category_scores_gemma":[0.004080515,0.0008881861,0.0008670539,0.0026031767,0.00055759726,0.00085209886,0.0015003291,0.0010568771,0.0004337506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008721628,0.00019507277,0.9949339,0.00006377226,0.00025119053,0.00031300992,0.00079075707,0.00005336325,0.00065496797,0.000036222023,0.00025395598,0.001581643],"study_design_scores_gemma":[0.00016936206,0.00027644815,0.9979679,0.00003762024,0.00016166574,0.0003518301,0.00038347914,0.000115750154,0.00006226947,0.000028203842,0.00043252693,0.000012872958],"about_ca_topic_score_codex":0.07120586,"about_ca_topic_score_gemma":0.064560056,"teacher_disagreement_score":0.07120586,"about_ca_system_score_codex":0.0009244164,"about_ca_system_score_gemma":0.0016997051,"threshold_uncertainty_score":0.14158279},"labels":[],"label_agreement":null},{"id":"W4396791055","doi":"10.1016/j.msard.2024.105631","title":"Cognitive impairment and its impact on employment: A qualitative interview-based study involving healthcare professionals and people living with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"Merck KGaA; Merck Healthcare KGaA","keywords":"Multiple sclerosis; Medicine; Health professionals; Cognition; Cognitive impairment; Qualitative research; Health care; Gerontology; Physical medicine and rehabilitation; Nursing; Psychiatry","score_opus":0.0787477139017309,"score_gpt":0.37515488283548515,"score_spread":0.29640716893375424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396791055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925685,0.0010001232,0.0013535791,0.00228266,0.00007493377,0.00030092945,0.00016802106,0.000010140381,0.0022411356],"genre_scores_gemma":[0.9945825,0.0013243972,0.00082970475,0.0012558867,0.000032271935,0.0006123433,0.000073236515,0.000011637758,0.001278043],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9922643,0.005158886,0.0003071826,0.00037745122,0.0004967409,0.001395474],"domain_scores_gemma":[0.9828941,0.0127253495,0.0011314254,0.00027394,0.0011687264,0.0018064305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011980313,0.0007332357,0.00096320274,0.0017862286,0.009078219,0.0035916017,0.0015305673,0.0022620384,0.0022223399],"category_scores_gemma":[0.016351122,0.0007869885,0.0006474772,0.0017962842,0.007786941,0.0033902023,0.0060546,0.0031416381,0.0002853065],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025294288,0.00003355144,0.0020651019,0.0001228195,0.0000033824183,0.0006354676,0.9949663,0.000016650894,0.0002803495,0.00019815155,0.00016698004,0.0014859157],"study_design_scores_gemma":[0.000003703427,0.000038266917,0.0009056704,0.000116643474,0.0000027267154,0.00015139855,0.997212,0.000025118878,0.00006863816,0.0000773451,0.0013926913,0.0000058161713],"about_ca_topic_score_codex":0.012580938,"about_ca_topic_score_gemma":0.018738713,"teacher_disagreement_score":0.012580938,"about_ca_system_score_codex":0.004983622,"about_ca_system_score_gemma":0.00576903,"threshold_uncertainty_score":0.063358665},"labels":[],"label_agreement":null},{"id":"W4396827426","doi":"10.1016/j.msard.2024.105675","title":"Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Crohn's and Colitis Canada; Multiple Sclerosis Society of Canada; Arthritis Society; Canadian Institutes of Health Research; Multiple Sclerosis Scientific Research Foundation; Bristol-Myers Squibb; Celgene; National Multiple Sclerosis Society; U.S. Department of Defense","keywords":"Multiple sclerosis; Medicine; Cognition; Quality of life (healthcare); Cognitive impairment; Association (psychology); Gerontology; Health Utilities Index; Clinical psychology; Health related quality of life; Psychiatry; Disease; Psychology; Pathology","score_opus":0.051828196535997934,"score_gpt":0.2894996284383571,"score_spread":0.23767143190235915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396827426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856657,0.00064588117,0.000024370753,0.00007251518,0.000008671116,0.0000022464592,0.000119840304,0.0000018382881,0.0005581339],"genre_scores_gemma":[0.99967706,0.00011175283,0.000022391398,0.000018326884,0.00000893377,0.0000017358885,0.00008178484,5.3572e-7,0.00007742435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999054,0.00038940425,0.00016490505,0.00008516608,0.00016439409,0.00014206624],"domain_scores_gemma":[0.99522436,0.0013245202,0.0021639417,0.00019961027,0.00041397457,0.00067354337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015167327,0.00026796755,0.00044382113,0.001376336,0.0005125991,0.0011194721,0.00042511613,0.00061665796,0.0017877477],"category_scores_gemma":[0.006999827,0.00021094299,0.0008740137,0.0017238812,0.00042474328,0.0005528951,0.0007191655,0.0008102398,0.00016337931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022568698,0.00008863823,0.99807906,0.00001579898,0.0002059107,0.00005369146,0.00008691719,0.00003939575,0.00003768361,0.000009104384,0.000038406302,0.0011196532],"study_design_scores_gemma":[0.000006134511,0.00010710451,0.99938333,0.0000068796894,0.00004994207,0.00010145191,0.00016987616,0.00008751884,0.000016554874,0.000016866072,0.000050142033,0.000004124227],"about_ca_topic_score_codex":0.00656415,"about_ca_topic_score_gemma":0.0065085664,"teacher_disagreement_score":0.00656415,"about_ca_system_score_codex":0.00037528187,"about_ca_system_score_gemma":0.00043180352,"threshold_uncertainty_score":0.0130518675},"labels":[],"label_agreement":null},{"id":"W4397292099","doi":"10.1016/j.msard.2024.105689","title":"Allied health professionals knowledge and clinical practice in telehealth exercise behavioural change for multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Perron Institute for Neurological and Translational Science; Department of Health, Government of Western Australia; Multiple Sclerosis Australia","keywords":"Multiple sclerosis; Medicine; Telehealth; Clinical Practice; Health professionals; Physical therapy; Physical medicine and rehabilitation; Telemedicine; Health care; Psychiatry","score_opus":0.162108875601603,"score_gpt":0.4109342839831743,"score_spread":0.24882540838157127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397292099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367833,0.0071432837,0.0006965895,0.029078804,0.00017643726,0.00032670354,0.00033244136,0.00003386487,0.025428582],"genre_scores_gemma":[0.9874724,0.005915239,0.0010345062,0.0039029703,0.000102216094,0.00021854149,0.00011837355,0.000005795079,0.0012298923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958775,0.0018000955,0.00041906393,0.00021073797,0.0011906758,0.0005019407],"domain_scores_gemma":[0.9796524,0.011039997,0.0043641366,0.0004270266,0.0023292273,0.0021872302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005973814,0.00013550011,0.00034366758,0.0009333253,0.00096251426,0.0015293887,0.00044235445,0.0011385867,0.008914273],"category_scores_gemma":[0.037642132,0.0002543348,0.00030767178,0.0014942803,0.0005774127,0.0012120283,0.0017642311,0.0010144206,0.0007912646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022155768,0.0009363065,0.6165549,0.0031686877,0.00009542414,0.0009821466,0.056886293,0.00031440635,0.0012086398,0.00035377647,0.009266019,0.3100119],"study_design_scores_gemma":[0.00008103944,0.0006254953,0.9406428,0.0022708662,0.00008259132,0.0012523613,0.036636997,0.00074271957,0.00023988468,0.00056958996,0.0168274,0.000028260618],"about_ca_topic_score_codex":0.013983704,"about_ca_topic_score_gemma":0.01151065,"teacher_disagreement_score":0.013983704,"about_ca_system_score_codex":0.0011667062,"about_ca_system_score_gemma":0.0033720038,"threshold_uncertainty_score":0.031592965},"labels":[],"label_agreement":null},{"id":"W4399051864","doi":"10.1016/j.msard.2024.105696","title":"Exploring the relationship between manual dexterity and cognition in people with multiple sclerosis: 9-hole peg and multiple cognitive functions","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; London Health Sciences Centre; Western University","funders":"","keywords":"Cognition; Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Psychology; Cognitive psychology; Neuroscience; Psychiatry","score_opus":0.12781204335563132,"score_gpt":0.2903082156520533,"score_spread":0.16249617229642196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399051864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908864,0.00014173472,0.00002799992,0.000045398192,0.0000044955436,0.000006404171,0.000056547527,0.0000015712006,0.0006272244],"genre_scores_gemma":[0.99935716,0.00009975183,0.00008760297,0.000026998403,0.000005588123,0.00000904762,0.000077103476,7.037774e-7,0.00033596597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952006,0.00013030093,0.0000843958,0.000069184156,0.000118882504,0.00007724383],"domain_scores_gemma":[0.9976277,0.00076235784,0.000948284,0.00012252247,0.00024163835,0.0002974562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010266824,0.0005370943,0.00046261284,0.0013184915,0.0007336124,0.0012102235,0.00046659738,0.0008349753,0.0020864548],"category_scores_gemma":[0.005536228,0.00027951083,0.0009812906,0.0012014838,0.00045357575,0.0010671827,0.0011092209,0.0010185756,0.0003085692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024583604,0.00037968173,0.9937982,0.000032960856,0.00019456394,0.000085325504,0.00058740086,0.00007242394,0.00015694422,0.000042579853,0.000054853645,0.0043492117],"study_design_scores_gemma":[0.000013656595,0.0003822621,0.9981139,0.000010621202,0.0000919067,0.00012043682,0.0007837217,0.00017642343,0.000096206866,0.00010090271,0.00010411475,0.000005879457],"about_ca_topic_score_codex":0.010308967,"about_ca_topic_score_gemma":0.015651897,"teacher_disagreement_score":0.010308967,"about_ca_system_score_codex":0.00042848446,"about_ca_system_score_gemma":0.00055821735,"threshold_uncertainty_score":0.020497978},"labels":[],"label_agreement":null},{"id":"W4399206876","doi":"10.1016/j.msard.2024.105698","title":"Can placebo-controlled phase 2 disease-modifying therapy trials in MS still be justified?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Placebo; Intensive care medicine; Phase (matter); Clinical trial; Physical therapy; Alternative medicine; Internal medicine; Psychiatry; Pathology","score_opus":0.10588300343890747,"score_gpt":0.35221963479255064,"score_spread":0.24633663135364317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399206876","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017789686,0.17740051,0.019454611,0.6868958,0.07770339,0.0040213205,0.0020630525,0.00055004685,0.014121618],"genre_scores_gemma":[0.17976251,0.07261274,0.06061811,0.6149277,0.054728016,0.007680561,0.0019708755,0.00038966048,0.007309755],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.89725304,0.07980613,0.008577039,0.0032621354,0.009122191,0.0019794835],"domain_scores_gemma":[0.5297813,0.40525803,0.020339902,0.011065681,0.02065549,0.012899618],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20854846,0.0030365167,0.012804381,0.0016186783,0.002048976,0.008934471,0.0046697105,0.02896881,0.015783243],"category_scores_gemma":[0.31944394,0.0014149676,0.006356489,0.002311434,0.008020901,0.015692495,0.002451395,0.019231912,0.003908295],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2741818,0.003450807,0.0045675323,0.02298509,0.012315167,0.0010071261,0.0011757682,0.0034619402,0.006497753,0.056238953,0.17190415,0.44221398],"study_design_scores_gemma":[0.23807134,0.029442566,0.014996582,0.032087337,0.011116116,0.00048448326,0.0015568367,0.0072202776,0.0023854151,0.16431728,0.49734685,0.0009749112],"about_ca_topic_score_codex":0.0027876163,"about_ca_topic_score_gemma":0.0043287906,"teacher_disagreement_score":0.7914516,"about_ca_system_score_codex":0.0028743248,"about_ca_system_score_gemma":0.008316923,"threshold_uncertainty_score":0.97600067},"labels":[],"label_agreement":null},{"id":"W4399849991","doi":"10.1016/j.msard.2024.105741","title":"Weak grip strength among persons with multiple sclerosis having minimal disability is not related to agility or integrity of the corticospinal tract","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec en Outaouais; Royal Ottawa Mental Health Centre; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Research and Development Corporation of Newfoundland and Labrador; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Medicine; Multiple sclerosis; Corticospinal tract; Physical medicine and rehabilitation; Grip strength; Pyramidal tracts; Structural integrity; Physical therapy; Psychiatry; Diffusion MRI; Magnetic resonance imaging","score_opus":0.05279707826570282,"score_gpt":0.2902823528825687,"score_spread":0.2374852746168659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399849991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928087,0.00020173014,0.000021150141,0.000030439476,0.000005163375,0.0000017264834,0.00004539125,0.0000011646086,0.00041236237],"genre_scores_gemma":[0.99974054,0.000051303698,0.00001306538,0.000015387719,0.000008483905,0.0000010359134,0.000047950594,4.956678e-7,0.00012180253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996712,0.00009947486,0.00003995842,0.00005895343,0.000056586166,0.00007385804],"domain_scores_gemma":[0.99844545,0.00040418585,0.000666427,0.00010036405,0.0001233994,0.00026019922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047744202,0.00035548708,0.00045481665,0.0009056385,0.00051487045,0.0005189377,0.00033385277,0.0006530446,0.0022693651],"category_scores_gemma":[0.0030201986,0.00029821225,0.00045331768,0.0007941384,0.00040954698,0.0005472505,0.00043417068,0.0005224327,0.00031605578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026675398,0.00007284682,0.9978733,0.000009615565,0.00008229741,0.000105197876,0.000094081566,0.000015026514,0.00037865675,0.000010651148,0.000028498729,0.0010631166],"study_design_scores_gemma":[0.0000029532578,0.00008039705,0.9996544,0.00000199632,0.00001640737,0.00010473599,0.000077831326,0.000015508595,0.00001670265,0.0000095411915,0.000018443416,0.0000010134935],"about_ca_topic_score_codex":0.0071507334,"about_ca_topic_score_gemma":0.00946658,"teacher_disagreement_score":0.0071507334,"about_ca_system_score_codex":0.00017309397,"about_ca_system_score_gemma":0.00021079803,"threshold_uncertainty_score":0.014218211},"labels":[],"label_agreement":null},{"id":"W4399914800","doi":"10.1016/j.msard.2024.105736","title":"DigiTRAC: Qualitative insights from knowledge users to inform the development of a Digital Toolkit for enhancing resilience among multiple sclerosis caregivers","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Kingston General Hospital; Queen's University","funders":"Social Sciences and Humanities Research Council of Canada","keywords":"Multiple sclerosis; Medicine; Resilience (materials science); Qualitative research; Psychological resilience; Knowledge management; Data science; Psychology; Psychotherapist; Psychiatry; Computer science; Sociology","score_opus":0.06006168724553255,"score_gpt":0.3100294550447945,"score_spread":0.24996776779926197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399914800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91139865,0.0012232255,0.018734474,0.025545796,0.000431577,0.0024671734,0.0009416733,0.00019037213,0.03906709],"genre_scores_gemma":[0.96981084,0.0008174928,0.015148466,0.0035985531,0.00003756359,0.0029689993,0.00016797049,0.00012134385,0.0073287436],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98273474,0.0141115,0.00049698877,0.00042027867,0.0009194669,0.0013170529],"domain_scores_gemma":[0.9377236,0.05166164,0.001313986,0.001991231,0.003997837,0.0033115903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029609714,0.000528854,0.0006850793,0.0017301447,0.010632383,0.0069692316,0.0019715324,0.0019690748,0.007759497],"category_scores_gemma":[0.049027517,0.00048810296,0.00041893264,0.0014967944,0.0075707035,0.007298918,0.012601557,0.0036618817,0.00066187157],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007467074,0.00015891655,0.0028986777,0.0006681736,0.000007699407,0.0005120094,0.9636343,0.00008210359,0.00046791212,0.004782821,0.0035199898,0.023192689],"study_design_scores_gemma":[0.000021976402,0.00007162041,0.00096225674,0.0008844075,0.000016602824,0.00015505176,0.9670209,0.00018587198,0.00039871866,0.0027015344,0.027555905,0.000025164058],"about_ca_topic_score_codex":0.009778431,"about_ca_topic_score_gemma":0.018154748,"teacher_disagreement_score":0.029609714,"about_ca_system_score_codex":0.006895964,"about_ca_system_score_gemma":0.019460568,"threshold_uncertainty_score":0.15659297},"labels":[],"label_agreement":null},{"id":"W4399926650","doi":"10.1016/j.msard.2024.105746","title":"Web scraping of user-simulated online nutrition information for people with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Multiple Sclerosis Trust; Multiple Sclerosis Australia; Multiple Sclerosis Society of Canada; Australian Government","keywords":"Multiple sclerosis; Medicine; The Internet; World Wide Web; Computer science; Immunology","score_opus":0.044057160769325796,"score_gpt":0.3289406019038564,"score_spread":0.28488344113453057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399926650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95608264,0.0015345303,0.0027675072,0.00046446756,0.000059093494,0.00076784304,0.026975553,0.0020006634,0.009347685],"genre_scores_gemma":[0.9318514,0.0013349331,0.031728182,0.00042209326,0.000049231996,0.0008673942,0.028362207,0.00027671838,0.0051079257],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99924326,0.00036786066,0.000109338376,0.00009480133,0.00014223266,0.000042535677],"domain_scores_gemma":[0.9925801,0.00586876,0.00055183127,0.00036436235,0.00045273983,0.00018218042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009358253,0.0004971253,0.00054500694,0.0025678205,0.00038278548,0.0012224359,0.00043462534,0.0007664447,0.0057203253],"category_scores_gemma":[0.0073324386,0.00018412186,0.001136792,0.0022955877,0.00023053068,0.0010760655,0.000793255,0.00027733602,0.0021854069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013993315,0.0044825096,0.40148932,0.022725163,0.0015262334,0.007007355,0.016377712,0.022635607,0.02095804,0.0029713088,0.07260303,0.41323045],"study_design_scores_gemma":[0.001812442,0.011540701,0.54929566,0.0060390774,0.003524053,0.007447688,0.017309286,0.16435361,0.024294524,0.010574216,0.2030103,0.0007984269],"about_ca_topic_score_codex":0.0043336474,"about_ca_topic_score_gemma":0.009995156,"teacher_disagreement_score":0.0057203253,"about_ca_system_score_codex":0.0005772827,"about_ca_system_score_gemma":0.00057279033,"threshold_uncertainty_score":0.01913637},"labels":[],"label_agreement":null},{"id":"W4400156306","doi":"10.1016/j.msard.2024.105749","title":"Impact of sex on clinical outcome in early Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chugai Pharmaceutical; Berlin Institute of Health; Stiftung Charité; Sanofi; Bayer HealthCare; European Commission; British Society for Immunology; Alexion Pharmaceuticals; Novartis Pharma; Novartis; Bundesministerium für Bildung und Forschung; Teva Pharmaceutical Industries; Bayer; Biogen; Arthur Arnstein Stiftung; Guthy-Jackson Charitable Foundation","keywords":"Multiple sclerosis; Medicine; Stage (stratigraphy); Pediatrics; Internal medicine; Immunology","score_opus":0.11221178175556924,"score_gpt":0.36798536385621233,"score_spread":0.2557735821006431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400156306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953745,0.0034798314,0.00013844983,0.00009789075,0.000022392473,0.0000066121424,0.00029170985,0.000005127685,0.00058344356],"genre_scores_gemma":[0.99933136,0.00033008275,0.00003665824,0.00002447094,0.000020492147,0.0000034883476,0.00013806864,0.0000028162856,0.000112521884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991805,0.00036505368,0.00006381898,0.00016442557,0.0001363076,0.000089858455],"domain_scores_gemma":[0.9942332,0.0024589358,0.002253152,0.0003320358,0.0002459277,0.0004768292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023186037,0.00034803193,0.00040388945,0.00052167906,0.0002254172,0.0006511401,0.00027922343,0.00037448722,0.002067784],"category_scores_gemma":[0.005530099,0.00011474612,0.0006239839,0.00048520343,0.00034156,0.0003411033,0.00040245435,0.0005264585,0.00022209065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085308787,0.000022561171,0.994348,0.000022987115,0.00013421205,0.00013363131,0.000038663613,0.00004749904,0.00011939766,0.000019959707,0.000045002333,0.0042150384],"study_design_scores_gemma":[0.000016527147,0.00023014653,0.9987691,0.000019675366,0.000087019595,0.0004646098,0.00003979282,0.00012434836,0.000056574692,0.00006550798,0.00012300741,0.0000036239494],"about_ca_topic_score_codex":0.0005448776,"about_ca_topic_score_gemma":0.00061572826,"teacher_disagreement_score":0.0023186037,"about_ca_system_score_codex":0.0001305504,"about_ca_system_score_gemma":0.0002062295,"threshold_uncertainty_score":0.012262106},"labels":[],"label_agreement":null},{"id":"W4400324635","doi":"10.1016/j.msard.2024.105758","title":"Depression and anxiety in MS: symptoms or comorbidity?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Comorbidity; Depression (economics); Anxiety; Multiple sclerosis; Psychiatry; Clinical psychology","score_opus":0.023569432671295663,"score_gpt":0.28552906913611664,"score_spread":0.26195963646482096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400324635","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004425537,0.028937483,0.00007220065,0.049443502,0.92088294,0.000018524703,0.000063923966,0.000024698014,0.0005125724],"genre_scores_gemma":[0.00035853032,0.007093808,0.000054377768,0.020209791,0.97094125,0.000023418119,0.000024991108,0.000012084035,0.0012817406],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98677725,0.004338446,0.0031940904,0.0011782652,0.003999679,0.000512287],"domain_scores_gemma":[0.91344506,0.057352137,0.005812381,0.001792021,0.016123515,0.0054748314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020846738,0.005387393,0.011219993,0.0069562485,0.003968606,0.009809636,0.006318022,0.030416662,0.010606911],"category_scores_gemma":[0.07952108,0.0027926737,0.0045280857,0.004328665,0.0041832784,0.007851453,0.0030844149,0.026688218,0.006167647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001601903,0.000020842612,0.00012846095,0.0015276707,0.00026424645,0.00020783512,0.000025225721,0.000024156603,0.000037430364,0.00027757333,0.98906076,0.008265526],"study_design_scores_gemma":[0.0016763434,0.00020273708,0.004141743,0.009142251,0.0025417665,0.0020480328,0.00039112242,0.00083960005,0.0001771469,0.004519381,0.97414327,0.00017654986],"about_ca_topic_score_codex":0.0045471606,"about_ca_topic_score_gemma":0.011325948,"teacher_disagreement_score":0.030416662,"about_ca_system_score_codex":0.0056569623,"about_ca_system_score_gemma":0.004731319,"threshold_uncertainty_score":0.1102494},"labels":[],"label_agreement":null},{"id":"W4400686863","doi":"10.1016/j.msard.2024.105761","title":"An analytical review on the use of artificial intelligence and machine learning in diagnosis, prediction, and risk factor analysis of multiple sclerosis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Multiple sclerosis; Artificial intelligence; Machine learning; Risk factor; Computer science; Pathology; Immunology","score_opus":0.21523875060423991,"score_gpt":0.3527226711326643,"score_spread":0.1374839205284244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400686863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038858274,0.9995202,0.000073457544,0.000109102824,0.000082144914,0.0000062426643,0.000023496023,0.0000021075773,0.00014448498],"genre_scores_gemma":[0.00021882546,0.9993236,0.00019901533,0.00010327734,0.00007086311,0.0000063510893,0.000020720932,6.11839e-7,0.000056789188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991672,0.00022398781,0.0002514638,0.00009020852,0.00023535521,0.00003180005],"domain_scores_gemma":[0.99613035,0.0029654515,0.0003130834,0.000057154844,0.0004750642,0.000058779806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020763811,0.0010431539,0.0028433774,0.005943244,0.00035114674,0.0014745487,0.0012547929,0.00108484,0.0037185275],"category_scores_gemma":[0.0051863166,0.00040498903,0.0016997295,0.006592951,0.0004940519,0.0015290312,0.00092975737,0.001529891,0.00092087017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012517993,0.000078200275,0.00032728858,0.16183586,0.0008688157,0.00017811875,0.00010382076,0.00028922144,0.0006262916,0.0027510093,0.019588236,0.813228],"study_design_scores_gemma":[0.00009635802,0.00026953954,0.0037734162,0.12667605,0.004840671,0.0013057614,0.00021710969,0.00027149302,0.0005667911,0.00394404,0.8579477,0.00009096765],"about_ca_topic_score_codex":0.0030644157,"about_ca_topic_score_gemma":0.005627292,"teacher_disagreement_score":0.005943244,"about_ca_system_score_codex":0.00082749623,"about_ca_system_score_gemma":0.0030703084,"threshold_uncertainty_score":0.012439728},"labels":[],"label_agreement":null},{"id":"W4400735818","doi":"10.1016/j.msard.2024.105759","title":"A preliminary investigation of sex differences in cognitive and fMRI changes following 28 days of cannabis abstinence","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"EGIDE; Multiple Sclerosis Society; University of Cambridge; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; Johns Hopkins University","keywords":"Abstinence; Cannabis; Medicine; Effects of cannabis; Multiple sclerosis; Cognition; Clinical psychology; Psychiatry; Cannabidiol","score_opus":0.03241972114625091,"score_gpt":0.26504211280508844,"score_spread":0.23262239165883752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400735818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999046,0.00018881007,0.000120561264,0.000013373001,0.0000051345583,0.000013747372,0.00016599798,0.0000036875706,0.0004426425],"genre_scores_gemma":[0.99862945,0.00008629559,0.00015174698,0.000016935614,0.0000076892275,0.000028062204,0.00020817707,0.0000043698064,0.00086730445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989605,0.000015166646,0.000007680938,0.00002997923,0.000028312337,0.000022756936],"domain_scores_gemma":[0.99945706,0.000118724434,0.00014175955,0.00005665093,0.00013160259,0.00009415336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025877258,0.00017944444,0.00021994625,0.0003031245,0.0002690925,0.00025877086,0.00016513187,0.00022472854,0.0027804147],"category_scores_gemma":[0.00092265656,0.00008714344,0.00015356987,0.00015598176,0.00022667565,0.00015177244,0.00018096527,0.00020730928,0.00022676472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014576984,0.00087485486,0.7666622,0.00018797314,0.00017593912,0.0011956536,0.001490588,0.000063163156,0.17704213,0.00008642927,0.00026603154,0.037378028],"study_design_scores_gemma":[0.000010179276,0.00074920926,0.9961504,0.0000028403695,0.000016740778,0.00028707038,0.00012776193,0.000040291463,0.0024155302,0.00001883854,0.00017832103,0.0000028270492],"about_ca_topic_score_codex":0.0015306809,"about_ca_topic_score_gemma":0.0030447473,"teacher_disagreement_score":0.0027804147,"about_ca_system_score_codex":0.00013759715,"about_ca_system_score_gemma":0.0002021863,"threshold_uncertainty_score":0.009301364},"labels":[],"label_agreement":null},{"id":"W4400766065","doi":"10.1016/j.msard.2024.105772","title":"Cross-prevalence of multiple sclerosis and stroke evaluated on cohorts of four independent specialty medical centers","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Multiple sclerosis; Specialty; Stroke (engine); Physical therapy; Physical medicine and rehabilitation; Family medicine; Immunology","score_opus":0.053556102475798936,"score_gpt":0.3081797112060037,"score_spread":0.25462360873020473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400766065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999265,0.000066892484,0.000027390824,0.000014246741,0.0000054667507,0.0000055552123,0.00040345584,0.000002369937,0.0002095317],"genre_scores_gemma":[0.99887925,0.000038197886,0.00002476609,0.00002729151,0.00000838977,0.000007973451,0.0007958652,0.000002965757,0.00021528288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974362,0.0006682775,0.00020513659,0.00080100505,0.00029870233,0.00059071084],"domain_scores_gemma":[0.9958216,0.00045620344,0.0014959454,0.00046825974,0.0007078419,0.0010500887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014601697,0.00080959505,0.0007684855,0.0025855114,0.0016502496,0.0016378235,0.0011072546,0.0011557087,0.0027926166],"category_scores_gemma":[0.0036780073,0.0008700179,0.0010552156,0.0024958018,0.00079891493,0.0011732789,0.002236681,0.0009689494,0.000584692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013186033,0.000029215113,0.999087,0.0000028575807,0.00012595851,0.00005167464,0.00016844041,0.000012587597,0.00017914339,0.000008308206,0.000054392447,0.00014852853],"study_design_scores_gemma":[0.0000057575876,0.000049159535,0.99939656,0.0000019482263,0.000028931028,0.00007039542,0.0003348783,0.000031782733,0.00002433534,0.000004203769,0.000049655122,0.0000023504267],"about_ca_topic_score_codex":0.049810957,"about_ca_topic_score_gemma":0.04029246,"teacher_disagreement_score":0.049810957,"about_ca_system_score_codex":0.00095002004,"about_ca_system_score_gemma":0.0009239215,"threshold_uncertainty_score":0.099042},"labels":[],"label_agreement":null},{"id":"W4401261205","doi":"10.1016/j.msard.2024.105794","title":"Mr. Machiavelli's Choice for Treatment of MOG Antibody Disease: Do the benefits of long-term corticosteroids justify the means?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Term (time); Multiple sclerosis; Intensive care medicine; Disease; Immunology; Dermatology; Pathology","score_opus":0.022044323290798095,"score_gpt":0.276277553475545,"score_spread":0.2542332301847469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401261205","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038945993,0.010625019,0.00011930482,0.07633381,0.91170424,0.00001852808,0.000031130894,0.00004452266,0.00108449],"genre_scores_gemma":[0.00041527543,0.0071730204,0.00011780873,0.053247154,0.9346836,0.0000196276,0.000016779219,0.000023279448,0.0043033427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578345,0.0010798539,0.0007256242,0.00039197053,0.0017891896,0.00022994222],"domain_scores_gemma":[0.97750777,0.012811567,0.0009655091,0.00045608854,0.0057465807,0.0025124962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008682809,0.004158842,0.0049564987,0.002852834,0.003209696,0.00552803,0.004767107,0.023595436,0.0064431066],"category_scores_gemma":[0.033735793,0.0015340829,0.0028347329,0.0015327645,0.0026471575,0.0062140794,0.0012678172,0.038070247,0.008268602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048544818,0.000014088409,0.000026063486,0.00021704468,0.000024557623,0.00015457392,0.000011739502,0.000025281843,0.000036571008,0.00029609058,0.99434304,0.004802469],"study_design_scores_gemma":[0.00017160016,0.00007580288,0.00044476957,0.00089834613,0.0001323196,0.00077743526,0.00007900426,0.00031970468,0.00014479482,0.0019445912,0.9949621,0.000049592134],"about_ca_topic_score_codex":0.0030762325,"about_ca_topic_score_gemma":0.008433082,"teacher_disagreement_score":0.023595436,"about_ca_system_score_codex":0.003305398,"about_ca_system_score_gemma":0.0027124754,"threshold_uncertainty_score":0.045919597},"labels":[],"label_agreement":null},{"id":"W4401284098","doi":"10.1016/j.msard.2024.105799","title":"Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stillwater Medical Foundation; Providence Health Care","keywords":"Melatonin; Medicine; Multiple sclerosis; Urine; Quality of life (healthcare); Internal medicine; Physiology; Endocrinology; Immunology","score_opus":0.06940536701506027,"score_gpt":0.2887385039214035,"score_spread":0.2193331369063432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401284098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988398,0.0007783249,0.000010216924,0.00005446504,0.000012372564,0.0000053437902,0.000040903724,0.000002596083,0.00025602966],"genre_scores_gemma":[0.99949074,0.00020907121,0.00003761044,0.0000349558,0.000010466817,0.0000048943148,0.00005057371,6.52164e-7,0.00016093352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983037,0.00005963191,0.00002067434,0.000024061874,0.000031913365,0.00003337988],"domain_scores_gemma":[0.9996278,0.00010596312,0.000085729334,0.000015780157,0.000046010173,0.000118783006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002966874,0.00025019678,0.00076413836,0.00013395683,0.0003747024,0.00036405365,0.00014866615,0.00039628494,0.0007938687],"category_scores_gemma":[0.0012752564,0.00012345484,0.0005798073,0.00019837041,0.000118938035,0.00021009192,0.00023797696,0.0003966839,0.00006398527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10946385,0.008674118,0.77879643,0.00048559648,0.0023971451,0.0006649535,0.00054588955,0.00055683305,0.008498447,0.00004690089,0.0007262281,0.08914363],"study_design_scores_gemma":[0.0009065567,0.0097255735,0.987194,0.000029494642,0.0007525069,0.00012683909,0.00026709348,0.00031063182,0.00043092665,0.000028599537,0.00021752644,0.0000102503955],"about_ca_topic_score_codex":0.007841252,"about_ca_topic_score_gemma":0.01153346,"teacher_disagreement_score":0.007841252,"about_ca_system_score_codex":0.00031941914,"about_ca_system_score_gemma":0.00040413364,"threshold_uncertainty_score":0.015591264},"labels":[],"label_agreement":null},{"id":"W4401344157","doi":"10.1016/j.msard.2024.105802","title":"Clinical characteristics and disease burden of African, Caribbean, and Black people with multiple sclerosis in Toronto, Canada","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"St. Michael's Hospital Foundation","keywords":"Multiple sclerosis; Medicine; Ethnic group; Disease; Caribbean region; Caribbean island; Gerontology; Immunology; Internal medicine; Latin Americans; Anthropology","score_opus":0.027578733667065702,"score_gpt":0.26870655399230087,"score_spread":0.24112782032523516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401344157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165326,0.001113373,0.000037939535,0.00042788923,0.000016951404,0.000030654395,0.0036894223,0.0000059786826,0.0030245238],"genre_scores_gemma":[0.9971917,0.0007385671,0.00005706153,0.00009854076,0.000009031477,0.00001358011,0.0009095769,0.000003268982,0.000978601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999371,0.00006614508,0.00006525544,0.00008518636,0.0001500996,0.0002623009],"domain_scores_gemma":[0.9985084,0.00007517552,0.00030455875,0.000034411427,0.00056047435,0.0005168662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003509968,0.00033500566,0.000447853,0.0017529356,0.0032411627,0.0012329961,0.0008262419,0.00041477018,0.003043066],"category_scores_gemma":[0.0015258278,0.00031154323,0.0005486978,0.004330112,0.0007104801,0.00041792387,0.00095828355,0.00069803407,0.0003303624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010606553,0.000028401813,0.99480706,0.000044611472,0.000053796575,0.0002053089,0.0016300353,0.000062729836,0.00023093275,0.00012278673,0.00089794496,0.001810336],"study_design_scores_gemma":[0.000007358691,0.000014453487,0.99651885,0.000036005084,0.000025740093,0.000114705595,0.0027004539,0.00007279014,0.000023995653,0.000019545369,0.0004565792,0.000009537795],"about_ca_topic_score_codex":0.991888,"about_ca_topic_score_gemma":0.99502903,"teacher_disagreement_score":0.014450778,"about_ca_system_score_codex":0.014450778,"about_ca_system_score_gemma":0.015697762,"threshold_uncertainty_score":0.104848266},"labels":[],"label_agreement":null},{"id":"W4401432774","doi":"10.1016/j.msard.2024.105804","title":"The association between vitamin D deficiency and multiple sclerosis: an updated systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Queensland; Cancer Australia","keywords":"Medicine; Multiple sclerosis; Meta-analysis; vitamin D deficiency; Vitamin D and neurology; Systematic review; Internal medicine; Vitamin; MEDLINE; Immunology; Biochemistry","score_opus":0.09829691247237747,"score_gpt":0.32712717454418394,"score_spread":0.22883026207180646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401432774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028082933,0.9950623,0.00045754176,0.00020092374,0.00014166496,0.00032885984,0.00080533,0.000023632227,0.00017156426],"genre_scores_gemma":[0.07367421,0.91969633,0.0027896105,0.00077181077,0.0002102992,0.0014516258,0.0010817964,0.000024867213,0.0002994955],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99066204,0.0037596445,0.0031775895,0.0008818043,0.0011698955,0.00034906613],"domain_scores_gemma":[0.9836685,0.0102959145,0.0030584452,0.00050596334,0.0022633283,0.00020786896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013776848,0.0026917027,0.019484194,0.010484331,0.0007267943,0.0032001522,0.002168444,0.002295744,0.0041459403],"category_scores_gemma":[0.036881447,0.0017557798,0.03390032,0.011622446,0.000654633,0.0021401413,0.0017585628,0.0016648268,0.00034121907],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043021,0.000025153036,0.003941817,0.58083045,0.39612952,0.00017431335,0.00010365505,0.00048381693,0.00022413698,0.00012397631,0.0011669978,0.015491915],"study_design_scores_gemma":[0.0005613514,0.00012697715,0.0043465416,0.042141993,0.9500415,0.00016342233,0.00003996931,0.0001417746,0.00009141024,0.00015704066,0.0021588604,0.000029129942],"about_ca_topic_score_codex":0.012630127,"about_ca_topic_score_gemma":0.026319794,"teacher_disagreement_score":0.019484194,"about_ca_system_score_codex":0.0036967322,"about_ca_system_score_gemma":0.006318219,"threshold_uncertainty_score":0.07285982},"labels":[],"label_agreement":null},{"id":"W4401445542","doi":"10.1016/j.msard.2024.105798","title":"Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Effects of Vibration on Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Neuroscience; Psychiatry; Psychology","score_opus":0.07077334335299279,"score_gpt":0.32056169809344953,"score_spread":0.24978835474045674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401445542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859697,0.00095697766,0.000045076606,0.00008498987,0.0000017211753,0.000015427597,0.00009067942,8.7723276e-7,0.00020741805],"genre_scores_gemma":[0.9993861,0.00034648506,0.00007212654,0.000041585143,0.000006767315,0.000019384994,0.000040210292,2.6853687e-7,0.000087106906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970645,0.00012674548,0.000026299082,0.000036654164,0.000046076104,0.000057631998],"domain_scores_gemma":[0.9995869,0.00017904954,0.00011095281,0.000010505787,0.000037173075,0.00007550098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007485724,0.0001772829,0.00047544853,0.0007943946,0.0003714391,0.00043570658,0.0001696018,0.0004616776,0.0014550423],"category_scores_gemma":[0.0011662062,0.0001424453,0.0005861997,0.00095727795,0.0002447321,0.0006203141,0.0006948241,0.00030716357,0.00008757696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027725592,0.00015670412,0.9887129,0.00015472126,0.00008702431,0.00017715614,0.0016470581,0.000031600586,0.00022675261,0.000026209349,0.00006861799,0.008434038],"study_design_scores_gemma":[0.000011249004,0.0003568077,0.99797016,0.000026297857,0.00004183468,0.00021173699,0.0011087192,0.000057697787,0.000014310748,0.000044685894,0.00015356363,0.0000029246687],"about_ca_topic_score_codex":0.0031168333,"about_ca_topic_score_gemma":0.0066759917,"teacher_disagreement_score":0.0031168333,"about_ca_system_score_codex":0.0002019836,"about_ca_system_score_gemma":0.00032220513,"threshold_uncertainty_score":0.006197393},"labels":[],"label_agreement":null},{"id":"W4401494334","doi":"10.1016/j.msard.2024.105815","title":"Comparison of SIMOA and VEUS technologies for serum neurofilament light chain measurement in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Vysoká Škola Bánská - Technická Univerzita Ostrava; Ministerstvo Zdravotnictví Ceské Republiky; Department of Clinical Neurosciences, University of Calgary; U.S. Embassy in The Czech Republic","keywords":"Multiple sclerosis; Medicine; Gold standard (test); Immunoglobulin light chain; Internal medicine; Immunology","score_opus":0.09904735862879491,"score_gpt":0.30376459555054264,"score_spread":0.20471723692174773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401494334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92025244,0.029476663,0.04294649,0.00029124704,0.00047146916,0.00033817484,0.0010873795,0.0005586525,0.0045774104],"genre_scores_gemma":[0.94119483,0.0034265951,0.05297204,0.00016002599,0.00011755635,0.00030630588,0.00059515657,0.000062848776,0.0011645408],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98961735,0.005468618,0.00045427325,0.001442544,0.0027650448,0.00025217506],"domain_scores_gemma":[0.9922087,0.003941052,0.0014006208,0.00043293028,0.0017674582,0.00024914782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008544508,0.0007995215,0.00086760893,0.0019304005,0.0002717074,0.0015737151,0.0007738493,0.00080086925,0.001330372],"category_scores_gemma":[0.011621842,0.00046905942,0.00066852424,0.0009258484,0.00052301236,0.00088166073,0.00095615676,0.00052287657,0.00048871094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027585892,0.00074662024,0.5278111,0.0027658655,0.002727918,0.00021825904,0.001767021,0.0049010594,0.09721544,0.0021187027,0.002034369,0.33010763],"study_design_scores_gemma":[0.00083323644,0.022491788,0.7320195,0.0010156247,0.0029352054,0.004408031,0.0017851221,0.08633382,0.12973136,0.0026572584,0.015408055,0.0003810674],"about_ca_topic_score_codex":0.0011622161,"about_ca_topic_score_gemma":0.0020248063,"teacher_disagreement_score":0.008544508,"about_ca_system_score_codex":0.0006104963,"about_ca_system_score_gemma":0.0005973806,"threshold_uncertainty_score":0.04518819},"labels":[],"label_agreement":null},{"id":"W4401537539","doi":"10.1016/j.msard.2024.105806","title":"Psychometric properties of the modified reaching performance scale in persons with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Universiteit Hasselt","keywords":"Multiple sclerosis; Physical medicine and rehabilitation; Scale (ratio); Medicine; Psychometrics; Stroke (engine); Physical therapy; Clinical psychology; Psychiatry; Cartography","score_opus":0.049952284528896454,"score_gpt":0.2662689274115954,"score_spread":0.21631664288269897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401537539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980653,0.0002725571,0.00019140539,0.00009473375,0.000027277098,0.000038952687,0.00013793581,0.000012104323,0.0011597595],"genre_scores_gemma":[0.9992293,0.00008914567,0.00019905523,0.000046996676,0.000015988258,0.0000365071,0.00019583912,0.0000041646895,0.00018309464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823356,0.0006210299,0.00026360713,0.00012100946,0.0006694128,0.00009138525],"domain_scores_gemma":[0.9902929,0.0050547575,0.0025353658,0.000376276,0.0010736423,0.00066699064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036927527,0.0004999345,0.00069717545,0.001057639,0.0003414828,0.00057733076,0.00044812096,0.00090662495,0.001422623],"category_scores_gemma":[0.024225013,0.00031078228,0.0014788758,0.0007205674,0.0004908871,0.000748033,0.00092037674,0.0009031826,0.00036309494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010620706,0.0004961048,0.97804534,0.000068423265,0.0004516588,0.000087959495,0.00042721294,0.0006597641,0.0006108045,0.000073681826,0.00037891368,0.017638037],"study_design_scores_gemma":[0.00007616299,0.0009817943,0.9970981,0.000023145345,0.00006510752,0.00017615549,0.00020256663,0.000977851,0.000109555,0.000084752304,0.00019222811,0.000012641255],"about_ca_topic_score_codex":0.001591304,"about_ca_topic_score_gemma":0.0014880975,"teacher_disagreement_score":0.0036927527,"about_ca_system_score_codex":0.00036762495,"about_ca_system_score_gemma":0.0003914422,"threshold_uncertainty_score":0.019529343},"labels":[],"label_agreement":null},{"id":"W4401799250","doi":"10.1016/j.msard.2024.105838","title":"Does serum neurofilament light chain measurement influence therapeutic decisions in multiple sclerosis?","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche España","keywords":"Multiple sclerosis; Medicine; Immunoglobulin light chain; Immunology; Neuroscience; Antibody","score_opus":0.06777445580225774,"score_gpt":0.2766102397854492,"score_spread":0.20883578398319144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401799250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735173,0.015198033,0.0005770921,0.004703136,0.00039503662,0.000029504075,0.00045268435,0.0000125566785,0.005114621],"genre_scores_gemma":[0.9967976,0.0015690712,0.0003233806,0.00066601177,0.0002778688,0.000011896422,0.000137774,0.0000049594973,0.00021146522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99369556,0.004310003,0.00061729935,0.00043197413,0.00058289926,0.0003622747],"domain_scores_gemma":[0.9618247,0.02673268,0.0063040024,0.0013594767,0.0025506958,0.0012284566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008644791,0.00039777774,0.0010674507,0.0008137247,0.0005955027,0.0019869192,0.0006610448,0.0016454573,0.0015973952],"category_scores_gemma":[0.04781416,0.00025866702,0.00071358384,0.0020054805,0.00083813997,0.0013489685,0.00040280822,0.0012704979,0.00041585558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016092547,0.00017203118,0.98285335,0.00008036753,0.00056161656,0.00007723837,0.00019982056,0.00009932056,0.00013012732,0.00009350515,0.0005756625,0.013547809],"study_design_scores_gemma":[0.00014378184,0.00089353445,0.99155915,0.00018850321,0.0012109223,0.00028329517,0.00072942756,0.0010875277,0.00043672844,0.00075232494,0.0026882016,0.00002661912],"about_ca_topic_score_codex":0.0047396966,"about_ca_topic_score_gemma":0.0069006584,"teacher_disagreement_score":0.008644791,"about_ca_system_score_codex":0.00058235414,"about_ca_system_score_gemma":0.0011264865,"threshold_uncertainty_score":0.04571855},"labels":[],"label_agreement":null},{"id":"W4401827972","doi":"10.1016/j.msard.2024.105833","title":"Head and neck cooling enhance exercise tolerance in individuals with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Head and neck; Physical medicine and rehabilitation; Core (optical fiber); Core temperature; Physical therapy; Internal medicine; Surgery; Psychiatry","score_opus":0.03095472140387017,"score_gpt":0.278468067140693,"score_spread":0.24751334573682282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401827972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885595,0.00046368208,0.000021729957,0.000040247265,0.000008793876,0.0000117295895,0.000021937094,0.0000016274793,0.00057430565],"genre_scores_gemma":[0.99882406,0.00024241197,0.00008805767,0.00005929829,0.000015501742,0.000016251064,0.000035330842,9.278923e-7,0.0007181827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980253,0.00009799848,0.000011778409,0.000023471437,0.00002157429,0.000042686188],"domain_scores_gemma":[0.99954224,0.00018367812,0.00011127485,0.00003093084,0.000047027537,0.00008481757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063769217,0.00031528148,0.00039651393,0.00023843392,0.0003504112,0.00036057594,0.0001665311,0.00044087032,0.0025113106],"category_scores_gemma":[0.0016005642,0.00019351038,0.00032730086,0.00017438213,0.00015651932,0.00027887573,0.00039198255,0.00034300098,0.000188526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039888546,0.013983308,0.84655046,0.000984407,0.0024449104,0.00029760288,0.00248417,0.0005557316,0.0206959,0.00012153039,0.0008976982,0.07109587],"study_design_scores_gemma":[0.00020578259,0.0038918855,0.9944423,0.00003892969,0.0003101889,0.000040463492,0.00024388998,0.00009821687,0.00043077167,0.00004787954,0.00024373281,0.000005987726],"about_ca_topic_score_codex":0.0024635436,"about_ca_topic_score_gemma":0.0053554773,"teacher_disagreement_score":0.0025113106,"about_ca_system_score_codex":0.00012104444,"about_ca_system_score_gemma":0.00016766346,"threshold_uncertainty_score":0.008401215},"labels":[],"label_agreement":null},{"id":"W4401946086","doi":"10.1016/j.msard.2024.105853","title":"The risks and benefits of using AI for diagnosis: beware of unconscious bias","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Unconscious mind; Multiple sclerosis; Psychiatry; Psychoanalysis; Psychology","score_opus":0.19861925603613798,"score_gpt":0.38231120890751324,"score_spread":0.18369195287137527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401946086","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043570093,0.015520417,0.00028129507,0.11522043,0.86762285,0.000014306418,0.000042977437,0.000039320992,0.0012148367],"genre_scores_gemma":[0.0004558007,0.0037623378,0.00016284492,0.03616067,0.9572933,0.00001890675,0.000007655558,0.000022123484,0.0021162669],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.985838,0.0038636457,0.0021373392,0.0014884224,0.0062110526,0.0004614934],"domain_scores_gemma":[0.8323371,0.12769419,0.004479042,0.003597702,0.026251886,0.005640151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018461283,0.002959719,0.005042471,0.0042514484,0.0043053566,0.0104136495,0.0058382805,0.044698827,0.008222729],"category_scores_gemma":[0.10950772,0.0018343882,0.003473256,0.0019040429,0.00796655,0.0074318643,0.0023604375,0.044151936,0.005193257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047979516,0.000010823602,0.000044209446,0.00048112284,0.00011835643,0.00018662107,0.000042903528,0.000032317374,0.000038325532,0.0013798113,0.9898941,0.0077234088],"study_design_scores_gemma":[0.00017112514,0.00004274161,0.00040718474,0.0019053722,0.00033333944,0.000711673,0.00014142707,0.0003982788,0.00016130175,0.012736022,0.98291045,0.000081120066],"about_ca_topic_score_codex":0.0023708402,"about_ca_topic_score_gemma":0.006128006,"teacher_disagreement_score":0.044698827,"about_ca_system_score_codex":0.003844081,"about_ca_system_score_gemma":0.0042559546,"threshold_uncertainty_score":0.09763378},"labels":[],"label_agreement":null},{"id":"W4402022965","doi":"10.1016/j.msard.2024.105854","title":"Physiological fitness in people with advanced multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Royal Ottawa Mental Health Centre","funders":"","keywords":"Cardiorespiratory fitness; Multiple sclerosis; Medicine; Quality of life (healthcare); Expanded Disability Status Scale; Psychological intervention; Gerontology; Physical therapy; Physical medicine and rehabilitation; Psychiatry","score_opus":0.03983157544512982,"score_gpt":0.2699278608351425,"score_spread":0.23009628539001264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402022965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687815,0.0011801284,0.000024106761,0.0001763834,0.000027168297,0.000008031163,0.00016292538,0.0000018614968,0.0015412415],"genre_scores_gemma":[0.99892753,0.00039681513,0.000024667388,0.00006858682,0.000025420894,0.000010440109,0.00012992312,6.704402e-7,0.00041595686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996873,0.00010110862,0.000039163395,0.000041926367,0.000041811054,0.00008862195],"domain_scores_gemma":[0.9993389,0.00012212317,0.00018799603,0.000026141606,0.00009644114,0.00022828605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041184595,0.00033552808,0.0005224518,0.0012364974,0.0008454621,0.0007735158,0.000230623,0.00081685325,0.0019735338],"category_scores_gemma":[0.0021454655,0.0002214259,0.0004874195,0.0013218946,0.0002552455,0.0004638835,0.00084747444,0.0008288113,0.00026250197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022901117,0.0002805572,0.9935502,0.00007292964,0.00013431926,0.00023293192,0.00064258924,0.00003539339,0.00021969689,0.000036474332,0.0001704662,0.0043954807],"study_design_scores_gemma":[0.0000052063297,0.00015658155,0.9991009,0.000013551824,0.000029392197,0.00007844597,0.00045181194,0.000025785852,0.000010280121,0.000023666402,0.000102069964,0.0000023486202],"about_ca_topic_score_codex":0.010571905,"about_ca_topic_score_gemma":0.013209111,"teacher_disagreement_score":0.010571905,"about_ca_system_score_codex":0.0002730177,"about_ca_system_score_gemma":0.00021575205,"threshold_uncertainty_score":0.02102071},"labels":[],"label_agreement":null},{"id":"W4402127373","doi":"10.1016/j.msard.2024.105865","title":"Social network characteristics and their relationships with physical activity in children with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Epilepsy Society; National Institutes of Health; Ontario Institute for Regenerative Medicine; Multiple Sclerosis Society of Canada; Hospital for Sick Children; Multiple Sclerosis Society; Biogen; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Medicine; Physical activity; Social network (sociolinguistics); Developmental psychology; Physical medicine and rehabilitation; Psychiatry; Psychology; World Wide Web","score_opus":0.04408072786230595,"score_gpt":0.26040377454005886,"score_spread":0.21632304667775293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402127373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989795,0.00026157027,0.000016074577,0.00008392072,0.0000061611186,0.0000025406234,0.00015120704,0.0000012584867,0.00049772527],"genre_scores_gemma":[0.99938834,0.00018483958,0.000031732587,0.000014965146,0.000008481821,0.000006078519,0.0001345333,0.0000011663368,0.00022982123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940073,0.00018275634,0.00006660237,0.000077285746,0.00009756704,0.00017507738],"domain_scores_gemma":[0.99627316,0.00085480564,0.0017783648,0.00010109405,0.00022035385,0.00077227684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052872655,0.00030959645,0.00033381712,0.0011722076,0.00076842913,0.00095178495,0.00041371697,0.0006129444,0.002572047],"category_scores_gemma":[0.0039742966,0.00028279956,0.000709283,0.0018089336,0.00039622016,0.0006842408,0.0008145672,0.0011516091,0.00023555857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002790875,0.00006462004,0.9989802,0.000006531455,0.000031447344,0.0000507342,0.00017329723,0.000017741624,0.000033473,0.000012802965,0.000029351393,0.0005718612],"study_design_scores_gemma":[0.0000013974018,0.000039448812,0.9990527,0.0000055808027,0.000015748668,0.000083790284,0.00067268463,0.00004160026,0.000012441219,0.000010091274,0.00006276063,0.0000018518041],"about_ca_topic_score_codex":0.02437224,"about_ca_topic_score_gemma":0.03555191,"teacher_disagreement_score":0.02437224,"about_ca_system_score_codex":0.00056029594,"about_ca_system_score_gemma":0.0005399534,"threshold_uncertainty_score":0.04846078},"labels":[],"label_agreement":null},{"id":"W4402293007","doi":"10.1016/j.msard.2024.105866","title":"Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Mental Health; National Institutes of Health; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Multiple sclerosis; Mendelian randomization; Depression (economics); Medicine; Psychiatry; Internal medicine; Clinical psychology; Genetics; Gene; Genetic variants; Genotype","score_opus":0.09936946771651545,"score_gpt":0.3235954973378941,"score_spread":0.22422602962137866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402293007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883201,0.0007306304,0.009418081,0.00027623065,0.00010752868,0.0001505359,0.00024951957,0.00008240666,0.0006649421],"genre_scores_gemma":[0.9961074,0.00006989773,0.0031424777,0.00015904728,0.000042134852,0.00009344194,0.00014158846,0.000028759243,0.0002153359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9335624,0.055131376,0.0026564053,0.0058017545,0.0018308328,0.0010172754],"domain_scores_gemma":[0.8853994,0.08647703,0.007725271,0.016953632,0.0020244187,0.0014202241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029718941,0.0022824307,0.002964896,0.0017467221,0.0013245404,0.0015471486,0.0029453575,0.0038555579,0.0060562273],"category_scores_gemma":[0.09029127,0.001224988,0.00294873,0.0016300218,0.0029445775,0.0013655196,0.0012469122,0.0014397237,0.0003925154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17659664,0.0030451112,0.70241886,0.0012717056,0.0343076,0.009305612,0.0037449475,0.0015339595,0.022593698,0.009233095,0.0020955966,0.033853106],"study_design_scores_gemma":[0.054496665,0.020718504,0.82245743,0.00029960976,0.043489467,0.01409724,0.0010385007,0.022427868,0.004540408,0.013402855,0.0025449896,0.00048658138],"about_ca_topic_score_codex":0.0018236111,"about_ca_topic_score_gemma":0.00094015035,"teacher_disagreement_score":0.029718941,"about_ca_system_score_codex":0.00037533624,"about_ca_system_score_gemma":0.00064572773,"threshold_uncertainty_score":0.15717065},"labels":[],"label_agreement":null},{"id":"W4402737724","doi":"10.1016/j.msard.2024.105905","title":"Alexithymia in radiologically isolated syndrome","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Psychosomatic Disorders and Their Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alexithymia; Multiple sclerosis; Medicine; Feeling; Clinically isolated syndrome; Clinical psychology; Psychiatry; Psychology","score_opus":0.01929018110445789,"score_gpt":0.23806913239692842,"score_spread":0.21877895129247055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402737724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782854,0.0005488506,0.00018327807,0.000058466172,0.000010123492,0.000013835723,0.000056354347,0.000012290125,0.0012881979],"genre_scores_gemma":[0.9996518,0.00011336788,0.000076449716,0.000015493917,0.000007996667,0.0000039332585,0.00005255916,0.0000010771323,0.00007728356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997733,0.0000519103,0.000035154793,0.000042327567,0.000055882618,0.000041364325],"domain_scores_gemma":[0.9995586,0.000108651904,0.00020002256,0.000017021614,0.00003558289,0.00007998122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018530189,0.0004465541,0.00035332778,0.0007086509,0.00027929692,0.00026611838,0.00018949939,0.0002981713,0.002763502],"category_scores_gemma":[0.0013377278,0.00010021201,0.00018225083,0.00043640364,0.00051620044,0.00017228811,0.0004608088,0.00029729106,0.00025913058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073671434,0.00014189324,0.9133995,0.00027442529,0.00018169411,0.033660732,0.00090459664,0.00019360062,0.02117257,0.00035348008,0.00078117166,0.028199634],"study_design_scores_gemma":[0.000032119406,0.0003935354,0.92834127,0.000042361567,0.000039323957,0.069479756,0.00024093944,0.00020201325,0.00065289077,0.0002096079,0.0003582265,0.000007989147],"about_ca_topic_score_codex":0.00091763784,"about_ca_topic_score_gemma":0.0011661057,"teacher_disagreement_score":0.002763502,"about_ca_system_score_codex":0.00023128759,"about_ca_system_score_gemma":0.00018129568,"threshold_uncertainty_score":0.009244859},"labels":[],"label_agreement":null},{"id":"W4403012968","doi":"10.1016/j.msard.2024.105916","title":"FROM BENCH TO BEDSIDE: A SNAIL IN TREACLE?","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Healthcare Systems and Challenges","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Snail; Bench to bedside; Multiple sclerosis; Medical physics; Immunology; Biology; Ecology","score_opus":0.05157816051834184,"score_gpt":0.3563943231415693,"score_spread":0.30481616262322747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403012968","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010320976,0.0038199965,0.000052053736,0.03690241,0.95864743,0.000008582892,0.00001884713,0.000024093575,0.00051629543],"genre_scores_gemma":[0.0001531183,0.002824464,0.00007026604,0.026510486,0.96771497,0.000017914346,0.000010522908,0.000018595774,0.0026797066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9827697,0.004476617,0.0021653308,0.0015829455,0.007986386,0.0010189043],"domain_scores_gemma":[0.92180663,0.038201056,0.0034818102,0.0019170569,0.023771357,0.0108220475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022518057,0.0056866133,0.0070883892,0.0068467925,0.0080944,0.020924153,0.0070410157,0.041009642,0.014539035],"category_scores_gemma":[0.07739949,0.0022047637,0.004090517,0.004045389,0.0063326564,0.013022586,0.0034831828,0.04148338,0.012206436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018814277,0.000011486041,0.00001665151,0.00023158129,0.00001898118,0.00004483525,0.00002292576,0.000011188147,0.000014767087,0.00029631707,0.99680954,0.0025029513],"study_design_scores_gemma":[0.000114424525,0.000041936753,0.00025796858,0.001685989,0.00011420245,0.00021920651,0.0002853212,0.00020052274,0.000061166305,0.002900599,0.99406564,0.00005300575],"about_ca_topic_score_codex":0.005237284,"about_ca_topic_score_gemma":0.0155907,"teacher_disagreement_score":0.041009642,"about_ca_system_score_codex":0.00597685,"about_ca_system_score_gemma":0.0104436325,"threshold_uncertainty_score":0.11908829},"labels":[],"label_agreement":null},{"id":"W4403432250","doi":"10.1016/j.msard.2024.105941","title":"New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; London Health Sciences Centre; Memorial University of Newfoundland; Western University","funders":"","keywords":"Medicine; Plasmapheresis; Multiple sclerosis; Dermatology; Pediatrics; Immunology; Antibody","score_opus":0.03988222858740705,"score_gpt":0.25247804793571266,"score_spread":0.2125958193483056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403432250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48961872,0.4449725,0.0022910668,0.03277899,0.0010691261,0.00008768367,0.0007584074,0.000026760938,0.028396754],"genre_scores_gemma":[0.8929679,0.095839515,0.0029199086,0.005397123,0.0017353682,0.000061421255,0.00030728235,0.000010106821,0.00076147896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979206,0.0010551409,0.0003136416,0.00021380954,0.00033454705,0.00016238462],"domain_scores_gemma":[0.9924649,0.005123166,0.0011270187,0.00024545423,0.00069862785,0.00034082364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003773047,0.00025696208,0.00077981886,0.0015382685,0.00034898266,0.0019723994,0.00051444955,0.00092565734,0.0021645536],"category_scores_gemma":[0.010478189,0.00018681033,0.00068699196,0.0014832112,0.0006770426,0.00168701,0.00043692542,0.0011375194,0.00014387975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024048518,0.0009697345,0.57002133,0.0015089116,0.000871469,0.001105279,0.0018574146,0.00037690063,0.0026264987,0.007636028,0.003136509,0.40748507],"study_design_scores_gemma":[0.0002679309,0.0011929881,0.947281,0.0034146337,0.0012100416,0.0028539598,0.0055330307,0.00092146633,0.0005981677,0.008107666,0.028544907,0.000074232834],"about_ca_topic_score_codex":0.006915342,"about_ca_topic_score_gemma":0.010298784,"teacher_disagreement_score":0.006915342,"about_ca_system_score_codex":0.0009401239,"about_ca_system_score_gemma":0.0019839883,"threshold_uncertainty_score":0.019954026},"labels":[],"label_agreement":null},{"id":"W4403563718","doi":"10.1016/j.msard.2024.105943","title":"Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver Hospital and Health Sciences Centre; University of Manitoba; Health Sciences Centre; Manitoba Health; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Multiple sclerosis; Association (psychology); Population; Psychiatry; Environmental health; Psychotherapist","score_opus":0.09448837981055583,"score_gpt":0.31349351624689004,"score_spread":0.2190051364363342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403563718","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006062959,0.9984218,0.00007375686,0.0002113969,0.000090897265,0.00019761661,0.00026396578,0.000005800691,0.00012854351],"genre_scores_gemma":[0.0062835934,0.99231404,0.0004957589,0.00024577905,0.000082491104,0.00034490423,0.00016597143,0.0000031504824,0.000064281274],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920008,0.0019932126,0.0036237254,0.00060281483,0.0015602439,0.00021920935],"domain_scores_gemma":[0.95999837,0.026720287,0.008858445,0.0005212916,0.0035425283,0.00035915917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008664699,0.0013695778,0.007015508,0.01992946,0.00060679443,0.0032212178,0.0015783395,0.0016703511,0.0033068703],"category_scores_gemma":[0.041890603,0.0010904834,0.0072160843,0.020870106,0.00072542176,0.0029470916,0.0016412039,0.00121104,0.00035474056],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021084199,0.000015550242,0.001761529,0.9330842,0.0057885475,0.00013387228,0.00020167323,0.00012667936,0.00017001468,0.00023670183,0.0019525602,0.056317832],"study_design_scores_gemma":[0.000176407,0.0002601759,0.010148076,0.9099659,0.05263528,0.00089473865,0.00030000944,0.00013088518,0.00015949557,0.0004568063,0.024815608,0.000056508114],"about_ca_topic_score_codex":0.00618549,"about_ca_topic_score_gemma":0.013499775,"teacher_disagreement_score":0.01992946,"about_ca_system_score_codex":0.0035179849,"about_ca_system_score_gemma":0.011222247,"threshold_uncertainty_score":0.045823872},"labels":[],"label_agreement":null},{"id":"W4404195695","doi":"10.1016/j.msard.2024.106151","title":"The multiple sclerosis gut microbiome and disease activity: A systematic review","year":2024,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Gut microbiome; Microbiome; Disease; Immunology; Gut flora; Bioinformatics; Biology; Pathology","score_opus":0.03280516436373126,"score_gpt":0.2700931285437865,"score_spread":0.2372879641800552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404195695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021312885,0.9993352,0.00003422546,0.000096280506,0.000048627586,0.000016035065,0.00016525616,0.0000022791758,0.00008885965],"genre_scores_gemma":[0.0015363343,0.99798214,0.00010326449,0.0001700105,0.000041750405,0.000021860747,0.0000916025,9.2269806e-7,0.000052087915],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9991543,0.00020878267,0.00027194683,0.00012621196,0.00018149044,0.000057240126],"domain_scores_gemma":[0.9973162,0.0018155228,0.0005354081,0.00003461171,0.00021813194,0.00008011061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001830217,0.0011498113,0.004630503,0.005632607,0.00028270468,0.0016636882,0.0012060209,0.0013512475,0.004806522],"category_scores_gemma":[0.00559594,0.00049392384,0.0033097616,0.00755402,0.00038201266,0.0014178313,0.0012533792,0.00088219147,0.0004338432],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043174508,0.000043606116,0.0011397847,0.7874347,0.009922393,0.00024387178,0.00013551934,0.00027275016,0.0005062962,0.00042974245,0.011575974,0.18786351],"study_design_scores_gemma":[0.00076159666,0.00035400616,0.015212007,0.7034902,0.11809683,0.0015474774,0.00046241152,0.00020258012,0.00036987397,0.001204447,0.15815645,0.000142036],"about_ca_topic_score_codex":0.005168192,"about_ca_topic_score_gemma":0.016762016,"teacher_disagreement_score":0.005632607,"about_ca_system_score_codex":0.0010228325,"about_ca_system_score_gemma":0.0042652967,"threshold_uncertainty_score":0.016079426},"labels":[],"label_agreement":null},{"id":"W4404412901","doi":"10.1016/j.msard.2024.106175","title":"Multiple Sclerosis and biological definitions in neurodegenerative diseases","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multiple sclerosis; Medicine; Amyotrophic lateral sclerosis; Neuroscience; Disease; Immunology; Pathology; Biology","score_opus":0.09696491196284833,"score_gpt":0.2809746982330748,"score_spread":0.18400978627022646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404412901","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30148053,0.5462372,0.016255401,0.045062598,0.0069293003,0.00021726306,0.000872412,0.00007030317,0.08287498],"genre_scores_gemma":[0.9199782,0.058590278,0.010673862,0.0038686618,0.0031394414,0.00053736125,0.0005529228,0.00003080174,0.0026284517],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9837631,0.012466553,0.0015773032,0.0005459367,0.0012810555,0.00036595366],"domain_scores_gemma":[0.96969384,0.02031147,0.0048934044,0.0014432701,0.0022208015,0.0014371066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015740087,0.00063907815,0.0009569533,0.011174817,0.002199532,0.0055285017,0.0013216838,0.0010531363,0.0022612044],"category_scores_gemma":[0.026699264,0.00020056806,0.0007342807,0.011834598,0.011936345,0.006796637,0.004247345,0.0020664837,0.00021806193],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028881512,0.0002504182,0.0570358,0.0024686863,0.00022377085,0.00040374207,0.026255714,0.0004579395,0.0009418742,0.8342965,0.007685964,0.069690645],"study_design_scores_gemma":[0.00016394012,0.0005992619,0.23818761,0.0057886615,0.00031750178,0.003364032,0.06691397,0.0007679979,0.00053887966,0.49006847,0.19315247,0.00013726257],"about_ca_topic_score_codex":0.0035338085,"about_ca_topic_score_gemma":0.0048815846,"teacher_disagreement_score":0.015740087,"about_ca_system_score_codex":0.0029617725,"about_ca_system_score_gemma":0.0040539354,"threshold_uncertainty_score":0.083242476},"labels":[],"label_agreement":null},{"id":"W4404421191","doi":"10.1016/j.msard.2024.106167","title":"Anticonvulsant and gabapentinoids pharmacotherapy in the multiple sclerosis prodrome: A population-based matched cohort study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Manitoba; Health Sciences Centre; Nova Scotia Health Authority; Dalhousie University; International Collaboration On Repair Discoveries; University of British Columbia; University of Saskatchewan","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Prodrome; Pharmacotherapy; Cohort; Cohort study; Population; Oncology; Internal medicine; Psychiatry; Environmental health","score_opus":0.0406043648057078,"score_gpt":0.2996232106483462,"score_spread":0.2590188458426384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404421191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991635,0.00019677967,0.00006558575,0.000017667591,0.000011334984,0.000015321526,0.00026528028,0.0000026789558,0.00026178244],"genre_scores_gemma":[0.999092,0.00012690808,0.000065382716,0.000035633533,0.000013514558,0.000018532206,0.00029052846,0.0000029661423,0.00035472348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994029,0.00012508019,0.000054456206,0.000227279,0.000076035765,0.00011425842],"domain_scores_gemma":[0.9993124,0.00008118465,0.00020948671,0.00014205651,0.00010307349,0.00015175882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006147408,0.00059934385,0.0006946017,0.00076054776,0.0010877635,0.0010042829,0.00051276106,0.0009692126,0.0023852068],"category_scores_gemma":[0.0013044197,0.00093562744,0.0012077574,0.0014436156,0.000345296,0.0007614198,0.00054724165,0.0011148592,0.00043852624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028878425,0.00056145247,0.9922579,0.000022373957,0.0009100264,0.00044419762,0.00016869859,0.00004045011,0.0012116357,0.000047885533,0.00018323468,0.0012642378],"study_design_scores_gemma":[0.00017699135,0.000723633,0.9974801,0.0000060021694,0.0004018809,0.00045611264,0.00029828705,0.00013954483,0.00007891166,0.000032400174,0.00019456222,0.00001151804],"about_ca_topic_score_codex":0.012806514,"about_ca_topic_score_gemma":0.0126244435,"teacher_disagreement_score":0.012806514,"about_ca_system_score_codex":0.00046810557,"about_ca_system_score_gemma":0.00055405643,"threshold_uncertainty_score":0.025463939},"labels":[],"label_agreement":null},{"id":"W4404704377","doi":"10.1016/j.msard.2024.106182","title":"Incorporation of the central vein sign into the McDonald criteria","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research; National Institutes of Health; Idorsia Pharmaceuticals; National Multiple Sclerosis Society; Horizon Therapeutics; Genentech; Multiple Sclerosis Society; Race to Erase MS; Multiple Sclerosis Society of Canada; Atara Biotherapeutics; University of California, San Francisco; MedDay Pharmaceuticals; NGM Biopharmaceuticals; TG Therapeutics; Biogen; Celgene; EMD Serono; University of Pennsylvania; Greenwich Biosciences; Alexion Pharmaceuticals; Eli Lilly and Company; U.S. Department of Defense; Sanofi; National Institute of Mental Health; Sanofi Genzyme; Patient-Centered Outcomes Research Institute; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Sign (mathematics); Multiple sclerosis; Psychiatry","score_opus":0.030716744617864514,"score_gpt":0.2739191439737593,"score_spread":0.24320239935589483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404704377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60882336,0.04795532,0.10185624,0.040623177,0.03021083,0.003050552,0.004240587,0.0014785753,0.16176142],"genre_scores_gemma":[0.83106375,0.006891235,0.14203647,0.0048963926,0.0026526442,0.00041153558,0.0022571196,0.00020191215,0.009588989],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99410796,0.0020280678,0.0019137084,0.00040271136,0.0012077524,0.00033994025],"domain_scores_gemma":[0.98586804,0.0038698947,0.0024852362,0.0009992765,0.005857259,0.0009201866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073447837,0.0008577662,0.0011677342,0.004776385,0.000812875,0.002399874,0.0012566635,0.0017336525,0.0025855312],"category_scores_gemma":[0.02974169,0.00045198353,0.0008758127,0.0018391563,0.0010667015,0.0025387784,0.0012176856,0.0026822034,0.00075001974],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002531151,0.00054094754,0.32627365,0.003368387,0.00079872494,0.01056693,0.0013223808,0.0016188038,0.043053363,0.025808744,0.040207423,0.5439095],"study_design_scores_gemma":[0.0012216481,0.004174577,0.463078,0.008490256,0.002168194,0.10856191,0.0031185644,0.010676589,0.024360651,0.024067516,0.3494153,0.00066690403],"about_ca_topic_score_codex":0.003810629,"about_ca_topic_score_gemma":0.0115515,"teacher_disagreement_score":0.0073447837,"about_ca_system_score_codex":0.0005967384,"about_ca_system_score_gemma":0.0038056893,"threshold_uncertainty_score":0.038843393},"labels":[],"label_agreement":null},{"id":"W4404768579","doi":"10.1016/j.msard.2024.106194","title":"Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis","year":2024,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Intensive care medicine; Physical medicine and rehabilitation; Psychiatry","score_opus":0.07449494065826186,"score_gpt":0.2949737730690436,"score_spread":0.22047883241078176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404768579","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031679723,0.0130989,0.0001251022,0.045271978,0.9407239,0.00001778321,0.000032343087,0.000038406313,0.00065987563],"genre_scores_gemma":[0.00024502183,0.005522,0.00008676499,0.020214511,0.97233015,0.000016192182,0.000011952536,0.000013627112,0.0015597166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98981583,0.0031726686,0.0019082462,0.0008736438,0.0037256435,0.0005039699],"domain_scores_gemma":[0.9446199,0.032823063,0.0032014349,0.0010115306,0.012530241,0.005813775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016815774,0.004204465,0.0075734016,0.0042399256,0.0038711445,0.009566567,0.0048019323,0.029773926,0.008065535],"category_scores_gemma":[0.053549834,0.001850595,0.0037896263,0.002104327,0.0035627782,0.0074124453,0.0023528186,0.033432197,0.0067369537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089808804,0.000020743533,0.000057299814,0.00066556106,0.00007241655,0.00019146006,0.000021478845,0.000029296907,0.000042723368,0.0003106459,0.989017,0.009481586],"study_design_scores_gemma":[0.0003393903,0.00012721348,0.00075719296,0.0029992464,0.00045708608,0.0010669266,0.00015356616,0.00054111925,0.00014235839,0.0027986795,0.9905301,0.00008700019],"about_ca_topic_score_codex":0.0022227871,"about_ca_topic_score_gemma":0.0070009907,"teacher_disagreement_score":0.029773926,"about_ca_system_score_codex":0.004292009,"about_ca_system_score_gemma":0.00443301,"threshold_uncertainty_score":0.08893132},"labels":[],"label_agreement":null},{"id":"W4405350116","doi":"10.1016/j.msard.2024.105975","title":"14. An Algorithm for Assessment and Correction of Walking in Patients with Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Algorithm; Physical therapy; Immunology; Computer science","score_opus":0.034792556029690794,"score_gpt":0.2855962218951882,"score_spread":0.2508036658654974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405350116","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09664134,0.0028615752,0.7017882,0.016437244,0.0023652515,0.012886623,0.057586968,0.04763349,0.061799362],"genre_scores_gemma":[0.112786755,0.0004416361,0.86165607,0.0008316536,0.00013256918,0.0038207518,0.01093951,0.00055572507,0.008835292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874204,0.00019529331,0.0003632748,0.00022900836,0.00032510835,0.00014528919],"domain_scores_gemma":[0.99724305,0.00048972416,0.00028102694,0.00010113487,0.0017278013,0.00015720102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015723692,0.0013847247,0.0009844778,0.0033812195,0.0010065741,0.0019229997,0.0018930385,0.0019958073,0.016011724],"category_scores_gemma":[0.008126376,0.000518531,0.0015265608,0.0011978004,0.00030483902,0.0011002901,0.0012737827,0.0014367336,0.011308149],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011677676,0.0005105624,0.09885942,0.00046333848,0.00024383169,0.00073028816,0.00033906294,0.007988452,0.0019447627,0.0033189899,0.16582607,0.71860737],"study_design_scores_gemma":[0.0027875525,0.0014869861,0.31720537,0.0033686233,0.0013985063,0.006860486,0.0016418627,0.33763573,0.028136857,0.030909566,0.26790243,0.0006660279],"about_ca_topic_score_codex":0.015400255,"about_ca_topic_score_gemma":0.019600078,"teacher_disagreement_score":0.016011724,"about_ca_system_score_codex":0.0013856606,"about_ca_system_score_gemma":0.002582553,"threshold_uncertainty_score":0.05356455},"labels":[],"label_agreement":null},{"id":"W4405364891","doi":"10.1016/j.msard.2024.106123","title":"162. Long-term Effectiveness of Cladribine Tablets over 4 years in Relapsing Multiple Sclerosis: Results from the MAGNIFY-MS Extension Study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Term (time); Dermatology; Internal medicine; Immunology","score_opus":0.044570029649524924,"score_gpt":0.28541333648339096,"score_spread":0.24084330683386604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946779,0.0033787964,0.0000743091,0.00008252099,0.000058726295,0.00015005526,0.0008629704,0.000017583881,0.00069711905],"genre_scores_gemma":[0.99640167,0.0009085088,0.00014203352,0.00017187597,0.00013264509,0.00013501305,0.0010145548,0.000004920679,0.0010887466],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991763,0.00039480004,0.00008370559,0.00012381958,0.00010902286,0.00011226638],"domain_scores_gemma":[0.9977678,0.0006675956,0.00072697527,0.00026088153,0.00016752415,0.0004092312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020995971,0.0006361436,0.0019309408,0.00042777884,0.00042873883,0.00061682577,0.00055016304,0.0013842066,0.0018582676],"category_scores_gemma":[0.0025426066,0.00037134066,0.001936336,0.00044162196,0.00039220665,0.0008370732,0.0002631091,0.0011491161,0.00057263253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8693758,0.010924732,0.041318152,0.0008698728,0.003897585,0.00022465187,0.00024125684,0.0007652524,0.010901383,0.00006261125,0.00092597044,0.06049286],"study_design_scores_gemma":[0.22608915,0.25408435,0.50823647,0.00015331361,0.0057720244,0.0002817646,0.00014202199,0.00078850554,0.002587861,0.000076074946,0.0016972043,0.00009122388],"about_ca_topic_score_codex":0.002111806,"about_ca_topic_score_gemma":0.0025080792,"teacher_disagreement_score":0.002111806,"about_ca_system_score_codex":0.0003808106,"about_ca_system_score_gemma":0.00048760025,"threshold_uncertainty_score":0.0111038685},"labels":[],"label_agreement":null},{"id":"W4405364903","doi":"10.1016/j.msard.2024.106137","title":"176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ocrelizumab; Multiple sclerosis; Pregnancy; Obstetrics; Pediatrics; Internal medicine; Immunology","score_opus":0.03299971466051489,"score_gpt":0.26735213029988897,"score_spread":0.2343524156393741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904259,0.0039846064,0.000111275236,0.000151786,0.000022081604,0.000022826001,0.004607142,0.000004742093,0.00066964416],"genre_scores_gemma":[0.99265856,0.0017942531,0.00032785712,0.00019468587,0.000042880874,0.00006452948,0.00415785,0.0000051197835,0.0007544066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990896,0.00031880432,0.00019173398,0.00013347331,0.00015985224,0.00010657659],"domain_scores_gemma":[0.996521,0.0010040402,0.0018800726,0.00020612053,0.00019423247,0.00019452888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016021347,0.00023630225,0.0003575861,0.0014131208,0.0003131844,0.00047833374,0.0004325665,0.00041914536,0.00087725336],"category_scores_gemma":[0.0049437736,0.0003056495,0.0013286296,0.0026474318,0.00015153168,0.00038216801,0.00041353444,0.00039241902,0.00019905668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022767087,0.000015360465,0.9968636,0.00004486604,0.00040906863,0.00007588309,0.00003837175,0.00003574267,0.0000638586,0.00001289569,0.00021444417,0.0019981123],"study_design_scores_gemma":[0.000024189636,0.00009889953,0.9987943,0.00002794406,0.00031378452,0.00012524136,0.00008688787,0.0000631725,0.00005018039,0.000008880304,0.00040275615,0.0000036011304],"about_ca_topic_score_codex":0.017246082,"about_ca_topic_score_gemma":0.028033137,"teacher_disagreement_score":0.017246082,"about_ca_system_score_codex":0.00046108323,"about_ca_system_score_gemma":0.0005681079,"threshold_uncertainty_score":0.034291387},"labels":[],"label_agreement":null},{"id":"W4405364924","doi":"10.1016/j.msard.2024.106115","title":"154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Phase (matter); Internal medicine; Oncology; Fingolimod; Immunology","score_opus":0.06294736156404931,"score_gpt":0.3237788504028992,"score_spread":0.2608314888388499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81060946,0.09910923,0.0016759167,0.017176285,0.0046473704,0.0025749947,0.017424844,0.0009894294,0.045792583],"genre_scores_gemma":[0.9307421,0.01856436,0.002594156,0.015419342,0.0023460733,0.0015119272,0.0100208195,0.00012569875,0.018675655],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996081,0.00016001194,0.000041546766,0.000064286935,0.00004458295,0.0000814857],"domain_scores_gemma":[0.9993487,0.0002349875,0.00017025514,0.000042365307,0.000050340477,0.00015335353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009682623,0.0006458413,0.0018463535,0.00034351592,0.0004392756,0.0009733416,0.00058858213,0.002061927,0.01166311],"category_scores_gemma":[0.0014455651,0.00030635082,0.0017221605,0.00040442115,0.00039226012,0.00085561204,0.00020349001,0.00293146,0.0028168943],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6114706,0.004075226,0.0029303664,0.0028057557,0.004061338,0.00020526287,0.00008703985,0.0008980815,0.017750036,0.00073022285,0.03126114,0.32372504],"study_design_scores_gemma":[0.842979,0.095107414,0.025049342,0.0005523739,0.0042267283,0.00037240004,0.0000746153,0.0010329289,0.004501415,0.00123097,0.024787044,0.00008571656],"about_ca_topic_score_codex":0.001152352,"about_ca_topic_score_gemma":0.004344275,"teacher_disagreement_score":0.01166311,"about_ca_system_score_codex":0.00085512944,"about_ca_system_score_gemma":0.0007208453,"threshold_uncertainty_score":0.039016962},"labels":[],"label_agreement":null},{"id":"W4405364934","doi":"10.1016/j.msard.2024.106114","title":"153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple sclerosis; Medicine; Placebo; Relapsing remitting; Internal medicine; Pathology; Immunology; Alternative medicine","score_opus":0.03891098586633257,"score_gpt":0.2788187953834719,"score_spread":0.2399078095171393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92356765,0.036479075,0.0011428179,0.005885236,0.0023362848,0.0023020557,0.008572115,0.0007782141,0.018936634],"genre_scores_gemma":[0.9708354,0.005761913,0.0011425115,0.006509996,0.0010589156,0.0015029967,0.00428958,0.000075718905,0.008822926],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994854,0.000249435,0.0000355447,0.000080535305,0.00003923473,0.000109885405],"domain_scores_gemma":[0.9993581,0.00023470975,0.00013889895,0.000051856834,0.000047218215,0.00016922624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011958652,0.0010637768,0.0024635342,0.00033131434,0.0005022975,0.0011497879,0.00071033416,0.0023275188,0.010962855],"category_scores_gemma":[0.0015251624,0.00037867686,0.0020633698,0.00036321263,0.00073082926,0.0011201933,0.00025211653,0.0037300063,0.0027809711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90870386,0.0030422786,0.00094857346,0.0011473302,0.0020871344,0.00012068105,0.000059926395,0.00044397413,0.0051863627,0.0002758289,0.0071160453,0.07086805],"study_design_scores_gemma":[0.9459932,0.044895783,0.0047011073,0.000102243124,0.00085307733,0.00009087779,0.000031164644,0.00033835013,0.0006392859,0.00035026603,0.001980847,0.000023650253],"about_ca_topic_score_codex":0.0009317487,"about_ca_topic_score_gemma":0.0024585275,"teacher_disagreement_score":0.010962855,"about_ca_system_score_codex":0.0006121496,"about_ca_system_score_gemma":0.0005907191,"threshold_uncertainty_score":0.03667438},"labels":[],"label_agreement":null},{"id":"W4405364984","doi":"10.1016/j.msard.2024.106120","title":"159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Pediatrics; Physical therapy; Internal medicine; Immunology","score_opus":0.02897219515397852,"score_gpt":0.24743764614453437,"score_spread":0.21846545099055584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586856,0.00050148333,0.00003351314,0.00014689207,0.000023620449,0.00026943325,0.0020373648,0.000012470984,0.0011066671],"genre_scores_gemma":[0.996367,0.0004785752,0.00021118205,0.00019086369,0.000022366006,0.00033708452,0.0015082298,0.0000024288108,0.00088223047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936885,0.0003116189,0.00008282529,0.00005078144,0.000077404315,0.000108514585],"domain_scores_gemma":[0.9974226,0.0007279331,0.0009381822,0.00009111059,0.0003064736,0.0005137021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298035,0.00024427893,0.00056676305,0.000603025,0.0005284227,0.00056985737,0.00047557201,0.0007252849,0.0026160532],"category_scores_gemma":[0.0035069694,0.00023396222,0.0009603364,0.00086578185,0.00017985386,0.0005192791,0.00066384376,0.00044414026,0.00053125643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022226,0.005148287,0.8487427,0.0012412288,0.00064241095,0.00030992064,0.0012646649,0.00032572664,0.0020165325,0.000037776572,0.0017673286,0.116277434],"study_design_scores_gemma":[0.0009559361,0.0038912818,0.99365765,0.000060992003,0.00027138583,0.000059602986,0.00037054866,0.000084946,0.00020245263,0.000009448819,0.00042437168,0.000011359851],"about_ca_topic_score_codex":0.009943941,"about_ca_topic_score_gemma":0.013009532,"teacher_disagreement_score":0.009943941,"about_ca_system_score_codex":0.0004934126,"about_ca_system_score_gemma":0.0007601854,"threshold_uncertainty_score":0.019772112},"labels":[],"label_agreement":null},{"id":"W4405364989","doi":"10.1016/j.msard.2024.106117","title":"156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Immune system; Immunology; Neuroscience; Biology","score_opus":0.029046992068251305,"score_gpt":0.26654000800382216,"score_spread":0.23749301593557084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405364989","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29363805,0.123941705,0.007988201,0.110490724,0.023425568,0.00066235434,0.006824077,0.0011805005,0.43184876],"genre_scores_gemma":[0.74441034,0.034640823,0.009544274,0.037462994,0.007911921,0.00031166803,0.0030621763,0.0001534503,0.16250236],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99957186,0.00008566684,0.000055728535,0.0000559933,0.00015800272,0.0000727396],"domain_scores_gemma":[0.99931395,0.0001917891,0.0001627246,0.00006640885,0.00017264798,0.00009248031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010685531,0.00020380807,0.0002989803,0.0002915971,0.00035419973,0.0008895403,0.00048572404,0.0015980653,0.014531201],"category_scores_gemma":[0.0019365352,0.00010476503,0.00045743145,0.00015363855,0.00026692008,0.00040652035,0.00025317207,0.0011715267,0.00361245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008928707,0.0010954258,0.0039189686,0.001247724,0.00030942017,0.0012955015,0.00018785035,0.0005582754,0.1909571,0.024039019,0.14798771,0.61947435],"study_design_scores_gemma":[0.00611885,0.010199148,0.03064872,0.00080567034,0.0008055297,0.004608202,0.00014533056,0.0011633255,0.101782896,0.008914603,0.83469635,0.00011141808],"about_ca_topic_score_codex":0.0011211113,"about_ca_topic_score_gemma":0.0035850843,"teacher_disagreement_score":0.014531201,"about_ca_system_score_codex":0.0006425854,"about_ca_system_score_gemma":0.000980465,"threshold_uncertainty_score":0.0486117},"labels":[],"label_agreement":null},{"id":"W4405365057","doi":"10.1016/j.msard.2024.106121","title":"160. Low Rate of Progression Independent of Relapse Activity (PIRA) in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal","funders":"","keywords":"Cladribine; Medicine; Multiple sclerosis; Relapsing remitting; Internal medicine; Oncology; Immunology","score_opus":0.023856342820409163,"score_gpt":0.25097005933029176,"score_spread":0.2271137165098826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405365057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946542,0.0016587039,0.00013665996,0.0000537882,0.000025945641,0.000033636243,0.00048525567,0.00001415081,0.0029376019],"genre_scores_gemma":[0.99875355,0.00018355962,0.0000716623,0.00003812819,0.00002326164,0.000013815254,0.00038729215,0.000003473358,0.0005252988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996729,0.0001409032,0.00003712253,0.000049941347,0.00006226121,0.000036839927],"domain_scores_gemma":[0.9977316,0.0010176665,0.0006341305,0.00022261048,0.00018459353,0.00020940401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011876746,0.0001727932,0.00041402396,0.00035227503,0.00020838816,0.00040128626,0.0001652267,0.0004384669,0.0025780727],"category_scores_gemma":[0.00363842,0.00010212052,0.000462928,0.00027997544,0.00013615443,0.00036553442,0.00014788569,0.00041424346,0.00059884426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03219138,0.0006507711,0.90100247,0.00046315198,0.0005400423,0.0006662959,0.00032708442,0.00018644896,0.011273614,0.00018746668,0.0007544072,0.051756855],"study_design_scores_gemma":[0.00027622172,0.0033543564,0.9940759,0.000016500471,0.00022413017,0.0005159541,0.00004113629,0.00021405544,0.0006047701,0.000039783525,0.0006286312,0.0000084439625],"about_ca_topic_score_codex":0.0009374406,"about_ca_topic_score_gemma":0.00091477495,"teacher_disagreement_score":0.0025780727,"about_ca_system_score_codex":0.00014368288,"about_ca_system_score_gemma":0.00019817929,"threshold_uncertainty_score":0.008624554},"labels":[],"label_agreement":null},{"id":"W4405365084","doi":"10.1016/j.msard.2024.106138","title":"177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Open label; Disease; Extension (predicate logic); Relapsing remitting; Clinical trial; Physical medicine and rehabilitation; Internal medicine; Immunology","score_opus":0.06102225189578062,"score_gpt":0.3068371326029154,"score_spread":0.24581488070713478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405365084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7934023,0.09098871,0.0022490514,0.02245528,0.00593071,0.004313402,0.0216453,0.00095562806,0.058059543],"genre_scores_gemma":[0.9135703,0.018900724,0.0037337164,0.017981064,0.0024053075,0.0039166906,0.01536623,0.00019423143,0.02393175],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99956423,0.00015716249,0.000031921063,0.000063080915,0.000066607485,0.00011697996],"domain_scores_gemma":[0.9993801,0.00016199214,0.000106143765,0.000053786578,0.000087152,0.0002107437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164712,0.0009357535,0.0022674892,0.0003814897,0.0006214745,0.0015255611,0.0008503607,0.0023211131,0.012088637],"category_scores_gemma":[0.0014837126,0.00034397308,0.0026048785,0.00041675582,0.0007329181,0.0012369137,0.0003554471,0.0039009412,0.0035478466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59876525,0.0046352395,0.002381914,0.0028673308,0.0041865017,0.00032001044,0.00015564876,0.0010416883,0.011678857,0.0020236752,0.04445239,0.32749155],"study_design_scores_gemma":[0.89679366,0.052941483,0.0118162,0.0005148926,0.0021380635,0.00039588616,0.00009792591,0.0006584013,0.0024159588,0.002013401,0.030125484,0.00008866381],"about_ca_topic_score_codex":0.0016517414,"about_ca_topic_score_gemma":0.0050911354,"teacher_disagreement_score":0.012088637,"about_ca_system_score_codex":0.0010458685,"about_ca_system_score_gemma":0.0011216919,"threshold_uncertainty_score":0.0404405},"labels":[],"label_agreement":null},{"id":"W4405663833","doi":"10.1016/j.msard.2024.106245","title":"Not for everyone: Factors influencing who receives psychotherapy in people with multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Multiple sclerosis; Medicine; Psychotherapist; Psychiatry; Psychology","score_opus":0.04155354934755087,"score_gpt":0.2807413214089716,"score_spread":0.23918777206142075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405663833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881026,0.0018691624,0.00004848349,0.0047639166,0.00009950282,0.000027417138,0.0001093102,0.0000037578372,0.004975727],"genre_scores_gemma":[0.9981179,0.0005097563,0.000091271635,0.00084229646,0.00005538941,0.000013238652,0.00003123446,0.000003107946,0.0003355999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959508,0.001974134,0.00044643265,0.00026807448,0.0005822016,0.00077837],"domain_scores_gemma":[0.98607534,0.0046413075,0.0050370446,0.00032381315,0.00095913484,0.0029634747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022906458,0.00016631195,0.00061933463,0.0007849057,0.003424067,0.0019190967,0.0005422085,0.0015373827,0.0040840358],"category_scores_gemma":[0.01973391,0.00028443034,0.00085245335,0.0014423528,0.00075868703,0.001444892,0.0010920729,0.0029650133,0.00026750145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024130949,0.00058761874,0.9813089,0.00013617796,0.0002508499,0.000272173,0.005563879,0.00004013242,0.00012017134,0.00022865317,0.00096037146,0.010289869],"study_design_scores_gemma":[0.000043766086,0.00023328305,0.9734169,0.00030009693,0.00025789643,0.00052272837,0.022944938,0.0001454638,0.00006247888,0.00034292185,0.0017082774,0.000021373138],"about_ca_topic_score_codex":0.021274827,"about_ca_topic_score_gemma":0.03697101,"teacher_disagreement_score":0.021274827,"about_ca_system_score_codex":0.0015299625,"about_ca_system_score_gemma":0.003955736,"threshold_uncertainty_score":0.042302012},"labels":[],"label_agreement":null},{"id":"W4406364993","doi":"10.1016/j.msard.2025.106269","title":"Potential mechanisms of how B-cell depletion works in MOGAD","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Massachusetts General Hospital","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.006078453973629121,"score_gpt":0.18570506113522695,"score_spread":0.1796266071615978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406364993","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121144345,0.01198539,0.00027524887,0.038730502,0.9471596,0.00002465726,0.000025473202,0.000042661293,0.0016353934],"genre_scores_gemma":[0.0012335253,0.006520957,0.00019758241,0.028174175,0.9559494,0.000033256576,0.000018831082,0.000020078089,0.00785224],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979394,0.00044431342,0.00028102638,0.0002866205,0.0008248049,0.00022388864],"domain_scores_gemma":[0.99478006,0.0021011154,0.00032748235,0.00017883579,0.0014676922,0.0011448459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007115693,0.0028948823,0.0022368417,0.0017581476,0.002059495,0.0042398516,0.0030286901,0.014567846,0.0051910453],"category_scores_gemma":[0.008535198,0.00091042253,0.0020079107,0.000552451,0.0022203478,0.0031425445,0.0014917823,0.017937921,0.0030565436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001980752,0.000034046694,0.0000649171,0.00041899303,0.000052717416,0.00046490427,0.000024872183,0.00004407941,0.00042019147,0.0014255779,0.98322356,0.013628007],"study_design_scores_gemma":[0.0003006561,0.00011716715,0.00056829554,0.00035065052,0.00017499675,0.00073521934,0.00005175164,0.00032129968,0.00062671164,0.0032730447,0.9934493,0.000030986597],"about_ca_topic_score_codex":0.00092240336,"about_ca_topic_score_gemma":0.0025472487,"teacher_disagreement_score":0.014567846,"about_ca_system_score_codex":0.0023698842,"about_ca_system_score_gemma":0.001449232,"threshold_uncertainty_score":0.03763181},"labels":[],"label_agreement":null},{"id":"W4406598422","doi":"10.1016/j.msard.2025.106280","title":"A glass half empty","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Aging, Elder Care, and Social Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Psychiatry","score_opus":0.032898406992676966,"score_gpt":0.32177722284827126,"score_spread":0.2888788158555943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406598422","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009421919,0.0025398696,0.0021550537,0.032788657,0.06542975,0.00030874796,0.0011168284,0.0028919245,0.89182705],"genre_scores_gemma":[0.0012243112,0.0005595117,0.00065935875,0.0066507254,0.0030746453,0.000055504242,0.00022955703,0.0006422412,0.98690414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991025,0.00009915409,0.00003812849,0.00014911218,0.00042525877,0.00018583026],"domain_scores_gemma":[0.9968976,0.0002687919,0.000078068406,0.00032946892,0.0010197272,0.0014063166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010440318,0.0016161213,0.0013830292,0.0017533954,0.0074933935,0.0084872935,0.0017821795,0.004754728,0.8140772],"category_scores_gemma":[0.0042903973,0.0008582515,0.0013847617,0.0011649377,0.0018801518,0.007897601,0.006004509,0.0077676917,0.6473212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051616604,0.000048488386,0.000057109097,0.00004779837,0.0000030547822,0.000076487566,0.000095976065,0.000018287348,0.00025125223,0.0029581592,0.96292204,0.033469707],"study_design_scores_gemma":[0.00001636546,0.000022895027,0.00018153452,0.000062793464,0.0000024939295,0.00005064962,0.00038269078,0.000018955427,0.000059247664,0.00093296374,0.99825877,0.000010764375],"about_ca_topic_score_codex":0.008917395,"about_ca_topic_score_gemma":0.020277902,"teacher_disagreement_score":0.8140772,"about_ca_system_score_codex":0.0011914229,"about_ca_system_score_gemma":0.002348816,"threshold_uncertainty_score":0.26519632},"labels":[],"label_agreement":null},{"id":"W4406753778","doi":"10.1016/j.msard.2025.106287","title":"A retrospective evaluation of patient characteristics and recommendations of a novel multidisciplinary clinic for persons with advanced disability from multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Parkwood Institute; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Multiple sclerosis; Multidisciplinary approach; Retrospective cohort study; Physical therapy; Physical medicine and rehabilitation; Pediatrics; Internal medicine; Psychiatry","score_opus":0.06388904227221708,"score_gpt":0.32901153694359403,"score_spread":0.26512249467137694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406753778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998722,0.00012998673,0.0000560664,0.000050029685,0.0000045752276,0.000025777055,0.00044246856,0.000002426916,0.0005667189],"genre_scores_gemma":[0.9991328,0.00006918275,0.000104615574,0.00007736818,0.000012543163,0.000028324419,0.00045681873,0.0000019576044,0.00011637101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871516,0.00041759224,0.00026189015,0.00020309069,0.00018297076,0.00021926108],"domain_scores_gemma":[0.993954,0.0015630074,0.0025719942,0.0002378455,0.0008420309,0.0008311668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011180525,0.00020502564,0.0003464238,0.0012668365,0.0012815661,0.0007240846,0.00027679765,0.000660955,0.0018534325],"category_scores_gemma":[0.0056537287,0.00022303326,0.00053233735,0.00165341,0.00036036235,0.0005891563,0.0004910776,0.00055340334,0.00025214898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017265514,0.0000698813,0.99858654,0.000008162487,0.000015743752,0.00012779814,0.000118341486,0.000021379281,0.000054134714,0.000015000345,0.00007181567,0.0007386971],"study_design_scores_gemma":[0.000022245758,0.0004946232,0.9966266,0.000015095273,0.00003930786,0.00086832803,0.0013246989,0.00014820092,0.000068126894,0.000029653445,0.00035348875,0.000009573276],"about_ca_topic_score_codex":0.008271421,"about_ca_topic_score_gemma":0.008145559,"teacher_disagreement_score":0.008271421,"about_ca_system_score_codex":0.00087211735,"about_ca_system_score_gemma":0.0012043684,"threshold_uncertainty_score":0.01644659},"labels":[],"label_agreement":null},{"id":"W4406821385","doi":"10.1016/j.msard.2025.106300","title":"Is there truly no progression in NMOSD and MOGAD?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunology","score_opus":0.013108387348026395,"score_gpt":0.25726935662227357,"score_spread":0.24416096927424719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406821385","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030353434,0.008036769,0.00006659781,0.0563114,0.9347156,0.000011345767,0.000036228703,0.0000266734,0.0007650341],"genre_scores_gemma":[0.00029605385,0.003067439,0.0000639109,0.040431373,0.9539804,0.000016537897,0.000017432487,0.000013259508,0.0021136375],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903024,0.0023661975,0.001869918,0.0009986986,0.0038095154,0.00065332185],"domain_scores_gemma":[0.95728606,0.024134347,0.002970215,0.0009793721,0.009962888,0.0046670143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015347929,0.0035529633,0.0063455505,0.004017463,0.0051080994,0.009794442,0.004861626,0.04146087,0.01040175],"category_scores_gemma":[0.05489767,0.0018908378,0.004383023,0.001774817,0.003787398,0.00618988,0.0027380474,0.040782046,0.008153071],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076877295,0.000014986723,0.000055674733,0.0003933579,0.000053929132,0.00020244371,0.000018457433,0.000019702777,0.000030052603,0.00039671196,0.99317145,0.005566359],"study_design_scores_gemma":[0.00033490514,0.000076194185,0.0006916859,0.0019394193,0.00038555602,0.0009257461,0.00011297084,0.0003231825,0.00011452871,0.0026796374,0.9923505,0.00006569276],"about_ca_topic_score_codex":0.0033270624,"about_ca_topic_score_gemma":0.009396354,"teacher_disagreement_score":0.04146087,"about_ca_system_score_codex":0.005763921,"about_ca_system_score_gemma":0.0050073112,"threshold_uncertainty_score":0.08116859},"labels":[],"label_agreement":null},{"id":"W4407164742","doi":"10.1016/j.msard.2025.106318","title":"Progressive unilateral tremor associated with large confluent perirolandic juxtacortical lesions in multiple sclerosis","year":2025,"lang":"en","type":"letter","venue":"Multiple Sclerosis and Related Disorders","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Institutes of Health","keywords":"Medicine; Multiple sclerosis; Pathology; Immunology","score_opus":0.02539278073944422,"score_gpt":0.23385080626685661,"score_spread":0.20845802552741238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407164742","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5878494,0.013239229,0.0038746493,0.23834245,0.009933476,0.00037538772,0.00071155926,0.000549458,0.14512436],"genre_scores_gemma":[0.9495512,0.0014110452,0.0008708864,0.024394749,0.017002098,0.00003493303,0.000088996596,0.000054489763,0.006591555],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99927455,0.00013621595,0.00012778037,0.00012074005,0.00013901775,0.00020162405],"domain_scores_gemma":[0.9964336,0.001896684,0.0004943065,0.00020181637,0.0002816721,0.0006920353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007234366,0.0012858069,0.001098459,0.0020766014,0.0026393335,0.001553395,0.0015605013,0.017240062,0.0031624744],"category_scores_gemma":[0.007228448,0.00081770134,0.0012839871,0.001362136,0.0019899416,0.001985596,0.0011052928,0.006705626,0.0011042804],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012338517,0.000023670416,0.0027568883,0.00003904487,0.00001371,0.9912559,0.0001053929,0.000053480402,0.0004888831,0.00025919444,0.0036747134,0.0012057445],"study_design_scores_gemma":[0.00017516033,0.00017173505,0.016093541,0.00009227026,0.000066694,0.9749263,0.00037584832,0.0014238424,0.0006272355,0.0011340543,0.0048763137,0.00003701609],"about_ca_topic_score_codex":0.0072002686,"about_ca_topic_score_gemma":0.010499852,"teacher_disagreement_score":0.017240062,"about_ca_system_score_codex":0.0029900544,"about_ca_system_score_gemma":0.0010178908,"threshold_uncertainty_score":0.021694422},"labels":[],"label_agreement":null},{"id":"W4407165175","doi":"10.1016/j.msard.2025.106322","title":"Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute on Aging","keywords":"Multiple sclerosis; Medicine; Cognition; Physical medicine and rehabilitation; Psychiatry","score_opus":0.03191505425122631,"score_gpt":0.2782034890622853,"score_spread":0.246288434811059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407165175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99786866,0.0007966942,0.00013736167,0.00022841763,0.000015442536,0.000009217037,0.000147713,0.0000044007406,0.00079210696],"genre_scores_gemma":[0.9996809,0.00010421209,0.00006468991,0.000029228853,0.00001552429,0.0000036768884,0.000060000835,9.547838e-7,0.000040847222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992398,0.00019658967,0.00012575297,0.00014441524,0.00017733368,0.00011603947],"domain_scores_gemma":[0.99543566,0.0014348885,0.0020039268,0.00028140986,0.00042240796,0.0004216811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015233184,0.00059977645,0.0005197897,0.0014532794,0.0005368039,0.0012980043,0.00061303354,0.0009278123,0.0018698153],"category_scores_gemma":[0.0102485195,0.00024147694,0.0009060303,0.001126023,0.0006152704,0.0006757511,0.0010092214,0.00087740726,0.00026567318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083392595,0.000050262854,0.9973435,0.000024326282,0.00008838272,0.000035017685,0.00016444853,0.000046625886,0.000044003606,0.000024509362,0.000037760594,0.0020577349],"study_design_scores_gemma":[0.0000028482775,0.0000691479,0.9991296,0.000018752222,0.0000417009,0.000102988415,0.00018887865,0.0002452198,0.000025050469,0.00012391715,0.000048514015,0.00000343224],"about_ca_topic_score_codex":0.0052182414,"about_ca_topic_score_gemma":0.0045093047,"teacher_disagreement_score":0.0052182414,"about_ca_system_score_codex":0.00031446313,"about_ca_system_score_gemma":0.0004244199,"threshold_uncertainty_score":0.010375738},"labels":[],"label_agreement":null},{"id":"W4407281743","doi":"10.1016/j.msard.2025.106335","title":"Associations between fronto-limbic white matter connections and internalizing symptoms in pediatric demyelinating disease","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Montreal Neurological Institute and Hospital; McGill University; Mental Health Research Canada; Hospital for Sick Children","funders":"","keywords":"Medicine; White matter; Multiple sclerosis; Demyelinating disease; Disease; Demyelinating Disorder; Neuroscience; Limbic system; Psychiatry; Pathology; Psychology; Magnetic resonance imaging; Internal medicine; Central nervous system","score_opus":0.023671289854620543,"score_gpt":0.2787222330779737,"score_spread":0.2550509432233532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407281743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992118,0.00029011696,0.000028641818,0.000023919909,0.000002252254,0.0000011176102,0.00007300494,0.000001338929,0.0003677779],"genre_scores_gemma":[0.9995447,0.0002022398,0.000049521637,0.000009391208,0.0000046088135,0.0000026777882,0.000072047165,0.0000012195985,0.000113604205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999648,0.00010110465,0.000032202668,0.000079249716,0.00005567588,0.00008385731],"domain_scores_gemma":[0.99829024,0.00036987354,0.0009820209,0.000056525354,0.00012572491,0.00017559442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038814434,0.00044985674,0.00025712186,0.0010131492,0.00044217738,0.00072171306,0.0002946429,0.0003950474,0.0017751955],"category_scores_gemma":[0.002250228,0.00019992937,0.00037522268,0.0011810872,0.00039340698,0.00044105967,0.00047305302,0.0005397368,0.00012333824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045121466,0.000025336038,0.99786395,0.000012683547,0.00008238333,0.00027549773,0.00011054671,0.00004284606,0.00040718625,0.000028315058,0.00002938718,0.0010767877],"study_design_scores_gemma":[0.0000011228909,0.000016330934,0.99938333,0.000005850784,0.000026574622,0.00027054953,0.000145499,0.000034029676,0.00006574786,0.000013946985,0.000036131594,9.883523e-7],"about_ca_topic_score_codex":0.010112152,"about_ca_topic_score_gemma":0.016414892,"teacher_disagreement_score":0.010112152,"about_ca_system_score_codex":0.00035973114,"about_ca_system_score_gemma":0.00042345727,"threshold_uncertainty_score":0.020106614},"labels":[],"label_agreement":null},{"id":"W4407635963","doi":"10.1016/j.msard.2025.106337","title":"Infectious mononucleosis is a more realistic target for preventing multiple sclerosis","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mononucleosis; Multiple sclerosis; Medicine; Virology; Immunology; Virus","score_opus":0.0192967379330133,"score_gpt":0.2624359087893843,"score_spread":0.243139170856371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407635963","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021482156,0.00797971,0.00006331419,0.03429549,0.9564619,0.000014899481,0.000023005354,0.000024832247,0.0011154271],"genre_scores_gemma":[0.00018186688,0.003402989,0.000057742935,0.021408353,0.97157425,0.000014226086,0.000011875575,0.000011475699,0.0033372089],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993602,0.0016601871,0.00087142724,0.00056238624,0.0028963648,0.00040765223],"domain_scores_gemma":[0.9736857,0.011889575,0.0021107206,0.0006824067,0.007548106,0.0040835217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01067168,0.0046692514,0.0051932344,0.00441617,0.0045502717,0.008873867,0.004023961,0.033564206,0.015647674],"category_scores_gemma":[0.026717613,0.0018243472,0.003989113,0.0018424558,0.002766651,0.0053181904,0.0023860955,0.0328739,0.011235616],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052350828,0.00001796475,0.000031931333,0.00034354112,0.0000328304,0.00012732933,0.00001164852,0.00002413961,0.000041683183,0.00028282215,0.99289215,0.006141627],"study_design_scores_gemma":[0.0002257534,0.000072793206,0.00040152218,0.00089539174,0.00017577535,0.00036650873,0.000059135717,0.00023509859,0.000084944375,0.0013351366,0.99611604,0.000031897525],"about_ca_topic_score_codex":0.002673676,"about_ca_topic_score_gemma":0.008908424,"teacher_disagreement_score":0.033564206,"about_ca_system_score_codex":0.0045474456,"about_ca_system_score_gemma":0.0035398516,"threshold_uncertainty_score":0.05643791},"labels":[],"label_agreement":null},{"id":"W4408535100","doi":"10.1016/j.msard.2025.106394","title":"Magnetic resonance imaging characteristics of myelin oligodendrocyte glycoprotein antibody positive patients -validation of current diagnostic criteria","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"University of Calgary","keywords":"Medicine; Magnetic resonance imaging; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Antibody; Myelin; Oligodendrocyte; Pathology; Nuclear magnetic resonance; Immunology; Radiology; Internal medicine; Central nervous system; Experimental autoimmune encephalomyelitis","score_opus":0.016212178922580346,"score_gpt":0.29155721240324456,"score_spread":0.2753450334806642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408535100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984659,0.0003040182,0.00016703972,0.000049711176,0.000010176883,0.000016767262,0.00018530707,0.0000067765573,0.0007942824],"genre_scores_gemma":[0.9992378,0.00006798837,0.00025655582,0.000020939206,0.000016796586,0.000010852555,0.00034544634,0.0000020752718,0.000041563748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999035,0.00020108496,0.00016381068,0.00014181907,0.00032155387,0.00013677106],"domain_scores_gemma":[0.9948079,0.0016959885,0.0015786357,0.00030414216,0.0011304261,0.0004829694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024018772,0.0004014443,0.00031486363,0.0016061723,0.00034005,0.000677497,0.00075474655,0.00068837486,0.0009937297],"category_scores_gemma":[0.010855788,0.00017504116,0.00026904044,0.00083710474,0.00049427286,0.0005944201,0.00042856127,0.00042950542,0.00044414238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049467148,0.000013888808,0.99872965,0.0000047539143,0.000006852214,0.00011257195,0.000030574018,0.00003260857,0.00025870113,0.00000788221,0.000042227126,0.00071078795],"study_design_scores_gemma":[0.000009335049,0.00010394597,0.9968495,0.000014167213,0.000021551718,0.0018545506,0.000107937136,0.000504343,0.0003034421,0.000025507527,0.00020228027,0.0000035175904],"about_ca_topic_score_codex":0.0042151175,"about_ca_topic_score_gemma":0.0047312425,"teacher_disagreement_score":0.0042151175,"about_ca_system_score_codex":0.0005427046,"about_ca_system_score_gemma":0.000553612,"threshold_uncertainty_score":0.012702465},"labels":[],"label_agreement":null},{"id":"W4408760219","doi":"10.1016/j.msard.2025.106392","title":"Comparison of vision-related quality of life in NMOSD and MOGAD","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Western University; University of Toronto; Dalhousie University; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Manitoba; Ottawa Hospital; University of Ottawa; Public Health Ontario; Toronto Public Health","funders":"Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes; Roche; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Dermatology; Quality of life (healthcare); Optometry; Immunology","score_opus":0.0663735583943237,"score_gpt":0.36057487976407016,"score_spread":0.29420132136974647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408760219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772793,0.0003112936,0.000042875166,0.000035462344,0.0000072062135,0.000034033266,0.0013087728,0.0000017427882,0.00053067156],"genre_scores_gemma":[0.99807656,0.000079869336,0.0000663129,0.000016221411,0.0000045210795,0.00003438989,0.001607072,8.4697473e-7,0.00011424584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908626,0.00018346848,0.00008085708,0.0001446719,0.0003227403,0.00018194283],"domain_scores_gemma":[0.9983923,0.0003025751,0.00048067825,0.000059622344,0.0003860086,0.00037876208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015250455,0.00028224522,0.0005174088,0.00093913235,0.00052282,0.00058584556,0.00075277186,0.00040274774,0.0016348251],"category_scores_gemma":[0.003173722,0.00013305678,0.0009225277,0.00088265183,0.0003347522,0.00038555896,0.000877022,0.00051420444,0.00013196847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010460269,0.0000803473,0.99602497,0.00004495176,0.00032167378,0.000018090312,0.000088300316,0.00009167711,0.00007582366,0.000023373614,0.0001738084,0.002011001],"study_design_scores_gemma":[0.000042403648,0.00025213545,0.9991014,0.000009856111,0.000055965447,0.00002655018,0.00012249523,0.00017080948,0.00002183827,0.00001460705,0.00017760714,0.0000045285715],"about_ca_topic_score_codex":0.095309354,"about_ca_topic_score_gemma":0.13208793,"teacher_disagreement_score":0.095309354,"about_ca_system_score_codex":0.0024790815,"about_ca_system_score_gemma":0.0014121184,"threshold_uncertainty_score":0.18950915},"labels":[],"label_agreement":null},{"id":"W4408787704","doi":"10.1016/j.msard.2025.106403","title":"IS MULTIPLE SCLEROSIS A MICROGLIOPATHY?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Immunology","score_opus":0.030279936535247572,"score_gpt":0.2327744734025983,"score_spread":0.20249453686735072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408787704","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045603225,0.014178735,0.00009339834,0.0386952,0.946031,0.000013504865,0.000024070525,0.000022995171,0.00089556054],"genre_scores_gemma":[0.00032119235,0.0045567863,0.000043560452,0.016064314,0.9770205,0.000011721298,0.000009714146,0.000007822564,0.0019643938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963062,0.00092299044,0.00064686075,0.0004654877,0.001395649,0.00026291606],"domain_scores_gemma":[0.98387766,0.008293147,0.0012387324,0.000474252,0.0038166486,0.0022994417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008044325,0.0042134165,0.0046381815,0.0037591315,0.003461084,0.007093966,0.0037608978,0.026258977,0.0074885082],"category_scores_gemma":[0.021276973,0.0014230554,0.0025111374,0.0015366502,0.0032477428,0.005357609,0.002336953,0.022479508,0.005401938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000855948,0.00001807769,0.000059221515,0.00042453047,0.000045997982,0.00043389664,0.000018741688,0.00002577818,0.00007006059,0.00040142774,0.99152243,0.006894166],"study_design_scores_gemma":[0.00022159787,0.00007821762,0.00065870647,0.0010554144,0.00025022813,0.0015461154,0.000094958676,0.00031097143,0.00014509285,0.0025986168,0.9929952,0.000044823573],"about_ca_topic_score_codex":0.001885445,"about_ca_topic_score_gemma":0.0052692085,"teacher_disagreement_score":0.026258977,"about_ca_system_score_codex":0.0034903816,"about_ca_system_score_gemma":0.0026581427,"threshold_uncertainty_score":0.042542934},"labels":[],"label_agreement":null},{"id":"W4409203845","doi":"10.1016/j.msard.2025.106410","title":"The utility of serum neurofilament light chain in MOGAD: Current insights and future directions","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Canadian Electricity Association; University of Ottawa","funders":"","keywords":"Medicine; Multiple sclerosis; Dermatology; Immunoglobulin light chain; Current (fluid); Pathology; Neuroscience; Immunology; Antibody","score_opus":0.042141862273776684,"score_gpt":0.31035300168288665,"score_spread":0.26821113940910996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409203845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005791883,0.9996557,0.000032535005,0.000120128665,0.000039858543,0.0000012124058,0.000010949711,0.0000013713237,0.00008032213],"genre_scores_gemma":[0.0008268155,0.9986706,0.00014630712,0.00015101967,0.00012136287,0.0000038792878,0.000018289147,5.97661e-7,0.00006111337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995197,0.00012426701,0.000110793626,0.00009908298,0.00011308555,0.000033116936],"domain_scores_gemma":[0.9979075,0.001447182,0.00026539568,0.00003236553,0.000294253,0.000053217966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002301103,0.00096128107,0.0029990904,0.0029066755,0.00018245827,0.0020223574,0.0010861512,0.0014554684,0.0027074805],"category_scores_gemma":[0.0031736451,0.0003282774,0.0010631578,0.0031526303,0.0007570397,0.0016637335,0.0008900291,0.0015828182,0.00078086177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033789006,0.00006919628,0.0012107055,0.042220645,0.00067373796,0.00020424294,0.00006361972,0.0002761402,0.00068314146,0.0022443875,0.009896999,0.94211924],"study_design_scores_gemma":[0.0003119484,0.0004958306,0.010121027,0.049157433,0.004798567,0.0031127755,0.000438042,0.00060149294,0.0010710375,0.0073260977,0.92242485,0.00014084518],"about_ca_topic_score_codex":0.0017388932,"about_ca_topic_score_gemma":0.0030019174,"teacher_disagreement_score":0.0029990904,"about_ca_system_score_codex":0.00064790505,"about_ca_system_score_gemma":0.0021771053,"threshold_uncertainty_score":0.01216948},"labels":[],"label_agreement":null},{"id":"W4409342705","doi":"10.1016/j.msard.2025.106439","title":"Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literature","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Montreal Neurological Institute and Hospital","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Multiple sclerosis; Medicine; Observational study; MEDLINE; Dermatology; Psychiatry; Pathology; Biology","score_opus":0.05250570815092951,"score_gpt":0.29305104643914787,"score_spread":0.24054533828821836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409342705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088684785,0.9986326,0.000040050367,0.00011800389,0.00004285621,0.0000059135564,0.00012165061,0.0000016575088,0.00015036407],"genre_scores_gemma":[0.0038055491,0.99564916,0.00013074384,0.0002015873,0.00006686135,0.000007709523,0.00010975267,8.5239634e-7,0.000027678563],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99884546,0.00018355552,0.00051928347,0.00022153187,0.00018389332,0.000046359277],"domain_scores_gemma":[0.994747,0.003707991,0.001077902,0.00007314769,0.0003199469,0.00007397041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015818261,0.00058185396,0.002415689,0.0053917156,0.00034871363,0.0014148753,0.0010555102,0.0010405678,0.0022510546],"category_scores_gemma":[0.0065654432,0.0003601546,0.0014435559,0.0072902855,0.0005116372,0.0016384076,0.0007969881,0.00080864626,0.00028359526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061926304,0.00011401581,0.035551228,0.3929504,0.0066272984,0.0033515154,0.000732107,0.000328426,0.0009846711,0.0013000375,0.016513854,0.5409271],"study_design_scores_gemma":[0.0002970399,0.000341764,0.16912644,0.4396867,0.049470384,0.045134928,0.0027952967,0.00030437225,0.00078357686,0.003035545,0.28874636,0.00027759516],"about_ca_topic_score_codex":0.0026841403,"about_ca_topic_score_gemma":0.0061326576,"teacher_disagreement_score":0.0053917156,"about_ca_system_score_codex":0.0005758143,"about_ca_system_score_gemma":0.002474088,"threshold_uncertainty_score":0.008365631},"labels":[],"label_agreement":null},{"id":"W4409451847","doi":"10.1016/j.msard.2025.106449","title":"Identifying axonal injury through the eye: can the cornea provide new clues to axonal injury in MS?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Cornea; Neuroscience; Ophthalmology; Psychology; Psychiatry","score_opus":0.034366259848986454,"score_gpt":0.3169360836789767,"score_spread":0.28256982382999024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409451847","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005754402,0.010447938,0.00012960029,0.030656796,0.95795065,0.000026900674,0.000043380536,0.00003978431,0.00064733974],"genre_scores_gemma":[0.00030941007,0.0049225776,0.00007637649,0.01849558,0.974481,0.00001782158,0.000014339445,0.000010924867,0.0016719254],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99439245,0.0014034116,0.0010779917,0.00061135844,0.002144323,0.0003705328],"domain_scores_gemma":[0.96851605,0.018606436,0.00140779,0.00062224857,0.0076843123,0.0031632502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013131229,0.005117988,0.0065762196,0.004587429,0.0030574023,0.007464991,0.0048576365,0.027595198,0.005813937],"category_scores_gemma":[0.03096071,0.0016493244,0.0039867,0.0016975979,0.0032644845,0.0055178995,0.0015732589,0.028447337,0.0049543194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024354494,0.000043411754,0.000096950345,0.0010132003,0.00011154534,0.00040112782,0.000027354658,0.000036884878,0.00012906911,0.00041561137,0.9870936,0.010387655],"study_design_scores_gemma":[0.00059634115,0.00025712774,0.0018233922,0.002364949,0.0007261996,0.0013808986,0.00020696371,0.0007894257,0.00038795924,0.003081688,0.9882708,0.000114150134],"about_ca_topic_score_codex":0.002536497,"about_ca_topic_score_gemma":0.0063662725,"teacher_disagreement_score":0.027595198,"about_ca_system_score_codex":0.0032458308,"about_ca_system_score_gemma":0.0027119906,"threshold_uncertainty_score":0.06944543},"labels":[],"label_agreement":null},{"id":"W4409785659","doi":"10.1016/j.msard.2025.106459","title":"Results from a multiple sclerosis relapse clinic","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast","keywords":"Multiple sclerosis; Medicine; Psychiatry","score_opus":0.05545720594714648,"score_gpt":0.29005607205315964,"score_spread":0.23459886610601316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95645833,0.0017285304,0.00042233925,0.00089442654,0.000083646904,0.0004808156,0.022534445,0.00009718686,0.017300328],"genre_scores_gemma":[0.99094266,0.00028841165,0.00039149873,0.0004487348,0.00005777757,0.00022914105,0.005050682,0.00005692034,0.0025341732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98424894,0.0043007913,0.002383849,0.0015596665,0.0054153204,0.0020915016],"domain_scores_gemma":[0.9563628,0.010837727,0.013603833,0.0019267978,0.012978819,0.0042900066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006612661,0.00046171917,0.00077395036,0.0031391631,0.001245718,0.0021221715,0.00091713824,0.0007857696,0.013014964],"category_scores_gemma":[0.024628168,0.000360506,0.0012849596,0.0036806013,0.0004793324,0.0008565423,0.00216919,0.0009651162,0.0023802118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009330884,0.0002853862,0.9700079,0.0005961674,0.00026686344,0.00044349517,0.0022846938,0.00010222242,0.00037686684,0.00012256714,0.0054355846,0.01914513],"study_design_scores_gemma":[0.000026550068,0.00025052988,0.99545926,0.00012027963,0.00012504168,0.0003466332,0.0011983197,0.000073522024,0.000114697,0.000023836237,0.0022438944,0.000017430168],"about_ca_topic_score_codex":0.047103647,"about_ca_topic_score_gemma":0.041404493,"teacher_disagreement_score":0.047103647,"about_ca_system_score_codex":0.0027690332,"about_ca_system_score_gemma":0.002257931,"threshold_uncertainty_score":0.093658924},"labels":[],"label_agreement":null},{"id":"W4410064939","doi":"10.1016/j.msard.2025.106502","title":"Evaluating the impact of systematic reporting of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"Sanofi Genzyme; University Hospital Foundation; University of Alberta","keywords":"Medicine; Multiple sclerosis; Randomized controlled trial; Depression (economics); Anxiety; Physical therapy; Psychiatry; Physical medicine and rehabilitation; Clinical psychology; Internal medicine","score_opus":0.10643477191936601,"score_gpt":0.3578644694380102,"score_spread":0.2514296975186442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410064939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45619318,0.28730375,0.012402303,0.011773518,0.013172451,0.20569476,0.0053525763,0.0009195912,0.007187823],"genre_scores_gemma":[0.7507061,0.052039895,0.018178737,0.0050593945,0.0026962473,0.16840677,0.0011397966,0.00007990537,0.0016931439],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.951661,0.03486362,0.0076351217,0.0023783252,0.0025547883,0.00090720906],"domain_scores_gemma":[0.9638413,0.01954005,0.01111909,0.0016912962,0.002276042,0.0015322168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03467062,0.0020094002,0.008711565,0.0016070183,0.0010809561,0.0029555259,0.001843633,0.005272526,0.007491064],"category_scores_gemma":[0.06962368,0.0010309618,0.010696154,0.0022787936,0.0019562356,0.0025160979,0.001433393,0.003558672,0.0005067139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8061325,0.0036498306,0.0023618164,0.08840013,0.049289316,0.00010285143,0.00025625233,0.0005820569,0.0006437534,0.00061356946,0.0018469939,0.046121016],"study_design_scores_gemma":[0.94383985,0.020406598,0.0019389385,0.007898565,0.023325644,0.00003462084,0.00007848262,0.0004442859,0.00022142455,0.0004281029,0.0013425449,0.00004095333],"about_ca_topic_score_codex":0.0024202818,"about_ca_topic_score_gemma":0.0032611599,"teacher_disagreement_score":0.03467062,"about_ca_system_score_codex":0.0024137283,"about_ca_system_score_gemma":0.00640566,"threshold_uncertainty_score":0.18335795},"labels":[],"label_agreement":null},{"id":"W4410091341","doi":"10.1016/j.msard.2025.106499","title":"Vitamin D- should we all take it?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Vitamin D and neurology; Intensive care medicine; Immunology; Internal medicine","score_opus":0.03766777249667159,"score_gpt":0.2990125943421173,"score_spread":0.2613448218454457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410091341","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013742512,0.009861681,0.0000538404,0.052235097,0.937214,0.0000138008,0.00003734466,0.000023124667,0.0005473053],"genre_scores_gemma":[0.00019779099,0.0045350017,0.00008038249,0.045160446,0.94729275,0.000029868263,0.000018899924,0.000017379074,0.002667525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98672897,0.004364949,0.0023019013,0.0011656993,0.0046619107,0.00077661837],"domain_scores_gemma":[0.9320704,0.035671514,0.004405715,0.0017546975,0.017783511,0.008314303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022351356,0.0053590243,0.008697383,0.0066313054,0.0060928594,0.012817419,0.0059895376,0.042389154,0.016085742],"category_scores_gemma":[0.06552599,0.0025678948,0.005288052,0.003364159,0.0039659115,0.0072562625,0.0035840075,0.0352182,0.011551309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057043537,0.00001158702,0.000032208856,0.00035270525,0.000057525707,0.00007122606,0.000013387998,0.000013508721,0.000019945832,0.00019781037,0.9953725,0.0038005859],"study_design_scores_gemma":[0.00037504887,0.00005723977,0.00044462743,0.0023299921,0.00043964354,0.0003210289,0.00011138586,0.00022500499,0.000075997326,0.0021259824,0.99343973,0.000054342625],"about_ca_topic_score_codex":0.005314534,"about_ca_topic_score_gemma":0.017080626,"teacher_disagreement_score":0.042389154,"about_ca_system_score_codex":0.0071069263,"about_ca_system_score_gemma":0.0068751737,"threshold_uncertainty_score":0.11820668},"labels":[],"label_agreement":null},{"id":"W4410220931","doi":"10.1016/j.msard.2025.106511","title":"High-intensity resistance training in people with multiple sclerosis-related fatigue – experiences from a randomized controlled trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Montreal Neurological Institute and Hospital","keywords":"Multiple sclerosis; Medicine; Randomized controlled trial; Physical therapy; Resistance training; Physical medicine and rehabilitation; Intensity (physics); Internal medicine; Psychiatry","score_opus":0.03343611215203489,"score_gpt":0.2630462221543362,"score_spread":0.2296101100023013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410220931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82649493,0.023009984,0.0025835563,0.0014291537,0.0019056083,0.13997559,0.0013225322,0.00019165351,0.0030870282],"genre_scores_gemma":[0.79678005,0.0077729295,0.007145362,0.0019058231,0.0008221598,0.18294516,0.0006791599,0.000026570591,0.0019227464],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98547345,0.010737708,0.0016900864,0.00066059123,0.00076446566,0.00067377056],"domain_scores_gemma":[0.9914302,0.0048615234,0.0016796377,0.00057022943,0.0007729358,0.0006853784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015659885,0.0008486588,0.0035077694,0.0009796605,0.0011365294,0.0014133063,0.0007453283,0.0027758821,0.0068417327],"category_scores_gemma":[0.018710904,0.0005279512,0.0034668434,0.0011601499,0.0012384428,0.0012251781,0.00087287807,0.001609909,0.00041461678],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86945665,0.022678247,0.003141148,0.021768298,0.0057652253,0.00046378947,0.00211735,0.00039498744,0.0024765888,0.00043325932,0.0014139359,0.06989064],"study_design_scores_gemma":[0.8481082,0.13659468,0.0054218434,0.0022065002,0.0030084376,0.00008583491,0.0008192741,0.00021939227,0.00036636431,0.00025321034,0.0028749655,0.000041374497],"about_ca_topic_score_codex":0.0012283735,"about_ca_topic_score_gemma":0.003703892,"teacher_disagreement_score":0.015659885,"about_ca_system_score_codex":0.0011767917,"about_ca_system_score_gemma":0.0035022537,"threshold_uncertainty_score":0.08281839},"labels":[],"label_agreement":null},{"id":"W4410616544","doi":"10.1016/j.msard.2025.106544","title":"Navigating a paradigm shift in the treatment of CNS demyelinating diseases in a middle-income country","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Hereditary Neurological Disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple sclerosis; Medicine; Demyelinating disease; Paradigm shift; Low and middle income countries; Neuroscience; Developing country; Immunology; Economic growth; Psychology; Economics","score_opus":0.03399252837059849,"score_gpt":0.2637806442357036,"score_spread":0.22978811586510509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410616544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017740456,0.014286928,0.0016405965,0.9558056,0.003516024,0.000025595697,0.00008326878,0.000032480773,0.0068689934],"genre_scores_gemma":[0.33269525,0.061879143,0.013708679,0.5720807,0.012797602,0.00023222464,0.00033657465,0.000119078766,0.006150771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954058,0.0019962124,0.00037782724,0.00028508584,0.00059281604,0.0013422248],"domain_scores_gemma":[0.9902181,0.0016156818,0.0008125991,0.00019400787,0.0013711539,0.005788427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010565427,0.0003861549,0.0008771318,0.00092948414,0.0038425494,0.007872556,0.002193356,0.005365879,0.008549624],"category_scores_gemma":[0.008386879,0.00022637587,0.000693544,0.0008371526,0.004438478,0.00615303,0.009945509,0.009922421,0.0012042663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012350372,0.0033220737,0.02686545,0.004074723,0.0003669038,0.0060811187,0.00993916,0.0025735216,0.0064611486,0.19530988,0.31321913,0.4305519],"study_design_scores_gemma":[0.00071908935,0.0019484014,0.04491831,0.008273862,0.00026377413,0.0039087376,0.033269767,0.0017892527,0.0013566228,0.11367885,0.78958493,0.0002884534],"about_ca_topic_score_codex":0.018791616,"about_ca_topic_score_gemma":0.03778567,"teacher_disagreement_score":0.018791616,"about_ca_system_score_codex":0.0054756487,"about_ca_system_score_gemma":0.04300421,"threshold_uncertainty_score":0.055876017},"labels":[],"label_agreement":null},{"id":"W4410720609","doi":"10.1016/j.msard.2025.106553","title":"Multiple sclerosis is associated with worse body composition across compartments: Results from a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Ottawa","funders":"","keywords":"Multiple sclerosis; Medicine; Meta-analysis; Composition (language); MEDLINE; Internal medicine; Immunology; Biology","score_opus":0.11377070512439319,"score_gpt":0.3423688427167629,"score_spread":0.2285981375923697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410720609","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011365073,0.98709756,0.0004088152,0.00013731491,0.00016329644,0.00011876535,0.00051865814,0.000021294609,0.00016923933],"genre_scores_gemma":[0.29769468,0.6962162,0.0023878876,0.0013457848,0.00033896693,0.0004533924,0.0010565744,0.000043955133,0.00046248865],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956247,0.0014648682,0.0014844534,0.000770589,0.00044299674,0.00021245702],"domain_scores_gemma":[0.9914642,0.0057625766,0.0016807079,0.0003528503,0.00057773176,0.00016194755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005960575,0.0028463183,0.015118106,0.0033895595,0.00067195855,0.0031284376,0.0017569162,0.0024867957,0.0039531947],"category_scores_gemma":[0.017831845,0.001617881,0.0287982,0.0054228273,0.0007537392,0.0018117497,0.0021935042,0.0020567519,0.00040117477],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019817692,0.000036118483,0.010884914,0.23724896,0.73933995,0.00014803227,0.0001319116,0.00021896872,0.0002948418,0.00007650616,0.000510676,0.009127317],"study_design_scores_gemma":[0.00043819507,0.00008500625,0.008419823,0.00937879,0.9805525,0.00008248751,0.00006596578,0.000061790364,0.000057337536,0.0000985976,0.0007340101,0.000025514842],"about_ca_topic_score_codex":0.009173933,"about_ca_topic_score_gemma":0.024369266,"teacher_disagreement_score":0.015118106,"about_ca_system_score_codex":0.0015067274,"about_ca_system_score_gemma":0.0022730809,"threshold_uncertainty_score":0.03152287},"labels":[],"label_agreement":null},{"id":"W4410845152","doi":"10.1016/j.msard.2025.106557","title":"Mental health as an unmet medical need in NMOSD: how can we do better?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Multiple sclerosis; Mental health; Psychiatry; Family medicine","score_opus":0.012416499943067115,"score_gpt":0.2603885103566481,"score_spread":0.247972010413581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410845152","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031605963,0.016494177,0.00005388233,0.09334094,0.8894378,0.00001685841,0.00006068365,0.000027283253,0.0005367426],"genre_scores_gemma":[0.00033154598,0.00927467,0.00006467321,0.047723785,0.9411729,0.00002509199,0.00002935118,0.000014028642,0.0013639698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99047637,0.0026877692,0.0020766035,0.00096564076,0.003118158,0.0006753969],"domain_scores_gemma":[0.9380111,0.03334913,0.0037295632,0.0009170307,0.016043566,0.007949666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014504548,0.0043478427,0.009172491,0.004391721,0.0046599023,0.01161451,0.0047347643,0.03778374,0.010158571],"category_scores_gemma":[0.05416181,0.0019396471,0.0046980334,0.0028113374,0.0031310918,0.007845289,0.0029419328,0.047483448,0.0063467175],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005409469,0.000018716246,0.00008928928,0.0007394495,0.00008157071,0.00013174434,0.000026986525,0.00001711306,0.000016730448,0.00020258628,0.993668,0.0049536047],"study_design_scores_gemma":[0.0005782934,0.00014045791,0.0021733665,0.007650543,0.0010376392,0.00090860145,0.0004742361,0.0005061213,0.00009844428,0.0025541189,0.98374474,0.0001333237],"about_ca_topic_score_codex":0.007187096,"about_ca_topic_score_gemma":0.02052545,"teacher_disagreement_score":0.03778374,"about_ca_system_score_codex":0.006182211,"about_ca_system_score_gemma":0.00948903,"threshold_uncertainty_score":0.07670832},"labels":[],"label_agreement":null},{"id":"W4410935111","doi":"10.1016/j.msard.2025.106560","title":"Informative patterns of health care utilization preceding the recognition of adult-onset multiple sclerosis: A population-based study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Nova Scotia Health Authority; Dalhousie University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Medicine; Cohort; Multiple sclerosis; Population; Confounding; Health care; Medical prescription; Cohort study; Pediatrics; Demography; Gerontology; Internal medicine; Psychiatry; Environmental health","score_opus":0.0663916041363021,"score_gpt":0.31105685961666474,"score_spread":0.24466525548036264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410935111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992841,0.00016917853,0.00004860655,0.000024895882,0.000004060251,0.000005731915,0.00021862636,0.00000171995,0.00024310415],"genre_scores_gemma":[0.9996469,0.00005129043,0.000031891508,0.0000153151,0.000006122042,0.000004406851,0.00017166966,0.000001063464,0.00007132654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988174,0.00041116448,0.0001532761,0.00030661633,0.00011582019,0.00019573691],"domain_scores_gemma":[0.9971718,0.0005754663,0.0011565987,0.00029474442,0.00028761942,0.0005136812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000983522,0.00037325616,0.000505887,0.0011583632,0.0007674712,0.001098018,0.0005523484,0.0012203354,0.0014883945],"category_scores_gemma":[0.0036452282,0.0005253462,0.00084227993,0.001906531,0.00044585357,0.0010668524,0.000638,0.0010986369,0.00020399122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015169899,0.00005736485,0.99921286,0.0000037049667,0.000066271314,0.000047796886,0.0000647533,0.000012263625,0.00011557591,0.000009296271,0.000025877382,0.00023247837],"study_design_scores_gemma":[0.0000036551658,0.00009483397,0.9994948,0.000001946947,0.000024254665,0.00009262,0.00017768148,0.000055887303,0.000015073714,0.000009214544,0.000027190605,0.0000028246334],"about_ca_topic_score_codex":0.012789657,"about_ca_topic_score_gemma":0.0131314695,"teacher_disagreement_score":0.012789657,"about_ca_system_score_codex":0.00039151855,"about_ca_system_score_gemma":0.00054313923,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4411050228","doi":"10.1016/j.msard.2025.106543","title":"Multiple Sclerosis in the Greenlandic population. A nationwide cohort study","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Nunatsinni Ilisimatusarnermik Siunnersuisoqatigiit; Eli Lilly and Company","keywords":"Medicine; Incidence (geometry); Danish; Demography; Population; Epidemiology; Cohort; Multiple sclerosis; Cohort study; Prevalence; Pediatrics; Environmental health; Internal medicine; Immunology","score_opus":0.036859660648470634,"score_gpt":0.28351488243103456,"score_spread":0.24665522178256394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411050228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866109,0.00080160226,0.0001461435,0.0001706651,0.000028374363,0.000103302766,0.011041284,0.0000111166055,0.0010866737],"genre_scores_gemma":[0.9861205,0.0008891908,0.00059889304,0.00040610915,0.000026734799,0.00021421019,0.0104129985,0.000011010093,0.001320276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951065,0.00007992691,0.000047839636,0.00017675289,0.00009454461,0.00009027809],"domain_scores_gemma":[0.9994368,0.000028456247,0.00016553447,0.00011265843,0.00012146004,0.00013522789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010272769,0.0004998575,0.0005259449,0.0010704176,0.001213571,0.000855491,0.00050538866,0.00070687936,0.0009846231],"category_scores_gemma":[0.0008252521,0.0006713044,0.0008356913,0.002425686,0.00030145957,0.0006094798,0.00078276265,0.00087340723,0.00058687275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013383466,0.00011516854,0.9951556,0.000036701378,0.00027474604,0.00027741605,0.0004341471,0.000051011702,0.0002951173,0.00004855655,0.0015579925,0.0016196682],"study_design_scores_gemma":[0.00002399657,0.000050671453,0.9981444,0.000027313754,0.00008577536,0.0001902663,0.00042601518,0.00007583718,0.000016548833,0.000021875814,0.0009310677,0.000006187227],"about_ca_topic_score_codex":0.16446447,"about_ca_topic_score_gemma":0.21232761,"teacher_disagreement_score":0.16446447,"about_ca_system_score_codex":0.0012456237,"about_ca_system_score_gemma":0.0019772726,"threshold_uncertainty_score":0.3270144},"labels":[],"label_agreement":null},{"id":"W4411251236","doi":"10.1016/j.msard.2025.106561","title":"Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia; Public Health Ontario; Centre for Advancing Health Outcomes; St. Michael's Hospital; Queen's University; McMaster University; University of Toronto; SickKids Foundation; University of Calgary; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Multiple sclerosis; Medicine; Quality of life (healthcare); Mental health; Physical health; Psychiatry; Gerontology","score_opus":0.051390492235226334,"score_gpt":0.3133559377619772,"score_spread":0.26196544552675083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411251236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990189,0.0042092376,0.00016640492,0.0006094114,0.0001323978,0.000016286505,0.000754715,0.00001029304,0.0039123236],"genre_scores_gemma":[0.99748355,0.0006459896,0.00008297646,0.00020532169,0.00004681084,0.00000658981,0.00037878653,0.000007763487,0.0011422213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984962,0.0005444545,0.00012579103,0.0002922688,0.0002253259,0.00031602033],"domain_scores_gemma":[0.9921335,0.0023521192,0.0028369902,0.0007104885,0.0006605879,0.001306397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018360461,0.0006714474,0.00085019495,0.0014668747,0.0005233937,0.001950577,0.00051896594,0.0011186865,0.00475376],"category_scores_gemma":[0.0077825245,0.0005697352,0.0028273184,0.0011330956,0.0006875566,0.00103418,0.0011953999,0.0012188926,0.00051584386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008065672,0.00010446269,0.99279517,0.000057556845,0.0010048844,0.00015234263,0.000328944,0.000082876715,0.00096594694,0.00010101126,0.0002118813,0.003388349],"study_design_scores_gemma":[0.0000070875785,0.0000509273,0.99935883,0.000016239092,0.00011311189,0.000045320565,0.00018142702,0.000028617089,0.000037625923,0.000042903164,0.000113550916,0.0000043342525],"about_ca_topic_score_codex":0.008811505,"about_ca_topic_score_gemma":0.010890482,"teacher_disagreement_score":0.008811505,"about_ca_system_score_codex":0.00042438877,"about_ca_system_score_gemma":0.0007363601,"threshold_uncertainty_score":0.017520428},"labels":[],"label_agreement":null},{"id":"W4411605538","doi":"10.1016/j.msard.2025.106593","title":"Comment on the use of AI-based protein design for autoimmune encephalitis: exciting possibilities and practical considerations","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"Autoimmune encephalitis; Medicine; Multiple sclerosis; Encephalitis; Immunology; Virology; Neuroscience; Virus; Biology","score_opus":0.13681636538055222,"score_gpt":0.3397781609027335,"score_spread":0.20296179552218127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411605538","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045595242,0.006800274,0.00094053254,0.8966994,0.09214464,0.000029249144,0.00012844024,0.00013079986,0.0026706618],"genre_scores_gemma":[0.0029828683,0.0029266658,0.00092185696,0.9406507,0.04841888,0.00005828935,0.000034627312,0.000035660698,0.003970524],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948449,0.00093404355,0.0008399256,0.0008899188,0.0019661284,0.00052509626],"domain_scores_gemma":[0.98588365,0.007801041,0.0010662286,0.00048095503,0.0037803822,0.0009878434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006032522,0.001274061,0.0013912666,0.0006791927,0.002501761,0.0028400037,0.004138179,0.044631984,0.005953264],"category_scores_gemma":[0.025617927,0.00062200427,0.0024653033,0.00066306605,0.0050371937,0.0043448713,0.0018223876,0.03878441,0.00785009],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023803143,0.000041726184,0.00022991089,0.0003406032,0.000060868573,0.0012907678,0.00016685332,0.0002453516,0.0015495945,0.0066843634,0.97890943,0.010242556],"study_design_scores_gemma":[0.00019623493,0.00016376008,0.0004670713,0.0002962542,0.000066513014,0.0010026582,0.00018655388,0.00033972255,0.0017755557,0.009721489,0.9857006,0.00008344464],"about_ca_topic_score_codex":0.005382249,"about_ca_topic_score_gemma":0.0055073197,"teacher_disagreement_score":0.044631984,"about_ca_system_score_codex":0.00337069,"about_ca_system_score_gemma":0.002565861,"threshold_uncertainty_score":0.031903446},"labels":[],"label_agreement":null},{"id":"W4411644443","doi":"10.1016/j.msard.2025.106595","title":"Heterogeneity in health care pathways preceding the classical recognition of adult-onset multiple sclerosis: A multichannel state sequence analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Nova Scotia Health Authority; Vancouver Coastal Health; University of British Columbia; BC Centre for Disease Control; Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; European Genomic Institute for Diabetes; European Committee for Treatment and Research in Multiple Sclerosis; National Multiple Sclerosis Society","keywords":"Medicine; Multiple sclerosis; Cohort; Health care; Neurology; Population; Cohort study; Disease; Pediatrics; Physical therapy; Psychiatry; Internal medicine","score_opus":0.07206775663767315,"score_gpt":0.30274204998045173,"score_spread":0.23067429334277859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411644443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99887675,0.00005230732,0.0006636423,0.00004453126,0.0000029152736,0.000012376327,0.0002421297,0.0000041034705,0.00010120485],"genre_scores_gemma":[0.99908936,0.000015444333,0.00035045616,0.00001618711,0.0000034268394,0.000011335083,0.00043992847,0.0000022858062,0.000071545706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977822,0.0010945232,0.00021676366,0.00044244228,0.00012532547,0.0003387619],"domain_scores_gemma":[0.98404443,0.010512982,0.0023976397,0.0012508858,0.0009857176,0.0008082875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004668015,0.00020742811,0.0005357004,0.001258839,0.0006343572,0.0012008585,0.00057446054,0.00059688353,0.0029352952],"category_scores_gemma":[0.017115027,0.00018802588,0.0010163903,0.0014363731,0.00047879765,0.0011127765,0.0012879642,0.0007810862,0.00014185527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020681317,0.00019979749,0.98675936,0.000027556503,0.00054770784,0.00021920746,0.0004266291,0.002056164,0.00086945645,0.00079802057,0.00020022724,0.005827779],"study_design_scores_gemma":[0.0000679977,0.00039399584,0.96981144,0.000022706648,0.00031038074,0.00024151645,0.0008073426,0.025834464,0.0003673044,0.0018187187,0.00029055588,0.0000336112],"about_ca_topic_score_codex":0.01948358,"about_ca_topic_score_gemma":0.018652793,"teacher_disagreement_score":0.01948358,"about_ca_system_score_codex":0.00073115074,"about_ca_system_score_gemma":0.0016177192,"threshold_uncertainty_score":0.038740337},"labels":[],"label_agreement":null},{"id":"W4412441076","doi":"10.1016/j.msard.2025.106616","title":"Ponesimod as add-on treatment in patients with active relapsing multiple sclerosis under dimethyl fumarate (POINT): A phase 3, randomized, placebo-controlled clinical trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Actelion Pharmaceuticals; Janssen Research and Development; Johnson and Johnson","keywords":"Medicine; Dimethyl fumarate; Multiple sclerosis; Placebo; Clinical endpoint; Randomized controlled trial; Clinical trial; Internal medicine; Phases of clinical research; Oncology; Immunology; Alternative medicine; Pathology","score_opus":0.04708319287789179,"score_gpt":0.3306873086080997,"score_spread":0.2836041157302079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412441076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641634,0.006814393,0.0005850309,0.0005918305,0.000558247,0.0026455466,0.0006460194,0.00016477366,0.0015778218],"genre_scores_gemma":[0.9858059,0.0061182724,0.0013633127,0.00087298034,0.0005513295,0.002396062,0.00080798066,0.000024067811,0.00206021],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99960667,0.0001758778,0.000025036557,0.000068336856,0.00003632529,0.000087765184],"domain_scores_gemma":[0.99935275,0.00019680118,0.00011413889,0.000039770992,0.00005089839,0.00024571567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015594155,0.0017179749,0.0036798532,0.00058401,0.0005302752,0.00093196484,0.0009221555,0.0018468616,0.0058228103],"category_scores_gemma":[0.0013959549,0.00052600005,0.0020964034,0.00043475168,0.0011421476,0.0014715196,0.00041007416,0.0029720906,0.0007500906],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96764284,0.0062184082,0.00042195985,0.00092645927,0.0009661742,0.000066115244,0.00006440814,0.00022005987,0.003115259,0.0001064001,0.00051183684,0.019739915],"study_design_scores_gemma":[0.9193021,0.07779187,0.0013946177,0.000032131906,0.00046460726,0.000036229903,0.00003106681,0.00019652063,0.00031773167,0.000105888634,0.00031568113,0.00001155105],"about_ca_topic_score_codex":0.0008578774,"about_ca_topic_score_gemma":0.001585565,"teacher_disagreement_score":0.0058228103,"about_ca_system_score_codex":0.0005123683,"about_ca_system_score_gemma":0.0008914104,"threshold_uncertainty_score":0.019479215},"labels":[],"label_agreement":null},{"id":"W4412441085","doi":"10.1016/j.msard.2025.106606","title":"The P42 epitope in MOG associated disorders: Understanding regional variations and predictive value","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Multiple sclerosis; Predictive value; Epitope; Value (mathematics); Immunology; Internal medicine; Antibody; Machine learning; Computer science","score_opus":0.012913026590431873,"score_gpt":0.22860285113822063,"score_spread":0.21568982454778876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412441085","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008928359,0.012140743,0.00029619763,0.035786536,0.95073813,0.000025833177,0.00005829441,0.00004563061,0.00081936695],"genre_scores_gemma":[0.0005007254,0.003842226,0.00013457399,0.01708957,0.9757824,0.000021047055,0.000021558422,0.000016505597,0.0025914852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960283,0.000949345,0.0006545322,0.0006379062,0.0014675648,0.0002623151],"domain_scores_gemma":[0.97758603,0.0121839475,0.0010460131,0.00050297,0.0061018905,0.0025791388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01193909,0.0040699504,0.0048196707,0.003563076,0.0022284596,0.006066698,0.0039916374,0.018288502,0.00509387],"category_scores_gemma":[0.02193887,0.0014343993,0.0027501686,0.0014199148,0.0024991718,0.003998863,0.0016379264,0.024096742,0.003879135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019981951,0.000030156585,0.00010874053,0.00044695067,0.00008551943,0.0004037553,0.0000199293,0.00005454063,0.00016010033,0.000478088,0.9883874,0.009624942],"study_design_scores_gemma":[0.00035703846,0.00016394255,0.0016614086,0.0010715077,0.00045667522,0.0014293084,0.0001018494,0.0010008413,0.00040116333,0.003308673,0.98996407,0.000083665014],"about_ca_topic_score_codex":0.0015470498,"about_ca_topic_score_gemma":0.0038375442,"teacher_disagreement_score":0.018288502,"about_ca_system_score_codex":0.0028213328,"about_ca_system_score_gemma":0.0021224683,"threshold_uncertainty_score":0.06314069},"labels":[],"label_agreement":null},{"id":"W4412467872","doi":"10.1016/j.msard.2025.106620","title":"Automated multiple sclerosis lesion segmentation from 3D-FLAIR MRI using R2AUNet: A deep learning approach with recurrent residual and attention mechanisms","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Fluid-attenuated inversion recovery; Medicine; Multiple sclerosis; Segmentation; Lesion; Magnetic resonance imaging; Residual; Radiology; Neuroscience; Artificial intelligence; Pathology; Computer science; Psychology","score_opus":0.042766705810173444,"score_gpt":0.27687851875551867,"score_spread":0.23411181294534522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412467872","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041828427,0.0007133851,0.94774765,0.00030487907,0.00009419939,0.0001388961,0.0006349113,0.00751521,0.0010224815],"genre_scores_gemma":[0.34441873,0.00062397163,0.64440006,0.0004467003,0.0001307817,0.00021145187,0.002701446,0.0010089723,0.00605786],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996611,0.00004770041,0.000021170481,0.00012271777,0.00006615375,0.00008117658],"domain_scores_gemma":[0.99959356,0.00012289827,0.00004697177,0.00006132453,0.0001359181,0.000039348695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011183023,0.0013428362,0.0015445454,0.0015327302,0.000542963,0.0012904364,0.0024130025,0.0025169067,0.0023975768],"category_scores_gemma":[0.0012757325,0.0010592958,0.0015569237,0.0011088141,0.00042026018,0.0011618846,0.00187821,0.0015089881,0.0017266367],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005992763,0.00032548484,0.002496913,0.0002536068,0.0002976878,0.0002905712,0.00015266257,0.19291058,0.03799263,0.0026528374,0.009911804,0.75211596],"study_design_scores_gemma":[0.000010555861,0.000046712095,0.0003584541,0.00001291119,0.000029805215,0.00006646609,0.000014626808,0.9916359,0.0059288885,0.001177107,0.00070535083,0.000013221343],"about_ca_topic_score_codex":0.011841364,"about_ca_topic_score_gemma":0.021549959,"teacher_disagreement_score":0.011841364,"about_ca_system_score_codex":0.0007782558,"about_ca_system_score_gemma":0.0015869613,"threshold_uncertainty_score":0.023544848},"labels":[],"label_agreement":null},{"id":"W4412529008","doi":"10.1016/j.msard.2025.106631","title":"Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Medicine; Watchful waiting; Multiple sclerosis; Pediatrics; Surgery; Dermatology; Psychiatry; Internal medicine; Cancer","score_opus":0.019271919074710903,"score_gpt":0.26887356785321725,"score_spread":0.24960164877850635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412529008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928254,0.00024202048,0.000010155237,0.000025239877,0.000006868481,0.0000028636564,0.000095675736,0.0000012461045,0.00033345167],"genre_scores_gemma":[0.9994843,0.000121124336,0.000010020911,0.000025089732,0.000012904068,0.0000037288112,0.00020283349,7.4330404e-7,0.00013927187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973994,0.000047580543,0.0000249913,0.00004306056,0.000030543364,0.00011387916],"domain_scores_gemma":[0.9990277,0.0001598893,0.0003902176,0.000048157002,0.00006931118,0.00030460235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004194391,0.00017280043,0.00037013544,0.00047755722,0.00062371814,0.00092104345,0.0002557342,0.00044623966,0.0015319064],"category_scores_gemma":[0.0020060646,0.00014243538,0.00050204067,0.00051328354,0.00021334211,0.0005740667,0.0004852157,0.00082816556,0.00016751357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013090584,0.00017234305,0.9955844,0.000019106506,0.00009764192,0.00012856617,0.0002054656,0.000021086036,0.0001552121,0.0000333333,0.00012926893,0.0021446384],"study_design_scores_gemma":[0.000038619568,0.00044762288,0.9982986,0.000018069737,0.00010957274,0.00021426496,0.0005516588,0.000076253666,0.000046001387,0.000044033695,0.00014793554,0.000007291733],"about_ca_topic_score_codex":0.0077835633,"about_ca_topic_score_gemma":0.007066786,"teacher_disagreement_score":0.0077835633,"about_ca_system_score_codex":0.00032088388,"about_ca_system_score_gemma":0.0005283129,"threshold_uncertainty_score":0.015476525},"labels":[],"label_agreement":null},{"id":"W4412702645","doi":"10.1016/j.msard.2025.106637","title":"Serum neurofilament light chain as a biomarker in multiple sclerosis: A cross-sectional observation in real-world clinical practice","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"Canadian Institutes of Health Research; University Hospital Foundation; Roche","keywords":"Multiple sclerosis; Medicine; Biomarker; Cross-sectional study; Clinical Practice; Immunology; Oncology; Pathology; Physical therapy","score_opus":0.11615171406844582,"score_gpt":0.37339559586724697,"score_spread":0.25724388179880114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412702645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990928,0.00039340204,0.0001014887,0.00006183537,0.000006747455,0.0000068043078,0.00008007664,0.0000031356924,0.00025363723],"genre_scores_gemma":[0.99969804,0.0000934022,0.00006179475,0.00003124589,0.000007865385,0.000004491792,0.00006526497,8.584687e-7,0.000037023125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829906,0.0007463652,0.0002525199,0.0003589033,0.00020519894,0.00013793536],"domain_scores_gemma":[0.9944706,0.0015705768,0.0023297656,0.0003695332,0.000676583,0.00058293354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020155234,0.00032871557,0.0004963431,0.00089445495,0.0005992539,0.001230728,0.00035114388,0.00085096457,0.0008438234],"category_scores_gemma":[0.0075499024,0.00045213656,0.00036675,0.0016146216,0.00055983255,0.001051391,0.00050917035,0.0006366467,0.0002172851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039888004,0.000030075584,0.9992162,0.000006196234,0.00003093774,0.000045976143,0.00012928496,0.0000073620217,0.00010381437,0.0000066936914,0.000024514902,0.00035907014],"study_design_scores_gemma":[0.000005312811,0.00016469046,0.99864024,0.000006235057,0.000040621013,0.0003515057,0.0005000873,0.00010178412,0.000057622383,0.000018528066,0.00010848636,0.000004873181],"about_ca_topic_score_codex":0.003078191,"about_ca_topic_score_gemma":0.0028293838,"teacher_disagreement_score":0.003078191,"about_ca_system_score_codex":0.00030495154,"about_ca_system_score_gemma":0.0004768594,"threshold_uncertainty_score":0.010659218},"labels":[],"label_agreement":null},{"id":"W4412713513","doi":"10.1016/j.msard.2025.106617","title":"Real-world change in annualized relapse rate and healthcare resource utilization following initiation of ofatumumab in people with multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Quebec Population Health Research Network","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Multiple sclerosis; Health care; Ofatumumab; Natalizumab; Resource (disambiguation); Physical medicine and rehabilitation; Physical therapy; Environmental health; Intensive care medicine; Internal medicine; Economic growth; Psychiatry","score_opus":0.06405300285565096,"score_gpt":0.3130705169597751,"score_spread":0.24901751410412415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412713513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705446,0.00047875862,0.000055213113,0.00019927026,0.000020648225,0.0000070611136,0.0018223724,0.0000074279474,0.00035476778],"genre_scores_gemma":[0.9985776,0.00013940892,0.0000473111,0.000059344242,0.000017725968,0.000009458863,0.0010404481,0.0000016856997,0.000107004686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998579,0.00048624421,0.00022499457,0.00027152497,0.00016705226,0.0002711717],"domain_scores_gemma":[0.99628437,0.00081538496,0.0019489665,0.00021043417,0.00032235432,0.00041844088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015494839,0.00024978656,0.0005665448,0.00070072286,0.00037056813,0.0011229551,0.00050660333,0.0011261496,0.0013040669],"category_scores_gemma":[0.0065029725,0.00027353564,0.001599248,0.0013688437,0.0002600069,0.001093143,0.0006666953,0.0015233887,0.00025233295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011525081,0.00011283491,0.9956014,0.000044781595,0.0004383178,0.00006632602,0.000120048,0.00029514474,0.00007032627,0.000036796555,0.00031468793,0.0017469147],"study_design_scores_gemma":[0.000020797695,0.00015303682,0.99860007,0.000013084946,0.000091337664,0.00007813687,0.00024187387,0.0005700091,0.000027182461,0.000040839575,0.00015388698,0.0000096781105],"about_ca_topic_score_codex":0.0249568,"about_ca_topic_score_gemma":0.022289112,"teacher_disagreement_score":0.0249568,"about_ca_system_score_codex":0.0010424947,"about_ca_system_score_gemma":0.0006197521,"threshold_uncertainty_score":0.049623072},"labels":[],"label_agreement":null},{"id":"W4412856400","doi":"10.1016/j.msard.2025.106619","title":"Systematic review on the wearing-off phenomenon of disease-modifying therapies in managing multiple sclerosis","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Regimen; Psychological intervention; Confidence interval; Disease; Physical therapy; Systematic review; Pediatrics; Internal medicine; MEDLINE; Psychiatry","score_opus":0.0776087536671738,"score_gpt":0.30965766634740216,"score_spread":0.23204891268022837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412856400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093250256,0.99825686,0.000079330384,0.00009782804,0.000118940334,0.00011271466,0.00016626737,0.000004060722,0.0002315847],"genre_scores_gemma":[0.019516665,0.9787233,0.0005972892,0.0005965571,0.00011354393,0.00018527471,0.00012133693,0.0000041055073,0.00014192965],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927457,0.0027478752,0.0026799284,0.0004935505,0.0011353615,0.00019752442],"domain_scores_gemma":[0.9800853,0.014889567,0.0037717926,0.00022689557,0.0008353612,0.00019110386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006627346,0.0011474561,0.0068144957,0.0045717848,0.00043325324,0.002309407,0.0014404436,0.0017407243,0.0052283728],"category_scores_gemma":[0.028054329,0.000758883,0.0078673065,0.0054520564,0.00075764087,0.0015705155,0.0015011252,0.0014362877,0.00022548407],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061578595,0.000021570599,0.0006598825,0.9232075,0.027470233,0.00009910333,0.00013545404,0.00007355546,0.0001755743,0.00020908428,0.0013996395,0.045932654],"study_design_scores_gemma":[0.0013815357,0.00042661463,0.008446089,0.6693014,0.2924718,0.00044544213,0.00026931678,0.00011106239,0.00022234087,0.00040168417,0.026456293,0.00006645875],"about_ca_topic_score_codex":0.007735732,"about_ca_topic_score_gemma":0.025758447,"teacher_disagreement_score":0.007735732,"about_ca_system_score_codex":0.002117079,"about_ca_system_score_gemma":0.0040438445,"threshold_uncertainty_score":0.0350492},"labels":[],"label_agreement":null},{"id":"W4413049549","doi":"10.1016/j.msard.2025.106665","title":"Treatment of First and Subsequent Attacks in Multiple Sclerosis","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Dermatology; Psychiatry","score_opus":0.02823803753599192,"score_gpt":0.2574638461557841,"score_spread":0.2292258086197922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413049549","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006524744,0.034440394,0.00014131724,0.037530363,0.9258891,0.000029727884,0.000041803505,0.000038753806,0.0018232276],"genre_scores_gemma":[0.0006888776,0.012189633,0.00010702078,0.023029841,0.9603791,0.000031938544,0.000023778573,0.000013586443,0.0035362595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947108,0.0017523611,0.000915713,0.0003939969,0.0019091615,0.0003180713],"domain_scores_gemma":[0.98193675,0.010054618,0.0015412853,0.00032862395,0.003935119,0.002203642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00877212,0.004010276,0.006132056,0.0036842613,0.003284862,0.005249125,0.003999999,0.024701497,0.0081715],"category_scores_gemma":[0.023501119,0.0015889351,0.003994397,0.0018113909,0.002088625,0.0035504268,0.0014802206,0.02644464,0.004915863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022796809,0.00003842254,0.00005563667,0.0009434136,0.00010366223,0.00027415378,0.000017330836,0.00005202115,0.000063721665,0.0003705823,0.9813703,0.016482761],"study_design_scores_gemma":[0.0008831624,0.0002541666,0.0013478581,0.0023567353,0.00067373045,0.0013292673,0.000087215514,0.0006061239,0.00016704299,0.0012254411,0.9910129,0.000056380584],"about_ca_topic_score_codex":0.003231592,"about_ca_topic_score_gemma":0.010701574,"teacher_disagreement_score":0.024701497,"about_ca_system_score_codex":0.004219962,"about_ca_system_score_gemma":0.0025824057,"threshold_uncertainty_score":0.046391964},"labels":[],"label_agreement":null},{"id":"W4413323873","doi":"10.1016/j.msard.2025.106697","title":"Gaps and discordance in assessment of PIRA identified between HCPs and people with MS: Results of international surveys","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Sanofi Genzyme; EMD Serono; National Institutes of Health; Genentech; Multiple Sclerosis Society; Moderna; Kiniksa Pharmaceuticals; Biogen; Merck KGaA; Sanofi; Fondation Brain Canada; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Vir Biotechnology; Eli Lilly and Company; Multiple Sclerosis Society of Canada; Amgen","keywords":"Medicine; Multiple sclerosis; Family medicine; Psychiatry","score_opus":0.02734716556446047,"score_gpt":0.303696548193095,"score_spread":0.2763493826286345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413323873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974094,0.00080076506,0.00025732463,0.00013561285,0.000011559126,0.00003403172,0.0002809808,0.0000040506175,0.0010663568],"genre_scores_gemma":[0.9993248,0.00021419821,0.000117802345,0.000050744446,0.00000617392,0.000030853884,0.000189245,0.0000014673549,0.00006475377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.989791,0.00530965,0.0016773259,0.0010257497,0.0015624558,0.00063380477],"domain_scores_gemma":[0.98084486,0.0077802422,0.006253505,0.0012017828,0.0032866122,0.00063295243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012783517,0.0001877908,0.0004485569,0.0014296392,0.00046971088,0.0010857763,0.0005597147,0.0005210447,0.0007403743],"category_scores_gemma":[0.029374326,0.0002007165,0.00039316027,0.0016381338,0.00088405155,0.0010850778,0.0022769948,0.0004519476,0.0001453149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084412764,0.000031790354,0.97960985,0.00014253956,0.000094821415,0.000044497425,0.009838721,0.000044221513,0.00015309291,0.000052187333,0.00018385294,0.009719965],"study_design_scores_gemma":[0.0000044038256,0.00009110865,0.99020594,0.000076977696,0.000021140642,0.000092039525,0.008842058,0.00006962525,0.000073016956,0.000024841584,0.0004927653,0.000006166869],"about_ca_topic_score_codex":0.0073878434,"about_ca_topic_score_gemma":0.005641941,"teacher_disagreement_score":0.012783517,"about_ca_system_score_codex":0.00048225335,"about_ca_system_score_gemma":0.0008132593,"threshold_uncertainty_score":0.06760651},"labels":[],"label_agreement":null},{"id":"W4413682646","doi":"10.1016/j.msard.2025.106696","title":"Correlations of myelin, axon, and inflammation metrics from multi echo T2 relaxation and multi-shell diffusion imaging in multiple sclerosis and healthy controls","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; International Collaboration On Repair Discoveries","funders":"Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Multiple Sclerosis Society of Canada","keywords":"Multiple sclerosis; Medicine; Myelin; Diffusion MRI; Diffusion imaging; Axon; White matter; Neuroscience; Inflammation; Echo (communications protocol); Shell (structure); Diffusion; Nuclear magnetic resonance; Magnetic resonance imaging; Pathology; Anatomy; Immunology; Central nervous system; Physics; Internal medicine; Biology; Radiology; Materials science","score_opus":0.04339920880491238,"score_gpt":0.2789367482793924,"score_spread":0.23553753947448003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413682646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936265,0.00018377337,0.000087440785,0.000016780594,0.0000054811717,0.0000040547234,0.00010653885,0.00000545309,0.0002278569],"genre_scores_gemma":[0.9996101,0.00004171145,0.000049396105,0.0000070554615,0.000010316926,0.0000037876255,0.00010132891,0.000002457468,0.00017379738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995041,0.00009524371,0.0000765404,0.00016869066,0.00007229435,0.00008313788],"domain_scores_gemma":[0.9986388,0.00040593714,0.00044652406,0.00013950988,0.00018402033,0.00018512929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090229016,0.00056862767,0.0005352132,0.0013495184,0.00039268215,0.00064816134,0.00031484594,0.00061988534,0.0016109094],"category_scores_gemma":[0.0039735436,0.00024218664,0.00029510874,0.00051089085,0.0004411806,0.000533892,0.00048973784,0.00041027516,0.00017805572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034066301,0.00018487722,0.98130184,0.00004194628,0.0003360601,0.00070228183,0.0005465046,0.00015980254,0.007119931,0.00012634168,0.00023556799,0.005838134],"study_design_scores_gemma":[0.00001698362,0.0002568105,0.9982267,0.0000034420607,0.00008689291,0.00042260034,0.00022984194,0.00023001758,0.00031218343,0.00010025454,0.00010906923,0.0000052912847],"about_ca_topic_score_codex":0.0054265885,"about_ca_topic_score_gemma":0.003609292,"teacher_disagreement_score":0.0054265885,"about_ca_system_score_codex":0.0002624194,"about_ca_system_score_gemma":0.00021154461,"threshold_uncertainty_score":0.01078999},"labels":[],"label_agreement":null},{"id":"W4413903534","doi":"10.1016/j.msard.2025.106720","title":"Subjective cognitive fatigability is associated with worse patient-reported physical disability in multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Psychological Association","keywords":"Multiple sclerosis; Medicine; Cognition; Physical disability; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.042468346747391035,"score_gpt":0.28022884915920115,"score_spread":0.23776050241181013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413903534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894434,0.0005146075,0.00003235374,0.000029552706,0.0000070189612,0.0000023471102,0.000039234703,0.0000014169791,0.00042913808],"genre_scores_gemma":[0.9996667,0.00012332207,0.000024454579,0.000016577105,0.000011832975,0.000001908784,0.000049750935,6.1812256e-7,0.00010487711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995314,0.00018542292,0.00009062674,0.00005679872,0.00007943236,0.000056293055],"domain_scores_gemma":[0.99549544,0.0010483292,0.0025525237,0.00014834816,0.0002943376,0.0004610711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007789804,0.00034402552,0.00041040813,0.0007388505,0.00032250138,0.0007167185,0.0002455293,0.000500359,0.001686005],"category_scores_gemma":[0.005855404,0.00017333477,0.00055074046,0.0007997863,0.00030218472,0.00034515795,0.000428216,0.00051541155,0.00013669912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025234587,0.000079933794,0.9970976,0.000035389825,0.00020743278,0.00008910756,0.00012392922,0.000031772703,0.00022530598,0.000007816442,0.000033001324,0.0018162417],"study_design_scores_gemma":[0.000003249467,0.00006675282,0.9996668,0.00000415038,0.00003203517,0.000078586345,0.00007043998,0.000029359777,0.000014931248,0.000007127502,0.00002488298,0.0000017431136],"about_ca_topic_score_codex":0.0027265109,"about_ca_topic_score_gemma":0.004443734,"teacher_disagreement_score":0.0027265109,"about_ca_system_score_codex":0.0001625624,"about_ca_system_score_gemma":0.00020725632,"threshold_uncertainty_score":0.0056402683},"labels":[],"label_agreement":null},{"id":"W4413923643","doi":"10.1016/j.msard.2025.106718","title":"When does multiple sclerosis start?","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Multiple sclerosis; Medicine; Physical medicine and rehabilitation; Immunology","score_opus":0.028666343054551614,"score_gpt":0.26593867714112135,"score_spread":0.23727233408656973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413923643","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000144604355,0.0067265113,0.00006156939,0.045488387,0.9469908,0.0000169528,0.00003815275,0.000028224516,0.0006349793],"genre_scores_gemma":[0.00019401369,0.0032443698,0.00007469551,0.03623156,0.95780605,0.000031551128,0.000021392581,0.000023513445,0.0023729026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98081094,0.006081235,0.003278197,0.0015151141,0.007200639,0.0011138325],"domain_scores_gemma":[0.90147275,0.051292844,0.0072873747,0.0022676974,0.024944376,0.012734922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029248428,0.005315121,0.009079346,0.008514619,0.006953838,0.015727408,0.0067179604,0.0449109,0.018470233],"category_scores_gemma":[0.09218829,0.003041712,0.00473047,0.004066133,0.004870349,0.009395763,0.0045759166,0.036754522,0.015180129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051246316,0.000009361673,0.00003229381,0.00039725853,0.000048903403,0.00008772007,0.000017732697,0.000011721693,0.000019667055,0.00019881387,0.99575895,0.0033664182],"study_design_scores_gemma":[0.00036839573,0.000059895352,0.0005491311,0.0032490292,0.0004303862,0.000387534,0.00016899666,0.00023805774,0.00008946852,0.0024518739,0.9919419,0.00006527112],"about_ca_topic_score_codex":0.004547748,"about_ca_topic_score_gemma":0.016141078,"teacher_disagreement_score":0.0449109,"about_ca_system_score_codex":0.007941397,"about_ca_system_score_gemma":0.007953122,"threshold_uncertainty_score":0.15468234},"labels":[],"label_agreement":null},{"id":"W4414298417","doi":"10.1016/j.msard.2025.106761","title":"Machine learning using clinical variables to screen for depression and anxiety in people with early multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; St. Michael's Hospital; Centre for Advancing Health Outcomes; University of British Columbia; University of Toronto; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"Mach-Gaensslen Foundation of Canada; University of Calgary","keywords":"Depression (economics); Multiple sclerosis; Anxiety; Identification (biology); MEDLINE","score_opus":0.04901473421761774,"score_gpt":0.3064524261605053,"score_spread":0.2574376919428875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414298417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551059,0.002418285,0.033004753,0.0030352762,0.00022099126,0.00026753644,0.0026436115,0.00035387024,0.0029497975],"genre_scores_gemma":[0.99146456,0.00032739565,0.0063456865,0.00020813967,0.00007196923,0.0000924573,0.0010827633,0.000008212675,0.0003987961],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983798,0.00086252345,0.00015258501,0.00028559912,0.00019601235,0.0001233934],"domain_scores_gemma":[0.9894797,0.007909992,0.0011542533,0.0003712943,0.000799494,0.0002851763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005489337,0.0008044898,0.0008181366,0.0024926008,0.00036083764,0.0011856994,0.0006930174,0.00080978865,0.001367402],"category_scores_gemma":[0.015920706,0.0002447314,0.001120571,0.0013934785,0.00044901273,0.0007255735,0.00066890474,0.0017174019,0.0004001746],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061192835,0.00048628365,0.8664337,0.00012384531,0.00087711716,0.00014632301,0.000097034834,0.05280797,0.00025363444,0.00029511278,0.0022527198,0.075614445],"study_design_scores_gemma":[0.00009006064,0.00075436523,0.24468157,0.00020022906,0.00036615663,0.00033266068,0.00016529056,0.7470394,0.0007544275,0.0040909024,0.0014658562,0.000059100967],"about_ca_topic_score_codex":0.0059653367,"about_ca_topic_score_gemma":0.0059243846,"teacher_disagreement_score":0.0059653367,"about_ca_system_score_codex":0.00070491503,"about_ca_system_score_gemma":0.0009637076,"threshold_uncertainty_score":0.02903074},"labels":[],"label_agreement":null},{"id":"W4414804539","doi":"10.1016/j.msard.2025.106783","title":"A conceptual approach to comprehensive interdisciplinary cognitive rehabilitation: A description using the TIDieR-rehab framework","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Educational and Psychological Assessments","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Ottawa; Memorial University of Newfoundland; McGill University; Queen's University","funders":"Multiple Sclerosis Society; International Progressive MS Alliance","keywords":"Cognition; Rehabilitation; Cognitive rehabilitation therapy; Intervention (counseling); Occupational therapy; Cognitive skill; Checklist; Process (computing); Cognitive Intervention","score_opus":0.07745267860194258,"score_gpt":0.35883785864246953,"score_spread":0.2813851800405269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414804539","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02152438,0.04128852,0.6863391,0.06457996,0.001647025,0.0021847459,0.0006038374,0.00030038922,0.18153208],"genre_scores_gemma":[0.4101701,0.028158952,0.5225971,0.012832226,0.000683021,0.005449157,0.00064126967,0.00018355712,0.01928456],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99665785,0.002023989,0.00033952494,0.00026348687,0.0004081447,0.00030702553],"domain_scores_gemma":[0.9986895,0.0005788879,0.00014148044,0.000060921393,0.00031100903,0.00021836399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005979624,0.0009882372,0.000701014,0.003206454,0.0033821112,0.007299695,0.0027083792,0.0029250109,0.0029062128],"category_scores_gemma":[0.0029306433,0.000539771,0.0014814078,0.0030361272,0.014250276,0.005256966,0.0040067486,0.005986008,0.0006196009],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015071233,0.000055679207,0.0007051546,0.00025699072,0.00001431711,0.0003591075,0.009289303,0.0008424791,0.0002850796,0.9716177,0.002977684,0.013581456],"study_design_scores_gemma":[0.000057584435,0.00020155664,0.0043796566,0.002150726,0.00006344754,0.0033636244,0.024184536,0.0062171803,0.00048825832,0.6961515,0.26263312,0.000108809334],"about_ca_topic_score_codex":0.016884856,"about_ca_topic_score_gemma":0.024369637,"teacher_disagreement_score":0.016884856,"about_ca_system_score_codex":0.010776655,"about_ca_system_score_gemma":0.014548651,"threshold_uncertainty_score":0.078190446},"labels":[],"label_agreement":null},{"id":"W4414804578","doi":"10.1016/j.msard.2025.106784","title":"Rehabilitation interventions for improving gait for people with multiple sclerosis: A scoping review of reviews","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University of Saskatchewan; University Health Network","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Saskatchewan Health Research Foundation; University of Saskatchewan","keywords":"Rehabilitation; Psychological intervention; Gait; International Classification of Functioning, Disability and Health; Systematic review; MEDLINE; Multiple sclerosis","score_opus":0.09290883554640164,"score_gpt":0.36568992787326343,"score_spread":0.27278109232686176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414804578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005158378,0.99813384,0.00018533309,0.00023208452,0.00013461146,0.0003456338,0.0001628929,0.000009020753,0.00028076262],"genre_scores_gemma":[0.004474373,0.9935294,0.00073404796,0.00029293966,0.00007389742,0.0006622265,0.00012834558,0.0000046669425,0.000100127094],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98622084,0.0045966553,0.005222389,0.00088762527,0.0026594573,0.0004130032],"domain_scores_gemma":[0.9663971,0.022346372,0.0061725304,0.00045938973,0.004351037,0.00027364577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013951925,0.0023132996,0.0074105375,0.017187564,0.0010048035,0.0038310275,0.0019933349,0.002685531,0.0034447485],"category_scores_gemma":[0.06318766,0.0015457842,0.008476154,0.016879847,0.0009333761,0.0031368271,0.0022426685,0.0017854924,0.00044476855],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010604231,0.000019081092,0.0003669643,0.93558025,0.0031867079,0.000093020295,0.0003559703,0.00011915246,0.0002063096,0.0002826816,0.001973118,0.057710722],"study_design_scores_gemma":[0.00006910071,0.00011723372,0.0014759385,0.9584687,0.021916032,0.00020975724,0.00027979998,0.00006633377,0.00016576161,0.0002073485,0.017002495,0.00002134891],"about_ca_topic_score_codex":0.008328804,"about_ca_topic_score_gemma":0.021622973,"teacher_disagreement_score":0.017187564,"about_ca_system_score_codex":0.004790461,"about_ca_system_score_gemma":0.017135726,"threshold_uncertainty_score":0.07378572},"labels":[],"label_agreement":null},{"id":"W4415224678","doi":"10.1016/j.msard.2025.106799","title":"The influence of manual dexterity on processing speed assessment in multiple sclerosis: A comparison of the PST and oral SDMT","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University; University of Calgary","funders":"Biogen Idec; Biogen","keywords":"Multiple sclerosis; Test (biology); Cohort; Expanded Disability Status Scale; Cognition; Correlation","score_opus":0.049759915345642676,"score_gpt":0.33300855357191367,"score_spread":0.283248638226271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415224678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981706,0.0005938988,0.00019164204,0.000016176793,0.000012244503,0.000016428483,0.000072971176,0.000004569837,0.0009214077],"genre_scores_gemma":[0.9988776,0.00024297861,0.00040102773,0.000023036684,0.000019314084,0.00002373379,0.00013757597,0.000004731852,0.00027004795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977647,0.00091020984,0.00025557633,0.00025338074,0.00074489927,0.000071124654],"domain_scores_gemma":[0.9905363,0.0054683145,0.0022807112,0.00044056604,0.0007771972,0.00049694884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034847555,0.00046521792,0.0005898448,0.00078281603,0.00016038715,0.0008090952,0.00025503366,0.00037420154,0.0010702569],"category_scores_gemma":[0.019074814,0.00015054042,0.00040651805,0.0006462252,0.0003686821,0.0006425253,0.0006833809,0.00031966038,0.00021266866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060580913,0.00024172792,0.9454195,0.00014314461,0.00041173614,0.00009010566,0.00031276757,0.00024905652,0.001676328,0.000046019934,0.00012722953,0.0452243],"study_design_scores_gemma":[0.00006190112,0.0030039346,0.99511355,0.000026820378,0.00013435022,0.0002521675,0.00010701941,0.0005730693,0.00047254065,0.000052926232,0.00019102887,0.000010697017],"about_ca_topic_score_codex":0.0012634661,"about_ca_topic_score_gemma":0.0020391413,"teacher_disagreement_score":0.0034847555,"about_ca_system_score_codex":0.00019012904,"about_ca_system_score_gemma":0.00026662857,"threshold_uncertainty_score":0.018429399},"labels":[],"label_agreement":null},{"id":"W4415610478","doi":"10.1016/j.msard.2025.106819","title":"Validity of model for predicting risk of relapse in MOGAD","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Frailty in Older Adults","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Incidence (geometry); Antibody; Disease; Autoimmune disease; Central nervous system; Optic neuritis; Immunopathology","score_opus":0.0355798650009472,"score_gpt":0.2633935466127812,"score_spread":0.227813681611834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415610478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976224,0.0011449063,0.013607579,0.0014774423,0.0005065718,0.00016804726,0.004182497,0.00027892343,0.0024099809],"genre_scores_gemma":[0.994472,0.00017664349,0.0023005116,0.00013687204,0.0000934898,0.00006738181,0.0018683915,0.000033735254,0.0008508801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600464,0.002081945,0.00031067978,0.0007357666,0.00038922532,0.00047776263],"domain_scores_gemma":[0.96057165,0.031800218,0.0014002856,0.0022282205,0.0028250918,0.0011745632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01768973,0.0015403171,0.001611359,0.0018272646,0.0008820414,0.0025494217,0.0015500814,0.0015421147,0.004388274],"category_scores_gemma":[0.049780555,0.00049238204,0.0032773644,0.0007525026,0.00055227755,0.0017604346,0.0014375295,0.002400624,0.0011345764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025471263,0.00045902145,0.9571288,0.00010338867,0.0019195479,0.00016661336,0.0001719747,0.016304411,0.00019322622,0.00034621308,0.0022556593,0.018404042],"study_design_scores_gemma":[0.0004257844,0.0020567395,0.36096498,0.00034212874,0.0030156365,0.00074006326,0.00085661316,0.6231234,0.00075152656,0.0052437526,0.0023644734,0.0001148263],"about_ca_topic_score_codex":0.016183889,"about_ca_topic_score_gemma":0.00905704,"teacher_disagreement_score":0.01768973,"about_ca_system_score_codex":0.0008781826,"about_ca_system_score_gemma":0.0029525035,"threshold_uncertainty_score":0.093553364},"labels":[],"label_agreement":null},{"id":"W4415613121","doi":"10.1016/j.msard.2025.106816","title":"A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; St. Michael's Hospital; McMaster University; Queen's University; University of British Columbia; Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Multiple Sclerosis Society of Canada; Fondation Brain Canada; Roche","keywords":"Multiple sclerosis; Association (psychology); Age of onset; Quality of life (healthcare); Young adult; MEDLINE","score_opus":0.03992407663709352,"score_gpt":0.29889150811099796,"score_spread":0.25896743147390444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415613121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993773,0.00011758146,0.000028908435,0.000026615651,0.000007700241,0.000012676303,0.00019144967,0.0000015596067,0.00023612285],"genre_scores_gemma":[0.9988518,0.0001444079,0.00011842396,0.00007984048,0.0000131306515,0.000030925217,0.0003582424,0.00000170339,0.0004016351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992036,0.0003046345,0.00013161615,0.00012286486,0.0001026541,0.00013456476],"domain_scores_gemma":[0.99471754,0.0013852089,0.0018392509,0.00036107175,0.00064849673,0.0010483759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001461286,0.00044991955,0.0005751602,0.0010827499,0.0010797097,0.0010804944,0.00037705194,0.0010095773,0.0022036845],"category_scores_gemma":[0.0042241015,0.0009390102,0.0009855616,0.001468368,0.00037725165,0.00095142453,0.0005895422,0.0015817756,0.00050339504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000941998,0.00032125533,0.9989178,0.0000071724453,0.0000703061,0.00004772913,0.00018415568,0.0000062931076,0.0000900054,0.0000051346933,0.000027530215,0.00022855836],"study_design_scores_gemma":[0.000009863037,0.00041317314,0.9987828,0.0000053099784,0.000039929648,0.000102529586,0.0005097878,0.000036116562,0.00002433081,0.0000055218406,0.0000675448,0.000003073203],"about_ca_topic_score_codex":0.010862196,"about_ca_topic_score_gemma":0.01480434,"teacher_disagreement_score":0.010862196,"about_ca_system_score_codex":0.00043142276,"about_ca_system_score_gemma":0.000779885,"threshold_uncertainty_score":0.021597981},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4415613154","doi":"10.1016/j.msard.2025.106818","title":"Patient-reported quality of life and perceived disease burden in mexican patients with neuromyelitis optica spectrum disorder: a cross-sectional analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Guthy-Jackson Charitable Foundation","keywords":"Quality of life (healthcare); Neuromyelitis optica; Disease burden; Multiple sclerosis; Multidisciplinary approach; Spectrum disorder; Disease; Burden of disease","score_opus":0.023110452325815392,"score_gpt":0.28165877251881116,"score_spread":0.2585483201929958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415613154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995846,0.00007088912,0.000019889947,0.000023090857,0.00000265064,0.0000037859324,0.00015616734,8.0517725e-7,0.0001381807],"genre_scores_gemma":[0.99962926,0.000056394918,0.000027717668,0.00001970383,0.000004834049,0.0000065338845,0.00019188183,5.81787e-7,0.000063069565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963593,0.0001407402,0.000050903058,0.00006494067,0.000047646834,0.000059838254],"domain_scores_gemma":[0.9989184,0.00019495038,0.0005243795,0.00006600721,0.0000999774,0.00019623278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008545968,0.0003375349,0.0003948219,0.0008436241,0.00056860194,0.00084739615,0.00031200572,0.00052171637,0.0012582768],"category_scores_gemma":[0.0018473864,0.00036762882,0.00068793085,0.0012553803,0.0003223185,0.0005969481,0.0005193249,0.0006720751,0.00016412143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009005132,0.00006498425,0.99921393,0.00000511742,0.00008929422,0.000028308785,0.00011792257,0.00001564241,0.000070170165,0.0000060447996,0.000028853558,0.00026960048],"study_design_scores_gemma":[0.000007803648,0.00008951301,0.999173,0.0000027359285,0.00004120358,0.00007513335,0.00046699744,0.00007287899,0.000014488211,0.000005146129,0.000048195667,0.0000028722145],"about_ca_topic_score_codex":0.007089934,"about_ca_topic_score_gemma":0.006717912,"teacher_disagreement_score":0.007089934,"about_ca_system_score_codex":0.00032632842,"about_ca_system_score_gemma":0.00025726508,"threshold_uncertainty_score":0.014097333},"labels":[],"label_agreement":null},{"id":"W4416168561","doi":"10.1016/j.msard.2025.106800","title":"Examining diagnostic performance of the 2023 MOGAD criteria: Lessons learned and future directions","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation; Academic Medical Organization of Southwestern Ontario","keywords":"Multiple sclerosis; MEDLINE; Disease; Perspective (graphical); Health professionals","score_opus":0.030559806083246436,"score_gpt":0.262967079254824,"score_spread":0.23240727317157756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416168561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73096496,0.10379098,0.028752655,0.08701475,0.0045003747,0.00040657847,0.0017274452,0.0003954393,0.04244679],"genre_scores_gemma":[0.953435,0.00992837,0.027625011,0.0046321624,0.002179702,0.00012423884,0.000958805,0.00010720553,0.0010094952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9609298,0.01903867,0.0073375166,0.0034747182,0.0069257603,0.0022934356],"domain_scores_gemma":[0.8270653,0.10569445,0.013429536,0.0074267,0.04197819,0.004405772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.077775575,0.0011634694,0.002128509,0.0049110367,0.001199525,0.007130338,0.0042056656,0.002877508,0.0021300116],"category_scores_gemma":[0.16737455,0.00067178404,0.0013517367,0.00286526,0.0023084404,0.0070758425,0.0026444294,0.0029148683,0.00095749146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026913514,0.00018005868,0.8754623,0.00043148128,0.00039725137,0.0003166486,0.001132384,0.00076574506,0.00045517262,0.0016546792,0.006213974,0.1127212],"study_design_scores_gemma":[0.0001199503,0.00093866506,0.9124183,0.0038685794,0.0009434921,0.0032130983,0.011409568,0.012704171,0.0015174034,0.017520493,0.03509629,0.00025001247],"about_ca_topic_score_codex":0.032735948,"about_ca_topic_score_gemma":0.048229076,"teacher_disagreement_score":0.077775575,"about_ca_system_score_codex":0.0027483539,"about_ca_system_score_gemma":0.0057704225,"threshold_uncertainty_score":0.41132146},"labels":[],"label_agreement":null},{"id":"W4416230718","doi":"10.1016/j.msard.2025.106859","title":"Adherence and compliance with exercise training in progressive multiple sclerosis: Rates and correlates from the CogEx trial","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Compliance (psychology); Multiple sclerosis; Clinical trial; Cognition; Patient compliance; Affect (linguistics); Exercise therapy","score_opus":0.07941670029547286,"score_gpt":0.2997765516977942,"score_spread":0.22035985140232134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416230718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901371,0.0060302396,0.0003226182,0.00016816024,0.000044056138,0.00048743005,0.0016076405,0.00001906875,0.0011837821],"genre_scores_gemma":[0.99511814,0.0011874855,0.00041013674,0.0001625509,0.00006058972,0.0007945042,0.0019720772,0.000009660548,0.00028498468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913896,0.005404789,0.0013027374,0.0005530003,0.0010943348,0.00025559016],"domain_scores_gemma":[0.9861232,0.006280452,0.0048337984,0.0012267473,0.0008552821,0.0006805112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012274217,0.00049281213,0.0022397914,0.0007457187,0.00041218763,0.001005154,0.00052872347,0.0012669336,0.0011964041],"category_scores_gemma":[0.015998282,0.00023514121,0.0023726241,0.0012908649,0.0004022984,0.00066904404,0.0008838308,0.0009905834,0.00014468885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29712585,0.002008546,0.6135309,0.0049381,0.02139038,0.000135615,0.0006467443,0.001150931,0.0008721315,0.00023729284,0.0022079023,0.055755664],"study_design_scores_gemma":[0.017315442,0.012208551,0.95606905,0.0007681698,0.009839862,0.00022638145,0.00018079506,0.0011692147,0.00047618165,0.0002358968,0.0014420007,0.00006860322],"about_ca_topic_score_codex":0.0011785536,"about_ca_topic_score_gemma":0.0014660353,"teacher_disagreement_score":0.012274217,"about_ca_system_score_codex":0.00028134385,"about_ca_system_score_gemma":0.000511897,"threshold_uncertainty_score":0.064913034},"labels":[],"label_agreement":null},{"id":"W4416589642","doi":"10.1016/j.msard.2025.106878","title":"Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Queen's University","funders":"Multiple Sclerosis International Federation","keywords":"Rituximab; Multiple sclerosis; MEDLINE; Relapsing remitting; Fingolimod; Natalizumab","score_opus":0.10129630030901161,"score_gpt":0.30766157208512906,"score_spread":0.20636527177611746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416589642","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074935956,0.053659756,0.014354469,0.81850636,0.01845971,0.012241192,0.0063568,0.0011454463,0.067782655],"genre_scores_gemma":[0.043505106,0.053289592,0.25598535,0.56561065,0.012076409,0.03784756,0.005977734,0.0006498894,0.02505764],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.89776736,0.06003518,0.025191018,0.0023960148,0.011090334,0.003520137],"domain_scores_gemma":[0.61903673,0.1871423,0.03604834,0.008358712,0.12149406,0.027919855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06732374,0.0015590094,0.0034248305,0.005086008,0.0034366273,0.007189297,0.0093329325,0.021160264,0.022663364],"category_scores_gemma":[0.24114989,0.0017036273,0.008284704,0.004525256,0.0031961694,0.006855277,0.00449556,0.01555805,0.006290483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017829161,0.0016948187,0.009428452,0.013734707,0.0009741055,0.00070110825,0.0012084823,0.0014803217,0.0010918467,0.0054420982,0.7078458,0.25461525],"study_design_scores_gemma":[0.009994523,0.0017529972,0.046148475,0.1278657,0.0030034396,0.00093019014,0.004871167,0.0019546372,0.0015729897,0.01513641,0.7860931,0.0006761685],"about_ca_topic_score_codex":0.03528552,"about_ca_topic_score_gemma":0.055861846,"teacher_disagreement_score":0.06732374,"about_ca_system_score_codex":0.005835226,"about_ca_system_score_gemma":0.039611872,"threshold_uncertainty_score":0.3560462},"labels":[],"label_agreement":null},{"id":"W4416642664","doi":"10.1016/j.msard.2025.106886","title":"Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Novartis Pharma; Novartis Animal Health; Novartis","keywords":"Multiple sclerosis; Ofatumumab; Natalizumab; Relapsing remitting; MEDLINE; Fingolimod","score_opus":0.02454122563384652,"score_gpt":0.2534625429958049,"score_spread":0.22892131736195837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416642664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994785,0.0030917348,0.00018086315,0.00012468713,0.000025305651,0.00006175145,0.00094946165,0.00001789864,0.0007633702],"genre_scores_gemma":[0.9977615,0.00036331898,0.00014976086,0.00009115545,0.000042409825,0.00005001914,0.0012087153,0.0000030699548,0.00033008857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987136,0.00043204761,0.0001795075,0.00023822101,0.00030082554,0.00013569294],"domain_scores_gemma":[0.9912066,0.0017253355,0.0048581883,0.00041957753,0.00093777763,0.0008526349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004094909,0.00039385766,0.0011461605,0.00054358394,0.0005875768,0.0008102032,0.00044712657,0.000850291,0.0015350824],"category_scores_gemma":[0.00605063,0.0002039634,0.0019158634,0.0005256665,0.00032032546,0.0010220016,0.0005166193,0.0013174183,0.00034891712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09714994,0.0021587345,0.81768423,0.0009729775,0.0032078584,0.00047009796,0.0004634524,0.0019347625,0.0032432273,0.00007984401,0.001065758,0.071568996],"study_design_scores_gemma":[0.0033599508,0.037825584,0.95200205,0.00008385889,0.0016985727,0.0011038946,0.000091195405,0.0009893737,0.0010816455,0.00012922134,0.0015788879,0.000055785727],"about_ca_topic_score_codex":0.0009327053,"about_ca_topic_score_gemma":0.0013392721,"teacher_disagreement_score":0.004094909,"about_ca_system_score_codex":0.0006023455,"about_ca_system_score_gemma":0.00040866146,"threshold_uncertainty_score":0.021656215},"labels":[],"label_agreement":null},{"id":"W4416756928","doi":"10.1016/j.msard.2025.106874","title":"Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis use","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; St. Michael's Hospital","funders":"","keywords":"Cannabis; Cognition; Metacognition; Effects of cannabis; Multiple sclerosis; Association (psychology)","score_opus":0.031053396506899845,"score_gpt":0.24001979167926155,"score_spread":0.2089663951723617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416756928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991043,0.00025203233,0.000036461897,0.000028061173,0.0000034307916,0.0000040472823,0.000057047124,9.306716e-7,0.00051363517],"genre_scores_gemma":[0.9996964,0.0000839217,0.00004804235,0.000011997754,0.000003485248,0.0000028190718,0.000058114787,6.209699e-7,0.00009467515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993186,0.00023081906,0.00009381731,0.00009934896,0.00018275074,0.00007458036],"domain_scores_gemma":[0.996358,0.0010725722,0.0017033517,0.00020028943,0.000349261,0.00031642208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010664866,0.00035853317,0.00047406688,0.0012513133,0.0006180736,0.0016167616,0.00039825143,0.0006569915,0.0008418294],"category_scores_gemma":[0.007685414,0.0002007701,0.0005046514,0.0010719242,0.0006344743,0.00081921474,0.001010554,0.0008188468,0.00010088143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033771773,0.00014372672,0.99428517,0.00003681617,0.00016140255,0.000103147395,0.0015445161,0.00006622558,0.00021469714,0.000058366993,0.000033606295,0.0030145138],"study_design_scores_gemma":[0.000003430721,0.00008667954,0.9984847,0.000007233921,0.000024862966,0.0000897404,0.0010668382,0.000083919884,0.000038832055,0.00006475148,0.00004249439,0.0000066061752],"about_ca_topic_score_codex":0.014447852,"about_ca_topic_score_gemma":0.02145039,"teacher_disagreement_score":0.014447852,"about_ca_system_score_codex":0.00067119306,"about_ca_system_score_gemma":0.00043265332,"threshold_uncertainty_score":0.028727472},"labels":[],"label_agreement":null},{"id":"W4416795925","doi":"10.1016/j.msard.2025.106891","title":"Brain Age","year":2025,"lang":"en","type":"editorial","venue":"Multiple Sclerosis and Related Disorders","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"","score_opus":0.01295941292726513,"score_gpt":0.2317520241208852,"score_spread":0.21879261119362006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416795925","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039284954,0.017070414,0.000074786876,0.04796401,0.9319458,0.000016922437,0.000055268738,0.000053578773,0.002779955],"genre_scores_gemma":[0.0004338833,0.0076858792,0.00007327719,0.032213055,0.9503897,0.000026872622,0.000042679967,0.000022284454,0.009112405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969242,0.00060613174,0.00039222874,0.00037269582,0.0013993825,0.0003053431],"domain_scores_gemma":[0.9903757,0.0030342042,0.0009807355,0.00040307787,0.003273024,0.0019332328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047650514,0.0032827037,0.0043434952,0.0036047949,0.0028127814,0.0066164243,0.0031233751,0.018136613,0.023034217],"category_scores_gemma":[0.01736156,0.0013236433,0.0027744083,0.0015833443,0.0019544025,0.0038975356,0.002832981,0.020066818,0.018519849],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040714665,0.000007435262,0.00003361673,0.00019835544,0.00002256079,0.00010356647,0.000005268038,0.000011524144,0.000026651493,0.00012843152,0.9920324,0.007389505],"study_design_scores_gemma":[0.00012023898,0.000027903168,0.0004345746,0.0005116225,0.00011752984,0.00036182223,0.000031249645,0.0000822613,0.00006401252,0.0007785904,0.9974535,0.000016661059],"about_ca_topic_score_codex":0.0025084072,"about_ca_topic_score_gemma":0.008969236,"teacher_disagreement_score":0.023034217,"about_ca_system_score_codex":0.0031787644,"about_ca_system_score_gemma":0.0026856102,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4417400612","doi":"10.1016/j.msard.2025.106936","title":"The association between antimicrobial exposure and subsequent multiple sclerosis risk: A systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Multiple sclerosis; Antimicrobial; Risk factor; Prospective cohort study; Antibiotics; Association (psychology); MEDLINE","score_opus":0.05041545858430147,"score_gpt":0.2793820052663783,"score_spread":0.22896654668207683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417400612","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020802032,0.97724223,0.00072817237,0.0001590134,0.00022406998,0.00015232086,0.000457555,0.000027072925,0.0002075691],"genre_scores_gemma":[0.49770188,0.49564758,0.003220582,0.001170007,0.00042031714,0.0005235518,0.0007884849,0.000041077885,0.0004865081],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9935049,0.002652201,0.0020262075,0.00096465426,0.0005533271,0.0002987673],"domain_scores_gemma":[0.986115,0.009789704,0.002212237,0.0007562272,0.0008845223,0.00024235726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008721433,0.0024205497,0.012978417,0.0038825031,0.0007405444,0.0029852039,0.0019432877,0.003202949,0.0030578836],"category_scores_gemma":[0.021419434,0.002004509,0.032743253,0.0056812908,0.0008252799,0.0019279777,0.0018067678,0.0021919308,0.00032739821],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026548007,0.000040163242,0.012344427,0.111714385,0.8676065,0.000159763,0.000081613114,0.00030883917,0.00031917225,0.000059432932,0.00026878176,0.004442121],"study_design_scores_gemma":[0.00046647535,0.00013621173,0.006369475,0.0037298603,0.9884906,0.00007172427,0.00003931418,0.00010395512,0.00006465218,0.000076761506,0.00043233932,0.000018676452],"about_ca_topic_score_codex":0.0068632155,"about_ca_topic_score_gemma":0.015843257,"teacher_disagreement_score":0.012978417,"about_ca_system_score_codex":0.0013264247,"about_ca_system_score_gemma":0.0020361315,"threshold_uncertainty_score":0.046123862},"labels":[],"label_agreement":null},{"id":"W7116845950","doi":"10.1016/j.msard.2025.106945","title":"Large language models in academic writing","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Academic writing; Language model; Content (measure theory); On Language; English language","score_opus":0.08925431665325552,"score_gpt":0.365534011795231,"score_spread":0.2762796951419755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116845950","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49368194,0.0058661015,0.44719982,0.01642576,0.00065861386,0.00032483472,0.007940131,0.0075417976,0.020361047],"genre_scores_gemma":[0.9482186,0.00052256515,0.037953224,0.0003682699,0.00020023918,0.00019759026,0.0033344533,0.00024236384,0.008962829],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9978933,0.001430114,0.000112637936,0.0002771838,0.00015086212,0.0001359058],"domain_scores_gemma":[0.9577504,0.038407195,0.0009562948,0.0011064562,0.0011860594,0.00059358677],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043052076,0.00075096235,0.0011794621,0.0024489264,0.001172622,0.0030156877,0.0017400607,0.0020972646,0.009373368],"category_scores_gemma":[0.029414646,0.00072794844,0.0013016887,0.0021242888,0.00092564186,0.0046646977,0.001658336,0.0027389782,0.0019367913],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015988742,0.0011402678,0.018067952,0.00044629647,0.00044164332,0.0007735408,0.0013731556,0.64363706,0.00095717824,0.071437955,0.038619213,0.2215069],"study_design_scores_gemma":[0.0000410646,0.00002244809,0.00067729305,0.00001989775,0.000024333522,0.000027431204,0.000087530825,0.9517371,0.00013067489,0.046202146,0.0010183811,0.000011735106],"about_ca_topic_score_codex":0.018707966,"about_ca_topic_score_gemma":0.022098893,"teacher_disagreement_score":0.9956948,"about_ca_system_score_codex":0.0021101125,"about_ca_system_score_gemma":0.0016736002,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null}]}